PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dubois, L; Lecourtois, M; Alexandre, C; Hirst, E; Vincent, JP				Dubois, L; Lecourtois, M; Alexandre, C; Hirst, E; Vincent, JP			Regulated endocytic routing modulates wingless signaling in Drosophila embryos	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; EGF RECEPTOR; GRADIENT FORMATION; SPEMANN ORGANIZER; HORSERADISH-PEROXIDASE; MORPHOGEN GRADIENT; VENTRAL ECTODERM; TYROSINE KINASE; CELL-SURFACE; EPIDERMIS	Embryos have evolved various strategies to confine the action of secreted signals. Using an HRP-Wingless fusion protein to track the fate of endocytosed Wingless, we show that degradation by targeting to lysosomes is one such strategy. Wingless protein is specifically degraded at the posterior of each stripe of wingless transcription, even under conditions of over-expression. If lysosomal degradation is compromised genetically or chemically, excess Wingless accumulates and ectopic signaling ensues. In the wild-type, Wingless degradation is slower at the anterior than at the posterior. This follows in part from the segmental activation of signaling by the epidermal growth factor receptor, which accelerates Wingless degradation at the posterior, thus leading to asymmetrical Wingless signaling along the anterior-posterior axis.	Natl Inst Med Res, London NW7 1AA, England	MRC National Institute for Medical Research	Vincent, JP (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.		LECOURTOIS, Magalie/AAL-2531-2020	LECOURTOIS, Magalie/0000-0002-4257-1974				Alexandre C, 1999, DEVELOPMENT, V126, P5689; ARIAS AM, 1993, DEV DROSOPHILA MELAN, P517; ASTROMOFF A, 1995, P NATL ACAD SCI USA, V92, P8110, DOI 10.1073/pnas.92.18.8110; BAZINET C, 1993, GENETICS, V134, P1119; BEJSOVEC A, 1995, GENETICS, V139, P309; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bergeron JJM, 1995, BIOSCIENCE REP, V15, P411, DOI 10.1007/BF01204345; Bohm SK, 1997, BIOCHEM J, V322, P1; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Carpenter G, 2000, BIOESSAYS, V22, P697, DOI 10.1002/1521-1878(200008)22:8<697::AID-BIES3>3.0.CO;2-1; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; CLIFFORD R, 1992, DEVELOPMENT, V115, P853; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dickinson WJ, 1997, CELL MOTIL CYTOSKEL, V38, P9; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gabay L, 1996, DEVELOPMENT, V122, P3355; GONZALEZ F, 1991, MECH DEVELOP, V35, P43, DOI 10.1016/0925-4773(91)90040-D; Incardona JP, 2000, P NATL ACAD SCI USA, V97, P12044, DOI 10.1073/pnas.220251997; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lawrence PA, 1996, DEVELOPMENT, V122, P4095; LECOURTOIS M, 2001, IN PRESS DEV BIOL; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Moline MM, 1999, DEVELOPMENT, V126, P4375; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Sunio A, 1999, MOL BIOL CELL, V10, P847, DOI 10.1091/mbc.10.4.847; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VINCENT JP, 1992, CELL, V68, P923, DOI 10.1016/0092-8674(92)90035-B; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang J, 1998, DEVELOPMENT, V125, P3075; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	50	175	175	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					613	624		10.1016/S0092-8674(01)00375-0	http://dx.doi.org/10.1016/S0092-8674(01)00375-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389831	Bronze			2022-12-01	WOS:000169123200008
J	Guenin, LM				Guenin, LM			Essays on science and society - Morals and primordials	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Guenin, LM (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.								0	17	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1659	1660		10.1126/science.1062513	http://dx.doi.org/10.1126/science.1062513			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387460				2022-12-01	WOS:000169031800024
J	Throop, HB; Bally, J; Esposito, LW; McCaughrean, MJ				Throop, HB; Bally, J; Esposito, LW; McCaughrean, MJ			Evidence for dust grain growth in young circumstellar disks	SCIENCE			English	Article							LIGHT-SCATTERING; ORION NEBULA; INTERSTELLAR; PARTICLES; ACCRETION; OBJECTS; IMAGES; STARS	Hundreds of circumstellar disks in the Orion nebula are being rapidly destroyed by the intense ultraviolet radiation produced by nearby bright stars. These young, million-year-old disks may not survive long enough to form planetary systems. Nevertheless, the first stage of planet formation-the growth of dust grains into larger particles-may have begun in these systems. Observational evidence for these large particles in Orion's disks is presented. A model of grain evolution in externally irradiated protoplanetary disks is developed and predicts rapid particle size evolution and sharp outer disk boundaries. We discuss implications for the formation rates of planetary systems.	Univ Colorado, Lab Atmospher & Planetary Sci, Boulder, CO 80309 USA; Univ Colorado, CASA, Boulder, CO 80309 USA; Astrophys Inst Potsdam, D-14482 Potsdam, Germany	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Throop, HB (corresponding author), SW Res Inst, 1050 Walnut St,Suite 426, Boulder, CO 80302 USA.	throop@boulder.swri.edu	ESPOSITO, LARRY W/AAB-3673-2021	ESPOSITO, LARRY W/0000-0003-3381-2016; McCaughrean, Mark/0000-0002-1452-5268				Bally J, 2000, ASTRON J, V119, P2919, DOI 10.1086/301385; Bally J, 1998, ASTRON J, V116, P854, DOI 10.1086/300469; Beckwith S. V. W., 2000, Protostars and planets 4, P533; Boss AP, 1997, SCIENCE, V276, P1836, DOI 10.1126/science.276.5320.1836; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; CHURCHWELL E, 1987, ASTROPHYS J, V321, P516, DOI 10.1086/165648; DUBRULLE B, 1995, ICARUS, V114, P237, DOI 10.1006/icar.1995.1058; Farinella P., 2000, Protostars and planets 4, P1255; Henney WJ, 1999, ASTRON J, V118, P2350, DOI 10.1086/301087; Johnstone D, 1998, ASTROPHYS J, V499, P758, DOI 10.1086/305658; KIM SH, 1994, ASTROPHYS J, V422, P164, DOI 10.1086/173714; Lumme K, 1997, ICARUS, V126, P455, DOI 10.1006/icar.1996.5650; MANNINGS V, 1994, MON NOT R ASTRON SOC, V267, P361, DOI 10.1093/mnras/267.2.361; McCaughrean M. J., 2000, Protostars and planets 4, P485; McCaughrean MJ, 1996, ASTRON J, V111, P1977, DOI 10.1086/117934; McCaughrean MJ, 1998, ASTROPHYS J, V492, pL157, DOI 10.1086/311110; Mishchenko MI, 1996, J QUANT SPECTROSC RA, V55, P535, DOI 10.1016/0022-4073(96)00002-7; MIZUNO H, 1988, ASTRON ASTROPHYS, V195, P183; MUNDY LG, 1995, ASTROPHYS J, V452, pL137, DOI 10.1086/309734; ODELL CR, 1993, ASTROPHYS J, V410, P696, DOI 10.1086/172786; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; Schneider G, 1999, ASTROPHYS J, V513, pL127, DOI 10.1086/311921; Storzer H, 1998, ASTROPHYS J, V495, P853, DOI 10.1086/305315; Storzer H, 1999, ASTROPHYS J, V515, P669, DOI 10.1086/307055; THROOP HB, 2000, THESIS U COLORADO BO; Visser AE, 1998, MON NOT R ASTRON SOC, V301, P585, DOI 10.1046/j.1365-8711.1998.02092.x; Walter F. M., 2000, Protostars and planets 4, P273; Watson A.M., UNPUB; WESTLEY MS, 1995, NATURE, V373, P405, DOI 10.1038/373405a0; YORKE HW, 1993, ASTROPHYS J, V411, P274, DOI 10.1086/172827	30	68	69	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1686	1689		10.1126/science.1059093	http://dx.doi.org/10.1126/science.1059093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11326083	Green Submitted			2022-12-01	WOS:000169031800035
J	Hugot, JP; Chamaillard, M; Zouali, H; Lesage, S; Cezard, JP; Belaiche, J; Almer, S; Tysk, C; O'Morain, CA; Gassull, M; Binder, V; Finkel, Y; Cortot, A; Modigliani, R; Laurent-Puig, P; Gower-Rousseau, C; Macry, J; Colombel, JF; Sahbatou, M; Thomas, G				Hugot, JP; Chamaillard, M; Zouali, H; Lesage, S; Cezard, JP; Belaiche, J; Almer, S; Tysk, C; O'Morain, CA; Gassull, M; Binder, V; Finkel, Y; Cortot, A; Modigliani, R; Laurent-Puig, P; Gower-Rousseau, C; Macry, J; Colombel, JF; Sahbatou, M; Thomas, G			Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FACTOR-KAPPA-B; COMPLEX SEGREGATION ANALYSIS; LINKAGE DISEQUILIBRIUM; GENE; ACTIVATION; FAMILIES; C3H/HEJ; SEARCH; MICE	Crohn's disease(1,2) and ulcerative colitis, the two main types of chronic inflammatory bowel disease, are multifactorial conditions of unknown aetiology. A susceptibility locus for Crohn's disease has been mapped(3) to chromosome 16. Here we have used a positional-cloning strategy, based on linkage analysis followed by linkage disequilibrium mapping, to identify three independent associations for Crohn's disease: a frameshift variant and two missense variants of NOD2, encoding a member of the Apaf-1/Ced-4 superfamily of apoptosis regulators that is expressed in monocytes. These NOD2 variants alter the structure of either the leucine-rich repeat domain of the protein or the adjacent region. NOD2 activates nuclear factor NF-kB; this activating function is regulated by the carboxy-terminal leucine-rich repeat domain, which has an inhibitory role and also acts as an intracellular receptor for components of microbial pathogens. These observations suggest that the NOD2 gene product confers susceptibility to Crohn's disease by altering the recognition of these components and/or by over-activating NF-kB in monocytes, thus documenting a molecular model for the pathogenic mechanism of Crohn's disease that can now be further investigated.	Fdn Jean Dausset CEPH, F-75010 Paris, France; Hop Robert Debre, Dept Pediat Gastroenterol, PEWG IBD, F-75019 Paris, France; CHU Liege, GETAID, B-4000 Liege, Belgium; CHU Liege, Dept Gastroenterol, B-4000 Liege, Belgium; Linkoping Univ, IHM, Div Gastroenterol & Hepatol, SE-58185 Linkoping, Sweden; Orebro Med Ctr Hosp, Dept Gastroenterol, SE-70185 Orebro, Sweden; Adelaide & Meath Hosp, Dept Gastroenterol, Dublin 24, Ireland; Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Badalona 08916, Spain; Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; Astrid Lindgren Childrens Hosp, SE-16176 Stockholm, Sweden; Hop Calmette, Registre EPIMAD, F-59037 Lille, France; Hop St Louis, Dept Gastroenterol, F-75475 Paris, France; Hop Robert Debre, INSERM, U458, F-75019 Paris, France; Hop St Antoine, Dept Surg, F-75012 Paris, France	Foundation Jean Dausset-CEPH; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Liege; University of Liege; Linkoping University; Trinity College Dublin; Hospital Germans Trias i Pujol; University of Copenhagen; Herlev & Gentofte Hospital; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Thomas, G (corresponding author), Fdn Jean Dausset CEPH, 27 Rue J Dodu, F-75010 Paris, France.	thomas@cephb.fr	CORTOT, Antoine/I-5796-2015; Laurent-Puig, Pierre/K-3641-2019; Gower-Rousseau, Corinne/I-2553-2018; Hugot, Jean-Pierre/F-6594-2012; CORTOT, ANTOINE/I-7739-2016; laurent-puig, pierre/B-2226-2013; Chamaillard, Mathias/L-6542-2013	Laurent-Puig, Pierre/0000-0001-8475-5459; Gower-Rousseau, Corinne/0000-0002-3925-5364; CORTOT, ANTOINE/0000-0002-1067-8996; laurent-puig, pierre/0000-0001-8475-5459; Chamaillard, Mathias/0000-0002-0243-9717; Hugot, Jean-Pierre/0000-0002-8446-6056; Almer, Sven/0000-0001-9334-1821				AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Bertin J, 1999, J BIOL CHEM, V274, P12955, DOI 10.1074/jbc.274.19.12955; Calkins BM, 1995, INFLAMM BOWEL DIS, P31; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cho JH, 2000, HUM MOL GENET, V9, P1425, DOI 10.1093/hmg/9.9.1425; Colombel JF, 1996, GASTROENTEROLOGY, V111, P604, DOI 10.1053/gast.1996.v111.pm8780563; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hugot JP, 1999, INT J COLORECTAL DIS, V14, P2, DOI 10.1007/s003840050175; Hugot JP, 1999, GASTROENTEROLOGY, V116, pA740; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2000, J BIOL CHEM, V275, P27823; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; KUSTER W, 1989, AM J MED GENET, V32, P105, DOI 10.1002/ajmg.1320320122; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; McKay DM, 1999, CAN J GASTROENTEROL, V13, P509, DOI 10.1155/1999/680206; MONSEN U, 1990, ACTA CHIR SCAND    S, V559, P7; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Olavesen MG, 2000, IMMUNOGENETICS, V51, P1, DOI 10.1007/s002510050001; ORHOLM M, 1993, BRIT MED J, V306, P20, DOI 10.1136/bmj.306.6869.20; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUNDBERG JP, 1994, GASTROENTEROLOGY, V107, P1726, DOI 10.1016/0016-5085(94)90813-3; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; ZOUALI H, UNPUB EUR J HUM GENE	30	4211	4374	13	256	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					599	603		10.1038/35079107	http://dx.doi.org/10.1038/35079107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385576				2022-12-01	WOS:000168982500055
J	Elkayam, U; Tummala, PP; Rao, K; Akhter, MW; Karaalp, IS; Wani, OR; Hameed, A; Gviazda, I; Shotan, A				Elkayam, U; Tummala, PP; Rao, K; Akhter, MW; Karaalp, IS; Wani, OR; Hameed, A; Gviazda, I; Shotan, A			Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR FUNCTION	Background: Peripartum cardiomyopathy is a rare but sometimes fatal form of heart failure. Little is known about the outcomes of subsequent pregnancies in women who have had the disorder. Methods: Through a survey of members of the American College of Cardiology, we identified 44 women who had had peripartum cardiomyopathy and had a total of 60 subsequent pregnancies. We then reviewed the medical records of these women and interviewed the women or their physicians. Results: Among the first subsequent pregnancies in the 44 women, 28 occurred in women in whom left ventricular function had returned to normal (group 1) and 16 occurred in women with persistent left ventricular dysfunction (group 2). The pregnancies were associated with a reduction in the mean (+/-SD) left ventricular ejection fraction both in the total cohort (from 49+/-12 percent to 42+/-13 percent, P<0.001) and in each group separately (from 56+/-7 percent to 49+/-10 percent in group 1, P=0.002; and from 36+/-9 percent to 32+/-11 percent in group 2, P=0.08). During these pregnancies, symptoms of heart failure occurred in 21 percent of the women in group 1 and 44 percent of those in group 2. The mortality rate was 0 percent in group 1 and 19 percent in group 2 (P=0.06). In addition, the frequency of premature delivery was higher in group 2 (37 percent vs. 11 percent), as was that of therapeutic abortions (25 percent vs. 4 percent). Conclusions: Subsequent pregnancy in women with a history of peripartum cardiomyopathy is associated with a significant decrease in left ventricular function and can result in clinical deterioration and even death. (N Engl J Med 2001;344:1567-71.) Copyright (C) 2001 Massachusetts Medical Society.	Univ So Calif, Sch Med, LAC USC Med Ctr, Dept Med,Div Cardiol,Sect Heart Failure, Los Angeles, CA 90033 USA; Univ So Calif, Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA	Los Angeles County+USC Medical Center; University of Southern California; University of Southern California	Elkayam, U (corresponding author), Univ So Calif, Sch Med, LAC USC Med Ctr, Dept Med,Div Cardiol,Sect Heart Failure, 2025 Zonal Ave,Rm 7621, Los Angeles, CA 90033 USA.		Wan Ahmad, Wan Azman/B-9879-2012					Ceci O, 1998, EUR J OBSTET GYN R B, V76, P29, DOI 10.1016/S0301-2115(97)00148-6; DEMAKIS JG, 1971, CIRCULATION, V44, P1053, DOI 10.1161/01.CIR.44.6.1053; ELKAYAM U, 1992, HEART DIS TXB CARDIO, P1790; FEIGENBAUM H, 1994, ECHOCARDIOGR-J CARD, P658; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Geva T, 1997, AM HEART J, V133, P53, DOI 10.1016/S0002-8703(97)70247-3; Heider A L, 1999, Obstet Gynecol Surv, V54, P526, DOI 10.1097/00006254-199908000-00023; Lampert MB, 1997, AM J OBSTET GYNECOL, V176, P189, DOI 10.1016/S0002-9378(97)80034-8; Lang R., 1998, CARDIAC PROBLEMS PRE, V3e, P87; OSTRZEGA E, 1995, CIRCULATION S1, V92, P333; Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183; SUTTON MS, 1991, AM HEART J, V121, P1776; Witlin AG, 1997, AM J OBSTET GYNECOL, V176, P182, DOI 10.1016/S0002-9378(97)80033-6	13	272	284	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1567	1571		10.1056/NEJM200105243442101	http://dx.doi.org/10.1056/NEJM200105243442101			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372007				2022-12-01	WOS:000168829700001
J	Hopfner, KP; Karcher, A; Craig, L; Woo, TT; Carney, JP; Tainer, JA				Hopfner, KP; Karcher, A; Craig, L; Woo, TT; Carney, JP; Tainer, JA			Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase	CELL			English	Article							CRYSTAL-STRUCTURE; CHROMOSOMES SMC; PROTEIN COMPLEX; RAD50; RECOMBINATION; MAINTENANCE; YEAST; MISMATCH; MUTANTS; BINDING	To clarify functions of the Mre11/Rad50 (MR) complex in DNA double-strand break repair, we report Pyrococcus furiosus Mre11 crystal structures, revealing a protein phosphatase-like, dimanganese binding domain capped by a unique domain controlling active site access. These structures unify Mre11's multiple nuclease activities in a single endo/exonuclease mechanism and reveal eukaryotic macromolecular interaction sites by mapping human and yeast Mre11 mutations. Furthermore, the structure of the P. furiosus Rad50 ABC-ATPase with its adjacent coiled-coil defines a compact Mre11/Rad50-ATPase complex and suggests that Rad50-ATP-driven conformational switching directly controls the Mre11 exonuclease. Electron microscopy, small angle X-ray scattering, and ultracentrifugation data of human and P. furiosus MR reveal a dual functional complex consisting of a (Mre11)(2)/(Rad50)(2) heterotetrameric DNA processing head and a double coiled-coil linker.	Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Dept Radiat Oncol,Radiat Oncol Res Lab, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Mol & Cell Biol Grad Program, Baltimore, MD 21201 USA	Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Tainer, JA (corresponding author), Scripps Res Inst, Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	jat@scripps.edu	Hopfner, Karl-Peter/B-6864-2014; Tainer, John/GWQ-4878-2022	Hopfner, Karl-Peter/0000-0002-4528-8357; Tainer, John/0000-0003-1659-2429; Craig, Lisa/0000-0001-8515-9915				ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bierne H, 1997, EMBO J, V16, P3332, DOI 10.1093/emboj/16.11.3332; Bressan DA, 1998, GENETICS, V150, P591; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chamankhah M, 2000, GENETICS, V155, P569; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; Fishel R, 1997, CURR OPIN GENET DEV, V7, P105, DOI 10.1016/S0959-437X(97)80117-7; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; JOHZUKA K, 1995, GENETICS, V139, P1521; KADYK LC, 1992, GENETICS, V132, P387; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lam WC, 1999, BIOCHEMISTRY-US, V38, P2661, DOI 10.1021/bi9820762; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LEACH DRF, 1996, GENETIC RECOMBINATIO; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; OTWINOWSKI Z, 1993, DATA COLLECTION PROC; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Paull TT, 2000, P NATL ACAD SCI USA, V97, P6409, DOI 10.1073/pnas.110144297; Petrini J H, 1997, Semin Immunol, V9, P181, DOI 10.1006/smim.1997.0067; PHILLIPS JW, 1994, MOL CELL BIOL, V14, P5794, DOI 10.1128/MCB.14.9.5794; RAYMOND WE, 1993, NUCLEIC ACIDS RES, V21, P3851, DOI 10.1093/nar/21.16.3851; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Roth D., 1988, GENETIC RECOMBINATIO, P621; RUSNACK F, 2000, METAL IONS BIOL SYST; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; TURK D, 1992, THESIS TU MUNCHEN; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/s0079-6603(08)60611-x; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zdzienicka MZ, 1996, CANCER SURV, V28, P281	63	392	406	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					473	485		10.1016/S0092-8674(01)00335-X	http://dx.doi.org/10.1016/S0092-8674(01)00335-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371344	Bronze			2022-12-01	WOS:000168840700007
J	Narod, SA; Sun, P; Ghadirian, P; Lynch, H; Isaacs, C; Garber, J; Weber, B; Karlan, B; Fishman, D; Rosen, B; Tung, N; Neuhausen, SL				Narod, SA; Sun, P; Ghadirian, P; Lynch, H; Isaacs, C; Garber, J; Weber, B; Karlan, B; Fishman, D; Rosen, B; Tung, N; Neuhausen, SL		Hereditary Ovarian Canc Clinical	Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study	LANCET			English	Article							BREAST-CANCER; WOMEN; HYSTERECTOMY	Background In several case-control and prospective studies, tubal ligation has been associated with a decreased risk of invasive epithelial ovarian cancer. We aimed to assess the potential of tubal ligation in reducing the risk of ovarian cancer in women who carry predisposing mutations in the BRCA1 or BRCA2 genes. Methods We did a matched case-control study among women from Canada, the USA, and the UK who had undergone genetic testing and who carried a pathogenic mutation in BRCA1 or BRCA2. Cases were 232 women with a history of invasive ovarian cancer, and controls were 232 women without ovarian cancer, and who had both ovaries intact. Cases and controls were matched for year of birth, country of residence, and mutation (BRCA1 or BRCA2). The odds ratio for developing ovarian cancer was estimated for tubal ligation, adjusting for oral contraceptive use, parity, history of breast cancer, and ethnic group. Findings In an unadjusted analysis among BRCA1 carriers, significantly fewer cases than controls had ever had tubal ligation (30 of 173 [18%] vs 60 of 173 [35%], odds ratio 0.37 [95% CI 0.21-0.63]; p=0.0003). After adjustment for oral contraceptive use, parity, history of breast cancer and ethnic group, the odds ratio was 0.39 (p=0.002). Combination of tubal ligation and past use of an oral contraceptive was associated with an odds ratio of 0.28 (0.15-0.52). No protective effect of tubal ligation was seen among carriers of the BRCA2 mutation. Interpretation Tubal ligation is a feasible option to reduce the risk of ovarian cancer in women with BRCA1 mutations who have completed childbearing.	Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada; Hotel Dieu, CHUM, Epidemiol Res Unit, Montreal, PQ, Canada; Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA; Georgetown Univ, Med Ctr, Lombardi Canc Ctr, Washington, DC 20007 USA; Dana Farber Canc Ctr, Boston, MA USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Northwestern Univ, Chicago, IL 60611 USA; Univ Hlth Network, Dept Obstet & Gynecol, Toronto, ON, Canada; Beth Israel Deaconess Hosp, Boston, MA USA; Univ Utah, Dept Med Informat, Salt Lake City, UT 84112 USA	University of Toronto; Laval University; Universite de Montreal; Creighton University; Georgetown University; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine; Cedars Sinai Medical Center; Northwestern University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Beth Israel Deaconess Medical Center; Utah System of Higher Education; University of Utah	Narod, SA (corresponding author), Univ Toronto, Ctr Res Womens Hlth, 790 Bay St,Room 750, Toronto, ON M5G 1N8, Canada.		Narod, Steven A/AAA-6112-2022		NCI NIH HHS [CA61231, 1RO1 CA 63682, N01-CN-67000, CA74415, CA 57601, CA 63678] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074415, R01CA063682, R01CA057601, R01CA063678, R01CA061231] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brinton LA, 2000, BRIT J CANCER, V82, P1600; Brinton LA, 1997, AM J OBSTET GYNECOL, V176, P572, DOI 10.1016/S0002-9378(97)70550-7; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Cramer DW, 1998, FERTIL STERIL, V70, P371, DOI 10.1016/S0015-0282(98)00153-8; Cramer DW, 1998, LANCET, V351, P104, DOI 10.1016/S0140-6736(97)08064-1; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gertig DM, 2000, J NATL CANCER I, V92, P249, DOI 10.1093/jnci/92.3.249; Green A, 1997, AUST NZ J PUBL HEAL, V21, P337, DOI 10.1111/j.1467-842X.1997.tb01710.x; HANKINSON SE, 1993, JAMA-J AM MED ASSOC, V270, P2813, DOI 10.1001/jama.270.23.2813; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459; Peterson HB, 2000, NEW ENGL J MED, V343, P1681, DOI 10.1056/NEJM200012073432303; RILMAN T, 1998, CLIN ENDOCRINOL, V49, P695; RISCH HA, 1995, CANCER EPIDEM BIOMAR, V4, P447; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Rosenblatt KA, 1996, CANCER EPIDEM BIOMAR, V5, P933; Thompson D, 2001, AM J HUM GENET, V68, P410, DOI 10.1086/318181; WHITTEMORE AS, 1992, AM J EPIDEMIOL, V136, P1184, DOI 10.1093/oxfordjournals.aje.a116427	21	138	146	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1467	1470		10.1016/S0140-6736(00)04642-0	http://dx.doi.org/10.1016/S0140-6736(00)04642-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377596				2022-12-01	WOS:000168614300008
J	Miura, A; Yonebayashi, S; Watanabe, K; Toyama, T; Shimada, H; Kakutani, T				Miura, A; Yonebayashi, S; Watanabe, K; Toyama, T; Shimada, H; Kakutani, T			Mobilization of transposons by a mutation abolishing full DNA methylation in Arabidopsis	NATURE			English	Article							CYTOSINE METHYLATION; DDM1 MUTATION; GENE; THALIANA; ELEMENT; RETROTRANSPOSONS; MAINTENANCE; HOMOLOGY; MUTANTS; VIRUS	A major component of the large genomes of higher plants and vertebrates comprises transposable elements and their derivatives, which potentially reduce the stability of the genome(1). It has been proposed that methylation of cytosine residues may suppress transposition, but experimental evidence for this has been limited(2-5). Reduced methylation of repeat sequences results from mutations in the Arabidopsis gene DDM1 (decrease in DNA methylation)(6), which encodes a protein similar to the chromatin-remodelling factor SWI2/SNF2 (ref. 7). In the ddm1-induced hypomethylation background, silent repeat sequences are often reactivated transcriptionally, but no transposition of endogenous elements has been observed(8-11). A striking feature of the ddm1 mutation is that it induces developmental abnormalities by causing heritable changes in other loci(12,13). Here we report that one of the ddm1-induced abnormalities is caused by insertion of CAC1, an endogenous CACTA family transposon. This class of Arabidopsis elements transposes and increases in copy number at high frequencies specifically in the ddm1 hypomethylation background. Thus the DDM1 gene not only epigenetically ensures proper gene expression(13-16), but also stabilizes transposon behaviour, possibly through chromatin remodelling or DNA methylation.	Natl Inst Genet, Shizuoka 4118540, Japan; Natl Inst Agrobiol Resources, Tsukuba, Ibaraki 3058602, Japan; Japan Sci & Technol Corp, CREST, Tokyo 1010062, Japan; Tokyo Univ Sci, Chiba 2788510, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institute of Agrobiological Sciences - Japan; Japan Science & Technology Agency (JST); Tokyo University of Science	Kakutani, T (corresponding author), Natl Inst Genet, Shizuoka 4118540, Japan.	tkakutan@lab.nig.ac.jp	Hu, Ruogu/B-2203-2008					Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; CHANDLER VL, 1986, P NATL ACAD SCI USA, V83, P1767, DOI 10.1073/pnas.83.6.1767; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fedoroff N., 1996, Epigenetic mechanisms of gene regulation., P575; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Furner IJ, 1998, GENETICS, V149, P651; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kakutani T, 1999, GENETICS, V151, P831; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; LAWSON EJR, 1994, MOL GEN GENET, V245, P608, DOI 10.1007/BF00282223; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; Matzke MA, 1999, GENETICA, V107, P271, DOI 10.1023/A:1003921710672; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; MCCLINTOCK B, 1958, CARNEGIE I WASHINGTO, V57, P415; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NACKEN WKF, 1991, MOL GEN GENET, V228, P201, DOI 10.1007/BF00282466; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; Scortecci KC, 1997, PLANT CELL PHYSIOL, V38, P336, DOI 10.1093/oxfordjournals.pcp.a029171; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(00)00078-2; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	33	434	461	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					212	214		10.1038/35075612	http://dx.doi.org/10.1038/35075612			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346800				2022-12-01	WOS:000168563000055
J	Hoerauf, A; Mand, S; Adjei, O; Fleischer, B; Buttner, DW				Hoerauf, A; Mand, S; Adjei, O; Fleischer, B; Buttner, DW			Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment	LANCET			English	Article							CHEMOTHERAPY	Ivermectin is the drug used for mass chemotherapy of onchocerciasis within the WHO African Programme for Onchocerciasis Control. This approach aims to eliminate the disease as a public health problem but using one dose per year may not completely interrupt transmission since it does not suppress microfilaridermia thoroughly enough. Here we show that additional treatment with doxycycline, previously shown to sterilise adult female worms for a few months by depletion of symbiotic wolbachia endobacteria, significantly enhances ivermectin-induced suppression of microfilaridermia, rendering anti-wolbachia treatment a promising basis for blocking transmission by a drug-based approach.	Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; Univ Sci & Technol Kumasi, Kumasi, Ghana	Bernhard Nocht Institut fur Tropenmedizin; Kwame Nkrumah University Science & Technology	Hoerauf, A (corresponding author), Bernhard Nocht Inst Trop Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.							Abiose A, 2000, LANCET, V356, P1523, DOI 10.1016/S0140-6736(05)73271-2; Awadzi K, 1995, TROP MED PARASITOL, V46, P213; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; REMME J, 1986, B WORLD HEALTH ORGAN, V64, P667; Richards F, 2000, LANCET, V355, P1663, DOI 10.1016/S0140-6736(00)02235-2	5	183	189	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1415	1416		10.1016/S0140-6736(00)04581-5	http://dx.doi.org/10.1016/S0140-6736(00)04581-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356444				2022-12-01	WOS:000168478200018
J	Emmerson, MC; Solan, M; Emes, C; Paterson, DM; Raffaelli, D				Emmerson, MC; Solan, M; Emes, C; Paterson, DM; Raffaelli, D			Consistent patterns and the idiosyncratic effects of biodiversity in marine ecosystems	NATURE			English	Article							SPECIES-DIVERSITY; PLANT DIVERSITY; PRODUCTIVITY; STABILITY; COMPLEMENTARITY; COMPETITION; COMMUNITIES; BIOMASS	Revealing the consequences of species extinctions for ecosystem function has been a chief research goal(1-7) and has been accompanied by enthusiastic debate(8-11). Studies carried out predominantly in terrestrial grassland and soil ecosystems have demonstrated that as the number of species in assembled communities increases, so too do certain ecosystem processes, such as productivity, whereas others such as decomposition can remain unaffected(12). Diversity can influence aspects of ecosystem function, but questions remain as to how generic the patterns observed are, and whether they are the product of diversity, as such, or of the functional roles and traits that characterize species in ecological systems. Here we demonstrate variable diversity effects for species representative of marine coastal systems at both global and regional scales. We provide evidence for an increase in complementary resource use as diversity increases and show strong evidence for diversity effects in naturally assembled com-munities at a regional scale. The variability among individual species responses is consistent with a positive but idiosyncratic pattern of ecosystem function with increased diversity.	Univ Aberdeen, Culterty Field Stn, Newburgh AB41 6AA, Ellon, Scotland; Univ St Andrews, Gatty Marine Lab, St Andrews KY16 8LB, Fife, Scotland	University of Aberdeen; University of St Andrews	Emmerson, MC (corresponding author), Univ Aberdeen, Culterty Field Stn, Newburgh AB41 6AA, Ellon, Scotland.		Paterson, David M/D-5202-2013; Solan, Martin/E-9338-2012; Ross, Donald J/F-7607-2012; Emmerson, Mark Charles/ABD-6274-2021	Paterson, David M/0000-0003-1174-6476; Solan, Martin/0000-0001-9924-5574; Ross, Donald J/0000-0002-8659-3833; Emmerson, Mark/0000-0003-1034-8572				Emmerson MC, 2000, OIKOS, V91, P195; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; HECTOR A, 2000, SCIENCE, V289, P1257; Hooper DU, 1998, ECOLOGY, V79, P704, DOI 10.1890/0012-9658(1998)079[0704:TROCAC]2.0.CO;2; Hughes JB, 2000, AM NAT, V155, P618, DOI 10.1086/303348; Huston M A, 2000, Science, V289, P1255; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Lawton JH, 1998, FUNCT ECOL, V12, P848; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; McGrady-Steed J, 2000, ECOLOGY, V81, P361; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Nedwell DB, 1999, ADV ECOL RES, V29, P43; Nixon S.W., 1981, ESTUARIES NUTRIENTS, P111, DOI DOI 10.1007/978-1-4612-5826-1_6; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Wardle DA, 1997, OIKOS, V80, P470, DOI 10.2307/3546620; Wardle DA, 2000, OIKOS, V89, P11, DOI 10.1034/j.1600-0706.2000.890102.x; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; [No title captured]	25	232	240	0	75	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					73	77		10.1038/35075055	http://dx.doi.org/10.1038/35075055			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333979				2022-12-01	WOS:000168432800045
J	Poinar, H; Kuch, M; Paabo, S				Poinar, H; Kuch, M; Paabo, S			Molecular analyses of oral polio vaccine samples	SCIENCE			English	Article							MONKEYS	It has been suggested that the human immunodeficiency virus (HIV), and thus the acquired immunodeficiency syndrome (AIDS) it causes, was inadvertently introduced to humans by the use of an oral polio vaccine (OPV) during a vaccination campaign launched by the Wistar Institute, Philadelphia, PA, USA, in the Belgian Congo in 1958 and 1959. The "OPV/AIDS hypothesis" suggests that the OBV used in this campaign was produced in chimpanzee kidney epithelial cell cultures rather than in monkey kidney cell cultures, as stated by H. Koprowski and co-workers, who produced the OPV. If chimpanzee cells were indeed used, this would lend support to the OPV/AIDS hypothesis, since chimpanzees harbor a simian immunodeficiency virus, widely accepted to be the origin of HIV-1. We analyzed several early OPV pools and found no evidence for the presence of chimpanzee DNA; by contrast, monkey DNA is present.	Max Planck Inst Evolut Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Paabo, S (corresponding author), Max Planck Inst Evolut Anthropol, Inselstr 22, D-04103 Leipzig, Germany.							COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Curtis T, 1992, ROLLING STONE   0319, P54; Greenwood AD, 1999, MOL ECOL, V8, P133, DOI 10.1046/j.1365-294X.1999.00507.x; Hooper E., 1999, RIVER JOURNEY SOURCE; MORIN PA, IN PRESS MOL ECOL; PLOTKIN SA, 1961, VIROLOGY, V15, P473, DOI 10.1016/0042-6822(61)90114-3; Plotkin SA, 2001, CLIN INFECT DIS, V32, P1068, DOI 10.1086/319612; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111	8	19	19	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					743	744		10.1126/science.1058463	http://dx.doi.org/10.1126/science.1058463			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326104				2022-12-01	WOS:000168478300056
J	Alter, DA; Naylor, CD; Austin, PC; Tu, JV				Alter, DA; Naylor, CD; Austin, PC; Tu, JV			Long term MI outcomes at hospitals with or without on-site revascularization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC-CATHETERIZATION FACILITIES; UNITED-STATES; HEART-FAILURE; ELDERLY PATIENTS; ST ELEVATION; MANAGEMENT; IMPACT; CANADA; ANGIOGRAPHY	Context Many studies have found that patients with acute myocardial infarction (AMI) who are admitted to hospitals with on-site revascularization facilities have higher rates of invasive cardiac procedures and better outcomes than patients in hospitals without such facilities. Whether such differences are due to invasive procedure rates alone or to other patient, physician, and hospital characteristics is unknown. Objective To determine whether invasive procedural rate Variations alone account for outcome differences in patients with AMI admitted to hospitals with or without on-site revascularization facilities. Design Retrospective, observational cohort study using linked population-based administrative data from a universal health insurance system. Setting One hundred ninety acute care hospitals in Ontario, 9 of which offered invasive procedures. Patients A total of 25697 patients hospitalized with AMI between April 1, 1992, and December 31, 1993, of whom 2832 (11%) were in invasive hospitals. Main Outcome Measures Mortality, recurrent cardiac hospitalizations, and emergency department Visits in the 5 years following the index admission, adjusted for patient age, sex, socioeconomic status, illness severity, and index revascularization procedures; attending physician specialty; and hospital volume, teaching status, and geographical proximity to invasive-procedure centers and compared by hospital type. Results Patients admitted to invasive-procedure hospitals were much more likely to undergo revascularization (11.4% vs 3.2% at other hospitals; P<.001). However, many other clinical and process-related factors differed between the 2 groups. Although mortality rates were similar between the 2 institution types, the nonfatal composite 5-year event rate tie, recurrent cardiac hospitalization and emergency department visits) was lower for patients initially admitted to invasive-procedure hospitals (71.3% vs 80.4%; unadjusted odds ratio [OR], 0.65; 95% confidence interval [CI], 0.52-0.82; P<.001). This advantage persisted after adjustment for sociodemographic and clinical factors and procedure utilization (adjusted OR, 0.68; 95% CI, 0.53-0.89; P<.001). However, the nonfatal outcome advantages of invasive-procedure hospitals were explained by their teaching status (adjusted OR, 0.98; 95% CI, 0.73-1.30; P=.87). Conclusions In this sample of patients admitted with AMI, the differing outcomes of apparently similar patients treated in 2 different practice settings were explained by multiple competing factors. Researchers conducting observational studies should be cautious about attributing patient outcome differences to any single factor.	Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada; Univ Toronto, Clin Epidemiol & Hlth Care Res Program, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Deans Off, Toronto, ON, Canada	University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto	Alter, DA (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	david.alter@ices.on.ca		Tu, Jack/0000-0003-0111-722X; Austin, Peter/0000-0003-3337-233X				Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; [Anonymous], CARDIOVASCULAR HLTH; Batchelor WB, 1999, J AM COLL CARDIOL, V34, P12, DOI 10.1016/S0735-1097(99)00174-6; BLUSTEIN J, 1993, JAMA-J AM MED ASSOC, V270, P344, DOI 10.1001/jama.270.3.344; BRYK A, 1996, HIERARCHICAL LINEAR; COS JL, 1994, J GEN INTERN MED, V9, P674, DOI 10.1007/BF02599007; DiSalvo TG, 1996, J AM COLL CARDIOL, V27, P262, DOI 10.1016/0735-1097(95)00488-2; EVERY NR, 1993, NEW ENGL J MED, V329, P546, DOI 10.1056/NEJM199308193290807; Every NR, 1997, CIRCULATION, V96, P1770, DOI 10.1161/01.CIR.96.6.1770; FEIT F, 1990, J AM COLL CARDIOL, V16, P1529, DOI 10.1016/0735-1097(90)90295-Z; Fonarow GC, 1997, J AM COLL CARDIOL, V30, P725, DOI 10.1016/S0735-1097(97)00208-8; Fox J., 1991, QUANTITATIVE APPL SO; Fu YL, 2000, CIRCULATION, V102, P1375, DOI 10.1161/01.CIR.102.12.1375; Go AS, 2000, AM J MED, V108, P216, DOI 10.1016/S0002-9343(99)00430-1; GUADAGNOLI E, 1995, NEW ENGL J MED, V333, P573, DOI 10.1056/NEJM199508313330908; Krumholz HM, 1998, CIRCULATION, V98, P2010, DOI 10.1161/01.CIR.98.19.2010; MARK DB, 1994, NEW ENGL J MED, V331, P1130, DOI 10.1056/NEJM199410273311706; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; PILOTE L, 1995, NEW ENGL J MED, V333, P565, DOI 10.1056/NEJM199508313330907; Psaty BM, 1999, J AM GERIATR SOC, V47, P749, DOI 10.1111/j.1532-5415.1999.tb01603.x; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; ROULEAU JL, 1993, NEW ENGL J MED, V328, P779, DOI 10.1056/NEJM199303183281108; Scull GS, 2000, J AM COLL CARDIOL, V35, P895, DOI 10.1016/S0735-1097(99)00643-9; Snijders T., 1999, MULTILEVEL ANAL INTR; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Tu JV, 1997, NEW ENGL J MED, V336, P1500, DOI 10.1056/NEJM199705223362106; Tu JV., 1999, CARDIOVASCULAR HLTH, P83; Tu LV, 1999, CAN MED ASSOC J, V161, P1257; Yusuf S, 1998, LANCET, V352, P507, DOI 10.1016/S0140-6736(97)11162-X	29	77	79	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2101	2108		10.1001/jama.285.16.2101	http://dx.doi.org/10.1001/jama.285.16.2101			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422QW	11311099	Bronze			2022-12-01	WOS:000168131600030
J	Macfarlane, GJ				Macfarlane, GJ			Identification and prevention of work-related carpal-tunnel syndrome	LANCET			English	Editorial Material							HEALTH INTERVIEW SURVEY; RISK-FACTORS; PREVALENCE; POPULATION		Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Macfarlane, GJ (corresponding author), Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England.		Macfarlane, Gary J/I-9521-2014	Macfarlane, Gary J/0000-0003-2322-3314				Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Davis L, 2001, AM J IND MED, V39, P58, DOI 10.1002/1097-0274(200101)39:1<58::AID-AJIM6>3.3.CO;2-V; Ferry S, 2000, AM J EPIDEMIOL, V151, P566, DOI 10.1093/oxfordjournals.aje.a010244; Harrington JM, 1998, OCCUP ENVIRON MED, V55, P264, DOI 10.1136/oem.55.4.264; Leclerc A, 1998, OCCUP ENVIRON MED, V55, P180, DOI 10.1136/oem.55.3.180; Lincoln AE, 2000, AM J PREV MED, V18, P37, DOI 10.1016/S0749-3797(00)00140-9; *NAT I OCC SAF HLT, DEP HLTH HUM SERV PU; Rempel D, 1998, AM J PUBLIC HEALTH, V88, P1447, DOI 10.2105/AJPH.88.10.1447; Sluiter J, 2000, CRITERIA DOCUMENT EV; STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134; TANAKA S, 1995, AM J IND MED, V27, P451, DOI 10.1002/ajim.4700270402; TANAKA S, 1994, AM J PUBLIC HEALTH, V84, P1846, DOI 10.2105/AJPH.84.11.1846; Tanaka S, 1997, AM J IND MED, V32, P550, DOI 10.1002/(SICI)1097-0274(199711)32:5<550::AID-AJIM18>3.0.CO;2-1	13	9	9	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1146	1147		10.1016/S0140-6736(00)04382-8	http://dx.doi.org/10.1016/S0140-6736(00)04382-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323038				2022-12-01	WOS:000168192100005
J	Mindel, A; Estcourt, C				Mindel, A; Estcourt, C			Sexual health education for male sex workers	LANCET			English	Editorial Material							MALE PROSTITUTES; TRANSMITTED INFECTIONS; HIV; BEHAVIOR; PROGRAM; CLIENTS		Westmead Hosp, Sexually Transmitted Infect Res Ctr, Sydney, NSW 2145, Australia; St Bartholomews Hosp, Barts Sexual Hlth Ctr, London EC1A 7BE, England	University of Sydney; University of London; Queen Mary University London	Mindel, A (corresponding author), Westmead Hosp, Sexually Transmitted Infect Res Ctr, Sydney, NSW 2145, Australia.			Mindel, Adrian/0000-0002-8780-9982				Church S, 2001, BMJ-BRIT MED J, V322, P524, DOI 10.1136/bmj.322.7285.524; COUTINHO RA, 1988, GENITOURIN MED, V64, P207; DEGRAAF R, 1994, AIDS CARE, V6, P277, DOI 10.1080/09540129408258640; Estcourt CS, 2000, SEX TRANSM INFECT, V76, P294, DOI 10.1136/sti.76.4.294; Ford K, 2000, INT J STD AIDS, V11, P731, DOI 10.1258/0956462001915156; Leonard L, 2000, AIDS EDUC PREV, V12, P21; Limpakarnjanarat K, 1999, SEX TRANSM INFECT, V75, P30, DOI 10.1136/sti.75.1.30; MINDEL A, 2000, CONDOMS, P112; PLEAK RR, 1990, J SEX RES, V27, P557, DOI 10.1080/00224499009551580; Tichonova L, 1997, LANCET, V350, P210, DOI 10.1016/S0140-6736(97)01382-2; TOMLINSON DR, 1991, GENITOURIN MED, V67, P103; Walden VM, 1999, HEALTH EDUC RES, V14, P545, DOI 10.1093/her/14.4.545; ZEKENG L, 1993, AIDS, V7, P725, DOI 10.1097/00002030-199305000-00018; Ziersch A, 2000, SEX TRANSM INFECT, V76, P447, DOI 10.1136/sti.76.6.447	14	1	1	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1148	1148		10.1016/S0140-6736(00)04384-1	http://dx.doi.org/10.1016/S0140-6736(00)04384-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423RX	11323040				2022-12-01	WOS:000168192100007
J	Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G				Stene, LC; Magnus, P; Lie, RT; Sovik, O; Joner, G		Norwegian Childhood Diabet Study G	Birth weight and childhood onset type 1 diabetes: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BETA-CELL ACTIVITY; PERINATAL DETERMINANTS; RISK-FACTORS; MORTALITY; MELLITUS; INCREASE; CHILDREN; SIZE; LIFE; AGE	Objective To assess the associations between birth weight or gestational age and risk of type 1 diabetes. Design Population based cohort study by record linkage of the medical birth registry and the National Childhood Diabetes Registry, Setting Two national registries in Norway. Participants. All live births in Norway between 1974 and 1998 (1 382 602 individuals) contributed a maximum of 15 years of observation, a total of 8 184 994 person) ears of observation in the period 1989 to 1998. 1824 children with thpe 1 diabetes were diagnosed between 1989 and 1998, Main outcome measures Estimates of rate ratios with 95% confidence intervals for type 1 diabetes from Poisson regression analyses. Results The incidence rate of type 1 diabetes increased almost linearly with birth weight The rate ratio for children with birth weights 4500 g or more compared with those with birth weights less than 2000 g was 2.21 (95% confidence interval 1.24 to 3.94), test for bend P = 0.0001, There was no significant association between gestational age and type 1 diabetes. The results persisted after adjustment for maternal diabetes and other potential confounders. Conclusion There is a relatively weak but significant association between birth weight and increased risk of type 1 diabetes consistent over a wide range of birth weights.	Natl Publ Hlth Inst, Dept Populat Hlth Sci, Epidemiol Sect, N-0403 Oslo, Norway; Ulleval Hosp, Dept Paediat, Aker Univ Hosp, Ctr Diabet Res, N-0407 Oslo, Norway; Ulleval Hosp, Dept Paediat, Ulleval Univ Hosp, Ctr Diabet Res, N-0407 Oslo, Norway; Haukeland Hosp, Dept Paediat, N-5021 Bergen, Norway; Haukeland Hosp, Med Birth Registry Norway, N-5021 Bergen, Norway	University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Stene, LC (corresponding author), Natl Publ Hlth Inst, Dept Populat Hlth Sci, Epidemiol Sect, POB 4404 Nydalen, N-0403 Oslo, Norway.	lars.christian.stene@folkehelsa.no						ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Bache I, 1999, DIABETES CARE, V22, P1063, DOI 10.2337/diacare.22.7.1063; BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; Barker D.J.P., 1998, MOTHERS BABIES HLTH; BJORK E, 1993, AUTOIMMUNITY, V16, P181, DOI 10.3109/08916939308993326; BLOM L, 1989, DIABETOLOGIA, V32, P7; BOCK T, 1994, DIABETES CARE, V17, P1154, DOI 10.2337/diacare.17.10.1154; CHANDRA RK, 1977, BIOL NEONATE, V31, P15; Dahlquist G, 1996, BRIT MED J, V313, P1174, DOI 10.1136/bmj.313.7066.1174; Dahlquist GG, 1999, DIABETES CARE, V22, P1698, DOI 10.2337/diacare.22.10.1698; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; Green A, 2000, LANCET, V355, P873; HILL D E, 1980, Clinical Obstetrics and Gynecology, V23, P837; JOHANSSON C, 1994, DIABETOLOGIA, V37, P91; Joner G, 2000, DIABETOLOGIA, V43, pA27; Jones ME, 1998, INT J EPIDEMIOL, V27, P444, DOI 10.1093/ije/27.3.444; KYVIK KO, 1992, DIABETIC MED, V9, P233, DOI 10.1111/j.1464-5491.1992.tb01767.x; Kyvik KO, 2000, DIABETIC MED, V17, P158, DOI 10.1046/j.1464-5491.2000.00249.x; LAWLERHEAVNER J, 1994, DIABETES RES CLIN PR, V24, P153, DOI 10.1016/0168-8227(94)90110-4; LESLIE RDG, 1994, DIABETES, V43, P843, DOI 10.2337/diabetes.43.7.843; McKinney PA, 1999, DIABETES CARE, V22, P928, DOI 10.2337/diacare.22.6.928; METCALFE MA, 1992, ARCH DIS CHILD, V67, P731, DOI 10.1136/adc.67.6.731; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; PALMER JP, 1989, DIABETES, V38, P1211, DOI 10.2337/diabetes.38.10.1211; PEDERSEN CR, 1994, AUTOIMMUNITY, V17, P261, DOI 10.3109/08916939409010666; Podar T, 1999, DIABETES CARE, V22, P2092, DOI 10.2337/diacare.22.12.2092a; Preston DL, 1993, EPICURE USERS GUIDE; READ JS, 1994, AM J EPIDEMIOL, V140, P721, DOI 10.1093/oxfordjournals.aje.a117320; Samuelsen SO, 1998, AM J EPIDEMIOL, V148, P983, DOI 10.1093/oxfordjournals.aje.a009575; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Stene LC, 2000, DIABETOLOGIA, V43, P1093, DOI 10.1007/s001250051499	31	123	125	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2001	322	7291					889	892		10.1136/bmj.322.7291.889	http://dx.doi.org/10.1136/bmj.322.7291.889			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302899	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000168311300017
J	Cullinan, T				Cullinan, T			Drug-resistant tuberculosis: desperate measures?	LANCET			English	Editorial Material									Merlin, London SE1 1DB, England		Cullinan, T (corresponding author), Merlin, 5-13 Trin St, London SE1 1DB, England.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1124	1124		10.1016/S0140-6736(00)04268-9	http://dx.doi.org/10.1016/S0140-6736(00)04268-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297986				2022-12-01	WOS:000167996200036
J	Imbert-Bismut, F; Ratziu, V; Pieroni, L; Charlotte, F; Benhamou, Y; Poynard, T				Imbert-Bismut, F; Ratziu, V; Pieroni, L; Charlotte, F; Benhamou, Y; Poynard, T		MULTIVIRC grp	Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study	LANCET			English	Article							GROWTH-FACTOR; ALPHA-2-MACROGLOBULIN; INDEX; HEPATOCYTES; EXPRESSION; PROTEIN; MATRIX	Background Liver biopsy is thought mandatory for management of patients with hepatitis C virus (HCV) infection, especially for staging fibrosis. We aimed, in our prospective study, to assess the predictive value of a combination of basic serum biochemical markers for diagnosis of clinically significant fibrosis (Including early stages). Methods We assessed liver-biopsy patients with detectable HCV by PCR, for eligibility, and took a blood sample on the day of the procedure. The analysis was done in a first-year period for 205 patients and then tested in a second period on 134 patients. We devised a fibrosis index that included the most informative markers (combined with age and sex) for the first-year group. 11 serum markers were assessed as well as fibrosis stage: F0=no fibrosis and F1=portal fibrosis; and for clinically significant fibrosis, F2=few septa, F3=many septa, and F4=cirrhosis. Statistical analysis was by logistic regression, neural connection,and receiver-operating characteristic (ROC) curves. Findings First-year and second-year patient-group characteristics and biochemical markers did not differ. The overall frequency of clinically significant fibrosis was 40% (138 patients). The most informative markers were: alpha (2) macroglobulin, alpha (2) globulin (or haptoglobin), gamma globulin, apolipoprotein A(1). gamma glutamyltranspeptidase, and total bilirubin. The areas (SD) under the ROC curves for the first-year (0.836 [0.430]) and second-year groups (0.870 [0.340]) did not differ (p=0.44). With the best index, a high negative predictive value (100% certainty of absence of F2, F3, or F4) was obtained for scores ranging from zero to 0.10 (12% [41] of all patients), and high positive predictive value (>90% certainty of presence of F2, F3, or F4) for scores ranging from 0.60 to 1.00 (34% [115] of all patients). Interpretation A combination of basic serum markers could be used to substantially reduce the number of liver biopsies done in patients with chronic HCV infection.	Hosp Pitie Salpetriere, Dept Biochem, Paris, France; Hosp Pitie Salpetriere, Dept Hepatogastroenterol, Paris, France; Hosp Pitie Salpetriere, Dept Pathol, Paris, France; Univ Paris 05, Fac Sci Pharmaceut & Biol Paris, Lab Immunol Tumeurs, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Poynard, T (corresponding author), Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75651 Paris 13, France.	tpoynard@teaser.fr	Poynard, Thierry/C-1355-2010; Hug, Balthasar L./G-1568-2010	Poynard, Thierry/0000-0002-3726-7230; Poynard, Thierry/0000-0002-2050-640X; Charlotte, Frederic/0000-0003-2803-6606				BACQ Y, 1993, GASTROEN CLIN BIOL, V17, P364; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; EDWARDS AM, 1987, CARCINOGENESIS, V8, P1837, DOI 10.1093/carcin/8.12.1837; *EUR ASS STUD LIV, 2000, J HEPATOL, V30, P956; Guechot J, 1996, CLIN CHEM, V42, P558; Guillen MI, 1996, HEPATOLOGY, V23, P1345, DOI 10.1053/jhep.1996.v23.pm0008675150; HINTZE JL, 1997, NCSS 97 USERS GUIDE; Kawser CA, 1998, CLIN SCI, V95, P179, DOI 10.1042/CS19980020; Louagie HK, 1996, J HEPATOL, V25, P10, DOI 10.1016/S0168-8278(96)80321-7; Mc Rosenberg W, 2000, HEPATOLOGY, V32, p183A; Meisse D, 1998, FEBS LETT, V422, P346, DOI 10.1016/S0014-5793(98)00038-6; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; NAVEAU S, 1994, DIGEST DIS SCI, V39, P2426, DOI 10.1007/BF02087661; Oberti F, 1997, GASTROENTEROLOGY, V113, P1609, DOI 10.1053/gast.1997.v113.pm9352863; Paradis V, 1996, CELL MOL BIOL, V42, P525; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2000, CAN J GASTROENTEROL, V14, P543, DOI 10.1155/2000/107982; POYNARD T, 1991, GASTROENTEROLOGY, V100, P1397; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Poynard T, 2000, SEMIN LIVER DIS, V20, P47, DOI 10.1055/s-2000-9258; Poynard T, 1997, J VIRAL HEPATITIS, V4, P199, DOI 10.1046/j.1365-2893.1997.00141.x; Sabile A, 1999, HEPATOLOGY, V30, P1064, DOI 10.1002/hep.510300429; SAKUMOTO I, 1976, Gastroenterologia Japonica, V11, P224; *SPSS, 1995, NEUR CONN 1 0 US GUI; TEARE JP, 1993, LANCET, V342, P895, DOI 10.1016/0140-6736(93)91946-J; Tiggelman AMBC, 1997, J HEPATOL, V26, P1220, DOI 10.1016/S0168-8278(97)80455-2; Tiggelman AMBC, 1996, HEPATOLOGY, V23, P1260; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x	32	1114	1185	1	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2001	357	9262					1069	1075		10.1016/S0140-6736(00)04258-6	http://dx.doi.org/10.1016/S0140-6736(00)04258-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297957				2022-12-01	WOS:000167996200008
J	Sink, H; Rehm, EJ; Richstone, L; Bulls, YM; Goodman, CS				Sink, H; Rehm, EJ; Richstone, L; Bulls, YM; Goodman, CS			sidestep encodes a target-derived attractant essential for motor axon guidance in Drosophila	CELL			English	Article							GROWTH CONE GUIDANCE; GENETIC-ANALYSIS; FASCICLIN-II; ADHESION MOLECULE; SYNAPSE FORMATION; MUSCLE; EXPRESSION; DEFASCICULATION; PROJECTIONS; PROTEIN	At specific choice points in the periphery, subsets of motor axons defasciculate from other axons in the motor nerves and steer into their muscle target regions. Using a large-scale genetic screen in Drosophila, we identified the sidestep (side) gene as essential for motor axons to leave the motor nerves and enter their muscle targets, side encodes a target-derived transmembrane protein (Side) that is a novel member of the immunoglobulin superfamily (IgSF). Side is expressed on embryonic muscles during the period when motor axons leave their nerves and extend onto these muscles. In side mutant embryos, motor axons fail to extend onto muscles and instead continue to extend along their motor nerves. Ectopic expression of Side results in extensive and prolonged motor axon contact with inappropriate tissues expressing Side.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; NYU, Sch Med, Dept Pharmacol, Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; New York University	Goodman, CS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 519 LSA, Berkeley, CA 94720 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038530] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38530] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BATE M, 1990, DEVELOPMENT, V110, P791; BIEBER AJ, 1994, METHODS CELL BIOL; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; CROSSLEY AC, 1978, GENETICS BIOL DROS B, V2; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; ELKINS T, 1990, J CELL BIOL, V110, P1825, DOI 10.1083/jcb.110.5.1825; Fambrough D, 1996, CELL, V87, P1049, DOI 10.1016/S0092-8674(00)81799-7; GOODMAN CS, 1984, SCIENCE, V225, P1271, DOI 10.1126/science.6474176; HALPERN ME, 1991, J NEUROSCI, V11, P3227; HARRELSON AL, 1988, SCIENCE, V242, P700, DOI 10.1126/science.3187519; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; JOHANSEN J, 1989, J NEUROSCI, V9, P4318; KANIA A, 1993, NEURON, V11, P673, DOI 10.1016/0896-6273(93)90078-6; Kopczynski CC, 1998, P NATL ACAD SCI USA, V95, P9973, DOI 10.1073/pnas.95.17.9973; Landgraf M, 1999, CURR BIOL, V9, P589, DOI 10.1016/S0960-9822(99)80262-0; Landgraf M, 1997, J NEUROSCI, V17, P9642; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; NOSE A, 1994, NEURON, V13, P525, DOI 10.1016/0896-6273(94)90023-X; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Rose D, 1997, DEVELOPMENT, V124, P1561; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Schmid A, 1999, DEVELOPMENT, V126, P4653; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; SINK H, 1991, DEVELOPMENT, V112, P307; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; YOUNOSSIHARTENSTEIN A, 1993, DEV BIOL, V158, P430, DOI 10.1006/dbio.1993.1201; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; ZINN K, 1988, CELL, V53, P577, DOI 10.1016/0092-8674(88)90574-0; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	39	59	59	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					57	67		10.1016/S0092-8674(01)00296-3	http://dx.doi.org/10.1016/S0092-8674(01)00296-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301002	Bronze			2022-12-01	WOS:000168063300007
J	Winter, CG; Wang, B; Ballew, A; Royou, A; Karess, R; Axelrod, JD; Luo, LQ				Winter, CG; Wang, B; Ballew, A; Royou, A; Karess, R; Axelrod, JD; Luo, LQ			Drosophila Rho-associated kinase (Drok) links frizzled-mediated planar cell polarity signaling to the actin cytoskeleton	CELL			English	Article							UNCONVENTIONAL MYOSINS; TISSUE POLARITY; NONMUSCLE MYOSIN; GENETIC-ANALYSIS; PROTEIN-KINASE; STRESS FIBERS; LIGHT-CHAIN; ROLES; PHOSPHORYLATION; MORPHOGENESIS	Frizzled (Fz) and Dishevelled (Dsh) are components of an evolutionarily conserved signaling pathway that regulates planar cell polarity. How this signaling pathway directs asymmetric cytoskeletal reorganization and polarized cell morphology remains unknown. Here, we show that Drosophila Rho-associated kinase (Drok) works downstream of Fz/Dsh to mediate a branch of the planar polarity pathway involved in ommatidial rotation in the eye and in restricting actin bundle formation to a single site in developing wing cells. The primary output of Drok signaling is regulating the phosphorylation of nonmuscle myosin regulatory light chain, and hence the activity of myosin II. Drosophila myosin VIIA, the homolog of the human Usher Syndrome 1B gene, also functions in conjunction with this newly defined portion of the Fz/Dsh signaling pathway to regulate the actin cytoskeleton.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; CNRS, Ctr Genet Mol, UPR 2167, F-91198 Gif Sur Yvette, France	Stanford University; Stanford University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu		Wang, Bruce/0000-0003-3486-5494; Luo, Liqun/0000-0001-5467-9264; Karess, Roger/0000-0002-7299-0600	NINDS NIH HHS [R01 NS36623] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036623] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Ashburner M, 1999, GENETICS, V153, P179; Ashburner M., 1989, DROSOPHILA LAB HDB; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHEN T-L, 1991, Journal of Cell Biology, V115, p330A; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Friedman TB, 1999, AM J MED GENET, V89, P147, DOI 10.1002/(SICI)1096-8628(19990924)89:3<147::AID-AJMG5>3.0.CO;2-6; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; GUBB D, 1984, CHROMOSOMA, V91, P54, DOI 10.1007/BF00286485; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Krasnow RE, 1995, DEVELOPMENT, V121, P4095; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leung T, 1996, MOL CELL BIOL, V16, P5313; Luo LQ, 1997, P NATL ACAD SCI USA, V94, P12963, DOI 10.1073/pnas.94.24.12963; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Mizuno T, 1999, GENE, V238, P437, DOI 10.1016/S0378-1119(99)00351-0; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Self T, 1998, DEVELOPMENT, V125, P557; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; Spradling AC, 1999, GENETICS, V153, P135; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; THEISEN H, 1994, DEVELOPMENT, V120, P347; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cellbio.8.1.257; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Weber U, 2000, DEVELOPMENT, V127, P3619; WEIL D, 1995, NATURE, V374, P62; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29; ZHENG L, 1995, DEVELOPMENT, V121, P3045	53	430	431	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					81	91		10.1016/S0092-8674(01)00298-7	http://dx.doi.org/10.1016/S0092-8674(01)00298-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301004	Bronze			2022-12-01	WOS:000168063300009
J	Brickley, SG; Revilla, V; Cull-Candy, SG; Wisden, W; Farrant, M				Brickley, SG; Revilla, V; Cull-Candy, SG; Wisden, W; Farrant, M			Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance	NATURE			English	Article							CEREBELLAR GRANULE NEURONS; DOMAIN K+ CHANNEL; GABA(A) RECEPTORS; RAT CEREBELLUM; SYNAPTIC INTEGRATION; ALPHA-6 SUBUNIT; GOLGI CELLS; CURRENTS; INHIBITION; ACTIVATION	Many neurons receive a continuous, or 'tonic', synaptic input, which increases their membrane conductance, and so modifies the spatial and temporal integration of excitatory signals(1-3). In cerebellar granule cells, although the frequency of inhibitory synaptic currents is relatively low, the spillover of synaptically released GABA (gamma -aminobutyric acid)(4) gives rise to a persistent conductance mediated by the GABA(A) receptor(5-7) that also modifies the excitability of granule cells(8). Here we show that this tonic conductance is absent in granule cells that lack the alpha6 and delta -subunits of the GABAA receptor. The response of these granule cells to excitatory synaptic input remains unaltered, owing to an increase in a 'leak' conductance, which is present at rest, with properties characteristic of the two-pore-domain K(+) channel TASK-1 (refs 9- 12). Our results highlight the importance of tonic inhibition mediated by GABAA receptors, loss of which triggers a form of homeostatic plasticity leading to a change in the magnitude of a voltage-independent K(+) conductance that maintains normal neuronal behaviour.	UCL, Dept Pharmacol, London WC1E 6BT, England; MRC Ctr, Mol Biol Lab, Cambridge CB2 2QH, England; UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London	Farrant, M (corresponding author), UCL, Dept Pharmacol, Mortimer St, London WC1E 6BT, England.	m.farrant@ucl.ac.uk	Wisden, William/A-4071-2011	Wisden, William/0000-0003-4743-0334; Cull-Candy, Stuart G/0000-0002-0831-8326; Farrant, Mark/0000-0002-9918-0376; Brickley, Stephen/0000-0002-0930-7346				BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; DEDSAI NS, 1999, NAT NEUROSCI, V2, P515; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; ECCLES JC, 1966, EXP BRAIN RES, V1, P82; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; Jones A, 1997, J NEUROSCI, V17, P1350; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; Korpi ER, 1999, EUR J NEUROSCI, V11, P233, DOI 10.1046/j.1460-9568.1999.00421.x; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Nusser Z, 1999, EUR J NEUROSCI, V11, P1685, DOI 10.1046/j.1460-9568.1999.00581.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Salin PA, 1996, J NEUROPHYSIOL, V75, P1573, DOI 10.1152/jn.1996.75.4.1573; Sassoe-Pognetto M, 2000, J COMP NEUROL, V420, P481, DOI 10.1002/(SICI)1096-9861(20000515)420:4<481::AID-CNE6>3.0.CO;2-5; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Tia S, 1996, J NEUROSCI, V16, P3630; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Watkins CS, 1996, J PHYSIOL-LONDON, V491, P401, DOI 10.1113/jphysiol.1996.sp021224	29	446	455	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					88	92		10.1038/35051086	http://dx.doi.org/10.1038/35051086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343119				2022-12-01	WOS:000166175600045
J	Papadopoulos, P; Ivison, R; Carilli, C; Lewis, G				Papadopoulos, P; Ivison, R; Carilli, C; Lewis, G			A massive reservoir of low-excitation molecular gas at high redshift	NATURE			English	Article							ABSORPTION-LINE QUASAR; APM 08279+5255; DUST EMISSION; CO 4-3; GALAXIES	Molecular hydrogen (H-2) is an important component of galaxies because it fuels star formation and the accretion of gas onto active galactic nuclei (AGN), the two processes that can generate the large infrared luminosities of gas-rich galaxies(1,2). Observations of spectral-line emission from the tracer molecule carbon monoxide (CO) are used to probe the properties of this gas. But the lines that have been studied in the local Universe-mostly the lower rotational transitions of J = 1 --> 0 and J = 2 --> 1 - have hitherto been unobservable in high-redshift galaxies. Instead, higher transitions have been used, although the densities and temperatures required to excite these higher transitions may not be reached by much of the gas. As a result, past observations may have underestimated the total amount of molecular gas by a substantial amount. Here we report the discovery of large amounts of low-excitation molecular gas around the infrared-luminous quasar APM08279+5255 at redshift z = 3.91, using the two lowest excitation lines of (CO)-C-12 (J = 1 --> 0 and J = 2 --> 1). The maps confirm the presence of hot and dense gas near the nucleus(3), and reveal an extended reservoir of molecular gas with low excitation that is 10 to 100 times more massive than the gas traced by the higher-excitation observations. This raises the possibility that significant amounts of low-excitation molecular gas may exist in the environments of high-redshift (z> 3) galaxies.	UCL, Dept Phys & Astron, London WC1E 6BT, England; Leiden Observ, NL-2300 RA Leiden, Netherlands; Natl Radio Astron Observ, Socorro, NM 87801 USA; Anglo Australian Observ, Epping, NSW 1710, Australia	University of London; University College London; Leiden University; Leiden University - Excl LUMC; National Radio Astronomy Observatory (NRAO)	Ivison, R (corresponding author), UCL, Dept Phys & Astron, Gower St, London WC1E 6BT, England.	rji@star.ucl.ac.uk	Ivison, R. J./G-4450-2011; Lewis, Geraint/F-9069-2015; Papadopoulos, Panagiotis/B-2822-2012	Ivison, R. J./0000-0001-5118-1313; Lewis, Geraint/0000-0003-3081-9319; Papadopoulos, Panagiotis/0000-0001-9913-9771				AALTO S, 1995, ASTRON ASTROPHYS, V300, P369; Carilli CL, 1999, RADIO SCI, V34, P817, DOI 10.1029/1999RS900048; Carilli CL, 1999, ASTROPHYS J, V521, pL25, DOI 10.1086/312179; DICKMAN RL, 1986, ASTROPHYS J, V309, P326, DOI 10.1086/164604; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; Downes D, 1999, ASTROPHYS J, V513, pL1, DOI 10.1086/311896; Egami E, 2000, ASTROPHYS J, V535, P561, DOI 10.1086/308862; HUGHES DH, 1994, MON NOT R ASTRON SOC, V270, P641, DOI 10.1093/mnras/270.3.641; Ibata RA, 1999, ASTRON J, V118, P1922, DOI 10.1086/301111; Irwin MJ, 1998, ASTROPHYS J, V505, P529, DOI 10.1086/306213; Ivison RJ, 1996, MON NOT R ASTRON SOC, V278, P669; Ivison RJ, 2000, ASTROPHYS J, V542, P27, DOI 10.1086/309536; JACKSON JM, 1995, ASTROPHYS J, V438, P695, DOI 10.1086/175113; Lewis GF, 1998, ASTROPHYS J, V505, pL1, DOI 10.1086/311603; Paglione TAD, 1997, ASTROPHYS J, V484, P656, DOI 10.1086/304356; Papadopoulos PP, 2000, ASTROPHYS J, V528, P626, DOI 10.1086/308215; Papadopoulos PP, 2000, ASTROPHYS J, V537, P631, DOI 10.1086/309066; Plume R, 2000, ASTROPHYS J, V539, pL133, DOI 10.1086/312847; SANDERS DB, 1991, ASTROPHYS J, V370, P158, DOI 10.1086/169800; Smail I, 1997, ASTROPHYS J, V490, pL5, DOI 10.1086/311017; TELESCO CM, 1988, ANNU REV ASTRON ASTR, V26, P343; YOUNG JS, 1982, ASTROPHYS J, V258, P467, DOI 10.1086/160099; YOUNG JS, 1991, ANNU REV ASTRON ASTR, V29, P581, DOI 10.1146/annurev.aa.29.090191.003053	23	71	71	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					58	60		10.1038/35051029	http://dx.doi.org/10.1038/35051029			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343109	Green Submitted			2022-12-01	WOS:000166175600035
J	Levy, JB; Turner, AN; Rees, AJ; Pusey, CD				Levy, JB; Turner, AN; Rees, AJ; Pusey, CD			Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression	ANNALS OF INTERNAL MEDICINE			English	Article							RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; GOODPASTURES-SYNDROME; MEDIATED DISEASE; NEPHRITIS; DIAGNOSIS; PROGNOSIS; COLLAGEN; THERAPY; ANTIGEN; CHAIN	Background: Anti-glomerular basement membrane (GBM) antibody disease is an autoantibody-mediated disorder that usually presents as rapidly progressive glomerulonephritis, often with pulmonary hemorrhage (the Goodpasture syndrome). It is reported that patients with severe renal failure do not generally recover renal function. Objective: To examine the long-term outcome of severe anti-GBM antibody disease. Design: Retrospective review of patients treated for confirmed anti-GBM antibody disease over 25 years. Setting: A tertiary referral center in the United Kingdom. Patients: 71 treated patients with anti-GBM antibody disease. Intervention: All patients received plasma exchange, prednisolone, and cyclophosphamide, Measurements: Patient and renal survival, renal histology, and antibody levels. Results: Patients who presented with a creatinine concentration less than 500 mu mol/L (5.7 mg/dL) (n = 19) had 100% patient survival and 95% renal survival at 1 year and 84% patient survival and 74% renal survival at last follow-up. In patients who presented with a creatinine concentration of 500 mu mol/L or more (greater than or equal to5.7 mg/dL) (n = 13) but did not require immediate dialysis, patient and renal survival were 83% and 82% at 1 year and 62% and 69% at last follow-up. In patients who presented with dialysis-dependent renal failure (n = 39), patient and renal survival were 65% and 8% at 1 year and 36% and 5% at last follow-up. All patients who required immediate dialysis and had 100% crescents on renal biopsy remained dialysis dependent. Conclusions: Patients with the Goodpasture syndrome and severe renal failure should be considered for urgent immunosuppression therapy, including plasma exchange, to maximize the chance of renal recovery. Patients needing immediate dialysis are less likely to recover.	Hammersmith Hosp, Imperial Coll Sch Med, Renal Sect, London W12 0NN, England; Univ Edinburgh, Royal Infirm, Edinburgh EH3 9YW, Midlothian, Scotland; Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	Imperial College London; Royal Infirmary of Edinburgh; University of Edinburgh; University of Aberdeen	Levy, JB (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Renal Sect, Ducane Rd, London W12 0NN, England.			Turner, Neil/0000-0003-4547-873X				ANDREWS PA, 1995, CLIN NEPHROL, V44, P262; BOLTON WK, 1989, AM J NEPHROL, V9, P368; Bolton WK, 1996, KIDNEY INT, V50, P1753, DOI 10.1038/ki.1996.495; BOUGET J, 1990, ANN MED INTERNE, V141, P409; BRIGGS WA, 1979, MEDICINE, V58, P348, DOI 10.1097/00005792-197909000-00002; Daly C, 1996, RENAL FAILURE, V18, P105, DOI 10.3109/08860229609052780; EWAN PW, 1976, NEW ENGL J MED, V295, P1391, DOI 10.1056/NEJM197612162952502; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HERODY M, 1993, CLIN NEPHROL, V40, P249; JOHNSON JP, 1985, MEDICINE, V64, P219, DOI 10.1097/00005792-198507000-00003; Katbamna I, 1995, J Clin Lab Immunol, V47, P11; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; Levy JB, 1996, AM J KIDNEY DIS, V27, P573, DOI 10.1016/S0272-6386(96)90169-9; LEVY JB, 2000, COMPREHENSIVE CLIN N; LEVY JB, 1997, NEPHROLOGY, P599; LOCKWOOD CM, 1976, LANCET, V1, P711; LOCKWOOD CM, 1975, BRIT MED J, V2, P252, DOI 10.1136/bmj.2.5965.252; MERKEL F, 1994, NEPHROL DIAL TRANSPL, V9, P372; PETERS DK, 1982, TRANSPLANT P, V14, P513; REES AJ, 1977, BMJ-BRIT MED J, V2, P723, DOI 10.1136/bmj.2.6089.723; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAVAGE COS, 1986, BRIT MED J, V292, P301, DOI 10.1136/bmj.292.6516.301; SIMPSON IJ, 1982, AM J NEPHROL, V2, P301, DOI 10.1159/000166666; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; WALKER RG, 1985, Q J MED, V54, P75; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14	26	342	356	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1033	1042		10.7326/0003-4819-134-11-200106050-00009	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	436YL	11388816				2022-12-01	WOS:000168963400003
J	Rushton, DH; Dover, R; Sainsbury, AW; Norris, MJ; Gilkes, JJH; Ramsay, ID				Rushton, DH; Dover, R; Sainsbury, AW; Norris, MJ; Gilkes, JJH; Ramsay, ID			Why should women have lower reference limits for haemoglobin and ferritin concentrations than men?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IRON-DEFICIENCY; SERUM FERRITIN; UNITED-STATES; POPULATION; ABSORPTION; STORES		Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England; Imperial Canc Res Fund, London WC2A 3PX, England; Zool Soc London, Inst Zool, London NW1 4RY, England; Lister Hosp, London SW1W 8RH, England	University of Portsmouth; Cancer Research UK; Zoological Society of London; Lister Hospital	Rushton, DH (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England.	rushton@btinternet.com	Rushton, D Hugh/AAE-8491-2020					Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; BOTHWELL TH, 1979, IRON METABOLISM MAN, P7; Bruner AB, 1996, LANCET, V348, P992, DOI 10.1016/S0140-6736(96)02341-0; COOK JD, 1986, BLOOD, V68, P726; COOK JD, 1976, BLOOD, V48, P449; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; DILLMANN E, 1979, AM J PHYSIOL, V237, pR337; FRASSINELLIGUNDERSON EP, 1985, AM J CLIN NUTR, V41, P703, DOI 10.1093/ajcn/41.4.703; Hallberg L, 1997, AM J CLIN NUTR, V66, P347, DOI 10.1093/ajcn/66.2.347; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; HALLBERG L, 1982, HUM NUTR-CLIN NUTR, V36, P259; Hallberg L., 1993, HUMAN NUTR DIETETICS; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; HARD S, 1963, ACTA DERM-VENEREOL, V43, P562; Hoffbrand AV, 1993, ESSENTIAL HAEMATOLOG, P419; Jain NC, 1993, ESSENTIALS VET HEMAT; JI G, 1987, J REPROD MED, V32, P822; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lynx, 2000, LYNX HAEM BIOCH DAT; *MIN AGR, 1994, DIET NUTR SURV BRIT, P72; MYERS AM, 1968, LANCET, V2, P261; NELSON M, 1999, 1 HOUS COMM ED EMPL; RUSHTON DH, 1992, CLIN ENDOCRINOL, V36, P421; SCRIMSHAW NS, 1984, J NUTR SCI VITAMINOL, V30, P47, DOI 10.3177/jnsv.30.47; SIMON TL, 1981, JAMA-J AM MED ASSOC, V245, P2038, DOI 10.1001/jama.245.20.2038; VALBERG LS, 1976, CAN MED ASSOC J, V114, P417; VITERI FE, 1972, BRIT J HAEMATOL, V23, P189, DOI 10.1111/j.1365-2141.1972.tb03472.x; WALKER ML, 1995, AM J PRIMATOL, V35, P59, DOI 10.1002/ajp.1350350106	28	71	75	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 2	2001	322	7298					1355	1357		10.1136/bmj.322.7298.1355	http://dx.doi.org/10.1136/bmj.322.7298.1355			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387188	Green Published			2022-12-01	WOS:000169167900024
J	Coulter, DM; Bate, A; Meyboom, RHB; Lindquist, M; Edwards, IR				Coulter, DM; Bate, A; Meyboom, RHB; Lindquist, M; Edwards, IR			Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To examine die relation between antipsychotic drugs and myocarditis and cardiomyopathy. Design Data mining using bayesian statistics implemented in a neural network architecture. Setting International database on adverse drug reactions run by the World Health Organization programme for international drug monitoring. Main outcome measures Reports mentioning antipsychotic drugs, cardiomyopathy or myocarditis. Results A strong signal existed for an association between clozapine and cardiomyopathy and myocarditis. An association was also seen with other antipsychotics as a group. The association was based on sufficient cases with adequate documentation and apparent lack of confounding to constitute a signal. Associations between myocarditis or cardiomyopathy and lithium, chlorpromazine, fluphenazine, haloperidol, and risperidone need further investigation. Conclusions Some antipsychotic drugs seem to be linked to cardiomyopathy and myocarditis, The study shows the potential of bayesian neural networks in analysing data on drug safety.	Uppsala Monitoring Ctr, WHO, Collaborating Ctr Int Drug Monitoring, S-75320 Uppsala, Sweden; Univ Otago, Dept Prevent & Social Med, Intens Med Monitoring Programme, Dunedin, New Zealand; Univ Otago, Ctr Adverse React Monitoring, Dunedin, New Zealand	World Health Organization; University of Otago; University of Otago	Edwards, IR (corresponding author), Uppsala Monitoring Ctr, WHO, Collaborating Ctr Int Drug Monitoring, S-75320 Uppsala, Sweden.	ralph.edwards@who-umc.org	Bate, Andrew/J-3799-2019					Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Edwards IR, 1997, BRIT MED J, V315, P500, DOI 10.1136/bmj.315.7107.500; EDWARDS IR, 1990, LANCET, V336, P156, DOI 10.1016/0140-6736(90)91669-2; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Hand D., 1999, SIGKDD EXPLORATIONS, V1, P16, DOI [10.1145/846170.846171, DOI 10.1145/846170.846171]; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Jensen V E, 1994, Ugeskr Laeger, V156, P4151; Kilian JG, 1999, LANCET, V354, P1841, DOI 10.1016/S0140-6736(99)10385-4; Olsson S, 1998, DRUG SAFETY, V19, P1, DOI 10.2165/00002018-199819010-00001	9	147	159	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2001	322	7296					1207	1209		10.1136/bmj.322.7296.1207	http://dx.doi.org/10.1136/bmj.322.7296.1207			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	435UV	11358771	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000168900700023
J	Sandercock, P				Sandercock, P			Statins for stroke prevention?	LANCET			English	Editorial Material							SERUM-CHOLESTEROL; TRIALS; RISK		Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Sandercock, P (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.		sandercock, peter/GQI-3167-2022	sandercock, peter/0000-0001-8484-0135				Bandyopadhyay S, 2001, QJM-INT J MED, V94, P127, DOI 10.1093/qjmed/94.3.127; Byington RP, 2001, CIRCULATION, V103, P387; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Di Mascio R, 2000, CEREBROVASC DIS, V10, P85, DOI 10.1159/000016035; DOWNS JR, 1995, AM J CARDIOL, V75, P1130; HEBERT PR, 1995, ARCH INTERN MED, V155, P50, DOI 10.1001/archinte.155.1.50; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kelly J, 2000, BMJ-BRIT MED J, V320, P1278, DOI 10.1136/bmj.320.7244.1278; LAW MR, 1994, BRIT MED J, V308, P373, DOI 10.1136/bmj.308.6925.373; Meade T, 1999, EUR HEART J, V20, P725; Oliver MF, 2000, BMJ-BRIT MED J, V320, P459, DOI 10.1136/bmj.320.7233.459; PICKIN DM, 1999, P ROYAL COLL PHYSICI, V29, P31; Qizilbash N, 1995, LANCET, V346, P1647; Rodgers A, 1998, LANCET, V352, P1801; Smith GD, 1999, LANCET, V353, P1097, DOI 10.1016/S0140-6736(05)76452-7; WADE DT, 2000, NATL CLIN GUIDELINES	16	19	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1548	1549		10.1016/S0140-6736(00)04779-6	http://dx.doi.org/10.1016/S0140-6736(00)04779-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377639				2022-12-01	WOS:000168830100005
J	Anderson, AK; Phelps, EA				Anderson, AK; Phelps, EA			Lesions of the human amygdala impair enhanced perception of emotionally salient events	NATURE			English	Article							MEDIAL TEMPORAL-LOBE; ATTENTIONAL BLINK; MEMORY; RECOGNITION; SUPPRESSION; RESPONSES; FEAR	Commensurate with the importance of rapidly and efficiently evaluating motivationally significant stimuli, humans are probably endowed with distinct faculties(1,2) and maintain specialized neural structures to enhance their detection. Here we consider that a critical function of the human amygdala(3,4) is to enhance the perception of stimuli that have emotional significance. Under conditions of limited attention for normal perceptual awareness-that is, the attentional blink(5,6)-we show that healthy observers demonstrate robust benefits for the perception of verbal stimuli of aversive content compared with stimuli of neutral content. In contrast, a patient with bilateral amygdala damage has no enhanced perception for such aversive stimulus events. Examination of patients with either left or right amygdala resections shows that the enhanced perception of aversive words depends specifically on the left amygdala. All patients comprehend normally the affective meaning of the stimulus events, despite the lack of evidence for enhanced perceptual encoding of these events in patients with left amygdala lesions. Our results reveal a neural substrate for affective influences on perception, indicating that similar neural mechanisms may underlie the affective modulation of both recollective(7-9) and perceptual experience.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA; NYU, Dept Psychol, New York, NY 10003 USA	Yale University; New York University	Anderson, AK (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	adam.k.anderson@stanford.edu						Adolphs R, 2000, J NEUROSCI, V20, P2683; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Adolphs R., 2000, AMYGDALA FUNCTIONAL, P587; AMARAL D G, 1992, P1; Amaral DG, 1992, AMYGDALA NEUROBIOLOG, P465; Anderson AK, 2000, PSYCHOL SCI, V11, P106, DOI 10.1111/1467-9280.00224; Anderson AK, 2000, NEUROPSYCHOLOGY, V14, P526, DOI 10.1037/0894-4105.14.4.526; ANDERSON AK, UNPUB J EXP PSYCHOL; BRUNER JS, 1947, J PERS, V16, P69, DOI 10.1111/j.1467-6494.1947.tb01076.x; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Canli T, 2000, J NEUROSCI, V20; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Derryberry D, 1994, HEARTS EYE EMOTIONAL, P166; FUNAYAMA ES, IN PRESS J COGN NEUR; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; KAPP BS, 1990, NEUROCOMPUTATION LEA, P53; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; LeDoux J.E., 1992, EMOTIONAL BRAIN; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Phelps EA, 1998, NEUROCASE, V4, P527, DOI 10.1080/13554799808410645; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; SPENCER DD, 1984, NEUROSURGERY, V15, P667, DOI 10.1227/00006123-198411000-00005; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Weinberger Norman M., 1995, P1071; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912	30	930	953	5	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					305	309		10.1038/35077083	http://dx.doi.org/10.1038/35077083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	432RT	11357132				2022-12-01	WOS:000168710000047
J	Frankland, PW; O'Brien, C; Ohno, M; Kirkwood, A; Silva, AJ				Frankland, PW; O'Brien, C; Ohno, M; Kirkwood, A; Silva, AJ			alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory	NATURE			English	Article							CALMODULIN KINASE-II; LONG-TERM-MEMORY; RETROGRADE-AMNESIA; HIPPOCAMPAL-FORMATION; MUTANT MICE; VISUAL-CORTEX; CONSOLIDATION; PROTEIN; LESIONS; NEOCORTEX	Cortical plasticity seems to be critical for the establishment of permanent memory traces(1-3). Little is known, however, about the molecular and cellular processes that support consolidation of memories in cortical networks(4,5). Here we show that mice heterozygous for a null mutation of a-calcium-calmodulin kinase II (alpha -CaMKII+/-) show normal learning and memory 1-3 days after training in two hippocampus-dependent tasks. However, their memory is severely impaired at longer retention delays (10-50 days). Consistent with this, we found that alpha -CaMKII+/- mice have impaired cortical, but not hippocampal, long-term potentiation. Our results represent a first step in unveiling the molecular and cellular mechanisms underlying the establishment of permanent memories, and they indicate that alpha -CaMKII may modulate the synaptic events required for the consolidation of memory traces in cortical networks.	Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Mid Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Silva, AJ (corresponding author), Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21218 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494				Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; CHO YH, 1993, J NEUROSCI, V13, P1759; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; Gordon JA, 1996, NEURON, V17, P491, DOI 10.1016/S0896-6273(00)80181-6; Graham KS, 1999, CURR OPIN NEUROBIOL, V9, P245, DOI 10.1016/S0959-4388(99)80035-X; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; Knowlton BJ, 1998, CURR OPIN NEUROBIOL, V8, P293, DOI 10.1016/S0959-4388(98)80154-2; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mumby DG, 1999, BEHAV BRAIN RES, V106, P97, DOI 10.1016/S0166-4328(99)00097-2; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Whishaw IQ, 1997, CURR OPIN NEUROBIOL, V7, P228, DOI 10.1016/S0959-4388(97)80011-6; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	30	319	332	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					309	313		10.1038/35077089	http://dx.doi.org/10.1038/35077089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357133				2022-12-01	WOS:000168710000048
J	Scott, RS; McMahon, EJ; Pop, SM; Reap, EA; Caricchio, R; Cohen, PL; Earp, HS; Matsushima, GK				Scott, RS; McMahon, EJ; Pop, SM; Reap, EA; Caricchio, R; Cohen, PL; Earp, HS; Matsushima, GK			Phagocytosis and clearance of apoptotic cells is mediated by MER	NATURE			English	Article							RECEPTOR TYROSINE KINASE; ARREST-SPECIFIC GENE-6; VITRONECTIN RECEPTOR; IN-VITRO; RCS RAT; RECOGNITION; AXL; PHOSPHATIDYLSERINE; ADHESION; MACROPHAGES	Apoptosis is fundamental to the development and maintenance of animal tissues and the immune system(1). Rapid clearance of apoptotic cells by macrophages is important to inhibit inflammation and autoimmune responses against intracellular antigens(2-4). Here we report a new function for Mer, a member of the Axl/Mer/ Tyro3 receptor tyrosine kinase family. mer(kd) mice with a cytoplasmic truncation of Mer had macrophages deficient in the clearance of apoptotic thymocytes. This was corrected in chimaeric mice reconstituted with bone marrow from wild-type animals. Primary macrophages isolated from mer(kd) mice showed that the phagocytic deficiency was restricted to apoptotic cells and was independent of Fc receptor-mediated phagocytosis or ingestion of other particles. The inability to clear apoptotic cells adequately may be linked to an increased number of nuclear autoantibodies in mer(kd) mice. Thus, the Mer receptor tyrosine kinase seems to be critical for the engulfment and efficient clearance of apoptotic cells. This has implications for inflammation and autoimmune diseases such as systemic lupus erythematosus.	Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Oral Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Comprehens Ctr Inflammatory Disorders, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; Alphavax Human Vaccines, Durham, NC 27701 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania	Matsushima, GK (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA.		Ariel, Pablo/AGJ-4118-2022					AGUILAR LK, 1994, J IMMUNOL, V152, P2645; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Casiano CA, 1996, INT ARCH ALLERGY IMM, V111, P308, DOI 10.1159/000237385; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; EISENBERG RA, 1982, J IMMUNOL, V129, P2146; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fridell YWC, 1998, J BIOL CHEM, V273, P7123, DOI 10.1074/jbc.273.12.7123; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; GRAHAM DK, 1995, ONCOGENE, V10, P2349; HSU SM, 1983, J HISTOCHEM CYTOCHEM, V31, P538, DOI 10.1177/31.4.6827084; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; LAI C, 1994, ONCOGENE, V9, P2567; Licht R, 1999, J IMMUNOL METHODS, V223, P237, DOI 10.1016/S0022-1759(98)00212-9; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; McCloskey P, 1997, J BIOL CHEM, V272, P23285, DOI 10.1074/jbc.272.37.23285; MERVORACH D, 1998, J EXP MED, V188, P387; MERYHEW NL, 1991, J LAB CLIN MED, V117, P181; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Platt N, 1996, P NATL ACAD SCI USA, V93, P12456, DOI 10.1073/pnas.93.22.12456; Reap EA, 1997, P NATL ACAD SCI USA, V94, P5750, DOI 10.1073/pnas.94.11.5750; Rosen A, 1999, CELL DEATH DIFFER, V6, P6, DOI 10.1038/sj.cdd.4400460; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; Stern M, 1996, AM J PATHOL, V149, P911; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359	30	872	904	1	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					207	211		10.1038/35075603	http://dx.doi.org/10.1038/35075603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346799				2022-12-01	WOS:000168563000054
J	Conway, JF; Wikoff, WR; Cheng, N; Duda, RL; Hendrix, RW; Johnson, JE; Steven, AC				Conway, JF; Wikoff, WR; Cheng, N; Duda, RL; Hendrix, RW; Johnson, JE; Steven, AC			Virus maturation involving large subunit rotations and local refolding	SCIENCE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; DOUBLE-STRANDED-RNA; STRUCTURAL TRANSITIONS; CAPSID PROTEIN; DENSITY MAPS; BACTERIOPHAGE-T4; BINDING; STATES; VISUALIZATION; RESOLUTION	Large-scale conformational changes transform viral precursors into infectious virions. The structure of bacteriophage HK97 capsid, Head-II, was recently solved by crystallography, revealing a catenated cross-linked topology. We have visualized its precursor, Prohead-II, by cryoelectron microscopy and modeled the conformational change by appropriately adapting Head-II. Rigid-body rotations (similar to 40 degrees) cause switching to an entirely different set of interactions; in addition, two motifs undergo refolding. These changes stabilize the capsid by increasing the surface area buried at interfaces and bringing the cross-link-forming residues, initially similar to 40 angstroms apart, close together. The inner surface of Prohead-II is negatively charged, suggesting that the transition is triggered electrostatically by DNA packaging.	NIAMSD, Struct Biol Res Lab, Bethesda, MD 20892 USA; Inst Biol Struct JP Ebel, F-38027 Grenoble, France; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Steven, AC (corresponding author), NIH, Bldg 6,Room B2-34,6 Ctr Dr MSC 2717, Bethesda, MD 20892 USA.		Conway, James F/A-2296-2010	Conway, James F/0000-0002-6581-4748; Duda, Robert/0000-0002-9517-2731	NIAID NIH HHS [R01 AI040101, AI40101] Funding Source: Medline; NIGMS NIH HHS [R01 GM47795, R01 GM047795] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR027002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047795] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; Canady MA, 2000, J MOL BIOL, V299, P573, DOI 10.1006/jmbi.2000.3723; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; FRICKS CE, 1990, J VIROL, V64, P1934, DOI 10.1128/JVI.64.5.1934-1945.1990; GALISTEO ML, 1993, BIOPHYS J, V65, P227, DOI 10.1016/S0006-3495(93)81073-7; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; Hendrix RW, 1998, ADV VIRUS RES, V50, P235, DOI 10.1016/S0065-3527(08)60810-6; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jontes JD, 1997, J CELL BIOL, V139, P683, DOI 10.1083/jcb.139.3.683; KING J, 1997, STRUCTURAL BIOL VIRU, P288; KISTLER J, 1978, J MOL BIOL, V126, P571, DOI 10.1016/0022-2836(78)90059-1; Lata R, 2000, CELL, V100, P253, DOI 10.1016/S0092-8674(00)81563-9; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ROSS PD, 1985, J MOL BIOL, V183, P353, DOI 10.1016/0022-2836(85)90006-3; ROSSMANN MG, 1985, VIRUS STRUCTURE ASSE, P29; Schumacher MA, 2000, J MOL BIOL, V298, P875, DOI 10.1006/jmbi.2000.3753; SIMON LD, 1972, P NATL ACAD SCI USA, V69, P907, DOI 10.1073/pnas.69.4.907; STEVEN AC, 1991, J STRUCT BIOL, V106, P221, DOI 10.1016/1047-8477(91)90072-5; STEVEN AC, 1990, BIOCHEMISTRY-US, V29, P5556, DOI 10.1021/bi00475a020; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; Tuma R, 1996, BIOCHEMISTRY-US, V35, P4619, DOI 10.1021/bi952793l; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang ZX, 2000, J MOL BIOL, V297, P615, DOI 10.1006/jmbi.2000.3601	33	167	172	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					744	748		10.1126/science.1058069	http://dx.doi.org/10.1126/science.1058069			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326105				2022-12-01	WOS:000168478300057
J	Schumacher, MA; Rivard, AF; Bachinger, HP; Adelman, JP				Schumacher, MA; Rivard, AF; Bachinger, HP; Adelman, JP			Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; PEPTIDE COMPLEX; CALMODULIN; RECOGNITION; SOFTWARE; PROGRAM; PORE; NMR	Small-conductance Ca2+-activated K+ channels (SK channels)(1,2) are independent of voltage and gated solely by intracellular Ca2+. These membrane channels are heteromeric complexes that comprise pore-forming a-subunits and the Ca2+-binding protein calmodulin (CaM). CaM binds to the SK channel through the CaM-binding domain (CaMBD), which is located in an intracellular region of the a-subunit immediately carboxy-terminal to the pore(3,4). Channel opening is triggered when Ca2+ binds the EF hands in the N-lobe of CaM4. Here we report the 1.60 Angstrom crystal structure of the SK channel CaMBD/Ca2+/CaM complex. The CaMBD forms an elongated dimer with a CaM molecule bound at each end; each CaM wraps around three alpha -helices, two from one CaMBD subunit and one from the other. As only the CaM N-lobe has bound Ca2+, the structure provides a view of both calcium-dependent and -independent CaM/protein interactions. Together with biochemical data, the structure suggests a possible gating mechanism for the SK channel.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Shriners Hosp Children, Res Unit, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Schumacher, MA (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.							BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ELHORST B, 1999, BIOCHEMISTRY-US, V38, P12320; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; FRAGIONI JV, 1993, ANAL BIOCHEM, V210, P179; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; IKURA M, 1992, CELL CALCIUM, V13, P391, DOI 10.1016/0143-4160(92)90052-T; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OSAVA M, 1999, NAT STRUCT BIOL, V6, P819; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	30	476	488	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1120	1124		10.1038/35074145	http://dx.doi.org/10.1038/35074145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323678				2022-12-01	WOS:000168285500054
J	Katz, SL; Syme, DA; Shadwick, RE				Katz, SL; Syme, DA; Shadwick, RE			Enhanced power in yellowfin tuna	NATURE			English	Article							RED MUSCLE; SCOMBRID FISHES; STEADY; LOCOMOTION; ACTIVATION; OUTPUT		Biol Lab Open Water Mech Engn, Oxnard, CA 93035 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92039 USA	University of Calgary; University of California System; University of California San Diego; Scripps Institution of Oceanography	Katz, SL (corresponding author), Biol Lab Open Water Mech Engn, 3241 Ocean Dr, Oxnard, CA 93035 USA.							ALTRINGHAM JD, 1990, J EXP BIOL, V148, P395; Fierstine H.L., 1968, MEM STH CALIF ACAD S, V6, P1, DOI DOI 10.5962/BHL.TITLE.146943; GRAHAM JB, 1983, CAN J ZOOL, V61, P2087, DOI 10.1139/z83-274; JOSEPHSON RK, 1985, J EXP BIOL, V114, P493; Katz SL, 1999, J EXP BIOL, V202, P529; Knower T, 1999, J EXP BIOL, V202, P2127; Korsmeyer KE, 1996, COMP BIOCHEM PHYS B, V113, P45, DOI 10.1016/0305-0491(95)02044-6; Magnuson J.J., 1979, FISH PHYSIOL, V7, P239, DOI DOI 10.1016/S1546-5098(08)60166-1; Shadwick RE, 1999, J EXP BIOL, V202, P2139; WESTNEAT MW, 1993, J MORPHOL, V217, P183, DOI 10.1002/jmor.1052170207	10	41	44	3	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					770	771		10.1038/35071170	http://dx.doi.org/10.1038/35071170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298434				2022-12-01	WOS:000168021900040
J	Wes, PD; Bargmann, CI				Wes, PD; Bargmann, CI			C-elegans odour discrimination requires asymmetric diversity in olfactory neurons	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; CHEMOTAXIS; RESPONSES; ENCODES	Caenorhabditis elegans senses at least five attractive odours with a single pair of olfactory neurons, AWC, but can distinguish among these odours in behavioural assays(1). The two AWC neurons are structurally and functionally similar, but the G-protein-coupled receptor STR-2 is randomly expressed in either the left or the right AWC neuron, never in both(2). Here we describe the isolation of a mutant, ky542, with specific defects in odour discrimination and odour chemotaxis. ky542 is an allele of nsy-1, a neuronal symmetry, or Nsy, mutant in which STR-2 is expressed in both AWC neurons(2). Other Nsy mutants exhibit discrimination and olfactory defects like those of nsy-1 mutants. Laser ablation of the AWC neuron that does not express STR-2 (AWC(OFF)) recapitulates the behavioural phenotype of Nsy mutants, whereas laser ablation of the STR-2-expressing AWC neuron (AWC(ON)) causes different chemotaxis defects. We propose that odour discrimination can be achieved by segregating the detection of different odours into distinct olfactory neurons or into unique combinations of olfactory neurons.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Wes, Paul/0000-0002-8903-3102; Bargmann, Cornelia/0000-0002-8484-0618				BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Chou JH, 2001, GENETICS, V157, P211; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TROEMEL ER, 1999, THESIS U CALIFORNIA; Weinshenker D, 1999, J NEUROSCI, V19, P9831	17	166	170	4	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					698	701		10.1038/35070581	http://dx.doi.org/10.1038/35070581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287957				2022-12-01	WOS:000167875400049
J	Giraud, A; Matic, I; Tenaillon, O; Clara, A; Radman, M; Fons, M; Taddei, F				Giraud, A; Matic, I; Tenaillon, O; Clara, A; Radman, M; Fons, M; Taddei, F			Costs and benefits of high mutation rates: Adaptive evolution of bacteria in the mouse gut	SCIENCE			English	Article							ESCHERICHIA-COLI; POPULATIONS; COMPETITION; GENETICS; MUTATORS; STRAINS; CANCER	We have shown that bacterial mutation rates change during the experimental colonization of the mouse gut. A high mutation rate was initially beneficial because it allowed faster adaptation, but this benefit disappeared once adaptation was achieved. Mutator bacteria accumulated mutations that. although neutral in the mouse gut, are often deleterious in secondary environments. Consistently, the competitiveness of mutator bacteria is reduced during transmission to and re-colonization of similar hosts. The short-term advantages and long-term disadvantages of mutator bacteria could account for their frequency in nature.	Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, E9916, F-75015 Paris, France; INRA, UEPSD FBI, F-78352 Jouy En Josas, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Taddei, F (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, E9916, 156 Rue Vaugirard, F-75015 Paris, France.	taddei@necker.fr	Giraud, Antoine/V-5368-2018; Tenaillon, Olivier/L-9857-2017; Radman, Miroslav/HDM-5955-2022	Giraud, Antoine/0000-0002-8559-5781; Radman, Miroslav/0000-0002-7034-4365; Tenaillon, Olivier/0000-0002-3796-1601; Fons, Michel/0000-0001-8263-3669; Radman, Miroslav/0000-0003-0216-3148				Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Funchain P, 2000, GENETICS, V154, P959; GROSS MD, 1981, MUTAT RES, V91, P107, DOI 10.1016/0165-7992(81)90081-6; HARTL DL, 1984, ANNU REV GENET, V18, P31, DOI 10.1146/annurev.ge.18.120184.000335; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Loeb LA, 1998, ADV CANCER RES, V72, P25, DOI 10.1016/S0065-230X(08)60699-5; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Picard B, 2001, INFECT IMMUN, V69, P9, DOI 10.1128/IAI.69.1.9-14.2001; RADMAN M, 1995, PHILOS T ROY SOC B, V347, P97, DOI 10.1098/rstb.1995.0015; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tenaillon O, 1999, GENETICS, V152, P485; TROBNER W, 1984, MOL GEN GENET, V198, P175, DOI 10.1007/BF00328719; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282	19	361	368	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2606	2608		10.1126/science.1056421	http://dx.doi.org/10.1126/science.1056421			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283373				2022-12-01	WOS:000167861000043
J	Kaplan, NM				Kaplan, NM			Cautions over the current epidemic of primary aldosteronism	LANCET			English	Editorial Material							PHEOCHROMOCYTOMA		Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kaplan, NM (corresponding author), Univ Texas, SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	norman.kaplan@utsouthwestern.edu						ANDERSEN GS, 1988, J HUM HYPERTENS, V2, P187; BUHLER FR, 1973, AM J CARDIOL, V32, P554, DOI 10.1016/S0002-9149(73)80047-5; CONN JW, 1965, J AMER MED ASSOC, V193, P200, DOI 10.1001/jama.1965.03090030022005; DUNN PJ, 1976, AUST NZ J MED, V6, P131, DOI 10.1111/j.1445-5994.1976.tb03306.x; FISHMAN LM, 1968, J AMER MED ASSOC, V205, P854; GALLAY BJ, IN PRESS AM J KIDNEY; Ganguly A, 1998, NEW ENGL J MED, V339, P1828, DOI 10.1056/NEJM199812173392507; Ghose RP, 1999, ANN INTERN MED, V131, P105, DOI 10.7326/0003-4819-131-2-199907200-00005; GORDON RD, 1994, LANCET, V344, P240, DOI 10.1016/S0140-6736(94)93003-1; HAMLET SM, 1985, CLIN EXP PHARMACOL P, V12, P249, DOI 10.1111/j.1440-1681.1985.tb02641.x; He F, 2000, J HYPERTENS, V18, pS53; HIRAMATSU K, 1981, ARCH INTERN MED, V141, P1589, DOI 10.1001/archinte.141.12.1589; KAPLAN NM, 1969, ARCH INTERN MED, V123, P152, DOI 10.1001/archinte.123.2.152; KAPLAN NM, 1998, PRIMARY HYPERTENSION, P60; LACK EE, 1990, CONT ISSUES SURGICAL, V14, P75; LIM PO, 1999, BR J CLIN PHARM, V131, P105; McAlister FA, 1998, CAN J SURG, V41, P299; MCKENNA TJ, 1990, J CLIN ENDOCR METAB, V78, P952; Montori V, 2000, J HYPERTENS, V18, pS84; Stewart PM, 1999, LANCET, V353, P1341, DOI 10.1016/S0140-6736(98)06102-9; Young WF, 1997, ENDOCRIN METAB CLIN, V26, P801, DOI 10.1016/S0889-8529(05)70283-8	21	78	81	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	2001	357	9260					953	954		10.1016/S0140-6736(00)04223-9	http://dx.doi.org/10.1016/S0140-6736(00)04223-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289366				2022-12-01	WOS:000167625300035
J	Hassan, AH; Neely, KE; Workman, JL				Hassan, AH; Neely, KE; Workman, JL			Histone acetyltransferase complexes stabilize SWI/SNF binding to promoter nucleosomes	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION FACTOR-BINDING; SWI-SNF; ACTIVATION DOMAIN; ORDERED RECRUITMENT; OCTAMER TRANSFER; IN-VITRO; YEAST; DNA; ACETYLATION	To investigate the function of SWI/SNF in site-specific chromatin remodeling at promoters, we have used a purified system to analyze its distribution, function, and retention following recruitment by a sequence-specific transcription activator. Activator recruitment of SWI/SNF bound the complex to promoter proximal nucleosomes and led to localized nucleosome disruption. However, retention of SWI/SNF on the promoter required either the continued binding of the transcription activator or acetylated histones. Histone acetylation by either the SAGA or NuA4 HAT complexes increased the retention of SWI/SNF on the promoter. These data illustrate a functional link between HAT complexes and the SWI/SNF chromatin remodeling complex and provide a mechanistic basis for the ordered recruitment of these complexes.	Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA; Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Workman, JL (corresponding author), Penn State Univ, Howard Hughes Med Inst, University Pk, PA 16802 USA.		Hassan, Ahmed/AAB-7241-2019	Al-Marzouqi, Ahmed/0000-0003-4586-5676				Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Armstrong JA, 1998, CURR OPIN GENET DEV, V8, P165, DOI 10.1016/S0959-437X(98)80137-8; BAICHWAL VR, 1990, CELL, V63, P815, DOI 10.1016/0092-8674(90)90147-7; Bazett-Jones DP, 1999, MOL CELL BIOL, V19, P1470; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Cote J, 1998, P NATL ACAD SCI USA, V95, P4947, DOI 10.1073/pnas.95.9.4947; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Imbalzano AN, 1996, J BIOL CHEM, V271, P20726, DOI 10.1074/jbc.271.34.20726; Imbalzano AN, 1998, CRIT REV EUKAR GENE, V8, P225, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.10; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; Logie C, 1997, EMBO J, V16, P6772, DOI 10.1093/emboj/16.22.6772; Logie C, 1999, BIOCHEMISTRY-US, V38, P2514, DOI 10.1021/bi982109d; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Muchardt C, 1999, J MOL BIOL, V293, P187, DOI 10.1006/jmbi.1999.2999; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Owen-Hughes T, 1999, METH MOL B, V119, P319; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Phelan ML, 2000, MOL CELL BIOL, V20, P6380, DOI 10.1128/MCB.20.17.6380-6389.2000; Quinn J, 1996, NATURE, V379, P844, DOI 10.1038/379844a0; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Steger DJ, 1998, P NATL ACAD SCI USA, V95, P12924, DOI 10.1073/pnas.95.22.12924; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; te J, 1995, METH MOL GENET, V6, P108, DOI [10.1016/S1067-2389(06)80009-9, DOI 10.1016/S1067-2389(06)80009-9]; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Utley RT, 1997, J BIOL CHEM, V272, P12642, DOI 10.1074/jbc.272.19.12642; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Wallberg AE, 2000, MOL CELL BIOL, V20, P2004, DOI 10.1128/MCB.20.6.2004-2013.2000; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; WINSTON F, 1992, TRENDS GENET, V8, P387, DOI 10.1016/0168-9525(92)90300-S; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369	56	286	289	4	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					817	827		10.1016/S0092-8674(01)00279-3	http://dx.doi.org/10.1016/S0092-8674(01)00279-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290320	Bronze			2022-12-01	WOS:000167869200005
J	Cardinal, RN; Pennicott, DR; Sugathapala, CL; Robbins, TW; Everitt, BJ				Cardinal, RN; Pennicott, DR; Sugathapala, CL; Robbins, TW; Everitt, BJ			Impulsive choice induced in rats by lesions of the nucleus accumbens core	SCIENCE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; REACTION-TIME-TASK; PREFRONTAL CORTEX; D-AMPHETAMINE; REWARD; BEHAVIOR; REINFORCEMENT; CINGULATE; DISSOCIATION	Impulsive choice is exemplified by choosing a small or poor reward that is available immediately, in preference to a Larger but delayed reward. Impulsive choice contributes to drug addiction, attention-deficit/hyperactivity disorder, mania, and personality disorders, but its neuroanatomical basis is unclear. Here, we show that selective Lesions of the nucleus accumbens core induce persistent impulsive choice in rats. In contrast, damage to two of its afferents, the anterior cingulate cortex and medial prefrontal cortex, had no effect on this capacity. Thus, dysfunction of the nucleus accumbens core may be a key element in the neuropathology of impulsivity.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Cardinal, RN (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.		Robbins, Trevor W/A-7551-2008; Cardinal, Rudolf/AAG-2597-2020	Cardinal, Rudolf/0000-0002-8751-5167; Everitt, Barry/0000-0003-4431-6536; Robbins, Trevor/0000-0003-0642-5977	Medical Research Council [G9537855] Funding Source: Medline; MRC [G9537855] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aberman JE, 1999, NEUROSCIENCE, V92, P545, DOI 10.1016/S0306-4522(99)00004-4; AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; ALEXANDER MC, 1985, J COMPUT ASSIST TOMO, V9, P357, DOI 10.1097/00004728-198503000-00024; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; [Anonymous], [No title captured]; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Bechara A, 1999, J NEUROSCI, V19, P5473; Bizot JC, 1999, PSYCHOPHARMACOLOGY, V146, P400, DOI 10.1007/PL00005485; Bowman EM, 1998, EXP BRAIN RES, V123, P439, DOI 10.1007/s002210050588; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; CHRISTAKOU A, UNPUB; COLE BJ, 1989, BEHAV BRAIN RES, V33, P165, DOI 10.1016/S0166-4328(89)80048-8; Dietrich A, 1998, BEHAV NEUROSCI, V112, P1043, DOI 10.1037/0735-7044.112.5.1043; Ernst M, 1998, J NEUROSCI, V18, P5901; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Ho MY, 1999, PSYCHOPHARMACOLOGY, V146, P362, DOI 10.1007/PL00005482; HOK JC, 1995, MODELS INFORMATION P, P249; Muir JL, 1996, CEREB CORTEX, V6, P470, DOI 10.1093/cercor/6.3.470; Parkinson JA, 2000, PROG BRAIN RES, V126, P263; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; RUSSELL V, 1995, BRAIN RES, V676, P343, DOI 10.1016/0006-8993(95)00135-D; Sadile AG, 2000, NEUROSCI BIOBEHAV R, V24, P161, DOI 10.1016/S0149-7634(99)00057-3; Sagvolden T, 1998, BEHAV BRAIN RES, V94, P1; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90	32	669	683	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2001	292	5526					2499	2501		10.1126/science.1060818	http://dx.doi.org/10.1126/science.1060818			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	448YU	11375482				2022-12-01	WOS:000169658200044
J	Calfee, JE				Calfee, JE			Pharmaceutical price controls and patient welfare	ANNALS OF INTERNAL MEDICINE			English	Article							INHALED INSULIN; SEVERE SEPSIS; DEPRESSION; REALITY	Price controls could have a substantial negative effect on pharmaceutical research and development. Extensive research is required before the development costs of a new drug or its benefits are known; most new drug development projects fail, sometimes after substantial financial and time costs. These conditions pose intractable practical problems for the operation of price controls, which cannot rest on objective, predictable standards such as the benefits or costs of individual drugs. In the absence of objective standards, pressure from health care providers and others would create powerful incentives for price regulators to decrease drug prices toward marginal costs of production and distribution, well below levels sufficient to reward innovative research. This downwardly biased price-setting mechanism would apply with particular force to the few successful projects that yield innovative drugs, whose prices would not be set by regulatory authorities until after research expenditures have been incurred and the new drugs are ready to enter the market. Manufacturers will expect price controls to reduce the potential payoffs from breakthrough drugs. This expectation would substantially reduce the incentives to pursue innovative research, as is evident in advanced economies in which price controls are now in force. Once established, price controls for pharmaceuticals, like those for medical services in the Medicare system, would also tend toward complexity and entrenchment of vested interests and could easily become permanent regardless of the harm they cause to patients.	Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA	American Enterprise Institute for Public Policy Research	Calfee, JE (corresponding author), Amer Enterprise Inst Publ Policy Res, 1150 17th St NW, Washington, DC 20036 USA.	calfeej@aei.org						Andress G, 2001, BRIT MED J, V322, P419, DOI 10.1136/bmj.322.7283.419; [Anonymous], 1997, PHARM PRICE REGULATI; Ball BG, 2000, JAMA-J AM MED ASSOC, V284, P2788, DOI 10.1001/jama.284.21.2788; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BERNDT ER, 2000, US DEP HLTH HUM SERV; BOOTH B, 1999, AM MED NEWS     1227; BURTON TM, 2000, WALL STREET J   0630; BUTLER L, 1999, AM MED NEWS     1227; Calfee JE, 2000, PHARMACOECONOMICS, V18, P47, DOI 10.2165/00019053-200018001-00007; CALFEE JE, 2000, PRICES MARKETS PHARM; CALFEE JE, 1997, FEAR PERSUASION NEEW; CALFEE JE, 2001, FRASER FORUM     FEB, P4; CLARKSON KW, 1996, COMPETITIVE STRATEGI, P238; DANZON PM, 1999, REV US CROSS NATL ST; DIMASI JA, 2001, US DEP HLTH HUM SERV; Dubois RW, 2000, HEALTH AFFAIR, V19, P231, DOI 10.1377/hlthaff.19.2.231; *FOOD DRUG ADM, 1999, FED REGISTER, V64, P43197; Gale EAM, 2001, LANCET, V357, P324, DOI 10.1016/S0140-6736(00)03631-X; GLENNERSTER R, 2000, WORLD BANK VACCINE C; Glick ID, 2001, ANN INTERN MED, V134, P47, DOI 10.7326/0003-4819-134-1-200101020-00013; GRABOWSKI HG, 1994, J HEALTH ECON, V13, P383, DOI 10.1016/0167-6296(94)90010-8; Grabowski HG, 2000, PHARMACOECONOMICS, V18, P21, DOI 10.2165/00019053-200018001-00005; GRABOWSKI HG, 1994, HLTH REFORM PHARM IN; GROOPMAN J, 2000, WALL STREE J    0502; *IMS HLTH, 2000, DRUG MON; Kettler H. E., 1998, COMPETITION INNOVATI; KING RT, 1999, WALL STREE J    0219; LANGRETH R, 2001, FORBES MAGAZINE 0222; LANGRETH R, 1999, WALL STREEJ J   0813; LEWERS DT, 2001, AM MED NEWS     0305; Matthay MA, 2001, NEW ENGL J MED, V344, P759, DOI 10.1056/NEJM200103083441009; Mintz M, 2001, WASHINGTON POST 1102, pB1; Monkman D, 2000, BMJ-BRIT MED J, V321, P1299, DOI 10.1136/bmj.321.7272.1299; MOORE SD, 1998, WALL STREET J   1207; Nathan DM, 2001, ANN INTERN MED, V134, P242, DOI 10.7326/0003-4819-134-3-200102060-00016; OLSON E, 1999, NY TIMES        1118; *PAT MED PRIC REV, 2000, ANN REP YEAR END DEC; Pickering TG, 2001, ANN INTERN MED, V134, P72, DOI 10.7326/0003-4819-134-1-200101020-00016; SAGER A, 1999, AFFORDABLE MED AM PR; SEIDEN C, 2001, POTENTIAL BLOCKBUSTE; Spilker B., 1994, MULTINATIONAL PHARM, V2nd; Thomas L. G., 1994, IND CORP CHANGE, V3, P451; Triplett JE, 1999, MEASURING PRICES MED; *US FOOD DRUG ADM, 2001, TEST TUB PAT NEW DRU, P67; WINSLOW R, 2000, WALL STREET J   1214; WINSLOW R, 2000, WALL STREET J   0420, P20; 1999, ECONOMIST       0814; 2000, WORLDS TOP 50 BEST S	48	11	11	2	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 5	2001	134	11					1060	1064		10.7326/0003-4819-134-11-200106050-00012	http://dx.doi.org/10.7326/0003-4819-134-11-200106050-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	436YL	11388819				2022-12-01	WOS:000168963400006
J	Both, C; Visser, ME				Both, C; Visser, ME			Adjustment to climate change is constrained by arrival date in a long-distance migrant bird	NATURE			English	Article							EGG-LAYING TRENDS; REPRODUCTION; TEMPERATURE; POPULATION; PHENOLOGY; EARLIER; BRITAIN; TITS	Spring temperatures in temperate regions have increased over the past 20 years(1), and many organisms have responded to this increase by advancing the date of their growth and reproduction(2-7). Here we show that adaptation to climate change in a long-distance migrant is constrained by the timing of its migratory journey. For long-distance migrants climate change may advance the phenology of their breeding areas, but the timing of some species' spring migration relies on endogenous rhythms that are not affected by climate change(8). Thus, the spring migration of these species will not advance even though they need to arrive earlier on their breeding grounds to breed at the appropriate time. We show that the migratory pied flycatcher Ficedula hypoleuca has advanced its laying date over the past 20 years. This temporal shift has been insufficient, however, as indicated by increased selection for earlier breeding over the same period. The shift is hampered by its spring arrival date, which has not advanced. Some of the numerous long-distance migrants will suffer from climate change, because either their migration strategy is unaffected by climate change, or the climate in breeding and wintering areas are changing at different speeds, preventing adequate adaptation.	Inst Ecol Res, NL-6666 ZG Heteren, Netherlands; Univ Groningen, Zool Lab, NL-9750 AA Haren, Netherlands	University of Groningen	Visser, ME (corresponding author), Inst Ecol Res, POB 40, NL-6666 ZG Heteren, Netherlands.		Visser, Marcel E/A-9151-2009; Both, Christiaan/E-6459-2011	Visser, Marcel E/0000-0002-1456-1939; Both, Christiaan/0000-0001-7099-9831				Alatalo R.V., 1992, PIED FLYCATCHER; ALATALO RV, 1986, NATURE, V323, P152, DOI 10.1038/323152a0; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Berthold P, 1998, NATURWISSENSCHAFTEN, V85, P350, DOI 10.1007/s001140050514; BERTHOLD P, 1990, 20 C INT ORN, P780; BILZECKER J, 1998, 982 VOG ARNH EO; Both C, 2000, J AVIAN BIOL, V31, P412, DOI 10.1034/j.1600-048X.2000.310317.x; Brown JL, 1999, P NATL ACAD SCI USA, V96, P5565, DOI 10.1073/pnas.96.10.5565; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Falconer D. S., 1996, INTRO QUANTATIVE GEN; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Huin N, 1998, BIRD STUDY, V45, P361, DOI 10.1080/00063659809461108; Huin N, 2000, BIRD STUDY, V47, P22, DOI 10.1080/00063650009461157; IPCC,, 1996, CLIMATE CHANGE 1995; MASON CF, 1995, BIRD STUDY, V42, P182, DOI 10.1080/00063659509477167; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; Myers J.P., 1992, P193; Przybylo R, 2000, J ANIM ECOL, V69, P395, DOI 10.1046/j.1365-2656.2000.00401.x; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; Stevenson IR, 2000, NATURE, V406, P366, DOI 10.1038/35019151; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	27	716	757	9	555	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					296	298		10.1038/35077063	http://dx.doi.org/10.1038/35077063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357129	Green Published			2022-12-01	WOS:000168710000044
J	Redelmeier, DA; Singh, SM				Redelmeier, DA; Singh, SM			Survival in academy award-winning actors and actresses	ANNALS OF INTERNAL MEDICINE			English	Article							LEAD TIME; MORTALITY; BIAS; INEQUALITIES	Background: Social status is an important predictor of poor health. Most studies of this issue have focused on the lower echelons of society. Objective: To determine whether the increase in status from winning an academy award is associated with long-term mortality among actors and actresses. Design: Retrospective cohort analysis. Setting: Academy of Motion picture Arts and Sciences. Participants: All actors and actresses ever nominated for an academy award in a leading or a supporting role were identified (n = 762). For each, another cast member of the same sex who was in the same film and was born in the same era was identified (n = 887). Measurements: Life expectancy and all-cause mortality rates. Results: All 1649 performers were analyzed; the median duration of follow-up time from birth was 66 years, and 772 deaths occurred (primarily from ischemic heart disease and malignant disease). Life expectancy was 3.9 years longer for Academy Award winners than for other, less recognized performers (79.7 vs. 75.8 years; P = 0.003). This difference was equal to a 28% relative reduction in death rates (95% CI, 10% to 42%). Adjustment for birth year, sex, and ethnicity yielded similar results, as did adjustments for birth country, possible name change, age at release of first film, and total films in career. Additional wins were associated with a 22% relative reduction in death rates (CI, 5% to 35%), whereas additional films and additional nominations were not associated with a significant reduction in death rates. Conclusion: The association of high status with increased longevity that prevails in the public also extends to celebrities, contributes to a large survival advantage, and is partially explained by factors related to success.	Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Clin Epidemiol & Hlth Care Res Program, Toronto, ON M4N 3M5, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Redelmeier, DA (corresponding author), Univ Toronto, Sunnybrook & Womens Coll, Hlth Sci Ctr, Clin Epidemiol & Hlth Care Res Program, Room G-151,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dar@ices.on.ca	Hegele, Robert/G-3301-2011; Staud, Roland/A-8442-2008					*BUR CENS, 1996, STAT ABSTR US 1996, P88; *BUR CENS, 1997, STAT ABSTR US 1997, P287; COX DR, 1984, ANAL SURVIVAL DATA, P112; Detsky AS, 1998, NEW ENGL J MED, V339, P402, DOI 10.1056/NEJM199808063390611; Evans R. G., 1994, WHY ARE SOME PEOPLE, P3; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; FULLER G, 1983, ILLUSTRATED WHOS WHO; GAIL MH, 1972, ANN INTERN MED, V76, P815, DOI 10.7326/0003-4819-76-5-815; Glesby MJ, 1996, ANN INTERN MED, V124, P999, DOI 10.7326/0003-4819-124-11-199606010-00008; KATZ E, 1979, FILM ENCY; KATZ MH, 1999, MULTIVARIABLE ANAL P, P173; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; MARMOT MG, 1984, LANCET, V1, P1003; MEDVEC VH, 1995, J PERS SOC PSYCHOL, V69, P603, DOI 10.1037/0022-3514.69.4.603; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; PELIKAN S, 1993, CANCER, V71, P1998, DOI 10.1002/1097-0142(19930315)71:6<1998::AID-CNCR2820710613>3.0.CO;2-P; SMITH GD, 1992, BRIT MED J, V305, P1554, DOI 10.1136/bmj.305.6868.1554; Syme SL, 1997, LANCET, V350, P231, DOI 10.1016/S0140-6736(05)62220-9; TAYLOR R, 1998, HDB PUBLIC HLTH METH, P57; TRUITT EM, 1979, WHO WAS WHO SCREEN; Tunnell RD, 1998, ANAESTHESIA, V53, P1045, DOI 10.1046/j.1365-2044.1998.00566.x; WALKER J, 1997, HALLIWELLS FILMGOERS	22	120	125	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					955	962		10.7326/0003-4819-134-10-200105150-00009	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352696				2022-12-01	WOS:000168682500003
J	Macintyre, K; Stewart, S; Chalmers, J; Pell, C; Finlayson, A; Boyd, J; Redpath, A; McMurray, J; Capewell, S				Macintyre, K; Stewart, S; Chalmers, J; Pell, C; Finlayson, A; Boyd, J; Redpath, A; McMurray, J; Capewell, S			Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis	BRITISH MEDICAL JOURNAL			English	Article							SURVIVAL		Univ Glasgow, Clin Res Initiat Heart Failure, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8QQ, Lanark, Scotland; Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland; Greater Glasgow Hlth Board, Glasgow G3 8RH, Lanark, Scotland; Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Glasgow; University of Glasgow; University of Liverpool	McMurray, J (corresponding author), Univ Glasgow, Clin Res Initiat Heart Failure, Glasgow G12 8QQ, Lanark, Scotland.		Macintyre, Kate/J-7174-2014; mcmurray, John/B-2467-2013; Stewart, Simon/M-3316-2016	Macintyre, Kate/0000-0003-2741-0467; mcmurray, John/0000-0002-6317-3975; Stewart, Simon/0000-0001-9032-8998; Pell, Jill/0000-0002-8898-7035; Boyd, James/0000-0002-8925-8811				BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Capewell S, 1996, HEART, V76, P70, DOI 10.1136/hrt.76.1.70; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; *NAT HEART FOR, 1999, SOC INEQ COR HEART D; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981	5	60	60	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2001	322	7295					1152	1153		10.1136/bmj.322.7295.1152	http://dx.doi.org/10.1136/bmj.322.7295.1152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348909	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-01	WOS:000168748900015
J	Marsh, AG; Mullineaux, LS; Young, CM; Manahan, DT				Marsh, AG; Mullineaux, LS; Young, CM; Manahan, DT			Larval dispersal potential of the tubeworm Riftia pachyptila at deep-sea hydrothermal vents	NATURE			English	Article							EAST PACIFIC RISE; FUCA RIDGE; ECOLOGICAL IMPLICATIONS; ENERGY-METABOLISM; LIPID-METABOLISM; PLUMES; EVENT; JUAN; CURRENTS; STORAGE	Hydrothermal vents are ephemeral because of frequent volcanic and tectonic activities associated with crust formation(1-3). Although the larvae of hydrothermal vent fauna can rapidly colonize new vent sites separated by tens to hundreds of kilometres(4,5), the mechanisms by which these larvae disperse and recruit are not understood. Here we integrate physiological, developmental and hydrodynamic data to estimate the dispersal potential of larvae of the giant tubeworm Riftia pachyptila. At in situ temperatures and pressures (2 degreesC and 250 atm), we estimate that the metabolic lifespan for a larva of R. pachyptila averages 38 days. In the measured flow regime at a fast-spreading ridge axis (9 degrees 50' N; East Pacific Rise), this lifespan results in potential along-ridge dispersal distances that rarely exceed 100 km. This limited dispersal results not from the physiological performance of the embryos and larvae, but instead from transport limitations imposed by periodic reversals in along-ridge flows and sustained episodes of across-ridge flow. The lifespan presented for these larvae can now be used to predict dispersal under current regimes at other hydrothermal vent sites.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Harbor Branch Oceanog Inst Inc, Div Marine Sci, Ft Pierce, FL 34946 USA	University of Southern California; Woods Hole Oceanographic Institution; Harbor Branch Oceanographic Institute Foundation	Manahan, DT (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.		Huffstickler, John/H-1745-2011	Mullineaux, Lauren/0000-0002-8932-2625				BAKER ET, 1994, EARTH PLANET SC LETT, V128, P1, DOI 10.1016/0012-821X(94)90022-1; Cannon GA, 1997, J GEOPHYS RES-OCEANS, V102, P24965, DOI 10.1029/97JC01910; CANNON GA, 1991, J GEOPHYS RES-OCEANS, V96, P12815, DOI 10.1029/91JC01023; CARY SC, 1989, MAR ECOL PROG SER, V52, P89, DOI 10.3354/meps052089; Chevaldonne P, 1997, LIMNOL OCEANOGR, V42, P67, DOI 10.4319/lo.1997.42.1.0067; CRANE K, 1988, MAR GEOPHYS RES, V9, P211, DOI 10.1007/BF00309974; Evanson M, 2000, MAR ECOL PROG SER, V192, P239, DOI 10.3354/meps192239; FOMARI DJ, 1995, PHYSICAL CHEM BIOL G, P1; Fornari DJ, 1998, EARTH PLANET SC LETT, V160, P419, DOI 10.1016/S0012-821X(98)00101-0; Hagen W, 1998, LIMNOL OCEANOGR, V43, P1894; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; Jannasch HW, 1996, APPL ENVIRON MICROB, V62, P1593, DOI 10.1128/AEM.62.5.1593-1596.1996; Kattner G, 1998, MAR ECOL PROG SER, V170, P203, DOI 10.3354/meps170203; KIM SL, 1994, J GEOPHYS RES-OCEANS, V99, P12655, DOI 10.1029/94JC00644; Lupton JE, 1998, SCIENCE, V280, P1052, DOI 10.1126/science.280.5366.1052; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Marsh AG, 1999, MAR ECOL PROG SER, V184, P1, DOI 10.3354/meps184001; Marsh AG, 1999, J EXP BIOL, V202, P2041; Miller CB, 1998, LIMNOL OCEANOGR, V43, P488, DOI 10.4319/lo.1998.43.3.0488; Mullineaux LS, 2000, OECOLOGIA, V123, P275, DOI 10.1007/s004420051014; MULLINEAUX LS, 1995, MAR BIOL, V122, P585, DOI 10.1007/BF00350680; SHILLING FM, 1994, BIOL BULL, V187, P398, DOI 10.2307/1542296; THOMSON RE, 1989, J GEOPHYS RES-OCEANS, V94, P4709, DOI 10.1029/JC094iC04p04709; THOMSON RE, 1990, J GEOPHYS RES, V95, P12961; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; Young CM, 1996, NATURE, V381, P514, DOI 10.1038/381514a0	26	173	182	2	92	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					77	80		10.1038/35075063	http://dx.doi.org/10.1038/35075063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333980				2022-12-01	WOS:000168432800046
J	Palmer, TD; Schwartz, PH; Taupin, P; Kaspar, B; Stein, SA; Gage, FH				Palmer, TD; Schwartz, PH; Taupin, P; Kaspar, B; Stein, SA; Gage, FH			Cell culture - Progenitor cells from human brain after death	NATURE			English	Article							NEURAL STEM-CELLS; IN-VITRO; TRANSPLANTATION; PROLIFERATION; NEURONS		Salk Inst, Genet Lab, La Jolla, CA 92122 USA; Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; Childrens Hosp Orange Cty, Brain & Tissue Bank Dev Disorders, Orange, CA 92868 USA	Salk Institute; Stanford University; Childrens Hospital of Orange County	Palmer, TD (corresponding author), Salk Inst, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92122 USA.		Palmer, Theo/GSI-6635-2022; Kaspar, Brian/E-3349-2011	Palmer, Theo/0000-0002-6266-1862				Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7	10	361	392	2	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					42	43		10.1038/35075141	http://dx.doi.org/10.1038/35075141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333968				2022-12-01	WOS:000168432800034
J	Toulokhonov, I; Artsimovitch, I; Landick, R				Toulokhonov, I; Artsimovitch, I; Landick, R			Allosteric control of RNA polymerase by a site that contacts nascent RNA hairpins	SCIENCE			English	Article							INTRINSIC TRANSCRIPTION TERMINATION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DNA HYBRID; ELONGATION; MECHANISM; INVITRO; BINDING; PAUSE; MODEL	DNA, RNA, and regulatory molecules control gene expression through interactions with RNA polymerase (RNAP). We show that a short or helix at the tip of the flaplike domain that covers the RNA exit channel of RNAP contacts a nascent RNA stem-loop structure (hairpin) that inhibits transcription, and that this flap-tip helix is required for activity of the regulatory protein NusA. Protein-RNA cross-linking, molecular modeling, and effects of alterations in RNAP and RNA all suggest that a tripartite interaction of RNAP, NusA, and the hairpin inhibits nucleotide addition in the active site, which is located 65 angstroms away. These findings favor an allosteric model for regulation of transcript elongation.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Landick, R (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.		Artsimovitch, Irina/L-3467-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038660, R29GM038660, R01GM038660] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38660] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Ennifar E, 2000, J MOL BIOL, V304, P35, DOI 10.1006/jmbi.2000.4204; FARNHAM PJ, 1980, CELL, V20, P739, DOI 10.1016/0092-8674(80)90320-7; Finn RD, 2000, EMBO J, V19, P6833, DOI 10.1093/emboj/19.24.6833; GRUBER T, UNPUB; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; LEE DN, 1992, J MOL BIOL, V228, P759, DOI 10.1016/0022-2836(92)90862-E; Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550; Mooney RA, 1999, CELL, V98, P687, DOI 10.1016/S0092-8674(00)81483-X; MUSTAEV A, 1991, J BIOL CHEM, V266, P23927; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; SAGITOV V, 1993, J BIOL CHEM, V268, P2195; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; SIGMUND CD, 1988, BIOCHEMISTRY-US, V27, P5622, DOI 10.1021/bi00415a034; Wang DG, 1997, P NATL ACAD SCI USA, V94, P8433, DOI 10.1073/pnas.94.16.8433; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	25	174	178	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					730	733		10.1126/science.1057738	http://dx.doi.org/10.1126/science.1057738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326100				2022-12-01	WOS:000168478300052
J	Bloch, G; Robinson, GE				Bloch, G; Robinson, GE			Chronobiology - Reversal of honeybee behavioural rhythms	NATURE			English	Article							DIVISION-OF-LABOR; BEE COLONIES; SLEEP; DROSOPHILA		Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; Univ Illinois, Program Neurosci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bloch, G (corresponding author), Univ Illinois, Dept Entomol, 505 S Goodwin Ave, Urbana, IL 61801 USA.		Bloch, Guy/I-5861-2019	Bloch, Guy/0000-0003-1624-4926				Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; KAISER W, 1983, NATURE, V301, P707, DOI 10.1038/301707a0; KAISER W, 1988, J COMP PHYSIOL A, V163, P565, DOI 10.1007/BF00603841; Moore D, 1998, BEHAV ECOL SOCIOBIOL, V43, P147, DOI 10.1007/s002650050476; Schulz DJ, 1999, J COMP PHYSIOL A, V184, P481, DOI 10.1007/s003590050348; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; STUSSI T, 1966, CR ACAD SCI D NAT, V262, P2066; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; Turek F, 1999, REGULATION SLEEP CIR; VONFIRSCH K, 1967, DANCE LANGUAGE ORIEN	12	90	94	1	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1048	1048		10.1038/35074183	http://dx.doi.org/10.1038/35074183			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323660	Bronze			2022-12-01	WOS:000168285500036
J	Mysterud, A; Stenseth, NC; Yoccoz, NG; Langvatn, R; Steinheim, G				Mysterud, A; Stenseth, NC; Yoccoz, NG; Langvatn, R; Steinheim, G			Nonlinear effects of large-scale climatic variability on wild and domestic herbivores	NATURE			English	Article							NORTH-ATLANTIC OSCILLATION; RED DEER; PLANT PHENOLOGY; POPULATION-DYNAMICS; BODY-MASS; CONSEQUENCES; DENSITY; SEX	Large-scale climatic fluctuations, such as the North Atlantic Oscillation (NAO)(1,2), have been shown to affect many ecological processes(3-6). Such effects have been typically assumed to be linear. Only one study has reported a nonlinear relation(7); however, that nonlinear relation was monotonic (that is, no reversal). Here we show that there is a strong nonlinear and non-monotonic (that is, reversed) effect of the NAO on body weight during the subsequent autumn for 23,838 individual wild red deer (Cervus elaphus) and 139,485 individual domestic sheep (Ovis aries) sampled over several decades on the west coast of Norway. These relationships are, at least in part, explained by comparable nonlinear and nonmonotonic relations between the NAO and local climatic variables (temperature, precipitation and snow depth). The similar patterns observed for red deer and sheep, the latter of which live indoors during winter and so experience a stable energy supply in winter, suggest that the (winter) climatic variability (for which the index is a proxy) must influence the summer foraging conditions directly or indirectly.	Univ Oslo, Dept Biol, Div Zool, N-0316 Oslo, Norway; Polar Environm Ctr, Norwegian Inst Nat Res, Dept Arctic Ecol, N-9296 Tromso, Norway; Univ Courses Svalbard UNIS, N-9170 Longyearbyen, Spitsbergen, Norway; Agr Univ Norway, Dept Anim Sci, N-1432 As, Norway	University of Oslo; Norwegian Institute Nature Research; University Centre Svalbard (UNIS); Norwegian University of Life Sciences	Stenseth, NC (corresponding author), Univ Oslo, Dept Biol, Div Zool, POB 1050 Blindern, N-0316 Oslo, Norway.	n.c.stenseth@bio.uio.no	Stenseth, Nils Chr./G-5212-2016; Yoccoz, Nigel Gille/A-1493-2008; Yoccoz, Nigel/C-8561-2014; Mysterud, Atle/AAQ-2864-2020	Stenseth, Nils Chr./0000-0002-1591-5399; Yoccoz, Nigel/0000-0003-2192-1039; Mysterud, Atle/0000-0001-8993-7382				ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; ALBON SD, 1987, J ANIM ECOL, V56, P69, DOI 10.2307/4800; Clutton-Brock T.H., 1982, RED DEER BEHAV ECOLO; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; Gaillard JM, 2000, P ROY SOC B-BIOL SCI, V267, P471, DOI 10.1098/rspb.2000.1024; Hastie TJ, 1990, GEN ADDITIVE MODELS; HOBBS NT, 1989, WILDLIFE MONOGR, P1; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Kettlewell PS, 1999, J CEREAL SCI, V29, P205, DOI 10.1006/jcrs.1999.0258; LAMB PJ, 1987, B AM METEOROL SOC, V68, P1218, DOI 10.1175/1520-0477(1987)068<1218:NAOCAA>2.0.CO;2; LANGVATN R, 1986, HOLARCTIC ECOL, V9, P285; Langvatn R, 1996, J ANIM ECOL, V65, P653, DOI 10.2307/5744; Loison A, 1999, ECOGRAPHY, V22, P20, DOI 10.1111/j.1600-0587.1999.tb00451.x; Mysterud A, 2000, J ANIM ECOL, V69, P959, DOI 10.1046/j.1365-2656.2000.00454.x; Mysterud A, 2000, OECOLOGIA, V124, P130, DOI 10.1007/s004420050032; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Post E, 1999, P NATL ACAD SCI USA, V96, P4467, DOI 10.1073/pnas.96.8.4467; Post E, 1997, P ROY SOC B-BIOL SCI, V264, P1317, DOI 10.1098/rspb.1997.0182; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN, V2nd; Venables W.M., 1994, MODERN APPL STAT S P; WHITE RG, 1983, OIKOS, V40, P377, DOI 10.2307/3544310; [No title captured]; [No title captured]; [No title captured]; [No title captured]	30	177	182	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1096	1099		10.1038/35074099	http://dx.doi.org/10.1038/35074099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323672				2022-12-01	WOS:000168285500048
J	Wang, L; Brock, A; Herberich, B; Schultz, PG				Wang, L; Brock, A; Herberich, B; Schultz, PG			Expanding the genetic code of Escherichia coli	SCIENCE			English	Article							TRANSFER-RNA-SYNTHETASE; SITE-SPECIFIC INCORPORATION; UNNATURAL AMINO-ACIDS; IN-VIVO; PROTEINS; EXPANSION; EVOLUTION; ORGANISM; PAIR	A unique transfer RNA (tRNA)/aminoacyl-tRNA synthetase pair has been generated that expands the number of genetically encoded amino acids in Escherichia coli, When introduced into E, coli, this pair leads to the in vivo incorporation of the synthetic amino acid O-methyl-L-tyrosine into protein in response to an amber nonsense codon, The fidelity of translation is greater than 99%, as determined by analysis of dihydrofolate reductase containing the unnatural amino acid. This approach should provide a general method for increasing the genetic repertoire of Living cells to include a variety of amino acids with novel structural, chemical, and physical properties not found in the common 20 amino acids.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute; Novartis	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Wang, Lei/E-7912-2011	Wang, Lei/0000-0002-5859-2526				BAIN JD, 1992, NATURE, V356, P537, DOI 10.1038/356537a0; BAIN JD, 1989, J AM CHEM SOC, V111, P8013, DOI 10.1021/ja00202a052; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; BRICK P, 1989, J MOL BIOL, V208, P83, DOI 10.1016/0022-2836(89)90090-9; Budisa N, 1999, FASEB J, V13, P41, DOI 10.1096/fasebj.13.1.41; GRAY GDP, 1993, FEBS LETT, V318, P167; Hamano-Takaku F, 2000, J BIOL CHEM, V275, P40324, DOI 10.1074/jbc.M003696200; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Kowal AK, 2001, P NATL ACAD SCI USA, V98, P2268, DOI 10.1073/pnas.031488298; Liu DR, 1999, P NATL ACAD SCI USA, V96, P4780, DOI 10.1073/pnas.96.9.4780; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; MENDEL D, 1995, ANNU REV BIOPH BIOM, V24, P435, DOI 10.1146/annurev.biophys.24.1.435; MICHAELS ML, 1990, P NATL ACAD SCI USA, V87, P3957, DOI 10.1073/pnas.87.10.3957; Moore B, 2000, J MOL BIOL, V298, P195, DOI 10.1006/jmbi.2000.3658; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Pastrnak M, 2000, HELV CHIM ACTA, V83, P2277, DOI 10.1002/1522-2675(20000906)83:9<2277::AID-HLCA2277>3.0.CO;2-L; Steer BA, 1999, J BIOL CHEM, V274, P35601, DOI 10.1074/jbc.274.50.35601; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; van Hest JCM, 2000, J AM CHEM SOC, V122, P1282, DOI 10.1021/ja992749j; Wang L, 2000, J AM CHEM SOC, V122, P5010, DOI 10.1021/ja000595y; Wang L., UNPUB; WELLS TNC, 1991, BIOCHEMISTRY-US, V30, P5151, DOI 10.1021/bi00235a006	23	1070	1264	16	411	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					498	500		10.1126/science.1060077	http://dx.doi.org/10.1126/science.1060077			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313494				2022-12-01	WOS:000168187300045
J	Wu, JY; Feng, LL; Park, HT; Havlioglu, N; Wen, L; Tang, H; Bacon, KB; Jiang, ZH; Zhang, XC; Rao, Y				Wu, JY; Feng, LL; Park, HT; Havlioglu, N; Wen, L; Tang, H; Bacon, KB; Jiang, ZH; Zhang, XC; Rao, Y			The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors	NATURE			English	Article							AXON GUIDANCE; DROSOPHILA-MELANOGASTER; CELL-MIGRATION; PROTEIN; CHEMOKINES; RECEPTORS; ROUNDABOUT; MIDLINE; SYSTEM; CNS	Migration is a basic feature of many cell types in a wide range of species(1). Since the 1800s, cell migration has been proposed to occur in the nervous and immune systems(2,3), and distinct molecular cues for mammalian neurons and leukocytes have been identified. Here we report that Slit, a secreted protein previously known for its role of repulsion in axon guidance and neuronal migration, can also inhibit leukocyte chemotaxis induced by chemotactic factors. Slit inhibition of the chemokine-induced chemotaxis can be reconstituted by the co-expression of a chemokine receptor containing seven transmembrane domains and Roundabout (Robo), a Slit receptor containing a single transmembrane domain. Thus, there is a functional interaction between single and seven transmembrane receptors. Our results reveal the activity of a neuronal guidance cue in regulating leukocyte migration and indicate that there may be a general conservation of guidance mechanisms underlying metazoan cell migration. In addition, we have uncovered an inhibitor of leukocyte chemotaxis, and propose a new therapeutic approach to treat diseases involving leukocyte migration and chemotactic factors.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; Bayer Yakuhin Ltd, Dept Biol, Kizu, Kyoto, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Baylor College of Medicine; Bayer AG	Wu, JY (corresponding author), Washington Univ, Sch Med, Dept Pediat, Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.		Tang, Hao/G-9841-2011		NCI NIH HHS [R01 CA114197, R01 CA114197-01A2] Funding Source: Medline; NEI NIH HHS [R01 EY014576, R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967, R01 GM070967-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cellbio.4.1.649; Downey GP, 1998, J IMMUNOL, V160, P434; HATTEN ME, 1998, FUNDAMENTAL NEUROSCI, P451; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Krump E, 1997, J BIOL CHEM, V272, P937, DOI 10.1074/jbc.272.2.937; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MCCUTCHEON M, 1946, PHYSIOL REV, V26, P319, DOI 10.1152/physrev.1946.26.3.319; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.immunol.12.1.593; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; OBRIEN PJ, 1984, METHOD ENZYMOL, V105, P370; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	30	337	375	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					948	952		10.1038/35073616	http://dx.doi.org/10.1038/35073616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309622	Green Accepted			2022-12-01	WOS:000168152300051
J	Cohen, I; Li, H; Hougland, JL; Mrksich, M; Nagel, SR				Cohen, I; Li, H; Hougland, JL; Mrksich, M; Nagel, SR			Using selective withdrawal to coat microparticles	SCIENCE			English	Article							ISLETS	We report a method that uses the process of selective withdrawal of one fluid through a second immiscible fluid to coat small particles with polymer films. Fluid is withdrawn through a tube with its orifice slightly above a water-oil interface, Upon increasing the flow rate, there is a transition from a state where only oil is withdrawn to a state where the water, containing the particles to be coated and appropriate prepolymer reagents, is entrained in a thin spout along with the oil. The entrained particles eventually cause the spout interface to break, producing a thin coat of controllable thickness around each particle, which can be subsequently polymerized using chemical reagents, Light, or heat. This method allows flexibility in the chemical composition and thickness of the conformal coatings.	Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Cohen, I (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.		Mrksich, Milan/G-2469-2011	Mrksich, Milan/0000-0002-4964-796X; Cohen, Itai/0000-0001-9218-043X; Li, Hui/0000-0003-3139-2898; Hougland, James/0000-0003-0444-1017				BLAKE S, 1986, J VOLCANOL GEOTH RES, V27, P153, DOI 10.1016/0377-0273(86)90084-3; COHEN I, UNPUB; Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Ganan-Calvo AM, 1998, PHYS REV LETT, V80, P285, DOI 10.1103/PhysRevLett.80.285; Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; LISTER JR, 1989, J FLUID MECH, V198, P231, DOI 10.1017/S002211208900011X; Mathiowitz E., 1999, ENCY CONTROLLED DRUG; Mendonca AJ, 1999, MED RES REV, V19, P451, DOI 10.1002/(SICI)1098-1128(199909)19:5<451::AID-MED10>3.0.CO;2-B; RAYLEIGH, 1892, PHILOS MAG, V34, P177; SAVART, 1883, ANN CHIM, V53, P337; Shuttleworth SJ, 1997, SYNTHESIS-STUTTGART, P1217; Soon-Shiong P, 1999, ADV DRUG DELIVER REV, V35, P259, DOI 10.1016/S0169-409X(98)00076-3; TIMM EE, 1984, Patent No. 4444961; Umbanhowar PB, 2000, LANGMUIR, V16, P347, DOI 10.1021/la990101e; VALGESAGUILERA O, 1992, MACROMOLECULES, V25, P541; WOLTERS GHJ, 1992, J APPL BIOMATER, V3, P281, DOI 10.1002/jab.770030407; YOSHIOKA T, 1990, BIOTECHNOL BIOENG, V35, P66, DOI 10.1002/bit.260350110	19	139	143	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					265	267		10.1126/science.1059175	http://dx.doi.org/10.1126/science.1059175			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303097	Green Submitted			2022-12-01	WOS:000168074000040
J	Greenberg, P				Greenberg, P			Implications of pathogenetic and prognostic features for management of myelodysplastic syndromes	LANCET			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; MARROW-CELLS; EXPRESSION; APOPTOSIS; PROLIFERATION; PHENOTYPE; PROTEINS; DISEASE		Stanford Univ, Med Ctr, Palo Alto VA Hlth Care Syst, Div Hematol, Palo Alto, CA 94304 USA	Stanford University	Greenberg, P (corresponding author), Stanford Univ, Med Ctr, Palo Alto VA Hlth Care Syst, Div Hematol, Palo Alto, CA 94304 USA.							Advani R, 1999, BLOOD, V93, P787, DOI 10.1182/blood.V93.3.787.403k30_787_795; Bouscary D, 1997, LEUKEMIA, V11, P839, DOI 10.1038/sj.leu.2400654; Gersuk GM, 1996, BLOOD, V88, P1122, DOI 10.1182/blood.V88.3.1122b.bloodjournal8831122b; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg P, 1999, BLOOD, V94, p383A; Greenberg PL, 1998, LEUKEMIA RES, V22, P1123, DOI 10.1016/S0145-2126(98)00112-X; Greenberg PL, 1999, HEMATOLOGY BASIC PRI, P1106; Greenbloom SL, 1998, CAN J GASTROENTEROL, V12, P53, DOI 10.1155/1998/349460; Leith CP, 1999, BLOOD, V94, P1086; LIST AF, 1993, J CLIN ONCOL, V11, P1652, DOI 10.1200/JCO.1993.11.9.1652; LIST AF, 1991, BRIT J HAEMATOL, V78, P28, DOI 10.1111/j.1365-2141.1991.tb04378.x; Parker JE, 2000, BLOOD, V96, P3932, DOI 10.1182/blood.V96.12.3932.h8003932_3932_3938; Poulain S, 2000, BRIT J HAEMATOL, V110, P591, DOI 10.1046/j.1365-2141.2000.02247.x; Rajapaksa R, 1996, BLOOD, V88, P4275; RAZA A, 1995, BLOOD, V86, P268, DOI 10.1182/blood.V86.1.268.bloodjournal861268; Shetty V, 1996, LEUKEMIA RES, V20, P891, DOI 10.1016/S0145-2126(96)00008-2; Shimazaki K, 2000, BRIT J HAEMATOL, V110, P584, DOI 10.1046/j.1365-2141.2000.02228.x; Sikic BI, 1997, SEMIN HEMATOL, V34, P40; SONNEVELD P, 1993, LEUKEMIA, V7, P963; WATTEL E, 2000, BRIT J HAEMATOL, V110, P1015	20	7	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1059	1060		10.1016/S0140-6736(00)04306-3	http://dx.doi.org/10.1016/S0140-6736(00)04306-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297953				2022-12-01	WOS:000167996200004
J	Downer, J				Downer, J			A tortured tale of supply and demand	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					624	624		10.1038/35070666	http://dx.doi.org/10.1038/35070666			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287919	Bronze			2022-12-01	WOS:000167875400015
J	Arendt, D; Technau, U; Wittbrodt, J				Arendt, D; Technau, U; Wittbrodt, J			Evolution of the bilaterian larval foregut	NATURE			English	Article							BRACHYURY GENE-EXPRESSION; HEMICHORDATE EMBRYOS; DROSOPHILA; SPECIFICATION; PATTERN; DEUTEROSTOMES; CONSERVATION; VERTEBRATES; HOMOLOG	Bilateria are subdivided into Protostomia and Deuterostomia(1,2). Indirect development through primary, ciliary larvae occurs in both of these branches; however, the closing blastopore develops into mouth and anus in Protostomia and into anus only in Deuterostomia. Because of this important difference in larval gut ontogeny, the tube-shaped guts in protostome and deuterostome primary larvae are thought to have evolved independently(2,3). To test this hypothesis, we have analysed the expression of brachyury, otx and goosecoid homologues in the polychaete Platynereis dumerilii(4), which develops by means of a trochophora larva-the primary, ciliary larva prototypic for Protostomia(2). Here we show that brachyury expression in the ventral portion of the developing foregut in Platynereis and also otx expression along ciliated bands in the mouth region of the trochophora larva parallels expression in primary larvae in Deuterostomia(5-9). In addition, goosecoid expression in the foregut of Platynereis mirrors the function in higher Deuterostomia(10). We present molecular evidence for the evolutionary conservation of larval foreguts and mouth regions of Protostomia and Deuterostomia. Our data indicate that Urbilateria, the common bilaterian ancestors, developed through a primary, ciliary larva that already possessed a tripartite tube-shaped gut.	European Mol Biol Lab, Dev Biol Programme, D-69012 Heidelberg, Germany; Tech Univ Darmstadt, Inst Zool, D-64287 Darmstadt, Germany	European Molecular Biology Laboratory (EMBL); Technical University of Darmstadt	Wittbrodt, J (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69012 Heidelberg, Germany.	technau@bio.tu-darmstadt.de; Jochen.Wittbrodt@EMBL-Heidelberg.de	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377; Technau, Ulrich/0000-0003-4472-8258				Arendt D, 1997, MECH DEVELOP, V61, P7, DOI 10.1016/S0925-4773(96)00620-X; Arendt D, 1999, DEVELOPMENT, V126, P2309; DeRobertis EM, 1997, NATURE, V387, P25, DOI 10.1038/387025a0; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; DORRESTEIJN AWC, 1993, ROUX ARCH DEV BIOL, V202, P260, DOI 10.1007/BF00363215; Goriely A, 1996, DEVELOPMENT, V122, P1641; Grobben K, 1909, VERH ZOOL BOT GES WI, V58, P491; HAECKEL E, 1896, SYSTEMATISCHE PHYLOG, V2, P259; Hahn M, 1996, EMBO J, V15, P3077, DOI 10.1002/j.1460-2075.1996.tb00670.x; Harada Y, 2000, MECH DEVELOP, V91, P337, DOI 10.1016/S0925-4773(99)00279-8; Hirth F, 1999, BIOESSAYS, V21, P677, DOI 10.1002/(SICI)1521-1878(199908)21:8<677::AID-BIES7>3.3.CO;2-#; Holland PWH, 1995, DEVELOPMENT, V121, P4283; KISPERT A, 1994, GENE DEV, V8, P2137, DOI 10.1101/gad.8.18.2137; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kusch T, 1999, DEVELOPMENT, V126, P3991; Loosli F, 1998, MECH DEVELOP, V74, P159, DOI 10.1016/S0925-4773(98)00055-0; Nielsen C., 1995, ANIMAL EVOLUTION INT; Peterson KJ, 2000, DEV BIOL, V219, P1, DOI 10.1006/dbio.1999.9475; Peterson KJ, 1999, DEVELOPMENT, V126, P85; Shoguchi E, 2000, GENESIS, V27, P58, DOI 10.1002/1526-968X(200006)27:2<58::AID-GENE20>3.0.CO;2-8; Shoguchi E, 1999, MECH DEVELOP, V82, P185, DOI 10.1016/S0925-4773(99)00008-8; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; STEINBEISSER H, 1993, CR ACAD SCI III-VIE, V316, P966; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tagawa K, 1998, MECH DEVELOP, V75, P139, DOI 10.1016/S0925-4773(98)00078-1; Willmer P, 1990, INVERTEBRATE RELATIO; Wilson EB, 1892, J MORPHOL, V6, P361; Woollard A, 2000, GENE DEV, V14, P596; Wu LH, 1998, DEVELOPMENT, V125, P2433; Yasuo H, 1998, DEV BIOL, V200, P158, DOI 10.1006/dbio.1998.8958	30	187	191	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					81	85		10.1038/35051075	http://dx.doi.org/10.1038/35051075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343117				2022-12-01	WOS:000166175600043
J	Schwetz, BA				Schwetz, BA			Oral therapy for CMV retinitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2705	2705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386912				2022-12-01	WOS:000168985800005
J	Kang, JG; Yun, J; Kim, DH; Chung, KS; Fujioka, S; Kim, JI; Dae, HW; Yoshida, S; Takatsuto, S; Song, PS; Park, CM				Kang, JG; Yun, J; Kim, DH; Chung, KS; Fujioka, S; Kim, JI; Dae, HW; Yoshida, S; Takatsuto, S; Song, PS; Park, CM			Light and brassinosteroid signals are integrated via a dark-induced small G protein in etiolated seedling growth	CELL			English	Article							GTP-BINDING PROTEINS; DOWN-REGULATED EXPRESSION; YEAST EXPRESSION; TIP GROWTH; ARABIDOPSIS; BIOSYNTHESIS; PEA; IDENTIFICATION; PLANTS; FAMILY	Plant growth and development are regulated through coordinated interactions between light and phytohormones. Here, we demonstrate that a dark-induced small G protein, pea Pra2, regulates a variant cytochrome P450 that catalyzes C-2 hydroxylation in brassinosteroid biosynthesis. The cytochrome P450 is dark-induced and predominantly expressed in the rapidly elongating zone of etiolated pea epicotyls, where Pra2 is also most abundant. Transgenic plants with reduced Pra2 exhibit a dark-specific dwarfism, which is completely rescued by exogenous brassinolide. Overexpression of the cytochrome P450 results in enhanced hypocotyl growth even in the light, which phenocopies the etiolated hypocotyls. We therefore propose that Pra2 and its orthologs are molecular mediators for the cross-talk between light and brassinosteroids in the etiolation process in plants.	Kumho Life & Environm Sci Lab, Kwangju 500712, South Korea; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA; KJIST, Kwangju 500712, South Korea; Joetsu Univ Educ, Dept Chem, Joetsu, Niigata 9438512, Japan	RIKEN; University of Nebraska System; University of Nebraska Lincoln; Gwangju Institute of Science & Technology (GIST); Joetsu University Education	Park, CM (corresponding author), Kumho Life & Environm Sci Lab, Oryong Dong, Kwangju 500712, South Korea.	pssong@unlserve.unl.edu; cmpark@ksc.kumho.co.kr	Park, Chung-Mo/B-6175-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036956] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-36956] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asami T, 1999, TRENDS PLANT SCI, V4, P348, DOI 10.1016/S1360-1385(99)01456-9; Bibikova TN, 1999, PLANT J, V17, P657, DOI 10.1046/j.1365-313X.1999.00415.x; Bishop GJ, 1999, P NATL ACAD SCI USA, V96, P1761, DOI 10.1073/pnas.96.4.1761; BRIGGS WR, 1965, PLANT PHYSIOL, V40, P934, DOI 10.1104/pp.40.5.934; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Fujioka S, 2000, PHYTOCHEMISTRY, V53, P549, DOI 10.1016/S0031-9422(99)00582-8; Fujioka S, 1997, PHYSIOL PLANTARUM, V100, P710, DOI 10.1034/j.1399-3054.1997.1000335.x; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; HAIZEL T, 1995, PLANT PHYSIOL, V108, P59, DOI 10.1104/pp.108.1.59; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Inaba T, 1999, PLANT PHYSIOL, V120, P491, DOI 10.1104/pp.120.2.491; Inaba T, 2000, J BIOL CHEM, V275, P19723, DOI 10.1074/jbc.M001337200; KIKUCHI A, 1995, METHOD ENZYMOL, V257, P57; Kost B, 1999, CURR OPIN PLANT BIOL, V2, P462, DOI 10.1016/S1369-5266(99)00024-2; Li H, 1999, PLANT CELL, V11, P1731, DOI 10.1105/tpc.11.9.1731; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; MA H, 1994, PLANT MOL BIOL, V26, P1611, DOI 10.1007/BF00016493; MATZKE MA, 1995, TRENDS GENET, V11, P1, DOI 10.1016/S0168-9525(00)88973-8; NAGANO Y, 1995, P NATL ACAD SCI USA, V92, P6314, DOI 10.1073/pnas.92.14.6314; Neff MM, 2000, GENE DEV, V14, P257; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Pan JY, 1996, J BIOL CHEM, V271, P1322, DOI 10.1074/jbc.271.3.1322; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; ROMERO LC, 1991, FEBS LETT, V282, P341, DOI 10.1016/0014-5793(91)80509-2; Schumacher K, 2000, CURR OPIN PLANT BIOL, V3, P79, DOI 10.1016/S1369-5266(99)00038-2; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Ueda T, 2000, PLANT J, V21, P341, DOI 10.1046/j.1365-313x.2000.00681.x; vonArnim A, 1996, ANNU REV PLANT PHYS, V47, P215, DOI 10.1146/annurev.arplant.47.1.215; WANG X, 2000, J BIOL CHEM, V275, P29198; WAXMAN DJ, 1991, METHOD ENZYMOL, V206, P462; YOSHIDA K, 1993, P NATL ACAD SCI USA, V90, P6636, DOI 10.1073/pnas.90.14.6636	36	136	154	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					625	636		10.1016/S0092-8674(01)00370-1	http://dx.doi.org/10.1016/S0092-8674(01)00370-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389832	Bronze			2022-12-01	WOS:000169123200009
J	Sesti, F; Shih, TM; Nikolaeva, N; Goldstein, SAN				Sesti, F; Shih, TM; Nikolaeva, N; Goldstein, SAN			Immunity to K1 killer toxin: Internal TOK1 blockade	CELL			English	Article							DOUBLE-STRANDED-RNA; 2 PORE DOMAINS; SACCHAROMYCES-CEREVISIAE; K+ CHANNEL; FUNCTIONAL EXPRESSION; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; POTASSIUM CHANNEL; YEAST K+; SECRETION	K1 killer strains of Saccharomyces cerevisiae harbor RNA viruses that mediate secretion of K1, a protein toxin that kills virus-free cells. Recently, external K1 toxin was shown to directly activate TOK1 channels in the plasma membranes of sensitive yeast cells, leading to excess potassium flux and cell death. Here, a mechanism by which killer cells resist their own toxin is shown: internal toxin inhibits TOK1 channels and suppresses activation by external toxin.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA	Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 295 Congress Ave, New Haven, CT 06536 USA.	steve.goldstein@yale.edu	Goldstein, Steven A./E-9817-2015	Goldstein, Steven A./0000-0001-5207-5061				Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; ALALDROOS K, 1978, CAN J MICROBIOL, V24, P228; ANDERSON JA, 1992, P NATL ACAD SCI USA, V89, P3736, DOI 10.1073/pnas.89.9.3736; BOONE C, 1990, J CELL BIOL, V110, P1833, DOI 10.1083/jcb.110.5.1833; BOONE C, 1986, CELL, V46, P105, DOI 10.1016/0092-8674(86)90864-0; BOSTIAN KA, 1984, CELL, V36, P741, DOI 10.1016/0092-8674(84)90354-4; BOSTIAN KA, 1980, CELL, V19, P403, DOI 10.1016/0092-8674(80)90514-0; BUSSEMAKERS MJG, 1991, PROGR UROLOGIE S, V1, P5; BUSSEY H, 1981, ADV MICROB PHYSIOL, V22, P93, DOI 10.1016/S0065-2911(08)60326-4; BUSSEY H, 1983, MOL CELL BIOL, V3, P1362, DOI 10.1128/MCB.3.8.1362; Eisfeld K, 2000, MOL MICROBIOL, V37, P926, DOI 10.1046/j.1365-2958.2000.02063.x; Fairman C, 1999, J MEMBRANE BIOL, V168, P149, DOI 10.1007/s002329900505; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kjeldsen T, 1999, J BIOTECHNOL, V75, P195, DOI 10.1016/S0168-1656(99)00159-5; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; LOLLE S, 1984, EMBO J, V3, P1383, DOI 10.1002/j.1460-2075.1984.tb01981.x; Lord JM, 1998, J CELL BIOL, V140, P733; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Magliani W, 1997, CLIN MICROBIOL REV, V10, P369, DOI 10.1128/CMR.10.3.369; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; PETTOELLOMANTOVANI M, 1995, GASTROENTEROLOGY, V109, P1900, DOI 10.1016/0016-5085(95)90757-2; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, FEBS LETT, V443, P241, DOI 10.1016/S0014-5793(98)01724-4; Schmitt MJ, 1995, ARCH MICROBIOL, V164, P435; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; SKIPPER N, 1984, EMBO J, V3, P107, DOI 10.1002/j.1460-2075.1984.tb01769.x; STARMER WT, 1987, CAN J MICROBIOL, V33, P783, DOI 10.1139/m87-134; STURLEY SL, 1986, EMBO J, V5, P3381, DOI 10.1002/j.1460-2075.1986.tb04654.x; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; THIELE DJ, 1982, NUCLEIC ACIDS RES, V10, P6903, DOI 10.1093/nar/10.21.6903; Vergani P, 1998, EMBO J, V17, P7190, DOI 10.1093/emboj/17.24.7190; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; WICKNER RB, 1974, J BACTERIOL, V117, P1356, DOI 10.1128/JB.117.3.1356-1357.1974; Wickner RB, 1996, ANNU REV GENET, V30, P109, DOI 10.1146/annurev.genet.30.1.109; WICKNER RB, 1976, GENETICS, V82, P429; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D; ZHU H, 1991, MOL CELL BIOL, V11, P175, DOI 10.1128/MCB.11.1.175	38	22	22	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					637	644		10.1016/S0092-8674(01)00376-2	http://dx.doi.org/10.1016/S0092-8674(01)00376-2			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389833	Bronze			2022-12-01	WOS:000169123200010
J	Farber, SA; Pack, M; Ho, SY; Johnson, LD; Wagner, DS; Dosch, R; Mullins, MC; Hendrickson, HS; Hendrickson, EK; Halpern, ME				Farber, SA; Pack, M; Ho, SY; Johnson, LD; Wagner, DS; Dosch, R; Mullins, MC; Hendrickson, HS; Hendrickson, EK; Halpern, ME			Genetic analysis of digestive physiology using fluorescent phospholipid reporters	SCIENCE			English	Article							ZEBRAFISH; A(2); CHOLESTEROL; ENZYMES; ASSAYS	Zebrafish are a valuable model for mammalian lipid metabolism; larvae process lipids similarly through the intestine and hepatobiliary system and respond to drugs that block cholesterol synthesis in humans. After ingestion of fluorescently quenched phospholipids, endogenous lipase activity and rapid transport of cleavage products results in intense gall bladder fluorescence. Genetic screening identifies zebrafish mutants, such as fat free, that show normal digestive organ morphology but severely reduced phospholipid and cholesterol processing. Thus, fluorescent lipids provide a sensitive readout of lipid metabolism and are a powerful tool for identifying genes that mediate vertebrate digestive physiology.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21210 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Mol Probes Inc, Eugene, OR 97402 USA; Univ Washington, Dept Chem, Seattle, WA 98133 USA	Carnegie Institution for Science; Jefferson University; University of Pennsylvania; University of Pennsylvania; University of Washington; University of Washington Seattle	Farber, SA (corresponding author), Carnegie Inst Washington, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.		Farber, Steven A/G-5851-2012; Dosch, Roland/H-9633-2019; Wagner, Daniel S/C-9379-2009	Farber, Steven A/0000-0002-8037-7312; Dosch, Roland/0000-0001-9247-8586; Wagner, Daniel S/0000-0002-0595-2436	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054942] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 54942] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cormier RT, 1997, NAT GENET, V17, P88, DOI 10.1038/ng0997-88; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; FARBER S, UNPUB; Farber SA, 1999, J BIOL CHEM, V274, P19338, DOI 10.1074/jbc.274.27.19338; Frolov A, 2000, J BIOL CHEM, V275, P12769, DOI 10.1074/jbc.275.17.12769; Goto T., 1997, Hepatology, V26, p295A; Hendrickson HS, 1999, ANAL BIOCHEM, V276, P27, DOI 10.1006/abio.1999.4280; HENDRICKSON HS, 1994, ANAL BIOCHEM, V219, P1, DOI 10.1006/abio.1994.1223; HOFMANN A, COMMUNICATION; HOMAN R, 2001, INTESTINAL LIPID MET, P81; Honkanen R.E., 1985, AM J PHYSIOL, V249, P399; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NAWROCKI JW, 1995, ARTERIOSCL THROM VAS, V15, P678, DOI 10.1161/01.ATV.15.5.678; Pack M, 1996, DEVELOPMENT, V123, P321; Rubin M, 1999, LIPIDS, V34, P571, DOI 10.1007/s11745-999-0400-x; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; SHERIDAN MA, 1988, COMP BIOCHEM PHYS B, V90, P679, DOI 10.1016/0305-0491(88)90322-7; STROBAND HWJ, 1979, HISTOCHEMISTRY, V64, P235, DOI 10.1007/BF00495024; Tocher Douglas R., 1995, Biochemistry and Molecular Biology of Fishes, V4, P119; WESTERFIELD M, 1995, ZEABRAFISH BOOK	21	249	258	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1385	1388		10.1126/science.1060418	http://dx.doi.org/10.1126/science.1060418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359013				2022-12-01	WOS:000168862900049
J	Krause, DS; Theise, ND; Collector, MI; Henegariu, O; Hwang, S; Gardner, R; Neutzel, S; Sharkis, SJ				Krause, DS; Theise, ND; Collector, MI; Henegariu, O; Hwang, S; Gardner, R; Neutzel, S; Sharkis, SJ			Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell	CELL			English	Article							TERM REPOPULATING CELLS; IN-VIVO; HEMATOPOIETIC-CELLS; TRANSCRIPTION FACTOR; CD34(+) CELLS; MICE; BLOOD; HEPATOCYTES; EXPRESSION; DIFFERENTIATION	Purification of rare hematopoietic stem cell(s) (HSC) to homogeneity is required to study their self-renewal, differentiation, phenotype, and homing. Long-term repopulation (LTR) of irradiated hosts and serial transplantation to secondary hosts represent the gold standard for demonstrating self-renewal and differentiation, the defining properties of HSC, We show that rare cells that home to bone marrow can LTR primary and secondary recipients. During the homing, CD34 and SCA-1 expression increases uniquely on cells that home to marrow. These adult bone marrow cells have tremendous differentiative capacity as they can also differentiate into epithelial cells of the liver, lung, GI tract, and skin. This finding may contribute to clinical treatment of genetic disease or tissue repair.	Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Johns Hopkins Univ, Sch Med, Ctr Oncol, Baltimore, MD 21231 USA	Yale University; Yale University; Johns Hopkins University; Johns Hopkins Medicine	Krause, DS (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06520 USA.	diane.krause@yale.edu		Gardner, Rebekah/0000-0001-5823-9178	NCI NIH HHS [P01 CA70970] Funding Source: Medline; NHLBI NIH HHS [R01 HL54330, P01 HL63357] Funding Source: Medline; NIDDK NIH HHS [R01 DK53037, R01 DK53812] Funding Source: Medline; PHS HHS [P30-34989] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA070970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054330, P01HL063357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053812, R01DK053037] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abonour R, 2000, NAT MED, V6, P652, DOI 10.1038/76225; Alison MR, 2000, NATURE, V406, P257, DOI 10.1038/35018642; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Craddock CF, 1997, BLOOD, V90, P4779, DOI 10.1182/blood.V90.12.4779.4779_4779_4788; Donnelly DS, 1999, EXP HEMATOL, V27, P788, DOI 10.1016/S0301-472X(99)00032-6; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HARRISON DE, 1990, J EXP MED, V172, P431, DOI 10.1084/jem.172.2.431; HAWKINS AL, 1992, CANCER GENET CYTOGEN, V64, P145, DOI 10.1016/0165-4608(92)90345-9; Healy L, 1995, P NATL ACAD SCI USA, V92, P12240, DOI 10.1073/pnas.92.26.12240; Ito M, 1997, HUM GENE THER, V8, P57, DOI 10.1089/hum.1997.8.1-57; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jones RJ, 1996, BLOOD, V88, P487, DOI 10.1182/blood.V88.2.487.bloodjournal882487; JONES RJ, 1989, BLOOD, V73, P397; KRAUSE DS, 1994, BLOOD, V84, P691; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Magdaleno S M, 1998, Adv Pediatr, V45, P363; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Morel F, 1996, BLOOD, V88, P3774, DOI 10.1182/blood.V88.10.3774.bloodjournal88103774; Nakamura Y, 1999, BLOOD, V94, P4053, DOI 10.1182/blood.V94.12.4053.424k41_4053_4059; NOLTA JA, 1992, EXP HEMATOL, V20, P1065; Nolta JA, 1996, P NATL ACAD SCI USA, V93, P2414, DOI 10.1073/pnas.93.6.2414; Oosterwijk JC, 1998, CYTOMETRY, V32, P170, DOI 10.1002/(SICI)1097-0320(19980701)32:3<170::AID-CYTO2>3.0.CO;2-O; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pazouki S, 1996, ACTA HISTOCHEM, V98, P29, DOI 10.1016/S0065-1281(96)80047-X; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rosen JM, 1998, BIOCHEM SOC SYMP, P101; Sato T, 1999, BLOOD, V94, P2548, DOI 10.1182/blood.V94.8.2548.420k38_2548_2554; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Sun TT, 1984, CANCER CELLS, V1, P169; Suzuki A, 1996, BLOOD, V87, P3550, DOI 10.1182/blood.V87.9.3550.bloodjournal8793550; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; TRAVIS EL, 1985, RADIOTHER ONCOL, V4, P341, DOI 10.1016/S0167-8140(85)80122-5; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zanjani ED, 1998, EXP HEMATOL, V26, P353	42	2101	2390	1	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					369	377		10.1016/S0092-8674(01)00328-2	http://dx.doi.org/10.1016/S0092-8674(01)00328-2			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348593	Bronze			2022-12-01	WOS:000168515900006
J	Ruelle, D				Ruelle, D			Here be no dragons	NATURE			English	Article									Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France	UDICE-French Research Universities; Universite Paris Saclay	Ruelle, D (corresponding author), Inst Hautes Etud Sci, 35 Route Chartres, F-91440 Bures Sur Yvette, France.							HAO BL, 1990, CHAOS, V2; Laskar J, 1996, CELEST MECH DYN ASTR, V64, P115, DOI 10.1007/BF00051610; LASKAR J, 1994, P 11 IOMP M PAR JUL, P75; OVITANOVIC P, 1984, U CHAOS; RUELLE D, 1991, CHANCE CHAOS	5	3	4	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					27	27		10.1038/35075175	http://dx.doi.org/10.1038/35075175			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333956	Bronze			2022-12-01	WOS:000168432800024
J	Chiang, SH; Baumann, CA; Kanzaki, M; Thurmond, DC; Watson, RT; Neudauer, CL; Macara, IG; Pessin, JE; Saltiel, AR				Chiang, SH; Baumann, CA; Kanzaki, M; Thurmond, DC; Watson, RT; Neudauer, CL; Macara, IG; Pessin, JE; Saltiel, AR			Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10	NATURE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING PATHWAYS; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; RAT ADIPOCYTES; RHO-GTPASES; FACTOR C3G; C-CBL; KINASE	The stimulation of glucose uptake by insulin in muscle and adipose tissue requires translocation of the GLUT4 glucose transporter protein from intracellular storage sites to the cell surface(1-6). Although the cellular dynamics of GLUT4 vesicle trafficking are well described, the signalling pathways that link the insulin receptor to GLUT4 translocation remain poorly understood. Activation of phosphatidylinositol-3-OH kinase (PI(3)K) is required for this trafficking event, but it is not sufficient to produce GLUT4 translocation(7). We previously described a pathway involving the insulin-stimulated tyrosine phosphorylation of Cbl, which is recruited to the insulin receptor by the adapter protein CAP(8,9). On phosphorylation, Cbl is translocated to lipid rafts. Blocking this step completely inhibits the stimulation of GLUT4 translocation by insulin(10). Here we show that phosphorylated Cbl recruits the CrkII-C3G complex to lipid rafts, where C3G specifically activates the small GTP-binding protein TC10. This process is independent of PI(3)K, but requires the translocation of Cbl, Crk and C3G to the lipid raft. The activation of TC10 is essential for insulin-stimulated glucose uptake and GLUT4 translocation. The TC10 pathway functions in parallel with PI(3)K to stimulate fully GLUT4 translocation in response to insulin.	Pfizer Global Res & Dev, Dept Cell Biol, Ann Arbor, MI 48105 USA; Univ Michigan, Sch Med, Dept Physiol & Med, Ann Arbor, MI 48109 USA; Univ Michigan, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA	Pfizer; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Iowa; University of Virginia	Saltiel, AR (corresponding author), Pfizer Global Res & Dev, Dept Cell Biol, Ann Arbor, MI 48105 USA.		Saltiel, Alan/L-3632-2019; Kanzaki, Makoto/H-6680-2017	Kanzaki, Makoto/0000-0002-6884-2955; Saltiel, Alan/0000-0002-9726-9828				Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Elmendorf JS, 1998, J BIOL CHEM, V273, P13289, DOI 10.1074/jbc.273.21.13289; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; HAUSDORFF SF, 1995, J BIOL CHEM, V270, P12965, DOI 10.1074/jbc.270.22.12965; HOLMAN GD, 1990, J BIOL CHEM, V265, P81172; HORII Y, 1994, EMBO J, V13, P4776, DOI 10.1002/j.1460-2075.1994.tb06803.x; ISAKOFF SJ, 1995, P NATL ACAD SCI USA, V92, P10247, DOI 10.1073/pnas.92.22.10247; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; OKADA T, 1994, J BIOL CHEM, V269, P3568; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; PIPER RC, 1991, AM J PHYSIOL, V260, P570; Ribon V, 1997, BIOCHEM J, V324, P839, DOI 10.1042/bj3240839; Ribon V, 1998, MOL CELL BIOL, V18, P872, DOI 10.1128/MCB.18.2.872; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; WIESE RJ, 1995, J BIOL CHEM, V270, P3442, DOI 10.1074/jbc.270.7.3442	27	453	477	1	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					944	948		10.1038/35073608	http://dx.doi.org/10.1038/35073608			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309621	Green Published			2022-12-01	WOS:000168152300050
J	Abramson, JL; Williams, SA; Krumholz, HM; Vaccarino, V				Abramson, JL; Williams, SA; Krumholz, HM; Vaccarino, V			Moderate alcohol consumption and risk of heart failure among older persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPONTANEOUSLY HYPERTENSIVE RATS; ATRIAL-NATRIURETIC-PEPTIDE; US MALE PHYSICIANS; TYPE-2 DIABETES-MELLITUS; SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; ETHANOL INTAKE; DISEASE; MORTALITY	Context Heavy consumption of alcohol can lead to heart failure, but the relationship between moderate alcohol consumption and risk of heart failure is largely unknown. Objective To determine whether moderate alcohol consumption predicts heart failure risk among older persons, independent of the association of moderate alcohol consumption with lower risk of myocardial infarction (MI). Design Prospective cohort study conducted from 1982 through 1996, with a maximum follow-up of 14 years. Setting and Participants Population-based sample of 2235 noninstitutionalized elderly persons (mean age, 73.7 years; 41.2% male; 21.3% nonwhite) residing in New Haven, Conn, who were free of heart failure at baseline. Persons who reported alcohol consumption of more than 70 oz in the month prior to baseline were excluded. Main Outcome Measure Time to first fatal or nonfatal heart failure event, according to the amount of alcohol consumed in the month prior to baseline. Results Increasing alcohol consumption in the moderate range was associated with decreasing heart failure rates. For persons consuming no alcohol (50.0%), 1 to 20 oz (40.2%), and 21 to 70 oz (9.8%) in the month prior to baseline, crude heart failure rates per 1000 years of follow-up were 16.1, 12.2, and 9.2, respectively. After adjustment for age, sex, race, education, angina, history of MI and diabetes, MI during follow-up, hypertension, pulse pressure, body mass index, and current smoking, the relative risks of heart failure for those consuming no alcohol, 1 to 20 oz, and 21 to 70 oz in the month prior to baseline were 1.00 (referent), 0.79 (95% confidence interval [CI], 0.60-1.02), and 0.53 (95% CI, 0.32-0.88) (P for trend =.02). Conclusions Increasing levels of moderate alcohol consumption are associated with a decreasing risk of heart failure among older persons. This association is independent of a number of confounding factors and does not appear to be entirely mediated by a reduction in MI risk.	Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30306 USA; AstraZeneca, Wayne, PA USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA	Emory University; AstraZeneca; Yale University; Yale University	Abramson, JL (corresponding author), Emory Univ, Sch Med, Dept Med, Div Cardiol, 1256 Briarcliff Rd NE,Suite 1 N, Atlanta, GA 30306 USA.	jerome@ecor.cardio.emory.edu	, Harlan/AAI-2875-2020		NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH014235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG002105] Funding Source: NIH RePORTER; NIA NIH HHS [N01-AG-02105] Funding Source: Medline; NIMH NIH HHS [2T32 MH14235] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025; Albert CM, 1999, CIRCULATION, V100, P944, DOI 10.1161/01.CIR.100.9.944; BRANDT RR, 1993, J AM COLL CARDIOL, V22, pA86, DOI 10.1016/0735-1097(93)90468-G; Camargo CA, 1997, ANN INTERN MED, V126, P372, DOI 10.7326/0003-4819-126-5-199703010-00005; COLANTONIO D, 1991, LIFE SCI, V48, P635, DOI 10.1016/0024-3205(91)90538-M; Cooper HA, 2000, J AM COLL CARDIOL, V35, P1753, DOI 10.1016/S0735-1097(00)00625-2; CORNONIHUNTLEY J, 1993, AGING-CLIN EXP RES, V5, P27; COX DR, 1972, J R STAT SOC B, V34, P187; CRISCIONE L, 1989, HYPERTENSION, V13, P964, DOI 10.1161/01.HYP.13.6.964; de Leon CFM, 1998, ARCH INTERN MED, V158, P2341; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; Gianoulakis C, 1997, ALCOHOL CLIN EXP RES, V21, P162; GILLMAN MW, 1995, HYPERTENSION, V25, P1106, DOI 10.1161/01.HYP.25.5.1106; GOLDSMITH SR, 1983, J AM COLL CARDIOL, V1, P1385, DOI 10.1016/S0735-1097(83)80040-0; GREENBERG BH, 1982, ANN INTERN MED, V97, P171, DOI 10.7326/0003-4819-97-2-171; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Guillaume P, 1996, ALCOHOL CLIN EXP RES, V20, P1653, DOI 10.1111/j.1530-0277.1996.tb01712.x; HARLAN WR, 1977, ANN INTERN MED, V86, P133, DOI 10.7326/0003-4819-86-2-133; HOWE PRC, 1989, HYPERTENSION, V13, P607, DOI 10.1161/01.HYP.13.6.607; JACKSON R, 1985, AM J EPIDEMIOL, V122, P1037, DOI 10.1093/oxfordjournals.aje.a114185; KLATSKY AL, 1977, NEW ENGL J MED, V296, P1194, DOI 10.1056/NEJM197705262962103; KOZAK LJ, 1999, VITAL HLTH STAT, V144, P1; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; MALIN H, 1986, 1983 NHIS ALCOHOL HL, P490; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Mukamal KJ, 1999, AM HEART J, V138, P926, DOI 10.1016/S0002-8703(99)70019-0; *NIH, 1998, DRINK US MAIN FIND 1; RIDKER PM, 1994, JAMA-J AM MED ASSOC, V272, P929, DOI 10.1001/jama.272.12.929; RUBIN E, 1994, ALCOHOL CLIN EXP RES, V18, P111, DOI 10.1111/j.1530-0277.1994.tb00889.x; Rubin R, 1999, ALCOHOL CLIN EXP RES, V23, P1114, DOI 10.1111/j.1530-0277.1999.tb04234.x; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; SHAPER AG, 1988, LANCET, V2, P1267; Solomon CG, 2000, CIRCULATION, V102, P494; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; Vaccarino V, 2000, J AM COLL CARDIOL, V36, P130, DOI 10.1016/S0735-1097(00)00687-2; Valmadrid CT, 1999, JAMA-J AM MED ASSOC, V282, P239, DOI 10.1001/jama.282.3.239; Vasdev S, 1999, MOL CELL BIOCHEM, V200, P85, DOI 10.1023/A:1006950414560; WANNAMETHEE G, 1992, BRIT HEART J, V68, P443	38	144	149	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1971	1977		10.1001/jama.285.15.1971	http://dx.doi.org/10.1001/jama.285.15.1971			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308433	Bronze			2022-12-01	WOS:000167995900025
J	Bell, JS; Campbell, DM; Graham, WJ; Penney, GC; Ryan, M; Hall, MH				Bell, JS; Campbell, DM; Graham, WJ; Penney, GC; Ryan, M; Hall, MH			Do obstetric complications explain high caesarean section rates among women over 30? A retrospective analysis	BRITISH MEDICAL JOURNAL			English	Article							MATERNAL AGE; RISE		Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen, Scotland; Univ Aberdeen, Hlth Econ Res Unit, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen	Bell, JS (corresponding author), Aberdeen Matern Hosp, Dept Obstet & Gynaecol, Dugald Baird Ctr Res Womens Hlth, Aberdeen, Scotland.		Hall, Mei-Hua/GLR-9172-2022	Hall, Mei-Hua/0000-0002-4558-7023; Bell, Jacqueline/0000-0003-1784-0180; Graham, Wendy/0000-0003-1473-5342				BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P659, DOI 10.1056/NEJM199003083221004; Leitch CR, 1998, BRIT J OBSTET GYNAEC, V105, P621, DOI 10.1111/j.1471-0528.1998.tb10176.x; MARTEL M, 1987, AM J OBSTET GYNECOL, V156, P305, DOI 10.1016/0002-9378(87)90273-0; Rosenthal AN, 1998, BRIT J OBSTET GYNAEC, V105, P1064, DOI 10.1111/j.1471-0528.1998.tb09937.x; SAMPHIER ML, 1981, PROSPECTIVE LONGITUD	5	45	46	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					894	895		10.1136/bmj.322.7291.894	http://dx.doi.org/10.1136/bmj.322.7291.894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302901	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000168311300019
J	Markewitz, D; Davidson, EA; Figueiredo, RDO; Victoria, RL; Krusche, AV				Markewitz, D; Davidson, EA; Figueiredo, RDO; Victoria, RL; Krusche, AV			Control of cation concentrations in stream waters by surface soil processes in an Amazonian watershed	NATURE			English	Article							EASTERN AMAZONIA; BRAZILIAN AMAZON; ATMOSPHERIC CO2; PASTURES; FORESTS; CARBON; PLANTS; CYCLES	The chemical composition of ground waters and stream waters is thought to be determined primarily by weathering of parent rock(1-5). In relatively young soils such as those occurring in most temperate ecosystems, dissolution of primary minerals by carbonic acid is the predominant weathering pathway that liberates Ca2+, Mg2+ and K+ and generates alkalinity in the hydrosphere(6). But control of water chemistry in old and highly weathered soils that have lost reservoirs of primary minerals (a common feature of many tropical soils) is less well understood. Here we present soil and water chemistry data from a 10,000-hectare watershed on highly weathered soil in the Brazilian Amazon. Streamwater cation concentrations and alkalinity are positively correlated to each other and to streamwater discharge, suggesting that cations and bicarbonate are mainly flushed from surface soil layers by rainfall rather than being the products of deep soil weathering carried by groundwater flow. These patterns contrast with the seasonal patterns widely recognized in temperate ecosystems with less strongly weathered soils(2,7). In this particular watershed, partial forest clearing and burning 30 years previously enriched the soils in cations and so may have increased the observed wet season leaching of cations. Nevertheless, annual inputs and outputs of cations from the watershed are low and nearly balanced, and thus soil cations from forest burning will remain available for forest regrowth over the next few decades. Our observations suggest that increased root and microbial respiration during the wet season generates CO2 that drives cation-bicarbonate leaching, resulting in a biologically mediated process of surface soil exchange controlling the streamwater inputs of cations and alkalinity from these highly weathered soils.	Woods Hole Res Ctr, Woods Hole, MA 02543 USA; Inst Pesquisa Ambiental Amazonia, BR-66035100 Belem, Para, Brazil; Ctr Energia Nucl Agr, BR-13400970 Piracicaba, SP, Brazil	Woods Hole Research Center	Markewitz, D (corresponding author), Univ Georgia, Warnell Sch Forest Resources, Athens, GA 30602 USA.		Krusche, Alex V/H-8988-2012; Figueiredo, Ricardo de Oliveira/A-6967-2013; Davidson, Eric A/K-4984-2013; Victoria, Reynaldo/F-5348-2012	Figueiredo, Ricardo de Oliveira/0000-0002-0933-4854; Davidson, Eric A/0000-0002-8525-8697; Krusche, Alex/0000-0001-7094-5577; Markewitz, Daniel/0000-0002-2697-9865				BERNER RA, 1992, GEOCHIM COSMOCHIM AC, V56, P3225, DOI 10.1016/0016-7037(92)90300-8; Berner RA, 1997, SCIENCE, V276, P544, DOI 10.1126/science.276.5312.544; Broecker WS, 1998, GLOBAL BIOGEOCHEM CY, V12, P403, DOI 10.1029/98GB01927; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; DAVIDSON EA, 1995, TELLUS B, V47, P550, DOI 10.1034/j.1600-0889.47.issue5.3.x; Drever J. I., 1997, GEOCHEMISTRY NATURAL, P138; EWEL J, 1981, ECOLOGY, V62, P816, DOI 10.2307/1937748; Furch K., 1984, AMAZON LIMNOLOGY LAN, P167, DOI [10.1007/978-94-009-6542-3_6, DOI 10.1007/978-94-009-6542-3_6]; GARRELS RM, 1967, EQUILIBRIUM CONCEPTS, P222; HOLLAND HD, 1984, CHEM EVOLUTION ATMOS, P128; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; KAUFFMAN JB, 1995, OECOLOGIA, V104, P397, DOI 10.1007/BF00341336; LASAGA AC, 1994, GEOCHIM COSMOCHIM AC, V58, P2361, DOI 10.1016/0016-7037(94)90016-7; LIKENS GE, 1995, BIOGEOCHEMISTRY FORE, P46; MCCOLL J G, 1968, Northwest Science, V42, P134; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Ohte N, 1999, GLOBAL BIOGEOCHEM CY, V13, P969, DOI 10.1029/1999GB900029; RANTZ SZ, 1982, MEASUREMENT COMPUTAT, V1; RICHTER DD, 1991, ADV ECOL RES, V21, P315, DOI 10.1016/S0065-2504(08)60100-2; Sombroek W. G., 1984, The Amazon: limnology and landscape ecology of a mighty tropical river and its basin, P521; SOMBROEK WG, 1996, AMAZON SOIL RECONNAI; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; Stumm W., 1996, AQUATIC CHEM CHEM EQ, P872; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; [No title captured]	26	113	119	1	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					802	805		10.1038/35071052	http://dx.doi.org/10.1038/35071052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298445				2022-12-01	WOS:000168021900051
J	Orlic, D; Kajstura, J; Chimenti, S; Jakoniuk, I; Anderson, SM; Li, BS; Pickel, J; McKay, R; Nadal-Ginard, B; Bodine, DM; Leri, A; Anversa, P				Orlic, D; Kajstura, J; Chimenti, S; Jakoniuk, I; Anderson, SM; Li, BS; Pickel, J; McKay, R; Nadal-Ginard, B; Bodine, DM; Leri, A; Anversa, P			Bone marrow cells regenerate infarcted myocardium	NATURE			English	Article							GROWTH-FACTOR-I; STEM-CELLS; ADULT MICE; C-KIT; EXPRESSION; HEART; VIVO; DIFFERENTIATE; PROLIFERATION; HYPERTROPHY	Myocardial infarction leads to loss of tissue and impairment of cardiac performance. The remaining myocytes are unable to reconstitute the necrotic tissue, and the post-infarcted heart deteriorates with time(1). Injury to a target organ is sensed by distant stem cells, which migrate to the site of damage and undergo alternate stem cell differentiation(2-5); these events promote structural and functional repair(6-8). This high degree of stem cell plasticity prompted us to test whether dead myocardium could be restored by transplanting bone marrow cells in infarcted mice. We sorted lineage-negative (Lin(-)) bone marrow cells from transgenic mice expressing enhanced green fluorescent protein(9) by fluorescence-activated cell sorting on the basis of c-kit expression(10). Shortly after coronary ligation, Lin(-) c-kit(POS) cells were injected in the contracting wall bordering the infarct. Here we report that newly formed myocardium occupied 68% of the infarcted portion of the ventricle 9 days after transplanting the bone marrow cells. The developing tissue comprised proliferating myocytes and vascular structures. Our studies indicate that locally delivered bone marrow cells can generate de novo myocardium, ameliorating the outcome of coronary artery disease.	New York Med Coll, Dept Med, Valhalla, NY 10595 USA; NHGRI, Hematopoiesis Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	New York Medical College; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Anversa, P (corresponding author), New York Med Coll, Dept Med, Valhalla, NY 10595 USA.							Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kajstura J, 2000, AM J PATHOL, V156, P813, DOI 10.1016/S0002-9440(10)64949-8; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Leri A, 1998, CIRCULATION, V97, P194, DOI 10.1161/01.CIR.97.2.194; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Li BS, 1999, CIRC RES, V84, P1007, DOI 10.1161/01.RES.84.9.1007; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cellbio.11.1.35; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; ORLIC D, 1993, BLOOD, V82, P762, DOI 10.1182/blood.V82.3.762.bloodjournal823762; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Theise ND, 2000, HEPATOLOGY, V32, P11, DOI 10.1053/jhep.2000.9124; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Vogel G, 2000, SCIENCE, V290, P1672, DOI 10.1126/science.290.5497.1672	30	4037	4667	4	544	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					701	705		10.1038/35070587	http://dx.doi.org/10.1038/35070587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287958				2022-12-01	WOS:000167875400050
J	Jones, LJF; Carballido-Lopez, R; Errington, J				Jones, LJF; Carballido-Lopez, R; Errington, J			Control of cell shape in bacteria: Helical, actin-like filaments in Bacillus subtilis	CELL			English	Article							PENICILLIN-BINDING-PROTEINS; ESCHERICHIA-COLI; SEPTUM PLACEMENT; ROD SHAPE; GENE; DIVISION; CHROMOSOME; SEQUENCE; CYCLE; CYTOSKELETON	In the absence of an overt cytoskeleton, the external cell wall of bacteria has traditionally been assumed to be the primary determinant of cell shape. In the Grampositive bacterium Bacillus subtilis, two related genes, mreB and mbl, were shown to be required for different aspects of cell morphogenesis. Subcellular localization of the MreB and Mbl proteins revealed that each forms a distinct kind of filamentous helical structure lying close to the cell surface. The distribution of the proteins in different species of bacteria, and the similarity of their sequence to eukaryotic actins, suggest that the MreB-like proteins have a cytoskeletal, actin-like role in bacterial cell morphogenesis.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Errington, J (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.		LOPEZ, RUT CARBALLIDO/G-2283-2015; Errington, Jeff/G-1832-2011	LOPEZ, RUT CARBALLIDO/0000-0001-9383-8811; Errington, Jeff/0000-0002-6977-9388				ABHAYAWARDHANE Y, 1995, J BACTERIOL, V177, P765, DOI 10.1128/jb.177.3.765-773.1995; ASYCOUGH KR, 1996, ANNU REV CELL DEV BI, V12, P129; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Daniel RA, 1996, J BACTERIOL, V178, P2343, DOI 10.1128/jb.178.8.2343-2350.1996; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; FEUCHT A, 2001, IN PRESS MOL MICROBI; Glaser P, 1997, GENE DEV, V11, P1160, DOI 10.1101/gad.11.9.1160; HAUSER PM, 1995, J BACTERIOL, V177, P3923, DOI 10.1128/jb.177.14.3923-3931.1995; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; HOLMES M, 1980, J BACTERIOL, V142, P254, DOI 10.1128/JB.142.1.254-261.1980; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; HONEYMAN AL, 1989, MOL MICROBIOL, V3, P1257, DOI 10.1111/j.1365-2958.1989.tb00276.x; ITAYA M, 1989, NUCLEIC ACIDS RES, V17, P4410, DOI 10.1093/nar/17.11.4410; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KORN ED, 1987, SCIENCE, V238, P638, DOI 10.1126/science.3672117; LEVIN PA, 1992, J BACTERIOL, V174, P6717, DOI 10.1128/JB.174.21.6717-6728.1992; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; Lewis PJ, 1999, GENE, V227, P101, DOI 10.1016/S0378-1119(98)00580-0; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Marston AL, 1999, MOL CELL, V4, P673, DOI 10.1016/S1097-2765(00)80378-0; Mata J, 1998, TRENDS CELL BIOL, V8, P163, DOI 10.1016/S0962-8924(98)01224-0; MUKHERJEE A, 1994, J BACTERIOL, V176, P2754, DOI 10.1128/JB.176.9.2754-2758.1994; NGUYEN LH, 1993, PROT OVEREXP PURIF, V4, P452; Pruyne D, 2000, J CELL SCI, V113, P571; Sambrook J., 1989, MOL CLONING LAB MANU; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; STEINMETZ M, 1994, GENE, V142, P79, DOI 10.1016/0378-1119(94)90358-1; STEVENS CM, 1992, J BACTERIOL, V174, P586, DOI 10.1128/jb.174.2.586-594.1992; TAMAKI S, 1980, J BACTERIOL, V141, P52, DOI 10.1128/JB.141.1.52-57.1980; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; VARLEY AW, 1992, J BACTERIOL, V174, P6729, DOI 10.1128/JB.174.21.6729-6742.1992; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014	35	719	735	2	114	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					913	922		10.1016/S0092-8674(01)00287-2	http://dx.doi.org/10.1016/S0092-8674(01)00287-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290328	Bronze			2022-12-01	WOS:000167869200013
J	Hellberg, ME; Balch, DP; Roy, K				Hellberg, ME; Balch, DP; Roy, K			Climate-driven range expansion and morphological evolution in a marine gastropod	SCIENCE			English	Article							GENE FLOW; DNA-SEQUENCES; ICE AGES; SPECIATION; PLEISTOCENE; POPULATIONS; GRADIENTS; RECORD; SIZE	Little is known about the phenotypic consequences of global climate change, despite the excellent Pleistocene fossil record of many taxa. We used morphological measurements from extant and Pleistocene populations of a marine gastropod (Acanthinucella spirata) in conjunction with mitochondrial DNA sequence variation from Living populations to determine how populations responded phenotypically to Pleistocene climatic changes. Northern populations show Little sequence variation as compared to southern populations, a pattern consistent with a recent northward range expansion. These recently recolonized northern populations also contain shell morphologies that are absent in extant southern populations and throughout the Pleistocene fossil record, Thus, contrary to traditional expectations that morphological evolution should occur Largely within Pleistocene refugia, our data show that geographical range shifts in response to climatic change can Lead to significant morphological evolution.	Univ Calif San Diego, Div Biol, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	University of California System; University of California San Diego; Louisiana State University System; Louisiana State University	Roy, K (corresponding author), Univ Calif San Diego, Div Biol, Sect Ecol Behav & Evolut, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Avise JC, 2000, PHYLOGEOGRAPHY HIST; Bell M. A., 1997, V82, P323; Bernardi G, 2000, EVOLUTION, V54, P226, DOI 10.1111/j.0014-3820.2000.tb00023.x; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Chiba S, 1998, PALEOBIOLOGY, V24, P99, DOI 10.1017/S0094837300019990; EXCOFFIER L, 1992, GENETICS, V131, P479; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; GIANNINY GL, 1992, VELIGER, V35, P195; Graham RW, 1996, SCIENCE, V272, P1601; Hadly EA, 1998, P NATL ACAD SCI USA, V95, P6893, DOI 10.1073/pnas.95.12.6893; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Kennedy G.L., 1978, THESIS U CALIFORNIA, pvii; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Lindberg David R., 1996, P161; Losos JB, 1997, NATURE, V387, P70, DOI 10.1038/387070a0; Marko PB, 1998, EVOLUTION, V52, P757, DOI 10.1111/j.1558-5646.1998.tb03700.x; Marko PB, 1999, MOL PHYLOGENET EVOL, V13, P275, DOI 10.1006/mpev.1999.0655; Nei M., 1987, MOL EVOLUTIONARY GEN; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Price TD, 1997, EVOLUTION, V51, P552, DOI 10.1111/j.1558-5646.1997.tb02442.x; Roy K, 1997, TRENDS ECOL EVOL, V12, P277, DOI 10.1016/S0169-5347(97)81026-9; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Roy K, 1996, TRENDS ECOL EVOL, V11, P458, DOI 10.1016/0169-5347(96)10054-9; ROY K, 1995, GEOLOGY, V23, P1071, DOI 10.1130/0091-7613(1995)023<1071:TAARPI>2.3.CO;2; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; SLATKIN M, 1991, GENETICS, V129, P555; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; SPIGHT T M, 1977, Nautilus, V91, P67; SWOFFORD DL, 1998, PAUP STAR PHYLOGENET; TAJIMA F, 1983, GENETICS, V105, P437; VALENTINE JW, 1966, LIMNOL OCEANOGR, V11, P198, DOI 10.4319/lo.1966.11.2.0198; VALENTINE JW, 1989, PALEOBIOLOGY, V15, P83, DOI 10.1017/S0094837300009295; Zink RM, 2000, CONSERV BIOL, V14, P1394, DOI 10.1046/j.1523-1739.2000.99082.x	39	136	141	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1707	1710		10.1126/science.1060102	http://dx.doi.org/10.1126/science.1060102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387473				2022-12-01	WOS:000169031800042
J	Shirali, GS; Ni, JY; Chinnock, RE; Johnston, JK; Rosenthal, GL; Bowles, NE; Towbin, JA				Shirali, GS; Ni, JY; Chinnock, RE; Johnston, JK; Rosenthal, GL; Bowles, NE; Towbin, JA			Association of viral genome with graft loss in children after cardiac transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLYMERASE-CHAIN-REACTION; IDIOPATHIC DILATED CARDIOMYOPATHY; INFANT HEART-TRANSPLANTATION; NUCLEIC-ACID HYBRIDIZATION; CORONARY-ARTERY DISEASE; COXSACKIEVIRUS B3 RNA; ENDOMYOCARDIAL BIOPSY; CYTOMEGALOVIRUS-INFECTION; ENTEROVIRUS RNA; ENDOCARDIAL FIBROELASTOSIS	Background: The survival of recipients of cardiac allografts is limited by rejection and coronary vasculopathy. The purpose of this study in children who had received heart transplants was to evaluate the cardiac allografts for myocardial viral infections and to determine whether the presence of viral genome in the myocardium correlates with rejection, coronary vasculopathy, or graft loss. Methods: We enrolled heart-transplant recipients 1 day to 18 years old who were undergoing evaluation for possible rejection and coronary vasculopathy. Endomyocardial-biopsy specimens were evaluated for evidence of rejection with the use of standard criteria and were analyzed for the presence of virus by the polymerase chain reaction (PCR). Results: PCR analyses were performed on 553 consecutive biopsy samples from 149 transplant recipients. Viral genome was amplified from 48 samples (8.7 percent) from 34 patients (23 percent); adenovirus was found in 30 samples, enterovirus in 9 samples, parvovirus in 5 samples, cytomegalovirus in 2 samples, herpes simplex virus in 1 sample, and Epstein-Barr virus in 1 sample. In 29 of the 34 patients with positive results on PCR (85 percent), an adverse cardiac event occurred within three months after the positive biopsy, and 9 of the 34 patients had graft loss due to coronary vasculopathy, chronic graft failure, or acute rejection. In 39 of the 115 patients with negative results on PCR (34 percent), an adverse cardiac event occurred within three months of the negative PCR finding; graft loss did not occur in any of the patients in this group. The odds of graft loss were 6.5 times as great among those with positive results on PCR (P = 0.006). The detection of adenovirus was associated with considerably reduced graft survival (P = 0.002). Conclusions: Identification of viral genome, particularly adenovirus, in the myocardium of pediatric transplant recipients is predictive of adverse clinical events, including coronary vasculopathy and graft loss. (N Engl J Med 2001;344:1498-503.) Copyright (C) 2001 Massachusetts Medical Society.	Baylor Coll Med, Dept Pediat Cardiol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Cardiovasc Sci, Houston, TX 77030 USA; Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA; Loma Linda Univ, Childrens Hosp, Dept Ambulatory Pediat, Loma Linda, CA 92350 USA; Loma Linda Univ, Childrens Hosp, Dept Nursing, Loma Linda, CA 92350 USA; Univ Washington, Dept Pediat Cardiol, Seattle, WA 98195 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Medical University of South Carolina; Children's Hospital Los Angeles; Loma Linda University; Children's Hospital Los Angeles; Loma Linda University; University of Washington; University of Washington Seattle	Towbin, JA (corresponding author), Baylor Coll Med, Dept Pediat Cardiol, Rm 333E,1 Baylor Plaza, Houston, TX 77030 USA.		Towbin, Jeffrey A./J-5595-2019	Towbin, Jeffrey A./0000-0002-6585-714X; Chinnock, Richard/0000-0002-9814-1762				Akhtar N, 1999, CIRCULATION, V99, P2011, DOI 10.1161/01.CIR.99.15.2011; Billingham M E, 1990, J Heart Transplant, V9, P587; BOUCEK MM, 1993, J HEART LUNG TRANSPL, V12, P824; BOUCEK MM, 1994, J HEART LUNG TRANSPL, V13, P66; BOWLES NE, 1989, CIRCULATION, V80, P1128, DOI 10.1161/01.CIR.80.5.1128; BOWLES NE, 1986, LANCET, V1, P1120; Bridges ND, 1998, J THORAC CARDIOV SUR, V116, P617, DOI 10.1016/S0022-5223(98)70168-0; CHAPMAN NM, 1990, J CLIN MICROBIOL, V28, P843, DOI 10.1128/JCM.28.5.843-850.1990; CHOW LH, 1989, J AM COLL CARDIOL, V14, P915, DOI 10.1016/0735-1097(89)90465-8; EISENSTEIN BI, 1990, NEW ENGL J MED, V322, P178; EVERETT JP, 1992, J HEART LUNG TRANS S, V11, P133; FABRICANT CG, 1978, J EXP MED, V148, P335, DOI 10.1084/jem.148.1.335; GRASSO M, 1992, AM J CARDIOL, V69, P658, DOI 10.1016/0002-9149(92)90160-Z; GRATTAN MT, 1989, JAMA-J AM MED ASSOC, V261, P3561, DOI 10.1001/jama.261.24.3561; GRIFFIN LD, 1995, CARDIOVASC PATHOL, V4, P3, DOI 10.1016/1054-8807(94)00025-M; HAUCK AJ, 1989, MAYO CLIN PROC, V64, P1235, DOI 10.1016/S0025-6196(12)61286-5; HILTON DA, 1993, J PATHOL, V170, P45, DOI 10.1002/path.1711700108; JIN O, 1990, CIRCULATION, V82, P8, DOI 10.1161/01.CIR.82.1.8; KANDOLF R, 1987, P NATL ACAD SCI USA, V84, P6272, DOI 10.1073/pnas.84.17.6272; KOSKINEN PK, 1993, J HEART LUNG TRANSPL, V12, P724; LIE JT, 1988, ANN INTERN MED, V109, P525, DOI 10.7326/0003-4819-109-7-525; LOEBE M, 1990, J HEART TRANSPLANT, V9, P707; MARTIN AB, 1994, CIRCULATION, V90, P330, DOI 10.1161/01.CIR.90.1.330; MCDONALD K, 1989, AM J CARDIOL, V64, P359, DOI 10.1016/0002-9149(89)90535-3; MELNICK JL, 1990, JAMA-J AM MED ASSOC, V263, P2204, DOI 10.1001/jama.263.16.2204; MORGANCAPNER P, 1984, VIRAL HEART DISEASE, P99; MUIR P, 1993, J CLIN MICROBIOL, V31, P31, DOI 10.1128/JCM.31.1.31-38.1993; Ni JY, 1997, CIRCULATION, V95, P133, DOI 10.1161/01.CIR.95.1.133; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; PETITJEAN J, 1992, J MED VIROL, V37, P76, DOI 10.1002/jmv.1890370114; PETITJEAN J, 1993, J MED VIROL, V41, P260; REDLINE RW, 1991, AM J CLIN PATHOL, V96, P568; Schowengerdt KO, 1997, CIRCULATION, V96, P3549; Schowengerdt KO, 1996, J HEART LUNG TRANSPL, V15, P111; WEISS LM, 1991, AM J PATHOL, V138, P497; WEISS LM, 1992, J CLIN INVEST, V90, P156, DOI 10.1172/JCI115830; Winters GL, 1998, J HEART LUNG TRANSPL, V17, P754	37	135	146	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1498	1503		10.1056/NEJM200105173442002	http://dx.doi.org/10.1056/NEJM200105173442002			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357152				2022-12-01	WOS:000168677200002
J	Larson, EB				Larson, EB			General internal medicine at the crossroads of prosperity and despair: Caring for patients with chronic diseases in an aging society	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE; CONTINUITY; THROMBOSIS; THERAPY; HOME	During the past quarter century, general internal medicine has emerged as a vital discipline. In the realm of patient care, it is the integrating discipline par excellence. Ironically, as general internists face the challenge of integrating advances of dizzying speed and complexity, and as their clinical practice becomes increasingly effective, it has become much more difficult for them to earn a living. General internists find themselves at the crossroads of prosperity and despair. Although general medicine research leads the research agenda in many departments of medicine, it is particularly vulnerable. The necessary multidisciplinary "programmatic" infrastructure is expensive, and results often take many years to obtain, particularly in the study of chronic disease. The educational environment in many institutions is particularly difficult for general medicine, both because the current emphasis on technical skills obscures patients' and learners' real needs and because complex patients on general medicine services are now so ill and their turnover so rapid. General internal medicine and geriatrics are synergistic, especially in today's marketplace. A focus on geriatric medicine could help general medicine continue to flourish. General internists are ideally suited to the integrated care of elderly patients with multiple problems, research opportunities are enormous in the geriatric population, and the teaching of geriatrics requires a high level of generalist skills. Problems that plague current generalist practice have unique significance to older patients. Organizations that represent general internists would do well to join forces with many other advocacy groups, especially those representing the interests of elderly patients and geriatric medicine.	Univ Washington, Med Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Larson, EB (corresponding author), Univ Washington, Med Ctr, Box 356330, Seattle, WA 98195 USA.	ebl@u.washington.edu						Burdi MD, 1999, HEALTH AFFAIR, V18, P134, DOI 10.1377/hlthaff.18.4.134; CAMPION EW, 1984, JAMA-J AM MED ASSOC, V252, P2459; Cunningham PJ, 2000, HEALTH AFFAIR, V19, P158, DOI 10.1377/hlthaff.19.3.158; EICHNA LW, 1980, NEW ENGL J MED, V303, P727, DOI 10.1056/NEJM198009253031304; Every NR, 1996, NEW ENGL J MED, V335, P1253, DOI 10.1056/NEJM199610243351701; FITZGERALD FT, 1990, WESTERN J MED, V152, P377; Grumbach K, 1999, NEW ENGL J MED, V341, P2008, DOI 10.1056/NEJM199912233412611; KASSIRER JP, 1983, NEW ENGL J MED, V309, P921, DOI 10.1056/NEJM198310133091511; KERN DC, 1985, JAMA-J AM MED ASSOC, V254, P70, DOI 10.1001/jama.254.1.70; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; LaCombe MA, 1997, ANN INTERN MED, V126, P217, DOI 10.7326/0003-4819-126-3-199702010-00007; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LEWIS CE, 1977, NEW ENGL J MED, V297, P423, DOI 10.1056/NEJM197708252970805; LOWRIE EG, 1981, NEW ENGL J MED, V305, P434, DOI 10.1056/NEJM198108203050805; *MA DEP PUBL HLTH, 1975, NEW ENGL J MED, V293, P775; MALMIVAARA A, 1995, NEW ENGL J MED, V332, P351, DOI 10.1056/NEJM199502093320602; Panzer RI, 1991, DIAGNOSTIC STRATEGIE; ROBACK G, 1977, PHYSICIAN DISTRIBUTI; ROBERG N, 1988, JAMA-J AM MED ASSOC, V260, P3645; SACKETT DL, 1987, J GEN INTERN MED, V2, P40, DOI 10.1007/BF02596250; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413	23	31	31	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					997	1000		10.7326/0003-4819-134-10-200105150-00013	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352700				2022-12-01	WOS:000168682500007
J	Tolfvenstam, T; Papadogiannakis, N; Norbeck, O; Petersson, K; Broliden, K				Tolfvenstam, T; Papadogiannakis, N; Norbeck, O; Petersson, K; Broliden, K			Frequency of human parvovirus B19 infection in intrauterine fetal death	LANCET			English	Article							ANTIGEN	Background Parvovirus B19 is known to cause fetal death in the second trimester, mainly in combination with hydrops fetalis. However, the frequency of parvovirus-B19-associated non-hydropic fetal loss in the late second and third trimester has not been thoroughly investigated. We aimed to investigate the frequency of parvovirus B19 infection in unselected cases of intrauterine fetal death and to assess the sensitivity of different diagnostic procedures. Methods Of 14 147 deliveries in three hospitals in the major Stockholm area of Sweden. all cases of intrauterine fetal death (greater than or equal to 22 gestational weeks) that occurred between January, 1998, and May, 1999 (n=47), referred cases of miscarriage (<22 gestational weeks, n=37), and induced abortions (n=29), were included in the study. Placental and fetal tissues were examined by means of parvovirus-B19-specific PCR, histopathology, and immunohistochemistry. Placental tissues from 53 normal pregnancies at term were also examined. Findings Significantly more cases of intrauterine fetal death were positive for parvovirus B19 DNA (seven [15%]) than were normal pregnancies at term (zero, p=0.049). Furthermore. parvovirus B19 DNA was found in two (5%) of the miscarriages but not in any of the cases of induced abortion. Only three of nine DNA-positive cases had parvovirus-B19-associated inclusions and stained positive for viral proteins. All but one of the DNA-positive cases of intrauterine fetal death were non-hydropic. Interpretation The presence of parvovirus B19 DNA in cases of late second-trimester and third-trimester fetal death is common, and most are non-hydropic. The sensitivity of conventional diagnostic procedures for intrauterine fetal death could be greatly improved by addition of parvovirus B19 PCR.	Huddinge Univ Hosp, Karolinska Inst, Dept Clin Virol, SE-14186 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Pathol, SE-14186 Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Obstet & Gynecol, SE-14186 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Tolfvenstam, T (corresponding author), Huddinge Univ Hosp, Karolinska Inst, Dept Clin Virol, SE-14186 Stockholm, Sweden.	Thomas.Tolfvenstam@impi.ki.se		Tolfvenstam, Thomas/0000-0003-3549-8083				ANAND A, 1987, NEW ENGL J MED, V316, P183, DOI 10.1056/NEJM198701223160403; ANDERSON MJ, 1983, LANCET, V1, P1378; ANDERSON MJ, 1987, LANCET, V1, P738; Broliden K, 1998, MED PEDIATR ONCOL, V31, P66; BROWN KE, 1993, SCIENCE, V262, P114, DOI 10.1126/science.8211117; BROWN KE, 1989, BRIT J OBSTET GYNAEC, V96, P764, DOI 10.1111/j.1471-0528.1989.tb03313.x; BROWN T, 1984, LANCET, V2, P1033; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P81; Centers for Disease Control (CDC), 1989, MMWR MORB MORTAL WKL, V38, P93; CLEWLEY JP, 1987, J MED VIROL, V23, P367, DOI 10.1002/jmv.1890230409; COHEN BJ, 1988, J MED MICROBIOL, V25, P151, DOI 10.1099/00222615-25-2-151; EHRLICH HA, 1989, PCR TECHNOLOGY PRINC, P193; ENDERS G, 1990, Behring Institute Mitteilungen, P74; FRICKHOFEN N, 1990, ANN INTERN MED, V113, P926, DOI 10.7326/0003-4819-113-12-926; HALL SM, 1990, BMJ-BRIT MED J, V300, P1166; Miller E, 1998, BRIT J OBSTET GYNAEC, V105, P174, DOI 10.1111/j.1471-0528.1998.tb10048.x; MOREY AL, 1992, BRIT J OBSTET GYNAEC, V99, P566, DOI 10.1111/j.1471-0528.1992.tb13822.x; PATTISON JR, 1981, LANCET, V1, P664; RODIS JF, 1988, OBSTET GYNECOL, V72, P733; Rogers BB, 1999, PEDIATR DEVEL PATHOL, V2, P296, DOI 10.1007/s100249900128; SERJEANT GR, 1993, LANCET, V341, P1237, DOI 10.1016/0140-6736(93)91145-C; Skjoldebrand-Sparre K, 2000, BRIT J OBSTET GYNAEC, V107, P476, DOI 10.1111/j.1471-0528.2000.tb13265.x; TOROK TJ, 1990, PEDIATR INFECT DIS J, V9, P772; WOOLF AD, 1989, ARCH INTERN MED, V149, P1153, DOI 10.1001/archinte.149.5.1153	24	103	114	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1494	1497		10.1016/S0140-6736(00)04647-X	http://dx.doi.org/10.1016/S0140-6736(00)04647-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377602				2022-12-01	WOS:000168614300014
J	Ganzini, L; Nelson, HD; Lee, MA; Kraemer, DF; Schmidt, TA; Delorit, MA				Ganzini, L; Nelson, HD; Lee, MA; Kraemer, DF; Schmidt, TA; Delorit, MA			Oregon physicians' attitudes about and experiences with end-of-life care since passage of the Oregon Death with Dignity Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSISTED SUICIDE; PATIENT REQUESTS; EUTHANASIA; PAIN; DIE	Context The Oregon Death with Dignity Act, passed by ballot measure in 1994 and enacted in October 1997, legalized physician-assisted suicide for competent, terminally ill Oregonians, but little is known about the effects of the act on clinical practice or physician perspective. Objective To examine Oregon physicians' attitudes toward and practices regarding care of dying patients since the passage of the Death with Dignity Act. Design, Setting, and Participants A self-administered questionnaire was mailed in February 1999 to Oregon physicians eligible to prescribe under the act. Of 3981 eligible physicians, 2641 (66%) returned the questionnaire by August 1999. Main Outcome Measures Physicians' reports of their efforts to improve care for dying patients since 1994, their attitudes, concerns, and sources of information about participating in the Death with Dignity Act, and their conversations with patients regarding assisted suicide. Results A total of 791 respondents (30%) reported that they had increased referrals to hospice. Of the 2094 respondents who cared for terminally ill patients, 76% reported that they made efforts to improve their knowledge of the use of pain medications in the terminally ill. Nine hundred forty-nine responding physicians (36%) had been asked by a patient if they were potentially willing to prescribe a lethal medication, Seven percent of all survey participants reported that 1 or more patients became upset after learning the physician's position on assisted suicide, and 2% reported that 1 or more patients left their care after learning the physician's position on assisted suicide. Of the 73 physicians who were willing to write a lethal prescription and who had received a request from a patient, 20 (27%) were not confident they could determine when a patient had less than 6 months to live. Conclusion Most Oregon physicians who care for terminally ill patients report that since 1994 they have made efforts to improve their ability to care for these patients acid many have had conversations with patients about assisted suicide.	Dept Vet Affairs, Portland, OR USA; Oregon Hlth Sci Univ, Dept Psychiat, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Dept Emergency Med, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Div Med Informat & Outcomes Res, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Ctr Eth & Hlth Care, Portland, OR 97201 USA; Providence Hlth Syst, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Ganzini, L (corresponding author), Vet Adm Med Ctr, Div Mental Hlth, P31DMH,POB 1034, Portland, OR 97207 USA.							ALPERS A, 1995, JAMA-J AM MED ASSOC, V274, P483, DOI 10.1001/jama.274.6.483; Bernat JL, 1997, SEMIN NEUROL, V17, P271, DOI 10.1055/s-2008-1040939; BLOCK SD, 1995, PSYCHOSOMATICS, V36, P445, DOI 10.1016/S0033-3182(95)71625-5; Caplan A L, 1997, Hosp J, V12, P17; *COMM PHYS ASS DEA, 1996, SUICIDE LIFE-THREAT, V26, P1; Emanuel EJ, 1996, ARCH INTERN MED, V156, P825, DOI 10.1001/archinte.156.8.825; Faber-Langendoen K, 1998, CANCER-AM CANCER SOC, V82, P35, DOI 10.1002/(SICI)1097-0142(19980101)82:1<35::AID-CNCR4>3.3.CO;2-#; FOLEY KM, 1991, J PAIN SYMPTOM MANAG, V6, P289, DOI 10.1016/0885-3924(91)90052-6; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Haley K., 1998, OREGON DEATH DIGNITY; Kelly BJ, 1996, AUST NZ J PSYCHIAT, V30, P3, DOI 10.3109/00048679609076068; MILES SH, 1994, JAMA-J AM MED ASSOC, V271, P1786, DOI 10.1001/jama.271.22.1786; Muskin PR, 1998, JAMA-J AM MED ASSOC, V279, P323, DOI 10.1001/jama.279.4.323; Portenoy RK, 1997, PSYCHOSOMATICS, V38, P277, DOI 10.1016/S0033-3182(97)71465-8; Quill TE, 1998, ANN INTERN MED, V128, P552, DOI 10.7326/0003-4819-128-7-199804010-00006; SINGER PA, 1990, NEW ENGL J MED, V322, P1881, DOI 10.1056/NEJM199006283222610; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; Tolle SW, 2000, WESTERN J MED, V172, P374, DOI 10.1136/ewjm.172.6.374; Tolle SW, 1998, ANN INTERN MED, V128, P567, DOI 10.7326/0003-4819-128-7-199804010-00009; Tolle SW, 1999, ANN INTERN MED, V130, P681, DOI 10.7326/0003-4819-130-8-199904200-00015	20	96	96	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2363	2369		10.1001/jama.285.18.2363	http://dx.doi.org/10.1001/jama.285.18.2363			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NB	11343484	Bronze			2022-12-01	WOS:000168411200028
J	Crisci, C				Crisci, C			Internet therapy	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1131	1131		10.1136/bmj.322.7294.1131	http://dx.doi.org/10.1136/bmj.322.7294.1131			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337456	Green Published			2022-12-01	WOS:000168628300057
J	Kral, AH; Bluthenthal, RN; Lorvick, J; Gee, L; Bacchetti, P; Edlin, BR				Kral, AH; Bluthenthal, RN; Lorvick, J; Gee, L; Bacchetti, P; Edlin, BR			Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis	LANCET			English	Article							REPEAT ANONYMOUS TESTERS; CRACK COCAINE USERS; PREVENTION INTERVENTION; HARM REDUCTION; SEROCONVERSION; SEROPREVALENCE; BEHAVIOR; FEMALE; EXCHANGE; SYRINGE	Background Many new HIV-1 infections in the USA occur in injection drug users (IDUs). HIV-1 seroconversion of IDUs is mainly associated with injection-related risk factors. Harm-reduction programmes concentrate on injection-risk behaviour. We aimed to establish whether injection or sexual risk factors, or both, were associated with HIV-1 antibody seroconversion of street-recruited IDUs in San Francisco. from 1986 to 1998. Methods IDUs were enrolled every 6 months from four community sites. We did a nested case-control study comparing 58 respondents who seroconverted between Visits with 1134 controls who remained seronegative. Controls were matched with cases by sex and date. Adjusted odds ratios and 95% CI were calculated for men and women by use of conditional logistic regression. Findings Men who had sex with men were 8.8 times as likely to seroconvert (95% CI 3.7-20.5) as heterosexual men. Women who reported having traded sex for money in the past year were 5.1 times as likely as others to seroconvert (95% CI 1.9-13.7). Women younger than 40 years were more likely to seroconvert than those 40 years or older (2.8 [1.05-7.6]). and women who reported having a steady sex-partner who injected drugs were less likely to seroconvert than other women (0.32 [0.11-0.92]). Interpretation HIV-1 seroconversion of street-recruited IDUs in San Francisco is strongly associated with sexual behaviour. HIV-1. risk might be reduced by incorporation of innovative sexual-risk-reduction strategies into harm-reduction programmes.	Univ Calif San Francisco, Inst Hlth Policy Studies, Urban Hlth Study, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94110 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Publ Hlth Biol & Epidemiol, Berkeley, CA 94720 USA; RAND Corp, Hlth Program, Los Angeles, CA USA; RAND Corp, Drug Policy Res Ctr, Los Angeles, CA USA; Charles R Drew Univ Med & Sci, Dept Psychiat, Los Angeles, CA 90059 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; RAND Corporation; RAND Corporation; Charles R. Drew University of Medicine & Science	Kral, AH (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, Urban Hlth Study, 3180 18th St, San Francisco, CA 94110 USA.	alkral@itsa.ucsf.edu	Bluthenthal, Ricky N/U-8203-2018; Edlin, Brian R/F-2966-2018	Bluthenthal, Ricky N/0000-0003-3491-1702; Edlin, Brian R/0000-0001-8172-8797; Lorvick, Jennifer/0000-0002-2836-3028; Kral, Alex/0000-0002-9092-3671	NIDA NIH HHS [R01-DA12109] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012109] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		[Anonymous], 1997, NIH Consens Statement, V15, P1; ASTEMBORSKI J, 1994, AM J PUBLIC HEALTH, V84, P382, DOI 10.2105/AJPH.84.3.382; Bluthenthal RN, 1998, J ACQ IMMUN DEF SYND, V18, P505, DOI 10.1097/00042560-199808150-00013; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; CALSYN DA, 1992, AM J PUBLIC HEALTH, V82, P573, DOI 10.2105/AJPH.82.4.573; CALSYN DA, 1992, AIDS, V6, P1207, DOI 10.1097/00002030-199210000-00023; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P465; *CDCP, 1991, MMWR-MORBID MORTAL W, V40, P692; DESJARLAIS DC, 1995, AM J PUBLIC HEALTH, V85, P10, DOI 10.2105/AJPH.85.1.10; Downing M, 1999, AIDS EDUC PREV, V11, P243; EDLIN BR, 1994, NEW ENGL J MED, V331, P1422, DOI 10.1056/NEJM199411243312106; Elifson KW, 1999, J ACQ IMMUN DEF SYND, V20, P195, DOI 10.1097/00042560-199902010-00013; Fishbein M, 1999, AM J PUBLIC HEALTH, V89, P336, DOI 10.2105/AJPH.89.3.336; Fisher DG, 1998, J PSYCHOACTIVE DRUGS, V30, P299; FRIEDMAN SR, 1995, AM J EPIDEMIOL, V142, P864, DOI 10.1093/oxfordjournals.aje.a117726; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; Kegeles SM, 1996, AM J PUBLIC HEALTH, V86, P1129, DOI 10.2105/AJPH.86.8_Pt_1.1129; Kellogg T, 1999, AIDS, V13, P2303, DOI 10.1097/00002030-199911120-00013; Kelly JA, 1997, LANCET, V350, P1500, DOI 10.1016/S0140-6736(97)07439-4; Kral AH, 1999, ADDICTION, V94, P675, DOI 10.1046/j.1360-0443.1999.9456755.x; Kral AH, 1998, AM J PUBLIC HEALTH, V88, P108, DOI 10.2105/AJPH.88.1.108; Kral AH, 2000, J ACQ IMMUN DEF SYND, V24, P162; KRAL AH, 1999, 127 M AM PUBL HLTH A; Latkin C A, 1998, Public Health Rep, V113 Suppl 1, P151; LURIE P, 1993, PUBLIC HLTH IMPACT N; McFarland W, 1997, AM J EPIDEMIOL, V146, P662, DOI 10.1093/oxfordjournals.aje.a009332; MOSS AR, 1994, AIDS, V8, P223, DOI 10.1097/00002030-199402000-00010; Nicolosi A, 1990, Epidemiology, V1, P453, DOI 10.1097/00001648-199011000-00007; NORMAND J, 1995, PREVENTING HIV TRANS; Paone D, 1995, J Am Med Womens Assoc (1972), V50, P109; Rhodes T, 1999, AIDS, V13, pS259; Rhodes T, 1996, SUBST USE MISUSE, V31, P375, DOI 10.3109/10826089609045817; *SAN FRANC DEP PUB, 1997, HIV PREV INC SAN FRA; SOLOMON L, 1993, AM J EPIDEMIOL, V137, P892, DOI 10.1093/oxfordjournals.aje.a116750; STRATHDEE SA, IN PRESS ARCH INTERN; VANAMEIJDEN EJC, 1992, AM J EPIDEMIOL, V136, P236, DOI 10.1093/oxfordjournals.aje.a116489; WATTERS JK, 1994, J ACQ IMMUN DEF SYND, V7, P1276; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; WEATHERBY NL, 1994, EVAL PROGRAM PLANN, V17, P347, DOI 10.1016/0149-7189(94)90035-3	40	298	302	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2001	357	9266					1397	1401		10.1016/S0140-6736(00)04562-1	http://dx.doi.org/10.1016/S0140-6736(00)04562-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	428TW	11356437				2022-12-01	WOS:000168478200011
J	Thomas, M; McKinley, RK; Freeman, E; Foy, C				Thomas, M; McKinley, RK; Freeman, E; Foy, C			Prevalence of dysfunctional breathing in patients treated for asthma in primary care: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							HYPERVENTILATION PROVOCATION TEST; PANIC DISORDER; QUESTIONNAIRE; PLACEBO	Objectives To estimate the prevalence of dysfunctional breathing in adults with asthma treated in the community. Design Postal questionnaire survey using Nijmegen questionnaire. Setting One general practice with 7033 patients, Participants All adult patients aged 17-65 with diagnosed asthma who were receiving treatment. Main outcome measure Score greater than or equal to 23 on Nijmegen questionnaire. Results 227/307 patients returned completed questionnaires; 219 (71.3%) questionnaires were suitable for analysis, 63 participants scored greater than or equal to 23. Those scoring greater than or equal to 23 were more likely to be female than male (46/132 (35%) v 17/87 (20%), P=0.016) and were younger (mean (SD) age 44.8 (14.7) v 49.0 (13.8, (P=0.05). Patients at different treatment steps of the British Thoracic Society asthma guidelines were affected equally. Conclusions About a third of women and a fifth of men had scores suggestive of dysfunctional breathing. Although further studies are needed to confirm the validity of this screening tool and these findings, these prevalences suggest scope for therapeutic intervention and may explain the anecdotal success of the Buteyko method of nearing asthma.	Surgery, Stroud GL6 9JF, Glos, England; Univ Leicester, Dept Gen Practice & Primary Hlth Care, Leicester LE5 4PW, Leics, England; Gloucestershire Hlth Author, Gloucestershire Res & Dev Support Unit, Gloucester GL1 2EL, England	University of Leicester	Thomas, M (corresponding author), Surgery, Stroud GL6 9JF, Glos, England.		McKinley, Robert Kee/H-9211-2013	McKinley, Robert Kee/0000-0002-3684-3435; Thomas, Mike/0000-0001-5939-1155				Bowler SD, 1998, MED J AUSTRALIA, V169, P575, DOI 10.5694/j.1326-5377.1998.tb123422.x; Britton J, 1998, BMJ-BRIT MED J, V317, P227, DOI 10.1136/bmj.317.7153.227; Carr RE, 1996, J ABNORM PSYCHOL, V105, P137, DOI 10.1037/0021-843X.105.1.137; Carr RE, 1998, J PSYCHOSOM RES, V44, P43, DOI 10.1016/S0022-3999(97)00137-2; DeGuire S, 1996, BIOFEEDBACK SELF-REG, V21, P191, DOI 10.1007/BF02284695; DEMETER SL, 1986, AM J MED, V81, P989, DOI 10.1016/0002-9343(86)90393-1; Dixhoorn J., 1997, BIOL PSYCHOL, V46, P90; Gardner WN, 1996, CHEST, V109, P516, DOI 10.1378/chest.109.2.516; GARDNER WN, 1986, LANCET, V1, P30; GARSSEN B, 1992, CLIN PSYCHOL REV, V12, P141, DOI 10.1016/0272-7358(92)90111-K; GROSSMAN P, 1985, J PSYCHOSOM RES, V29, P49, DOI 10.1016/0022-3999(85)90008-X; Han JN, 1999, AM J RESP CRIT CARE, V159, pA788; Han JN, 1997, EUR RESPIR J, V10, P167, DOI 10.1183/09031936.97.10010167; Hornsveld HK, 1996, LANCET, V348, P154, DOI 10.1016/S0140-6736(96)02024-7; HOWELL JBL, 1990, THORAX, V45, P287, DOI 10.1136/thx.45.4.287; HOWELL LBL, 1997, THORAX S, V52, pS30; LEWIS RA, 1986, B EUR PHYSIOPATH RES, V22, P201; LUM LC, 1994, BEHAV PSYCHOL APPROA; LUM LC, 1983, J DRUG RES, V8, P1867; *LUNG ASTHM INF AG, 1999, 991 LAIA; Malmberg LP, 2000, THORAX, V55, P295, DOI 10.1136/thorax.55.4.295; MARGARIAN GJ, 1982, MEDICINE, V61, P219; Maskell N, 1999, AM J RESP CRIT CARE, V159, pA832; McLean AN, 1999, AM J RESP CRIT CARE, V159, pA652; VANDIXHOORN J, 1985, J PSYCHOSOM RES, V29, P199, DOI 10.1016/0022-3999(85)90042-X; VANDIXHOORN J, 1998, ONTSPANNINGSINSTRUCT; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	27	127	129	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1098	1100		10.1136/bmj.322.7294.1098	http://dx.doi.org/10.1136/bmj.322.7294.1098			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	431JP	11337441	Green Submitted, Green Published			2022-12-01	WOS:000168628300023
J	Whincup, PH; Gilg, JA; Odoki, K; Taylor, SJC; Cook, DG				Whincup, PH; Gilg, JA; Odoki, K; Taylor, SJC; Cook, DG			Age of menarche in contemporary British teenagers: survey of girls born between 1982 and 1986	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England; Univ London Queen Mary & Westfield Coll, Dept Gen Practice & Primary Care Med Sci, London E1 4NS, England	St Georges University London; University of London; Queen Mary University London	Whincup, PH (corresponding author), St George Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England.			Taylor, Stephanie/0000-0001-7454-6354; Whincup, Peter/0000-0002-5589-4107; Cook, Derek/0000-0002-9723-5759	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ELLEN B, 2000, OBSERVER        0618, V1, P4; Eveleth P.B., 1990, WORLDWIDE VARIATION; TANNER JM, 1973, NATURE, V243, P95, DOI 10.1038/243095a0; Whincup PH, 1996, BMJ-BRIT MED J, V313, P79, DOI 10.1136/bmj.313.7049.79	4	105	109	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1095	1096		10.1136/bmj.322.7294.1095	http://dx.doi.org/10.1136/bmj.322.7294.1095			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337438	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000168628300020
J	Paterson, L; MacDonald, MP; Arlt, J; Sibbett, W; Bryant, PE; Dholakia, K				Paterson, L; MacDonald, MP; Arlt, J; Sibbett, W; Bryant, PE; Dholakia, K			Controlled rotation of optically trapped microscopic particles	SCIENCE			English	Article							GAUSSIAN LASER MODES; ORBITAL ANGULAR-MOMENTUM; LIGHT; BEAM	We demonstrate controlled rotation of optically trapped objects in a spiral interference pattern. This pattern is generated by interfering an annular shaped laser beam with a reference beam. Objects are trapped in the spiral arms of the pattern. Changing the optical path length causes this pattern, and thus the trapped objects, to rotate. Structures of silica microspheres, microscopic glass rods, and chromosomes are set into rotation at rates in excess of 5 hertz. This technique does not depend on intrinsic properties of the trapped particle and thus offers important applications in optical and biological micromachines.	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland	University of St Andrews; University of St Andrews	Dholakia, K (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.		MacDonald, Michael P/F-5880-2011; Arlt, Jochen/B-7435-2009; Dholakia, Kishan/C-9873-2009	MacDonald, Michael P/0000-0003-4415-5437; Arlt, Jochen/0000-0002-4152-5896; Paterson, Lynn/0000-0003-0493-5041; Dholakia, Kishan/0000-0001-6534-9009				ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; Beth RA, 1936, PHYS REV, V50, P115, DOI 10.1103/PhysRev.50.115; Clifford MA, 1998, OPT COMMUN, V156, P300, DOI 10.1016/S0030-4018(98)00464-7; Friese MEJ, 1998, NATURE, V394, P348, DOI 10.1038/28566; Friese MEJ, 1996, PHYS REV A, V54, P1593, DOI 10.1103/PhysRevA.54.1593; Friese MEJ, 2001, APPL PHYS LETT, V78, P547, DOI 10.1063/1.1339995; Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258; HE H, 1995, PHYS REV LETT, V75, P826, DOI 10.1103/PhysRevLett.75.826; LIANG H, 1993, EXP CELL RES, V204, P110, DOI 10.1006/excr.1993.1015; Padgett M, 1996, AM J PHYS, V64, P77, DOI 10.1119/1.18283; Simpson NB, 1997, OPT LETT, V22, P52, DOI 10.1364/OL.22.000052	13	802	841	12	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					912	914		10.1126/science.1058591	http://dx.doi.org/10.1126/science.1058591			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340200				2022-12-01	WOS:000168514900038
J	Yiangou, Y; Facer, P; Dyer, NHC; Chan, CLH; Knowles, C; Williams, NS; Anand, P				Yiangou, Y; Facer, P; Dyer, NHC; Chan, CLH; Knowles, C; Williams, NS; Anand, P			Vanilloid receptor 1 immunoreactivity in inflamed human bowel	LANCET			English	Article							NOCICEPTION; CAPSAICIN	Vanilloid receptor 1(VR1) is expressed by sensory neurons. Once activated, these neurons evoke the sensation of burning pain and release neuropeptides that induce neurogenic Inflammation. We used immunoblotting and immunostaining to estimate the density of VR1 in colonic tissues of patients with inflammatory bowel disease and of controls. Our study results indicate that VR1 immunoreactivity is greatly increased in colonic nerve fibres of patients with active inflammatory bowel disease. Thus, the discovery of new drugs that can bind the VRI receptor, or antagonise endogenous inflammatory substances that activate this receptor, could lead to new therapies for pain and dysmotility.	Hammersmith Hosp, Imperial Coll Sch Med, Peripheral Neuropathy Unit, London, England; Roche Biosci, Neurobiol Unit, Palo Alto, CA USA; St Bartholomews & Royal London Sch Med & Dent, Acad Dept Surg, London, England	Imperial College London; Roche Holding; University of London; Queen Mary University London	Anand, P (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Peripheral Neuropathy Unit, London, England.			Yiangou, Yiangos/0000-0003-3518-5474				Anand P, 1996, NAT MED, V2, P703, DOI 10.1038/nm0696-703; Baron R, 2000, LANCET, V356, P785, DOI 10.1016/S0140-6736(00)02649-0; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Yiangou Y, 2000, FEBS LETT, V467, P249, DOI 10.1016/S0014-5793(00)01166-2	5	290	317	2	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1338	1339		10.1016/S0140-6736(00)04503-7	http://dx.doi.org/10.1016/S0140-6736(00)04503-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343743				2022-12-01	WOS:000168411400016
J	Rice, L; Ruiz, W; Driscoll, T; Whitley, CE; Tapia, R; Hachey, DL; Gonzales, GF; Alfrey, CP				Rice, L; Ruiz, W; Driscoll, T; Whitley, CE; Tapia, R; Hachey, DL; Gonzales, GF; Alfrey, CP			Neocytolysis on descent from altitude: A newly recognized mechanism for the control of red cell mass	ANNALS OF INTERNAL MEDICINE			English	Article								Background: studies of space-flight anemia have uncovered a physiologic process, neocytolysis, by which young red blood cells are selectively hemolyzed, allowing rapid adaptation when red cell mass is excessive for a new environment. Objectives: 1) To confirm that neocytolysis occurs in another situation of acute plethora-when high-altitude dwellers with polycythemia descend to sea level; and 2) to clarify the role of erythropoietin suppression. Design: Prospective observational and interventional study. Setting: Cerro de Pasco (4380 m) and Lima (sea level), Peru. Participants: Nine volunteers with polycythemia. Interventions: Volunteers were transported to sea level; three received low-dose erythropoietin. Measurements: Changes in red cell mass, hematocrit, hemoglobin concentration, reticulocyte count, ferritin level, serum erythropoietin, and enrichment of administered C-13 in heme. Results: In six participants, red cell mass decreased by 7% to 10% within a few days of descent; this decrease was mirrored by a rapid increase in serum ferritin level, Reticulocyte production did not decrease, a finding that establishes a hemolytic mechanism. C-13 changes in circulating heme were consistent with hemolysis of young cells. Erythropoietin was suppressed, and administration of exogenous erythropoietin prevented the changes in red cell mass, serum ferritin level, and C-13-heme. Conclusions: Neocytolysis and the role of erythropoietin are confirmed in persons with polycythemia who descend from high altitude. This may have implications that extend beyond space and altitude medicine to renal disease and other situations of erythropoietin suppression, hemolysis, and polycythemia.	Baylor Coll Med, Houston, TX 77030 USA; Univ Peruana Cayetano Heredia, Lima, Peru	Baylor College of Medicine; Universidad Peruana Cayetano Heredia	Rice, L (corresponding author), 6565 Fannin,MS 902-Main, Houston, TX 77030 USA.	lrice@bcm.tmc.edu	Gonzales, Gustavo F/I-9153-2016	Gonzales, Gustavo F/0000-0003-1611-2894				ALFREY C, IN PRESS GRAVITY BIO; Alfrey CP, 1997, LANCET, V349, P1389, DOI 10.1016/S0140-6736(96)09208-2; Alfrey CP, 1996, J APPL PHYSIOL, V81, P98, DOI 10.1152/jappl.1996.81.1.98; [Anonymous], 1980, BRIT J HAEMATOL, V45, P659; ARRIE A, 1996, MASS SPECTROMETRY SO, P1; BESARAB A, 1993, AM J KIDNEY DIS, V22, P13, DOI 10.1016/0272-6386(93)70177-Z; CHRISTENSEN P, 1993, CRIT CARE MED, V21, P1535, DOI 10.1097/00003246-199310000-00023; HANN IM, 1991, FETAL NEONATAL HAEMA, P29; HUFF RL, 1951, MEDICINE, V30, P197, DOI 10.1097/00005792-195109000-00001; KOURY MJ, 1992, EUR J BIOCHEM, V210, P649, DOI 10.1111/j.1432-1033.1992.tb17466.x; LABBE RF, 1957, BIOCHIM BIOPHYS ACTA, V26, P437, DOI 10.1016/0006-3002(57)90033-1; MENTZER WC, 1971, J CLIN INVEST, V50, P688, DOI 10.1172/JCI106539; MERINO CF, 1950, BLOOD, V5, P1; PACE N, 1956, J APPL PHYSIOL, V9, P141, DOI 10.1152/jappl.1956.9.2.141; Rice L, 2000, PFLUG ARCH EUR J PHY, V441, pR91, DOI 10.1007/s004240000333; Rice L, 1999, AM J KIDNEY DIS, V33, P59, DOI 10.1016/S0272-6386(99)70258-1; SAMSON D, 1976, BRIT J HAEMATOL, V34, P33, DOI 10.1111/j.1365-2141.1976.tb00171.x; Trial J, 1999, BLOOD, V94, p405A; UDDEN MM, 1995, J LAB CLIN MED, V125, P442	19	107	116	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					652	656		10.7326/0003-4819-134-8-200104170-00010	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304105				2022-12-01	WOS:000168177500004
J	Burroughs, AK				Burroughs, AK			Assessment of value of consensus definitions in acute variceal bleeding	LANCET			English	Editorial Material							THERAPEUTIC STRATEGIES; PORTAL-HYPERTENSION; METHODOLOGY; WORKSHOP; BAVENO		Royal Free Hosp, Hepatobiliary & Liver Transplantat Unit, London NW3 2QG, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Burroughs, AK (corresponding author), Royal Free Hosp, Hepatobiliary & Liver Transplantat Unit, Pond St, London NW3 2QG, England.	andrew.burroughs@talk21.com	Burroughs, Andrew K/C-5645-2009	Burroughs, Andrew K/0000-0001-6527-457X				BURROUGHS AK, 1990, GASTROENTEROLOGY, V99, P1388, DOI 10.1016/0016-5085(90)91166-4; Burroughs AK, 1996, PORTAL HYPERTENSION II, P10; Burroughs AK, 1996, HEPATOLOGY, V24, P737, DOI 10.1053/jhep.1996.v24.ajhep0240737; BURROUGHS AK, 1987, EXCERPTA MED C SERVI, V763; Cales P, 2000, J HEPATOL, V33, P738, DOI 10.1016/S0168-8278(00)80304-9; Cales P, 2001, NEW ENGL J MED, V344, P23, DOI 10.1056/NEJM200101043440104; de Franchis R, 2000, J HEPATOL, V33, P846; deFranchis R, 1996, J HEPATOL, V25, P390, DOI 10.1016/S0168-8278(96)80127-9; DEFRANCHIS R, 1992, J HEPATOL, V15, P256, DOI 10.1016/0168-8278(92)90044-P; Goulis J, 1999, EVIDENCE BASED GASTR, P389; Kjaergard LL, 1999, HEPATOLOGY, V30, P1134, DOI 10.1002/hep.510300510	11	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2001	357	9263					1147	1148		10.1016/S0140-6736(00)04383-X	http://dx.doi.org/10.1016/S0140-6736(00)04383-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323039				2022-12-01	WOS:000168192100006
J	Bellwood, DR; Hughes, TP				Bellwood, DR; Hughes, TP			Regional-scale assembly rules and biodiversity of coral reefs	SCIENCE			English	Article							LONG-TERM; DIVERSITY; CONSEQUENCES; RECOVERY; PATTERNS; DISTURBANCE; LEVEL	Tropical reef fishes and corals exhibit highly predictable patterns of taxonomic composition across the Indian and Pacific Oceans. Despite steep Longitudinal and Latitudinal gradients in total species richness, the composition of these key taxa is constrained within a remarkably narrow range of values. Regional-scale variation in reef biodiversity is best explained by Large-scale patterns in the availability of shallow-water habitat. Once habitat area is accounted for, there is surprisingly little residual effect of Latitude or Longitude. Low-diversity regions are most vulnerable to human impacts such as global warming, underscoring the urgent need for integrated management at multinational scales.	James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia	James Cook University	Bellwood, DR (corresponding author), James Cook Univ N Queensland, Dept Marine Biol, Ctr Coral Reef Biodivers, Townsville, Qld 4811, Australia.	david.bellwood@jcu.edu.au	Bellwood, David/E-2497-2011; Hughes, Terry P/L-4721-2013	Hughes, Terry P/0000-0002-5257-5063				Ayre DJ, 2000, EVOLUTION, V54, P1590; Bellwood D. R., 1997, P 8 INT COR REEF S, V1, P379; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; BROWN BE, 1985, ADV MAR BIOL, V22, P1, DOI 10.1016/S0065-2881(08)60049-8; Bryant D., 1998, REEFS RISK MAP BASED; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Glynn PW, 2000, CORAL REEFS, V19, P1, DOI 10.1007/s003380050220; Hastie TJ, 1990, GEN ADDITIVE MODELS; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; JABLONSKI D, 1986, SCIENCE, V231, P129, DOI 10.1126/science.231.4734.129; JABLONSKI D, 1987, SCIENCE, V238, P360, DOI 10.1126/science.238.4825.360; JACKSON JBC, 1974, AM NAT, V108, P541, DOI 10.1086/282933; JACKSON JBC, 1993, SCIENCE, V260, P1624, DOI 10.1126/science.260.5114.1624; JACKSON JBC, IN PRESS SCIENCE; Leis J.M., 1991, P183; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Palumbi SR, 1997, CORAL REEFS, V16, pS47, DOI 10.1007/s003380050241; PAULAY G, 1990, PALEOBIOLOGY, V16, P415, DOI 10.1017/S0094837300010162; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosenzweig ML, 1999, SCIENCE, V284, P276, DOI 10.1126/science.284.5412.276; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Veron J.E.N., 2022, CORALS WORLD; Wilson Moyra E. J., 1998, P165	33	420	445	3	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1532	1534		10.1126/science.1058635	http://dx.doi.org/10.1126/science.1058635			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375488				2022-12-01	WOS:000168963800041
J	Silagy, C; Formica, N				Silagy, C; Formica, N			Place of bupropion in smoking-cessation therapy	LANCET			English	Editorial Material									Monash Med Ctr, Monash Inst Hlth Serv Res, Melbourne, Vic 3168, Australia	Monash University	Silagy, C (corresponding author), Monash Med Ctr, Monash Inst Hlth Serv Res, Melbourne, Vic 3168, Australia.							Fiore MC., 2000, TREATING TOBACCO USE; HUGHES JR, 2000, COCHRANE DATABASE SY, V2; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; Peto R., 2000, CRITICAL ISSUES GLOB, P154; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987	6	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 19	2001	357	9268					1550	1550		10.1016/S0140-6736(00)04781-4	http://dx.doi.org/10.1016/S0140-6736(00)04781-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RR	11377641				2022-12-01	WOS:000168830100007
J	Baker, DA; Mille-Baker, B; Wainwright, SM; Ish-Horowicz, D; Dibb, NJ				Baker, DA; Mille-Baker, B; Wainwright, SM; Ish-Horowicz, D; Dibb, NJ			Mae mediates MAP kinase phosphorylation of Ets transcription factors in Drosophila	NATURE			English	Article							EMBRYONIC VENTRAL ECTODERM; EGF RECEPTOR PATHWAY; SIGNALING PATHWAY; DOMAIN PROTEIN; FEEDBACK LOOP; DNA-BINDING; YAN GENE; MIDLINE; MOTIF; DIFFERENTIATION	The evolutionarily conserved Ras/mitogen-activated protein kinase (MAPK) cascade is an integral part of the processes of cell division, differentiation, movement and death. Signals received at the cell surface are relayed into the nucleus, where MAPK phosphorylates and thereby modulates the activities of a subset of transcription factors(1,2). Here we report the cloning and characterization of a new component of this signal transduction pathway called Mae (for modulator of the activity of Ets). Mae is a signalling intermediate that directly links the MAPK signalling pathway to its downstream transcription factor targets. Phosphorylation by MAPK of the critical serine residue (Ser 127) of the Drosophila transcription factor Yan depends on Mae, and is mediated by the binding of Yan to Mae through their Pointed domains. This phosphorylation is both necessary and sufficient to abrogate transcriptional repression by Yan. Mae also regulates the activity of the transcriptional activator Pointed-P2 by a similar mechanism. Mae is essential for the normal development and viability of Drosophila, and is required in vivo for normal signalling of the epidermal growth factor receptor. Our study indicates that MAPK signalling specificity may depend on proteins that couple specific substrates to the kinase.	Hammersmith Hosp, Imperial Coll Sch Med, Inst Reprod & Dev Biol, Cell Signalling Unit, London W12 0NN, England; Imperial Canc Res Fund, Dev Genet Lab, London WC2A 3PX, England	Imperial College London; Cancer Research UK	Baker, DA (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, Inst Reprod & Dev Biol, Cell Signalling Unit, Du Cane Rd, London W12 0NN, England.			Ish-Horowicz, David/0000-0001-5684-7129				BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0; Dumstrei K, 1998, DEVELOPMENT, V125, P3417; Gabay L, 1996, DEVELOPMENT, V122, P3355; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Golembo M, 1999, GENE DEV, V13, P158, DOI 10.1101/gad.13.2.158; Golembo M, 1996, DEVELOPMENT, V122, P3363; Golembo M, 1996, DEVELOPMENT, V122, P223; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KLAMBT C, 1993, DEVELOPMENT, V117, P163; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MAYER U, 1988, GENE DEV, V2, P1496, DOI 10.1101/gad.2.11.1496; NYE JA, 1992, GENE DEV, V6, P975, DOI 10.1101/gad.6.6.975; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Rebay I, 2000, GENETICS, V154, P695; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; Roch F, 1998, MOL GEN GENET, V257, P103, DOI 10.1007/s004380050629; Rogge R, 1995, DEVELOPMENT, V121, P3947; Scholz H, 1997, MECH DEVELOP, V64, P137; SOUDANT N, 1994, NUCLEIC ACIDS RES, V22, P3871, DOI 10.1093/nar/22.19.3871; Spradling AC, 1999, GENETICS, V153, P135; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wieschaus E., 1986, P199; Yagi Y, 1998, DEVELOPMENT, V125, P3625	31	58	59	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					330	334		10.1038/35077122	http://dx.doi.org/10.1038/35077122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357138				2022-12-01	WOS:000168710000053
J	Hughes, RAC				Hughes, RAC			Sensory form of Guillain-Barre syndrome	LANCET			English	Editorial Material									Guys Kings & St Thomas Sch Med, Dept Neuroimmunol, London SE1 9RT, England	University of London; King's College London	Hughes, RAC (corresponding author), Guys Kings & St Thomas Sch Med, Dept Neuroimmunol, Guys Campus, London SE1 9RT, England.							Chiba A, 1997, BRAIN RES, V745, P32, DOI 10.1016/S0006-8993(96)01123-7; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Oh SJ, 2001, NEUROLOGY, V56, P82, DOI 10.1212/WNL.56.1.82; Wilmshurst J M, 1999, Eur J Paediatr Neurol, V3, P277, DOI 10.1016/S1090-3798(99)90983-2; WINDEBANK AJ, 1990, NEUROLOGY, V40, P584, DOI 10.1212/WNL.40.4.584	7	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1465	1465		10.1016/S0140-6736(00)04672-9	http://dx.doi.org/10.1016/S0140-6736(00)04672-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377594				2022-12-01	WOS:000168614300006
J	Johnson, N; Revenga, C; Echeverria, J				Johnson, N; Revenga, C; Echeverria, J			Ecology - Managing water for people and nature	SCIENCE			English	Article									World Resources Inst, Washington, DC 20002 USA		Johnson, N (corresponding author), World Resources Inst, Washington, DC 20002 USA.							Abramowitz J.N, 1996, 128 WORLDW I; BRAUTIGAM A, 1999, WORLD CONSERV BIOL, V30, P4; CONSTANCE P, 1999, IDB AM, V26, P2; Faeth P., 2000, FERTILE GROUND NUTR; FALKENMARK M, 1992, POPUL BULL, V47, P2; *FAO, 1999, REV WORLD FISH AQ 19; Gleick Peter H., 1998, WORLDS WATER 1998 19; Moyle Peter B., 1992, P127; OECD, 1997, ENV TAX GREEN TAX RE; POSTEL S, 1995, HAVE ALL RIVERS GONE; RAMESH B, 2000, SUMMARY WATER EC SES; REID WV, 2001, MONOGRAPHS SYSTEMATI, V84, P197; Revenga C., 2000, PILOT ANAL GLOBAL EC; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; ROSEGRANT MW, 1995, FOOD POLICY, V20, P203, DOI 10.1016/0306-9192(95)00014-6; Shiklomanov I.A., 1997, COMPREHENSIVE ASSESS; Solorzano R., 1995, VALORACION EC ECOLOG; *UNEP, 1996, GROUNDW THREAT RES; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Vu┬ru┬smarty C., 2001, EOS T AM GEOPHYS UN, V82, P1999, DOI [10.1029/01EO00031, DOI 10.1029/01EO00031, 10.1029/01-o00031]; *WMO, 1997, COMPR ASS FRESHW RES; *WRI, 2000, WORLD RES 2000 01 PE	22	163	177	9	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1071	1072		10.1126/science.1058821	http://dx.doi.org/10.1126/science.1058821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352054				2022-12-01	WOS:000168609200030
J	Rudolf, MCJ; Sahota, P; Barth, JH; Walker, J				Rudolf, MCJ; Sahota, P; Barth, JH; Walker, J			Increasing prevalence of obesity in primary school children: cohort study	BRITISH MEDICAL JOURNAL			English	Article							BRITISH CHILDREN; UK		Leeds Community & Mental Hlth Trust, Community Paediat, Leeds LS2 9NP, W Yorkshire, England; Leeds Metropolitan Univ, Sch Hlth Sci, Leeds LS1 3HE, W Yorkshire, England; Gen Infirm, Reg Paediat Endocrinol Clin, Leeds LS1 3EX, W Yorkshire, England	Leeds Beckett University; Leeds General Infirmary	Rudolf, MCJ (corresponding author), Leeds Community & Mental Hlth Trust, Community Paediat, Leeds LS2 9NP, W Yorkshire, England.		Barth, Julian H/F-6028-2010					COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Reilly JJ, 1999, LANCET, V354, P1874, DOI 10.1016/S0140-6736(99)04555-9; Reilly JJ, 1999, BRIT MED J, V319, P1039, DOI 10.1136/bmj.319.7216.1039; SAHOTA P, IN PRESS BMJ; TANNER JM, 1975, ARCH DIS CHILD, V50, P142, DOI 10.1136/adc.50.2.142	5	77	81	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1094	1095		10.1136/bmj.322.7294.1094	http://dx.doi.org/10.1136/bmj.322.7294.1094			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337437	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000168628300019
J	Lorenz, KA; Shapiro, MF; Asch, SM; Bozzette, SA; Hays, RD				Lorenz, KA; Shapiro, MF; Asch, SM; Bozzette, SA; Hays, RD			Associations of symptoms and health-related quality of life: Findings from a national study of persons with HIV infection	ANNALS OF INTERNAL MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; OF-LIFE; SERVICES UTILIZATION; PALLIATIVE CARE; UNITED-STATES; COST; AIDS	Background: Health-related quality of life refers to how well people are able to perform daily activities (functioning) and how they feel about their lives (well-being). The relationship between symptoms and health-related quality of life has not been fully explored, Objective: To estimate the association of HIV symptoms with health-related quality of life and with disability days. Design: Prospective cohort study. Setting: HIV providers in 28 urban and 24 rural randomly selected sites throughout the United States. Patients: Nationally representative sample of 2267 adults with known HIV infection who were interviewed in 1996 and again between 1997 and 1998. Measurements: Symptoms, two single-item global measures of health-related quality of life (perceived health and perceived quality of life), and disability days. Results: White patches in the mouth; nausea or loss of appetite; persistent cough, difficulty breathing, or difficulty catching one's breath; and weight loss were associated with more disability days and worse scores on both health-related quality-of-life measures. Headache; pain in the mouth, lips, or gums; dry mouth; and sinus infection, pain, or discharge were associated with worse perceived health, Pain in the mouth, lips, or gums; trouble with eyes; pain, numbness, or tingling of hands or feet; and diarrhea or loose or watery stools were associated with worse perceived quality of life. Headache and fever, sweats, or chills were associated with more disability days. Conclusions: Several symptoms are associated with worse health-related quality of life and more disability days in persons with HIV infection. In such patients, targeting specific symptoms may improve health-related quality of life and reduce disability.	Vet Affairs Greater Los Angeles Healthcare Syst, Div Gen Internal Med, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Lorenz, KA (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Div Gen Internal Med, 11303 Wilshire Blvd,Code 111-G, Los Angeles, CA 90073 USA.	klorenz@ucla.edu	Hays, Ronald/D-5629-2013	Hays, Ronald/0000-0001-6697-907X	AHRQ HHS [HS08578] Funding Source: Medline; ASC OASH HHS [R01AS10227] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U01HS008578] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); ASC OASH HHS; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		[Anonymous], 1992, AM HERITAGE DICT; Bozzette SA, 1998, NEW ENGL J MED, V339, P1897, DOI 10.1056/NEJM199812243392606; Crofton C, 1999, MED CARE, V37, pMS1, DOI 10.1097/00005650-199903001-00001; Cunningham WE, 1998, AM J MED, V104, P129, DOI 10.1016/S0002-9343(97)00349-5; DUAN N, 1060 RAND; Frankel MR, 1999, HEALTH SERV RES, V34, P969; Grimes R M, 1998, Gastrointest Endosc Clin N Am, V8, P783; Hays RD, 2000, AM J MED, V108, P714, DOI 10.1016/S0002-9343(00)00387-9; Hays RD, 1997, KIDNEY DIS QUALITY L; Justice AC, 1999, J ACQ IMMUN DEF SYND, V21, P126; KALTON G, 1983, COMPENSATING MISSING; Kaplan RM, 1997, QUAL LIFE RES, V6, P507, DOI 10.1023/A:1018456031659; MATHEWS W, 1980, MED CARE, V38, P750; Meyer M, 1999, INT J STD AIDS, V10, P80, DOI 10.1258/0956462991913682; Meyer M, 1999, INT J STD AIDS, V10, P495, DOI 10.1258/0956462991914573; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; ROSK K, 2000, ARCH FAM MED, V9, P150; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59	20	114	117	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			854	860		10.7326/0003-4819-134-9_Part_2-200105011-00009	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346321				2022-12-01	WOS:000168543100009
J	Que, L; Watanabe, Y				Que, L; Watanabe, Y			Bioinorganic chemistry - Oxygenase pathways: Oxo, peroxo, and superoxo	SCIENCE			English	Editorial Material							CYTOCHROME P450CAM; HYDROXYLATION; DIOXYGEN; COMPLEX		Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Inst Mol Sci, Okazaki, Aichi 4448585, Japan	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Que, L (corresponding author), Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA.	que@chem.umn.edu; yoshi@ims.ac.jp						Chavez FA, 2001, CHEM COMMUN, P111, DOI 10.1039/b006647h; Collman JP, 1999, J AM CHEM SOC, V121, P1387, DOI 10.1021/ja983351a; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Ghiladi RA, 1999, J AM CHEM SOC, V121, P9885, DOI 10.1021/ja992296i; Girerd JJ, 2000, STRUCT BOND, V97, P145; Itoh S, 2000, ANGEW CHEM INT EDIT, V39, P398, DOI 10.1002/(SICI)1521-3773(20000117)39:2<398::AID-ANIE398>3.0.CO;2-2; Jaron S, 1999, BIOCHEMISTRY-US, V38, P15086, DOI 10.1021/bi991341w; Lee D, 1999, J AM CHEM SOC, V121, P9893, DOI 10.1021/ja9923686; LIU AMF, UNPUB; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; Nam W, 2000, J AM CHEM SOC, V122, P10805, DOI 10.1021/ja0010554; Naruta Y, 2001, J INORG BIOCHEM, V83, P239, DOI 10.1016/S0162-0134(00)00170-7; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; *PAC BAS SOC, 2000, 2000 INT CHEM C PAC; Prigge ST, 1999, NAT STRUCT BIOL, V6, P976; Rogers MS, 2000, J AM CHEM SOC, V122, P990, DOI 10.1021/ja993385y; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shiren K, 2000, J AM CHEM SOC, V122, P254, DOI 10.1021/ja990311d	18	23	23	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					651	653						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11330325				2022-12-01	WOS:000168478300032
J	Wilkie, GS; Davis, I				Wilkie, GS; Davis, I			Drosophila wingless and pair-rule transcripts localize apically by dynein-mediated transport of RNA particles	CELL			English	Article							MATERNAL MESSENGER-RNA; CYTOPLASMIC DYNEIN; BICOID RNA; ASYMMETRIC LOCALIZATION; CELL-DIVISION; ANTERIOR POLE; IN-VIVO; PROTEIN; MICROTUBULES; DIFFUSION	Asymmetric mRNA localization targets proteins to their cytoplasmic site of function. We have elucidated the mechanism of apical localization of wingless and pair-rule transcripts in the Drosophila blastoderm embryo by directly visualizing intermediates along the entire path of transcript movement. After release from their site of transcription, mRNAs diffuse within the nucleus and are exported to all parts of the cytoplasm, regardless of their cytoplasmic destinations. Endogenous and injected apical RNAs assemble selectively into cytoplasmic particles that are transported apically along microtubules. Cytoplasmic dynein is required for correct localization of endogenous transcripts and apical movement of injected RNA particles. We propose that dynein-dependent movement of RNA particles is a widely deployed mechanism for mRNA localization.	Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Davis, I (corresponding author), Univ Edinburgh, Inst Cell & Mol Biol, Wellcome Trust Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3JR, Midlothian, Scotland.	ilan.davis@ed.ac.uk	Davis, Ilan/F-4975-2010	Davis, Ilan/0000-0002-5385-3053				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X; BRENIERE Y, 1989, J MOTOR BEHAV, V21, P20; Carson JH, 1998, CURR OPIN NEUROBIOL, V8, P607, DOI 10.1016/S0959-4388(98)80088-3; Cote CA, 1999, MOL CELL, V4, P431, DOI 10.1016/S1097-2765(00)80345-7; Daneholt B, 1997, CELL, V88, P585, DOI 10.1016/S0092-8674(00)81900-5; Davis I, 2000, PRACT APPROACH SER, V218, P133; DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251; DAVIS I, 1993, COLD SPRING HARB SYM, V58, P793, DOI 10.1101/SQB.1993.058.01.086; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; Dubowy J, 1998, MECH DEVELOP, V70, P193, DOI 10.1016/S0925-4773(97)00185-8; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; EDGAR BA, 1987, GENE DEV, V1, P1226, DOI 10.1101/gad.1.10.1226; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; EDGAR BA, 1986, CELL, V47, P747, DOI 10.1016/0092-8674(86)90517-9; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Fischer JA, 2000, CURR OPIN GENET DEV, V10, P489, DOI 10.1016/S0959-437X(00)00117-9; Foe Victoria E., 1993, P149; FrancisLang H, 1996, EMBO J, V15, P640, DOI 10.1002/j.1460-2075.1996.tb00396.x; Gepner J, 1996, GENETICS, V142, P865; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Hazelrigg T, 1998, CELL, V95, P451, DOI 10.1016/S0092-8674(00)81613-X; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; Joseph EM, 1998, DEVELOPMENT, V125, P2677; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; Lall S, 1999, CELL, V98, P171, DOI 10.1016/S0092-8674(00)81012-0; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; McGrail M, 1997, DEVELOPMENT, V124, P2409; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Norvell A, 1999, GENE DEV, V13, P864, DOI 10.1101/gad.13.7.864; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; Pante N, 1997, RNA, V3, P498; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; Singh OP, 1999, EXP CELL RES, V251, P135, DOI 10.1006/excr.1999.4490; STEPHENSON EC, 1988, GENE DEV, V2, P1655, DOI 10.1101/gad.2.12a.1655; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; SUNDELL CL, 1990, J CELL BIOL, V111, P2397, DOI 10.1083/jcb.111.6.2397; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; THEURKAUF WE, 1993, DEVELOPMENT, V118, P1169, DOI 10.1016/0168-9525(93)90134-4; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0; WILKIE GS, 1998, ELSEVIER TRENDS J TE; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; ZACHAR Z, 1993, J CELL BIOL, V121, P729, DOI 10.1083/jcb.121.4.729	62	185	191	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					209	219		10.1016/S0092-8674(01)00312-9	http://dx.doi.org/10.1016/S0092-8674(01)00312-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336671	Bronze			2022-12-01	WOS:000168384300008
J	Komarneni, S; Kozai, N; Paulus, WJ				Komarneni, S; Kozai, N; Paulus, WJ			Superselective clay for radium uptake	NATURE			English	Article							EXCHANGE		Penn State Univ, Dept Agron, University Pk, PA 16802 USA; Penn State Univ, Mat Res Lab, University Pk, PA 16802 USA; Japan Atom Energy Res Inst, Dept Environm Sci, Tokai, Ibaraki 3191195, Japan; GM Corp, AC Rochester Div, Dept 32 84, Flint, MI 48556 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Japan Atomic Energy Agency; General Motors	Komarneni, S (corresponding author), Penn State Univ, Dept Agron, University Pk, PA 16802 USA.							Breck D., 1984, ZEOLITE MOL SIEVES; FINKELSTEIN MM, 1994, CAN MED ASSOC J, V151, P565; JuradoVargas M, 1997, J RADIOANAL NUCL CH, V218, P153, DOI 10.1007/BF02039327; Komarneni S, 1998, J MATER CHEM, V8, P205, DOI 10.1039/a706050e; KOMARNENI S, 1988, SCIENCE, V239, P1286, DOI 10.1126/science.239.4845.1286; KOMARNENI S, 1982, NATURE, V299, P707, DOI 10.1038/299707a0; LYMAN GH, 1985, JAMA-J AM MED ASSOC, V254, P621, DOI 10.1001/jama.254.5.621; PAULUS WJ, 1992, NATURE, V357, P571, DOI 10.1038/357571a0	8	91	93	2	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					771	771		10.1038/35071173	http://dx.doi.org/10.1038/35071173			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298435				2022-12-01	WOS:000168021900041
J	Ahmad, K; Henikoff, S				Ahmad, K; Henikoff, S			Modulation of a transcription factor counteracts heterochromatic gene silencing in Drosophila	CELL			English	Article							POSITION-EFFECT VARIEGATION; MOLECULAR ASPECTS; WHITE GENE; IN-VIVO; DEVELOPMENTAL REGULATION; CHROMATIN STRUCTURE; P-ELEMENT; MELANOGASTER; EXPRESSION; PROTEIN	Variegation is a common feature of gene silencing phenomena, yet the basis for stochastic on/off expression is unknown. We used a conditional system that allows probing of heterochromatin at a reporter GFP gene by altering GAL4 transcription factor levels during Drosophila eye development. Surprisingly, the frequency of gene silencing is exquisitely sensitive to GAL4 levels, as though binding site occupancy affects the silenced state. The silent state is plastic, as spontaneous derepression occasionally occurs in both mitotically active and differentiating cells. By simultaneously assaying expression of a nearby gene, we further show that the size of an activated region within heterochromatin is small. We propose that variegation occurs because heterochromatin inhibits the transient exposure of factor binding sites.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA.		Furia, maria/AHD-7483-2022	Henikoff, Steven/0000-0002-7621-8685				Ahmad K, 1996, GENETICS, V144, P657; APARICIO OM, 1994, GENE DEV, V8, P1133, DOI 10.1101/gad.8.10.1133; BELYAEVA ES, 1991, CHROMOSOMA, V100, P453, DOI 10.1007/BF00364556; Boivin A, 1998, GENETICS, V150, P1539; Bonifer C, 2000, TRENDS GENET, V16, P310, DOI 10.1016/S0168-9525(00)02029-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; CLARK SH, 1986, GENETICS, V114, P819; Cryderman DE, 1999, NUCLEIC ACIDS RES, V27, P3364, DOI 10.1093/nar/27.16.3364; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; HAYASHI S, 1990, CHROMOSOMA, V99, P391, DOI 10.1007/BF01726690; HENIKOFF S, 1990, TRENDS GENET, V6, P422, DOI 10.1016/0168-9525(90)90304-O; Henikoff S, 1997, CURR OPIN CELL BIOL, V9, P388, DOI 10.1016/S0955-0674(97)80012-9; Ito K, 1997, DEVELOPMENT, V124, P761; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; LEVIS R, 1985, EMBO J, V4, P3489, DOI 10.1002/j.1460-2075.1985.tb04108.x; LI CL, 1995, J NEUROBIOL, V28, P363, DOI 10.1002/neu.480280309; Lu BY, 1996, EMBO J, V15, P1323, DOI 10.1002/j.1460-2075.1996.tb00474.x; Lu BY, 1998, DEVELOPMENT, V125, P2223; ORLANDO V, 1995, CURR OPIN GENET DEV, V5, P174, DOI 10.1016/0959-437X(95)80005-0; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Polach KJ, 2000, J MOL BIOL, V298, P211, DOI 10.1006/jmbi.2000.3644; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROSEMAN RR, 1995, GENETICS, V141, P1061; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Sabl JF, 1996, GENETICS, V142, P447; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Sass GL, 1999, GENETICS, V152, P595; SPOFFORD J, 1976, GENETICS BIOL DROSOP; Steger David J., 1996, Bioessays, V18, P875, DOI 10.1002/bies.950181106; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Talbert PB, 2000, GENETICS, V154, P259; TARTOF KD, 1989, DEV GENET, V10, P162, DOI 10.1002/dvg.1020100306; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Walters MC, 1996, GENE DEV, V10, P185, DOI 10.1101/gad.10.2.185; Widom J, 1999, METH MOL B, V119, P61; WILDER EL, 1995, DEVELOPMENT, V121, P477; Wines DR, 1996, CHROMOSOMA, V104, P332, DOI 10.1007/s004120050123; ZHIMULEV IF, 1988, CHROMOSOMA, V96, P255, DOI 10.1007/BF00302365; ZHIMULEV IF, 1986, CHROMOSOMA, V94, P492, DOI 10.1007/BF00292759	51	129	133	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					839	847		10.1016/S0092-8674(01)00281-1	http://dx.doi.org/10.1016/S0092-8674(01)00281-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290322	Bronze			2022-12-01	WOS:000167869200007
J	Yamaguchi, Y; Filipovska, J; Yano, K; Furuya, A; Inukai, N; Narita, T; Wada, T; Sugimoto, S; Konarska, MM; Handa, H				Yamaguchi, Y; Filipovska, J; Yano, K; Furuya, A; Inukai, N; Narita, T; Wada, T; Sugimoto, S; Konarska, MM; Handa, H			Stimulation of RNA polymerase II elongation by hepatitis delta antigen	SCIENCE			English	Article							TRANSCRIPTION ELONGATION; VIRUS; DSIF; REPLICATION; INITIATION; GENOME; SPT4; GENE	Transcription elongation by RNA polymerase II (RNAPII) is negatively regulated by the human factors DRB-sensitivity inducing factor (DSIF) and negative elongation factor (NELF). A 66-kilodalton subunit of NELF (NELF-A) shows limited sequence similarity to hepatitis delta antigen (HDAg), the viral protein required for replication of hepatitis delta virus (HDV). The host RNAPII has been implicated in HDV replication, but the detailed mechanism and the role of HDAg in this process are not understood. We show that HDAg binds RNAPII directly and stimulates transcription by displacing NELF and promoting RNAPII elongation. These results suggest that HDAg may regulate RNAPII elongation during both cellular messenger RNA synthesis and HDV RNA replication.	Tokyo Inst Technol, Frontier Collaborat Res Ctr, Yokohama, Kanagawa 2268503, Japan; Rockefeller Univ, New York, NY 10021 USA; Tokyo Res Labs, Tokyo 1948533, Japan	Tokyo Institute of Technology; Rockefeller University	Handa, H (corresponding author), Tokyo Inst Technol, Frontier Collaborat Res Ctr, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	hhanda@bio.titech.ac.jp	Yamaguchi, Yuki/B-9390-2015; Filipovska, Julija/AAI-5306-2021; Konarska, Maria M./AAT-2572-2021; Konarska, Maria/ABG-6405-2020	Yamaguchi, Yuki/0000-0002-0197-614X; Konarska, Maria M./0000-0001-9235-1702				Bichko VV, 1996, J VIROL, V70, P8064, DOI 10.1128/JVI.70.11.8064-8070.1996; Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; CASEY JL, 1993, P NATL ACAD SCI USA, V90, P9016, DOI 10.1073/pnas.90.19.9016; CHANG FL, 1991, P NATL ACAD SCI USA, V88, P8490, DOI 10.1073/pnas.88.19.8490; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Corpet F, 1998, NUCLEIC ACIDS RES, V26, P323, DOI 10.1093/nar/26.1.323; Filipovska J, 2000, RNA, V6, P41, DOI 10.1017/S1355838200991167; Garber ME, 1999, CURR OPIN IMMUNOL, V11, P460, DOI 10.1016/S0952-7915(99)80077-6; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; KUO MYP, 1989, J VIROL, V63, P1945, DOI 10.1128/JVI.63.5.1945-1950.1989; LAI MMC, 1995, ANNU REV BIOCHEM, V64, P259, DOI 10.1146/annurev.bi.64.070195.001355; Lo K, 1998, VIROLOGY, V247, P178, DOI 10.1006/viro.1998.9253; Modahl LE, 2000, J VIROL, V74, P7375, DOI 10.1128/JVI.74.16.7375-7380.2000; Robertson HD, 1996, SCIENCE, V274, P66, DOI 10.1126/science.274.5284.66; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wei Y, 1998, J VIROL, V72, P2089, DOI 10.1128/JVI.72.3.2089-2096.1998; Wright TJ, 1999, GENOMICS, V59, P203, DOI 10.1006/geno.1999.5871; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1998, GENES CELLS, V3, P9, DOI 10.1046/j.1365-2443.1998.00162.x	23	117	122	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2001	293	5527					124	127		10.1126/science.1057925	http://dx.doi.org/10.1126/science.1057925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	451BB	11387440				2022-12-01	WOS:000169780300043
J	Walter, LC; Covinsky, KE				Walter, LC; Covinsky, KE			Cancer screening in elderly patients - A framework for individualized decision making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL-OCCULT-BLOOD; QUALITY-OF-LIFE; CARCINOMA IN-SITU; BREAST-CANCER; COLORECTAL-CANCER; COST-EFFECTIVENESS; CONTROLLED TRIAL; CERVICAL-CANCER; OLDER WOMEN; FOLLOW-UP	Considerable uncertainty exists about the use of cancer screening tests in older people, as illustrated by the different age cutoffs recommended by various guideline panels. We suggest that a framework to guide individualized cancer screening decisions in older patients may be more useful to the practicing clinician than age guidelines, Like many medical decisions, cancer screening decisions require weighing quantitative information, such as risk of cancer death and likelihood of beneficial and adverse screening outcomes, as well as qualitative factors, such as individual patients' values and preferences, Our framework first anchors decisions through quantitative estimates of life expectancy, risk of cancer death, and screening outcomes based on published data. Potential benefits of screening are presented as the number needed to screen to prevent 1 cancer-specific death, based on the estimated life expectancy during which a patient will be screened. Estimates reveal substantial variability in the likelihood of benefit for patients of similar ages with varying life expectancies. In fact, patients with life expectancies of less than 5 years are unlikely to derive any survival benefit from cancer screening. We also consider the likelihood of potential harm from screening according to patient factors and test characteristics. Some of the greatest harms of screening occur by detecting cancers that would never have become clinically significant. This becomes more likely as life expectancy decreases. Finally, since many cancer screening decisions in older adults cannot be answered solely by quantitative estimates of benefits and harms, considering the estimated outcomes according to the patient's own values and preferences is the final step for making informed screening decisions.	Vet Affairs Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Walter, LC (corresponding author), Vet Affairs Med Ctr, Div Geriatr, 111G,4150 Clement St, San Francisco, CA 94121 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS000006] Funding Source: NIH RePORTER; AHRQ HHS [K02HS00006-01] Funding Source: Medline; PHS HHS [T-32] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Barratt A, 1999, JAMA-J AM MED ASSOC, V281, P2029, DOI 10.1001/jama.281.21.2029; Bennahum DA, 1997, CLIN GERIATR MED, V13, P33; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1037, DOI 10.1001/jama.281.11.1037; CASSEL CK, 1992, J GERONTOL, V47, P126; COSTANZA ME, 1994, CANCER-AM CANCER SOC, V74, P2046, DOI 10.1002/1097-0142(19941001)74:7+<2046::AID-CNCR2820741710>3.0.CO;2-U; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; Cruickshank ME, 1997, BRIT J OBSTET GYNAEC, V104, P586, DOI 10.1111/j.1471-0528.1997.tb11537.x; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; DIXON JM, 1988, BRIT J SURG, V75, P918, DOI 10.1002/bjs.1800750931; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2493, DOI 10.1001/jama.263.18.2493; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; Essink-Bot ML, 1998, J NATL CANCER I, V90, P925, DOI 10.1093/jnci/90.12.925; EUSEBI V, 1989, SEMIN DIAGN PATHOL, V6, P165; FISCHHOFF B, 1999, MONOGR NAT CANC I, V25, P7; Fonseca R, 1997, ANN INTERN MED, V127, P1013, DOI 10.7326/0003-4819-127-11-199712010-00013; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; HARRIS R, 1995, ANN INTERN MED, V122, P539, DOI 10.7326/0003-4819-122-7-199504010-00011; HUGHES JE, 1987, CANCER SURV, V6, P455; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 1999, JAMA-J AM MED ASSOC, V282, P2156, DOI 10.1001/jama.282.22.2156; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LAARA E, 1987, LANCET, V1, P1247; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; Lurie JD, 1999, J NATL CANCER I, V91, P1641, DOI 10.1093/jnci/91.19.1641; MALENKA DJ, 1992, J GEN INTERN MED, V92, P121; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Marshall KG, 1996, CAN MED ASSOC J, V155, P169; MAZUR DJ, 1993, J GEN INTERN MED, V8, P374, DOI 10.1007/BF02600076; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; MOSKOWITZ M, 1986, RADIOLOGY, V161, P37, DOI 10.1148/radiology.161.1.3532183; *NAT CTR HLTH STAT, 2000, LIF TABL US 1997; National Hospice Organization, 1996, MED GUID DET PROGN S; PAGE DL, 1982, CANCER, V49, P751, DOI 10.1002/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y; Pignone M, 2000, ANN INTERN MED, V133, P761, DOI 10.7326/0003-4819-133-10-200011210-00008; Pignone M, 1999, J GEN INTERN MED, V14, P432, DOI 10.1046/j.1525-1497.1999.00018.x; Prevost TC, 1998, AM J EPIDEMIOL, V148, P609; Ransohoff DF, 1997, ANN INTERN MED, V127, P1029, DOI 10.7326/0003-4819-127-11-199712010-00016; Ransohoff DF, 1997, ANN INTERN MED, V126, P811, DOI 10.7326/0003-4819-126-10-199705150-00014; REDELMEIER DA, 1993, JAMA-J AM MED ASSOC, V270, P72, DOI 10.1001/jama.270.1.72; Ries LAG, 1999, SEER CANC STAT REV 1; Robinson B, 1997, CLIN GERIATR MED, V13, P97; Sackett D, 1991, CLIN EPIDEMIOLOGY BA; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Smith RA, 2000, CA-CANCER J CLIN, V50, P34, DOI 10.3322/canjclin.50.1.34; Sox HC, 1998, J GEN INTERN MED, V13, P424, DOI 10.1046/j.1525-1497.1998.00126.x; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, V2nd; WARDLE J, 1992, J PSYCHOSOM RES, V36, P609, DOI 10.1016/0022-3999(92)90051-3; WARREN R, 1988, BRIT MED J, V297, P969, DOI 10.1136/bmj.297.6654.969; Weingarten S, 1999, ANN INTERN MED, V130, P454, DOI 10.7326/0003-4819-130-5-199903020-00023; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Welch HG, 1998, J NATL CANCER I, V90, P1389, DOI 10.1093/jnci/90.18.1389; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; YANCIK R, 1994, CANCER, V74, P1995, DOI 10.1002/1097-0142(19941001)74:7+<1995::AID-CNCR2820741702>3.0.CO;2-Y	64	663	669	0	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2750	2756		10.1001/jama.285.21.2750	http://dx.doi.org/10.1001/jama.285.21.2750			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386931				2022-12-01	WOS:000168985800028
J	Zheng, BH; Albrecht, U; Kaasik, K; Sage, M; Lu, WQ; Vaishnav, S; Li, Q; Sun, ZS; Eichele, G; Bradley, A; Lee, CC				Zheng, BH; Albrecht, U; Kaasik, K; Sage, M; Lu, WQ; Vaishnav, S; Li, Q; Sun, ZS; Eichele, G; Bradley, A; Lee, CC			Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock	CELL			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; DROSOPHILA-PERIOD; POSITIONAL CLONING; PROTEIN; HEME; EXPRESSION; TRANSCRIPTION; PACEMAKER; COMPONENT; ORTHOLOG	Mice carrying a null mutation in the Period 1 (mPer1) gene were generated using embryonic stem cell technology. Homozygous mPer1 mutants display a shorter circadian period with reduced precision and stability. Mice deficient in both mPer1 and mPer2 do not express circadian rhythms. While mPER2 regulates clock gene expression at the transcriptional level, mPER1 is dispensable for the rhythmic RNA expression of mPer1 and mPer2 and may instead regulate mPER2 at a posttranscriptional level. Studies of clock-controlled genes (CCGs) reveal a complex pattern of regulation by mPER1 and mPER2, suggesting independent controls by the two proteins over some output pathways. Genes encoding key enzymes in heme biosynthesis are under circadian control and are regulated by mPER1 and mPER2. Together, our studies show that mPER1 and mPER2 have distinct and complementary roles in the mouse clock mechanism.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Bradley, A (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	abradley@sanger.ac.uk; ching@bcm.tmc.edu	Jansen, Heiko T./A-5770-2008; Sun, Zhongsheng/AAS-4883-2020; Albrecht, Urs/A-9831-2011	Jansen, Heiko T./0000-0003-0178-396X; Sun, Zhongsheng/0000-0002-7640-5026; Albrecht, Urs/0000-0002-0663-8676; Bradley, Allan/0000-0002-2349-8839				Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Albrecht U, 1997, MOL CELLULAR METHODS, P23; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bracewell R. N., 1986, HARTLEY TRANSFORM; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Clayton JD, 2001, NATURE, V409, P829, DOI 10.1038/35057006; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Festing MFW, 1999, MAMM GENOME, V10, P836, DOI 10.1007/s003359901099; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; HAMILTON JW, 1991, ARCH BIOCHEM BIOPHYS, V289, P387, DOI 10.1016/0003-9861(91)90428-L; KAPPAS A, 1968, Seminars in Hematology, V5, P323; KIKUCHI G, 1981, MOL CELL BIOCHEM, V37, P27, DOI 10.1007/BF02355885; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas KA, 2000, PHARMACOL REV, V52, P375; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Pellequer JL, 1999, CURR BIOL, V9, pR416, DOI 10.1016/S0960-9822(99)80257-7; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Young MW, 2000, SCI AM, V282, P64, DOI 10.1038/scientificamerican0300-64; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	53	658	690	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					683	694		10.1016/S0092-8674(01)00380-4	http://dx.doi.org/10.1016/S0092-8674(01)00380-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389837	Bronze			2022-12-01	WOS:000169123200014
J	Annas, GJ				Annas, GJ			Testing poor pregnant women for cocaine - Physicians as police investigators.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth Law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				ANNAS GJ, 1991, NEW ENGL J MED, V325, P740, DOI 10.1056/NEJM199109053251020; Annas GJ, 2001, NEW ENGL J MED, V344, P152, DOI 10.1056/NEJM200101113440220; ANNAS GJ, 1989, HASTINGS CENT REP, V19, P1935; Chavkin W, 2001, JAMA-J AM MED ASSOC, V285, P1626, DOI 10.1001/jama.285.12.1626; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; GANTZ LH, 1989, AM J PUBLIC HEALTH, V79, P1427; GREEN V, 1993, DOPED UP KNOCKED UP; Mariner Wendy K, 1990, Crim Justice Ethics, V9, P30; Paltrow Lynn M, 1990, Crim Justice Ethics, V9, P41; Roberts Dorothy, 1999, J HLTH CARE LAW POLI, V3, P72; SIEGEL B, 1994, LA TIMES        0807, P14	11	17	17	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2001	344	22					1729	1732		10.1056/NEJM200105313442219	http://dx.doi.org/10.1056/NEJM200105313442219			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	436YG	11386286	Green Published			2022-12-01	WOS:000168963000028
J	Nadler, MJS; Hermosura, MC; Inabe, K; Perraud, AL; Zhu, QQ; Stokes, AJ; Kurosaki, T; Kinet, JP; Penner, R; Scharenberg, AM; Fleig, A				Nadler, MJS; Hermosura, MC; Inabe, K; Perraud, AL; Zhu, QQ; Stokes, AJ; Kurosaki, T; Kinet, JP; Penner, R; Scharenberg, AM; Fleig, A			LTRPC7 is a Mg center dot ATP-regulated divalent cation channel required for cell viability	NATURE			English	Article								The molecular mechanisms that regulate basal or background entry of divalent cations into mammalian cells are poorly understood. Here we describe the cloning and functional characterization of a Ca2+ - and Mg2+-permeable divalent cation channel, LTRPC7 (nomenclature compatible with that proposed in ref. 1), a new member of the LTRPC family of putative ion channels. Targeted deletion of LTRPC7 in DT-40 B cells was lethal, indicating that LTRPC7 has a fundamental and nonredundant role in cellular physiology. Electrophysiological analysis of HEK-293 cells overexpressing recombinant LTRPC7 showed large currents regulated by millimolar levels of intracellular Mg.ATP and Mg.GTP with the permeation properties of a voltage-independent divalent cation influx pathway. Analysis of several cultured cell types demonstrated small magnesium-nucleotide-regulated metal ion currents (MagNuM) with regulation and permeation properties essentially identical to the large currents observed in cells expressing recombinant LTRPC7. Our data indicate that LTRPC7, by virtue of its sensitivity to physiological Mg.ATP levels, may be involved in a fundamental process that adjusts plasma membrane divalent cation fluxes according to the metabolic state of the cell.	Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Hawaii, Queens Med Ctr, Biomed Res Ctr, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Kansai Med Univ, Inst Liver Res, Dept Mol Genet, Osaka 5708506, Japan; Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Kansai Medical University; Harvard University; Beth Israel Deaconess Medical Center	Scharenberg, AM (corresponding author), Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA.		Stokes, Alexander/B-1086-2015; Kurosaki, Tomohiro/D-1306-2009	Stokes, Alexander/0000-0002-3526-4685; Kurosaki, Tomohiro/0000-0002-6352-304X; Fleig, Andrea/0000-0001-8396-7249; Penner, Reinhold/0000-0002-5366-1537				Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Luthi D, 1999, EXP PHYSIOL, V84, P231, DOI 10.1111/j.1469-445X.1999.01799.x; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 1997, P NATL ACAD SCI USA, V94, P4884, DOI 10.1073/pnas.94.10.4884	5	734	766	2	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					590	595		10.1038/35079092	http://dx.doi.org/10.1038/35079092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385574				2022-12-01	WOS:000168982500053
J	Jallepalli, PV; Waizenegger, IC; Bunz, F; Langer, S; Speicher, MR; Peters, JM; Kinzler, KW; Vogelstein, B; Lengauer, C				Jallepalli, PV; Waizenegger, IC; Bunz, F; Langer, S; Speicher, MR; Peters, JM; Kinzler, KW; Vogelstein, B; Lengauer, C			Securin is required for chromosomal stability in human cells	CELL			English	Article							SISTER-CHROMATID SEPARATION; MITOTIC CHECKPOINT GENES; KINETOCHORE LOCALIZATION; SPINDLE CHECKPOINT; HUMAN HOMOLOG; ANAPHASE; PROTEIN; LACKING; COHESIN; INHIBITOR	Abnormalities of chromosome number are the most common genetic aberrations in cancer. The mechanisms regulating the fidelity of mitotic chromosome transmission in mammalian cells are therefore of great interest. Here we show that human cells without an hSecurin gene lose chromosomes at a high frequency. This loss was linked to abnormal anaphases during which cells underwent repetitive unsuccessful attempts to segregate their chromosomes. The abnormal mitoses were associated with biochemical defects in the activation of separin, the sister-separating protease, rendering it unable to cleave the cohesin subunit Scc1 efficiently. These results illuminate the function of mammalian securin and show that it is essential for the maintenance of euploidy.	Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA; Howard Hughes Med Inst, Baltimore, MD 21231 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Munich, Inst Anthropol & Human Genet, D-80333 Munich, Germany	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Munich	Lengauer, C (corresponding author), Johns Hopkins Oncol Ctr, 1650 Orleans St, Baltimore, MD 21231 USA.	lengauer@jhmi.edu	Speicher, Michael R/B-5362-2013	Speicher, Michael R/0000-0003-0105-955X	NCI NIH HHS [CA 43460, CA 57345, CA 62924] Funding Source: Medline; NIGMS NIH HHS [GM07309, GM 41690] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057345, R37CA057345, R37CA043460, R01CA043460, P50CA062924] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cahill DP, 1999, TRENDS CELL BIOL, V9, pM57, DOI 10.1016/S0962-8924(99)01661-X; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Duesberg P, 1999, ANTICANCER RES, V19, P4887; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Gardner RD, 2000, TRENDS CELL BIOL, V10, P154, DOI 10.1016/S0962-8924(00)01727-X; Gemma A, 2000, GENE CHROMOSOME CANC, V29, P213, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1027>3.0.CO;2-G; Glotzer M, 1999, CURR BIOL, V9, pR531, DOI 10.1016/S0960-9822(99)80329-7; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Imai Y, 1999, JPN J CANCER RES, V90, P837, DOI 10.1111/j.1349-7006.1999.tb00824.x; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lee H, 1999, MOL CELL, V4, P1, DOI 10.1016/S1097-2765(00)80182-3; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; LOEB LA, 1991, CANCER RES, V51, P3075; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; Masramon L, 2000, CANCER GENET CYTOGEN, V121, P17, DOI 10.1016/S0165-4608(00)00219-3; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Peters JM, 1999, EXP CELL RES, V248, P339, DOI 10.1006/excr.1999.4443; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Saez C, 1999, ONCOGENE, V18, P5473, DOI 10.1038/sj.onc.1202914; Speicher MR, 1996, NAT GENET, V12, P368, DOI 10.1038/ng0496-368; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	52	336	360	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					445	457		10.1016/S0092-8674(01)00340-3	http://dx.doi.org/10.1016/S0092-8674(01)00340-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371342	Bronze			2022-12-01	WOS:000168840700005
J	Mao, BY; Wu, W; Li, Y; Hoppe, D; Stannek, P; Glinka, A; Niehrs, C				Mao, BY; Wu, W; Li, Y; Hoppe, D; Stannek, P; Glinka, A; Niehrs, C			LDL-receptor-related protein 6 is a receptor for Dickkopf proteins	NATURE			English	Article							SPEMANN ORGANIZER; SIGNAL-TRANSDUCTION; SECRETED PROTEINS; HEAD INDUCTION; WNT; XENOPUS; ACTIVATION; EXPRESSION; ANTAGONIST; CERBERUS	Wnt glycoproteins have been implicated in diverse processes during embryonic patterning in metazoa. They signal through frizzled-type seven-transmembrane-domain receptors to stabilize beta -catenin(1,2). Wnt signalling is antagonized by the extracellular Wnt inhibitor dickkopf1 (dkk1), which is a member of a multigene family(3). dkk1 was initially identified as a head inducer in Xenopus embryos but the mechanism by which it blocks Wnt signalling is unknown. LDL-receptor-related protein 6 (LRP6) is required during Wnt/beta -catenin signalling in Drosophila, Xenopus and mouse, possibly acting as a co-receptor for Wnt(4-6). Here we show that LRP6 (ref. 7) is a specific, high-affinity receptor for Dkk1 and Dkk2. Dkk1 blocks LRP6-mediated Wnt/beta -catenin signalling by interacting with domains that are distinct from those required for Wnt/Frizzled interaction. dkk1 and LRP6 interact antagonistically during embryonic head induction in Xenopus where LRP6 promotes the posteriorizing role of Wnt/beta -catenin signalling. Thus, DKKs inhibit Wnt co-receptor function, exemplifying the modulation of LRP signalling by antagonists.	Deutsch Krebsforschungszentrum, Div Mol Embryol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.		Mao, Bingyu/L-9955-2014	Mao, Bingyu/0000-0002-7993-3158				Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; Brown SP, 1998, J AGING PHYS ACTIV, V6, P248, DOI 10.1123/japa.6.3.248; Carnac G, 1996, DEVELOPMENT, V122, P3055; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X	26	834	897	3	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					321	325		10.1038/35077108	http://dx.doi.org/10.1038/35077108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357136				2022-12-01	WOS:000168710000051
J	Yung, RC; Orens, JB				Yung, RC; Orens, JB			Radicalism in therapy of lung cancer	LANCET			English	Editorial Material							BRONCHOGENIC-CARCINOMA; CT; MANAGEMENT		Johns Hopkins Univ, Dept Med & Oncol, Baltimore, MD 21208 USA; Johns Hopkins Univ, Dept Pulm & Crit Care Med, Baltimore, MD 21208 USA	Johns Hopkins University; Johns Hopkins University	Orens, JB (corresponding author), Johns Hopkins Univ, Dept Med & Oncol, Baltimore, MD 21208 USA.							*AM CANC SOC, 1998, CANC FACTS FIG, P1; COOPER JD, 1995, J THORAC CARDIOV SUR, V109, P106, DOI 10.1016/S0022-5223(95)70426-4; Dietlein M, 2000, EUR J NUCL MED, V27, P1598, DOI 10.1007/s002590000376; Fountain SW, 2001, THORAX, V56, P89; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Jett James, 1997, American Journal of Respiratory and Critical Care Medicine, V156, P320; Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234; Lowe VJ, 1998, ANN THORAC SURG, V65, P1821, DOI 10.1016/S0003-4975(98)00106-4; MCLOUD TC, 1992, RADIOLOGY, V182, P319, DOI 10.1148/radiology.182.2.1732943; MOUNTAIN CF, 1997, CHEST, V111, P1701; *NAT COMPR CANC NE, 2000, COMPL LIB NCCN ONC P, V1; Ost D, 2000, AM J RESP CRIT CARE, V162, P782, DOI 10.1164/ajrccm.162.3.9812152; Pisters KMW, 2000, J THORAC CARDIOV SUR, V119, P429, DOI 10.1016/S0022-5223(00)70120-6; TOCKMAN MS, 1985, LUNG CANC; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P135; WANG KP, 1983, AM REV RESPIR DIS, V127, P344	16	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1306	1307		10.1016/S0140-6736(00)04526-8	http://dx.doi.org/10.1016/S0140-6736(00)04526-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343729				2022-12-01	WOS:000168411400003
J	Niederlander, C; Walsh, JJ; Episkopou, V; Jones, CM				Niederlander, C; Walsh, JJ; Episkopou, V; Jones, CM			Arkadia enhances nodal-related signalling to induce mesendoderm	NATURE			English	Article							BONE MORPHOGENETIC PROTEIN-4; EARLY XENOPUS DEVELOPMENT; MESODERM INDUCTION; MATERNAL VEGT; EMBRYOS; BMP; GASTRULATION; LEFTY; MOUSE; ACTS	Nodal-related members of the transforming growth factor (TGF)-beta family regulate the induction of mesoderm, endoderm, and mesendoderm, a tissue specific to the Spemann organizer(1-7). How these different tissues form in response to the same signalling molecules is not completely understood. It has been suggested that concentration-dependent effects, mediated by extracellular cofactors and antagonists, are responsible for the differences(1,8-10). Here we show that the nuclear protein Arkadia specifically potentiates the mesendoderm-inducing activity of a subset of TGF-beta family members. The combined activities of Arkadia and Xenopus nodal-related-1 are sufficient to induce mesendoderm and suppress mesoderm. Arkadia dorsalizes ventral tissues, resulting in the induction of organizer-specific gene expression. Blocking nodal signalling extracellularly inhibits these effects. Arkadia influences nodal activity when co-expressed and can function in cells adjacent to those producing the nodal signal. Our findings, together with the observation that Arkadia mutant mice lack a node and node-derived mesendoderm, identify Arkadia as an essential modulator of the nodal signalling cascade that leads to induction of Spemann's organizer.	Inst Canc Res, Chester Beatty Labs, Sect Gene Funct & Regulat, London SW3 6JB, England; Hammersmith Hosp, Imperial Coll, Sch Med, MRC,Clin Sci Ctr,Mammalian Neurogenesis Grp, London W12 0NN, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Imperial College London	Jones, CM (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Gene Funct & Regulat, 237 Fulham Rd, London SW3 6JB, England.		Episkopou, Vasso/E-2952-2010		Medical Research Council [MC_U120074332] Funding Source: Medline; MRC [MC_U120074332] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agius E, 2000, DEVELOPMENT, V127, P1173; Armes NA, 1997, DEVELOPMENT, V124, P3797; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Cheng AMS, 2000, DEVELOPMENT, V127, P1049; Clements D, 1999, DEVELOPMENT, V126, P4903; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Dale L, 1999, BIOESSAYS, V21, P751, DOI 10.1002/(SICI)1521-1878(199909)21:9<751::AID-BIES6>3.0.CO;2-I; Episkopou V, 2001, NATURE, V410, P825, DOI 10.1038/35071095; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Jones CM, 1996, DEVELOPMENT, V122, P1545; JONES CM, 1995, DEVELOPMENT, V121, P3651; Kofron M, 1999, DEVELOPMENT, V126, P5759; Massague J, 2000, GENE DEV, V14, P627; Osada SI, 1999, DEVELOPMENT, V126, P3229; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Sampath K, 1997, DEVELOPMENT, V124, P3293; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Sun BI, 1999, DEVELOPMENT, V126, P1467; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Yasuo H, 1999, CURR BIOL, V9, P869, DOI 10.1016/S0960-9822(99)80391-1; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	29	60	63	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					830	834		10.1038/35071103	http://dx.doi.org/10.1038/35071103			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298453				2022-12-01	WOS:000168021900059
J	Moseley, M; Fielder, A				Moseley, M; Fielder, A			Improvement in amblyopic eye function and contralateral eye disease: evidence of residual plasticity	LANCET			English	Editorial Material									Western Eye Hosp, Imperial Coll Sch Med, Dept Ophthalmol, London NW1 5QH, England	Imperial College London	Moseley, M (corresponding author), Western Eye Hosp, Imperial Coll Sch Med, Dept Ophthalmol, London NW1 5QH, England.							ALLEN HF, 1967, ARCH OPHTHALMOL-CHIC, V77, P1; BIELSCHOWSDKY A, UEBER MONOCULARE DIP; BURIAN HM, 1969, AM J OPHTHALMOL, V67, P1; *DEP HLTH, 2000, REP CHILDR SUB GROUP; El Mallah MK, 2000, BRIT J OPHTHALMOL, V84, P952, DOI 10.1136/bjo.84.9.952; HAMED LM, 1991, BINOC VIS, V6, P97; Levi DM, 1997, INVEST OPHTH VIS SCI, V38, P1493; MINTZHITTNER HA, 1908, ARCH OPHTHALMOL-CHIC, V118, P1535; Moseley M. J., 1998, IOVS, V39, pS332; RABIN J, 1984, AM J OPTOM PHYS OPT, V61, P334; Rahi JS, 2000, INVEST OPHTH VIS SCI, V41, pS296; Simmers AJ, 1999, OPTOMETRY VISION SCI, V76, P82, DOI 10.1097/00006324-199902000-00014; SNOWDON SH, 9 CRD NHS CTR REV DI; VEREECKEN EP, 1984, ARCH OPHTHALMOL-CHIC, V102, P220; VONNOORDEN GK, 1979, T OPHTHAL SOC UK, V99, P442	15	13	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					902	904		10.1016/S0140-6736(00)04231-8	http://dx.doi.org/10.1016/S0140-6736(00)04231-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289343				2022-12-01	WOS:000167625300005
J	Suh, I; Jee, SH; Kim, HC; Nam, CM; Kim, IS; Appel, LJ				Suh, I; Jee, SH; Kim, HC; Nam, CM; Kim, IS; Appel, LJ			Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study	LANCET			English	Article							FACTOR INTERVENTION TRIAL; CEREBRAL-HEMORRHAGE; RISK; MORTALITY; PROGRAM	Background In some prospective studies. haemorrhagic stroke occurs more frequently in individuals with low serum cholesterol than in those with higher concentrations. We aimed to determine whether low total serum cholesterol is an independent risk factor for haemorrhagic stroke (intracerebral haemorrhage and subarachnoid haemorrhage) in South Korea. a country that has a population with relatively low concentrations of total serum cholesterol. Methods We measured total serum cholesterol and other cardiovascular risk factors in 114793 Korean men, aged between 35-59 years in 1990 and 1992, in a prospective observational study. We used data obtained in 1992 for smoking and alcohol consumption. We divided total serum cholesterol into quintiles (<4.31 mmol/L, 4.31-<4.74, 4.74-<5.16, 5.16-<5.69 and greater than or equal to5.69). Our primary outcomes were hospital admissions and deaths from intracerebral and subarachnoid haemorrhage in a 6 year follow-up between 1993 and 1998. Findings 528 men had a haemorrhagic stroke-372 intracerebral and 98 subarachnoid haemorrhage-and 58 were unspecified strokes. The relative risks of intracerebral haemorrhage in each quintile of total serum cholesterol (lowest to highest were: 1.22 (95% CI 0.88-1.69); 0.86 (0.60-1.21); 1.08 (0.78-1.48): and 1.03 (0.75-1.41). The corresponding relative risks for subarachnoid haemorrhage were: 1.44 (0.76-2.73); 1.13 (0.59-2.20): 1.21 (0.64-2.29): and 1.12 (0.59-2.14). Interpretation Low total serum cholesterol Is not independent risk factor for either intracerebral subarachnoid haemorrhagic stroke in Korean men.	Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul 120752, South Korea; Yonsei Univ, Grad Sch Hlth Sci & Management, Dept Epidemiol & Dis Control, Seoul 120752, South Korea; Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA	Yonsei University; Yonsei University Health System; Yonsei University; Johns Hopkins University; Johns Hopkins Medicine	Suh, I (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul 120752, South Korea.		Appel, Larry/GLT-2608-2022; Kim, Hyeon Chang/F-8796-2019	Suh, Il/0000-0002-9689-7849; Nam, Chung Mo/0000-0003-0985-0928; Kim, Hyeon Chang/0000-0001-7867-1240; Jee, Sun Ha/0000-0001-9519-3068				CHUNG WS, 1991, J CLIN PATHOL QUAL C, V13, P1; Gavin JR, 1997, DIABETES CARE, V20, P1183; IRIBARREN C, 1995, JAMA-J AM MED ASSOC, V273, P1926, DOI 10.1001/jama.273.24.1926; Iribarren C, 1996, STROKE, V27, P1993, DOI 10.1161/01.STR.27.11.1993; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kim YK, 1993, J CLIN PATHOL QUAL C, V15, P1; Murray CJL., 1996, GLOBAL BURDEN DIS CO; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; *NIH, 1997, NIH PUBL; O'Donnell HC, 2000, NEW ENGL J MED, V342, P240, DOI 10.1056/NEJM200001273420403; Puddey IB, 1996, ATHEROSCLEROSIS, V119, P1, DOI 10.1016/0021-9150(95)05634-3; Rodgers A, 1998, LANCET, V352, P1801; Ross SD, 1999, ARCH INTERN MED, V159, P1793, DOI 10.1001/archinte.159.15.1793; TANAKA H, 1982, STROKE, V13, P62, DOI 10.1161/01.STR.13.1.62; Whitehead TP, 1977, QUALITY CONTROL CLIN; YANO K, 1989, STROKE, V20, P1460, DOI 10.1161/01.STR.20.11.1460	16	107	116	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					922	925		10.1016/S0140-6736(00)04213-6	http://dx.doi.org/10.1016/S0140-6736(00)04213-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289349				2022-12-01	WOS:000167625300011
J	Abbott, A				Abbott, A			Human Proteome Index launched	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					3	3		10.1038/35051220	http://dx.doi.org/10.1038/35051220			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343075	Bronze			2022-12-01	WOS:000166175600003
J	McAdam, AJ; Greenwald, RJ; Levin, MA; Chernova, T; Malenkovich, N; Ling, V; Freeman, GJ; Sharpe, AH				McAdam, AJ; Greenwald, RJ; Levin, MA; Chernova, T; Malenkovich, N; Ling, V; Freeman, GJ; Sharpe, AH			ICOS is critical for CD40-mediated antibody class switching	NATURE			English	Article							CO-STIMULATION; MOLECULE ICOS; DIFFERENTIATION; COSTIMULATION; EXPRESSION; IDENTIFICATION; ACTIVATION; IMMUNITY; PROTEIN; CD4(+)	The inducible co-stimulatory molecule (ICOS) is a CD28 homologue implicated in regulating T-cell differentiation(1-5). Because co-stimulatory signals are critical for regulating T-cell activation, an understanding of co-stimulatory signals may enable the design of rational therapies for immune-mediated diseases(6). According to the two-signal model for T-cell activation, T cells require an antigen-specific signal and a second, co-stimulatory, signal for optimal T-cell activation(6). The co-stimulatory signal promotes T-cell proliferation, lymphokine secretion and effector function. The B7-CD28 pathway provides essential signals for T-cell activation, but does not account for all co-stimulation. We have generated mice lacking ICOS (ICOS-/-) to determine the essential functions of ICOS. Here we report that ICOS-/- mice exhibit profound deficits in immunoglobulin isotype class switching, accompanied by impaired germinal centre formation. Class switching was restored in ICOS-/- mice by CD40 stimulation, showing that ICOS promotes T-cell/B-cell collaboration through the CD40/CD40L pathway.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Genet Inst Inc, Dept Immunol, Cambridge, MA 02081 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Sharpe, AH (corresponding author), Brigham & Womens Hosp, Dept Pathol, 221 Longwood Ave, Boston, MA 02115 USA.	asharpe@rics.bwh.harvard.edu	Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616; Sharpe, Arlene/0000-0002-9736-2109				Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Brodie D, 2000, CURR BIOL, V10, P333, DOI 10.1016/S0960-9822(00)00383-3; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Greenwald RJ, 1997, J IMMUNOL, V158, P4088; HASBOLD J, 1994, EUR J IMMUNOL, V24, P1835, DOI 10.1002/eji.1830240817; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; Ling V, 2000, J IMMUNOL, V164, P1653, DOI 10.4049/jimmunol.164.4.1653; Mages HW, 2000, EUR J IMMUNOL, V30, P1040, DOI 10.1002/(SICI)1521-4141(200004)30:4<1040::AID-IMMU1040>3.0.CO;2-6; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2000, J VIROL, V74, P203, DOI 10.1128/JVI.74.1.203-208.2000; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243; Schweitzer AN, 1997, J IMMUNOL, V158, P2713; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Tarlinton D, 1998, CURR OPIN IMMUNOL, V10, P245, DOI 10.1016/S0952-7915(98)80161-1; Wang SD, 2000, BLOOD, V96, P2808; Yip HC, 1999, J IMMUNOL, V162, P3942; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	22	514	569	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					102	105		10.1038/35051107	http://dx.doi.org/10.1038/35051107			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343122				2022-12-01	WOS:000166175600048
J	Koivisto, UM; Hubbard, AL; Mellman, R				Koivisto, UM; Hubbard, AL; Mellman, R			A novel cellular phenotype for familial hypercholesterolemia due to a defect in polarized targeting of LDL receptor	CELL			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; PLASMA-MEMBRANE PROTEINS; MDCK CELLS; EPITHELIAL-CELLS; MONOCLONAL-ANTIBODIES; DOMAIN; GENE; ENDOCYTOSIS; TRAFFICKING; GOLGI	Basolateral targeting of membrane proteins in polarized epithelial cells typically requires cytoplasmic domain sorting signals. In the familial hypercholesterolemia (FH)-Turku LDL receptor allele, a mutation of glycine 823 residue affects the signal required for basolateral targeting in MDCK cells. We show that the mutant receptor is mistargeted to the apical surface in both MDCK and hepatic epithelial cells, resulting in reduced endocytosis of LDL from the basolateral/sinusoidal surface. Consequently, virally encoded mutant receptor fails to mediate cholesterol clearance in LDL receptor-deficient mice, suggesting that a defect in polarized LDL receptor expression in hepatocytes underlies the hypercholesterolemia in patients harboring this allele. This evidence directly links the pathogenesis of a human disease to defects in basolateral targeting signals, providing a genetic confirmation of these signals in maintaining epithelial cell polarity.	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Ludwig Institute for Cancer Research; Yale University; Johns Hopkins University	Mellman, R (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.				NIDDK NIH HHS [DK44375] Funding Source: Medline; NIGMS NIH HHS [GM28765] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044375] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ameen NA, 2000, TRAFFIC, V1, P76, DOI 10.1034/j.1600-0854.2000.010111.x; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Charron AJ, 2000, J CELL BIOL, V149, P111, DOI 10.1083/jcb.149.1.111; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Folsch H, 2001, J CELL BIOL, V152, P595, DOI 10.1083/jcb.152.3.595; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HERZ J, 1993, P NATL ACAD SCI USA, V90, P2812, DOI 10.1073/pnas.90.7.2812; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HUETTINGER M, 1984, J CLIN INVEST, V74, P1017, DOI 10.1172/JCI111469; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; IHRKE G, 1993, J CELL BIOL, V123, P1761, DOI 10.1083/jcb.123.6.1761; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Keller P, 1997, J CELL SCI, V110, P3001; Kipp H, 2000, J BIOL CHEM, V275, P15917, DOI 10.1074/jbc.M909875199; KNIGHT A, 1995, MOL BIOL CELL, V6, P597, DOI 10.1091/mbc.6.5.597; KOIVISTO UM, 1995, AM J HUM GENET, V57, P789; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; MATTER K, 1994, CURR OPIN CELL BIOL, V6, P545, DOI 10.1016/0955-0674(94)90075-2; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; MATTER K, 1994, J CELL BIOL, V126, P991, DOI 10.1083/jcb.126.4.991; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Tuma PL, 1999, J CELL BIOL, V145, P1089, DOI 10.1083/jcb.145.5.1089; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; YOKODE M, 1992, J CELL BIOL, V117, P39, DOI 10.1083/jcb.117.1.39; Yu Q, 2000, J CLIN INVEST, V105, P741, DOI 10.1172/JCI7997	41	76	78	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					575	585		10.1016/S0092-8674(01)00371-3	http://dx.doi.org/10.1016/S0092-8674(01)00371-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389828	Bronze			2022-12-01	WOS:000169123200005
J	Esch, HE; Zhang, SW; Srinivasan, MV; Tautz, J				Esch, HE; Zhang, SW; Srinivasan, MV; Tautz, J			Honeybee dances communicate distances measured by optic flow	NATURE			English	Article								In honeybees, employed foragers recruit unemployed hive mates to food sources by dances from which a human observer can read the distance and direction of the food source(1). When foragers collect food in a short, narrow tunnel, they dance as if the food source were much farther away. Dancers gauge distance by retinal image flow on the way to their destination. Their visually driven odometer misreads distance because the close tunnel walls increase optic flow(2). We examined how hive mates interpret these dances. Here we show that recruited bees search outside in the direction of the tunnel at exaggerated distances and not inside the tunnel where the foragers come from. Thus, dances must convey information about the direction of the food source and the total amount of image motion en route to the food source, but they do not convey information about absolute distances. We also found that perceived distances on various outdoor routes from the same hive could be considerably different. Navigational errors are avoided as recruits and dancers tend to fly in the same direction. Reported racial differences in honeybee dances(1) could have arisen merely from differences in the environments in which these bees flew.	Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia; Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany	University of Notre Dame; Australian National University; University of Wurzburg	Esch, HE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.		Srinivasan, Mandyam V/G-5571-2010; Zhang, Shaowu/C-9139-2009	Zhang, Shaowu/0000-0002-3551-5587				Esch HE, 1996, J EXP BIOL, V199, P155; HERAN H, 1959, Z VERGL PHYSIOL, V42, P103, DOI 10.1007/BF00298733; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; von Frisch K, 1969, DANCE LANGUAGE ORIEN	4	184	190	1	71	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					581	583		10.1038/35079072	http://dx.doi.org/10.1038/35079072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385571				2022-12-01	WOS:000168982500050
J	Nemergut, ME; Mizzen, CA; Stukenberg, T; Allis, CD; Macara, IG				Nemergut, ME; Mizzen, CA; Stukenberg, T; Allis, CD; Macara, IG			Chromatin docking and exchange activity enhancement of RCC1 by histones H2A and H2B	SCIENCE			English	Article							XENOPUS EGG EXTRACTS; DNA-REPLICATION; RAN; NUCLEOPLASMIN; CYTOPLASM; RANGAP1; MITOSIS; PROTEIN; GTPASE	The Ran guanosine triphosphatase (GTPase) controls nucleocytoplasmic transport, mitotic spindle formation, and nuclear envelope assembly. These functions rely on the association of the Ran-specific exchange factor, RCC1 (regulator of chromosome condensation 1), with chromatin. We find that RCC1 binds directly to mononucleosomes and to histones H2A and H2B. RCC1 utilizes these histones to bind Xenopus sperm chromatin, and the binding of RCC1 to nucleosomes or histones stimulates the catalytic activity-of RCC1, We propose that the docking of RCC1 to H2A/H2B establishes the polarity of the Ran-CTP gradient that drives nuclear envelope assembly, nuclear transport, and other nuclear events.	Univ Virginia, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biochem, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Nemergut, ME (corresponding author), Univ Virginia, Ctr Cell Signaling, Hosp W RM 7191,POB 800577 HSC, Charlottesville, VA 22908 USA.			Stukenberg, Todd/0000-0002-6788-2111; Nemergut, Michael/0000-0002-6803-1765	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-50526] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; DASSO M, 1992, MOL CELL BIOL, V12, P3337, DOI 10.1128/MCB.12.8.3337; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; de la Barre AE, 2000, EMBO J, V19, P379, DOI 10.1093/emboj/19.3.379; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Karantza V, 1996, BIOCHEMISTRY-US, V35, P2037, DOI 10.1021/bi9518858; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Leno GH, 1998, METHOD CELL BIOL, V53, P497; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Nemergut ME, 2000, J CELL BIOL, V149, P835, DOI 10.1083/jcb.149.4.835; NEMERGUT ME, UNPUB; PHILPOTT A, 1992, CELL, V69, P759, DOI 10.1016/0092-8674(92)90288-N; PHILPOTT A, 1991, CELL, V65, P569, DOI 10.1016/0092-8674(91)90089-H; RICH G, 1995, VENEREOLOGY, V8, P270; SEINO H, 1992, J CELL SCI, V102, P393; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429	20	180	186	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1540	1543		10.1126/science.292.5521.1540	http://dx.doi.org/10.1126/science.292.5521.1540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375490				2022-12-01	WOS:000168963800043
J	Ohki, I; Shimotake, N; Fujita, N; Jee, JG; Ikegami, T; Nakao, M; Shirakawa, M				Ohki, I; Shimotake, N; Fujita, N; Jee, JG; Ikegami, T; Nakao, M; Shirakawa, M			Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA	CELL			English	Article							TRANSCRIPTIONAL REPRESSOR MECP2; HISTONE DEACETYLASE COMPLEX; RETT-SYNDROME MUTATIONS; PROTEIN MBD1; ASSOCIATION; NUCLEOSOME; GENE; NMR; METHYLTRANSFERASE; CHROMATIN	In vertebrates, the biological consequences of DNA methylation are often mediated by protein factors containing conserved methyl-CpG binding domains (MBDs). Mutations in the MBD protein MeCP2 cause the neurodevelopmental disease Rett syndrome. We report here the solution structure of the MBD of the human methylation-dependent transcriptional regulator MBD1 bound to methylated BRA. DNA binding causes a loop in MBD1 to fold into a major and novel DNA binding interface. Recognition of the methyl groups and CG sequence at the methylation site is due to five highly conserved residues that form a hydrophobic patch. The structure indicates how MBD may access nucleosomal DNA without encountering steric interference from core histones, and provides a basis to interpret mutations linked to Rett syndrome in MeCP2.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Yokohama City Univ, Grad Sch Integrated Sci, Kanagawa 2300045, Japan; Kumamoto Univ, Sch Med, Dept Tumor Genet & Biol, Kumamoto 8600811, Japan	Nara Institute of Science & Technology; Yokohama City University; Kumamoto University	Shirakawa, M (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan.		Ohki, Izuru/O-4816-2019; Ikegami, Takahisa/I-9626-2017; Ohki, Izuru/C-7883-2013	Ohki, Izuru/0000-0002-0667-5936; Ikegami, Takahisa/0000-0002-1429-1844; 				Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; Ballestar E, 2000, BIOCHEMISTRY-US, V39, P7100, DOI 10.1021/bi0001271; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRUENGER AT, 1993, XPLOR 3 1 SYSTEM XRA; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Connolly KM, 2000, J MOL BIOL, V300, P841, DOI 10.1006/jmbi.2000.3888; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Dragich J, 2000, HUM MOL GENET, V9, P2365, DOI 10.1093/hmg/9.16.2365; Free A, 2001, J BIOL CHEM, V276, P3353, DOI 10.1074/jbc.M007224200; Fujita N, 2000, MOL CELL BIOL, V20, P5107, DOI 10.1128/MCB.20.14.5107-5118.2000; Fujita N, 1999, MOL CELL BIOL, V19, P6415; Guschin D, 1998, BIOCHEMISTRY-US, V37, P8629, DOI 10.1021/bi9805846; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Katoh E, 1999, J AM CHEM SOC, V121, P2607, DOI 10.1021/ja984041v; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee KM, 1998, BIOCHEMISTRY-US, V37, P8622, DOI 10.1021/bi980499y; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MEEHAN RR, 1989, CELL, V69, P905; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohki I, 1999, EMBO J, V18, P6653, DOI 10.1093/emboj/18.23.6653; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Van den Veyver IB, 2000, CURR OPIN GENET DEV, V10, P275, DOI 10.1016/S0959-437X(00)00083-6; VUISTER GW, 1998, BIOL MAGN RESON, P195; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wakefield RID, 1999, J MOL BIOL, V291, P1055, DOI 10.1006/jmbi.1999.3023; Wojciak JM, 1999, NAT STRUCT BIOL, V6, P366; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; YAMAZAKI T, 1995, J AM CHEM SOC, V117, P3556, DOI 10.1021/ja00117a025; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	48	238	249	2	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					487	497		10.1016/S0092-8674(01)00324-5	http://dx.doi.org/10.1016/S0092-8674(01)00324-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371345	Bronze			2022-12-01	WOS:000168840700008
J	Turner, BL; Haygarth, PM				Turner, BL; Haygarth, PM			Biogeochemistry - Phosphorus solubilization in rewetted soils	NATURE			English	Article									Inst Grassland & Environm Res, Soil Sci Grp, Okehampton EX20 2SB, Devon, England		Turner, BL (corresponding author), ARS, USDA, NW Irrigat & Soils Res Lab, Kimberly, ID 83341 USA.		Turner, Benjamin L/E-5940-2011; Haygarth, Philip Matthew/F-6790-2014	Turner, Benjamin L/0000-0002-6585-0722; 				BIRCH H. F., 1960, Plant and Soil, V12, P81, DOI 10.1007/BF01377763; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; HOUGHTON JT, 1992, CLIMATE CHANGE IPCC; Pote DH, 1999, J ENVIRON QUAL, V28, P170, DOI 10.2134/jeq1999.00472425002800010020x; SALEMA MP, 1982, SOIL BIOL BIOCHEM, V14, P15, DOI 10.1016/0038-0717(82)90071-2; Turner BL, 2000, SOIL SCI SOC AM J, V64, P1090, DOI 10.2136/sssaj2000.6431090x	6	308	325	11	162	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					258	258		10.1038/35077146	http://dx.doi.org/10.1038/35077146			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357117				2022-12-01	WOS:000168710000032
J	Potter, CJ; Huang, H; Xu, T				Potter, CJ; Huang, H; Xu, T			Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size	CELL			English	Article							TUBEROUS SCLEROSIS; PHOSPHOINOSITIDE 3-KINASE; GENETIC MOSAICS; EYE DEVELOPMENT; PROTEIN-KINASE; HOMOLOG; EXPRESSION; HAMARTIN; ENCODES; IDENTIFICATION	Tuberous sclerosis complex is a dominant disorder that leads to the development of benign tumors in multiple organs. We have isolated a mutation in the Drosophila homolog of TSC1 (Tsc1). Cells mutant for Tsc1 are dramatically increased in size yet differentiate normally. Organ size is also increased in tissues that contain a majority of mutant cells. Clones of Tsc1 mutant cells in the imaginal discs undergo additional divisions but retain normal ploidy. We also show that the Tsc1 protein binds to Drosophila Tsc2 in vitro. Overexpression of Tsc1 or Tsc2 alone in the wing and eye has no effect, but co-overexpression leads to a decrease in cell size, cell number, and organ size. Genetic epistasis data are consistent with a model that Tsc1 and Tsc2 function together in the insulin signaling pathway.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst,Dept Genet, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Xu, T (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Howard Hughes Med Inst,Dept Genet, 295 Congress Ave, New Haven, CT 06536 USA.	tian.xu@yale.edu	Potter, Christopher John/H-5884-2019	Potter, Christopher John/0000-0002-5223-8112	NCI NIH HHS [CA69408] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; CANAL I, 1994, EUR J NEUROSCI, V6, P1423, DOI 10.1111/j.1460-9568.1994.tb01004.x; Cheadle JP, 2000, HUM GENET, V107, P97, DOI 10.1007/s004390000348; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Halder G, 1998, DEVELOPMENT, V125, P2181; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang H, 1999, DEVELOPMENT, V126, P5365; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; JOHNSON WG, 1991, ANN NY ACAD SCI, V615, P211; Jones AC, 1997, HUM MOL GENET, V6, P2155, DOI 10.1093/hmg/6.12.2155; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; NELLIST M, 1993, CELL, V75, P1305; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Plank TL, 1998, CANCER RES, V58, P4766; Soucek T, 1998, P NATL ACAD SCI USA, V95, P15653, DOI 10.1073/pnas.95.26.15653; Staveley BE, 1998, CURR BIOL, V8, P599, DOI 10.1016/S0960-9822(98)70231-3; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Stowers RS, 1999, GENETICS, V152, P1631; TABATA T, 1995, DEVELOPMENT, V121, P3359; Tang AH, 2001, DEVELOPMENT, V128, P801; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Theodosiou NA, 1998, DEVELOPMENT, V125, P3411; THOMAS BJ, 1994, CELL, V77, P1003, DOI 10.1016/0092-8674(94)90440-5; van Slegtenhorst M, 1999, J MED GENET, V36, P285; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Wittwer F, 2001, DEVELOPMENT, V128, P791; WOLFF T, 2000, DROSOPHILA PROTOCOLS, P201; Wolff T, 1993, DEV DROSOPHILA MELAN; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	45	414	428	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					357	368		10.1016/S0092-8674(01)00333-6	http://dx.doi.org/10.1016/S0092-8674(01)00333-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348592	Bronze			2022-12-01	WOS:000168515900005
J	Obsil, T; Ghirlando, R; Klein, DC; Ganguly, S; Dyda, F				Obsil, T; Ghirlando, R; Klein, DC; Ganguly, S; Dyda, F			Crystal structure of the 14-3-35 zeta : serotonin N-acetyltransferase complex: A role for scaffolding in enzyme regulation	CELL			English	Article							MULTIPLE SIGNALING PATHWAYS; 14-3-3 PROTEIN; SERINE PHOSPHORYLATION; MELATONIN PRODUCTION; CATALYTIC MECHANISM; ANGSTROM RESOLUTION; CELL-SURVIVAL; BRAIN 14-3-3; PINEAL-GLAND; ZETA-ISOFORM	Serotonin N-acetyltransferase (AANAT) controls the daily rhythm in melatonin synthesis. When isolated from tissue, AANAT copurifies with isoforms epsilon and zeta of 14-3-3. We have determined the structure of AANAT bound to 14-3-3 zeta, an association that is phosphorylation dependent. AANAT is bound in the central channel of the 14-3-3 zeta dimer, and is held in place by extensive interactions both with the amphipathic phosphopeptide binding groove of 14-3-3 zeta and with other parts of the central channel. Thermodynamic and activity measurements, together with crystallographic analysis, indicate that binding of AANAT by 14-3-3 zeta modulates AANAT's activity and affinity for its substrates by stabilizing a region of AANAT involved in substrate binding.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dyda, F (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	dyda@ulti.niddk.nih.gov	Obsil, Tomas/B-7142-2012; Ghirlando, Rodolfo/A-8880-2009	Obsil, Tomas/0000-0003-4602-1272; Ganguly, Surajit/0000-0002-1876-9147; Klein, David/0000-0002-1792-5806	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000095, ZIAHD000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036122] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Arendt J., 1995, MELATONIN MAMMALIAN; Banik U, 1997, J BIOL CHEM, V272, P26219, DOI 10.1074/jbc.272.42.26219; BIJMA K, 1994, LANGMUIR, V10, P2578, DOI 10.1021/la00020a015; BOSTON PF, 1982, J NEUROCHEM, V38, P1466, DOI 10.1111/j.1471-4159.1982.tb07927.x; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; COON SL, 1995, SCIENCE, V270, P1681, DOI 10.1126/science.270.5242.1681; De Angelis J, 1998, J BIOL CHEM, V273, P3045, DOI 10.1074/jbc.273.5.3045; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Finnie C, 1999, PLANT MOL BIOL, V40, P545, DOI 10.1023/A:1006211014713; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Hickman AB, 1999, MOL CELL, V3, P23, DOI 10.1016/S1097-2765(00)80171-9; Hickman AB, 1999, CELL, V97, P361, DOI 10.1016/S0092-8674(00)80745-X; HINZ HJ, 1983, ANNU REV BIOPHYS BIO, V12, P285, DOI 10.1146/annurev.bb.12.060183.001441; Khalil EM, 1998, J AM CHEM SOC, V120, P6195, DOI 10.1021/ja981365a; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Klein DC, 1997, RECENT PROG HORM RES, V52, P307; Klein DC, 1998, HDB BEHAV STATE CONT, P45; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Liu YC, 1997, J BIOL CHEM, V272, P9979, DOI 10.1074/jbc.272.15.9979; MacNicol MC, 2000, J BIOL CHEM, V275, P3803, DOI 10.1074/jbc.275.6.3803; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NAMBOODIRI MAA, 1985, COMP BIOCHEM PHYS B, V80, P731, DOI 10.1016/0305-0491(85)90453-5; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Roseboom PH, 1996, ENDOCRINOLOGY, V137, P3033, DOI 10.1210/en.137.7.3033; ROSEBOOM PH, 1994, DNA CELL BIOL, V13, P629, DOI 10.1089/dna.1994.13.629; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Sutherland GRJ, 1997, BIOCHEMISTRY-US, V36, P8567, DOI 10.1021/bi970484k; TANJI M, 1994, J NEUROCHEM, V63, P1908; THIBAULT C, 1993, J NEUROCHEM, V61, P332, DOI 10.1111/j.1471-4159.1993.tb03572.x; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tronrud DE, 1996, J APPL CRYSTALLOGR, V29, P100, DOI 10.1107/S002188989501421X; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Xiao Bing, 1995, Nature (London), V376, P188, DOI 10.1038/376188a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; [No title captured]	53	317	326	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					257	267		10.1016/S0092-8674(01)00316-6	http://dx.doi.org/10.1016/S0092-8674(01)00316-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336675	Bronze			2022-12-01	WOS:000168384300012
J	Shamah, SM; Lin, MZ; Goldberg, JL; Estrach, S; Sahin, M; Hu, L; Bazalakova, M; Neve, RL; Corfas, G; Debant, A; Greenberg, ME				Shamah, SM; Lin, MZ; Goldberg, JL; Estrach, S; Sahin, M; Hu, L; Bazalakova, M; Neve, RL; Corfas, G; Debant, A; Greenberg, ME			EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin	CELL			English	Article							TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; EMBRYONIC-DEVELOPMENT; FOCAL COMPLEXES; CELL-ADHESION; RHO; PROTEINS; FAMILY; RAC; ACTIVATION	Eph receptors transduce short-range repulsive signals for axon guidance by modulating actin dynamics within growth cones. We report the cloning and characterization of ephexin, a novel Eph receptor-interacting protein that is a member of the Dbl family of guanine nucleotide exchange factors (GEFs) for Rho GTPases. Ephrin-A stimulation of EphA receptors modulates the activity of ephexin leading to RhoA activation, Cdc42 and Rac1 inhibition, and cell morphology changes. In addition, expression of a mutant form of ephexin in primary neurons interferes with ephrin-A-induced growth cone collapse. The association of ephexin with Eph receptors constitutes a molecular link between Eph receptors and the actin cytoskeleton and provides a novel mechanism for achieving highly localized regulation of growth cone motility.	Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Stanford Univ, Dept Neurol, SUMC, Stanford, CA 94305 USA; Ctr Rech Biochim Macromol, CNRS, UPR 1086, F-34293 Montpellier 5, France; McLean Hosp, Belmont, MA 02478 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Stanford University; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Harvard University; McLean Hospital	Greenberg, ME (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	greenberg@a1.tch.harvard.edu	Corfas, Gabriel/AAH-2378-2020; Estrach, Soline/D-4226-2017; SAHIN, MUSTAFA/I-8653-2019; Estrach, Soline/GYA-4499-2022	Corfas, Gabriel/0000-0001-5412-9473; SAHIN, MUSTAFA/0000-0001-7044-2953; estrach, soline/0000-0003-2088-5988; Goldberg, Jeffrey/0000-0002-1390-7360; Lin, Michael/0000-0002-0492-1961; Bazalakova, Mihaela/0000-0002-1718-3320	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD001384] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884, R01NS045500] Funding Source: NIH RePORTER; NCI NIH HHS [CA43855] Funding Source: Medline; NEI NIH HHS [R01 EY11310] Funding Source: Medline; NICHD NIH HHS [1K08HD01384, HD18655] Funding Source: Medline; NINDS NIH HHS [R01 NS35884, NS10070-02, R01 NS045500] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; BECKER N, 1995, FEBS LETT, V368, P353, DOI 10.1016/0014-5793(95)00652-P; Blangy A, 2000, J CELL SCI, V113, P729; CHAN AML, 1994, ONCOGENE, V9, P1057; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FINLEY RL, 1996, DNA CLONING EXPRESSI, P169; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MORI T, 1995, MOL BRAIN RES, V29, P325, DOI 10.1016/0169-328X(94)00263-E; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olson MF, 1996, CURR BIOL, V6, P1628, DOI 10.1016/S0960-9822(02)70786-0; PANDEY A, 1994, J BIOL CHEM, V269, P30154; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rodrigues NR, 2000, GENOMICS, V65, P53, DOI 10.1006/geno.2000.6138; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SHU HKG, 1994, MOL CELL BIOL, V14, P6868, DOI 10.1128/MCB.14.10.6868; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797, DOI 10.1083/jcb.139.3.797; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wu CB, 1997, J BIOL CHEM, V272, P3554, DOI 10.1074/jbc.272.6.3554; Wyszynski M, 1999, Methods Enzymol, V294, P371; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yoshii S, 1999, ONCOGENE, V18, P5680, DOI 10.1038/sj.onc.1202936	36	427	447	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					233	244		10.1016/S0092-8674(01)00314-2	http://dx.doi.org/10.1016/S0092-8674(01)00314-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336673	Bronze			2022-12-01	WOS:000168384300010
J	Giurfa, M; Zhang, SW; Jenett, A; Menzel, R; Srinivasan, MV				Giurfa, M; Zhang, SW; Jenett, A; Menzel, R; Srinivasan, MV			The concepts of 'sameness' and 'difference' in an insect	NATURE			English	Article							HONEYBEES; PIGEONS; NAVIGATION; PATTERNS; STIMULI; ODDITY; MEMORY	Insects process and learn information flexibly to adapt to their environment. The honeybee Apis mellifera constitutes a traditional model for studying learning and memory at behavioural, cellular and molecular levels(1). Earlier studies focused on elementary associative and non-associative forms of learning determined by either olfactory conditioning of the proboscis extension reflex(1) or the learning of visual stimuli(2) in an operant context. However, research has indicated that bees are capable of cognitive performances that were thought to occur only in some vertebrate species. For example, honeybees can interpolate visual information(3), exhibit associative recall(4,5), categorize visual information(6-8) and learn contextual information(9). Here we show that honeybees can form 'sameness' and 'difference' concepts. They learn to solve 'delayed matching-to-sample' tasks, in which they are required to respond to a matching stimulus, and 'delayed non-matching-to-sample' tasks, in which they are required to respond to a different stimulus; they can also transfer the learned rules to new stimuli of the same or a different sensory modality. Thus, not only can bees learn specific objects and their physical parameters, but they can also master abstract inter-relationships, such as sameness and difference.	Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; Univ Toulouse 3, F-30162 Toulouse 4, France; Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia	Free University of Berlin; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Australian National University	Giurfa, M (corresponding author), Free Univ Berlin, Inst Biol, Konigin Luise Str 28-30, D-14195 Berlin, Germany.		Srinivasan, Mandyam V/G-5571-2010; Giurfa, Martin/AAS-4945-2020; Giurfa, Martin MG/A-7322-2008; Zhang, Shaowu/C-9139-2009; Giurfa, Martin/H-5140-2016	Giurfa, Martin/0000-0001-7173-769X; Zhang, Shaowu/0000-0002-3551-5587; Giurfa, Martin/0000-0001-7173-769X; Jenett, Arnim/0000-0003-3039-2060				COLLETT TS, 1995, J COMP PHYSIOL A, V177, P287, DOI 10.1007/BF00192418; Collett TS, 1997, J COMP PHYSIOL A, V181, P343, DOI 10.1007/s003590050120; DAMATO MR, 1985, J EXP PSYCHOL ANIM B, V11, P35, DOI 10.1037/0097-7403.11.1.35; Davey G., 1989, ECOLOGICAL LEARNING; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; HATEREN JH, 1990, J COMP PHYSIOL A, V167, P649; HERMAN L M, 1974, Journal of the Experimental Analysis of Behavior, V21, P19, DOI 10.1901/jeab.1974.21-19; HOLMES PW, 1979, J EXP ANAL BEHAV, V31, P103, DOI 10.1901/jeab.1979.31-103; HORRIDGE GA, 1995, J INSECT PHYSIOL, V41, P681, DOI 10.1016/0022-1910(95)00021-L; LOMBARDI CM, 1984, ANIM LEARN BEHAV, V12, P2, DOI 10.3758/BF03199807; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Menzel R, 1985, EXPT BEHAV ECOLOGY, P55; MOON LE, 1955, J COMP PHYSIOL PSYCH, V48, P188, DOI 10.1037/h0046959; ODEN DL, 1988, J EXP PSYCHOL ANIM B, V14, P140, DOI 10.1037/0097-7403.14.2.140; Srinivasan MV, 1998, NATURE, V396, P637, DOI 10.1038/25272; Strong PN, 1966, PSYCHON SCI, V5, P13, DOI 10.3758/BF03328254; THOMAS RK, 1973, ANIM LEARN BEHAV, V1, P151, DOI 10.3758/BF03214583; WILSON B, 1985, Q J EXP PSYCHOL-B, V37, P313, DOI 10.1080/14640748508401173; Wright A.A., 1983, QUANTITATIVE ANAL BE, V4, P295; ZENTALL TR, 1978, J EXP ANAL BEHAV, V30, P177, DOI 10.1901/jeab.1978.30-177; Zhang SW, 1999, NEUROBIOL LEARN MEM, V72, P180, DOI 10.1006/nlme.1998.3901	23	391	400	2	109	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					930	933		10.1038/35073582	http://dx.doi.org/10.1038/35073582			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	423AG	11309617				2022-12-01	WOS:000168152300046
J	Lu, YF; Yang, Y; Sellinger, A; Lu, MC; Huang, JM; Fan, HY; Haddad, R; Lopez, G; Burns, AR; Sasaki, DY; Shelnutt, J; Brinker, CJ				Lu, YF; Yang, Y; Sellinger, A; Lu, MC; Huang, JM; Fan, HY; Haddad, R; Lopez, G; Burns, AR; Sasaki, DY; Shelnutt, J; Brinker, CJ			Self-assembly of mesoscopically ordered chromatic polydiacetylene/silica nanocomposites	NATURE			English	Article							MESOPOROUS SILICA; FILMS; ACID; TRANSITION; NANOSTRUCTURES; COMPOSITES; LIPOSOMES; LAYER	Nature abounds with intricate composite architectures composed of hard and soft materials synergistically intertwined to provide both useful functionality and mechanical integrity. Recent synthetic efforts to mimic such natural designs have focused on nanocomposites(1-5), prepared mainly by slow procedures like monomer or polymer infiltration of inorganic nanostructures(6,7) or sequential deposition(8,9). Here we report the self-assembly of conjugated polymer/silica nanocomposite films with hexagonal, cubic or lamellar mesoscopic order using polymerizable amphiphilic diacetylene molecules as both structure-directing agents and monomers. The self-assembly procedure is rapid and incorporates the organic monomers uniformly within a highly ordered, inorganic environment. Polymerization results in polydiacetylene/silica nanocomposites that are optically transparent and mechanically robust. Compared to ordered diacetylene-containing films prepared as Langmuir monolayers(10) or by Langmuir-Blodgett deposition(10), the nanostructured inorganic host alters the diacetylene polymerization behaviour, and the resulting nanocomposite exhibits unusual chromatic changes in response to thermal, mechanical and chemical stimuli. The inorganic framework serves to protect, stabilize, and orient the polymer, and to mediate its function. The nanocomposite architecture also provides sufficient mechanical integrity to enable integration into devices and microsystems.	Univ New Mexico, Ctr Microengineered Ceram, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87131 USA; Sandia Natl Labs, Adv Mat Lab, Albuquerque, NM 87106 USA	University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories	Brinker, CJ (corresponding author), Univ New Mexico, Ctr Microengineered Ceram, Albuquerque, NM 87131 USA.		Sellinger, Alan/C-6250-2015; Shelnutt, John A/A-9987-2009	Sellinger, Alan/0000-0001-6705-1548; Shelnutt, John A/0000-0001-7368-582X				Asefa T, 2000, J MATER CHEM, V10, P1751, DOI 10.1039/b000950o; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R; BURNS AR, IN PRESS TRIBOL LETT; CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021; Cheng Q, 1998, LANGMUIR, V14, P1974, DOI 10.1021/la980185b; Cheng Q, 2000, LANGMUIR, V16, P5333, DOI 10.1021/la9916169; COLLINS MA, 1988, J POLYM SCI POL PHYS, V26, P367, DOI 10.1002/polb.1988.090260212; Dagani R, 1999, CHEM ENG NEWS, V77, P25, DOI 10.1021/cen-v077n023.p025; DAY D, 1978, J POLYM SCI POL LETT, V16, P205, DOI 10.1002/pol.1978.130160501; DAY DR, 1981, J APPL POLYM SCI, V26, P1605, DOI 10.1002/app.1981.070260516; Fan HY, 2000, NATURE, V405, P56, DOI 10.1038/35011026; FRANKEL DA, 1991, J AM CHEM SOC, V113, P7436, DOI 10.1021/ja00019a059; FRYE GC, 1988, MATER RES SOC S P, V121, P349; GAINES GL, 1966, INSOLUBLE MONOLAYERS, P281; Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104; ISRAELACHVILI JN, 1992, INTERMOLECULAR SURFA, pCH17; KELLER SW, 1994, J AM CHEM SOC, V116, P8817, DOI 10.1021/ja00098a055; KLEINFELD ER, 1994, SCIENCE, V265, P370, DOI 10.1126/science.265.5170.370; Kuriyama K, 1996, LANGMUIR, V12, P6468, DOI 10.1021/la960164m; Lu YF, 1999, NATURE, V398, P223, DOI 10.1038/18410; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Mazumdar S, 2000, SCIENCE, V288, P630, DOI 10.1126/science.288.5466.630; Menzel H, 1998, J PHYS CHEM B, V102, P9550, DOI 10.1021/jp9830023; Moller K, 1998, CHEM MATER, V10, P1841, DOI 10.1021/cm980020o; MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299; Nguyen TQ, 2000, SCIENCE, V288, P652, DOI 10.1126/science.288.5466.652; PATEL GN, 1979, J CHEM PHYS, V70, P4387, DOI 10.1063/1.438012; Sasaki DY, 2000, J COLLOID INTERF SCI, V229, P490, DOI 10.1006/jcis.2000.7043; Sellinger A, 1998, NATURE, V394, P256, DOI 10.1038/28354; Smith RC, 1997, J AM CHEM SOC, V119, P4092, DOI 10.1021/ja963837w; SPEVAK W, 1993, J AM CHEM SOC, V115, P1146, DOI 10.1021/ja00056a047; SUZUOKI Y, 1991, P 7 INT S EL IEEE NE, P850	32	507	529	5	279	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					913	917		10.1038/35073544	http://dx.doi.org/10.1038/35073544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309612				2022-12-01	WOS:000168152300041
J	Xie, JY; Black, DL				Xie, JY; Black, DL			A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels	NATURE			English	Article							PRE-MESSENGER-RNA; ACTIVATED POTASSIUM CHANNELS; ADRENAL CHROMAFFIN CELLS; COMBINATORIAL CONTROL; BINDING-PROTEIN; HAIR-CELLS; EXPRESSION; MECHANISM; VARIANTS; KINASE	Calcium regulation of gene expression is critical for the longlasting activity-dependent changes in cellular electrical properties that underlie important physiological functions such as learning and memory(1). Cellular electrical properties are diversified through the extensive alternative splicing of ion channel premessenger RNAs2; however, the regulation of splicing by cell signalling pathways has not been well explored. Here we show that depolarization of GH(3) pituitary cells represses splicing of the STREX exon(3) in BK potassium channel transcripts through the action of Ca2+/calmodulin-dependent protein kinases (CaMKs). Overexpressing constitutively active CaMK IV, but not CaMK I or II, specifically decreases STREX inclusion in the mRNA. This decrease is prevented by mutations in particular RNA repressor sequences. Transferring 54 nucleotides from the 3' splice site upstream of STREX to a heterologous gene is sufficient to confer CaMK IV repression on an otherwise constitutive exon. These experiments define a CaMK IV-responsive RNA element (CaRRE), which mediates the alternative splicing of ion channel pre-mRNAs. The CaRRE presents a unique molecular target for inducing long-term adaptive changes in cellular electrical properties. It also provides a model system for dissecting the effect of signal transduction pathways on alternative splicing.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Microbiol & Mol Genet, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Black, DL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.		Xie, Jiuyong/D-2899-2013	Xie, Jiuyong/0000-0003-2909-1033				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; DOMINSKI Z, 1991, MOL CELL BIOL, V11, P6075, DOI 10.1128/MCB.11.12.6075; Ferrer J, 1996, DIABETOLOGIA, V39, P891, DOI 10.1007/BF00403907; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Hille B., 1992, IONIC CHANNELS EXCIT; Jones EMC, 1999, J PHYSIOL-LONDON, V518, P653, DOI 10.1111/j.1469-7793.1999.0653p.x; LAGRUTTA A, 1994, J BIOL CHEM, V269, P20347; Lingle C J, 1996, Ion Channels, V4, P261; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Modafferi EF, 1999, RNA, V5, P687, DOI 10.1017/S1355838299990155; Modafferi EF, 1997, MOL CELL BIOL, V17, P6537, DOI 10.1128/MCB.17.11.6537; Navaratnam DS, 1997, NEURON, V19, P1077, DOI 10.1016/S0896-6273(00)80398-0; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; ROSE ML, 1997, CARDIOVASC ENG, V2, P19; Saito M, 1997, J BIOL CHEM, V272, P11710, DOI 10.1074/jbc.272.18.11710; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Spitzer NC, 1998, J NEUROBIOL, V37, P190, DOI 10.1002/(SICI)1097-4695(199810)37:1<190::AID-NEU14>3.3.CO;2-2; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zhang L, 1999, RNA, V5, P117, DOI 10.1017/S1355838299981530; Zhang L, 1996, RNA, V2, P682	30	196	202	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					936	939		10.1038/35073593	http://dx.doi.org/10.1038/35073593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309619				2022-12-01	WOS:000168152300048
J	Smith, IC; Jones, MW				Smith, IC; Jones, MW			Surgeons' attitudes to intraoperative death: questionnaire survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Dept Trauma & Orhtopaed, Bangor LL57 2PW, Gwynedd, Wales		Smith, IC (corresponding author), Dept Trauma & Orhtopaed, Bangor LL57 2PW, Gwynedd, Wales.	lasoksmith@aol.com						Firth-Cozens J, 1999, HOSP MED, V60, P751, DOI 10.12968/hosp.1999.60.10.1222; Gottlieb S, 1999, BRIT MED J, V318, P349	2	20	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2001	322	7291					896	897		10.1136/bmj.322.7291.896	http://dx.doi.org/10.1136/bmj.322.7291.896			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302903	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000168311300021
J	Tian, B; Reser, D; Durham, A; Kustov, A; Rauschecker, JP				Tian, B; Reser, D; Durham, A; Kustov, A; Rauschecker, JP			Functional specialization in rhesus monkey auditory cortex	SCIENCE			English	Article							SOUND-LOCALIZATION BEHAVIOR; MACAQUE MONKEYS; CEREBRAL-CORTEX; COMPLEX SOUNDS; CONNECTIONS; NEURONS; AREAS; SUBDIVISIONS; STREAMS; HUMANS	Neurons in the Lateral belt areas of rhesus monkey auditory cortex prefer complex sounds to pure tones, but functional specializations of these multiple maps in the superior temporal region have not been determined. We tested the specificity of neurons in the Lateral belt with species-specific communication calls presented at different azimuth positions. We found that neurons in the anterior belt are more selective for the type of call, whereas neurons in the caudal belt consistently show the greatest spatial selectivity. These results suggest that cortical processing of auditory spatial and pattern information is performed in specialized streams rather than one homogeneously distributed system.	Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA	Georgetown University	Rauschecker, JP (corresponding author), Georgetown Univ, Med Ctr, Dept Physiol & Biophys, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA.		Rauschecker, Josef P/A-4120-2013	Rauschecker, Josef P./0000-0003-4353-9084; Reser, David/0000-0002-5130-1255	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC003845, R01DC003489] Funding Source: NIH RePORTER; NIDCD NIH HHS [R03-DC03845, R01-DC03489] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bregman A. S, 1990, AUDITORY SCENE ANAL; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; Hauser MD., 1996, EVOLUTION COMMUNICAT; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; JENKINS WM, 1984, J NEUROPHYSIOL, V52, P819, DOI 10.1152/jn.1984.52.5.819; Jones E. G., 1985, CEREB CORTEX, V4, P3; JONES EG, 1995, J COMP NEUROL, V362, P153, DOI 10.1002/cne.903620202; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Konishi M., 1988, AUDITORY FUNCTION NE, P721; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; RAJAN R, 1990, J NEUROPHYSIOL, V64, P872, DOI 10.1152/jn.1990.64.3.872; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Tian B, 1998, J NEUROPHYSIOL, V79, P2629, DOI 10.1152/jn.1998.79.5.2629; Ungerleider L, 1982, ANAL VISUAL BEHAV, P549	31	512	518	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					290	293		10.1126/science.1058911	http://dx.doi.org/10.1126/science.1058911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303104				2022-12-01	WOS:000168074000048
J	Srinivasarao, M; Collings, D; Philips, A; Patel, S				Srinivasarao, M; Collings, D; Philips, A; Patel, S			Three-dimensionally ordered array of air bubbles in a polymer film	SCIENCE			English	Article							CRYSTAL; CRYSTALLIZATION; LITHOGRAPHY; SUPPRESSION; COALESCENCE; POLYSTYRENE; COPOLYMERS; TEMPLATES; SILICA	We report the formation of a three-dimensionally ordered array of air bubbles of monodisperse pore size in a polymer film through a templating mechanism based on thermocapillary convection. Dilute solutions of a simple, coil-like polymer in a volatile solvent are cast on a glass slide in the presence of moist air flowing across the surface, Evaporative cooling and the generation of an ordered array of breath figures Leads to the formation of multilayers of hexagonally packed water droplets that are preserved in the final, solid polymer film as spherical air bubbles. The dimensions of these bubbles can be controlled simply by changing the velocity of the airflow across the surface. When these three-dimensionally ordered macroporous materials have pore dimensions comparable to the wavelength of visible Light, they are of interest as photonic band gaps and optical stop-bands.	Georgia Inst Technol, Sch Text & Fiber Engn, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; N Carolina State Univ, Dept Bot, Raleigh, NC 27695 USA; N Carolina State Univ, Dept Text Engn Chem & Sci, Raleigh, NC 27695 USA; Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Alcatel-Lucent; Lucent Technologies; AT&T	Srinivasarao, M (corresponding author), Georgia Inst Technol, Sch Text & Fiber Engn, Atlanta, GA 30332 USA.		Srinivasarao, Mohan/M-9810-2013; Srinivasarao, Mohan/L-4041-2019	Collings, David/0000-0003-3863-5979				Aitkek J, 1911, NATURE, V86, P516, DOI DOI 10.1038/086516A0; BAKER JT, 1922, PHILOS MAG, V56, P752; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; BEYSENS D, 1986, PHYS REV LETT, V57, P1433, DOI 10.1103/PhysRevLett.57.1433; BEYSENS D, 1991, PHASE TRANSIT, V31, P219, DOI 10.1080/01411599108206932; Blanco A, 2000, NATURE, V405, P437, DOI 10.1038/35013024; BRAGG WL, 1947, P ROY SOC LOND A MAT, V190, P474; BRISCOE BJ, 1990, J PHYS D APPL PHYS, V23, P422, DOI 10.1088/0022-3727/23/4/005; Busch K, 1999, PHYS REV LETT, V83, P967, DOI 10.1103/PhysRevLett.83.967; Dam TH, 1999, REV SCI INSTRUM, V70, P3982, DOI 10.1063/1.1150024; Davis SA, 1997, NATURE, V385, P420, DOI 10.1038/385420a0; Dell'Aversana P, 1998, PHYS TODAY, V51, P38, DOI 10.1063/1.882133; DellAversana P, 1997, PHYS FLUIDS, V9, P2475, DOI 10.1063/1.869471; DellAversana P, 1996, PHYS FLUIDS, V8, P15, DOI 10.1063/1.868811; DUSHKIN CD, 1993, LANGMUIR, V9, P3695, DOI 10.1021/la00036a055; FAMILY F, 1988, PHYS REV LETT, V61, P428, DOI 10.1103/PhysRevLett.61.428; Holland BT, 1998, SCIENCE, V281, P538, DOI 10.1126/science.281.5376.538; Imhof A, 1997, NATURE, V389, P948, DOI 10.1038/40105; Jenekhe SA, 1999, SCIENCE, V283, P372, DOI 10.1126/science.283.5400.372; Joannopoulos J., 1995, PHOTONIC CRYSTALS MO, DOI DOI 10.2307/J.CTVCM4GZ9; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Karthaus O, 2000, LANGMUIR, V16, P6071, DOI 10.1021/la0001732; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kulinowski KM, 2000, ADV MATER, V12, P833, DOI 10.1002/(SICI)1521-4095(200006)12:11<833::AID-ADMA833>3.0.CO;2-X; Li Z, 1996, J AM CHEM SOC, V118, P10892, DOI 10.1021/ja961713d; Limaye AV, 1996, PHYS REV LETT, V76, P3762, DOI 10.1103/PhysRevLett.76.3762; MONNIER A, 1993, SCIENCE, V261, P1299, DOI 10.1126/science.261.5126.1299; MORKVED TL, 1994, APPL PHYS LETT, V64, P422, DOI 10.1063/1.111118; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Pitois O, 1999, EUR PHYS J B, V8, P225, DOI 10.1007/s100510050685; Pitois O, 1999, COLLOID POLYM SCI, V277, P574, DOI 10.1007/s003960050427; Rayleigh, 1911, NATURE, V86, P416, DOI 10.1038/086416d0; RAYLEIGH, 1899, PHILOS MAG, V36, P21; RAYLEIGH, 1912, NATURE, V90, P436; RAYLEIGH, 1882, P ROY SOC LONDON, V34, P130; Rayleigh Lord, 1879, P ROY SOC LONDON, V28, P406; Reynolds O., 1881, CHEM NEWS, V44, P211; Rossier JS, 1999, ANAL CHEM, V71, P4294, DOI 10.1021/ac981382i; SRINIVASARAO M, UNPUB; Velev OD, 1997, NATURE, V389, P447, DOI 10.1038/38921; Voldman J, 1999, ANNU REV BIOMED ENG, V1, P401, DOI 10.1146/annurev.bioeng.1.1.401; Walker J., 1978, SCI AM, V238, P123; WIDAWSKI G, 1994, NATURE, V369, P387, DOI 10.1038/369387a0; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yan HW, 1999, ADV MATER, V11, P1003, DOI 10.1002/(SICI)1521-4095(199908)11:12<1003::AID-ADMA1003>3.0.CO;2-K; ZHONG XF, 1994, MACROMOLECULES, V27, P1751, DOI 10.1021/ma00085a013	46	789	827	9	425	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					79	83		10.1126/science.1057887	http://dx.doi.org/10.1126/science.1057887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292866				2022-12-01	WOS:000167995200040
J	Borgstein, J				Borgstein, J			A sense sf language	LANCET			English	Editorial Material									Univ Rotterdam Hosp, NL-3015 GD Rotterdam, Netherlands; Natl Inst Resp Dis, Mexico City, DF, Mexico; Natl Autonomous Univ Mexico, Mexico City 04510, DF, Mexico	Erasmus University Rotterdam; Erasmus MC; Universidad Nacional Autonoma de Mexico	Borgstein, J (corresponding author), Univ Rotterdam Hosp, Dr Molewaterpl 60, NL-3015 GD Rotterdam, Netherlands.								0	2	2	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1036	1037		10.1016/S0140-6736(00)04241-0	http://dx.doi.org/10.1016/S0140-6736(00)04241-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293610				2022-12-01	WOS:000167791500037
J	Lamolet, B; Pulichino, AM; Lamonerie, T; Gauthier, Y; Brue, T; Enjalbert, A; Drouin, J				Lamolet, B; Pulichino, AM; Lamonerie, T; Gauthier, Y; Brue, T; Enjalbert, A; Drouin, J			A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins	CELL			English	Article							RECEPTOR STEROIDOGENIC FACTOR-1; HOLT-ORAM SYNDROME; TRANSGENIC MICE; PROOPIOMELANOCORTIN GENE; MOUSE DEVELOPMENT; PTX1; EXPRESSION; FAMILY; GLAND; RAT	The pituitary gland has provided unique insight into molecular mechanisms and regulatory factors controling both differentiation and gene transcription. We identified Tpit, a novel T box factor only present in the two pituitary POMC-expressing lineages, the corticotrophs and melanotrophs, and apparently in no other tissue, including hypothalamic POMC neurons. In pituitary cells, Tpit activation of POMC gene transcription requires cooperation with Pitx1, the two factors binding to contiguous sites within the same regulatory element. In gain-of-function experiments, Tpit induces POMC expression in undifferentiated pituitary cells, indicating that it can initiate differentiation into POMC-expressing lineages. TPIT gene mutations were found in patients with isolated deficiency of pituitary POMC-derived ACTH, in support of an essential role of Tpit for differentiation of the pituitary POMC lineage.	Inst Rech Clin Montreal, Genet Mol Lab, Montreal, PQ H2W 1R7, Canada; Univ Mediterranee, Lab Interact Cellulaires Neuroendocriniennes, CNRS, UMR 6544, Marseille, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Drouin, J (corresponding author), Inst Rech Clin Montreal, Genet Mol Lab, 110 Pins Ouest, Montreal, PQ H2W 1R7, Canada.		Brue, Thierry/P-6571-2019; Brue, Thierry/AAI-2328-2019	Brue, Thierry/0000-0001-8482-6691; Brue, Thierry/0000-0001-8482-6691; Pulichino, Anne-Marie/0000-0002-2419-8344; Drouin, Jacques/0000-0001-8226-5691; Lamonerie, Thomas/0000-0003-2371-2708				Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Drouin J, 1998, MOL CELL ENDOCRINOL, V140, P31, DOI 10.1016/S0303-7207(98)00026-4; ELKABES S, 1989, DEV BRAIN RES, V46, P85, DOI 10.1016/0165-3806(89)90145-4; Gage PJ, 1999, MAMM GENOME, V10, P197, DOI 10.1007/s003359900970; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gage PJ, 1997, HUM MOL GENET, V6, P457, DOI 10.1093/hmg/6.3.457; GEE CE, 1983, NATURE, V306, P374, DOI 10.1038/306374a0; HAMMER GD, 1990, MOL ENDOCRINOL, V4, P1689, DOI 10.1210/mend-4-11-1689; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; INGRAHAM HA, 1994, GENE DEV, V8, P2302, DOI 10.1101/gad.8.19.2302; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; KENDALL SK, 1994, MOL ENDOCRINOL, V8, P1420, DOI 10.1210/me.8.10.1420; Kioussi C, 1999, MECH DEVELOP, V81, P23, DOI 10.1016/S0925-4773(98)00229-9; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; Knezevic V, 1997, DEVELOPMENT, V124, P411; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lanctot C, 1999, ENDOCRINOLOGY, V140, P1416, DOI 10.1210/en.140.3.1416; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lanctot C, 1997, DEVELOPMENT, V124, P2807; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li QY, 1997, NAT GENET, V15, P21; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; LIN SC, 1994, DEVELOPMENT, V120, P515; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Maira M, 1999, MOL CELL BIOL, V19, P7549; MALPUECH G, 1988, AM J MED GENET, V29, P125, DOI 10.1002/ajmg.1320290115; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; NEMESKERI A, 1988, NEUROENDOCRINOLOGY, V48, P534, DOI 10.1159/000125060; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Poulin G, 2000, MOL CELL BIOL, V20, P4826, DOI 10.1128/MCB.20.13.4826-4837.2000; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; RUBINSTEIN M, 1993, NEUROENDOCRINOLOGY, V58, P373, DOI 10.1159/000126566; Sheng HZ, 1999, TRENDS GENET, V15, P236, DOI 10.1016/S0168-9525(99)01742-4; Sheng HZ, 1997, SCIENCE, V278, P1809, DOI 10.1126/science.278.5344.1809; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Tremblay JJ, 2000, NEUROENDOCRINOLOGY, V71, P277, DOI 10.1159/000054547; Tremblay JJ, 1999, EMBO J, V18, P3431, DOI 10.1093/emboj/18.12.3431; Tremblay JJ, 1999, MOL CELL BIOL, V19, P2567; Tremblay JJ, 1998, MOL ENDOCRINOL, V12, P428, DOI 10.1210/me.12.3.428; TREMBLAY Y, 1988, P NATL ACAD SCI USA, V85, P8890, DOI 10.1073/pnas.85.23.8890; Young JI, 1998, J NEUROSCI, V18, P6631	53	367	375	2	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					849	859		10.1016/S0092-8674(01)00282-3	http://dx.doi.org/10.1016/S0092-8674(01)00282-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290323	Bronze			2022-12-01	WOS:000167869200008
J	Rybczynski, N; Reisz, RR				Rybczynski, N; Reisz, RR			Earliest evidence for efficient oral processing in a terrestrial herbivore	NATURE			English	Article							EVOLUTION	Herbivores can increase their digestion rate by mechanically reducing particle size through oral trituration(1). Groups of terrestrial vertebrates with the greatest capacity to reduce tough plant foods orally are also the most abundant and diverse, as exemplified by ornithopod dinosaurs during the Mesozoic and extant artiodactyl and perissodactyl mammals(2). Thus, the effective oral processing of high-fibre plant material seems to represent an evolutionary innovation of both functional and macroevolutionary significance. However, evidence for oral processing is poorly documented in the fossil record, especially during the initial stages of terrestrial vertebrate diversification(3,4). Here we report on the basal anomodont Suminia getmanovi, the only known Palaeozoic vertebrate in which unequivocal specializations in its cranium and teeth for high-fibre herbivory are well preserved. We propose that the capacity to comminute tough plant foods was critical to the diversification of anomodonts, the most diverse, widely dispersed and abundant group of Palaeozoic terrestrial vertebrates, and to the onset of modern terrestrial ecosystems.	Univ Toronto, Dept Zool, Mississauga, ON L5L 1C6, Canada; Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA	University of Toronto; University Toronto Mississauga; Duke University	Reisz, RR (corresponding author), Univ Toronto, Dept Zool, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.							BJORNDAL KA, 1990, PHYSIOL ZOOL, V63, P710, DOI 10.1086/physzool.63.4.30158172; COSTA RL, 1981, J PALEONTOL, V55, P635; Dimichele William A., 1992, P205; Galton P.M., 1986, P203; Hotton N. III, 1986, P71; Hotton Nicholas III, 1997, P207; IVACHNENKO MF, 1994, PALEONTOLOG J, V28, P96; KING G., 1996, REPTILES HERBIVORY; KING GM, 1994, J ZOOL, V232, P651, DOI 10.1111/j.1469-7998.1994.tb04620.x; NORMAN DB, 1985, AM NAT, V126, P151, DOI 10.1086/284406; Popowics TE, 1997, ANN ZOOL FENN, V34, P73; Reisz Robert R., 2000, P9, DOI 10.1017/CBO9780511549717.003; RENSBERGER JM, 1973, J PALEONTOL, V47, P515; RENSBERGER JM, 1975, J PALEONTOL, V49, P10; Rybczynski N, 2000, ZOOL J LINN SOC-LOND, V130, P329, DOI 10.1006/zjls.1999.0218; Sues HD, 1998, TRENDS ECOL EVOL, V13, P141, DOI 10.1016/S0169-5347(97)01257-3; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307	17	40	41	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					684	687		10.1038/35079567	http://dx.doi.org/10.1038/35079567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395768				2022-12-01	WOS:000169112500042
J	Vicsek, T				Vicsek, T			A question of scale	NATURE			English	Article									Eotvos Lorand Univ, Dept Biol Phys, H-1117 Budapest, Hungary	Eotvos Lorand University	Vicsek, T (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Pazmany P Stny 1A, H-1117 Budapest, Hungary.		Vicsek, Tamas/A-3305-2009					Coleman J.S., 1990, FDN SOCIAL THEORY; Huang K, 1987, STAT MECH; VICSEK T, 2001, SCALING FLUCTUATIONS	3	93	102	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					421	421		10.1038/35078161	http://dx.doi.org/10.1038/35078161			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373653	Green Submitted			2022-12-01	WOS:000168858700024
J	Goel, V				Goel, V		Crossroads 99 Grp	Appraising organised screening programmes for testing for genetic susceptibility to cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COLORECTAL-CANCER; ABC		Dept Hlth Adm, Toronto, ON M5S 1A8, Canada		Goel, V (corresponding author), Dept Hlth Adm, McMurrich Bldg, Toronto, ON M5S 1A8, Canada.	vivek.goel@utoronto.ca	Bottorff, Joan L./A-6420-2018	Bottorff, Joan L./0000-0001-9724-5351; Goel, Vivek/0000-0002-1389-2007				Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; CADMAN D, 1991, AM J PREV MED, V7, P117; CLARKE A, 1995, BMJ-BRIT MED J, V311, P35, DOI 10.1136/bmj.311.6996.35; Cole TRP, 2000, BRIT MED J, V321, P943, DOI 10.1136/bmj.321.7266.943; *COUNC EUR, 2001, 164 ETS COUNC EUR; Haddow JE, 1999, BRIT MED J, V319, P531, DOI 10.1136/bmj.319.7209.531; Hardy RG, 2000, BRIT MED J, V321, P886, DOI 10.1136/bmj.321.7265.886; Holtzman NA, 1998, BMJ-BRIT MED J, V316, P852, DOI 10.1136/bmj.316.7134.852; KIZER KW, 1991, AM J PREV MED, V7, P117, DOI 10.1016/S0749-3797(18)30948-6; Scholefield JH, 2000, BRIT MED J, V321, P1004, DOI 10.1136/bmj.321.7267.1004; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wilson JMG, 1968, PRINCIPLES PRACTICE	13	31	31	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2001	322	7295					1174	1178		10.1136/bmj.322.7295.1174	http://dx.doi.org/10.1136/bmj.322.7295.1174			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348918	Green Published			2022-12-01	WOS:000168748900023
J	Ogle, JM; Brodersen, DE; Clemons, WM; Tarry, MJ; Carter, AP; Ramakrishnan, V				Ogle, JM; Brodersen, DE; Clemons, WM; Tarry, MJ; Carter, AP; Ramakrishnan, V			Recognition of cognate transfer RNA by the 30S ribosomal subunit	SCIENCE			English	Article							AMINOACYL-TRANSFER-RNA; PHENYLALANINE TRANSFER-RNA; ESCHERICHIA-COLI RIBOSOME; ELONGATION-FACTOR TU; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; A-SITE; DNA-REPLICATION; 70S RIBOSOME; P-SITE	Crystal structures of the 30S ribosomal subunit in complex with messenger RNA and cognate transfer RNA in the A site, both in the presence and absence of the antibiotic paromomycin, have been solved at between 3.1 and 3.3 angstroms resolution. Cognate transfer RNA (tRNA) binding induces global domain movements of the 30S subunit and changes in the conformation of the universally conserved and essential bases A1492, A1493, and G530 of 16S RNA. These bases interact intimately with the minor groove of the first two base pairs between the codon and anticodon, thus sensing Watson-Crick base-pairing geometry and discriminating against near-cognate tRNA, The third, or "wobble," position of the codon is free to accommodate certain noncanonical base pairs. By partially inducing these structural changes, paromomycin facilitates binding of near-cognate tRNAs.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ramak@mrc-lmb.cam.ac.uk	Brodersen, Ditlev E./AAQ-5241-2020; Clemons, William M/D-1026-2009	Clemons, William M/0000-0002-0021-889X; Brodersen, Ditlev/0000-0002-5413-4667; Carter, Andrew/0000-0001-7292-5430; Ramakrishnan, V/0000-0002-4699-2194	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM019384, R01GM044973] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 44973, F31 GM019384] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EIGEN M, 1966, NATURWISSENSCHAFTEN, V53, P50, DOI 10.1007/BF00594747; Fourmy D, 1998, J MOL BIOL, V277, P333, DOI 10.1006/jmbi.1997.1551; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Gate JH, 1996, SCIENCE, V273, P1696, DOI 10.1126/science.273.5282.1696; Goldgur Y, 1997, STRUCTURE, V5, P59, DOI 10.1016/S0969-2126(97)00166-4; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Jovine L, 2000, J MOL BIOL, V301, P401, DOI 10.1006/jmbi.2000.3950; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KURLAND CG, 1996, CELLULAR MOL BIOL, V1, P979; MCCARTHY BJ, 1965, P NATL ACAD SCI USA, V54, P880, DOI 10.1073/pnas.54.3.880; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mueller F, 1997, J MOL BIOL, V271, P566, DOI 10.1006/jmbi.1997.1212; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; NISSEN P, 2001, P NATL ACAD SCI US 1; OConnor M, 1995, BIOCHEM CELL BIOL, V73, P859, DOI 10.1139/o95-093; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Pape T, 2000, NAT STRUCT BIOL, V7, P104; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; POTAPOV AP, 1995, J BIOL CHEM, V270, P17680, DOI 10.1074/jbc.270.30.17680; POTAPOV AP, 1982, FEBS LETT, V146, P5, DOI 10.1016/0014-5793(82)80693-5; POWERS T, 1990, P NATL ACAD SCI USA, V87, P1042, DOI 10.1073/pnas.87.3.1042; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; THOMPSON RC, 1977, P NATL ACAD SCI USA, V74, P198, DOI 10.1073/pnas.74.1.198; THOMPSON RC, 1982, P NATL ACAD SCI-BIOL, V79, P4922, DOI 10.1073/pnas.79.16.4922; VanLoock MS, 1999, J MOL BIOL, V285, P2069, DOI 10.1006/jmbi.1998.2442; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yokoyama Shigeyuki, 1995, P207; Yoshizawa S, 1999, SCIENCE, V285, P1722, DOI 10.1126/science.285.5434.1722	50	934	992	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					897	902		10.1126/science.1060612	http://dx.doi.org/10.1126/science.1060612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340196				2022-12-01	WOS:000168514900034
J	Schwetz, BA				Schwetz, BA			Two ophthalmic solutions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2186	2186		10.1001/jama.285.17.2186	http://dx.doi.org/10.1001/jama.285.17.2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325309				2022-12-01	WOS:000168256100008
J	McNamee, D				McNamee, D			Cancer paper retracted	LANCET			English	News Item																		BEZWODA WR, 1995, J CLIN ONCOL, V13, P2483, DOI 10.1200/JCO.1995.13.10.2483	1	0	0	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1343	1343		10.1016/S0140-6736(00)04535-9	http://dx.doi.org/10.1016/S0140-6736(00)04535-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343749				2022-12-01	WOS:000168411400022
J	Hunt, K; Emslie, C; Watt, G				Hunt, K; Emslie, C; Watt, G			Lay constructions of a family history of heart disease: potential for misunderstandings in the clinical encounter?	LANCET			English	Article							QUALITATIVE-RESEARCH; LIFE-STYLE; HEALTH; RISK; PERCEPTIONS; ADVICE; CARE	Background Family history is recognised as a risk factor for coronary heart disease (CHD) by epidemiologists, health professionals, and the public, and could act either as a spur or barrier to changing health behaviour. However, there has been no systematic investigation of which factors affect whether people regard themselves as having a family history of CHD or not. Methods We used purposive sampling to select 61 men and women who were middle class or working class from a large cross-sectional survey. Half the respondents had indicated in this previous survey that they had heart disease in their family. The range of understanding of the meaning of having a family history was explored in detailed qualitative ssmistructured interviews. Findings Perception of a family history of heart disease depended on knowledge of the health of family members, the number and closeness of relatives with heart conditions, the age of affected relatives, and the respondent's sex and social class. Men, particularly working-class men, required a greater number of close relatives to be affected to perceive that they had a family history. Even when respondents judged that heart disease ran in their family, they did not always perceive themselves as at increased risk because they felt different in crucial ways from affected relatives. Interpretation The factors that people and epidemiologists judge as relevant to establish presence of a family history can differ. We suggest that these differences could lead to misunderstandings between doctor and patient, which could undermine advice on CHD risks and associated behavioural changes.	Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow G12 8RZ, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Glasgow	Hunt, K (corresponding author), Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.		G, G/A-3459-2012	Emslie, Carol/0000-0003-2170-2039				BACKETT KC, 1995, SOC SCI MED, V40, P629, DOI 10.1016/0277-9536(94)E0120-H; Britten N, 2000, BMJ-BRIT MED J, V320, P484, DOI 10.1136/bmj.320.7233.484; BRITTEN N, 1995, FAM PRACT, V311, P42; Brorsson A, 1995, FAM PRACT, V12, P433, DOI 10.1093/fampra/12.4.433; Butler CC, 1998, BMJ-BRIT MED J, V316, P1878; Canter D., 1985, RES INTERVIEW USES A, P115; DAVISON C, 1989, Health Education Research, V4, P329, DOI 10.1093/her/4.3.329; *DEP HLTH, 1998, OUR HLTH NAT CONTR H; Emslie C, 2001, SOCIOL HEALTH ILL, V23, P203, DOI 10.1111/1467-9566.00248; Hunt K, 2000, HEALTH EDUC RES, V15, P131, DOI 10.1093/her/15.2.131; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; KREUTER MW, 1995, HEALTH PSYCHOL, V14, P56, DOI 10.1037/0278-6133.14.1.56; MARTEAU TM, 1995, BRIT J GEN PRACT, V45, P5; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Ponder M, 1996, J MED GENET, V33, P485, DOI 10.1136/jmg.33.6.485; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Richards M, 1996, TROUBLED HELIX SOCIA, P249, DOI DOI 10.1017/CBO9780511570049.014; Silberberg J, 1999, GENET EPIDEMIOL, V16, P344, DOI 10.1002/(SICI)1098-2272(1999)16:4<344::AID-GEPI2>3.0.CO;2-Q; Silberberg JS, 1998, AM J EPIDEMIOL, V147, P1133; Stott NCH, 1995, FAM PRACT, V12, P413, DOI 10.1093/fampra/12.4.413; The Scottish Office, 1999, HLTH SCOTL WHIT PAP; Upton MN, 2000, BMJ-BRIT MED J, V321, P88, DOI 10.1136/bmj.321.7253.88; Watt G, 2000, J EPIDEMIOL COMMUN H, V54, P859, DOI 10.1136/jech.54.11.859; [No title captured]	26	75	75	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1168	1171		10.1016/S0140-6736(00)04334-8	http://dx.doi.org/10.1016/S0140-6736(00)04334-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423RX	11323044				2022-12-01	WOS:000168192100011
J	Essex, C				Essex, C			Delivering bad news - Receiving bad news will always be unpleasant	BRITISH MEDICAL JOURNAL			English	Letter									Gulson Hosp, Child Dev Univ, Coventry CV1 2HR, W Midlands, England		Essex, C (corresponding author), Gulson Hosp, Child Dev Univ, Coventry CV1 2HR, W Midlands, England.							HOSKING EJ, 2000, BRIT MED J, V321, P2; 2000, BMJ, V321, P1233	2	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					864	865						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11321015				2022-12-01	WOS:000168063000054
J	Philip, P; Vervialle, F; Le Breton, P; Taillard, J; Horne, JA				Philip, P; Vervialle, F; Le Breton, P; Taillard, J; Horne, JA			Fatigue, alcohol, and serious road crashes in France: factorial study of national data	BRITISH MEDICAL JOURNAL			English	Article							AUTOMOBILE DRIVERS		Ctr Hosp Univ, Clin Sommeil, F-33076 Bordeaux, France; Serv Etud Tech Routes & Autoroutes, Bagneux, France; Univ Loughborough, Sleep Res Lab, Loughborough LE11 3TU, Leics, England	CHU Bordeaux; Loughborough University	Philip, P (corresponding author), Ctr Hosp Univ, Clin Sommeil, F-33076 Bordeaux, France.		PHILIP, Pierre/AAS-8889-2020; Taillard, Jacques/H-5063-2018	PHILIP, Pierre/0000-0003-3267-634X; Taillard, Jacques/0000-0001-9067-8189				BIECHELEN MB, 1995, CONDUITE AUTOMOBILE; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; *OBS NAT INT SEC R, 1999, BIL ANN STAT COMM; Philip P, 1996, J PSYCHOSOM RES, V41, P279, DOI 10.1016/0022-3999(96)00127-4; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475	5	125	129	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					829	830		10.1136/bmj.322.7290.829	http://dx.doi.org/10.1136/bmj.322.7290.829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	421KF	11290636	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000168063000023
J	Pletnev, SV; Zhang, W; Mukhopadhyay, S; Fisher, BR; Hernandez, R; Brown, DT; Baker, TS; Rossmann, MG; Kuhn, RJ				Pletnev, SV; Zhang, W; Mukhopadhyay, S; Fisher, BR; Hernandez, R; Brown, DT; Baker, TS; Rossmann, MG; Kuhn, RJ			Locations of carbohydrate sites on alphavirus glycoproteins show that E1 forms an icosahedral scaffold	CELL			English	Article							SEMLIKI-FOREST-VIRUS; INFECTIOUS RNA TRANSCRIPTS; BORNE ENCEPHALITIS-VIRUS; SINDBIS VIRUS; SPIKE-PROTEIN; CRYOELECTRON MICROSCOPY; MEMBRANE-GLYCOPROTEINS; 3-DIMENSIONAL RECONSTRUCTION; NUCLEOTIDE-SEQUENCE; ENVELOPED VIRUS	There are 80 spikes on the surface of Sindbis virus arranged as an icosahedral surface lattice. Each spike consists of three copies of each of the glycoproteins E1 and E2. There are two glycosylation sites on E1 and two on E2. These four sites have been located by removal of the glycosylation recognition motifs using site-specific mutagenesis, followed by cryoelectron microscopy. The positions of these sites have demonstrated that E2 forms the protruding spikes and that E1 must be long and narrow, lying flat on the viral surface, forming an icosahedral scaffold analogous to the arrangement of the E glycoprotein in flaviviruses. This arrangement of E1 leads to both dimeric and trimeric intermolecular contacts, consistent with the observed structural changes that occur on fusion with host cell membranes, suggesting a similar fusion mechanism for alpha- and flaviviruses.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of North Carolina; North Carolina State University	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.		Kuhn, Richard/AAR-2722-2021	Kuhn, Richard/0000-0003-4148-1026; , Timothy/0000-0001-6543-8968	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033050, R01GM056279] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI045976, AI45976] Funding Source: Medline; NIGMS NIH HHS [R37 GM033050, GM56279, R01 GM056279] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; ANTHONY RP, 1991, J VIROL, V65, P1187, DOI 10.1128/JVI.65.3.1187-1194.1991; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Baker TS, 1996, J STRUCT BIOL, V116, P120, DOI 10.1006/jsbi.1996.0020; BONATTI S, 1979, J CELL BIOL, V80, P219, DOI 10.1083/jcb.80.1.219; CANCEDDA R, 1975, CELL, V6, P215, DOI 10.1016/0092-8674(75)90012-4; Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CHENG RH, 1995, CELL, V80, P621; Choi HK, 1997, PROTEINS, V27, P345, DOI 10.1002/(SICI)1097-0134(199703)27:3<345::AID-PROT3>3.0.CO;2-C; CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0; DUBUISSON J, 1993, J VIROL, V67, P3363, DOI 10.1128/JVI.67.6.3363-3374.1993; EKSTROM M, 1994, EMBO J, V13, P1058, DOI 10.1002/j.1460-2075.1994.tb06354.x; Ferlenghi I, 1998, J MOL BIOL, V283, P71, DOI 10.1006/jmbi.1998.2066; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Forsell K, 2000, EMBO J, V19, P5081, DOI 10.1093/emboj/19.19.5081; FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2; Fuller SD, 1996, J STRUCT BIOL, V116, P48, DOI 10.1006/jsbi.1996.0009; GAROFF H, 1980, NATURE, V288, P236, DOI 10.1038/288236a0; GAROFF H, 1978, J MOL BIOL, V124, P587, DOI 10.1016/0022-2836(78)90173-0; HARRISON SC, 1992, CURR OPIN STRUC BIOL, V2, P293; HELENIUS A, 1980, EUR J BIOCHEM, V106, P613, DOI 10.1111/j.1432-1033.1980.tb04609.x; KENNEY JM, 1994, STRUCTURE, V2, P823, DOI 10.1016/S0969-2126(94)00083-2; Kielian M, 1996, J CELL BIOL, V134, P863, DOI 10.1083/jcb.134.4.863; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; KUHN RJ, 1991, VIROLOGY, V182, P430, DOI 10.1016/0042-6822(91)90584-X; Lee S, 1996, STRUCTURE, V4, P531, DOI 10.1016/S0969-2126(96)00059-7; LEVYMINTZ P, 1991, J VIROL, V65, P4292, DOI 10.1128/JVI.65.8.4292-4300.1991; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; MAYNE JT, 1985, VIROLOGY, V142, P121, DOI 10.1016/0042-6822(85)90427-1; MURPHY FA, 1980, TOGAVIRUSES BIOL STR, P241; PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095; Phinney BS, 2000, J VIROL, V74, P5667, DOI 10.1128/JVI.74.12.5667-5678.2000; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; RICE CM, 1981, P NATL ACAD SCI-BIOL, V78, P2062, DOI 10.1073/pnas.78.4.2062; RICE CM, 1987, J VIROL, V61, P3809, DOI 10.1128/JVI.61.12.3809-3819.1987; ROBBINS PW, 1977, CELL, V12, P893, DOI 10.1016/0092-8674(77)90153-2; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; ROSSMANN MG, 1975, J BIOL CHEM, V250, P7525; ROSSMMANN M G, 1983, Journal of Molecular Biology, V166, P37, DOI 10.1016/S0022-2836(83)80049-7; SCHACHTER H, 1980, BIOCH GLYCOPROTEINS, P85; SCHLESINGER RW, 1980, TOGAVIRUSES BIOL STR; Schlesinger S., 1986, TOGAVIRIDAE FLAVIVIR, P121, DOI [10.1007/978-1-4757-0785-4_5, DOI 10.1007/978-1-4757-0785-4_5]; SCHMALJOHN AL, 1983, VIROLOGY, V130, P144, DOI 10.1016/0042-6822(83)90124-1; SEFTON BM, 1977, CELL, V10, P659, DOI 10.1016/0092-8674(77)90099-X; Skoging U, 1996, STRUCTURE, V4, P519, DOI 10.1016/S0969-2126(96)00058-5; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; VENIENBRYAN C, 1994, J MOL BIOL, V236, P572, DOI 10.1006/jmbi.1994.1166; VONBONSDORFF CH, 1978, J VIROL, V28, P578, DOI 10.1128/JVI.28.2.578-583.1978; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; WILEY DC, 1978, J MOL BIOL, V120, P375, DOI 10.1016/0022-2836(78)90425-4	55	159	163	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					127	136		10.1016/S0092-8674(01)00302-6	http://dx.doi.org/10.1016/S0092-8674(01)00302-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301008	Bronze, Green Accepted			2022-12-01	WOS:000168063300013
J	Annas, GJ				Annas, GJ			Conjoined twins - The limits of law at the limits of life.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Annas, George/0000-0001-5836-7831				ANNAS GJ, 1987, HASTINGS CENT REP, V17, P27, DOI 10.2307/3562040; Bleich JD, 1996, TRADITION, V31, P92; BUNYAN N, 2000, DAILY TELEGRAPH 1216, P9; CRAMB A, 2001, DAILY TELEGRAPH 0120, P3; CULLEN K, 2000, BOSTON GLOBE    0911, pA1; DRAKE DC, 1977, PHILADELPHIA IN 1016; Fuller LL, 1949, HARVARD LAW REV, V62, P616, DOI 10.2307/1336025; LAVILLE S, 2000, DAILY TELEGRAPH 1207, P1; Norwitz ER, 2000, NEW ENGL J MED, V343, P399, DOI 10.1056/NEJM200008103430604; ONEILL JA, 1998, PEDIAT SURG, P1925; Rosato J L, 2000, Temple Law Rev, V73, P1; Simpson AWB, 1984, CANNIBALISM COMMON L; Smith AM, 2000, BRIT MED J, V321, P782, DOI 10.1136/bmj.321.7264.782; Spitz L, 2000, LANCET, V356, P1765, DOI 10.1016/S0140-6736(00)03220-7; Styron W, 1979, SOPHIES CHOICE; Thomasma DC, 1996, HASTINGS CENT REP, V26, P4, DOI 10.2307/3527600; WELLS M, 2000, GUARDIAN LONDON 1208, P13; 2001, TORONTO STAR    0107, P1	18	15	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1104	1108		10.1056/NEJM200104053441419	http://dx.doi.org/10.1056/NEJM200104053441419			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287982	Green Published			2022-12-01	WOS:000167860400027
J	Salzberg, SL; White, O; Peterson, J; Eisen, JA				Salzberg, SL; White, O; Peterson, J; Eisen, JA			Microbial genes in the human genome: Lateral transfer or gene loss?	SCIENCE			English	Article							SEQUENCE; EVOLUTION; BACTERIA	The human genome was analyzed for evidence that genes had been Laterally transferred into the genome from prokaryotic organisms. Protein sequence comparisons of the proteomes of human, fruit fly, nematode worm, yeast, mustard weed, eukaryotic parasites, and all completed prokaryote genomes were performed, and all genes shared between human and each of the other groups of organisms were collected. About 40 genes were found to be exclusively shared by humans and bacteria and are candidate examples of horizontal transfer from bacteria to vertebrates. Gene Loss combined with sample size effects and evolutionary rate variation provide an alternative, more biologically plausible explanation.	Inst Genome Res, Rockville, MD 20850 USA	J. Craig Venter Institute	Salzberg, SL (corresponding author), Inst Genome Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	salzberg@tigr.org	Salzberg, Steven L/F-6162-2011; Eisen, Jonathan A./H-2706-2019; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Eisen, Jonathan A./0000-0002-0159-2197; Salzberg, Steven/0000-0002-8859-7432	NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1993, J MOL EVOL, V36, P290, DOI 10.1007/BF00160485; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Braun EL, 2000, GENOME RES, V10, P416, DOI 10.1101/gr.10.4.416; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Doolittle WF, 1999, TRENDS CELL BIOL, V9, pM5, DOI 10.1016/S0962-8924(99)01664-5; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Eisen JA, 2000, CURR OPIN GENET DEV, V10, P606, DOI 10.1016/S0959-437X(00)00143-X; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gogarten JP, 1999, BIOL BULL, V196, P359, DOI 10.2307/1542970; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W.H., 1997, MOL EVOLUTION; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Nelson KE, 2000, NAT BIOTECHNOL, V18, P1049, DOI 10.1038/80235; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Palmer JD, 2000, P NATL ACAD SCI USA, V97, P6960, DOI 10.1073/pnas.97.13.6960; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	23	199	208	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2001	292	5523					1903	1906		10.1126/science.1061036	http://dx.doi.org/10.1126/science.1061036			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11358996				2022-12-01	WOS:000169200700047
J	Nirenberg, S; Carcieri, SM; Jacobs, AL; Latham, PE				Nirenberg, S; Carcieri, SM; Jacobs, AL; Latham, PE			Retinal ganglion cells act largely as independent encoders	NATURE			English	Article							VISUAL INFORMATION; X-CELL; Y-CELL; HYPOTHESIS; POPULATION; LIGHT	Correlated firing among neurons is widespread in the visual system. Neighbouring neurons, in areas from retina to cortex, tend to fire together more often than would be expected by chance. The importance of this correlated firing for encoding visual information is unclear and controversial(1-5). Here we examine its importance in the retina. We present the retina with natural stimuli and record the responses of its output cells, the ganglion cells. We then use information theoretic techniques to measure the amount of information about the stimuli that can be obtained from the cells under two conditions: when their correlated firing is taken into account, and when their correlated firing is ignored. We rnd that more than 90% of the information about the stimuli can be obtained from the cells when their correlated firing is ignored. This indicates that ganglion cells act largely independently to encode information, which greatly simplifies the problem of decoding their activity.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Nirenberg, S (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	sheilan@ucla.edu						Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chichilnisky E. J., 1999, Society for Neuroscience Abstracts, V25, P1042; Cover T.M., 1991, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X, DOI 10.1002/047174882X.CH11]; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; DODD RL, 1988, PROGRAM NEUROSCIENCE, P153; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P303, DOI 10.1152/jn.1983.49.2.303; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P325, DOI 10.1152/jn.1983.49.2.325; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Nirenberg S, 1997, NEURON, V18, P637, DOI 10.1016/S0896-6273(00)80304-9; Nirenberg S, 1998, CURR OPIN NEUROBIOL, V8, P488, DOI 10.1016/S0959-4388(98)80036-6; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shannon C., 1964, MATH THEORY COMMUNIC; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336	26	217	226	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					698	701		10.1038/35079612	http://dx.doi.org/10.1038/35079612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395773				2022-12-01	WOS:000169112500047
J	Siller, S				Siller, S			Sexual selection and the maintenance of sex	NATURE			English	Article							DELETERIOUS MUTATIONS; AFFECTING FITNESS; EVOLUTION; ADVANTAGE; EPISTASIS; PLANTS	Sex is expensive. A population of females that reproduce asexually should prima facie have twice the growth rate of an otherwise equivalent anisogamous sexual population lacking paternal care, or a population with modes of paternal care that can be co-opted by parthenogenetic females(1-6). The two leading theories for the maintenance of sex require either synergistic interactions between deleterious mutations, or antagonistic epistasis between beneficial mutations(5). Current evidence is equivocal as to whether the required levels of epistasis exist(6-10). Here I show that a third factor, differential male mating success (or, more generally, higher variance in male than in female fitness), can drastically reduce mutational load in sexual populations with or without any form of epistasis. Differential mating success has the further advantage of being ubiquitous, and is likely to have preceded or evolved concurrently with anisogamy(11).	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Siller, S (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	steven.siller@zoo.ox.ac.uk						ARNOLD SJ, 1994, AM NAT, V144, pS1, DOI 10.1086/285650; ATMAR W, 1991, ANIM BEHAV, V41, P195, DOI 10.1016/S0003-3472(05)80471-3; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Bell G., 1982, MASTERPIECE NATURE E; DALE S, 1992, BEHAV ECOL SOCIOBIOL, V30, P165, DOI 10.1007/BF00166699; de Visser JAGM, 1998, GENET RES, V71, P39, DOI 10.1017/S0016672397003091; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Fisher R.A., 1930, GENETICAL THEORY NAT; Holland B, 1999, P NATL ACAD SCI USA, V96, P5083, DOI 10.1073/pnas.96.9.5083; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Keightley PD, 1999, GENETICS, V153, P515; Kodric-Brown A, 1987, EVOL ECOL, V1, P95, DOI 10.1007/BF02067393; KOESLAG PD, 1994, J THEOR BIOL, V166, P251, DOI 10.1006/jtbi.1994.1023; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1988, GENETICS, V120, P853; Kondrashov AS, 2001, TRENDS GENET, V17, P75, DOI 10.1016/S0168-9525(00)02188-0; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MANNING JT, 1984, J THEOR BIOL, V108, P215, DOI 10.1016/S0022-5193(84)80067-3; Maynard Smith J., 1971, GROUP SELECTION, P163; PETRIE M, 1991, ANIM BEHAV, V41, P323, DOI 10.1016/S0003-3472(05)80484-1; Rohlf F. J., 1994, STAT TABLES; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; TRIVERS RL, 1976, EVOLUTION, V30, P253, DOI 10.1111/j.1558-5646.1976.tb00908.x; West SA, 1998, GENETICS, V149, P435; West SA, 1999, J EVOLUTION BIOL, V12, P1003	28	179	179	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					689	692		10.1038/35079578	http://dx.doi.org/10.1038/35079578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395770				2022-12-01	WOS:000169112500044
J	Chavis, P; Westbrook, G				Chavis, P; Westbrook, G			Integrins mediate functional pre- and postsynaptic maturation at a hippocampal synapse	NATURE			English	Article							LONG-TERM POTENTIATION; CELL-ADHESION MOLECULES; D-ASPARTATE RECEPTOR; TYROSINE PHOSPHORYLATION; TRANSMITTER RELEASE; EXCITATORY SYNAPSES; NMDA RECEPTORS; ALPHA-IIB-BETA-3; ALPHA-V-BETA-3; ALPHA-5-BETA-1	Coordinated signalling between presynaptic terminals and their postsynaptic targets is essential for the development and function of central synapses. In addition to diffusible molecules(1), this bidirectional flow of information could involve direct interactions through cell-adhesion molecules(2,3). Here, we show that one class of cell-adhesion molecule, the integrins, are required for the functional maturation of hippocampal synapses in vitro. At immature synapses, a high probability of glutamate release (P-r) was correlated with the expression of postsynaptic NMDA (N-methyl-D-aspartate) receptors containing the NR2B subunit. The activity-dependent reduction in P-r and a switch in the subunit composition of synaptic NMDA receptors was prevented by chronic blockade with peptides containing the integrin-binding site Arg-Gly-Asp (RGD), or by a functional antibody against the beta3 integrin subunit. Active synapses, monitored by the uptake of antibodies against the intraluminal domain of synaptotagmin I, also had beta3 subunit immunoreactivity. Our results provide evidence that integrin-mediated signalling is essential for the orchestrated maturation of central excitatory synapses.	Univ Portland, Vollum Inst Oregon Hlth Sci, Portland, OR 97201 USA	University of Portland	Chavis, P (corresponding author), CNRS, UPR 9023, 141 Rue Cardonille, F-34094 Montpellier, France.		Chavis, Pascale/M-8312-2016	Chavis, Pascale/0000-0002-3038-1014				Aplin AE, 1998, PHARMACOL REV, V50, P197; Blaess S, 1998, J NEUROCHEM, V71, P2615, DOI 10.1046/j.1471-4159.1998.71062615.x; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; CHAVIS P, 1998, SOC NEUR ABS; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; PFAFF M, 1994, CELL ADHES COMMUN, V2, P491, DOI 10.3109/15419069409014213; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schlaepfer DD, 1998, TRENDS CELL BIOL, V8, P151, DOI 10.1016/S0962-8924(97)01172-0; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Staubli U, 1998, J NEUROSCI, V18, P3460; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	27	247	254	0	19	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					317	321		10.1038/35077101	http://dx.doi.org/10.1038/35077101			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357135				2022-12-01	WOS:000168710000050
J	Baumann, P; Cech, TR				Baumann, P; Cech, TR			Pot1, the putative telomere end-binding protein in fission yeast and humans	SCIENCE			English	Article							CATALYTIC SUBUNIT GENE; HUMAN-CHROMOSOMES; DNA-BINDING; OXYTRICHA; HOMOLOGS; PROTECTION; MODULATION; SEQUENCE; SUGGEST; CLONING	Telomere proteins from ciliated protozoa bind to the single-stranded C-rich DNA extensions at the ends of macronuclear chromosomes. We have now identified homologous proteins in fission yeast and in humans. These Pot1 (protection of telomeres) proteins each bind the G-rich strand of their own telomeric repeat sequence, consistent with a direct role in protecting chromosome ends. Deletion of the fission yeast pot1(+) gene has an immediate effect on chromosome stability, causing rapid loss of telomeric DNA and chromosome circularization. It now appears that the protein that caps the ends of chromosomes is widely dispersed throughout the eukaryotic kingdom.	Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA.	thomas.cech@colorado.edu		Baumann, Peter/0000-0003-4892-1485				Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Eversole A, 2000, MOL CELL BIOL, V20, P5425, DOI 10.1128/MCB.20.15.5425-5432.2000; FAN JB, 1989, NUCLEIC ACIDS RES, V17, P2801, DOI 10.1093/nar/17.7.2801; FANG GW, 1991, NUCLEIC ACIDS RES, V19, P5515, DOI 10.1093/nar/19.20.5515; FANG GW, 1993, P NATL ACAD SCI USA, V90, P6056, DOI 10.1073/pnas.90.13.6056; FANG GW, 1993, GENE DEV, V7, P870, DOI 10.1101/gad.7.5.870; Froelich-Ammon SJ, 1998, GENE DEV, V12, P1504, DOI 10.1101/gad.12.10.1504; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; GOTTSCHLING DE, 1986, CELL, V47, P195, DOI 10.1016/0092-8674(86)90442-3; GRAY JT, 1991, CELL, V67, P807, DOI 10.1016/0092-8674(91)90075-A; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; ISHIKAWA F, 1993, MOL CELL BIOL, V13, P4301, DOI 10.1128/MCB.13.7.4301; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; KLOBUTCHER LA, 1981, P NATL ACAD SCI-BIOL, V78, P3015, DOI 10.1073/pnas.78.5.3015; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; MCKAY SJ, 1992, NUCLEIC ACIDS RES, V20, P6461, DOI 10.1093/nar/20.24.6461; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Naito T, 1998, NAT GENET, V20, P203, DOI 10.1038/2517; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; PETERSEN JM, 1995, SCIENCE, V269, P1866, DOI 10.1126/science.7569926; Prescott JD, 1998, CHROMOSOMA, V107, P293, DOI 10.1007/s004120050311; WANG WL, 1992, NUCLEIC ACIDS RES, V20, P6621, DOI 10.1093/nar/20.24.6621; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801	31	771	818	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1171	1175		10.1126/science.1060036	http://dx.doi.org/10.1126/science.1060036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349150	Green Published			2022-12-01	WOS:000168609200062
J	Sekinger, EA; Gross, DS				Sekinger, EA; Gross, DS			Silenced chromatin is permissive to activator binding and PIC recruitment	CELL			English	Article							RNA-POLYMERASE-II; HEAT-SHOCK FACTOR; RESOLUTION STRUCTURAL-ANALYSIS; SACCHAROMYCES-CEREVISIAE; IN-VIVO; TRANSCRIPTION FACTORS; TELOMERIC HETEROCHROMATIN; PREINITIATION COMPLEX; HISTONE ACETYLATION; NUCLEOSOMAL DNA	Chromatin is thought to repress transcription by limiting access of the DNA to transcription factors. Using a yeast heat shock gene flanked by mating-type silencers as a model system, we find that repressive, SIR-generated heterochromatin is permissive to the constitutive binding of an activator, HSF, and two components of the preinitiation complex (PIC), TBP and Pol II. These factors cohabitate the promoter with Sir silencing proteins and deacetylated nucleosomal histones. The heterochromatic HMRa1 promoter is also occupied by TBP and pol II, suggesting that SIR regulates gene expression not by restricting factor access to DNA but rather by blocking a step downstream of PIC recruitment. Interestingly, activation of silent promoter chromatin occurs in the absence of histone displacement and without change in histone acetylation state.	Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Gross, DS (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045842] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45842] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blair WS, 1996, EMBO J, V15, P1658, DOI 10.1002/j.1460-2075.1996.tb00511.x; Blau J, 1996, MOL CELL BIOL, V16, P2044; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brown SA, 1996, GENE DEV, V10, P1479, DOI 10.1101/gad.10.12.1479; CHASMAN DI, 1990, GENE DEV, V4, P503, DOI 10.1101/gad.4.4.503; Cheng TH, 1998, P NATL ACAD SCI USA, V95, P5521, DOI 10.1073/pnas.95.10.5521; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; DAHMUS ME, 1994, PROG NUCLEIC ACID RE, V48, P143, DOI 10.1016/S0079-6603(08)60855-7; de Bruin D, 2000, MOL CELL BIOL, V20, P7991, DOI 10.1128/MCB.20.21.7991-8000.2000; Erkine AM, 1996, MOL CELL BIOL, V16, P7004; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; GIARDINA C, 1995, MOL CELL BIOL, V15, P2737; GODDE JS, 1995, NUCLEIC ACIDS RES, V23, P4557, DOI 10.1093/nar/23.22.4557; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GROSS DS, 1990, J MOL BIOL, V216, P611, DOI 10.1016/0022-2836(90)90387-2; GROSS DS, 1993, EMBO J, V12, P3931, DOI 10.1002/j.1460-2075.1993.tb06071.x; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee D, 1998, NATURE, V393, P389, DOI 10.1038/30770; LEE SW, 1993, MOL CELL BIOL, V13, P727, DOI 10.1128/MCB.13.2.727; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; MCDANIEL D, 1989, MOL CELL BIOL, V9, P4789, DOI 10.1128/MCB.9.11.4789; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Ravindra A, 1999, MOL CELL BIOL, V19, P7944; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Sekinger EA, 1999, EMBO J, V18, P7041, DOI 10.1093/emboj/18.24.7041; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; SUSSEL L, 1993, MOL CELL BIOL, V13, P3919, DOI 10.1128/MCB.13.7.3919; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0; Venturi CB, 2000, MOL CELL BIOL, V20, P6435, DOI 10.1128/MCB.20.17.6435-6448.2000; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cb.11.110195.002301; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Zou S, 1996, GENE DEV, V10, P634, DOI 10.1101/gad.10.5.634	58	122	125	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2001	105	3					403	414		10.1016/S0092-8674(01)00329-4	http://dx.doi.org/10.1016/S0092-8674(01)00329-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348596	Bronze			2022-12-01	WOS:000168515900009
J	Katon, W; Sullivan, M; Walker, E				Katon, W; Sullivan, M; Walker, E			Medical symptoms without identified pathology: Relationship to psychiatric disorders, childhood and adult trauma, and personality traits	ANNALS OF INTERNAL MEDICINE			English	Article							IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL DISABILITY; CHRONIC-FATIGUE; PRIMARY-CARE; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; UNEXPLAINED SYMPTOMS; PSYCHOSOCIAL FACTORS; HIGH UTILIZERS; HEALTH	Community studies have shown that stressful life events, psychological distress, and depressive and anxiety disorders are associated with 1) a range of medical symptoms without identified pathology, 2) increased health care utilization, and 3) increased costs. In both primary care and medical specialty samples, patients who have syndromes with ill-defined pathologic mechanisms (such as the irritable bowel syndrome and fibromyalgia) have been shown to have significantly higher rates of anxiety and depressive disorders than do patients with comparable, well-defined medical diseases and similar symptoms. Other studies show that after adjustment for severity of medical illness, patients with depression or anxiety and comorbid medical disease have significantly more medical symptoms without identified pathology than do patients with a similar medical disease alone. Both childhood maltreatment and psychological trauma in adulthood have been associated with increased vulnerability to psychiatric illness and more medical symptoms. The substantial functional impairment, distress, and costs associated with medical symptoms without identified pathology suggest that research studies promoting a better understanding of the biopsychosocial cause of these symptoms may yield pragmatic, cost-effective approaches to treatment in medical settings.	Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Katon, W (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Bos 356560,1959 NE Pacific St, Seattle, WA 98195 USA.	wkaton@u.washington.edu			NIMH NIH HHS [MH-01643] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001643] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; BRIDGES KW, 1985, J PSYCHOSOM RES, V29, P563, DOI 10.1016/0022-3999(85)90064-9; Ciechanowski PS, 2000, ARCH INTERN MED, V160, P3278, DOI 10.1001/archinte.160.21.3278; CLARK MR, 1995, AM J MED, V98, P187, DOI 10.1016/S0002-9343(99)80403-3; DEMERS RY, 1980, J FAM PRACTICE, V11, P1085; Dickinson LM, 1999, ARCH FAM MED, V8, P35, DOI 10.1001/archfami.8.1.35; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701, DOI 10.1016/S0016-5085(88)80017-9; Dwight MM, 2000, J PSYCHOSOM RES, V49, P311, DOI 10.1016/S0022-3999(00)00155-0; Engel C. C., 1999, STRATEGIES PROTECT H, P173; ESCOBAR JI, 1992, AM J PSYCHIAT, V149, P965; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FOGARTY J, 1994, ARCH FAM MED, V3, P55; Gureje O, 1997, AM J PSYCHIAT, V154, P989; Hotopf M, 1999, AM J PSYCHIAT, V156, P1796; KATON W, 1988, AM J MED, V84, P1, DOI 10.1016/0002-9343(88)90001-0; KATON W, 1990, GEN HOSP PSYCHIAT, V12, P355, DOI 10.1016/0163-8343(90)90002-T; KATON W, 1992, ARCH INTERN MED, V152, P1604, DOI 10.1001/archinte.152.8.1604; KATON W, 1991, AM J PSYCHIAT, V148, P34; Katon W J, 1991, Psychiatr Med, V9, P577; KATON WJ, 1991, J GEN INTERN MED, V6, P277, DOI 10.1007/BF02597420; KIRMAYER LJ, 1993, AM J PSYCHIAT, V150, P734; KOSS MP, 1991, ARCH INTERN MED, V151, P342, DOI 10.1001/archinte.151.2.342; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kroenke K, 1994, Arch Fam Med, V3, P774; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; Kroenke K, 2000, PSYCHOTHER PSYCHOSOM, V69, P205, DOI 10.1159/000012395; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; LUSTMAN PJ, 1988, INT J PSYCHIAT MED, V18, P295; MAGNUS K, 1993, J PERS SOC PSYCHOL, V65, P1046, DOI 10.1037/0022-3514.65.5.1046; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; MCFARLANE AC, 1994, J PSYCHOSOM RES, V38, P715, DOI 10.1016/0022-3999(94)90024-8; MECHANIC D, 1978, J HUM STRESS, V4, P26, DOI 10.1080/0097840X.1978.10545983; O'Malley PG, 1999, J FAM PRACTICE, V48, P980; ORMEL J, 1991, J PERS SOC PSYCHOL, V60, P744, DOI 10.1037/0022-3514.60.5.744; Pearson SD, 1999, J GEN INTERN MED, V14, P461, DOI 10.1046/j.1525-1497.1999.06278.x; PENNEBAKER JW, 1982, PSYCHOL PHYSICAL SYM; ROBBINS PR, 1974, J PERS ASSESS, V38, P578, DOI 10.1080/00223891.1974.10120020; RUSSO J, 1994, PSYCHOSOMATICS, V35, P546, DOI 10.1016/S0033-3182(94)71723-0; Schappert S M, 1992, Vital Health Stat 13, P1; SHARPE M, 1992, International Review of Psychiatry, V4, P81, DOI 10.3109/09540269209066305; SIMON GE, 1995, ARCH GEN PSYCHIAT, V52, P850; SIMON GE, 1991, AM J PSYCHIAT, V148, P1494; SIMPSON RJ, 1994, BRIT J GEN PRACT, V44, P352; SOLOMON Z, 1988, BEHAV MED, V14, P179, DOI 10.1080/08964289.1988.9935143; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; STEWART WF, 1992, AM J MED, V92, pS35, DOI 10.1016/0002-9343(92)90135-X; SULLIVAN M, 1993, ARCH INTERN MED, V153, P1479, DOI 10.1001/archinte.153.12.1479; Sullivan MD, 2000, AM J CARDIOL, V86, P1135, DOI 10.1016/S0002-9149(00)01174-7; SULLIVAN MD, 1988, GEN HOSP PSYCHIAT, V10, P285, DOI 10.1016/0163-8343(88)90037-0; SVENSSON TH, 1987, PSYCHOPHARMACOLOGY, V92, P1, DOI 10.1007/BF00215471; TRULL TJ, 1992, J ABNORM PSYCHOL, V101, P553, DOI 10.1037/0021-843X.101.3.553; Unutzer J, 1997, JAMA-J AM MED ASSOC, V277, P1618, DOI 10.1001/jama.277.20.1618; Van Os J, 1999, PSYCHOL MED, V29, P1055, DOI 10.1017/S0033291799001026; VANHEMERT AM, 1993, PSYCHOL MED, V23, P167, DOI 10.1017/S0033291700038952; VONKORFF M, 1987, ARCH GEN PSYCHIAT, V44, P152; Walker EA, 1999, AM J MED, V107, P332, DOI 10.1016/S0002-9343(99)00235-1; WALKER EA, 1995, PSYCHOSOMATICS, V36, P531, DOI 10.1016/S0033-3182(95)71608-5; Walker EA, 1996, J PSYCHOSOM OBST GYN, V17, P39, DOI 10.3109/01674829609025662; WALKER EA, 1995, PSYCHOL MED, V25, P1259, DOI 10.1017/S0033291700033225; Walker EA, 1997, PSYCHOSOM MED, V59, P565, DOI 10.1097/00006842-199711000-00002; WALKER EA, 1993, J GEN INTERN MED, V8, P436, DOI 10.1007/BF02599621; Walker EA, 1999, ARCH GEN PSYCHIAT, V56, P609, DOI 10.1001/archpsyc.56.7.609; Walker EA, 1997, PSYCHOSOM MED, V59, P572, DOI 10.1097/00006842-199711000-00003; Walker EA, 1996, GEN HOSP PSYCHIAT, V18, P220, DOI 10.1016/0163-8343(96)00036-9; Walker EA, 1996, PSYCHOSOM MED, V58, P16, DOI 10.1097/00006842-199601000-00003; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805	68	272	281	1	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			917	925		10.7326/0003-4819-134-9_Part_2-200105011-00017	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00017			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346329				2022-12-01	WOS:000168543100017
J	Enne, VI; Livermore, DM; Stephens, P; Hall, LMC				Enne, VI; Livermore, DM; Stephens, P; Hall, LMC			Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction	LANCET			English	Article							GRAM-NEGATIVE BACTERIA; ANTIBIOTIC-RESISTANCE; CONSUMPTION; EVOLUTION; FINLAND	Background There is a clear association between heavy antimicrobial consumption within a population and the frequent recovery of resistant bacteria, but whether a reduction in antimicrobial use can reverse this process is less clear. We investigated the effect of a national restriction of sulphonamide prescribing in the UK on the prevalence of sulphonamide resistance in Escherichia coli. Methods Consecutive clinical isolates of E coli were collected at the Royal London Hospital in 1991 and 1999. These collections, each of more than 350 isolates, were compared. Minimum inhibitory concentrations of sulphamethoxazole and eight other antimicrobials were determined. The presence and locations of sulphonamide-resistance genes were examined by PCR, plasmid extraction, Southern hybridisation, and transconjugation. Findings Despite a huge decrease in sulphonamide prescriptions (from 320 000 prescriptions per year in 1991 to 7 000 in 1999), the frequency of resistance remained high in 1999 (165/359 [46.0%] vs 143/360 [39.7%] in 1991; difference 6.2% [95% CI -0.9 to 13.3]). Integron- borne sulI was present in 16.4% of isolates in 1991 and 17.5% in 1999, The prevalence of sulII increased from 26.7% in 1991 to 36.5% in 1999 (difference 9.8% [3.1 to 16.5] p=0.0046). SulII was located on large plasmids, at least some of which were conjugative multiresistance determinants. Interpretation These results show that a huge decrease in antibiotic prescribing does not necessarily reduce resistance within a useful time. The main reason seems to be the genetic linkage of the index resistance to other resistance determinants.	St Bartholomews & Royal London Sch Med & Dent, Dept Med Microbiol, London E1 2AD, England; Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England; IMS Hlth, Pinner, Middx, England	University of London; Queen Mary University London; Public Health England	Hall, LMC (corresponding author), St Bartholomews & Royal London Sch Med & Dent, Dept Med Microbiol, London E1 2AD, England.		Enne, Virve/AAP-2357-2021					[Anonymous], 1995, DRUG THER B, V33, P92; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; *BRIT SOC ANT CHEM, 1998, BSAC STAND DISK SENS, P19; Hall RM, 1997, CIBA F SYMP, V207, P192; Huovinen P, 1997, CIBA F SYMP, V207, P36; LAWRENSON RA, 1998, J INFORM PRIMARY MAY; LIU PYF, 1992, J ANTIMICROB CHEMOTH, V30, P429, DOI 10.1093/jac/30.4.429; LIVERMORE DM, 1996, ANTIBIOTICS LAB MED, P561; *NCCLS, 1999, PERF STAND ANT SUSC, V19, P32; RADSTROM P, 1991, ANTIMICROB AGENTS CH, V35, P1840, DOI 10.1128/AAC.35.9.1840; Sambrook J., 1989, MOL CLONING LAB MANU; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; *VET MED DIR, 2001, SAL ANT PROD US VET	14	339	353	1	79	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1325	1328		10.1016/S0140-6736(00)04519-0	http://dx.doi.org/10.1016/S0140-6736(00)04519-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343738				2022-12-01	WOS:000168411400011
J	Blancou, P; Vartanian, JP; Christopherson, C; Chenciner, N; Basilico, C; Kwok, S; Wain-Hobson, S				Blancou, P; Vartanian, JP; Christopherson, C; Chenciner, N; Basilico, C; Kwok, S; Wain-Hobson, S			Polio vaccine samples not linked to AIDS - A search through the archives clears early vaccines of starting the AIDS pandemic.	NATURE			English	Article							POLIOMYELITIS VIRUS		Inst Pasteur, Unite Retrovirol Mol, F-75724 Paris 15, France; Roche Mol Syst, Dept Infect Dis, Alameda, CA 94501 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Roche Holding; New York University	Blancou, P (corresponding author), Inst Pasteur, Unite Retrovirol Mol, 28 Rue Dr Roux, F-75724 Paris 15, France.	simon@pasteur.fr	Blancou, Philippe/M-4149-2018	Blancou, Philippe/0000-0003-0305-8622; Vartanian, Jean-Pierre/0000-0001-8079-8814				Curtis T, 1992, ROLLING STONE   0319, P54; Hooper E., 1999, RIVER JOURNEY SOURCE; HULL RN, 1962, J EXP MED, V115, P903, DOI 10.1084/jem.115.5.903; KOPROWSKI H, 1961, JAMA-J AM MED ASSOC, V178, P1151, DOI 10.1001/jama.1961.73040510005008; Plotkin SA, 1999, SCIENCE, V286, P2450; PLOTKIN SA, 1961, B WORLD HEALTH ORGAN, V24, P785; PLOTKIN SA, 1961, P 6 INT C MICR STAND, P48; POLTKIN SA, 1966, AM J DIS CHILD, V111, P27, DOI 10.1001/archpedi.1966.02090040063004; SAITOU N, 1994, MOL BIOL EVOL, V11, P504; VANDERKUYL AC, 1995, J MOL EVOL, V40, P173, DOI 10.1007/BF00167111; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	11	18	20	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1045	1046		10.1038/35074171	http://dx.doi.org/10.1038/35074171			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323657				2022-12-01	WOS:000168285500033
J	Rubery, E				Rubery, E			A year of opportunity - Now is the time for the UK Food Standards Agency to flex its muscles.	NATURE			English	Editorial Material									Univ Cambridge, Sch Business, Judge Inst Management Studies, Cambridge Univ Hlth, Cambridge CB2 1AG, England	University of Cambridge	Rubery, E (corresponding author), Univ Cambridge, Sch Business, Judge Inst Management Studies, Cambridge Univ Hlth, Cambridge CB2 1AG, England.							Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; 2001, NATURE, V410, P501	2	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					867	868		10.1038/35073692	http://dx.doi.org/10.1038/35073692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309587				2022-12-01	WOS:000168152300020
J	Wu, L; Hickson, ID				Wu, L; Hickson, ID			DNA ends RecQ-uire attention	SCIENCE			English	Editorial Material							WERNER-SYNDROME PROTEIN; FUNCTIONAL INTERACTION; SYNDROME GENE; HELICASE; KU; RECOMBINATION; REPLICATION; SGS1		Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Imperial Canc Res Fund Labs, Oxford OX3 9DS, England	Cancer Research UK; University of Oxford	Wu, L (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Imperial Canc Res Fund Labs, Oxford OX3 9DS, England.		Hickson, Ian/AAJ-7548-2020	Hickson, Ian/0000-0002-0583-566X				Chakraverty RK, 1999, BIOESSAYS, V21, P286; Cohen H, 2001, P NATL ACAD SCI USA, V98, P3174, DOI 10.1073/pnas.061579598; Cooper MP, 2000, GENE DEV, V14, P907; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; Frei C, 2000, GENE DEV, V14, P81; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kamath-Loeb AS, 2000, P NATL ACAD SCI USA, V97, P4603, DOI 10.1073/pnas.97.9.4603; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Karow JK, 2000, CURR OPIN GENET DEV, V10, P32, DOI 10.1016/S0959-437X(99)00039-8; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Nehlin JO, 2000, ANN NY ACAD SCI, V908, P167; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; WU L, IN PRESS COLD SPRING; WU L, IN PRESS J BIOL CHEM; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630	22	14	16	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					229	230		10.1126/science.1060832	http://dx.doi.org/10.1126/science.1060832			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305313				2022-12-01	WOS:000168074000029
J	Zachos, JC; Shackleton, NJ; Revenaugh, JS; Palike, H; Flower, BP				Zachos, JC; Shackleton, NJ; Revenaugh, JS; Palike, H; Flower, BP			Climate response to orbital forcing across the Oligocene-Miocene boundary	SCIENCE			English	Article							NORTHERN-HEMISPHERE GLACIATION; ATMOSPHERIC CARBON-DIOXIDE; ASTRONOMICAL CALIBRATION; ROSS-SEA; RECORD; PALEOCLIMATE; CYCLES; TIME; TEMPERATURE; CIRCULATION	Spectral analyses of an uninterrupted 5.5-million-year (My)-long chronology of late Oligocene-early Miocene climate and ocean carbon chemistry from two deep-sea cores recovered in the western equatorial Atlantic reveal variance concentrated at all Milankovitch frequencies. Exceptional spectral power in climate is recorded at the 406-thousand-year (ky) period eccentricity band over a 3.4-million-year period [20 to 23.4 My ago (Ma)] as well as in the 125- and 95-ky bands over a 1.3-million-year period (21.7 to 23.0 Ma) of suspected Low greenhouse gas Levels. Moreover, a major transient glaciation at the epoch boundary (similar to 23 Ma), Mi-1, corresponds with a rare orbital congruence involving obliquity and eccentricity. The anomaly, which consists of Low-amplitude variance in obliquity (a node) and a minimum in eccentricity, results in an extended period (similar to 200 ky) of low seasonality orbits favorable to ice-sheet expansion on Antarctica.	Univ Calif Santa Cruz, Dept Earth Sci, Ctr Dynam & Evolut Land Sea Interface, Santa Cruz, CA 95064 USA; Univ Cambridge, Godwin Lab Quaternary Studies, Cambridge CB2 3SA, England; Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA	University of California System; University of California Santa Cruz; University of Cambridge; State University System of Florida; University of South Florida	Zachos, JC (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Ctr Dynam & Evolut Land Sea Interface, Santa Cruz, CA 95064 USA.		Revenaugh, Justin/GVR-8368-2022; Zachos, James C/A-7674-2008; Palike, Heiko/A-6560-2008	Revenaugh, Justin/0000-0002-7855-5159; Zachos, James C/0000-0001-8439-1886; Palike, Heiko/0000-0003-3386-0923				Clemens SC, 1997, NATURE, V385, P801, DOI 10.1038/385801a0; CURRY WB, 1995, INIT REP P OCEAN DRI, V154; EDINGER EN, 1994, PALAIOS, V9, P576, DOI 10.2307/3515129; Ehrmann W, 1998, PALAEOGEOGR PALAEOCL, V139, P213, DOI 10.1016/S0031-0182(97)00138-7; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Herbert TD, 1997, P NATL ACAD SCI USA, V94, P8362, DOI 10.1073/pnas.94.16.8362; LASKAR J, 1993, ASTRON ASTROPHYS, V270, P522; LECKIE RM, 1983, GEOLOGY, V11, P578, DOI 10.1130/0091-7613(1983)11<578:LOMGRO>2.0.CO;2; Lourens LJ, 1997, QUATERN INT, V40, P43, DOI 10.1016/S1040-6182(96)00060-2; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Maslin MA, 1998, QUATERNARY SCI REV, V17, P411, DOI 10.1016/S0277-3791(97)00047-4; MIKOLAJEWICZ U, 1993, PALEOCEANOGRAPHY, V8, P409, DOI 10.1029/93PA00893; MILLER KG, 1991, J GEOPHYS RES-SOLID, V96, P6829, DOI 10.1029/90JB02015; Nong GT, 2000, GEOPHYS RES LETT, V27, P2689, DOI 10.1029/1999GL011072; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI DOI 10.1029/96E000259; Palike H, 2000, EARTH PLANET SC LETT, V182, P1, DOI 10.1016/S0012-821X(00)00229-6; PARK J, 1993, J GEOPHYS RES-SOL EA, V98, P447, DOI 10.1029/92JB01815; Paul HA, 2000, PALEOCEANOGRAPHY, V15, P471, DOI 10.1029/1999PA000443; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; RAYMO ME, 1994, ANNU REV EARTH PL SC, V22, P353, DOI 10.1146/annurev.ea.22.050194.002033; Rutherford S, 2000, NATURE, V408, P72, DOI 10.1038/35040533; Sagnotti L, 1998, GEOPHYS J INT, V134, P653, DOI 10.1046/j.1365-246x.1998.00559.x; Shackleton NJ, 1999, PHILOS T R SOC A, V357, P1907, DOI 10.1098/rsta.1999.0407; Shackleton NJ, 2000, GEOLOGY, V28, P447, DOI 10.1130/0091-7613(2000)028<0447:ACAFTO>2.3.CO;2; SHORT DA, 1991, QUATERNARY RES, V35, P157, DOI 10.1016/0033-5894(91)90064-C; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; Zachos JC, 1997, NATURE, V388, P567, DOI 10.1038/41528; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216	29	318	347	7	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					274	278		10.1126/science.1058288	http://dx.doi.org/10.1126/science.1058288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303100	Green Submitted			2022-12-01	WOS:000168074000043
J	Young, MA; Gonfloni, S; Superti-Furga, G; Roux, B; Kuriyan, J				Young, MA; Gonfloni, S; Superti-Furga, G; Roux, B; Kuriyan, J			Dynamic coupling between the SH2 and SH3 domains of c-Src and hck underlies their inactivation by C-terminal tyrosine phosphorylation	CELL			English	Article							MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; KINASE HCK; REGULATORY INTERACTIONS; PROTEIN; ACTIVATION; AFFINITY; BINDING; DNA; SIMULATIONS	The effect of C-terminal tyrosine phosphorylation on molecular motions in the Src kinases Hck and c-Src is investigated by molecular dynamics simulations. The SH2 and SH3 domains of the inactive kinases are seen to be tightly coupled by the connector between them, impeding activation. Dephosphorylation of the tail reduces the coupling between the SH2 and SH3 domains in the simulations, as does replacement of connector residues with glycine. A mutational analysis of c-Src expressed in Schizosaccharomyces pombe demonstrates that replacement of residues in the SH2-SH3 connector with glycine activates c-Src. The SH2-SH3 connector appears to be an inducible "snap lock" that clamps the SH2 and SH3 domains upon tail phosphorylation, but which allows flexibility when the tail is released.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; European Molecular Biology Laboratory (EMBL); Cornell University	Kuriyan, J (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.		Superti-Furga, Giulio/AAE-5681-2019; Young, Matthew/D-2033-2011; Young, Matthew/AAE-2632-2020; Superti-Furga, Giulio/F-4755-2015	Young, Matthew/0000-0003-2921-3432; Young, Matthew/0000-0003-2921-3432; Superti-Furga, Giulio/0000-0002-0570-1768; GONFLONI, STEFANIA/0000-0002-9392-4258				Alexandropoulos K, 1996, SIN GENES DEV, V10, P1341; AROLD ST, 2001, IN PRESS J BIOL CHEM; Bradshaw JM, 1998, BIOCHEMISTRY-US, V37, P15400, DOI 10.1021/bi9814991; BRASHER BB, 2001, IN PRESS ONCOGENE; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1995, CURR OPIN STRUC BIOL, V5, P211, DOI 10.1016/0959-440X(95)80078-6; CASE D, 1997, AMBER 5 0; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ECK MJ, 1994, NATURE, V368, P764, DOI 10.1038/368764a0; Engen JR, 1999, J MOL BIOL, V287, P645, DOI 10.1006/jmbi.1999.2619; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; GUILBERT C, 1995, COMPUT PHYS COMMUN, V91, P263, DOI 10.1016/0010-4655(95)00052-H; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; LIU XQ, 1993, ONCOGENE, V8, P1119; MACAULEY A, 1989, MOL CELL BIOL, V9, P2648, DOI 10.1128/MCB.9.6.2648; MATSUDA M, 1990, SCIENCE, V248, P1537, DOI 10.1126/science.1694307; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, CURR OPIN STRUC BIOL, V7, P777, DOI 10.1016/S0959-440X(97)80146-7; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; SUPERTIFURGA G, 1993, EMBO J, V12, P2625, DOI 10.1002/j.1460-2075.1993.tb05923.x; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tong L, 1996, J MOL BIOL, V256, P601, DOI 10.1006/jmbi.1996.0112; Wang DX, 2001, BIOCHEMISTRY-US, V40, P2004, DOI 10.1021/bi002342n; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0	40	319	326	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					115	126		10.1016/S0092-8674(01)00301-4	http://dx.doi.org/10.1016/S0092-8674(01)00301-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301007	Bronze			2022-12-01	WOS:000168063300012
J	Spurgeon, D				Spurgeon, D			Farmer fined for growing GM seed	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					615	615		10.1038/35070736	http://dx.doi.org/10.1038/35070736			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287907	Bronze			2022-12-01	WOS:000167875400004
J	McCord, TB; Hansen, GB; Hibbitts, CA				McCord, TB; Hansen, GB; Hibbitts, CA			Hydrated salt minerals on Ganymede's surface: Evidence of an ocean below	SCIENCE			English	Article							ICY GALILEAN SATELLITES; WATER-ICE; MU-M; EUROPA	Reflectance spectra from Galileo's near-infrared mapping spectrometer (NIMS) suggests that the surface of Ganymede, the Largest satellite of Jupiter, contains hydrated materials. These materials are interpreted to be similar to those found on Europa, that is, mostly frozen magnesium sulfate brines that are derived from a subsurface briny Layer of fluid.	Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Hawaii System	McCord, TB (corresponding author), Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	tom@higp.hawaii.edu	Hibbitts, Charles/B-7787-2016	Hibbitts, Charles/0000-0001-9089-4391				Anderson JD, 1997, SCIENCE, V276, P1236, DOI 10.1126/science.276.5316.1236; CALVIN WM, 1995, J GEOPHYS RES-PLANET, V100, P19041, DOI 10.1029/94JE03349; Carlson RW, 1999, SCIENCE, V286, P97, DOI 10.1126/science.286.5437.97; CLARK RN, 1980, ICARUS, V41, P323, DOI 10.1016/0019-1035(80)90217-1; Collins G. C, 2000, LUNAR PLANET SCI, P1034; DUFRESNE ER, 1962, GEOCHIM COSMOCHIM AC, V26, P1058; FANALE FP, 1989, ICARUS, V82, P97, DOI 10.1016/0019-1035(89)90026-2; FANALE FP, 1998, LUNAR PLANET SCI, V29, P1248; FANALE FP, 1977, PLANETARY SATELLITES, P379; HANSEN GB, 2000, EOS, V81, pF792; KARGEL JS, 1991, ICARUS, V94, P368, DOI 10.1016/0019-1035(91)90235-L; KIVELSON MG, 2000, EOS, V81, pF789; McCord TB, 1998, J GEOPHYS RES-PLANET, V103, P8603, DOI 10.1029/98JE00788; McCord TB, 1998, SCIENCE, V280, P1242, DOI 10.1126/science.280.5367.1242; McCord TB, 1999, J GEOPHYS RES-PLANET, V104, P11827, DOI 10.1029/1999JE900005; McCord TB, 2001, J GEOPHYS RES-PLANET, V106, P3311, DOI 10.1029/2000JE001282; MCCORD TB, IN PRESS J GEOPHYS R; MCCORD TB, 2000, EOS, V81, P209; Moore JM, 1999, ICARUS, V140, P294, DOI 10.1006/icar.1999.6132; PAPPALARDO RT, 2000, EOS, V81, pF791; PILCHER CB, 1972, SCIENCE, V178, P1087, DOI 10.1126/science.178.4065.1087; SHOEMAKER G, 1982, SATELLITES JUPITER, P435; SPENCER JR, 1987, ICARUS, V69, P297, DOI 10.1016/0019-1035(87)90107-2; VANKEULEN L, 2000, LUNAR PLANET SCI, V31, P1539; ZOLOTOV MY, IN PRESS J GEOPHYS R	25	110	115	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1523	1525		10.1126/science.1059916	http://dx.doi.org/10.1126/science.1059916			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375486				2022-12-01	WOS:000168963800038
J	Cronin, DC; Millis, JM; Siegler, M				Cronin, DC; Millis, JM; Siegler, M			Transplantation of liver grafts from living donors into adults - Too much, too soon.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RIGHT LOBE GRAFT; SURGICAL TECHNIQUES; WAITING TIME; MORTALITY; CHILDREN; SIZE; FAILURE; ETHICS		Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Cronin, DC (corresponding author), Univ Chicago, Chicago, IL 60637 USA.		Millis, Michael/K-5346-2019					Amersi F, 1998, Clin Transpl, P255; Ben-Haim M, 2000, TRANSPLANTATION, V69, pS290; BROELSCH C, 2000, WORKSH LIV DON LIV T; BROELSCH CE, 1991, ANN SURG, V214, P428, DOI 10.1097/00000658-199110000-00007; BROWN R, 2000, WORKSH LIV DON LIV T; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; EMOND JC, 1989, HEPATOLOGY, V10, P867, DOI 10.1002/hep.1840100520; EMOND JC, 1990, ANN SURG, V212, P14, DOI 10.1097/00000658-199007000-00003; Emre S, 1999, LIVER TRANSPLANT SUR, V5, P161, DOI 10.1002/lt.500050315; Everhart JE, 1997, TRANSPLANTATION, V64, P1300, DOI 10.1097/00007890-199711150-00012; Fan ST, 1996, HEPATO-GASTROENTEROL, V43, P893; Fan ST, 2000, ANN SURG, V231, P126, DOI 10.1097/00000658-200001000-00018; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Freeman RB, 2000, LIVER TRANSPLANT, V6, P543, DOI 10.1053/jlts.2000.9744; Goss JA, 1997, TRANSPLANTATION, V64, P871, DOI 10.1097/00007890-199709270-00014; Grewal HP, 1998, ANN SURG, V228, P214, DOI 10.1097/00000658-199808000-00011; Hirano I, 2000, LIVER TRANSPLANT, V6, P250, DOI 10.1016/S1527-6465(00)80023-4; Inomata Y, 2000, TRANSPLANTATION, V69, P258, DOI 10.1097/00007890-200001270-00011; Kim WR, 1998, HEPATOLOGY, V28, P33, DOI 10.1002/hep.510280106; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Lo CM, 1997, TRANSPLANTATION, V63, P1524, DOI 10.1097/00007890-199705270-00027; Lo CM, 1997, ANN SURG, V226, P261, DOI 10.1097/00000658-199709000-00005; MALAGO M, 1994, TRANSPLANT P, V26, P3620; Marcos A, 1999, TRANSPLANTATION, V68, P798, DOI 10.1097/00007890-199909270-00012; MARCOS A, 2000, 1 JOINT ANN M AM SOC; Millis J M, 1995, Clin Transpl, P187; Millis JM, 2000, ANN SURG, V232, P104, DOI 10.1097/00000658-200007000-00015; Miwa S, 1999, HEPATOLOGY, V30, P1521, DOI 10.1002/hep.510300621; MOORE FD, 1988, TRANSPLANT P, V20, P1061; MORI K, 1992, TRANSPLANTATION, V54, P263, DOI 10.1097/00007890-199208000-00014; Piper J B, 1992, Clin Transpl, P179; Pomposelli JJ, 2000, TRANSPLANTATION, V69, pS291; ROGIERS X, 1994, BRIT J SURG, V81, P1251, DOI 10.1002/bjs.1800810903; SINGER PA, 1989, NEW ENGL J MED, V321, P620, DOI 10.1056/NEJM198908313210919; STRONG RW, 1990, NEW ENGL J MED, V322, P1505, DOI 10.1056/NEJM199005243222106; Strong RW, 1999, LIVER TRANSPLANT SUR, V5, P536, DOI 10.1002/lt.500050613; TANAKA K, 1993, ANN SURG, V217, P82, DOI 10.1097/00000658-199301000-00014; Testa G, 1999, LANGENBECK ARCH SURG, V384, P536, DOI 10.1007/s004230050240; *US SCI REG TRANSP, 2000, 2000 ANN REP US SCI; Wachs ME, 1998, TRANSPLANTATION, V66, P1313, DOI 10.1097/00007890-199811270-00008; YAMAOKA Y, 1995, TRANSPLANTATION, V59, P224	42	160	160	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1633	1637		10.1056/NEJM200105243442112	http://dx.doi.org/10.1056/NEJM200105243442112			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372018				2022-12-01	WOS:000168829700012
J	Ku, NO; Gish, R; Wright, TL; Omary, MB				Ku, NO; Gish, R; Wright, TL; Omary, MB			Keratin 8 mutations in patients with cryptogenic liver disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; GENETIC SKIN DISEASES; ENCODING LAMIN A/C; INTERMEDIATE FILAMENTS; TRANSGENIC MICE; PARTIAL LIPODYSTROPHY; HEPATOCYTE INTEGRITY; MISSENSE MUTATIONS; SKELETAL MYOPATHY; RAT HEPATOCYTES	Background: About 10 percent of patients who undergo liver transplantation have cryptogenic liver disease. In animal models, the absence of heteropolymeric keratins 8 and 18 or the presence of mutant keratins in hepatocytes causes or promotes liver disease. We have previously described a mutation in the keratin 18 gene in a patient with cryptogenic cirrhosis, but the importance of mutations in the keratin 8 and keratin 18 genes in such patients is unclear. Methods: We tested for mutations in the keratin 8 and keratin 18 genes in purified genomic DNA isolated from 150 explanted livers and 89 peripheral-blood specimens from three groups of patients: 55 patients with cryptogenic liver disease; 98 patients with noncryptogenic liver disease, with causes that included alcohol use, autoimmunity, drug use, and viral infections; and 86 randomly selected inpatients and outpatients who provided blood to the hematology laboratory. Results: Of the 55 patients with cryptogenic liver disease, 3 had glycine-to-cysteine mutations at position 61 (a highly conserved glycine) of keratin 8, and 2 had tyrosine-to-histidine mutations at position 53 of keratin 8. These mutations were not detected in the patients with other liver diseases or in the randomly selected patients. In transfected cells, the glycine-to-cysteine mutation limited keratin-filament reorganization when the cells were exposed to oxidative stress. In contrast, the tyrosine-to-histidine mutation destabilized keratin filaments when transfected cells were exposed to heat or okadaic acid stress. Conclusions: Mutations in the keratin 8 gene may predispose people to liver disease and may account for cryptogenic liver disease in some patients. (N Engl J Med 2001;344:1580-7.) Copyright (C) 2001 Massachusetts Medical Society.	Vet Affairs Med Ctr, Gastroenterol Sect, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; Calif Pacific Med Ctr, Dept Transplantat, San Francisco, CA USA; Vet Affairs Med Ctr, Gastroenterol Sect, San Francisco, CA 94121 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University; California Pacific Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ku, NO (corresponding author), Vet Affairs Med Ctr, Gastroenterol Sect, Mail Code 154J,3801 Miranda Ave, Palo Alto, CA 94304 USA.		Wilson, Matthew H/K-3193-2013; Gish, Robert/B-3605-2018	Gish, Robert/0000-0001-6306-3189; Omary, Bishr/0000-0002-8624-2347	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052951] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52951] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; CHAN YM, 1993, P NATL ACAD SCI USA, V90, P7414, DOI 10.1073/pnas.90.15.7414; Charlton M R, 1997, Liver Transpl Surg, V3, P359, DOI 10.1002/lt.500030402; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; Covello SP, 1998, BRIT J DERMATOL, V139, P475; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FUCHS E, 1992, CELL, V69, P899, DOI 10.1016/0092-8674(92)90607-E; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Hoet P, 1997, LANCET, V350, P556, DOI 10.1016/S0140-6736(97)03094-8; Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jochimsen EM, 1998, NEW ENGL J MED, V339, P139; Kingham JGC, 2000, GUT, V47, P328, DOI 10.1136/gut.47.3.328; Ku NO, 2000, J CELL BIOL, V149, P547, DOI 10.1083/jcb.149.3.547; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108, DOI 10.1152/ajpgi.1999.277.6.G1108; Ku NO, 1996, J CLIN INVEST, V98, P1034, DOI 10.1172/JCI118864; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Ku NO, 1997, J CLIN INVEST, V99, P19, DOI 10.1172/JCI119127; KULESH DA, 1989, MOL CELL BIOL, V9, P1553, DOI 10.1128/MCB.9.4.1553; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIAO J, 1995, EXP CELL RES, V219, P348, DOI 10.1006/excr.1995.1238; Liao J, 1996, ELECTROPHORESIS, V17, P1671, DOI 10.1002/elps.1150171104; Loranger A, 1997, AM J PATHOL, V151, P1673; Magin T M, 1998, Subcell Biochem, V31, P141; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Muller FB, 1998, J INVEST DERMATOL, V111, P900, DOI 10.1046/j.1523-1747.1998.00374.x; Muller T, 1999, J PEDIATR-US, V135, P189, DOI 10.1016/S0022-3476(99)70021-1; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; OHTA T, 1992, CARCINOGENESIS, V13, P2443, DOI 10.1093/carcin/13.12.2443; Omary MB, 1997, HEPATOLOGY, V25, P1043, DOI 10.1002/hep.510250537; Ponsoda X, 1999, BIOCHEM PHARMACOL, V58, P1579, DOI 10.1016/S0006-2952(99)00249-X; Poonawala A, 2000, HEPATOLOGY, V32, P689, DOI 10.1053/jhep.2000.17894; QUINLAN RA, 1984, J MOL BIOL, V178, P365, DOI 10.1016/0022-2836(84)90149-9; RAGHU G, 1986, BRIT J EXP PATHOL, V67, P105; *SAS I, 1995, JMP STAT GRAPH GUID; Shackleton S, 2000, NAT GENET, V24, P153, DOI 10.1038/72807; STEINERT PM, 1993, J BIOL CHEM, V268, P2878; STEINERT PM, 1993, TRENDS GENET, V9, P280, DOI 10.1016/0168-9525(93)90014-9; Struben VMD, 2000, AM J MED, V108, P9, DOI 10.1016/S0002-9343(99)00315-0; Toivola DM, 1998, HEPATOLOGY, V28, P116, DOI 10.1002/hep.510280117; Toivola DM, 1997, J CELL SCI, V110, P23; YANG JM, 1994, J INVEST DERMATOL, V102, P17, DOI 10.1111/1523-1747.ep12371725; Yang JM, 1996, J INVEST DERMATOL, V107, P439, DOI 10.1111/1523-1747.ep12365483; Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8	53	136	142	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1580	1587		10.1056/NEJM200105243442103	http://dx.doi.org/10.1056/NEJM200105243442103			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372009				2022-12-01	WOS:000168829700003
J	Jepson, P; Jarvie, JK; MacKinnon, K; Monk, KA				Jepson, P; Jarvie, JK; MacKinnon, K; Monk, KA			The end for Indonesia's lowland forests?	SCIENCE			English	Editorial Material									Univ Oxford, Sch Geog & Environm, Oxford OX3 1TB, England; World Bank, Dept Environm, Washington, DC 20433 USA	University of Oxford; The World Bank	MacKinnon, K (corresponding author), Leuser Management Unit, Jl D Mansyur 68, Medan 20154, Indonesia.		Monk, Kathryn/GRR-2773-2022					*EIA TEL, 2000, FIN CUT ILL LOGG IND; EIA Telepak, 1999, FIN CUT ILL LOGG IND; Holmes D, 2000, DEFORESTATION INDONE; Human Factors International, 2000, NEWSLETTER; MCCARTHY F, 31 CIFOR; Schweithelm J., 2000, TRIAL FIRE	6	138	141	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					859	+		10.1126/science.1061727	http://dx.doi.org/10.1126/science.1061727			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341279				2022-12-01	WOS:000168514900024
J	Bouchon, A; Facchetti, F; Weigand, MA; Colonna, M				Bouchon, A; Facchetti, F; Weigand, MA; Colonna, M			TREM-1 amplifies inflammation and is a crucial mediator of septic shock	NATURE			English	Article							INNATE IMMUNITY; RECEPTOR ANTAGONIST; LETHAL ENDOTOXEMIA; MICE; CACHECTIN; INFECTION; CELLS; MONOCYTOGENES; PATHOGENESIS; PERITONITIS	Host innate responses to bacterial infections are primarily mediated by neutrophils and monocytes/macrophages(1,2). These cells express pattern recognition receptors (PRRs) that bind conserved molecular structures shared by groups of microorganisms(3,4). Stimulation of PRR signalling pathways initiates secretion of proinflammatory mediators(3,4), which promote the elimination of infectious agents and the induction of tissue repair. Excessive inflammation owing to bacterial infections can lead to tissue damage and septic shock(5-9). Here we show that inflammatory responses to microbial products are amplified by a pathway mediated by triggering receptor expressed on myeloid cells (TREM)-1. TREM-1 is an activating receptor expressed at high levels on neutrophils and monocytes that infiltrate human tissues infected with bacteria. Furthermore, it is upregulated on peritoneal neutrophils of patients with microbial sepsis and mice with experimental lipopolysaccaride (LPS)-induced shock. Notably, blockade of TREM-1 protects mice against LPS-induced shock, as well as microbial sepsis caused by live Escherichia coli or caecal ligation and puncture. These results demonstrate a critical function of TREM-1 in acute inflammatory responses to bacteria and implicate TREM-1 as a potential therapeutic target for septic shock.	Basel Inst Immunol, CH-4005 Basel, Switzerland; Univ Brescia, Inst Pathol, Spedali Civili 1, Brescia, Italy; Univ Heidelberg, Clin Anaesthesiol, D-69120 Heidelberg, Germany; German Canc Res Inst DKFZ, Tumor Immunol Program, D-69120 Heidelberg, Germany	University of Brescia; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Colonna, M (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.		Facchetti, Fabio/E-7190-2010	Facchetti, Fabio/0000-0003-4975-2388; Colonna, Marco/0000-0001-5222-4987				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; ALEXANDER HR, 1991, J EXP MED, V173, P1029, DOI 10.1084/jem.173.4.1029; APPELMELK BJ, 1986, A VAN LEEUW J MICROB, V52, P537, DOI 10.1007/BF00423414; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; ECHTENACHER B, 1990, J IMMUNOL, V145, P3762; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; FACCHETTI F, 1992, AM J SURG PATHOL, V16, P955, DOI 10.1097/00000478-199210000-00005; GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; Peschon JJ, 1998, J IMMUNOL, V160, P943; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248	27	782	891	2	43	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1103	1107		10.1038/35074114	http://dx.doi.org/10.1038/35074114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323674				2022-12-01	WOS:000168285500050
J	Edwards, TA; Pyle, SE; Wharton, RP; Aggarwal, AK				Edwards, TA; Pyle, SE; Wharton, RP; Aggarwal, AK			Structure of Pumilio reveals similarity between RNA and peptide binding motifs	CELL			English	Article							HUNCHBACK MESSENGER-RNA; CRYSTAL-STRUCTURE; TRANSLATIONAL REGULATION; DIFFRACTION DATA; PROTEIN; DROSOPHILA; DOMAIN; NANOS; REPRESSION; COMPLEX	Translation regulation plays an essential role in the differentiation and development of animal cells. One well-studied case is the control of hunchback mRNA during early Drosophila embryogenesis by the transacting factors Pumilio, Nanos, and Brain Tumor. We report here a crystal structure of the critical region of Pumilio, the Puf domain, that organizes a multivalent repression complex on the 3' untranslated region of hunchback mRNA. The structure reveals an extended, rainbow shaped molecule, with tandem helical repeats that bear unexpected resemblance to the armadillo repeats in beta -catenin and the HEAT repeats in protein phosphatase 2A. Based on the structure and genetic experiments, we identify putative interaction surfaces for hunchback mRNA and the cofactors Nanos and Brain Tumor. This analysis suggests that similar features in helical repeat proteins are used to bind extended peptides and RNA.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, New York, NY 10029 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Genet, Durham, NC 27710 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Duke University; Howard Hughes Medical Institute	Aggarwal, AK (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Struct Biol Program, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	aggarwal@inka.mssm.edu		edwards, thomas/0000-0002-1467-3674	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062947] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM62947] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; Dahanukar A, 1999, MOL CELL, V4, P209, DOI 10.1016/S1097-2765(00)80368-8; DALBY B, 1993, EMBO J, V12, P1219, DOI 10.1002/j.1460-2075.1993.tb05763.x; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards TA, 2000, J STRUCT BIOL, V132, P251, DOI 10.1006/jsbi.2000.4319; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; GAVIS ER, 1994, NATURE, V369, P315, DOI 10.1038/369315a0; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR A, V47, P110; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Macdonald PM, 1996, CURR OPIN GENET DEV, V6, P403, DOI 10.1016/S0959-437X(96)80060-8; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nagai K, 1996, CURR OPIN STRUC BIOL, V6, P53, DOI 10.1016/S0959-440X(96)80095-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM; RYU SE, 1990, NATURE, V348, P419, DOI 10.1038/348419a0; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Smibert CA, 1999, RNA, V5, P1535, DOI 10.1017/S1355838299991392; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Willis AE, 1999, INT J BIOCHEM CELL B, V31, P73, DOI 10.1016/S1357-2725(98)00133-2; Wreden C, 1997, DEVELOPMENT, V124, P3015; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297	53	196	204	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					281	289		10.1016/S0092-8674(01)00318-X	http://dx.doi.org/10.1016/S0092-8674(01)00318-X			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336677	Bronze			2022-12-01	WOS:000168384300014
J	Rathore, SS; Weinfurt, KP; Gersh, BJ; Oetgen, WJ; Schulman, KA; Solomon, AJ				Rathore, SS; Weinfurt, KP; Gersh, BJ; Oetgen, WJ; Schulman, KA; Solomon, AJ			Treatment of patients with myocardial infarction who present with a paced rhythm	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTROCARDIOGRAPHIC DIAGNOSIS; MEDICARE; OUTCOMES; PACEMAKERS; HOSPITALS; RISK; CARE	Background: A paced rhythm can mask the electrocardiographic features of an acute myocardial infarction, complicating timely recognition and treatment. Objective: To evaluate characteristics, treatment, and outcomes among patients presenting with paced rhythms during myocardial infarction. Design: Retrospective cohort study. Setting: U.S. acute care hospitals. Patients: 102 249 Medicare beneficiaries at least 65 years of age who were treated for acute myocardial infarction between 1994 and 1996. Measurements: Provision of three treatments for acute myocardial infarction (emergent reperfusion, aspirin, and beta -blockers), death at 30 days, and long-term follow-up. Results: 1954 patients (1.9%) presented with paced rhythms during myocardial infarction. These patients were older; were predominantly male; and had higher rates of congestive heart failure, diabetes, and previous infarction. They were significantly less likely to receive emergent reperfusion (relative risk [RR], 0.27 [95% Cl, 0.22 to 0.33]), aspirin (88 at admission, 0.91 [Cl, 0.88 to 0.94]; RR at discharge, 0.87 [Cl, 0.83 to 0.92]), and beta -blockers at admission (RR, 0.89 [Cl, 0.82 to 0.96]). In addition, there was a trend toward decreased use of beta -blockers at discharge (RR, 0.91 [Cl, 0.76 to 1.06]). Crude mortality rates were higher among patients with paced rhythms than among those without at 30 days (25.8% vs. 21.3%; P = 0.001) and at 1 year (47.1% vs. 36.1%; P = 0.001). Among patients with paced rhythms, risk for death at 30 days decreased after adjustment for illness severity and decreased use of therapy (RR, 1.03 [Cl, 0.93 to 1.14]). Patients with paced rhythms remained at additional risk for long-term mortality (hazard ratio, 1.12 [Cl, 1.06 to 1.18]). Conclusions: Patients with paced rhythms were less likely than those without to receive treatment for acute myocardial infarction and had poorer short- and long-term outcomes. However, this mortality risk diminished after adjustment for treatment This suggests that improved recognition and treatment of myocardial infarction may improve outcomes, particularly in the short term.	Georgetown Univ, Med Ctr, Div Cardiol, Washington, DC 20007 USA; Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA; Maryland HealthCare Associates, Clinton, MD USA; Delmarva Fdn Med Care, Easton, MD USA	Georgetown University; Duke University; Mayo Clinic	Solomon, AJ (corresponding author), Georgetown Univ, Med Ctr, Div Cardiol, Room M4222,3800 Reservoir Rd NW, Washington, DC 20007 USA.	solomona@gunet.georgetown.edu			PHS HHS [500-96-P624, 500-96-P623] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALI M, 1978, ARCH INTERN MED, V138, P1534, DOI 10.1001/archinte.138.10.1534; Barold S S, 1987, Cardiol Clin, V5, P403; BATHEN J, 1973, BRIT HEART J, V35, P1336; Bernstein AD, 1996, AM J CARDIOL, V78, P187, DOI 10.1016/S0002-9149(96)90394-X; *COMM PROF HOSP AC, 1991, INT CLASS DIS 9 REV; CRAGG DR, 1991, ANN INTERN MED, V115, P173, DOI 10.7326/0003-4819-115-3-173; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; Kozlowski FH, 1998, ACAD EMERG MED, V5, P52, DOI 10.1111/j.1553-2712.1998.tb02575.x; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; *NAT RES POL CTR L, 1996, GUID OP AOAS DEF RUR; Rathore SS, 2000, J AM COLL CARDIOL, V35, p396A; Rosner MH, 1999, AM J EMERG MED, V17, P182, DOI 10.1016/S0735-6757(99)90058-X; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Sgarbossa EB, 1996, AM J CARDIOL, V77, P423, DOI 10.1016/S0002-9149(97)89377-0; Shlipak MG, 2000, J AM COLL CARDIOL, V36, P706, DOI 10.1016/S0735-1097(00)00789-0; SMITH EE, 1995, ANN EMERG MED, V25, P274, DOI 10.1016/S0196-0644(95)70342-X; *US CENS BUR, 1992, 1990 CENS POP HOUS; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	20	20	20	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					644	651		10.7326/0003-4819-134-8-200104170-00009	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304104				2022-12-01	WOS:000168177500003
J	Lescar, J; Roussel, A; Wien, MW; Navaza, J; Fuller, SD; Wengler, G; Wengler, G; Rey, FA				Lescar, J; Roussel, A; Wien, MW; Navaza, J; Fuller, SD; Wengler, G; Wengler, G; Rey, FA			The fusion glycoprotein shell of Semliki Forest virus: An icosahedral assembly primed for fusogenic activation at endosomal pH	CELL			English	Article							BORNE ENCEPHALITIS-VIRUS; RECOMBINANT SUBVIRAL PARTICLES; MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; SPIKE PROTEIN; RECEPTOR-BINDING; ORGANIZATION; COMPLEX; MODEL; HEMAGGLUTININ	Semliki Forest virus (SFV) has been extensively studied as a model for analyzing entry of enveloped viruses into target cells. Here we describe the trace of the polypeptide chain of the SFV fusion glycoprotein, E1, derived from an electron density map at 3.5 Angstrom resolution and describe its interactions at the surface of the virus. E1 is unexpectedly similar to the flavivirus envelope protein, with three structural domains disposed in the same primary sequence arrangement. These results introduce a new class of membrane fusion proteins which display lateral interactions to induce the necessary curvature and direct budding of closed particles. The resulting surface protein lattice is primed to cause membrane fusion when exposed to the acidic environment of the endosome.	CNRS, Lab Genet Virus, UPR 9053, F-91198 Gif Sur Yvette, France; European Synchrotron Radiat Facil, F-38043 Grenoble, France; Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; Univ Giessen, Inst Virol, D-35392 Giessen, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; European Synchrotron Radiation Facility (ESRF); University of Oxford; Wellcome Centre for Human Genetics; Justus Liebig University Giessen	Rey, FA (corresponding author), CNRS, Lab Genet Virus, UPR 9053, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	rey@gv.cnrs-gif.fr	Rey, Felix/B-6497-2012	Rey, Felix/0000-0002-9953-7988				ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995; ALLISON SL, 2001, IN PRESS J VIROL; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth BU, 1997, J VIROL, V71, P7857, DOI 10.1128/JVI.71.10.7857-7865.1997; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CHENG RH, 1995, CELL, V80, P621; Chernomordik LV, 1999, MOL MEMBR BIOL, V16, P33; Choi HK, 1997, PROTEINS, V27, P345, DOI 10.1002/(SICI)1097-0134(199703)27:3<345::AID-PROT3>3.0.CO;2-C; Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; DUFFUS WA, 1995, J VIROL, V69, P2471, DOI 10.1128/JVI.69.4.2471-2479.1995; Ferlenghi I, 1998, J MOL BIOL, V283, P71, DOI 10.1006/jmbi.1998.2066; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Forsell K, 2000, EMBO J, V19, P5081, DOI 10.1093/emboj/19.19.5081; FULLER SD, 1995, CELL, V81, P715, DOI 10.1016/0092-8674(95)90533-2; GAROFF H, 1994, ARCH VIROL, P329; Gibbons DL, 2000, J VIROL, V74, P7772, DOI 10.1128/JVI.74.17.7772-7780.2000; Harrison S. C., 1986, TOGAVIRIDAE FLAVIVIR, P21; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; HELENIUS A, 1976, BIOCHIM BIOPHYS ACTA, V436, P895, DOI 10.1016/0005-2736(76)90421-1; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIELIAN M, 1985, J CELL BIOL, V101, P2284, DOI 10.1083/jcb.101.6.2284; KIELIAN M, 1995, ADV VIRUS RES, V45, P113, DOI 10.1016/S0065-3527(08)60059-7; KLIMJACK MR, 1994, J VIROL, V68, P6940, DOI 10.1128/JVI.68.11.6940-6946.1994; Mancini EJ, 2000, MOL CELL, V5, P255, DOI 10.1016/S1097-2765(00)80421-9; MATHIEU M, 2001, IN PRESS EMBO J; NAVAZA J, 1987, ACTA CRYSTALLOGR A, V43, P645, DOI 10.1107/S0108767387098787; OMAR A, 1988, VIROLOGY, V166, P17, DOI 10.1016/0042-6822(88)90141-9; OTWINOWSKI Z, 1996, METHOD ENZYMOL, P307; Paredes AM, 1998, J VIROL, V72, P1534, DOI 10.1128/JVI.72.2.1534-1541.1998; PAREDES AM, 1993, P NATL ACAD SCI USA, V90, P9095, DOI 10.1073/pnas.90.19.9095; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; RICE CM, 1996, VIROLOGY, P931; Rothman JE, 1996, PROTEIN SCI, V5, P185; ROUSSEL A, 1991, SILICON GRAPHICS GEO; RUMENAPF T, 1995, J VIROL, V69, P1741; RUSSELL PK, 1980, TOGAVIRUSES, P501; SCHLESINGER S, 1996, VIROLOGY, P825; Sheehan B, 1996, J STRUCT BIOL, V116, P99, DOI 10.1006/jsbi.1996.0017; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; VENIENBRYAN C, 1994, J MOL BIOL, V236, P572, DOI 10.1006/jmbi.1994.1166; WAHLBERG JM, 1992, J CELL BIOL, V116, P339, DOI 10.1083/jcb.116.2.339; WAHLBERG JM, 1992, J VIROL, V66, P7309, DOI 10.1128/JVI.66.12.7309-7318.1992; Weissenhorn W, 1999, MOL MEMBR BIOL, V16, P3, DOI 10.1080/096876899294706; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K	57	410	425	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					137	148		10.1016/S0092-8674(01)00303-8	http://dx.doi.org/10.1016/S0092-8674(01)00303-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301009	Bronze			2022-12-01	WOS:000168063300014
J	Christenson, B; Lundbergh, P; Hedlund, J; Ortqvist, A				Christenson, B; Lundbergh, P; Hedlund, J; Ortqvist, A			Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study	LANCET			English	Article							POLYSACCHARIDE VACCINE; ELDERLY PERSONS; COST-EFFECTIVENESS; EFFICACY; PNEUMONIA; TRIAL; BENEFITS; HEALTH; RISK	Background The effectiveness of influenza and pneumococcal vaccination in the prevention of hospital admissions and death has not been assessed prospectively. We have therefore examined the effects of influenza and pneumococcal vaccination in individuals aged 65 years and older in a 3-year prospective study, between Dec 1, 1998 and May 31, 1999. Methods All individuals in Stockholm County aged 65 years or order (259 627) were invited to take part in a vaccination campaign against influenza and pneumococcal infection. We recorded for all Vaccine recipients (100 242) name, and date of birth, and whether they had been given both or one of the vaccines. All individuals (greater than or equal to 65 years) admitted to hospital in Stockholm County with influenza and pneumonia related diagnoses were identified between Dec 1, 1998, and May 31, 1999. Findings. The incidence (per 100 000 inhabitants per year) of Findings The incidence (per 100 000 inhabitants per year) of hospital treatment was lower in the Vaccinated than in the unvaccinated cohort for all diagnoses: 263 versus 484 (-46% [95% CI 30-56]) for influenza; 2199 versus 3097 (-29% [24-34]) for pneumonia; 64 versus 100 (-36% [3-58]) for pneumococcal pneumonia; and 20 versus 40 (-52% [1-77]) for invasive pneumococcal disease. The total mortality was 57% (55-60) fewer in Vaccinated than in unvaccinated individuals (15.1 vs 34.7 deaths per 1000 inhabitants). Interpretation These findings show that general Vaccination leads to substantial health benefits and to a reduction of mortality from all causes in this age group.	Karolinska Inst, Karolinska Hosp, Dept Communicable Dis Control & Prevent, S-17176 Stockholm, Sweden; Karolinska Inst, Karolinska Hosp, Dept Infect Dis, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Christenson, B (corresponding author), Karolinska Inst, Karolinska Hosp, Dept Communicable Dis Control & Prevent, S-17176 Stockholm, Sweden.							Ahmed AH, 1997, EPIDEMIOL INFECT, V118, P27, DOI 10.1017/S0950268896007121; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P797; FARR BM, 1995, ARCH INTERN MED, V155, P2336, DOI 10.1001/archinte.155.21.2336; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; FOSTER DA, 1992, AM J EPIDEMIOL, V136, P296, DOI 10.1093/oxfordjournals.aje.a116495; GAILLAT J, 1985, REV EPIDEMIOL SANTE, V33, P437; GILLICK MR, 1991, ARCH INTERN MED, V151, P1742, DOI 10.1001/archinte.151.9.1742; GOAVERT ME, 1994, JAMA-J AM MED ASSOC, V272, P1661; Hoglund D, 2001, Lakartidningen, V98, P156; Honkanen PO, 1999, VACCINE, V17, P2493, DOI 10.1016/S0264-410X(99)00069-9; Koivula I, 1997, AM J MED, V103, P281, DOI 10.1016/S0002-9343(97)00149-6; MULLOOLY JP, 1994, ANN INTERN MED, V121, P947, DOI 10.7326/0003-4819-121-12-199412150-00008; Nichol KL, 1999, ARCH INTERN MED, V159, P2437, DOI 10.1001/archinte.159.20.2437; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; NICHOLSON KG, 1987, VACCINE, V5, P302, DOI 10.1016/0264-410X(87)90156-3; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101	19	174	184	1	14	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					1008	1011		10.1016/S0140-6736(00)04237-9	http://dx.doi.org/10.1016/S0140-6736(00)04237-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293594				2022-12-01	WOS:000167791500012
J	Thomas, DW; Blondel, J; Perret, P; Lambrechts, MM; Speakman, JR				Thomas, DW; Blondel, J; Perret, P; Lambrechts, MM; Speakman, JR			Energetic and fitness costs of mismatching resource supply and demand in seasonally breeding birds	SCIENCE			English	Article							TITS PARUS-CAERULEUS; GREAT TITS; RECRUITMENT; SELECTION; DATE	By advancing spring leaf flush and ensuing food availability, climatic warming results in a mismatch between the timing of peak food supply and nestling demand, shifting the optimal time for reproduction in birds. Two populations of blue tits (Parus caeruleus) that breed at different dates in similar, but spatially distinct, habitat types in Corsica and southern France provide a unique opportunity to quantify the energetic and fitness consequences when breeding is mismatched with local productivity. As food supply and demand become progressively mismatched, the increased cost of rearing young pushes the metabolic effort of adults beyond their apparent sustainable limit, drastically reducing the persistence of adults in the breeding population. We provide evidence that the economics of parental foraging and limits to sustainable metabolic effort are key selective forces underlying synchronized seasonal breeding and long-term shifts in breeding date in response to climatic change.	Univ Sherbrooke, Grp Rech Ecol Nutr & energet, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; CNRS, Ctr Ecol Fonct & Evolut, F-34293 Montpellier 5, France; Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland; Rowett Res Inst, Aberdeen, Scotland	University of Sherbrooke; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Aberdeen; University of Aberdeen	Thomas, DW (corresponding author), Univ Sherbrooke, Grp Rech Ecol Nutr & energet, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.		Speakman, John R./A-9494-2008	Speakman, John R./0000-0002-2457-1823				BLONDEL J, 1992, LANDSCAPE ECOL, V6, P213, DOI 10.1007/BF00130032; Blondel J, 1999, SCIENCE, V285, P1399, DOI 10.1126/science.285.5432.1399; BLONDEL J, 1993, AUK, V110, P511, DOI 10.2307/4088415; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; Bryant DM, 1997, P NUTR SOC, V56, P1025, DOI 10.1079/PNS19970107; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Dias PC, 1996, OECOLOGIA, V107, P79, DOI 10.1007/BF00582237; Dias PC, 1996, IBIS, V138, P644, DOI 10.1111/j.1474-919X.1996.tb04766.x; DRENT RH, 1980, ARDEA, V68, P225; Lambrechts MM, 1997, P NATL ACAD SCI USA, V94, P5153, DOI 10.1073/pnas.94.10.5153; LAMBRECHTS MM, 1993, IBIS, V135, P451, DOI 10.1111/j.1474-919X.1993.tb02118.x; Lambrechts MM, 1996, P ROY SOC B-BIOL SCI, V263, P19, DOI 10.1098/rspb.1996.0004; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; PETERSON CC, 1990, P NATL ACAD SCI USA, V87, P2324, DOI 10.1073/pnas.87.6.2324; Speakman J.R., 1997, DOUBLY LABELLED WATE; THOMAS DW, IN PRESS ZOOLOGY; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 1999, OIKOS, V85, P445, DOI 10.2307/3546694	21	292	295	3	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2598	2600		10.1126/science.1057487	http://dx.doi.org/10.1126/science.1057487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283370				2022-12-01	WOS:000167861000040
J	Ward, SA; Bray, PG				Ward, SA; Bray, PG			Is reversal of chloroquine resistance ready for the clinic?	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; DESIPRAMINE; MALARIA		Univ Liverpool, Liverpool Sch Trop Med, Dept Pharmacol & Therapeut, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Ward, SA (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Pharmacol & Therapeut, Liverpool L3 5QA, Merseyside, England.		Ward, Steve/G-6003-2015	Ward, Steve/0000-0003-2331-3192				BOULTER MK, 1993, T ROY SOC TROP MED H, V87, P303, DOI 10.1016/0035-9203(93)90137-F; BRAY PG, 1998, PHARMACOL THERAPEUT, V1, P1; Haruki K, 2000, ANTIMICROB AGENTS CH, V44, P2706, DOI 10.1128/AAC.44.10.2706-2708.2000; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; Sowunmi A, 1998, T ROY SOC TROP MED H, V92, P77, DOI 10.1016/S0035-9203(98)90964-6; Taylor D, 2000, ANTIMICROB AGENTS CH, V44, P2689, DOI 10.1128/AAC.44.10.2689-2692.2000; TSURUO T, 1981, CANCER RES, V41, P1967; VERDIER F, 1985, ANTIMICROB AGENTS CH, V27, P561, DOI 10.1128/AAC.27.4.561; WARSAME M, 1992, T ROY SOC TROP MED H, V86, P235, DOI 10.1016/0035-9203(92)90288-N; Winstanley PA, 2000, PARASITOL TODAY, V16, P146, DOI 10.1016/S0169-4758(99)01622-1	10	12	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					904	904		10.1016/S0140-6736(00)04232-X	http://dx.doi.org/10.1016/S0140-6736(00)04232-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289344				2022-12-01	WOS:000167625300006
J	Tromans, A				Tromans, A			Entomology - The alkaloid defence	NATURE			English	Editorial Material																		Conner WE, 2000, P NATL ACAD SCI USA, V97, P14406, DOI 10.1073/pnas.260503797	1	0	0	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					28	28		10.1038/35051196	http://dx.doi.org/10.1038/35051196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343096				2022-12-01	WOS:000166175600022
J	Wang, HB; Huang, ZQ; Xia, L; Feng, Q; Erdjument-Bromage, H; Strahl, BD; Briggs, SD; Allis, CD; Wong, JM; Tempst, P; Zhang, Y				Wang, HB; Huang, ZQ; Xia, L; Feng, Q; Erdjument-Bromage, H; Strahl, BD; Briggs, SD; Allis, CD; Wong, JM; Tempst, P; Zhang, Y			Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor	SCIENCE			English	Article							METHYLTRANSFERASES; CELLS; YEAST; H3	Acetylation of core histone tails plays a fundamental role in transcription regulation. In addition to acetylation, other posttranslational modifications, such as phosphorylation and methylation, occur in core histone tails. Here, we report the purification, molecular identification, and functional characterization of a histone H4-specific methyltransferase PRMT1, a protein arginine methyltransferase. PRMT1 specifically methylates arginine 3 (Arg 3) of H4 in vitro and in vivo. Methylation of Arg 3 by PRMT1 facilitates subsequent acetylation of H4 tails by p300. However, acetylation of H4 inhibits its methylation by PRMT1. Most important, a mutation in the S-adenosyl-L-methionine-binding site of PRMT1 substantially crippled its nuclear receptor coactivator activity. Our finding reveals Arg 3 of H4 as a novel methylation site by PRMT1 and indicates that Arg 3 methylation plays an important role in transcriptional regulation.	Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center; University of Virginia	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.		Strahl, Brian/C-7601-2012	Strahl, Brian/0000-0002-4947-6259; Wong, Jiemin/0000-0002-5311-842X; Zhang, Yi/0000-0002-2789-0811; Briggs, Scott D/0000-0003-2852-3594; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIGMS NIH HHS [GM63067-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063067] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANNUNZIATO AT, 1995, BIOCHEMISTRY-US, V34, P2916, DOI 10.1021/bi00009a023; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Luger K, 1999, METHOD ENZYMOL, V304, P3; McBride AE, 2000, J BIOL CHEM, V275, P3128, DOI 10.1074/jbc.275.5.3128; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pawlak MR, 2000, MOL CELL BIOL, V20, P4859, DOI 10.1128/MCB.20.13.4859-4869.2000; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Scott HS, 1998, GENOMICS, V48, P330, DOI 10.1006/geno.1997.5190; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; WANG H, UNPUB; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	19	545	574	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 3	2001	293	5531					853	857		10.1126/science.1060781	http://dx.doi.org/10.1126/science.1060781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	459FU	11387442				2022-12-01	WOS:000170241000042
J	Ogura, Y; Bonen, DK; Inohara, N; Nicolae, DL; Chen, FF; Ramos, R; Britton, H; Moran, T; Karaliuskas, R; Duerr, RH; Achkar, JP; Brant, SR; Bayless, TM; Kirschner, BS; Hanauer, SB; Nunez, G; Cho, JH				Ogura, Y; Bonen, DK; Inohara, N; Nicolae, DL; Chen, FF; Ramos, R; Britton, H; Moran, T; Karaliuskas, R; Duerr, RH; Achkar, JP; Brant, SR; Bayless, TM; Kirschner, BS; Hanauer, SB; Nunez, G; Cho, JH			A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SUPPORTS LINKAGE; GENETIC-ANALYSIS; CHROMOSOME-16; LOCUS; IDENTIFICATION; TOMATO; IBD1	Crohn's disease is a chronic inflammatory disorder of the gastrointestinal tract, which is thought to result from the effect of environmental factors in a genetically predisposed host. A gene location in the pericentromeric region of chromosome 16, IBD1, that contributes to susceptibility to Crohn's disease has been established through multiple linkage studies(1-6), but the specific gene(s) has not been identified. NOD2, a gene that encodes a protein with homology to plant disease resistance gene products is located in the peak region of linkage on chromosome 16 (ref. 7). Here we show, by using the transmission disequilibium test and case-control analysis, that a frameshift mutation caused by a cytosine insertion, 3020insC, which is expected to encode a truncated NOD2 protein, is associated with Crohn's disease. Wild-type NOD2 activates nuclear factor NF-kappaB, making it responsive to bacterial lipopolysaccharides; however, this induction was deficient in mutant NOD2. These results implicate NOD2 in susceptibility to Crohn's disease, and suggest a link between an innate immune response to bacterial components and development of disease.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Chicago Hosp, Dept Med, Gastroenterol Sect, Martin Boyer Labs, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Genom Sci, Pittsburgh, PA 15260 USA; Cleveland Clin Fdn, Dept Gastroenterol, Cleveland, OH 44195 USA; Johns Hopkins Univ, Sch Med, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21205 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Chicago; University of Illinois System; University of Chicago; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Johns Hopkins University	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Nuñez, Gabriel/A-7160-2014; Duerr, Richard H/B-4188-2009	Duerr, Richard H/0000-0001-6586-3905; Kirschner, Barbara/0000-0003-4640-2438; Nicolae, Dan/0000-0002-0918-4630				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Binder V, 1998, DIGEST DIS, V16, P351, DOI 10.1159/000016891; Cavanaugh JA, 1998, ANN HUM GENET, V62, P291, DOI 10.1046/j.1469-1809.1998.6240291.x; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Dixon MS, 2000, P NATL ACAD SCI USA, V97, P8807, DOI 10.1073/pnas.97.16.8807; Ellis JG, 1999, PLANT CELL, V11, P495, DOI 10.1105/tpc.11.3.495; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Han CS, 2000, GENOME RES, V10, P714, DOI 10.1101/gr.10.5.714; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; KYLE J, 1992, GASTROENTEROLOGY, V103, P392, DOI 10.1016/0016-5085(92)90826-K; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; Parniske M, 1997, CELL, V91, P821, DOI 10.1016/S0092-8674(00)80470-5; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Spielman RS, 1996, AM J HUM GENET, V59, P983	22	3757	3907	5	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					603	606		10.1038/35079114	http://dx.doi.org/10.1038/35079114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385577	Green Published			2022-12-01	WOS:000168982500056
J	Lower, SK; Hochella, MF; Beveridge, TJ				Lower, SK; Hochella, MF; Beveridge, TJ			Bacterial recognition of mineral surfaces: Nanoscale interactions between Shewanella and alpha-FeOOH	SCIENCE			English	Article							CRYSTALLINE IRON(III) OXIDES; ATOMIC-FORCE MICROSCOPY; PUTREFACIENS MR-1; OUTER-MEMBRANE; MICROBIAL REDUCTION; DISSIMILATORY REDUCTION; MN(IV) REDUCTION; CYTOCHROME-C; IRON; FE(III)	Force microscopy has been used to quantitatively measure the infinitesimal forces that characterize interactions between Shewanella oneidensis (a dissimilatory metal-reducing bacterium) and goethite (alpha -FeOOH), both commonly found in Earth near-surface environments. Force measurements with subnano-newton resolution were made in real time with living cells under aerobic and anaerobic solutions as a function of the distance, in nanometers, between a cell and the mineral surface. Energy values [in attojoules (10(-18) joules)] derived from these measurements show that the affinity between S. oneidensis and goethite rapidly increases by two to five times under anaerobic conditions in which electron transfer from bacterium to mineral is expected. Specific signatures in the force curves suggest that a 150-kilodalton putative iron reductase is mobilized within the outer membrane of S. oneidensis and specifically interacts with the goethite surface to facilitate the electron transfer process.	Virginia Polytech Inst & State Univ, Dept Geol Sci, Nanogeosci & Technol Lab, Blacksburg, VA 24061 USA; Univ Guelph, Coll Biol Sci, Dept Microbiol, Guelph, ON N1G 2W1, Canada	Virginia Polytechnic Institute & State University; University of Guelph	Lower, SK (corresponding author), Univ Maryland, Dept Geol, College Pk, MD 20742 USA.		Lower, Steven/A-2440-2008	Lower, Steven/0000-0001-9796-0830				ARNOLD RG, 1990, APPL ENVIRON MICROB, V56, P2811, DOI 10.1128/AEM.56.9.2811-2817.1990; ARNOLD RG, 1988, BIOTECHNOL BIOENG, V32, P1081, DOI 10.1002/bit.260320902; Beliaev AS, 1998, J BACTERIOL, V180, P6292; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; BROWN S, 1992, P NATL ACAD SCI USA, V89, P8651, DOI 10.1073/pnas.89.18.8651; Caccavo F, 1997, APPL ENVIRON MICROB, V63, P3837, DOI 10.1128/AEM.63.10.3837-3843.1997; CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209; DCOSTA NP, 1995, REV SCI INSTRUM, V66, P5096, DOI 10.1063/1.1146135; DICHRISTINA TJ, 1994, J BACTERIOL, V176, P1468, DOI 10.1128/jb.176.5.1468-1474.1994; DUCKER WA, 1992, LANGMUIR, V8, P1831, DOI 10.1021/la00043a024; Flory P. J., 1989, STAT MECH CHAIN MOL, P401; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; KARLSSON JJ, 1996, PROTEIN FOLDS DISTAN, P56; KORENEVSKY A, UNPUB; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; LOVLEY DR, 1986, APPL ENVIRON MICROB, V52, P751, DOI 10.1128/AEM.52.4.751-757.1986; Lower SK, 2000, GEOCHIM COSMOCHIM AC, V64, P3133, DOI 10.1016/S0016-7037(00)00430-0; Lower SK, 2001, GEOMICROBIOL J, V18, P63, DOI 10.1080/01490450151079798; Mueller H, 1999, BIOPHYS J, V76, P1072, DOI 10.1016/S0006-3495(99)77272-3; Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170; MYERS CR, 1992, J BACTERIOL, V174, P3429, DOI 10.1128/JB.174.11.3429-3438.1992; Myers CR, 1997, BBA-BIOMEMBRANES, V1326, P307, DOI 10.1016/S0005-2736(97)00034-5; MYERS CR, 1993, FEMS MICROBIOL LETT, V108, P15; Myers CR, 1997, J BACTERIOL, V179, P1143, DOI 10.1128/jb.179.4.1143-1152.1997; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; Myers JM, 1998, BBA-BIOMEMBRANES, V1373, P237, DOI 10.1016/S0005-2736(98)00111-4; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Myers JM, 2000, J BACTERIOL, V182, P67, DOI 10.1128/JB.182.1.67-75.2000; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; OHMURA N, 1993, APPL ENVIRON MICROB, V59, P4044, DOI 10.1128/AEM.59.12.4044-4050.1993; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Roden EE, 1996, ENVIRON SCI TECHNOL, V30, P1618, DOI 10.1021/es9506216; Sokolov I, 2001, ENVIRON SCI TECHNOL, V35, P341, DOI 10.1021/es001258s; STUMM W, 1996, AQUAT CHEM, P534; Urrutia MM, 1999, ENVIRON SCI TECHNOL, V33, P4022, DOI 10.1021/es990447b; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Zachara JM, 1998, AM MINERAL, V83, P1426, DOI 10.2138/am-1998-11-1232	40	344	363	7	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1360	1363		10.1126/science.1059567	http://dx.doi.org/10.1126/science.1059567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359008				2022-12-01	WOS:000168862900041
J	Wang, YM; Zhang, WG; Jin, Y; Johansen, J; Johansen, KM				Wang, YM; Zhang, WG; Jin, Y; Johansen, J; Johansen, KM			The JIL-1 tandem kinase mediates histone H3 phosphorylation and is required for maintenance of chromatin structure in Drosophila	CELL			English	Article							MITOTIC CHROMOSOME CONDENSATION; DOSAGE COMPENSATION; X-CHROMOSOMES; GENE; ACETYLATION; MELANOGASTER; NUCLEOSOMES; ACTIVATION; SERINE-10; MITOSIS	To analyze the function of the chromosomal kinase JIL-1, we generated an allelic series of hypomorphic and null mutations. JIL-1 is an essential kinase for viability, and reduced levels of JIL-1 kinase activity lead to a global change in chromatin structure. in JIL-1 hypomorphs, euchromatic regions of polytene chromosomes are severely reduced and the chromosome arms condensed. This is correlated with decreased levels of histone H3 Ser10 phosphorylation. These levels can be restored by a JIL-1 transgene placing JIL-1 directly in the pathway mediating histone H3 phosphorylation. We propose a model where JIL-1 kinase activity is required for maintaining the structure of the more open chromatin regions that facilitate gene transcription.	Iowa State Univ, Dept Zool & Genet, Ames, IA 50011 USA	Iowa State University	Johansen, KM (corresponding author), Iowa State Univ, Dept Zool & Genet, 3154 Mol Biol Bldg, Ames, IA 50011 USA.			Wang, Yanming/0000-0002-0710-043X; Zhang, Weiguo/0000-0002-3045-0569	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62916] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; BAKER BS, 1994, ANNU REV GENET, V28, P491, DOI 10.1146/annurev.ge.28.120194.002423; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; De Souza CPC, 2000, CELL, V102, P293, DOI 10.1016/S0092-8674(00)00035-0; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Johansen KM, 1996, J CELL BIOCHEM, V63, P268, DOI 10.1002/(SICI)1097-4644(19961201)63:3<268::AID-JCB2>3.0.CO;2-V; Kaszas E, 2000, J CELL SCI, V113, P3217; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KELLEY RL, 1995, SCIENCE, V270, P1607, DOI 10.1126/science.270.5242.1607; Lindsley D.L., 1992, GENOME DROSOPHILA ME; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lucchesi JC, 1998, CURR OPIN GENET DEV, V8, P179, DOI 10.1016/S0959-437X(98)80139-1; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MITCHISON TJ, 1983, DEV BIOL, V99, P261, DOI 10.1016/0012-1606(83)90275-0; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Pimpinelli S., 2000, DROSOPHILA PROTOCOLS, P3; Preston CR, 1996, GENETICS, V144, P1611; Roberts D. B, 1986, DROSOPHILA PRACTICAL; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1998, DEVELOPMENT, V125, P1049; RYKOWSKI MC, 1988, CELL, V54, P461, DOI 10.1016/0092-8674(88)90067-0; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; ZHOU SB, 1995, EMBO J, V14, P2884, DOI 10.1002/j.1460-2075.1995.tb07288.x; ZINK B, 1989, NATURE, V337, P468, DOI 10.1038/337468a0	39	166	173	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					433	443		10.1016/S0092-8674(01)00325-7	http://dx.doi.org/10.1016/S0092-8674(01)00325-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371341	Bronze			2022-12-01	WOS:000168840700004
J	Surrey, T; Nedelec, F; Leibler, S; Karsenti, E				Surrey, T; Nedelec, F; Leibler, S; Karsenti, E			Physical properties determining self-organization of motors and microtubules	SCIENCE			English	Article							KINESIN; PROTEIN; NCD; LOCALIZATION	In eukaryotic cells, microtubules and their associated motor proteins can be organized into various Large-scale patterns. Using a simplified experimental system combined with computer simulations, we examined how the concentrations and kinetic parameters of the motors contribute to their collective behavior. We observed self-organization of generic steady-state structures such as asters, vortices, and a network of interconnected poles. We identified parameter combinations that determine the generation of each of these structures. In general, this approach may become useful for correlating the morphogenetic phenomena taking place in a biological system with the biophysical characteristics of its constituents.	European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Karsenti, E (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany.	karsenti@embl-heidelberg.de	Surrey, Thomas/AAC-4608-2021; Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019	Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Surrey, Thomas/0000-0001-9082-1870				BARTON NR, 1995, MOL BIOL CELL, V6, P1563, DOI 10.1091/mbc.6.11.1563; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; deCastro MJ, 1999, BIOCHEMISTRY-US, V38, P5076, DOI 10.1021/bi9829175; FRAENKELCONRAT H, 1955, P NATL ACAD SCI USA, V41, P690, DOI 10.1073/pnas.41.10.690; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hyman AA, 1996, CELL, V84, P401, DOI 10.1016/S0092-8674(00)81285-4; INOUE S, 1982, 40 S SOC DEV BIOL, P30; MITCHISON TJ, 1992, PHILOS T ROY SOC B, V336, P99, DOI 10.1098/rstb.1992.0049; Nedelec F, 2001, METH MOL B, V164, P213; Nedelec F, 2001, PHYS REV LETT, V86, P3192, DOI 10.1103/PhysRevLett.86.3192; NEDELEC F, 1998, THESIS U PARIS 11 OR; NEDELEC F, UNPUB; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; PRIGOGINE I, 1967, J CHEM PHYS, V46, P3542, DOI 10.1063/1.1841255; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Sleigh M. A., 1973, BIOL PROTOZOA; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; Surrey T, 1998, P NATL ACAD SCI USA, V95, P4293, DOI 10.1073/pnas.95.8.4293; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3	25	419	429	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1167	1171		10.1126/science.1059758	http://dx.doi.org/10.1126/science.1059758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349149				2022-12-01	WOS:000168609200061
J	Ideker, T; Thorsson, V; Ranish, JA; Christmas, R; Buhler, J; Eng, JK; Bumgarner, R; Goodlett, DR; Aebersold, R; Hood, L				Ideker, T; Thorsson, V; Ranish, JA; Christmas, R; Buhler, J; Eng, JK; Bumgarner, R; Goodlett, DR; Aebersold, R; Hood, L			Integrated genomic and proteomic analyses of a systematically perturbed metabolic network	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; YEAST; OVEREXPRESSION; TRANSCRIPTION; MECHANISMS; PATTERNS; SYSTEM	We demonstrate an integrated approach to build, test, and refine a model of a cellular pathway, in which perturbations to critical pathway components are analyzed using DNA microarrays, quantitative proteomics, and databases of known physical interactions. Using this approach, we identify 997 messenger RNAs responding to 20 systematic perturbations of the yeast galactose-utilization pathway, provide evidence that approximately 15 of 289 detected proteins are regulated posttranscriptionally, and identify explicit physical interactions governing the cellular response to each perturbation. We refine the model through further iterations of perturbation and global measurements, suggesting hypotheses about the regulation of galactose utilization and physical interactions between this and a variety of other metabolic pathways.	Inst Syst Biol, Seattle, WA 98105 USA; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Univ Washington, Dept Comp Sci, Seattle, WA 98195 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ideker, T (corresponding author), Inst Syst Biol, 4225 Roosevelt Way NE,Suite 200, Seattle, WA 98105 USA.		Bumgarner, Roger E/K-3531-2015; Bumgarner, Roger/AAA-6846-2020; Eng, Jimmy K/I-4202-2012	Bumgarner, Roger E/0000-0002-8168-6985; Eng, Jimmy K/0000-0001-6352-6737; Ideker, Trey/0000-0002-1708-8454				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; DOUGLAS HC, 1964, GENETICS, V49, P837; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fu LW, 2000, J BIOL CHEM, V275, P5431, DOI 10.1074/jbc.275.8.5431; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; JOHNSTON M, 1994, MOL CELL BIOL, V14, P3834, DOI 10.1128/MCB.14.6.3834; Lai K, 2000, BIOCHEM BIOPH RES CO, V271, P392, DOI 10.1006/bbrc.2000.2629; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Mehlhorn K., 1999, LEDA PLATFORM COMBIN; Peng G, 2000, MOL CELL BIOL, V20, P5140, DOI 10.1128/MCB.20.14.5140-5148.2000; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reece RJ, 2000, CELL MOL LIFE SCI, V57, P1161, DOI 10.1007/PL00000756; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Rudoni S, 2000, INT J BIOCHEM CELL B, V32, P215, DOI 10.1016/S1357-2725(99)00121-1; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zheng WJ, 1997, J BIOL CHEM, V272, P30350, DOI 10.1074/jbc.272.48.30350; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	29	1463	1548	5	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					929	934		10.1126/science.292.5518.929	http://dx.doi.org/10.1126/science.292.5518.929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340206				2022-12-01	WOS:000168514900044
J	Shi, SH; Hayashi, Y; Esteban, JA; Malinow, R				Shi, SH; Hayashi, Y; Esteban, JA; Malinow, R			Subunit-specific rules governing AMPA receptor trafficking to synapses in hippocampal pyramidal neurons	CELL			English	Article							LONG-TERM DEPRESSION; DOMAIN-CONTAINING PROTEIN; SILENT SYNAPSES; SYNAPTIC PLASTICITY; POSTSYNAPTIC EXPRESSION; GLUTAMATE RECEPTORS; LTP; POTENTIATION; BINDING; PHOSPHORYLATION	AMPA-type glutamate receptors (AMPA-Rs) mediate a majority of excitatory synaptic transmission in the brain. In hippocampus, most AMPA-Rs are heterooligomers composed of GluR1/GluR2 or GluR2/GluR3 subunits. Here we show that these AMPA-R forms display different synaptic delivery mechanisms. GluR1/ GluR2 receptors are added to synapses during plasticity; this requires interactions between GluR1 and group I PDZ domain proteins. In contrast, GluR2/GluR3 receptors replace existing synaptic receptors continuously; this occurs only at synapses that already have AMPA-Rs and requires interactions by GluR2 with NSF and group I! PDZ domain proteins. The combination of regulated addition and continuous replacement of synaptic receptors can stabilize long-term changes in synaptic efficacy and may serve as a general model for how surface receptor number is established and maintained.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; MIT, Dept Brain & Cognit Sci, Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA	Cold Spring Harbor Laboratory; Massachusetts Institute of Technology (MIT); RIKEN	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org	Hayashi, Yasunori/AAF-1408-2019; Hayashi, Yasunori/C-2249-2008; Esteban, Jose/L-4944-2014	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Esteban, Jose/0000-0002-3759-3300				Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear MF, 1999, P NATL ACAD SCI USA, V96, P9457, DOI 10.1073/pnas.96.17.9457; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Cline HT, 1996, COLD SPRING HARB SYM, V61, P95; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DINGLEDINE R, 1992, J NEUROSCI, V12, P4080; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hayashi Y, 1997, MOL BRAIN RES, V46, P338, DOI 10.1016/S0169-328X(97)00073-9; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hirai H, 2001, NEUROSCI RES, V39, P261, DOI 10.1016/S0168-0102(00)00237-6; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Inagaki H, 1999, BIOCHEM BIOPH RES CO, V265, P462, DOI 10.1006/bbrc.1999.1723; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KOHLER M, 1994, J BIOL CHEM, V269, P17367; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Liao DZ, 1996, LEARN MEMORY, V3, P138, DOI 10.1101/lm.3.2-3.138; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.neuro.18.1.319; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 1999, INTRO GREEN FLUORESC; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Racca C, 2000, J NEUROSCI, V20, P2512; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Rumpel S, 1998, J NEUROSCI, V18, P8863; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Sudo M, 1999, MOL BRAIN RES, V65, P176, DOI 10.1016/S0169-328X(98)00348-9; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Ziff EB, 1999, ANN NY ACAD SCI, V868, P465, DOI 10.1111/j.1749-6632.1999.tb11315.x	77	814	843	2	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					331	343		10.1016/S0092-8674(01)00321-X	http://dx.doi.org/10.1016/S0092-8674(01)00321-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348590	Bronze			2022-12-01	WOS:000168515900003
J	Yoshida, N; Oeda, K; Watanabe, E; Mikami, T; Fukita, Y; Nishimura, K; Komai, K; Matsuda, K				Yoshida, N; Oeda, K; Watanabe, E; Mikami, T; Fukita, Y; Nishimura, K; Komai, K; Matsuda, K			Protein function - Chaperonin turned insect toxin	NATURE			English	Article							CRYSTAL-STRUCTURE; GROEL		Kinki Univ, Fac Agr, Dept Agr Chem, Nara 6318505, Japan; Sumitomo Chem Co Ltd, Agr Chem Res Lab, Takarazuka, Hyogo 6658555, Japan; Sumitomo Chem Co Ltd, Organ Synth Res Lab, Takarazuka, Hyogo 6658555, Japan; Sumitomo Pharmaceut Co Ltd, Genom Sci Labs, Takarazuka, Hyogo 6658555, Japan; Univ Osaka Prefecture, Adv Sci & Technol Res Inst, Osaka 5998570, Japan	Kindai University (Kinki University); Sumitomo Chem Co Ltd; Sumitomo Chem Co Ltd; Japan Advanced Institute of Science & Technology (JAIST); Osaka Metropolitan University	Yoshida, N (corresponding author), Kinki Univ, Fac Agr, Dept Agr Chem, 3327-204 Nakamachi, Nara 6318505, Japan.							Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Matsura T., 1986, Ecological Research, V1, P15, DOI 10.1007/BF02361201; RANFORD JC, 2000, EXP REV MOL MED; Ranson NA, 1998, BIOCHEM J, V333, P233, DOI 10.1042/bj3330233; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505	9	87	91	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					44	44		10.1038/35075148	http://dx.doi.org/10.1038/35075148			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333970				2022-12-01	WOS:000168432800036
J	Vastag, B				Vastag, B			Mixed message on prescription drug abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2183	2184		10.1001/jama.285.17.2183	http://dx.doi.org/10.1001/jama.285.17.2183			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325305				2022-12-01	WOS:000168256100003
J	Fernandez, JM; Chu, S; Oberhauser, AF				Fernandez, JM; Chu, S; Oberhauser, AF			RNA structure - Pulling on hair(pins)	SCIENCE			English	Editorial Material							PROTEIN; HAIRPIN		Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, Rochester, MN 55905 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Mayo Clinic; Stanford University	Fernandez, JM (corresponding author), Mayo Clin & Mayo Fdn, Dept Physiol & Biophys, 200 1st St SW, Rochester, MN 55905 USA.							BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CHEONG CJ, 1990, NATURE, V346, P680, DOI 10.1038/346680a0; Kortemme T, 1998, SCIENCE, V281, P253, DOI 10.1126/science.281.5374.253; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Rief M, 1999, NAT STRUCT BIOL, V6, P346; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0	9	21	25	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					653	654		10.1126/science.1060884	http://dx.doi.org/10.1126/science.1060884			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11330326				2022-12-01	WOS:000168478300033
J	Espinal, MA; Laszlo, A; Simonsen, L; Boulahbal, F; Kim, SJ; Reniero, A; Hoffner, S; Rieder, HL; Binkin, N; Dye, C; Williams, R; Raviglione, MC				Espinal, MA; Laszlo, A; Simonsen, L; Boulahbal, F; Kim, SJ; Reniero, A; Hoffner, S; Rieder, HL; Binkin, N; Dye, C; Williams, R; Raviglione, MC		World Hlth Org	Global trends in resistance to antituberculosis drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SHORT-COURSE CHEMOTHERAPY; MYCOBACTERIUM-TUBERCULOSIS; DOTS; PREVALENCE; PROGRAM	Background: Data on global trends in resistance to antituberculosis drugs are lacking. Methods: We expanded the survey conducted by the World Health Organization and the International Union against Tuberculosis and Lung Disease to assess trends in resistance to antituberculosis drugs in countries on six continents. We obtained data using standard protocols from ongoing surveillance or from surveys of representative samples of all patients with tuberculosis. The standard sampling techniques distinguished between new and previously treated patients, and laboratory performance was checked by means of an international program of quality assurance. Results: Between 1996 and 1999, patients in 58 geographic sites were surveyed; 28 sites provided data for at least two years. For patients with newly diagnosed tuberculosis, the frequency of resistance to at least one antituberculosis drug ranged from 1.7 percent in Uruguay to 36.9 percent in Estonia (median, 10.7 percent). The prevalence increased in Estonia, from 28.2 percent in 1994 to 36.9 percent in 1998 (P=0.01), and in Denmark, from 9.9 percent in 1995 to 13.1 percent in 1998 (P=0.04). The median prevalence of multidrug resistance among new cases of tuberculosis was only 1.0 percent, but the prevalence was much higher in Estonia (14.1 percent), Henan Province in China (10.8 percent), Latvia (9.0 percent), the Russian oblasts of Ivanovo (9.0 percent) and Tomsk (6.5 percent), Iran (5.0 percent), and Zhejiang Province in China (4.5 percent). There were significant decreases in multidrug resistance in France and the United States. In Estonia, the prevalence in all cases increased from 11.7 percent in 1994 to 18.1 percent in 1998 (P<0.001). Conclusions: Multidrug-resistant tuberculosis continues to be a serious problem, particularly among some countries of eastern Europe. Our survey also identified areas with a high prevalence of multidrug-resistant tuberculosis in such countries as China and Iran. (N Engl J Med 2001;344:1294-303.) Copyright (C) 2001 Massachusetts Medical Society.	WHO, CH-1211 Geneva, Switzerland; Int Union Against TB & Lung Dis, Paris, France; Lab Ctr Dis Control, Ottawa, ON K1A 0L2, Canada; Inst Pasteur, Algiers, Algeria; Korean Inst TB, Seoul, South Korea; Inst Panamer Protecc Alimentos & Zoonosis, Buenos Aires, DF, Argentina; Swedish Inst Infect Dis Control, Stockholm, Sweden; Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA	World Health Organization; Swedish Institute for Infectious Disease Control; Centers for Disease Control & Prevention - USA	Espinal, MA (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva, Switzerland.	espinalm@who.int	Simonsen, Lone/K-4531-2014; ROBERT, Jérôme/C-3993-2011; Dye, Christopher/AIC-4659-2022	Simonsen, Lone/0000-0003-1535-8526; ROBERT, Jérôme/0000-0002-9380-0570; RAVIGLIONE, Mario/0000-0002-9331-2067; Dye, Christopher/0000-0002-2957-1793				ALLAN WGL, 1977, AM REV RESPIR DIS, V115, P727; [Anonymous], 1985, Am Rev Respir Dis, V131, P727; Bloch AB, 1999, INT J TUBERC LUNG D, V3, P273; BORCHARDT J, 1995, EUR RESPIR J, V8, P1076, DOI 10.1183/09031936.95.08071076; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Chaisson RE, 1999, INT J TUBERC LUNG D, V3, P1; Chan-Tack KM, 1998, NEW ENGL J MED, V339, P1079, DOI 10.1056/NEJM199810083391511; DAWSON DJ, 1995, MED J AUSTRALIA, V162, P287, DOI 10.5694/j.1326-5377.1995.tb139901.x; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; FARGA V, 1991, REV CHIL ENF RESP, V7, P94; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Hong YP, 1998, INT J TUBERC LUNG D, V2, P365; Kenyon TA, 1999, INT J TUBERC LUNG D, V3, P4; Laszlo A, 1997, INT J TUBERC LUNG D, V1, P231; MAHMOUDI A, 1993, JAMA-J AM MED ASSOC, V270, P65, DOI 10.1001/jama.270.1.65; Marrero A, 2000, THORAX, V55, P39, DOI 10.1136/thorax.55.1.39; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Netto EM, 1999, INT J TUBERC LUNG D, V3, P310; PablosMendez A, 1998, NEW ENGL J MED, V339, P139; Raviglione M C, 1997, AIDS, V11 Suppl B, pS115; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; Thomsen VO, 2000, EUR RESPIR J, V16, P203, DOI 10.1183/09031936.00.16220300; Trebucq A, 1999, INT J TUBERC LUNG D, V3, P466; *UN, 1999, WORLD POP PROSP 1998; WHO, 1998, INT J TUBERC LUNG D, V2, P71; *WHO, 1999, WHOCDSCPCTB99259 GLO; *WHO, 1997, WHOTB97225 GLOB TUB; *WHO, 1998, WHOTB98237 GLOB TUB; *WHO, 2000, WHOCDSTB2000275; *WHO IUATLD GLOB P, 1997, WHOTB97229 IUATLD GL; World Bank, 1993, WORLD DEV REP 1993 I, V1; World Health Organization, 1994, WHOTB94179	36	527	553	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2001	344	17					1294	1303		10.1056/NEJM200104263441706	http://dx.doi.org/10.1056/NEJM200104263441706			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424UM	11320389				2022-12-01	WOS:000168252400006
J	Hayashi, F; Smith, KD; Ozinsky, A; Hawn, TR; Yi, EC; Goodlett, DR; Eng, JK; Akira, S; Underhill, DM; Aderem, A				Hayashi, F; Smith, KD; Ozinsky, A; Hawn, TR; Yi, EC; Goodlett, DR; Eng, JK; Akira, S; Underhill, DM; Aderem, A			The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5	NATURE			English	Article							SALMONELLA-TYPHI FLAGELLA; EXPRESSION; PROTEIN; MECHANISMS; INDUCTION; FAMILY; RECOGNITION; ACTIVATION; CLONING; GENES	The innate immune system recognizes pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, but not on the host. Toll-like receptors (TLRs) recognize PAMPs and mediate the production of cytokines necessary for the development of effective immunity(1-4). Flagellin, a principal component of bacterial flagella, is a virulence factor that is recognized by the innate immune system in organisms as diverse as flies, plants and mammals(5-11). Here we report that mammalian TLR5 recognizes bacterial flagellin from both Gram-positive and Gram-negative bacteria, and that activation of the receptor mobilizes the nuclear factor NF-kappaB and stimulates tumour necrosis factor-alpha production. TLR5-stimulating activity was purified from Listeria monocytogenes culture supernatants and identified as flagellin by tandem mass spectrometry. Expression of L. monocytogenes flagellin in non-flagellated Escherichia coli conferred on the bacterium the ability to activate TLR5, whereas deletion of the flagellin genes from Salmonella typhimurium abrogated TLR5-stimulating activity. All known TLRs signal through the adaptor protein MyD88. Mice challenged with bacterial flagellin rapidly produced systemic interleukin-6, whereas MyD88-null mice did not respond to flagellin. Our data suggest that TLR5, a member of the evolutionarily conserved Toll-like receptor family, has evolved to permit mammals specifically to detect flagellated bacterial pathogens.	Inst Syst Biol, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Osaka University	Aderem, A (corresponding author), Inst Syst Biol, 4225 Roosevelt Way NE,Suite 200, Seattle, WA 98195 USA.	aderem@systemsbiology.org	Akira, Shizuo/C-3134-2009; UNDERHILL, DAVID/ABE-2185-2021; Eng, Jimmy K/I-4202-2012	Eng, Jimmy K/0000-0001-6352-6737; Underhill, David/0000-0002-2989-658X				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Brightbill HD, 2000, IMMUNOLOGY, V101, P1, DOI 10.1046/j.1365-2567.2000.00093.x; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Chaudhary PM, 1998, BLOOD, V91, P4020, DOI 10.1182/blood.V91.11.4020.411a44_4020_4027; Ciacci-Wooline F, 1999, INFECT IMMUN, V67, P5176, DOI 10.1128/IAI.67.10.5176-5185.1999; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FUJITA H, 1973, J GEN MICROBIOL, V76, P127, DOI 10.1099/00221287-76-1-127; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Goodlett DR, 2000, ANAL CHEM, V72, P1112, DOI 10.1021/ac9913210; IBRAHIM GF, 1985, J CLIN MICROBIOL, V22, P1040, DOI 10.1128/JCM.22.6.1040-1044.1985; Luna MD, 2000, RES MICROBIOL, V151, P575, DOI 10.1016/S0923-2508(00)00227-8; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MimoriKiyosue Y, 1997, J MOL BIOL, V270, P222, DOI 10.1006/jmbi.1997.1111; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; PEEL M, 1988, J GEN MICROBIOL, V134, P2171; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SAMAKOVLIS C, 1992, BIOCHEM BIOPH RES CO, V188, P1169, DOI 10.1016/0006-291X(92)91354-S; Sebastiani G, 2000, GENOMICS, V64, P230, DOI 10.1006/geno.2000.6115; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Stocker B A, 1994, Int Rev Immunol, V11, P167, DOI 10.3109/08830189409061724; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wyant TL, 1999, INFECT IMMUN, V67, P3619, DOI 10.1128/IAI.67.7.3619-3624.1999; Wyant TL, 1999, INFECT IMMUN, V67, P1338, DOI 10.1128/IAI.67.3.1338-1346.1999	30	2630	2827	3	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1099	1103		10.1038/35074106	http://dx.doi.org/10.1038/35074106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323673				2022-12-01	WOS:000168285500049
J	Lin, WC; Burgess, RW; Dominguez, B; Pfaff, SL; Sanes, JR; Lee, KF				Lin, WC; Burgess, RW; Dominguez, B; Pfaff, SL; Sanes, JR; Lee, KF			Distinct roles of nerve and muscle in postsynaptic differentiation of the neuromuscular synapse	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR CLUSTERS; TYROSINE KINASES; TRANSGENIC MICE; ALPHA-SUBUNIT; GROWTH CONES; MUTANT MICE; CRD DOMAIN; AGRIN GENE; JUNCTION; SYNAPTOGENESIS	The development of chemical synapses is regulated by interactions between pre- and postsynaptic cells. At the vertebrate skeletal neuromuscular junction, the organization of an acetylcholine receptor (AChR)-rich postsynaptic apparatus has been well studied. Much evidence suggests that the nerve-derived protein agrin activates muscle-specific kinase (MuSK) to cluster AChRs through the synapse-specific cytoplasmic protein rapsyn. But how postsynaptic differentiation is initiated, or why most synapses are restricted to an 'end-plate band' in the middle of the muscle remains unknown. Here we have used genetic methods to address these issues. We report that the initial steps in postsynaptic differentiation and formation of an end-plate band require MuSK and rapsyn, but are not dependent on agrin or the presence of motor axons. In contrast, the subsequent stages of synaptic growth and maintenance require nerve-derived agrin, and a second nerve-derived signal that disperses ectopic postsynaptic apparatus.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Salk Institute; Washington University (WUSTL)	Lee, KF (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	klee@salk.edu	Tuluc, Petronel/C-2527-2011	Burgess, Robert/0000-0002-9229-3407				ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BENNETT MR, 1975, COLD SPRING HARB SYM, V40, P409, DOI 10.1101/SQB.1976.040.01.039; BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; BRAITHWAITE AW, 1979, NATURE, V279, P549, DOI 10.1038/279549a0; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; DAHM LM, 1991, J NEUROSCI, V11, P238; DAVEY DF, 1986, J NEUROSCI, V6, P673; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; FALLON JR, 1989, J CELL BIOL, V108, P1527, DOI 10.1083/jcb.108.4.1527; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; GODFREY EW, 1988, DEV BIOL, V130, P471, DOI 10.1016/0012-1606(88)90343-0; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; Halfter W, 1997, J COMP NEUROL, V383, P1; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HARRIS A J, 1981, Philosophical Transactions of the Royal Society of London B Biological Sciences, V293, P287, DOI 10.1098/rstb.1981.0078; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; HUME RI, 1983, NATURE, V305, P632, DOI 10.1038/305632a0; KLARSFELD A, 1991, EMBO J, V10, P625, DOI 10.1002/j.1460-2075.1991.tb07990.x; KUES WA, 1995, J CELL BIOL, V130, P949, DOI 10.1083/jcb.130.4.949; KUROMI H, 1984, DEV BIOL, V103, P53, DOI 10.1016/0012-1606(84)90006-X; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; LUPA MT, 1989, J NEUROSCI, V9, P3937; Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5; MCMAHAN UJ, 1990, COLD SH Q B, V55, P407; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	43	424	440	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1057	1064		10.1038/35074025	http://dx.doi.org/10.1038/35074025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323662				2022-12-01	WOS:000168285500038
J	Warkentin, TE; Kelton, JG				Warkentin, TE; Kelton, JG			Temporal aspects of heparin-induced thrombocytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DRUG PURPURA; ANTIBODIES; PLATELETS; QUINIDINE; EXPLANATION; QUININE; COMPLEX; SERA	Background: Heparin-induced thrombocytopenia is a relatively common antibody-mediated drug reaction. We studied the temporal relation between previous or current heparin therapy and the onset of heparin-induced thrombocytopenia. Methods: We examined the time between the start of heparin therapy and the onset of thrombocytopenia in 243 patients with serologically confirmed heparin-induced thrombocytopenia. We also investigated the persistence of circulating heparin-dependent antibodies by performing a platelet serotonin-release assay and an assay for antibodies against platelet factor 4. The outcome in seven patients who had previously had an episode of heparin-induced thrombocytopenia and were later treated again with heparin was also examined. Results: A fall in the platelet count beginning four or more days after the start of heparin therapy occurred in 170 of the 243 patients (70 percent); in these patients, a history of previous heparin treatment did not influence the timing of the onset of thrombocytopenia. In the remaining 73 patients (30 percent), the onset of thrombocytopenia was rapid (median time of onset, 10.5 hours after the start of heparin administration); all these patients had been treated with heparin within the previous 100 days. During recovery from thrombocytopenia, heparin-dependent antibodies in the serum fell to undetectable levels at a median of 50 to 85 days, depending on the assay performed. In the seven patients who were given heparin again after the disappearance of heparin-dependent antibodies, a new episode of heparin-induced thrombocytopenia did not occur. Conclusions: Heparin-induced thrombocytopenia can begin rapidly in patients who have received heparin within the previous 100 days. Heparin-dependent antibodies do not invariably reappear with subsequent heparin use. (N Engl J Med 2001;344:1286-92.) Copyright (C) 2001 Massachusetts Medical Society.	Hamilton Hlth Sci Corp, Hamilton Reg Lab Med Program, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON, Canada; McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Warkentin, TE (corresponding author), Hamilton Hlth Sci Corp, Hamilton Reg Lab Med Program, Gen Site,237 Barton St E, Hamilton, ON L8L 2X2, Canada.							Amiral J, 1999, SEMIN HEMATOL, V36, P7; AMIRAL J, 1992, THROMB HAEMOSTASIS, V68, P95; Arepally G, 1997, BLOOD, V89, P370, DOI 10.1182/blood.V89.2.370; BABCOCK RB, 1976, NEW ENGL J MED, V295, P237, DOI 10.1056/NEJM197607292950501; BOLTON FG, 1953, J CLIN PATHOL, V6, P320, DOI 10.1136/jcp.6.4.320; CHONG BH, 1994, BLOOD, V83, P1535; CINES DB, 1980, NEW ENGL J MED, V303, P788, DOI 10.1056/NEJM198010023031404; COLLETT D, 1994, MODELLING SURVIVAL D, P15; Denomme GA, 1997, J LAB CLIN MED, V130, P278, DOI 10.1016/S0022-2143(97)90022-6; GREINACHER A, 1994, THROMB HAEMOSTASIS, V71, P247; KELTON JG, 1988, BLOOD, V72, P925; KELTON JG, 1994, BLOOD, V83, P3232; KING DJ, 1984, ANN INTERN MED, V100, P535, DOI 10.7326/0003-4819-100-4-535; LASTER J, 1989, J VASC SURG, V9, P677, DOI 10.1067/mva.1989.vs0090677; MOLLISON PL, 1997, BLOOD TRANSFUSION CL, P60; Newman PM, 2000, BLOOD, V96, P182, DOI 10.1182/blood.V96.1.182.013k18_182_187; PAGANO M, 1993, PRINCIPLES BIOSTATIS, P273; Potzsch B, 2000, NEW ENGL J MED, V343, P515, DOI 10.1056/NEJM200008173430718; POWELL SE, 1988, J BONE JOINT SURG AM, V70A, P1097, DOI 10.2106/00004623-198870070-00022; REID DM, 1988, ANN INTERN MED, V108, P206, DOI 10.7326/0003-4819-108-2-206; RHODES GR, 1973, SURG GYNECOL OBSTET, V136, P409; SHERIDAN D, 1986, BLOOD, V67, P27; SHULMAN NR, 1958, J EXP MED, V107, P711, DOI 10.1084/jem.107.5.711; SILVER D, 1983, ANN SURG, V198, P301, DOI 10.1097/00000658-198309000-00006; VANDERWEERDT CM, 1967, VOX SANG, V12, P265; VISENTIN GP, 1994, J CLIN INVEST, V93, P81, DOI 10.1172/JCI116987; Warkentin T, 2000, FUND CL CAR, P43; Warkentin TE, 2000, BLOOD, V96, P1703, DOI 10.1182/blood.V96.5.1703.h8001703_1703_1708; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; WARKENTIN TE, 1992, J LAB CLIN MED, V120, P371; WARKENTIN TE, 2000, FUND CL CAR, V39, P211; WEISMANN RE, 1958, ARCH SURG-CHICAGO, V76, P219	33	628	647	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 26	2001	344	17					1286	1292		10.1056/NEJM200104263441704	http://dx.doi.org/10.1056/NEJM200104263441704			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424UM	11320387				2022-12-01	WOS:000168252400004
J	Pascual-Leone, A; Walsh, V				Pascual-Leone, A; Walsh, V			Fast backprojections from the motion to the primary visual area necessary for visual awareness	SCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE NEUROSCIENCE; CORTEX V1; BRAIN; DISCRIMINATION; PHOSPHENES; MACAQUE; SYSTEM; PERCEPTION; VISION	Much is known about the pathways from photoreceptors to higher visual areas in the brain. However, how we become aware of what we see or of having seen at all is a problem that has eluded neuroscience. Recordings from macaque V1 during deactivation of MT+/V5 and psychophysical studies of perceptual integration suggest that feedback from secondary visual areas to V1 is necessary for visual awareness. We used transcranial magnetic stimulation to probe the timing and function of feedback from human area MT+/V5 to V1 and found its action to be early and critical for awareness of visual motion.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Magnet Brain Stimulat, Boston, MA 02115 USA; Univ Oxford, Oxford OX1 3UD, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Oxford	Pascual-Leone, A (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Magnet Brain Stimulat, 330 Brookline Ave,Kirstein Hall KS454, Boston, MA 02115 USA.	apleone@caregroup.harvard.edu	Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011	Pascual-Leone, Alvaro/0000-0001-8975-0382; 	NATIONAL EYE INSTITUTE [R01EY012873] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY12873] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amassian VE, 1998, J CLIN NEUROPHYSIOL, V15, P288, DOI 10.1097/00004691-199807000-00002; BABUR JL, 1993, BRAIN, V116, P1293; Boroojerdi B, 2000, CEREB CORTEX, V10, P529, DOI 10.1093/cercor/10.5.529; Cowey A, 2000, NEUROREPORT, V11, P3269, DOI 10.1097/00001756-200009280-00044; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Edelman G.M., 1992, BRIGHT AIR BRILLIANT; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; HELLER J, 1995, J COMPUT NEUROSCI, V2, P175, DOI 10.1007/BF00961433; HOTSON J, 1994, VISION RES, V34, P2115, DOI 10.1016/0042-6989(94)90321-2; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; HUPE JM, 2000, J NEUROPHYSIOL; Kamitani Y, 1999, NAT NEUROSCI, V2, P767, DOI 10.1038/11245; Kammer T, 1999, NEUROPSYCHOLOGIA, V37, P191; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; MARG E, 1994, OPTOMETRY VISION SCI, V71, P301, DOI 10.1097/00006324-199405000-00001; MERIGAN WH, 1991, J NEUROSCI, V11, P994; Nowak LG, 1997, CEREBR CORT, V12, P205; NOWAK LG, 1995, VISUAL NEUROSCI, V12, P371, DOI 10.1017/S095252380000804X; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; POLLEN DA, 1995, NATURE, V377, P293, DOI 10.1038/377293b0; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; Siebner HR, 1998, NEUROREPORT, V9, P943, DOI 10.1097/00001756-199803300-00033; Stewart L, 1999, EEG CL N SU, P334; Stoerig P, 1995, BEHAV BRAIN RES, V71, P147, DOI 10.1016/0166-4328(95)00050-X; Vaina LM, 1996, P ROY SOC B-BIOL SCI, V263, P1225, DOI 10.1098/rspb.1996.0180; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; WEISKRANTZ L, 1995, P NATL ACAD SCI USA, V92, P6122, DOI 10.1073/pnas.92.13.6122; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25	36	569	575	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					510	512		10.1126/science.1057099	http://dx.doi.org/10.1126/science.1057099			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313497				2022-12-01	WOS:000168187300049
J	Walraven, G; Scherf, C; West, B; Ekpo, G; Paine, K; Coleman, R; Bailey, R; Morison, L				Walraven, G; Scherf, C; West, B; Ekpo, G; Paine, K; Coleman, R; Bailey, R; Morison, L			The burden of reproductive-organ disease in rural women in The Gambia, West Africa	LANCET			English	Article							TRADITIONAL BIRTH ATTENDANTS; SIMPLEX-VIRUS TYPE-2; INFERTILITY; PREVALENCE; MORTALITY; INFECTION; PREGNANCY; MORBIDITY; COMMUNITY; BEHAVIOR	Background Data on the epidemiology of reproductive-organ morbidity are needed to guide effective interventions, to set health-care priorities, and to target future research. This study aimed to find out the prevalence of reproductive-organ disease in a sample of rural Gambian women. Methods A questionnaire on reproductive health was administered by fieldworkers to women aged 15-54 years living in a rural area under demographic surveillance. A female gynaecologist questioned and examined the women (including speculum and bimanual pelvic examinations). Vaginal swabs were taken to test for Trichomonas vaginalis, Candida albicans, and bacterial vaginosis, cervical smears for cytology, cervical swabs for Chlamydia trachomatis PCR and Neisseria gonorrhoeae culture, and venous blood for haemoglobin, HIV, herpes simplex virus 2, and syphilis serology, Findings 1348 (72.0%) of 1871 eligible women took part. Reproductive-organ symptoms were more likely to be reported to the gynaecologist (52.7% of women) than to the fieldworker (26.5%). Menstrual problems, abnormal vaginal discharge, and vaginal itching were the most commonly reported symptoms. A minority of women said they had sought health care for their symptoms. The frequencies of reproductive-organ morbidity were high: menstrual dysfunction 34.1% (95% CI 29.6-39.1), infertility 9.8% (8.2-11.6), reproductive-tract infections 47.3% (43.7-51.0), pelvic tenderness 9.8% ((7.0-13.5), cervical dysplasia 6.7% (5.2-8.4), masses 15.9% (12.5-20.1), and childbirth-related damage to pelvic structures 46.1% (40.1-52.3). 948 (70.3%) women had at least one reproductive-organ disorder. Interpretation For these rural women, whose lives depend heavily on their reproductive function, reproductive-organ disease is a large burden. In inadequately resourced rural areas, with poor education,;heavy agricultural and domestic labour, and limited access to quality health care, many women are not able to attain and maintain reproductive health and wellbeing.	MRC Labs, Farafenni Field Stn, Banjul, Gambia; Cardiff Univ, Dept Obstet & Gynaecol, Cardiff CF4 4XN, S Glam, Wales; London Sch Hyg & Trop Med, London WC1, England	MRC Laboratory Molecular Biology; Cardiff University; University of London; London School of Hygiene & Tropical Medicine	Walraven, G (corresponding author), MRC Labs, Farafenni Field Stn, POB 273, Banjul, Gambia.	gwalraven@mrc.gm	Morison, Linda A/H-9738-2013; Swaibu, Ramadhani A/H-3164-2011					BAILEY RL, 1994, J INFECT DIS, V170, P709, DOI 10.1093/infdis/170.3.709; BANG RA, 1989, LANCET, V1, P85; *BETH COMM, 1993, ACTA CYTOL, V37, P115; BLEDSOE CH, 1994, POPUL DEV REV, V20, P81, DOI 10.2307/2137631; BRABIN L, 1995, LANCET, V345, P300, DOI 10.1016/S0140-6736(95)90281-3; Bulut A, 1997, STUD FAMILY PLANN, V28, P35, DOI 10.2307/2137969; CATES W, 1985, LANCET, V2, P596; FATHALLA MF, 1988, RES NEEDS HUMAN REPR; Favot I, 1997, INT J EPIDEMIOL, V26, P414, DOI 10.1093/ije/26.2.414; Filippi V, 1997, TROP MED INT HEALTH, V2, P47, DOI 10.1046/j.1365-3156.1997.d01-126.x; GRAHAM WJ, 1995, ASKING QUESTIONS WOM; GREENWOOD AM, 1992, J INFECT DIS, V166, P842, DOI 10.1093/infdis/166.4.842; GREENWOOD BM, 1989, T ROY SOC TROP MED H, V83, P589, DOI 10.1016/0035-9203(89)90362-3; Harrison KA, 1997, LANCET, V349, P644, DOI 10.1016/S0140-6736(97)02192-2; Hawkes S, 1999, LANCET, V354, P1776, DOI 10.1016/S0140-6736(99)02463-0; HERRERO R, 1997, PAN AM J PUBLIC HLTH, V1, P362; Hill AG, 2000, TROP MED INT HEALTH, V5, P107, DOI 10.1046/j.1365-3156.2000.00528.x; INHORN MC, 1994, SOC SCI MED, V39, P459, DOI 10.1016/0277-9536(94)90089-2; Lancaster EJ, 1999, E AFR MED J, V76, P101; Marsden HS, 1998, J MED VIROL, V56, P79, DOI 10.1002/(SICI)1096-9071(199809)56:1&lt;79::AID-JMV13&gt;3.0.CO;2-R; MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Donovan D, 2000, AIDS, V14, P441, DOI 10.1097/00002030-200003100-00019; Obasi A, 1999, J INFECT DIS, V179, P16, DOI 10.1086/314555; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Ratcliffe AA, 2000, B WORLD HEALTH ORGAN, V78, P570; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; TSUI AO, 1997, REPROD HLTH DEV COUN, P178; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Walraven G, 2000, B WORLD HEALTH ORGAN, V78, P603; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; WOLFENDALE MR, 1987, BRIT MED J, V294, P33, DOI 10.1136/bmj.294.6563.33; YOUNIS N, 1993, STUD FAMILY PLANN, V24, P175, DOI 10.2307/2939232; ZURAYK H, 1995, STUD FAMILY PLANN, V26, P14, DOI 10.2307/2138047	34	90	90	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	2001	357	9263					1161	1167		10.1016/S0140-6736(00)04333-6	http://dx.doi.org/10.1016/S0140-6736(00)04333-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423RX	11323043				2022-12-01	WOS:000168192100010
J	Enquist, BJ; Niklas, KJ				Enquist, BJ; Niklas, KJ			Invariant scaling relations across tree-dominated communities	NATURE			English	Article							PLANT; DENSITY; SIZE; PRODUCTIVITY; ENERGETICS; DIVERSITY; DIMENSION; EVOLUTION; ECOLOGY; RATES	Organizing principles are needed to link organismal, community and ecosystem attributes across spatial and temporal scales. Here we extend allometric theory-how attributes of organisms change with variation in their size-and test its predictions against worldwide data sets for forest communities by quantifying the relationships among tree size-frequency distributions, standing biomass, species number and number of individuals per unit area. As predicted, except for the highest latitudes, the number of individuals scales as the -2 power of basal stem diameter or as the -3/4 power of above-ground biomass. Also as predicted, this scaling relationship varies little with species diversity, total standing biomass, latitude and geographic sampling area. A simulation model in which individuals allocate biomass to leaf, stem and reproduction, and compete for space and light obtains features identical to those of a community. In tandem with allometric theory, our results indicate that many macroecological features of communities may emerge from a few allometric principles operating at the level of the individual.	Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	University of Arizona; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Cornell University	Enquist, BJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	benquist@u.arizona.edu	Niklas, Karl/AAV-4760-2021; Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096				BARENBLATT GI, 1983, P NATL ACAD SCI-BIOL, V80, P3540, DOI 10.1073/pnas.80.11.3540; Brown J.H., 1995, MACROECOLOGY; Brown S, 1997, 134 FAO; Cannell MGR, 1982, WORLD FOREST BIOMASS; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DELIOCOURT F, 1998, B SOC FORESTIERE FRA; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Gentry AH, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P103; Gross KL, 2000, OIKOS, V89, P417, DOI 10.1034/j.1600-0706.2000.890301.x; Huston M A, 2000, Science, V289, P1255; Huston M.A., 1994, BIOL DIVERSITY; Jack SB, 1996, FOREST ECOL MANAG, V86, P205, DOI 10.1016/S0378-1127(96)03770-X; MAC ARTHUR ROBERT H., 1967; MORSE DR, 1985, NATURE, V314, P731, DOI 10.1038/314731a0; Niklas, 1994, PLANT ALLOMETRY; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; NIKLAS KJ, 1994, AM J BOT, V81, P134, DOI 10.2307/2445626; NIKLAS KJ, 1994, P NATL ACAD SCI USA, V91, P6772, DOI 10.1073/pnas.91.15.6772; Niklas KJ, 2000, ANN BOT-LONDON, V85, P411, DOI 10.1006/anbo.1999.1100; Niklas KJ., 1997, EVOLUTIONARY BIOL PL; OKUBO A, 1989, ECOLOGY, V70, P329, DOI 10.2307/1937537; OLSON JS, 1985, NDP017 CDIC ORNL; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 2000, P NATL ACAD SCI USA, V97, P13150, DOI 10.1073/pnas.97.24.13150; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman David, 1993, P13; Valentini R, 2000, NATURE, V404, P861, DOI 10.1038/35009084; Waring RH, 1998, TREE PHYSIOL, V18, P129; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; WHITE J, 1981, J THEOR BIOL, V89, P475, DOI 10.1016/0022-5193(81)90363-5; WHITTAKE.RH, 1968, J ECOL, V56, P1, DOI 10.2307/2258063; WHITTAKER R H, 1975, P385; Whittaker RJ, 1999, NATURE, V401, P865, DOI 10.1038/44732	40	427	474	5	138	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					655	660		10.1038/35070500	http://dx.doi.org/10.1038/35070500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287945				2022-12-01	WOS:000167875400037
J	Parker, AR; McPhedran, RC; McKenzie, DR; Botten, LC; Nicorovici, NAP				Parker, AR; McPhedran, RC; McKenzie, DR; Botten, LC; Nicorovici, NAP			Photonic engineering - Aphrodite's iridescence	NATURE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; Univ Technol Sydney, Sch Math Sci, Sydney, NSW 2007, Australia	University of Oxford; University of Sydney; University of Technology Sydney	Parker, AR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Botten, Lindsay/R-6678-2019; McPhedran, Ross/ABE-8263-2020; Botten, Lindsay C/G-3160-2017	Botten, Lindsay/0000-0001-6471-6954; Botten, Lindsay C/0000-0001-6471-6954				ATKINS EDT, 1979, INT J BIOL MACROMOL, V1, P29, DOI 10.1016/0141-8130(79)90006-0; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; McPhedran RC, 1999, AUST J PHYS, V52, P791, DOI 10.1071/PH98110; Parker AR, 1995, P ROY SOC B-BIOL SCI, V262, P349, DOI 10.1098/rspb.1995.0216; Parker AR, 1999, FUNCTIONAL MORPHOLOG, P65; ROUSE G, 1998, INVERTEBRATE ZOOLOGY, P174; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794	8	208	216	4	117	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					36	37		10.1038/35051168	http://dx.doi.org/10.1038/35051168			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343102				2022-12-01	WOS:000166175600028
J	Agrawal, AF				Agrawal, AF			Sexual selection and the maintenance of sexual reproduction	NATURE			English	Article							DELETERIOUS MUTATIONS; EVOLUTION; LOAD; ADVANTAGE; DOMINANCE; BALANCE	The maintenance of sexual reproduction is a problem in evolutionary theory because, all else being equal, asexual populations have a twofold fitness advantage over their sexual counterparts(1,2) and should rapidly outnumber a sexual population because every individual has the potential to reproduce. The twofold cost of sex exists because of anisogamy or gamete dimorphism(2)-egg-producing females make a larger contribution to the zygote compared with the small contribution made by the sperm of males, but both males and females contribute 50% of the genes. Anisogamy also generates the conditions for sexual selection(3), a powerful evolutionary force that does not exist in asexual populations. The continued prevalence of sexual reproduction indicates that the 'all else being equal' assumption is incorrect. Here I show that sexual selection can mitigate or even eliminate the cost of sex. If sexual selection causes deleterious mutations to be more deleterious in males than females, then deleterious mutations are maintained at lower equilibrium frequency in sexual populations relative to asexual populations. The fitness of sexual females is higher than asexuals because there is no difference in the fecundity of sexual females and asexuals of the same genotype, but the equilibrium frequency of deleterious mutations is lower in sexual populations. The results are not altered by synergistic epistasis in males.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Agrawal, AF (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	aagrawal@bio.indiana.edu						Andersson Malte, 1994; ARNOLD SJ, 1984, EVOLUTION, V38, P720, DOI 10.1111/j.1558-5646.1984.tb00345.x; Bell G., 1982, MASTERPIECE NATURE E; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Chasnov JR, 2000, GENETICS, V156, P1419; CROW J. F., 1970, Biomathematics. Volume 1. Mathematical topics in population genetics., P128; Drickamer LC, 2000, ANIM BEHAV, V59, P371, DOI 10.1006/anbe.1999.1316; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Evans JP, 2000, P NATL ACAD SCI USA, V97, P10074, DOI 10.1073/pnas.180207297; Garcia-Dorado A, 2000, GENETICS, V155, P1991; HOWARD RS, 1994, NATURE, V367, P554, DOI 10.1038/367554a0; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; Keightley PD, 2000, SCIENCE, V290, P331, DOI 10.1126/science.290.5490.331; Keightley PD, 1999, GENETICS, V153, P515; KIMURA M, 1966, GENETICS, V54, P1337; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kodric-Brown A, 1987, EVOL ECOL, V1, P95, DOI 10.1007/BF02067393; KOESLAG JH, 1993, J HERED, V84, P396, DOI 10.1093/oxfordjournals.jhered.a111360; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; Lynch M., 1998, AM J HUM GENET; MANNING JT, 1984, J THEOR BIOL, V108, P215, DOI 10.1016/S0022-5193(84)80067-3; Maynard Smith J., 1978, EVOLUTION SEX, DOI DOI 10.1093/bioinformatics/btg412; MULCAHY DL, 1979, SCIENCE, V206, P20, DOI 10.1126/science.206.4414.20; Peck JR, 2000, NATURE, V406, P399, DOI 10.1038/35019055; TRIVERS RL, 1972, SEXUAL SELECTION DES, P141; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; Whitlock MC, 2000, EVOLUTION, V54, P1654, DOI 10.1111/j.0014-3820.2000.tb00709.x; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x	30	227	229	0	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					692	695		10.1038/35079590	http://dx.doi.org/10.1038/35079590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395771				2022-12-01	WOS:000169112500045
J	Zhou, M; Morais-Cabral, JH; Mann, S; MacKinnon, R				Zhou, M; Morais-Cabral, JH; Mann, S; MacKinnon, R			Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors	NATURE			English	Article							SHAKER K-CHANNELS; PORE; MECHANISMS; BLOCKADE	Many voltage-dependent K+ channels open when the membrane is depolarized and then rapidly close by a process called inactivation. Neurons use inactivating K+ channels to modulate their firing frequency. In Shaker-type K+ channels, the inactivation gate, which is responsible for the closing of the channel, is formed by the channel's cytoplasmic amino terminus. Here we show that the central cavity and inner pore of the K+ channel form the receptor site for both the inactivation gate and small-molecule inhibitors. We propose that inactivation occurs by a sequential reaction in which the gate binds initially to the cytoplasmic channel surface and then enters the pore as an extended peptide. This mechanism accounts for the functional properties of K+ channel inactivation and indicates that the cavity may be the site of action for certain drugs that alter cation channel function.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu	Morais-Cabral, Joao H/J-4914-2013	Morais-Cabral, Joao H/0000-0002-4461-9716				Antz C, 1997, NATURE, V385, P272, DOI 10.1038/385272a0; Antz C, 1998, NEWS PHYSIOL SCI, V13, P177; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; ISACOFF EY, 1991, NATURE, V353, P86, DOI 10.1038/353086a0; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LU Z, 1994, J GEN PHYSIOL, V104, P477, DOI 10.1085/jgp.104.3.477; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P977, DOI 10.1085/jgp.102.6.977; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK SER; Rasmusson RL, 1995, J PHYSIOL-LONDON, V489, P709, DOI 10.1113/jphysiol.1995.sp021085; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Schott MK, 1998, EUR BIOPHYS J BIOPHY, V27, P99, DOI 10.1007/s002490050115; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Yarov-Yarovoy V, 2001, J BIOL CHEM, V276, P20, DOI 10.1074/jbc.M006992200; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	31	484	494	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					657	661		10.1038/35079500	http://dx.doi.org/10.1038/35079500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395760				2022-12-01	WOS:000169112500034
J	Daily, GC				Daily, GC			Ecological forecasts	NATURE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA	Stanford University	Daily, GC (corresponding author), Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, 371 Serra Mall, Stanford, CA 94305 USA.							[Anonymous], 1997, NATURES SERVICES; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; MYERS N, IN PRESS FUTURE COUR; SALZMAN J, IN PRESS STANFORD EN	4	126	134	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					245	245		10.1038/35077178	http://dx.doi.org/10.1038/35077178			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357107				2022-12-01	WOS:000168710000024
J	Retallack, GJ				Retallack, GJ			A 300-million-year record of atmospheric carbon dioxide from fossil plant cuticles	NATURE			English	Article							CO2 CONCENTRATIONS; BOUNDARY; PALEOCLIMATE; AUSTRALIA; GERMANY; CLIMATE	To understand better the link between atmospheric CO2 concentrations and climate over geological time, records of past CO2 are reconstructed from geochemical proxies(1-4). Although these records have provided us with a broad picture of CO2 variation throughout the Phanerozoic eon (the past 544 Myr), inconsistencies and gaps remain that still need to be resolved. Here I present a continuous 300-Myr record of stomatal abundance from fossil leaves of four genera of plants that are closely related to the present-day Ginkgo tree. Using the known relationship between leaf stomatal abundance and growing season CO2 concentrations(5,6), I reconstruct past atmospheric CO2 concentrations. For the past 300 Myr, only two intervals of low CO2 (<1,000 p.p.m.v.) are inferred, both of which coincide with known ice ages in Neogene (1-8 Myr) and early Permian (275- 290 Myr) times. But for most of the Mesozoic era (65-250 Myr), CO2 levels were high (1,000-2,000 p.p.m.v.), with transient excursions to even higher CO2 (>2,000 p.p.m.v.) concentrations. These results are consistent with some reconstructions of past CO2 (refs 1, 2) and palaeotemperature records(7), but suggest that CO2 reconstructions based on carbon isotope proxies(3,4) may be compromised by episodic outbursts of isotopically light methane(8,9). These results support the role of water vapour, methane and CO2 in greenhouse climate warming over the past 300 Myr.	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA	University of Oregon	Retallack, GJ (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.							[Anonymous], PALAEOFLORA SO AFRIC; Arens NC, 2000, PALAIOS, V15, P314, DOI 10.2307/3515539; Beerling DJ, 1998, J EXP BOT, V49, P1603, DOI 10.1093/jexbot/49.326.1603; BERNER RA, 1997, SCIENCE, V276, P543; Cowling SA, 1999, SCIENCE, V285, P1500, DOI 10.1126/science.285.5433.1500; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; FLORIN R., 1931, KUNGLIGA SVENSKA VET, V10, P1; Gomankov A.V., 1986, TATARINOVAYA FLORA S, P401; GRADSTEIN FM, 1995, SEPM SPEC PUBL, V54, P95; Jahren AH, 2001, GEOLOGY, V29, P159, DOI 10.1130/0091-7613(2001)029<0159:TROMHD>2.0.CO;2; Khalil MAK, 2000, ATMOSPHERIC METHANE, P86; Krull ES, 2000, NEW ZEAL J GEOL GEOP, V43, P21, DOI 10.1080/00288306.2000.9514868; Kurschner WM, 1996, MAR MICROPALEONTOL, V27, P299, DOI 10.1016/0377-8398(95)00067-4; Lemarchand D, 2000, NATURE, V408, P951, DOI 10.1038/35050058; McElwain JC, 1996, PALAIOS, V11, P376, DOI 10.2307/3515247; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; McGowran B, 1997, MICROPALEONTOLOGY, V43, P129, DOI 10.2307/1485778; Meyen S.V., 1987, FUNDAMENTALS PALAEOB; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Palfy J, 2000, GEOLOGY, V28, P39, DOI 10.1130/0091-7613(2000)28<39:TTEMEF>2.0.CO;2; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Retallack GJ, 1999, GEOL SOC AM BULL, V111, P52, DOI 10.1130/0016-7606(1999)111<0052:PGPRBE>2.3.CO;2; RETALLACK GJ, 2000, GEOL SOC AM SPEC PAP, V344, P1, DOI DOI 10.1130/0-8137-2344-21; RETALLACK GJ, 1997, COLOUR GUIDE PALEOSO, P117; ROYER DL, 2000, GEOL SOC AM ABSTR, V32, pA196; Schwarz T, 1997, PALAEOGEOGR PALAEOCL, V129, P37, DOI 10.1016/S0031-0182(96)00065-X; Thomas Ellen, 2000, P132; Utescher T, 2000, PALAIOS, V15, P430, DOI 10.2307/3515514; VAKRAMEEV VA, 1991, JURASSIC CRETACEOUS, P53; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044	30	301	345	4	130	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					287	290		10.1038/35077041	http://dx.doi.org/10.1038/35077041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357126				2022-12-01	WOS:000168710000041
J	Woolhouse, M; Chase-Topping, M; Haydon, D; Friar, J; Matthews, L; Hughes, G; Shaw, D; Wilesmith, J; Donaldson, A; Cornell, S; Keeling, M; Grenfell, B				Woolhouse, M; Chase-Topping, M; Haydon, D; Friar, J; Matthews, L; Hughes, G; Shaw, D; Wilesmith, J; Donaldson, A; Cornell, S; Keeling, M; Grenfell, B			Epidemiology - Foot-and-mouth disease under control in the UK	NATURE			English	Article									Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland; Univ Guelph, Dept Zool, Guelph, ON N1G 2W1, Canada; Eoscene Corp, Seattle, WA 98104 USA; AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England; Vet Labs Agcy, Addlestone KT15 3NB, Surrey, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Edinburgh; University of Guelph; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute; Veterinary Laboratories Agency; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge	Woolhouse, M (corresponding author), Univ Edinburgh, Ctr Trop Vet Med, Roslin EH25 9RG, Midlothian, Scotland.		Cornell, Stephen J/D-3955-2009; Matthews, Louise/E-2913-2013; Keeling, Matt J/J-9280-2012	Matthews, Louise/0000-0003-4420-8367; Keeling, Matt J/0000-0003-4639-4765; Haydon, Daniel/0000-0002-1240-1886; Shaw, Darren/0000-0003-2016-1541				ANDERSON R M, 1991; FERGUSON N, 2001, SCIENCE         0413; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; PATIL GP, 1971, STAT ECOLOGY, V2; SELLERS RF, 1981, BRIT VET J, V137, P608, DOI 10.1016/S0007-1935(17)31539-7; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; 2001, VET REC, V148, P390; 2001, VET REC, V148, P286	8	76	76	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					258	259		10.1038/35077149	http://dx.doi.org/10.1038/35077149			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357118				2022-12-01	WOS:000168710000033
J	Crowley, TJ; Berner, RA				Crowley, TJ; Berner, RA			Paleoclimate - CO2 and climate change	SCIENCE			English	Editorial Material							ATMOSPHERIC CO2; GLACIATION; RECORD		Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	Texas A&M University System; Texas A&M University College Station; Yale University	Crowley, TJ (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	robert.berner@yale.edu						Barron E. J, 1985, CARBON CYCLE ATMOSPH, P546, DOI [10.1029/GM032p0546, DOI 10.1029/GM032P0546]; BERNER RA, IN PRESS AM J SCI; CROWLEY TJ, 1993, J GEOPHYS RES-ATMOS, V98, P16723, DOI 10.1029/93JD01415; CROWLEY TJ, 1995, J GEOPHYS RES-ATMOS, V100, P1093, DOI 10.1029/94JD02521; CROWLEY TJ, 2000, WARM CLIMATES EARTH, P425; DOUGLAS RG, 1981, SEA, V7, P1233; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; ENDAL AS, 1981, ASTROPHYS J, V243, P625, DOI 10.1086/158628; Gibbs MT, 1997, GEOLOGY, V25, P447, DOI 10.1130/0091-7613(1997)025<0447:AAPCTF>2.3.CO;2; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; MIKOLAJEWICZ U, 1993, PALEOCEANOGRAPHY, V8, P409, DOI 10.1029/93PA00893; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; ROYER DL, IN PRESS EARTH SCI R; ROYER DL, UNPUB; Schrag DP, 1999, CHEM GEOL, V161, P215, DOI 10.1016/S0009-2541(99)00088-1; SHACKLETON N, 1981, J GEOL SOC LONDON, V138, P153, DOI 10.1144/gsjgs.138.2.0153; Tajika E, 1998, EARTH PLANET SC LETT, V160, P695, DOI 10.1016/S0012-821X(98)00121-6; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; WALLMANN K, IN PRESS GEOCHEM COS; YAPP CJ, 1992, NATURE, V355, P342, DOI 10.1038/355342a0; [No title captured]	24	178	195	2	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					870	872		10.1126/science.1061664	http://dx.doi.org/10.1126/science.1061664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341284				2022-12-01	WOS:000168514900031
J	Ogawa, H; Amagai, Y; Koike, I; Kaiser, K; Benner, R				Ogawa, H; Amagai, Y; Koike, I; Kaiser, K; Benner, R			Production of refractory dissolved organic matter by bacteria	SCIENCE			English	Article							AMINO-ACIDS; CARBON; SEAWATER; NITROGEN; RELEASE	Most of the oceanic reservoir of dissolved organic matter (DOM) is of marine origin and is resistant to microbial oxidation, but little is known about the mechanisms of its formation. In a laboratory study. natural assemblages of marine bacteria rapidly (in < 48 hours) utilized labile compounds (glucose, glutamate) and produced refractory DOM that persisted for more than a year. Only 10 to 15% of the bacterially derived DOM was identified as hydrolyzable amino acids and sugars, a feature consistent with marine DOM. These results suggest that microbial processes alter the molecular structure of DOM, making it resistant to further degradation and thereby preserving fixed carbon in the ocean.	Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Univ S Carolina, Marine Sci Program, Columbia, SC 29208 USA	University of Tokyo; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Ogawa, H (corresponding author), Univ Tokyo, Ocean Res Inst, 1-5-1 Minamidai, Tokyo 1648639, Japan.	hogawa@ori.u-tokyo.ac.jp	Benner, Ronald/M-4412-2015; Kaiser, Karl/AHB-7688-2022	Benner, Ronald/0000-0002-1238-2777; 				Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; BARBER RT, 1968, NATURE, V220, P274, DOI 10.1038/220274a0; Benner R, 1997, MAR CHEM, V57, P243, DOI 10.1016/S0304-4203(97)00013-3; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; BROPHY JE, 1989, DEEP-SEA RES, V36, P497, DOI 10.1016/0198-0149(89)90002-2; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; COWIE GL, 1992, LIMNOL OCEANOGR, V37, P703, DOI 10.4319/lo.1992.37.4.0703; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; FUHRMAN JA, 1986, MAR ECOL PROG SER, V33, P237, DOI 10.3354/meps033237; HARVEY GR, 1983, MAR CHEM, V12, P119, DOI 10.1016/0304-4203(83)90075-0; HATCHER PG, 1983, NATURE, V305, P498, DOI 10.1038/305498a0; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HUBBERTEN U, 1994, MAR CHEM, V45, P121, DOI 10.1016/0304-4203(94)90096-5; Kaiser K, 2000, ANAL CHEM, V72, P2566, DOI 10.1021/ac991407t; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; McCarthy M, 1997, NATURE, V390, P150, DOI 10.1038/36535; McCarthy M, 1996, MAR CHEM, V55, P281, DOI 10.1016/S0304-4203(96)00041-2; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; NAGATA T, 1992, MAR ECOL PROG SER, V83, P233, DOI 10.3354/meps083233; NEIDHARDT FC, 1990, PHYSL BACTERIAL CELL, P102; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Ogawa H, 1999, DEEP-SEA RES PT I, V46, P1809, DOI 10.1016/S0967-0637(99)00027-8; OGAWA H, 1992, NATURE, V356, P696, DOI 10.1038/356696a0; OGURA N, 1972, MAR BIOL, V13, P89, DOI 10.1007/BF00366559; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rich JH, 1996, LIMNOL OCEANOGR, V41, P595, DOI 10.4319/lo.1996.41.4.0595; Skoog A, 1997, LIMNOL OCEANOGR, V42, P1803, DOI 10.4319/lo.1997.42.8.1803; Stoderegger K, 1998, LIMNOL OCEANOGR, V43, P877, DOI 10.4319/lo.1998.43.5.0877; TANOUE E, 1995, GEOCHIM COSMOCHIM AC, V59, P2643, DOI 10.1016/0016-7037(95)00134-4; TRANVIK LJ, 1993, FEMS MICROBIOL ECOL, V12, P177; TSUGITA A, 1987, J BIOCHEM-TOKYO, V102, P1593, DOI 10.1093/oxfordjournals.jbchem.a122209; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0; WILLIAMS PM, 1988, OCEANOGRAPHY, V1, P14	34	464	480	25	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2001	292	5518					917	920		10.1126/science.1057627	http://dx.doi.org/10.1126/science.1057627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340202				2022-12-01	WOS:000168514900040
J	Steinberg, KK; Cogswell, ME; Chang, JC; Caudill, SP; McQuillan, GM; Bowman, BA; Grummer-Strawn, LM; Sampson, EJ; Khoury, MJ; Gallagher, ML				Steinberg, KK; Cogswell, ME; Chang, JC; Caudill, SP; McQuillan, GM; Bowman, BA; Grummer-Strawn, LM; Sampson, EJ; Khoury, MJ; Gallagher, ML			Prevalence of CY282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEREDITARY HEMOCHROMATOSIS; IRON OVERLOAD; POPULATION; CYS282TYR; HEALTH; EXPRESSION; PRODUCT; C282Y	Context Population-based estimates of the prevalence of disease-associated mutations. such as hemochromatosis (HFE) gene mutations, are needed to determine the usefulness of genetic screening. Objective To estimate the prevalence of the HFE mutations C282Y and H63D in the US population. Design Cross-sectional population-based study of samples in the DNA bank from phase 2 of the Third National Health and Nutrition Examination Survey conducted from 1992 to 1994. Setting and Participants Genotyped samples of cells from a total of 5171 participants, cross-classified by sex, age, and race/ethnicity in the analysis. Main Outcome Measures Estimates of the prevalence of C282Y and H63D mutations. Results The prevalence of C282Y homozygosity is estimated to be 0.26% (95% confidence interval [CI], 0.12%-0.49%); 1.89% (95% CI, 1.48%-2.43%) for H63D homozygosity; and 1.97% (95% CI, 1.54%-2.49%) for compound heterozygosity. The prevalence estimates for C282Y heterozygosity (C282Y/wild type) are 9.54% among non-Hispanic whites, 2.33% among non-Hispanic blacks, and 2.75% among Mexican-Americans. The prevalence estimates of the C282Y mutation in the US population are 5.4% (95% CI, 4.7%-6.2%) and 13.5% (95% CI, 12.5%-14.8%) for the H63D mutation. Conclusions Estimates of prevalence of HFE mutations are within the expected range for non-Hispanic whites and blacks but the estimated prevalence of the C282Y mutation among Mexican-Americans is less than expected. Mutation data now need to be linked to clinically relevant indices, such as transferrin saturation level.	Ctr Dis Control & Prevent, Mol Biol Branch, Div Sci Lab, Natl Ctr Environm Hlth, Chamblee, GA 30341 USA; Ctr Dis Control & Prevent, Off Genet & Dis Prevent, Natl Ctr Environm Hlth, Chamblee, GA 30341 USA; Ctr Dis Control & Prevent, Div Nutr & Phys Act, Natl Ctr Chron Dis Prevent & Hlth Promot, Chamblee, GA 30341 USA; Ctr Dis Control & Prevent, Div Diabet Transplantat, Natl Ctr Chron Dis Prevent & Hlth Promot, Chamblee, GA 30341 USA; Ctr Dis Control & Prevent, Div Hlth Examinat Stat, Natl Ctr Hlth Stat, Rockville, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Steinberg, KK (corresponding author), Ctr Dis Control & Prevent, Mol Biol Branch, Div Sci Lab, Natl Ctr Environm Hlth, Mailstop F-24, Chamblee, GA 30341 USA.							[Anonymous], VITAL HLTH STAT; Bacon BR, 1999, ANN INTERN MED, V130, P953, DOI 10.7326/0003-4819-130-12-199906150-00002; Bacon Bruce R., 1999, Gastroenterology, V116, P193, DOI 10.1016/S0016-5085(99)70244-1; Barton JC, 1998, ANN INTERN MED, V129, P932, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00003; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; Beutler E, 2000, ANN INTERN MED, V133, P329, DOI 10.7326/0003-4819-133-5-200009050-00008; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Bradley LA, 1998, J MED SCREEN, V5, P34, DOI 10.1136/jms.5.1.34; Burke W, 1998, JAMA-J AM MED ASSOC, V280, P172, DOI 10.1001/jama.280.2.172; Burt MJ, 1998, GUT, V43, P830, DOI 10.1136/gut.43.6.830; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P991; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; Cogswell ME, 1998, ANN INTERN MED, V129, P971, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00008; Cullen LM, 1998, AM J HUM GENET, V62, P1403, DOI 10.1086/301878; Distante S, 1999, SCAND J GASTROENTERO, V34, P529, DOI 10.1080/003655299750026290; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Fabrega E, 1999, MED CLIN-BARCELONA, V112, P451; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gangaidzo IT, 1999, GUT, V45, P278, DOI 10.1136/gut.45.2.278; Jeffery S, 1999, GENET TEST, V3, P375, DOI 10.1089/gte.1999.3.375; LIVAK KJ, 1995, PCR METH APPL, V4, P357; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; Looker AC, 1998, ANN INTERN MED, V129, P940, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00004; Lynas C, 1997, BLOOD, V90, P4235, DOI 10.1182/blood.V90.10.4235; Marshall DS, 1999, INT J MOL MED, V4, P389; McDonnell SM, 1999, AM J MED, V107, P30, DOI 10.1016/S0002-9343(99)00163-1; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; Mortimore M, 1999, J GASTROEN HEPATOL, V14, P838, DOI 10.1046/j.1440-1746.1999.01980.x; *NAT CTR HLTH STAT, 1996, WEIGHT EST METH REP; *NAT CTR HTLH STAT, 1996, AN REP GUID 3 NAT HL; Nielsen P, 1998, BRIT J HAEMATOL, V103, P842; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; *PERK APPL BIOS DI, 1995, TAQMAN PROB DES SYNT; Powell LW, 1998, ANN INTERN MED, V129, P925, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00002; Rivard SR, 2000, BRIT J HAEMATOL, V108, P854, DOI 10.1046/j.1365-2141.2000.01954.x; Roy CN, 1999, J BIOL CHEM, V274, P9022, DOI 10.1074/jbc.274.13.9022; Sanchez M, 1998, J HEPATOL, V29, P725, DOI 10.1016/S0168-8278(98)80252-3; Steinberg KK, 1997, EPIDEMIOL REV, V19, P156, DOI 10.1093/oxfordjournals.epirev.a017938; Weisberg S., 1985, APPL LINEAR REGRESSI	40	172	177	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2216	2222		10.1001/jama.285.17.2216	http://dx.doi.org/10.1001/jama.285.17.2216			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325323	Bronze			2022-12-01	WOS:000168256100024
J	Evron, E; Dooley, WC; Umbricht, CB; Rosenthal, D; Sacchi, N; Gabrielson, E; Soito, AB; Hung, DT; Ljung, BM; Davidson, NE; Sukumar, S				Evron, E; Dooley, WC; Umbricht, CB; Rosenthal, D; Sacchi, N; Gabrielson, E; Soito, AB; Hung, DT; Ljung, BM; Davidson, NE; Sukumar, S			Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR	LANCET			English	Article								If detected early, breast cancer is curable. We tested cells collected from the breast ducts by methylation-specific PCR (MSP), Methylated alleles of Cyclln D2, RAR-beta and Twist genes were frequently detected in fluid from mammary ducts containing endoscopically visualised carcinomas (17 cases of 20), and ductal carcinoma in situ (two of seven), but rarely in ductal lavage fluid from healthy ducts (five of 45), Two of the women with healthy mammograms whose ductal lavage fluid contained methylated markers and cytologically abnormal cells were subsequently diagnosed with breast cancer. Carrying out MSP in these quid samples may provide a sensitive and powerful addition to mammographic screening for early detection of breast cancer.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; ProDuct Hlth, Menlo Pk, CA USA	Johns Hopkins University; University of California System; University of California San Francisco	Sukumar, S (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21231 USA.	saras@jhmi.edu	Dooley, William Chesnut/E-7660-2013	Dooley, William Chesnut/0000-0002-0223-5677; Evron, Ella/0000-0002-1003-5042	NATIONAL CANCER INSTITUTE [P50CA088843] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA88843] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dooley WC, 2000, JAMA-J AM MED ASSOC, V284, P1518, DOI 10.1001/jama.284.12.1518-b; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Evron E, 2001, CANCER RES, V61, P2782; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Sirchia SM, 2000, ONCOGENE, V19, P1556, DOI 10.1038/sj.onc.1203456	5	269	292	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1335	1336		10.1016/S0140-6736(00)04501-3	http://dx.doi.org/10.1016/S0140-6736(00)04501-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343741				2022-12-01	WOS:000168411400014
J	Tatar, M; Kopelman, A; Epstein, D; Tu, MP; Yin, CM; Garofalo, RS				Tatar, M; Kopelman, A; Epstein, D; Tu, MP; Yin, CM; Garofalo, RS			A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function	SCIENCE			English	Article							REPRODUCTIVE DIAPAUSE; GENE; MELANOGASTER; REDUCTION; EXTENSION; SURVIVAL; DIPTERA; CHICO	The Drosophila melanogaster gene insulin-like receptor (InR) is homologous to mammalian insulin receptors as well as to Caenorhabditis elegans daf-2, a signal transducer regulating worm dauer formation and adult Longevity. We describe a heteroallelic, hypomorphic genotype of mutant InR, which yields dwarf females with up to an 85% extension of adult longevity and dwarf males with reduced Late age-specific mortality. Treatment of the Long-lived InR dwarfs with a juvenile hormone analog restores Life expectancy toward that of wild-type controls. We conclude that juvenile hormone deficiency, which results from InR signal pathway mutation, is sufficient to extend life-span, and that in flies, insulin-like Ligands nonautonomously mediate aging through retardation of growth or activation of specific endocrine tissue.	Brown Univ, Providence, RI 02912 USA; Univ Massachusetts, Amherst, MA 01003 USA; Pfizer Inc, Global Res & Dev, Groton, CT 06340 USA	Brown University; University of Massachusetts System; University of Massachusetts Amherst; Pfizer	Tatar, M (corresponding author), Brown Univ, Providence, RI 02912 USA.	Marc_Tatar@Brown.edu		Tatar, Marc/0000-0003-3232-6884	NATIONAL INSTITUTE ON AGING [R01AG016632] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG16632] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTARATZ M, 1991, MOL CELL ENDOCRINOL, V81, P205, DOI 10.1016/0303-7207(91)90219-I; BARTKE A, 2000, MOL GENETICS AGING, V29; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Davey KG, 2000, INSECT BIOCHEM MOLEC, V30, P877, DOI 10.1016/S0965-1748(00)00061-8; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; GAROFALO RS, 1988, MOL CELL BIOL, V8, P1638, DOI 10.1128/MCB.8.4.1638; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kimura MT, 1988, FUNCT ECOL, V2, P177, DOI 10.2307/2389693; KIMURA MT, 1992, J INSECT PHYSIOL, V38, P871, DOI 10.1016/0022-1910(92)90098-X; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LUMME J, 1974, J INSECT PHYSIOL, V20, P2023, DOI 10.1016/0022-1910(74)90109-7; MARINHINCAPIE M, 1995, ENDOCRINOLOGY, V136, P2357, DOI 10.1210/en.136.6.2357; Nagi MN, 1995, BIOCHEM MOL BIOL INT, V36, P633; PENER MP, 1992, CHRONOBIOL INT, V9, P102, DOI 10.3109/07420529209064521; RUAN YM, 1995, J BIOL CHEM, V270, P4236, DOI 10.1074/jbc.270.9.4236; SAUNDERS DS, 1990, GEN COMP ENDOCR, V79, P174, DOI 10.1016/0016-6480(90)90102-R; SCIACCHITANO S, UNPUB; Spradling Allan C., 1993, P1; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; TATAR M, IN PRESS AM NAT; Tu MP, 2001, J INSECT PHYSIOL, V47, P233, DOI 10.1016/S0022-1910(00)00110-4	29	1173	1232	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					107	110		10.1126/science.1057987	http://dx.doi.org/10.1126/science.1057987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292875				2022-12-01	WOS:000167995200049
J	Ozcan, C; Jahangir, A; Friedman, PA; Patel, PJ; Munger, TM; Rea, RF; Lloyd, MA; Packer, DL; Hodge, DO; Gersh, BJ; Hammill, SC; Shen, WK				Ozcan, C; Jahangir, A; Friedman, PA; Patel, PJ; Munger, TM; Rea, RF; Lloyd, MA; Packer, DL; Hodge, DO; Gersh, BJ; Hammill, SC; Shen, WK			Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CATHETER ABLATION; FOLLOW-UP; PHARMACOLOGICAL TREATMENT; ANTIARRHYTHMIC DRUGS; JUNCTION ABLATION; NATURAL-HISTORY; HEART-FAILURE; MORTALITY; RISK; POPULATION	Background: In patients with atrial fibrillation that is refractory to drug therapy, radio-frequency ablation of the atrioventricular node and implantation of a permanent pacemaker are an alternative therapeutic approach. The effect of this procedure on long-term survival is unknown. Methods: We studied all patients who underwent ablation of the atrioventricular node and implantation of a permanent pacemaker at the Mayo Clinic between 1990 and 1998. Observed survival was compared with the survival rates in two control populations: age- and sex-matched members of the Minnesota population between 1970 and 1990 and consecutive patients with atrial fibrillation who received drug therapy in 1993. Results: A total of 350 patients (mean [+/-SD] age, 68+/-11 years) were studied. During a mean of 36+/-26 months of follow-up, 78 patients died. The observed survival rate was significantly lower than the expected survival rate based on the general Minnesota population (P<0.001). Previous myocardial infarction (P<0.001), a history of congestive heart failure (P=0.02), and treatment with cardiac drugs after ablation (P=0.03) were independent predictors of death. Observed survival among patients without these three risk factors was similar to expected survival (P=0.43). None of the 26 patients with lone atrial fibrillation died during follow-up (37+/-27 months). The observed survival rate among patients who underwent ablation was similar to that among 229 controls with atrial fibrillation (mean age, 67+/-12 years) who received drug therapy (P=0.44). Conclusions: In the absence of underlying heart disease, survival among patients with atrial fibrillation after ablation of the atrioventricular node is similar to expected survival in the general population. Long-term survival is similar for patients with atrial fibrillation, whether they receive ablation or drug therapy. Control of the ventricular rate by ablation of the atrioventricular node and permanent pacing does not adversely affect long-term survival. (N Engl J Med 2001;344:1043-51.) Copyright (C) 2001 Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Biostat Sect, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Shen, WK (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1St St SW, Rochester, MN 55905 USA.		Jahangir, Arshad/M-7916-2016					*AM HEART ASS, 1999, 2000 HEART STROK STA; ANTMAN EM, 1990, J AM COLL CARDIOL, V15, P698, DOI 10.1016/0735-1097(90)90649-A; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BRAND FN, 1985, JAMA-J AM MED ASSOC, V254, P3449, DOI 10.1001/jama.254.24.3449; Brignole M, 1998, CIRCULATION, V98, P953, DOI 10.1161/01.CIR.98.10.953; Brignole M, 1996, PACE, V19, P348, DOI 10.1111/j.1540-8159.1996.tb03337.x; Brignole M, 1997, CIRCULATION, V96, P2617, DOI 10.1161/01.CIR.96.8.2617; Brignole M, 1998, HEART, V79, P531, DOI 10.1136/hrt.79.6.531; COX DR, 1972, J R STAT SOC B, V34, P187; CRIJNS HJ, 1991, AM J CARDIOL, V68, P335, DOI 10.1016/0002-9149(91)90828-9; Dries DL, 1998, J AM COLL CARDIOL, V32, P695, DOI 10.1016/S0735-1097(98)00297-6; Fitzpatrick AP, 1996, AM HEART J, V131, P499, DOI 10.1016/S0002-8703(96)90528-1; GAJEWSKI J, 1981, JAMA-J AM MED ASSOC, V245, P1540; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Kay GN, 1998, J INTERV CARD ELECTR, V2, P121, DOI 10.1023/A:1009795330454; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; Marshall HJ, 1998, HEART, V79, P543, DOI 10.1136/hrt.79.6.543; Nemec J, 1999, Expert Opin Pharmacother, V1, P81, DOI 10.1517/14656566.1.1.81; OLGIN JE, 1993, J AM COLL CARDIOL, V21, P557, DOI 10.1016/0735-1097(93)90084-E; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; PHILLIPS SJ, 1990, MAYO CLIN PROC, V65, P344, DOI 10.1016/S0025-6196(12)62535-X; PRITCHETT ELC, 1992, NEW ENGL J MED, V326, P1264; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; SCHEINMAN MM, 1982, JAMA-J AM MED ASSOC, V248, P851, DOI 10.1001/jama.248.7.851; Therneau TMSJ, 1994, TECHNICAL REPORT SER, V52; Touboul P, 1999, AM J CARDIOL, V83, p241D; TROHMAN RG, 1992, AM J CARDIOL, V70, P1438, DOI 10.1016/0002-9149(92)90296-B; TWIDALE N, 1993, PACE, V16, P1275, DOI 10.1111/j.1540-8159.1993.tb01714.x; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; ZEHENDER M, 1992, J AM COLL CARDIOL, V19, P1054, DOI 10.1016/0735-1097(92)90294-W	33	226	233	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2001	344	14					1043	1051		10.1056/NEJM200104053441403	http://dx.doi.org/10.1056/NEJM200104053441403			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	417XH	11287974	Bronze			2022-12-01	WOS:000167860400003
J	Agrawal, AF; Brodie, ED; Brown, J				Agrawal, AF; Brodie, ED; Brown, J			Parent-offspring coadaptation and the dual genetic control of maternal care	SCIENCE			English	Article							BURROWER BUG; SOLICITATION; SIGNALS; NEED	In many animal species, the amount of care provided by parents is determined through a complex interaction of offspring signals and responses by parents to those signals. As predicted by honest signaling theory, we show that in the burrower bug, Sehirus cinctus, maternal provisioning responds to experimental manipulations of offspring condition. Despite this predicted environmental influence, we find evidence from two cross-foster experiments that variation in maternal care also stems from two distinct genetic sources: variation among offspring in their ability to elicit care and variation among parents in their response to offspring signals, Furthermore, as predicted by maternal-offspring coadaptation theory, offspring signaling is negatively genetically correlated with maternal provisioning.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Agrawal, AF (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	aagrawal@bio.indiana.edu	Brodie, Edmund D/B-2335-2013; Brown, Jeremy/B-4544-2010	Brown, Jeremy/0000-0002-1447-8633				AGRAWAL AF, UNPUB; Bergstrom CT, 1998, P NATL ACAD SCI USA, V95, P5100, DOI 10.1073/pnas.95.9.5100; CHEVERUD JM, 1984, QUANTITATIVE GENETIC, P67; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; Kight SL, 1997, ANIM BEHAV, V53, P105, DOI 10.1006/anbe.1996.0282; Kight SL, 1998, PHYSIOL ENTOMOL, V23, P38, DOI 10.1046/j.1365-3032.1998.2310038.x; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kolliker M, 2000, P ROY SOC B-BIOL SCI, V267, P2127, DOI 10.1098/rspb.2000.1259; Lynch M., 1998, AM J HUM GENET; Mock D.W., 1997, EVOLUTION SIBLING RI; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Rauter CM, 1999, P ROY SOC B-BIOL SCI, V266, P1691, DOI 10.1098/rspb.1999.0833; SITES RW, 1982, ANN ENTOMOL SOC AM, V75, P210, DOI 10.1093/aesa/75.2.210; TALFAMY DW, 1999, ANIM BEHAV, V57, P727; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wade MJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P5; Wolf JB, 2000, EVOLUTION, V54, P1882, DOI 10.1111/j.0014-3820.2000.tb01235.x; Wolf JB, 1998, EVOLUTION, V52, P299, DOI 10.1111/j.1558-5646.1998.tb01632.x	21	144	146	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1710	1712		10.1126/science.1059910	http://dx.doi.org/10.1126/science.1059910			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387474				2022-12-01	WOS:000169031800043
J	Reisz, RR; Smith, MM				Reisz, RR; Smith, MM			Developmental biology - Lungfish dental pattern conserved for 360 Myr	NATURE			English	Article									Kings Coll London, Inst Dent, London SE1 9RT, England; Univ Toronto, Mississauga, ON L5L 1C6, Canada	University of London; King's College London; University of Toronto; University Toronto Mississauga	Reisz, RR (corresponding author), Univ Toronto, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.	moya.smith@kcl.ac.uk		Meredith Smith, Moya/0000-0002-3397-873X				KEMP A, 1995, J MORPHOL, V225, P345, DOI 10.1002/jmor.1052250306; Krupina Natasha I., 1999, Modern Geology, V24, P99; KRUPINA NI, IN PRESS CAN J EARTH; Smith M.M., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P179; SMITH MM, IN PRESS J ANAT	5	22	25	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					548	548		10.1038/35079187	http://dx.doi.org/10.1038/35079187			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385561	Bronze			2022-12-01	WOS:000168982500040
J	Kikkawa, M; Sablin, EP; Okada, Y; Yajima, H; Fletterick, RJ; Hirokawa, N				Kikkawa, M; Sablin, EP; Okada, Y; Yajima, H; Fletterick, RJ; Hirokawa, N			Switch-based mechanism of kinesin motors	NATURE			English	Article							X-RAY STRUCTURE; FACTOR EF-TU; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; MOLECULAR MOTOR; NUCLEOTIDE-BINDING; MICROTUBULE; PROTEIN; DOMAIN; NCD	Kinesin motors are specialized enzymes that use hydrolysis of ATP to generate force and movement along their cellular tracks, the microtubules. Although numerous biochemical and biophysical studies have accumulated much data that link microtubule-assisted ATP hydrolysis to kinesin motion, the structural view of kinesin movement remains unclear. This study of the monomeric kinesin motor KIF1A combines X-ray crystallography and cryo-electron microscopy, and allows analysis of force-generating conformational changes at atomic resolution. The motor is revealed in its two functionally critical states-complexed with ADP and with a non-hydrolysable analogue of ATP. The conformational change observed between the ADP-bound and the ATP-like structures of the KIF1A catalytic core is modular, extends to all kinesins and is similar to the conformational change used by myosin motors and G proteins. Docking of the ADP-bound and ATP-like crystallographic models of KIF1A into the corresponding cryo-electron microscopy maps suggests a rationale for the plus-end directional bias associated with the kinesin catalytic core.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Univ Calif San Francisco, Dept Biochem Biophys, San Francisco, CA 94143 USA	University of Tokyo; University of California System; University of California San Francisco	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Okada, Yasushi/N-5067-2015; Yajima, Hiroaki/AAS-6021-2020; Kikkawa, Masahide/I-7958-2015	Okada, Yasushi/0000-0003-2601-3689; Kikkawa, Masahide/0000-0001-7656-8194				Alonso MC, 1998, EMBO J, V17, P945, DOI 10.1093/emboj/17.4.945; Arnal I, 1998, STRUCTURE, V6, P33, DOI 10.1016/S0969-2126(98)00005-7; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; Henningsen U, 1997, NATURE, V389, P93, DOI 10.1038/38022; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirose K, 2000, EMBO J, V19, P5308, DOI 10.1093/emboj/19.20.5308; HIROSE K, 1995, NATURE, V376, P277, DOI 10.1038/376277a0; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hoenger A, 1998, J CELL BIOL, V141, P419, DOI 10.1083/jcb.141.2.419; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kjeldgaard M, 1996, FASEB J, V10, P1347, DOI 10.1096/fasebj.10.12.8903506; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polekhina G, 1996, STRUCTURE, V4, P1141, DOI 10.1016/S0969-2126(96)00122-0; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Sack S, 1999, EUR J BIOCHEM, V262, P1, DOI 10.1046/j.1432-1327.1999.00341.x; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Song HB, 1998, NATURE, V396, P587, DOI 10.1038/25153; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; Vale RD, 2000, PHILOS T ROY SOC B, V355, P449, DOI 10.1098/rstb.2000.0586; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3	50	286	299	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					439	445		10.1038/35078000	http://dx.doi.org/10.1038/35078000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373668				2022-12-01	WOS:000168858700037
J	Olsen, SJ; DeBess, EE; McGivern, TE; Marano, N; Eby, T; Mauvais, S; Balan, VK; Zirnstein, G; Cieslak, PR; Angulo, FJ				Olsen, SJ; DeBess, EE; McGivern, TE; Marano, N; Eby, T; Mauvais, S; Balan, VK; Zirnstein, G; Cieslak, PR; Angulo, FJ			A nosocomial outbreak of fluoroquinolone-resistant salmonella infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES	Background: Infection with fluoroquinolone-resistant strains of salmonella is rare, as is nosocomial salmonella infection. We describe the first recognized outbreak of fluoroquinolone-resistant salmonella infection in the United States, which occurred in two nursing homes and one hospital in Oregon. Methods: We interviewed medical staff and reviewed patients' charts and death certificates. In Nursing Home A we conducted a case-control study. Patients were defined as residents of the nursing home from whom fluoroquinolone-resistant Salmonella enterica serotype Schwarzengrund was isolated between February 1996 and December 1998. Controls were residents with similar medical conditions whose cultures did not yield salmonella. Results: Eleven patients with fluoroquinolone-resistant salmonellosis were identified at two nursing homes. In nine patients a urine culture was positive, in one a stool culture, and in one a wound culture. The index patient had been hospitalized in the Philippines and had probably acquired the infection there. Transmission was probably direct (from patient to patient) or through contact with contaminated surfaces. Treatment with fluoroquinolones during the six months before a culture was obtained was associated with a significant risk of salmonella infection. More fluoroquinolones were used at Nursing Home A than at similar nursing homes in Oregon. The isolates from the outbreak had similar patterns on pulsed-field gel electrophoresis and the same gyrA mutations. The isolates from the outbreak were also similar to the only previous isolate of fluoroquinolone-resistant salmonella in the United States, which came from a patient in New York who had been transferred from a hospital in the Philippines. Conclusions: We describe a prolonged nosocomial outbreak of infection with fluoroquinolone-resistant S. enterica serotype Schwarzengrund. More such outbreaks are likely in institutional settings, particularly those in which there is heavy use of antimicrobial agents. (N Engl J Med 2001;344:1572-9.) Copyright (C) 2001 Massachusetts Medical Society.	CDCP, Foodborne Diarrheal Dis Branch, Div Bacterial Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Oregon Dept Human Serv, Hlth Div, Portland, OR USA; Oregon Dept Human Serv, Hlth Div, Portland, OR USA; Multnomah Cty Dept Hlth, Portland, OR USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Olsen, SJ (corresponding author), CDCP, Foodborne Diarrheal Dis Branch, Div Bacterial Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,Mailstop A-38, Atlanta, GA 30333 USA.	sco2@cdc.gov						Acar JF, 1997, CLIN INFECT DIS, V24, pS67, DOI 10.1093/clinids/24.Supplement_1.S67; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; *CDCP, 1998, STAND MOL SUBT FOODB; COHEN ML, 1986, SCIENCE, V234, P964, DOI 10.1126/science.3535069; Griggs DJ, 1996, ANTIMICROB AGENTS CH, V40, P1009, DOI 10.1128/AAC.40.4.1009; Herikstad H, 1997, EMERG INFECT DIS, V3, P371, DOI 10.3201/eid0303.970316; Kumar A, 1995, Indian Pediatr, V32, P881; LEE LA, 1994, J INFECT DIS, V170, P128, DOI 10.1093/infdis/170.1.128; LEPAGE P, 1987, LANCET, V1, P1458; Li JH, 1996, AM J EPIDEMIOL, V143, P1042; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller S.I., 2000, PRINCIPLES PRACTICE, V2, P2344; OLSEN S, 2000, INT C EM INF DIS ATL, P144; PAVIA AT, 1990, J INFECT DIS, V161, P255, DOI 10.1093/infdis/161.2.255; Pers C, 1996, SCAND J INFECT DIS, V28, P529, DOI 10.3109/00365549609037954; Piddock L J, 1995, Drugs, V49 Suppl 2, P29; PIDDOCK LJV, 1993, ANTIMICROB AGENTS CH, V37, P662, DOI 10.1128/AAC.37.4.662; RILEY LW, 1984, J INFECT DIS, V150, P236, DOI 10.1093/infdis/150.2.236; TAUXE RV, 1991, J FOOD PROTECT, V54, P563, DOI 10.4315/0362-028X-54.7.563; Turnidge J, 1995, Drugs, V49 Suppl 2, P43; Vasallo FJ, 1998, CLIN INFECT DIS, V26, P535, DOI 10.1086/517087; *WHO, 1998, WHOEMCZDI9812	22	107	116	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2001	344	21					1572	1579		10.1056/NEJM200105243442102	http://dx.doi.org/10.1056/NEJM200105243442102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	434RM	11372008				2022-12-01	WOS:000168829700002
J	Lyapina, S; Cope, G; Shevchenko, A; Serino, G; Tsuge, T; Zhou, CS; Wolf, DA; Wei, N; Shevchenko, A; Deshaies, RJ				Lyapina, S; Cope, G; Shevchenko, A; Serino, G; Tsuge, T; Zhou, CS; Wolf, DA; Wei, N; Shevchenko, A; Deshaies, RJ			Promotion of NEDD8-CUL1 conjugate cleavage by COP9 signalosome	SCIENCE			English	Article							UBIQUITIN-LIGASE; FISSION YEAST; COMPLEX; PROTEIN; DEGRADATION; P27(KIP1); SCF; ARABIDOPSIS; REGULATOR; SUBUNITS	SCF ubiquitin ligases control various processes by marking regulatory proteins for ubiquitin-dependent proteolysis. To illuminate how SCF complexes are regulated, we sought proteins that interact with the human SCF component CUL1. The COP9 signalosome (CSN), a suppressor of plant photomorphogenesis, associated with multiple cullins and promoted cleavage of the ubiquitin-like protein NEDD8 from Schizosaccharomyces pombe CUL1 in vivo and in vitro. Multiple NEDD8-modified proteins uniquely accumulated in CSN-deficient S. pombe cells. We propose that the broad spectrum of activities previously attributed to CSN subunits-including repression of photomorphogenesis, activation of JUN, and activation of p27 nuclear export-underscores the importance of dynamic cycles of NEDD8 attachment and removal in biological regulation.	CALTECH, Dept Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; European Mol Biol Lab, Prot & Peptide Grp, D-69012 Heidelberg, Germany; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Harvard Univ, Sch Publ Hlth, Dept Canc Cell Biol, Boston, MA 02115 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; European Molecular Biology Laboratory (EMBL); Yale University; Harvard University; Harvard T.H. Chan School of Public Health	Deshaies, RJ (corresponding author), CALTECH, Dept Biol, Pasadena, CA 91125 USA.		Serino, Giovanna/W-4683-2019; Deshaies, Raymond/B-8354-2014; Tsuge, Tomohiko/GVY-1467-2022; Wolf, Dieter/AAE-5890-2021	Serino, Giovanna/0000-0001-8689-6132; Deshaies, Raymond/0000-0002-3671-9354; Tsuge, Tomohiko/0000-0003-2736-0295; Wolf, Dieter/0000-0002-3761-1070				BLANCHI E, 2000, NATURE, V404, P617; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; COPE G, UNPUB; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Li SH, 2000, J BIOL CHEM, V275, P13386, DOI 10.1074/jbc.275.18.13386; Lyapina SA, 1998, P NATL ACAD SCI USA, V95, P7451, DOI 10.1073/pnas.95.13.7451; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Mundt KE, 1999, CURR BIOL, V9, P1427, DOI 10.1016/S0960-9822(00)80091-3; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; SCHWARZ S, UNPUB; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Shevchenko A, 2000, ANAL CHEM, V72, P2132, DOI 10.1021/ac9913659; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Verma R. P., UNPUB; Wei N, 1998, PHOTOCHEM PHOTOBIOL, V68, P237; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; ZHOU CS, UNPUB	28	541	576	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1382	1385		10.1126/science.1059780	http://dx.doi.org/10.1126/science.1059780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11337588				2022-12-01	WOS:000168862900048
J	Carding, P; Welch, A; Owen, S; Stafford, F				Carding, P; Welch, A; Owen, S; Stafford, F			Surgical voice restoration	LANCET			English	Editorial Material							QUALITY-OF-LIFE; TOTAL LARYNGECTOMY; NECK-CANCER; HEAD		Freeman Hosp, No Head & Neck Canc Ctr, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital	Carding, P (corresponding author), Freeman Hosp, No Head & Neck Canc Ctr, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.			Carding, Paul/0000-0002-4206-1827				BLOM ED, 1998, TRACHEOESOPHAGEAL VO; BLOM ED, 1998, TRACHEOESOPHAGEAL VO, pCH10; *BRIT ASS HEAD NEC, 2000, EFF HEAD NECK CANC M; Deleyiannis FWB, 1999, HEAD NECK-J SCI SPEC, V21, P319, DOI 10.1002/(SICI)1097-0347(199907)21:4<319::AID-HED5>3.0.CO;2-H; Hoffman HT, 1997, HEAD NECK-J SCI SPEC, V19, P92, DOI 10.1002/(SICI)1097-0347(199703)19:2<92::AID-HED2>3.0.CO;2-P; JOHNS MME, 1998, TRACHEOESOPHAGEAL VO; Jones AS, 2000, CLIN OTOLARYNGOL, V25, P396, DOI 10.1046/j.1365-2273.2000.00387.x; KAO WW, 1994, ARCH OTOLARYNGOL, V120, P301; LEWIN JS, 1998, TRACHEOESOPHAGEAL VO, pCH9; MORRIS HL, 1992, ANN OTO RHINOL LARYN, V101, P503, DOI 10.1177/000348949210100611; SINGER MI, 1981, ARCH OTOLARYNGOL, V107, P670; STGUILY JL, 1990, ANN OTOLARYNGOL, V107, P205; Weymuller EA, 2000, ARCH OTOLARYNGOL, V126, P329, DOI 10.1001/archotol.126.3.329	13	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1463	1464		10.1016/S0140-6736(00)04671-7	http://dx.doi.org/10.1016/S0140-6736(00)04671-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377593				2022-12-01	WOS:000168614300005
J	Leonard, J; Grunewald, S; Clayton, P				Leonard, J; Grunewald, S; Clayton, P			Diversity of congenital disorders of glycosylation	LANCET			English	Editorial Material							DEFICIENT GLYCOPROTEIN SYNDROME		Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 1EH, England; Inst Child Hlth, Biochem Endocrinol & Metab Unit, London WC1N 1EH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Leonard, J (corresponding author), Great Ormond St Hosp Sick Children, Metab Unit, London WC1N 1EH, England.	j.leonard@ich.ucl.ac.uk	Clayton, Peter T/C-1523-2008	Clayton, Peter/0000-0001-7592-4302				de Lonlay P, 2001, J MED GENET, V38, P14, DOI 10.1136/jmg.38.1.14; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; Grunewald S, 2000, ANN NEUROL, V47, P776; Imbach T, 2000, J CLIN INVEST, V105, P233, DOI 10.1172/JCI8691; Korner C, 1999, EMBO J, V18, P6816, DOI 10.1093/emboj/18.23.6816; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Tan J, 1996, AM J HUM GENET, V59, P810; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; Vestweber D, 2000, BLOOD, V95, P3642	10	19	19	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 5	2001	357	9266					1382	1383		10.1016/S0140-6736(00)04618-3	http://dx.doi.org/10.1016/S0140-6736(00)04618-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356431				2022-12-01	WOS:000168478200005
J	Horne, AW; White, JO; Margara, RA; Williams, R; Winston, RML; Lalani, E				Horne, AW; White, JO; Margara, RA; Williams, R; Winston, RML; Lalani, E			MUC 1: a genetic susceptibility to infertility?	LANCET			English	Article								In man and some animals regulation of embryo Implantation by endometrial expression of the highly polymorphic MUC 1 mucin has been suggested. We assessed the polymorphism of MUC 1 in women known to be fertile and those with infertility due to suspected failure of embryo implantation. The median of the lower allele size in the infertile group was only 2.5 kb compared with 3.4 kb in the fertile group (p=0.0029, difference 0.9, [95% CI 0.1-1.3]). Woman with unexplained Infertility might have a genetic susceptibility to failure of embryo implantation due to small MUC 1 allele size.	Imperial Coll Sch Med, Inst Reprod & Dev Biol, London W12 0NN, England	Imperial College London	Lalani, E (corresponding author), Imperial Coll Sch Med, Inst Reprod & Dev Biol, Hammersmith Hosp Campus, London W12 0NN, England.			Lalani, El-Nasir/0000-0001-9733-459X; Horne, Andrew/0000-0002-9656-493X				Aplin JD, 1998, GLYCOBIOLOGY, V8, P269, DOI 10.1093/glycob/8.3.269; Carson DD, 1998, BIOESSAYS, V20, P577, DOI 10.1002/(SICI)1521-1878(199807)20:7<577::AID-BIES9>3.3.CO;2-2; Carvalho F, 1997, GLYCOCONJUGATE J, V14, P107, DOI 10.1023/A:1018573201347; GENDLER SJ, 1990, INT J CANCER, V45, P431, DOI 10.1002/ijc.2910450309; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693	5	37	39	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1336	1337		10.1016/S0140-6736(00)04502-5	http://dx.doi.org/10.1016/S0140-6736(00)04502-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343742				2022-12-01	WOS:000168411400015
J	Sagasti, A; Hisamoto, N; Hyodo, J; Tanaka-Hino, M; Matsumoto, K; Bargmann, CI				Sagasti, A; Hisamoto, N; Hyodo, J; Tanaka-Hino, M; Matsumoto, K; Bargmann, CI			The CaMKII UNC-43 activates the MAPKKK NSY-1 to execute a lateral signaling decision required for asymmetric olfactory neuron fates	CELL			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PROTEIN-KINASE CASCADE; C-ELEGANS; REGULATING KINASE-1; APOPTOSIS; ASK1; TRANSDUCTION; EXPRESSION; PATHWAY; MORPHOGENESIS	A stochastic cell fate decision mediated by axon contact and calcium signaling causes one of the two bilaterally symmetric AWC neurons, either AWCL or AWCR, to express the candidate olfactory receptor str-2 nsy-1 mutants express str-2 in both neurons, disrupting AWC asymmetry, nsy-1 encodes a homolog of the human MAP kinase kinase kinase (MAPKKK) ASK1, an activator of JNK and p38 kinases. Based on genetic epistasis analysis, nsy-1 appears to act downstream of the CaMKII unc-43, and NSY-1 associates with UNC-43, suggesting that UNC-43/CaMKII activates the NSY-1 MAP kinase cassette. Mosaic analysis demonstrates that UNC-43 and NSY-1 act primarily in a cell-autonomous execution step that represses str-2 expression in one AWC cell, downstream of the initial lateral signaling pathway that coordinates the fates of the two cells.	Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Nagoya University; Japan Science & Technology Agency (JST)	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618				Berestetskaya YV, 1998, J BIOL CHEM, V273, P27816, DOI 10.1074/jbc.273.43.27816; BRENNER S, 1974, GENETICS, V77, P71; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; HERMAN RK, 1984, GENETICS, V108, P165; Hirotsu T, 2000, NATURE, V404, P289, DOI 10.1038/35005101; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Noselli S, 1998, TRENDS GENET, V14, P33, DOI 10.1016/S0168-9525(97)01320-6; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Reiner DJ, 1999, NATURE, V402, P199, DOI 10.1038/46072; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rongo C, 1999, NATURE, V402, P195, DOI 10.1038/46065; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SEYDOUX G, 1989, CELL, V57, P1237, DOI 10.1016/0092-8674(89)90060-3; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Watt WC, 2001, J BIOL CHEM, V276, P2047, DOI 10.1074/jbc.M006703200; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Williams BD, 1995, METHOD CELL BIOL, V48, P81; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	35	158	166	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					221	232		10.1016/S0092-8674(01)00313-0	http://dx.doi.org/10.1016/S0092-8674(01)00313-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336672	Bronze			2022-12-01	WOS:000168384300009
J	Polanczyk, CA; Marcantonio, E; Goldman, L; Rohde, LEP; Orav, J; Mangione, CM; Lee, TH				Polanczyk, CA; Marcantonio, E; Goldman, L; Rohde, LEP; Orav, J; Mangione, CM; Lee, TH			Impact of age on perioperative complications and length of stay in patients undergoing noncardiac surgery	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIAC RISK-ASSESSMENT; ELECTIVE SURGERY; PULMONARY COMPLICATIONS; MYOCARDIAL-ISCHEMIA; ACTIVITY SCALE; VALIDATION; MORBIDITY; MORTALITY; INDEX; PREDICTION	Background: Major surgical procedures are performed with increasing frequency in elderly persons, but the impact of age on resource use and outcomes is uncertain. Objective: To evaluate the influence of age on perioperative cardiac and noncardiac complications and length of stay in patients undergoing noncardiac surgery. Design: Prospective cohort study. Setting: Urban academic medical center. Patients: Consecutive sample of 4315 patients 50 years of age or older who underwent nonemergent major noncardiac procedures. Measurements: Major perioperative complications (cardiac and noncardiac), in-hospital mortality, and length of stay. Results: Major perioperative complications occurred in 4.3% (44 of 1015) of patients 59 years of age or younger, 5.7% (93 of 1646) of patients 60 to 69 years of age, 9.6% (129 of 1341) of patients 70 to 79 years of age, and 12.5% (39 of 313) of patients 80 years of age or older (P < 0.001). In-hospital mortality was significantly higher in patients 80 years of age or older than in those younger than 80 years of age (0.7% vs. 2.6%, respectively). Multivariate analyses indicated an increased odds ratio for perioperative complications or in-hospital mortality in patients 70 to 79 years of age (1.8 [95% Cl, 1.2 to 2.7]) and those 80 years of age or older (OR, 2.1 [Cl, 1.2 to 3.6]) compared with patients 50 to 59 years of age. Patients 80 years of age or older stayed an average of 1 day more in the hospital, after adjustment for other clinical data (P = 0.001). Conclusions: Elderly patients had a higher rate of major perioperative complications and mortality after noncardiac surgery and a longer length of stay, but even in patients 80 years of age or older, mortality was low.	Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Lee, TH (corresponding author), Partners Community HealthCare Inc, Prudential Tower,11th Floor,800 Boylston St, Boston, MA 02199 USA.	thlee@partners.org	Polanczyk, Carisi CAP/D-6208-2013; Marcantonio, Edward R/U-3929-2017; Rohde, Luis Eduardo/I-4216-2013	Marcantonio, Edward R/0000-0002-2911-4250; 	AHRQ HHS [R01-HS06573] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006573] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ACKERMANN RJ, 1995, J FAM PRACTICE, V40, P129; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DETSKY AS, 1986, ARCH INTERN MED, V146, P2131, DOI 10.1001/archinte.146.11.2131; GERSON MC, 1990, AM J MED, V88, P101, DOI 10.1016/0002-9343(90)90456-N; GOLDMAN L, 1981, CIRCULATION, V64, P1227, DOI 10.1161/01.CIR.64.6.1227; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HEDGES JR, 1992, ANN EMERG MED, V21, P402, DOI 10.1016/S0196-0644(05)82659-9; HOSKING MP, 1989, JAMA-J AM MED ASSOC, V261, P1909; LAHEY SJ, 1992, CIRCULATION, V86, P181; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lee TH, 1996, AM J CARDIOL, V77, P1031, DOI 10.1016/S0002-9149(96)00126-9; LEE TH, 1988, AM HEART J, V115, P203, DOI 10.1016/0002-8703(88)90545-5; LItalien GJ, 1996, J AM COLL CARDIOL, V27, P779, DOI 10.1016/0735-1097(95)00566-8; Macario A, 1997, ANESTHESIOLOGY, V86, P92, DOI 10.1097/00000542-199701000-00013; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; Mangano DT, 1995, NEW ENGL J MED, V333, P1750, DOI 10.1056/NEJM199512283332607; MANGIONE CM, 1993, J AM GERIATR SOC, V41, P377, DOI 10.1111/j.1532-5415.1993.tb06944.x; Mangione CM, 1997, J GEN INTERN MED, V12, P686, DOI 10.1046/j.1525-1497.1997.07142.x; WONG T, 1992, ANN INTERN MED, V116, P743, DOI 10.7326/0003-4819-116-9-743	21	331	352	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2001	134	8					637	643		10.7326/0003-4819-134-8-200104170-00008	http://dx.doi.org/10.7326/0003-4819-134-8-200104170-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	423LJ	11304103	Green Published			2022-12-01	WOS:000168177500002
J	Gupta, A; Tsai, LH				Gupta, A; Tsai, LH			A kinase to dampen the effects of cocaine?	SCIENCE			English	Editorial Material							CYCLIN-DEPENDENT KINASE-5; P35; CDK5; NEURODEGENERATION; ADHESION; MICE; P25		Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Gupta, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.							Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; BIBB JA, IN PRESS J BIOL CHEM; Bothwell M, 2000, CELL, V102, P271, DOI 10.1016/S0092-8674(00)00032-5; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen JS, 2000, J NEUROSCI, V20, P8965; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; HEICHMAN KA, 1994, CELL, V79, P557, DOI 10.1016/0092-8674(94)90541-X; Hiroi N, 1999, EUR J NEUROSCI, V11, P1114, DOI 10.1046/j.1460-9568.1999.00570.x; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Reiner O, 2000, NEURON, V28, P633, DOI 10.1016/S0896-6273(00)00142-2; Satoh A, 1998, J BIOL CHEM, V273, P3470, DOI 10.1074/jbc.273.6.3470; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9	20	10	16	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					236	237		10.1126/science.1060028	http://dx.doi.org/10.1126/science.1060028			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305318				2022-12-01	WOS:000168074000034
J	Falck, J; Mailand, N; Syljuasen, RG; Bartek, J; Lukas, J				Falck, J; Mailand, N; Syljuasen, RG; Bartek, J; Lukas, J			The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis	NATURE			English	Article							CELL-CYCLE REGULATION; DAMAGE CHECKPOINT; ATAXIA-TELANGIECTASIA; HUMAN CDC25A; FHA DOMAIN; PHOSPHORYLATION; CHK1; P53; ATM; ACTIVATION	When exposed to ionizing radiation (IR), eukaryotic cells activate checkpoint pathways to delay the progression of the cell cycle(1-3). Defects in the IR-induced S-phase checkpoint cause 'radioresistant DNA synthesis', a phenomenon that has been identified in cancer-prone patients suffering from ataxia-telangiectasia, a disease caused by mutations in the ATM gene(4-6). The Cdc25A phosphatase(7) activates the cyclin-dependent kinase 2 (Cdk2) needed for DNA synthesis(8,9), but becomes degraded in response to DNA damage(10) or stalled replication(11). Here we report a functional link between ATM, the checkpoint signalling kinase Chk2/Cds1 (Chk2)(12) and Cdc25A, and implicate this mechanism in controlling the S-phase checkpoint. We show that IR-induced destruction of Cdc25A requires both ATM and the Chk2-mediated phosphorylation of Cdc25A on serine 123. An IR-induced loss of Cdc25A protein prevents dephosphorylation of Cdk2 and leads to a transient blockade of DNA replication. We also show that tumour-associated Chk2 alleles(13) cannot bind or phosphorylate Cdc25A, and that cells expressing these Chk2 alleles, elevated Cdc25A or a Cdk2 mutant unable to undergo inhibitory phosphorylation (Cdk2AF) fail to inhibit DNA synthesis when irradiated. These results support Chk2 as a candidate tumour suppressor, and identify the ATM-Chk2-Cdc25A-Cdk2 pathway as a genomic integrity checkpoint that prevents radioresistant DNA synthesis.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark	Danish Cancer Society	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.		Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X				Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chehab NH, 2000, GENE DEV, V14, P278; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; GALAKTIONOV K, 1991, CELL, V67, P1181, DOI 10.1016/0092-8674(91)90294-9; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Molinari M, 2000, EMBO REP, V1, P71, DOI 10.1093/embo-reports/kvd018; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Rotman G, 1999, ONCOGENE, V18, P6135, DOI 10.1038/sj.onc.1203124; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Xie GF, 1998, ONCOGENE, V16, P721, DOI 10.1038/sj.onc.1201793; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	30	821	859	1	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					842	847		10.1038/35071124	http://dx.doi.org/10.1038/35071124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298456				2022-12-01	WOS:000168021900062
J	van Staa, TP; Wegman, S; de Vries, F; Leufkens, B; Cooper, C				van Staa, TP; Wegman, S; de Vries, F; Leufkens, B; Cooper, C			Use of statins and risk of fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COA REDUCTASE INHIBITORS; ORAL CORTICOSTEROIDS; IN-VITRO; DATABASE; VALIDATION; WOMEN; UK	Context Previous studies have reported lower fracture risks in patients taking 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins). Objective To investigate risk of fracture among statin users. Design Case-control study of data from the General Practice Research Database (GPRD). Setting A total of 683 general clinical practices in the United Kingdom. Patients Cases were 81 880 patients aged 50 years or older who had a fracture of the vertebrae, clavicle, humerus, radius/ulna, carpus, hip, ankle, or foot occurring between the enrollment date of their practice into the GPRD and Jury 1999, paired with 81 880 age-, sex-, and practice-matched controls. Main Outcome Measure Risk of fracture in current users vs nonusers of statins. Odds ratios were estimated from conditional logistic regression and adjusted for smoking, medications and illnesses associated with fracture risk, and body mass index when known. Results The adjusted odds ratio (OR) for current use of statins compared with non-use was 1.01 (95% confidence interval [CI], 0.88-1.16). For forearm, hip, and vertebral fractures, the ORs were 1.01 (95% CI, 0.80-1.27), 0.59 (95% CI, 0.31-1.13), and 1.15 (95% CI, 0.62-2.14), respectively. Relative to nonuse, a statin dosage of less than 20 mg/d (standardized to simvastatin) was associated with an adjusted OR of fracture of 1.13 (95% CI, 0.96-1.33); this OR was 1.07 (95% CI, 0.82-1.38) at dosages of 20 to 39.9 mg/d and 0.85 (95% CI, 0.47-1.53) at dosages of 40 mg/d or more. The adjusted OR was 0.71 (95% CI, 0.50-1.01) for statin use durations of 0 to 3 months, 1.31 (95% CI, 0.87-1.95) for durations of 3 to 6 months, 1.14 (95%: CI, 0.82-1.58) for durations of 6 to 12 months, and 1.17 (95% CI, 0.99-1.40) for durations of more than 12 months. Conclusion In this study, use of statins at dosages prescribed in clinical practice was not associated with a reduction in risk of fracture.	Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England; Univ Utrecht, Dept Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands; Proctor & Gamble Pharmaceut, Staines, England	University of Southampton; Utrecht University; Procter & Gamble	Cooper, C (corresponding author), Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England.	cc@mrc.soton.ac.uk	de Vries, Frank/E-4934-2011	de Vries, Frank/0000-0003-3837-8319; van Staa, Tjeerd/0000-0001-9363-742X; Cooper, Cyrus/0000-0003-3510-0709				Bauer DC, 1999, J BONE MINER RES, V14, pS179; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; Corsini A, 1999, PHARMACOL THERAPEUT, V84, P413, DOI 10.1016/S0163-7258(99)00045-5; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Grisso Jeane Ann, 1996, P599; HALL G, 1992, PHARMACOEPIDEM DR S, V1, P33; HOLLOWELL J, 1994, GEN PRACTICE RES DAT; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; KLEINBAUM DG, 1988, APPL REGRESSION ANAL, P164; LaCroix AZ, 2000, J BONE MINER RES, V15, pS155; LIS Y, 1995, J CLIN EPIDEMIOL, V48, P431, DOI 10.1016/0895-4356(94)00137-F; MANN RD, 1992, POSTMARKETING SURVEI, V5, P259; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; NAZARETH I, 1993, BRIT MED J, V307, P32, DOI 10.1136/bmj.307.6895.32; *OFF NAT STAT, 1996, GEN PRACT RES DAT IN; PEDERSEN TR, 1994, LANCET, V344, P1383; SENN S, 1997, STAT ISSUES DRUG DEV, P132; Shane Elizabeth, 1996, P925; van Beek E, 1999, J BONE MINER RES, V14, P722, DOI 10.1359/jbmr.1999.14.5.722; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Van Staa TP, 2000, PHARMACOEPIDEM DR S, V9, P359, DOI 10.1002/1099-1557(200009/10)9:5<359::AID-PDS507>3.0.CO;2-E; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Wang PS, 2000, JAMA-J AM MED ASSOC, V283, P3211, DOI 10.1001/jama.283.24.3211	27	228	231	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1850	1855		10.1001/jama.285.14.1850	http://dx.doi.org/10.1001/jama.285.14.1850			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308398	Bronze			2022-12-01	WOS:000167876700025
J	Ruehm, SG; Goyen, M; Barkhausen, J; Kroger, K; Bosk, S; Ladd, ME; Debatin, JF				Ruehm, SG; Goyen, M; Barkhausen, J; Kroger, K; Bosk, S; Ladd, ME; Debatin, JF			Rapid magnetic resonance angiography for detection of atherosclerosis	LANCET			English	Article							3-DIMENSIONAL MR-ANGIOGRAPHY; PERIPHERAL VASCULAR-DISEASE; LOWER-EXTREMITY; DIGITAL SUBTRACTION; OCCLUSIVE DISEASE; RUNOFF VESSELS; RENAL-ARTERIES; BREATH-HOLD; ARTERIOGRAPHY; SINGLE	Background Choice of treatment for atherosclerosis depends on various clinical factors and radiological techniques. We aimed to assess the diagnostic accuracy of a new three-dimensional magnetic resonance angiography (3D MRA) strategy for the display of arterial vasculature from supraaortic arteries to distal runoff vessels in 72 s. Methods We examined five healthy volunteers and six patients over 6 weeks. Conventional digital subtraction angiography (DSA) was available as reference standard in all six patients. Magnetic resonance imaging was done on a commercially available 1.5 Tesla scanner. The imaging technique was based on the acquisition of five 3D data sets in rapid succession with an optimum single injection protocol. Findings Compared with conventional catheter angiography, according to the findings of two independent and masked readers, whole-body MRA had overall sensitivities of 91% (95% CI 0.76-0.98) and 94% (0.8-0.99), and specificities of 93% (0.85-0.97) and 90% (0.82-0.96) for the detection of substantial vascular disease (luminal narrowing >50%). Interobserver agreement for assessment of whole-body magnetic angiograms was very good (kappa =0.94: 95% CI 0.9-0.98). Interpretation The technique provides a comprehensive noninvasive approach for morphological screening assessment of the arterial vasculature from supra-aortic arteries to the distal runoff arteries.	Univ Hosp Essen, Dept Diagnost Radiol, D-45122 Essen, Germany; Univ Hosp Essen, Dept Angiol, D-45122 Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Ruehm, SG (corresponding author), Univ Hosp Essen, Dept Diagnost Radiol, D-45122 Essen, Germany.		Barkhausen, Joerg/E-3921-2010; Ladd, Mark E./B-3285-2011	Ladd, Mark/0000-0002-4128-9440				CARPENTER JP, 1992, J VASC SURG, V16, P807; Chiowanich P, 2000, AM J ROENTGENOL, V175, P523, DOI 10.2214/ajr.175.2.1750523; DOUEK PC, 1995, AM J ROENTGENOL, V165, P431, DOI 10.2214/ajr.165.2.7618572; Gross CM, 1997, AM J CARDIOL, V80, P1478, DOI 10.1016/S0002-9149(97)00727-3; Hany TF, 1997, RADIOLOGY, V204, P357, DOI 10.1148/radiology.204.2.9240520; Ho KYJAM, 1998, RADIOLOGY, V206, P683, DOI 10.1148/radiology.206.3.9494486; MALDEN ES, 1994, RADIOLOGY, V191, P149, DOI 10.1148/radiology.191.1.8134562; MCCAULEY TR, 1994, RADIOLOGY, V192, P351, DOI 10.1148/radiology.192.2.8029396; Meaney JFM, 1999, RADIOLOGY, V211, P59, DOI 10.1148/radiology.211.1.r99ap1859; OWEN RS, 1993, RADIOLOGY, V187, P627, DOI 10.1148/radiology.187.3.8497607; OWEN RS, 1992, NEW ENGL J MED, V326, P1577, DOI 10.1056/NEJM199206113262428; Picus D, 1991, J Vasc Interv Radiol, V2, P359, DOI 10.1016/S1051-0443(91)72263-X; PRINCE MR, 1993, JMRI-J MAGN RESON IM, V3, P877, DOI 10.1002/jmri.1880030614; Reddy KS, 1998, CIRCULATION, V97, P596; Rubin GD, 2000, RADIOLOGY, V215, P670, DOI 10.1148/radiology.215.3.r00jn18670; Ruehm SG, 2000, AM J ROENTGENOL, V174, P1127, DOI 10.2214/ajr.174.4.1741127; SMITH TP, 1992, AM J ROENTGENOL, V158, P431, DOI 10.2214/ajr.158.2.1729803; SNIDOW JJ, 1995, J VASC INTERV RADIOL, V6, P595, DOI 10.1016/S1051-0443(95)71143-5; SNIDOW JJ, 1995, RADIOLOGY, V196, P371, DOI 10.1148/radiology.196.2.7617847; Snidow JJ, 1996, RADIOLOGY, V198, P725, DOI 10.1148/radiology.198.3.8628861; Wang Y, 1998, RADIOLOGY, V207, P263, DOI 10.1148/radiology.207.1.9530326; YUCEL EK, 1994, AM J ROENTGENOL, V163, P197, DOI 10.2214/ajr.163.1.8010214; YUCEL EK, 1993, RADIOLOGY, V187, P637, DOI 10.1148/radiology.187.3.8497608	23	143	146	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1086	1091		10.1016/S0140-6736(00)04261-6	http://dx.doi.org/10.1016/S0140-6736(00)04261-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297960				2022-12-01	WOS:000167996200011
J	Thakker, RV				Thakker, RV			Genetic developments in hypoparathyroidism	LANCET			English	Editorial Material							MUTATIONS; RECEPTOR		Univ Oxford, Dept Clin Med, Dept Med, Oxford OX3 9DU, England	University of Oxford	Thakker, RV (corresponding author), Univ Oxford, Dept Clin Med, Dept Med, Oxford OX3 9DU, England.			Thakker, Rajesh/0000-0002-1438-3220				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; BILEZIKIAN JP, 1998, CURR OPIN ENDOCRINOL, V4, P427; BILOUS RW, 1992, NEW ENGL J MED, V327, P1069, DOI 10.1056/NEJM199210083271506; DING C, 2000, AM END SOC M; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; Van Esch H, 2000, NATURE, V406, P419, DOI 10.1038/35019088	13	22	25	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 31	2001	357	9261					974	976		10.1016/S0140-6736(00)04254-9	http://dx.doi.org/10.1016/S0140-6736(00)04254-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	416QK	11293637				2022-12-01	WOS:000167791500004
J	Hu, JT; Li, LS; Yang, WD; Manna, L; Wang, LW; Alivisatos, AP				Hu, JT; Li, LS; Yang, WD; Manna, L; Wang, LW; Alivisatos, AP			Linearly polarized emission from colloidal semiconductor quantum rods	SCIENCE			English	Article							CDSE NANOCRYSTALS; II-VI; DOTS; SPECTROSCOPY; LUMINESCENCE; COMPOSITES; CLUSTERS; POLYMER; GROWTH	Colloidal quantum rods of cadmium selenide (CdSe) exhibit linearly polarized emission. Empirical pseudopotential calculations predict that slightly elongated CdSe nanocrystals have polarized emission along the long axis, unlike spherical dots, which emit plane-polarized light. Single-molecule luminescence spectroscopy measurements on CdSe quantum rods with an aspect ratio between 1 and 30 confirm a sharp transition from nonpolarized to purely linearly polarized emission at an aspect ratio of 2. Linearly polarized luminescent chromophores are highly desirable in a variety of applications.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Sci Mat, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Energy Res Sci Comp Ctr, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Alivisatos, AP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Alivisatos, Paul/N-8863-2015; Manna, Liberato/G-2339-2010	Alivisatos, Paul/0000-0001-6895-9048; Manna, Liberato/0000-0003-4386-7985	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014891] Funding Source: NIH RePORTER; NCRR NIH HHS [1 R01 RR-14891-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALIVISATOS AP, 1989, J CHEM PHYS, V90, P3463, DOI 10.1063/1.455855; Alivisatos AP, 1996, J PHYS CHEM-US, V100, P13226, DOI 10.1021/jp9535506; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; BRUS L, 1991, APPL PHYS A-MATER, V53, P465, DOI 10.1007/BF00331535; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; COLVIN VL, 1994, NATURE, V370, P354, DOI 10.1038/370354a0; DABBOUSI BO, 1995, APPL PHYS LETT, V66, P1316, DOI 10.1063/1.113227; DANEK M, 1994, J CRYST GROWTH, V145, P714, DOI 10.1016/0022-0248(94)91132-0; EFROS AL, 1992, PHYS REV B, V46, P7448, DOI 10.1103/PhysRevB.46.7448; Efros AL, 1996, PHYS REV B, V54, P4843, DOI 10.1103/PhysRevB.54.4843; Efros AL, 2000, ANNU REV MATER SCI, V30, P475, DOI 10.1146/annurev.matsci.30.1.475; Empedocles SA, 1999, NATURE, V399, P126, DOI 10.1038/20138; GRUNDMANN M, 1995, PHYS REV LETT, V74, P4043, DOI 10.1103/PhysRevLett.74.4043; Ha T, 1999, J PHYS CHEM B, V103, P6839, DOI 10.1021/jp990948j; Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562; KLEIN MC, 1990, PHYS REV B, V42, P11123, DOI 10.1103/PhysRevB.42.11123; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; KOVALEV D, 1995, APPL PHYS LETT, V67, P1585, DOI 10.1063/1.114947; LEON R, 1995, SCIENCE, V267, P1966, DOI 10.1126/science.267.5206.1966; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; MIRMAL M, 1996, NATURE, V383, P802; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335; Peng XG, 2000, NATURE, V404, P59, DOI 10.1038/35003535; Peng XG, 1998, J AM CHEM SOC, V120, P5343, DOI 10.1021/ja9805425; Peng XG, 1997, J AM CHEM SOC, V119, P7019, DOI 10.1021/ja970754m; Peng ZA, 2001, J AM CHEM SOC, V123, P1389, DOI 10.1021/ja0027766; Rabani E, 1999, J CHEM PHYS, V110, P5355, DOI 10.1063/1.478431; Shim M, 1999, J CHEM PHYS, V111, P6955, DOI 10.1063/1.479988; Wang LW, 1996, PHYS REV B, V53, P9579, DOI 10.1103/PhysRevB.53.9579; YANG W, UNPUB	32	1100	1144	10	351	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2060	2063		10.1126/science.1060810	http://dx.doi.org/10.1126/science.1060810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11337589				2022-12-01	WOS:000169284700042
J	Arp, G; Reimer, A; Reitner, J				Arp, G; Reimer, A; Reitner, J			Photosynthesis-induced biofilm calcification and calcium concentrations in phanerozoic oceans	SCIENCE			English	Article							ALKALINE SALT LAKES; CARBONATE MINERALOGY; SEAWATER CHEMISTRY; CYANOBACTERIA	Photosynthetic carbon assimilation is commonly invoked as the cause of calcium carbonate precipitation in cyanobacterial biofilms that results in the formation of calcareous stromatolites. However, biofilm calcification patterns in recent lakes and simulation of photosynthetically induced rise in calcium carbonate supersaturation demonstrate that this mechanism applies only in settings Low in dissolved inorganic carbon and high in calcium. Taking into account paleo-partial pressure curves for carbon dioxide, we show that Phanerozoic oceans sustaining calcified cyanobacteria must have had considerably higher calcium concentrations than oceans of today. In turn, the enigmatic lack of calcified cyanobacteria in stromatolite-bearing Precambrian sequences can now be explained as a result of high dissolved inorganic carbon concentrations.	Univ Gottingen, Gottinger Zentrum Geowissensch, Abt Geobiol, D-37077 Gottingen, Germany	University of Gottingen	Arp, G (corresponding author), Univ Gottingen, Gottinger Zentrum Geowissensch, Abt Geobiol, Goldschmidtstr 3, D-37077 Gottingen, Germany.	garp@gwdg.de						[Anonymous], 1994, EARLY LIFE EARTH; Arp G, 1999, SEDIMENT GEOL, V126, P159, DOI 10.1016/S0037-0738(99)00038-X; Arp G, 1999, EUR J PHYCOL, V34, P393, DOI 10.1017/S0967026299002292; Arp G, 1998, PALAIOS, V13, P581, DOI 10.2307/3515349; AWRAMIK SM, 1971, SCIENCE, V174, P825, DOI 10.1126/science.174.4011.825; Berner RA, 1998, PHILOS T ROY SOC B, V353, P75, DOI 10.1098/rstb.1998.0192; BERTRANDSARFATI J, 1981, PRECAMBRIAN RES, V15, P353, DOI 10.1016/0301-9268(81)90057-7; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Ekart DD, 1999, AM J SCI, V299, P805, DOI 10.2475/ajs.299.10.805; Gebelein C. D., 1976, STROMATOLITES, P499; Grotzinger JP, 1996, NATURE, V383, P423, DOI 10.1038/383423a0; GROTZINGER JP, 1993, J GEOL, V101, P235, DOI 10.1086/648218; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Kempe Stephan, 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V13, P61; KNOLL AH, 1993, PALAIOS, V8, P512, DOI 10.2307/3515029; Knoll AH, 1992, EARLY ORGANIC EVOLUT, P450, DOI DOI 10.1007/978-3-642-76884-2_35; Laval B, 2000, NATURE, V407, P626, DOI 10.1038/35036579; Mann S., 1989, BIOMINERALIZATION CH; Merz M.U., 1992, FACIES, V26, P81, DOI [10.1007/BF02539795, DOI 10.1007/BF02539795]; PARKHURST D, 1990, 8096 US GEOL SURV; PENTECOST A, 1985, GEOMICROBIOL J, V4, P285, DOI 10.1080/01490458509385936; PENTECOST A, 1986, BIOMINERALIZATION LO, P73; RIDING R, 1992, J GEOL SOC LONDON, V149, P979, DOI 10.1144/gsjgs.149.6.0979; RIDING R, 1982, NATURE, V299, P814, DOI 10.1038/299814a0; RIDING R, 1977, Palaeontology (Oxford), V20, P33; Riding R., 1991, CALCAREOUS ALGAE STR, P21, DOI DOI 10.1007/978-3-642-52335-9_2; RIDING R, 1994, EARLY LIFE EARTH, P426; SANDBERG PA, 1983, NATURE, V305, P19, DOI 10.1038/305019a0; Simkiss K., 1989, BIOMINERALIZATION CE; Stanley SM, 1998, PALAEOGEOGR PALAEOCL, V144, P3, DOI 10.1016/S0031-0182(98)00109-6; Stumm W., 1996, AQUAT CHEM; Thompson JB, 1997, LIMNOL OCEANOGR, V42, P133	32	341	386	3	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1701	1704		10.1126/science.1057204	http://dx.doi.org/10.1126/science.1057204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387471				2022-12-01	WOS:000169031800040
J	Bence, NF; Sampat, RM; Kopito, RR				Bence, NF; Sampat, RM; Kopito, RR			Impairment of the ubiquitin-proteasome system by protein aggregation	SCIENCE			English	Article							MULTICATALYTIC PROTEINASE; GLUTAMINE REPEATS; DEGRADATION; NEURODEGENERATION; PROTEOLYSIS; INHIBITOR; DISEASE; ARREST; CELLS; SCA1	Intracellular deposition of aggregated and ubiquitylated proteins is a prominent cytopathological feature of most neurodegenerative disorders. Whether protein aggregates themselves are pathogenic or are the consequence of an underlying molecular lesion is unclear. Here, we report that protein aggregation directly impaired the function of the ubiquitin-proteasome system. Transient expression of two unrelated aggregation-prone proteins, a huntingtin fragment containing a pathogenic polyglutamine repeat and a folding mutant of cystic fibrosis transmembrane conductance regulator, caused nearly complete inhibition of the ubiquitin-proteasome system. Because of the central role of ubiquitin-dependent proteolysis in regulating fundamental cellular events such as cell division and apoptosis, our data suggest a potential mechanism Linking protein aggregation to cellular disregulation and cell death.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Kopito, RR (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Bercovich B, 1997, J BIOL CHEM, V272, P9002; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; HOWARD M, 1995, AM J PHYSIOL, V269, pC1595; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; KWAK S, 1991, NEUROSCI LETT, V128, P21, DOI 10.1016/0304-3940(91)90751-E; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Mayer R J, 1989, Prog Clin Biol Res, V317, P809; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Raina A K, 2000, Prog Cell Cycle Res, V4, P235; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Schulz JB, 1999, CURR OPIN NEUROL, V12, P433, DOI 10.1097/00019052-199908000-00010; SHERWOOD SW, 1993, P NATL ACAD SCI USA, V90, P3353, DOI 10.1073/pnas.90.8.3353; Wigley WC, 1999, J CELL BIOL, V145, P481; Wojcik C, 1996, EUR J CELL BIOL, V70, P172; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	24	1702	1760	2	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1552	1555		10.1126/science.292.5521.1552	http://dx.doi.org/10.1126/science.292.5521.1552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375494				2022-12-01	WOS:000168963800047
J	Elbashir, SM; Harborth, J; Lendeckel, W; Yalcin, A; Weber, K; Tuschl, T				Elbashir, SM; Harborth, J; Lendeckel, W; Yalcin, A; Weber, K; Tuschl, T			Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells	NATURE			English	Article							DOUBLE-STRANDED-RNA; DROSOPHILA CELLS; PROTEIN-KINASE; GENE; METHYLATION; INHIBITION	RNA interference (RNAi) is the process of sequence-specific, post-transcriptional gene silencing in animals and plants, initiated by double-stranded RNA (dsRNA) that is homologous in sequence to the silenced gene(1-4). The mediators of sequence-specific messenger RNA degradation are 21- and 22-nucleotide small interfering RNAs (siRNAs) generated by ribonuclease III cleavage from longer dsRNAs(5-9). Here we show that 21-nucleotide siRNA duplexes specifically suppress expression of endogenous and heterologous genes in different mammalian cell lines, including human embryonic kidney (293) and HeLa cells. Therefore, 21-nucleotide siRNA duplexes provide a new tool for studying gene function in mammalian cells and may eventually be used as gene-specific therapeutics.	Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37033 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Biochem & Cell Biol, D-37033 Gottingen, Germany	Max Planck Society; Max Planck Society	Tuschl, T (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37033 Gottingen, Germany.		Yalcin, Abdullah/AAG-4175-2019; hu, jenny/AAK-8712-2020	Yalcin, Abdullah/0000-0001-8604-4749; 				Bahramian MB, 1999, MOL CELL BIOL, V19, P274; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; CLEMENS MJ, 1978, CELL, V13, P565, DOI 10.1016/0092-8674(78)90329-X; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Harborth J, 1999, EMBO J, V18, P1689, DOI 10.1093/emboj/18.6.1689; Kehlenbach RH, 1998, J CELL BIOL, V141, P863, DOI 10.1083/jcb.141.4.863; KREIS T, 1999, GUIDEBOOK CYTOSKE 2B; KREIS T, 1999, GUIDEBOOK CYTOSKE 3A; Macejak DG, 2000, HEPATOLOGY, V31, P769, DOI 10.1002/hep.510310331; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; MINKS MA, 1979, J BIOL CHEM, V254, P180; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; ROBER RA, 1990, EXP CELL RES, V190, P185, DOI 10.1016/0014-4827(90)90184-C; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Svoboda P, 2000, DEVELOPMENT, V127, P4147; Tuschl T, 2001, CHEMBIOCHEM, V2, P239, DOI 10.1002/1439-7633(20010401)2:4<239::AID-CBIC239>3.3.CO;2-I; Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4; Wang MB, 2001, RNA, V7, P16, DOI 10.1017/S1355838201001224; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	31	7394	9452	34	1104	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					494	498		10.1038/35078107	http://dx.doi.org/10.1038/35078107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373684				2022-12-01	WOS:000168858700053
J	Brejc, K; van Dijk, WJ; Klaassen, RV; Schuurmans, M; van der Oost, J; Smit, AB; Sixma, TK				Brejc, K; van Dijk, WJ; Klaassen, RV; Schuurmans, M; van der Oost, J; Smit, AB; Sixma, TK			Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors	NATURE			English	Article							TORPEDO ACETYLCHOLINE-RECEPTOR; MAIN IMMUNOGENIC REGION; ALPHA-SUBUNIT; MOLECULAR DISSECTION; EXTRACELLULAR DOMAIN; IDENTIFICATION; SITE; RESIDUES; AGONIST; LOCATION	Pentameric ligand gated ion-channels, or Cys-loop receptors, mediate rapid chemical transmission of signals. This superfamily of allosteric transmembrane proteins includes the nicotinic acetylcholine (nAChR), serotonin 5-HT3, gamma -aminobutyric-acid (GABA(A) and GABA(C)) and glycine receptors. Biochemical and electrophysiological information on the prototypic nAChRs is abundant but structural data at atomic resolution have been missing. Here we present the crystal structure of molluscan acetylcholine-binding protein (AChBP), a structural and functional homologue of the amino-terminal ligand-binding domain of an nAChR alpha -subunit. In the AChBP homopentamer, the protomers have an immunoglobulin-like topology. Ligand-binding sites are located at each of five subunit interfaces and contain residues contributed by biochemically determined 'loops' A to F. The subunit interfaces are highly variable within the ion-channel family, whereas the conserved residues stabilize the protomer fold. This AChBP structure is relevant for the development of drugs against, for example, Alzheimer's disease and nicotine addiction.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Free Univ Amsterdam, Fac Biol, Neurosci Res Inst, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands	Netherlands Cancer Institute; Vrije Universiteit Amsterdam	Sixma, TK (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	sixma@nki.nl	Smit, August B/E-8410-2011; van+der+Oost, John/Y-2548-2019	Sixma, Titia K/0000-0001-6180-0632				Alexeev T, 1999, EUR J BIOCHEM, V259, P310, DOI 10.1046/j.1432-1327.1999.00041.x; Arias HR, 2000, NEUROCHEM INT, V36, P595, DOI 10.1016/S0197-0186(99)00154-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEROUKHIM R, 1995, NEURON, V15, P323, DOI 10.1016/0896-6273(95)90037-3; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CORRINGER PJ, 1995, J BIOL CHEM, V270, P11749, DOI 10.1074/jbc.270.20.11749; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; CZAJKOWSKI C, 1993, P NATL ACAD SCI USA, V90, P6285, DOI 10.1073/pnas.90.13.6285; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; FU DX, 1994, J BIOL CHEM, V269, P26152; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; GALZI JL, 1990, J BIOL CHEM, V265, P10430; Green WN, 1998, J NEUROSCI, V18, P5555; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; HEMMINGSEN JM, 1994, PROTEIN SCI, V3, P1927, DOI 10.1002/pro.5560031104; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAO PN, 1986, J BIOL CHEM, V261, P8085; Kleywegt G. J., 1994, P CCP4 STUD WEEK 1 M, P59; Le Novere N, 1999, BIOPHYS J, V76, P2329, DOI 10.1016/S0006-3495(99)77390-X; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; MACHOLD J, 1995, EUR J BIOCHEM, V234, P427, DOI 10.1111/j.1432-1033.1995.427_b.x; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MISHINA M, 1985, NATURE, V313, P364, DOI 10.1038/313364a0; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; OLEARY ME, 1994, AM J PHYSIOL, V266, pC648, DOI 10.1152/ajpcell.1994.266.3.C648; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Schrattenholz A, 1998, J BIOL CHEM, V273, P32393, DOI 10.1074/jbc.273.49.32393; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tierney ML, 2000, J MOL BIOL, V303, P185, DOI 10.1006/jmbi.2000.4137; TZARTOS SJ, 1991, MOL NEUROBIOL, V5, P1, DOI 10.1007/BF02935610; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VALENZUELA CF, 1994, BIOPHYS J, V66, P674, DOI 10.1016/S0006-3495(94)80841-0; Wells GB, 1998, J BIOL CHEM, V273, P964, DOI 10.1074/jbc.273.2.964; West AP, 1997, J BIOL CHEM, V272, P25468, DOI 10.1074/jbc.272.41.25468; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	50	1527	1568	5	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					269	276		10.1038/35077011	http://dx.doi.org/10.1038/35077011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357122				2022-12-01	WOS:000168710000037
J	Istvan, ES; Deisenhofer, J				Istvan, ES; Deisenhofer, J			Structural mechanism for statin inhibition of HMG-CoA reductase	SCIENCE			English	Article							ELECTRON-DENSITY MAPS; 3-HYDROXY-3-METHYLGLUTARYL COENZYME; CRYSTAL-STRUCTURE; CATALYSIS; INSIGHTS; ML-236B	HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase (HMGR) catalyzes the committed step in cholesterol biosynthesis. Statins are HMGR inhibitors with inhibition constant values in the nanomolar range that effectively lower serum cholesterol levels and are widely prescribed in the treatment of hypercholesterolemia. We have determined structures of the catalytic portion of human HMGR complexed with six different statins. The statins occupy a portion of the binding site of HMG-CoA, thus blocking access of this substrate to the active site. Near the carboxyl terminus of HMGR, several catalytically relevant residues are disordered in the enzyme-statin complexes. If these residues were not flexible, they would sterically hinder statin binding.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Deisenhofer, J (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA.	Johann.Deisenhofer@UTSouthwestern.edu						BISCHOFF KM, 1992, BIOCHEM MED METAB B, V48, P149, DOI 10.1016/0885-4505(92)90060-C; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CORSINI A, 1995, PHARMACOL RES, V31, P9, DOI 10.1016/1043-6618(95)80042-5; Davignon J, 1999, CURR OPIN LIPIDOL, V10, P543, DOI 10.1097/00041433-199912000-00010; Eisenberg Daniel A., 1998, American Journal of Medicine, V104, p2S, DOI 10.1016/S0002-9343(98)00038-2; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; ESSER L, COMMUNICATION; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; HOLDGATE GA, UNPUB; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Istvan ES, 2000, BBA-MOL CELL BIOL L, V1529, P9, DOI 10.1016/S1388-1981(00)00134-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; LAWRENCE CM, 1995, SCIENCE, V268, P1758, DOI 10.1126/science.7792601; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Tabernero L, 1999, P NATL ACAD SCI USA, V96, P7167, DOI 10.1073/pnas.96.13.7167	20	1060	1110	9	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1160	1164		10.1126/science.1059344	http://dx.doi.org/10.1126/science.1059344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349148				2022-12-01	WOS:000168609200059
J	Fukami, K; Nakao, K; Inoue, T; Kataoka, Y; Kurokawa, M; Fissore, RA; Nakamura, K; Katsuki, M; Mikoshiba, K; Yoshida, N; Takenawa, T				Fukami, K; Nakao, K; Inoue, T; Kataoka, Y; Kurokawa, M; Fissore, RA; Nakamura, K; Katsuki, M; Mikoshiba, K; Yoshida, N; Takenawa, T			Requirement of phospholipase C delta 4 for the zona pellucida-induced acrosome reaction	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INTRACELLULAR CA2+; MAMMALIAN SPERM; MOUSE SPERM; C DELTA-4; EXOCYTOSIS; BETA; EGGS; FERTILIZATION; SPERMATOZOA	Several phospholipase C (PLC) isoforms have been found in male and female mammalian gametes, and splicing isoforms of PLC delta4 are predominantly expressed in testis. Here we report that male mice in which the PLC delta4 gene had been disrupted either produced few small litters or were sterile. In vitro fertilization studies showed that insemination with PLC delta4(-/-) sperm resulted in significantly fewer eggs becoming activated and that the calcium transients associated with fertilization were absent or delayed. PLC delta4(-/-) sperm were unable to initiate the acrosome reaction, an exocytotic event required for fertilization and induced by interaction with the egg coat, the zona pellucida. These data demonstrate that PLC delta4 functions in the acrosome reaction that is induced by the zona pellucida during mammalian fertilization.	Univ Tokyo, Inst Med Sci, Dept Biochem, Tokyo 1088039, Japan; Univ Tokyo, Inst Med Sci, Div DNA Biol & Embryo Engn, Ctr Med Expt, Tokyo 1088039, Japan; Univ Tokyo, Inst Med Sci, Dept Neurobiol, Tokyo 1088039, Japan; Univ Tokyo, Inst Med Sci, Div Gene Express & Regulat, Tokyo 1088039, Japan; Univ Massachusetts, Paige Lab, Dept Vet & Anim Sci, Amherst, MA 01003 USA; RIKEN, Brian Sci Inst, Wako, Saitama 3510198, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; University of Massachusetts System; University of Massachusetts Amherst; RIKEN	Fukami, K (corresponding author), Univ Tokyo, Inst Med Sci, Dept Biochem, Tokyo 1088039, Japan.		Inoue, Takafumi/AAM-9533-2020; Mikoshiba, Katsuhiko/N-7943-2015	Inoue, Takafumi/0000-0002-2728-0060; Kurokawa, Manabu/0000-0002-4138-5934				CAMILLI PD, 1996, SCIENCE, V271, P1533; Dupont G, 1996, BIOCHEM J, V316, P583, DOI 10.1042/bj3160583; FLORMAN HM, 1994, DEV BIOL, V165, P152, DOI 10.1006/dbio.1994.1242; Jones KT, 2000, BIOCHEM J, V346, P743, DOI 10.1042/0264-6021:3460743; Kaznacheyeva E, 2000, J BIOL CHEM, V275, P4561, DOI 10.1074/jbc.275.7.4561; Lee SB, 1996, J BIOL CHEM, V271, P25, DOI 10.1074/jbc.271.1.25; Liu NS, 1996, J BIOL CHEM, V271, P355, DOI 10.1074/jbc.271.1.355; Llanos MN, 1998, MOL REPROD DEV, V51, P84, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;84::AID-MRD10&gt;3.0.CO;2-U; Nagano K, 1999, J BIOL CHEM, V274, P2872, DOI 10.1074/jbc.274.5.2872; Nolan JP, 1997, FASEB J, V11, P670, DOI 10.1096/fasebj.11.8.9240968; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; Runft LL, 1999, DEV BIOL, V214, P399, DOI 10.1006/dbio.1999.9415; Shirakawa H, 1999, DEV BIOL, V208, P70, DOI 10.1006/dbio.1998.9194; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; WARD CR, 1992, J BIOL CHEM, V267, P14061; Wassarman PM, 1999, CELL, V96, P175, DOI 10.1016/S0092-8674(00)80558-9; Wu H, 1998, DEV BIOL, V203, P369, DOI 10.1006/dbio.1998.9070	19	149	150	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					920	923		10.1126/science.1059042	http://dx.doi.org/10.1126/science.1059042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340203				2022-12-01	WOS:000168514900041
J	Fabrega, C; Farrow, MA; Mukhopadhyay, B; de Crecy-Lagard, V; Ortiz, AR; Schimmel, P				Fabrega, C; Farrow, MA; Mukhopadhyay, B; de Crecy-Lagard, V; Ortiz, AR; Schimmel, P			An aminoacyl tRNA synthetase whose sequence fits into neither of the two known classes	NATURE			English	Article							TRANSFER-RNA-SYNTHETASE; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; METHANOCOCCUS-JANNASCHII; TWILIGHT ZONE; SIMILARITIES; ALIGNMENT; PROTEINS; HOMOLOGY; SEARCH	Aminoacyl transfer RNA synthetases catalyse the first step of protein synthesis and establish the rules of the genetic code through the aminoacylation of tRNAs. There is a distinct synthetase for each of the 20 amino acids and throughout evolution these enzymes have been divided into two classes of ten enzymes each(1,2). These classes are defined by the distinct architectures of their active sites, which are associated with specific and universal sequence motifs(1-5). Because the synthesis of aminoacyl-tRNAs containing each of the twenty amino acids is a universally conserved, essential reaction, the absence of a recognizable gene for cysteinyl tRNA synthetase in the genomes of Archae such as Methanococcus jannaschii and Methanobacterium thermoautotrophicum(6-8) has been difficult to interpret. Here we describe a different cysteinyl-tRNA synthetase from M. jannaschii and Deinococcus radiodurans and its characterization in vitro and in vivo. This protein lacks the characteristic sequence motifs seen in the more than 700 known members of the two canonical classes of tRNA synthetase and may be of ancient origin. The existence of this protein contrasts with proposals that aminoacylation with cysteine in M. jannaschii is an auxiliary function of a canonical prolyl-tRNA synthetase(9,10).	Scripps Res Inst, Skaggs Inst Chem Biol, Beckman Ctr, La Jolla, CA 92037 USA; Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	Scripps Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, Beckman Ctr, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Fabrega, Carme/AAZ-5469-2021; Fàbrega, MCarme/K-9847-2014; de Crecy-Lagard, Valerie/AAN-8995-2020	Fàbrega, MCarme/0000-0003-3816-7634; Mukhopadhyay, Biswarup/0000-0003-0736-0298				Abagyan RA, 1997, J MOL BIOL, V273, P355, DOI 10.1006/jmbi.1997.1287; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; BOHMAN K, 1979, MOL GEN GENET, V176, P53, DOI 10.1007/BF00334295; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Bunjun S, 2000, P NATL ACAD SCI USA, V97, P12997, DOI 10.1073/pnas.230444397; CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1681, DOI 10.1021/bi00869a033; Chung SY, 1996, STRUCTURE, V4, P1123, DOI 10.1016/S0969-2126(96)00119-0; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Glasfeld E, 1996, BIOCHEMISTRY-US, V35, P4139, DOI 10.1021/bi9527810; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Hamann CS, 1999, J BACTERIOL, V181, P5880, DOI 10.1128/JB.181.18.5880-5884.1999; HOUNTONDJI C, 1986, BIOCHIMIE, V68, P1071, DOI 10.1016/S0300-9084(86)80181-X; Johnson RA, 2007, APPL MULTIVARIATE ST; Lipman RSA, 2000, BIOCHEMISTRY-US, V39, P7792, DOI 10.1021/bi0004955; LUDMERER SW, 1987, J BIOL CHEM, V262, P10801; Mukhopadhyay B, 1999, APPL ENVIRON MICROB, V65, P5059; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Reeve JN, 1999, J BACTERIOL, V181, P3613, DOI 10.1128/JB.181.12.3613-3617.1999; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sambrook J., 1989, MOL CLONING LAB MANU; SHEPARD A, 1992, P NATL ACAD SCI USA, V89, P9964, DOI 10.1073/pnas.89.20.9964; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; Stathopoulos C, 2000, SCIENCE, V287, P479, DOI 10.1126/science.287.5452.479; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392	29	25	28	1	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					110	114		10.1038/35075121	http://dx.doi.org/10.1038/35075121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333988				2022-12-01	WOS:000168432800054
J	Guillin, O; Diaz, J; Carroll, P; Griffon, N; Schwartz, JC; Sokoloff, P				Guillin, O; Diaz, J; Carroll, P; Griffon, N; Schwartz, JC; Sokoloff, P			BDNF controls dopamine D-3 receptor expression and triggers behavioural sensitization	NATURE			English	Article							COCAINE-SEEKING BEHAVIOR; NEUROTROPHIC FACTOR; ANTEROGRADE TRANSPORT; MESSENGER-RNA; RAT-BRAIN; AXONAL-TRANSPORT; NEURONS; LESIONS; SCHIZOPHRENIA; MECHANISM	Brain-derived neurotrophic factor (BDNF), like other neurotrophins, is a polypeptidic factor initially regarded to be responsible for neuron proliferation, differentiation and survival, through its uptake at nerve terminals and retrograde transport to the cell body(1). A more diverse role for BDNF has emerged progressively from observations showing that it is also transported anterogradely(2,3), is released on neuron depolarization(1), and triggers rapid intracellular signals(4) and action potentials in central neurons(5). Here we report that BDNF elicits long-term neuronal adaptations by controlling the responsiveness of its target neurons to the important neurotransmitter, dopamine. Using lesions and gene-targeted mice lacking BDNF, we show that BDNF from dopamine neurons is responsible for inducing normal expression of the dopamine D-3 receptor in nucleus accumbens(6-8) both during development and in adulthood. BDNF from corticostriatal neurons(3) also induces behavioural sensitization, by triggering overexpression of the D-3 receptor in striatum of hemiparkinsonian rats(9). Our results suggest that BDNF may be an important determinant of pathophysiological conditions such as drug addiction(10), schizophrenia(11) or Parkinson's disease(12), in which D-3 receptor expression is abnormal.	Ctr Paul Broca, INSERM, U109, Unite Neurobiol & Pharmacol Mol, F-75014 Paris, France; Univ Paris 05, Physiol Lab, F-75006 Paris, France; INSERM, U382, IBDM, Unite Dev & Pathol Motoneurone Spinal, F-13288 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Sokoloff, P (corresponding author), Ctr Paul Broca, INSERM, U109, Unite Neurobiol & Pharmacol Mol, 2Ter Rue Alesia, F-75014 Paris, France.		Carroll, Patrick/AAL-7773-2021	Diaz, Jorge/0000-0001-9894-0444				Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Bordet R, 1997, P NATL ACAD SCI USA, V94, P3363, DOI 10.1073/pnas.94.7.3363; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; COLE DG, 1994, P NATL ACAD SCI USA, V91, P9631, DOI 10.1073/pnas.91.20.9631; Conner JM, 1997, J NEUROSCI, V17, P2295; Diaz J, 1997, J NEUROSCI, V17, P4282; DIAZ J, 1995, NEUROSCIENCE, V65, P731, DOI 10.1016/0306-4522(94)00527-C; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Flores G, 1996, J NEUROSCI, V16, P2020; Gurevich EV, 1997, ARCH GEN PSYCHIAT, V54, P225; Horger BA, 1999, J NEUROSCI, V19, P4110; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LEVESQUE D, 1995, P NATL ACAD SCI USA, V92, P1719, DOI 10.1073/pnas.92.5.1719; Numan S, 1997, EUR J NEUROSCI, V9, P489, DOI 10.1111/j.1460-9568.1997.tb01626.x; OBRIEN CP, 1992, RES P ARNMD, V70, P157; Pilla M, 1999, NATURE, V400, P371, DOI 10.1038/43944; Ryoo HL, 1998, MOVEMENT DISORD, V13, P788, DOI 10.1002/mds.870130506; SEROOGY KB, 1994, J COMP NEUROL, V342, P321, DOI 10.1002/cne.903420302; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; Staley JK, 1996, J NEUROSCI, V16, P6100; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; vonBartheld CS, 1996, NATURE, V379, P830, DOI 10.1038/379830a0; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/s002130050079	30	454	470	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					86	89		10.1038/35075076	http://dx.doi.org/10.1038/35075076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333982				2022-12-01	WOS:000168432800048
J	Okabe, M; Imai, T; Kurusu, M; Hiromi, Y; Okano, H				Okabe, M; Imai, T; Kurusu, M; Hiromi, Y; Okano, H			Translational repression determines a neuronal potential in Drosophila asymmetric cell division	NATURE			English	Article							SENSORY ORGAN DEVELOPMENT; FATE DETERMINATION; GLIAL-CELL; STEM-CELL; PROTEIN; TRAMTRACK; BINDING; NOTCH; RNA; LINEAGE	Asymmetric cell division is a fundamental strategy for generating cellular diversity during animal development(1). Daughter cells manifest asymmetry in their differential gene expression. Transcriptional regulation of this process has been the focus of many studies, whereas cell-type-specific 'translational' regulation has been considered to have a more minor role. During sensory organ development in Drosophila, Notch signalling directs the asymmetry between neuronal and non-neuronal lineages(2), and a zinc-finger transcriptional repressor Tramtrack69 (TTK69) acts downstream of Notch as a determinant of non-neuronal identity(3,4). Here we show that repression of TTK69 protein expression in the neuronal lineage occurs translationally rather than transcriptionally. This translational repression is achieved by a direct interaction between cis-acting sequences in the 3' untranslated region of ttk69 messenger RNA and its trans-acting repressor, the RNA-binding protein Musashi (MSI)(5). Although msi can act downstream of Notch, Notch signalling does not affect MSI expression. Thus, Notch signalling is likely to regulate MSI activity rather than its expression. Our results define cell-type-specific translational control of ttk69 by MSI as a downstream event of Notch signalling in asymmetric cell division.	Grad Univ Adv Studies, Div Dev Genet, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka 4118540, Japan; Osaka Univ, Grad Sch Med, Dept Neurosci,Biomed Res Ctr, Div Neuroanat D12, Osaka 5650871, Japan; Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; Osaka Univ, Grad Sch Engn Sci, Div Biophys Engn, Neurosci Lab, Osaka 5608531, Japan; Univ Tsukuba, Inst Basic Med Sci, Dept Mol Neurobiol, Tsukuba, Ibaraki 3058572, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Minato Ku, Tokyo 1050011, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Osaka University; Keio University; Osaka University; University of Tsukuba; Japan Science & Technology Agency (JST)	Okabe, M (corresponding author), Grad Univ Adv Studies, Div Dev Genet, Natl Inst Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan.		Imai, Takao/L-1232-2013; Okano, Hideyuki/I-7584-2019					BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; CHANG HC, 1995, CELL, V80, P463, DOI 10.1016/0092-8674(95)90497-2; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gho M, 1996, DEVELOPMENT, V122, P1673; Gho M, 1999, DEVELOPMENT, V126, P3573; GHYSEN A, 1989, DEVELOPMENT, V105, P35; Giesen K, 1997, DEVELOPMENT, V124, P2307; Goto S, 1997, DEV GENES EVOL, V207, P194, DOI 10.1007/s004270050107; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; GUO M, 1995, NEURON, V14, P913, DOI 10.1016/0896-6273(95)90330-5; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hirota Y, 1999, MECH DEVELOP, V87, P93, DOI 10.1016/S0925-4773(99)00143-4; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jacobsen TL, 1998, DEVELOPMENT, V125, P4531; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; Jin MH, 2000, MOL CELL BIOL, V20, P2098, DOI 10.1128/MCB.20.6.2098-2107.2000; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Ramaekers G, 1997, DEV GENES EVOL, V207, P97, DOI 10.1007/s004270050096; Reddy GV, 1999, DEVELOPMENT, V126, P4617; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; SPANA EP, 1995, DEVELOPMENT, V121, P3187; XIONG WC, 1993, GENE DEV, V7, P1085, DOI 10.1101/gad.7.6.1085; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	29	149	161	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					94	98		10.1038/35075094	http://dx.doi.org/10.1038/35075094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333984				2022-12-01	WOS:000168432800050
J	Sellman, BR; Mourez, M; Collier, RJ				Sellman, BR; Mourez, M; Collier, RJ			Dominant-negative mutants of a toxin subunit: An approach to therapy of anthrax	SCIENCE			English	Article							PROTECTIVE ANTIGEN; LETHAL FACTOR; MACROPHAGES; TRANSLOCATION; RECEPTOR; EFFICACY; TERMINUS; CHANNEL; SURFACE; CELLS	The protective antigen moiety of anthrax toxin translocates the toxin's enzymic moieties to the cytosol of mammalian cells by a mechanism that depends on its ability to heptamerize and insert into membranes. We identified dominant-negative mutants of protective antigen that co-assemble with the wild-type protein and block its ability to translocate the enzymic moieties across membranes. These mutants strongly inhibited toxin action in cell culture and in an animal intoxication model, suggesting that they could be useful in therapy of anthrax.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Collier, RJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.			Collier, R John/0000-0002-2427-4239	NIAID NIH HHS [5T32AI07410, R37-AI22021] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI022021, T32AI007410] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; ESCUYER V, 1991, INFECT IMMUN, V59, P3381, DOI 10.1128/IAI.59.10.3381-3386.1991; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Friedlander AM, 1999, JAMA-J AM MED ASSOC, V282, P2104, DOI 10.1001/jama.282.22.2104; IVINS BE, 1989, APPL ENVIRON MICROB, V55, P2098, DOI 10.1128/AEM.55.8.2098-2100.1989; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KOEHLER TM, 1991, MOL MICROBIOL, V5, P1501, DOI 10.1111/j.1365-2958.1991.tb00796.x; Leppla S.H., 1991, SOURCEBOOK BACTERIAL, P277; McBride B, 1998, VACCINE, V16, P810, DOI 10.1016/S0264-410X(97)00268-5; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; RAPUOLI R, 2000, CELLULAR MICROBIOLOG, P193; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; SINGH Y, IN PRESS J BIOL CHEM; Vinion-Dubiel AD, 1999, J BIOL CHEM, V274, P37736, DOI 10.1074/jbc.274.53.37736; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; WALKER B, 1992, J BIOL CHEM, V267, P21782; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i	26	165	178	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					695	697		10.1126/science.109563	http://dx.doi.org/10.1126/science.109563			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326092	Green Submitted			2022-12-01	WOS:000168478300042
J	Min, JR; Landry, J; Sternglanz, R; Xu, RM				Min, JR; Landry, J; Sternglanz, R; Xu, RM			Crystal structure of a SIR2 homolog-NAD complex	CELL			English	Article							SILENCING PROTEIN SIR2; SACCHAROMYCES-CEREVISIAE; TELOMERIC HETEROCHROMATIN; DEACETYLASE ACTIVITY; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; DIFFRACTION DATA; GENE-EXPRESSION; ZINC RIBBON; YEAST	The SIR2 protein family comprises a novel class of nicotinamide-adenine dinucleotide (NAD)-dependent protein deacetylases that function in transcriptional silencing, DNA repair, and life-span extension in Saccharomyces cerevisiae. Two crystal structures of a SIR2 homolog from Archaeoglobus fulgidus complexed with NAD have been determined at 2.1 Angstrom and 2.4 Angstrom resolutions. The structures reveal that the protein consists of a large domain having a Rossmann fold and a small domain containing a three-stranded zinc ribbon motif. NAD is bound in a pocket between the two domains. A distinct mode of NAD binding and an unusual configuration of the zinc ribbon motif are observed. The structures also provide important insights into the catalytic mechanism of NAB-dependent protein deacetylation by this family of enzymes.	Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Xu, RM (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		xu, rui/GRX-5734-2022; Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130	NIGMS NIH HHS [GM55641] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055641] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afshar G, 1999, GENE, V234, P161, DOI 10.1016/S0378-1119(99)00162-6; ALLSHIRE RC, 1996, EPIGENETIC MECH GENE, P443; APARICIO OM, 1991, CELL, V66, P1; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cockell MM, 2000, GENETICS, V154, P1069; Cuperus G, 2000, EMBO J, V19, P2641, DOI 10.1093/emboj/19.11.2641; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fritze CE, 1997, EMBO J, V16, P6495, DOI 10.1093/emboj/16.21.6495; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Gartenberg MR, 2000, CURR OPIN MICROBIOL, V3, P132, DOI 10.1016/S1369-5274(00)00064-3; Gottschling DE, 2000, CURR BIOL, V10, pR708, DOI 10.1016/S0960-9822(00)00714-4; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Holm L, 1996, METHOD ENZYMOL, V266, P653; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prasad GS, 1999, NAT STRUCT BIOL, V6, P1126; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; RINE J, 1987, GENETICS, V116, P9; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tsang AW, 1998, J BIOL CHEM, V273, P31788, DOI 10.1074/jbc.273.48.31788; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Wang B, 1998, STRUCTURE, V6, P555, DOI 10.1016/S0969-2126(98)00058-6; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	55	260	274	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					269	279		10.1016/S0092-8674(01)00317-8	http://dx.doi.org/10.1016/S0092-8674(01)00317-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336676	Bronze			2022-12-01	WOS:000168384300013
J	Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP				Le Grand, R; Mondloch, CJ; Maurer, D; Brent, HP			Neuroperception - Early visual experience and face processing	NATURE			English	Article							CONFIGURATION; RECOGNITION; INVERSION		McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Le Grand, R (corresponding author), McMaster Univ, Dept Psychol, Hamilton, ON L8S 4K1, Canada.							BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; de Schonen S., 1989, EUROPEAN B COGNITIVE, V9, P3; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Ellemberg D, 1999, VISION RES, V39, P3480, DOI 10.1016/S0042-6989(99)00078-4; Farah MJ., 2000, COGNITIVE NEUROSCIEN; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; GELDART S, 2000, THESIS MCMASTER U; Kanwisher N, 1997, J NEUROSCI, V17, P4302; MAURER D, IN PRESS CLIN NEUROS; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301	13	335	336	2	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					890	890		10.1038/35073749	http://dx.doi.org/10.1038/35073749			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	423AG	11309606				2022-12-01	WOS:000168152300035
J	Episkopou, V; Arkell, R; Timmons, PM; Walsh, JJ; Andrew, RL; Swan, D				Episkopou, V; Arkell, R; Timmons, PM; Walsh, JJ; Andrew, RL; Swan, D			Induction of the mammalian node requires Arkadia function in the extraembryonic lineages	NATURE			English	Article							EMBRYONIC STEM-CELLS; VISCERAL ENDODERM; PRIMITIVE ENDODERM; MOUSE; EXPRESSION; TISSUES; GENE; FOREBRAIN; GASTRULATION; ORGANIZER	The early mammalian embryo is patterned by signals emanating from extraembryonic and embryonic signalling centres, most notably the anterior visceral endoderm (AVE) and the node, respectively(1). The AVE is responsible for anterior development, whereas further axis specification depends on the node, the equivalent of Spemann's organizer(2,3). Formation of the node, at the anterior primitive streak, depends on expression of the transcription factor HNF3 beta (ref. 4). However, both the source and the nature of the signals responsible for inducing the node have been unknown. Here we describe a recessive lethal mutation, arkadia, generated using gene-trap mutagenesis. Mutant embryos establish an AVE but fail to maintain anterior embryonic structures and lack a node. The mutation has disrupted the Arkadia gene, which encodes a putative intracellular protein containing a RING domain. Arkadia is essential for HNF3 beta expression in the anterior primitive streak. Analysis with chimaeras, however, shows that Arkadia functions within extraembryonic tissues, revealing that these are required to induce the node. Furthermore, our experiments show that Arkadia interacts genetically with the transforming growth factor (TGF)beta -like factor Nodal(5-7), implying that Nodal mediates the function of Arkadia in node induction.	Hammersmith Hosp, Imperial Coll, Sch Med, MRC,Clin Sci Ctr, London W12 0NN, England	Imperial College London	Episkopou, V (corresponding author), Hammersmith Hosp, Imperial Coll, Sch Med, MRC,Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	vasso.episkopou@csc.mrc.ac.uk	Arkell, Ruth/AAR-8471-2021; Episkopou, Vasso/E-2952-2010; Greiver, Michelle/N-8764-2015; arkell, ruth m/D-1525-2009; Swan, Daniel/A-7167-2008	Arkell, Ruth/0000-0002-6213-7323; Greiver, Michelle/0000-0001-8957-0285; arkell, ruth m/0000-0002-6213-7323; Swan, Daniel/0000-0001-8978-8129	MRC [MC_U120074332] Funding Source: UKRI; Medical Research Council [MC_U120074332] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBANO RM, 1994, INT J DEV BIOL, V38, P543; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; CONLON FL, 1991, DEVELOPMENT, V111, P969; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Dufort D, 1998, DEVELOPMENT, V125, P3015; DZIADEK M, 1978, J EMBRYOL EXP MORPH, V43, P289; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Filosa S, 1997, DEVELOPMENT, V124, P2843; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Niederlander C, 2001, NATURE, V410, P830, DOI 10.1038/35071103; Rhinn M, 1998, DEVELOPMENT, V125, P845; ROWITCH DH, 1995, MECH DEVELOP, V52, P3, DOI 10.1016/0925-4773(95)00380-J; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shawlot W, 1999, DEVELOPMENT, V126, P4925; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tam PPL, 1999, DEVELOPMENT, V126, P5171; Varlet I, 1997, DEVELOPMENT, V124, P1033; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	30	83	86	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					825	830		10.1038/35071095	http://dx.doi.org/10.1038/35071095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298452				2022-12-01	WOS:000168021900058
J	Rupert, PB; Ferre-D'Amare, AR				Rupert, PB; Ferre-D'Amare, AR			Crystal structure of a hairpin ribozyme-inhibitor complex with implications for catalysis	NATURE			English	Article							DELTA VIRUS RIBOZYME; TERTIARY STRUCTURE FORMATION; LOOP-B DOMAIN; GUANOSINE REQUIREMENT; SECONDARY STRUCTURE; BINDING-SITES; METAL-IONS; IN-VITRO; RNA; CLEAVAGE	The hairpin ribozyme catalyses sequence-specific cleavage of RNA. The active site of this natural RNA results from the docking of two irregular helices: stems A and B. One strand of stem A harbours the scissile bond. The 2.4 Angstrom resolution structure of a hairpin ribozyme-inhibitor complex reveals that the ribozyme aligns the 2'-OH nucleophile and the 5'-oxo leaving group by twisting apart the nucleotides that flank the scissile phosphate. The base of the nucleotide preceding the cleavage site is stacked within stem A; the next nucleotide, a conserved guanine, is extruded from stem A and accommodated by a highly complementary pocket in the minor groove of stem B. Metal ions are absent from the active site. The bases of four conserved purines are positioned potentially to serve as acid-base catalysts. This is the first structure determination of a fully assembled ribozyme active site that catalyses a phosphodiester cleavage without recourse to metal ions.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Ferre-D'Amare, AR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.							Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTCHER SE, 1994, BIOCHEMISTRY-US, V33, P992, DOI 10.1021/bi00170a018; BUTCHER SE, 1995, J BIOL CHEM, V270, P29648; Butcher SE, 2000, BIOCHEMISTRY-US, V39, P2174, DOI 10.1021/bi9923454; Butcher SE, 1999, NAT STRUCT BIOL, V6, P212; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHOWRIRA BM, 1991, NATURE, V354, P320, DOI 10.1038/354320a0; CHOWRIRA BM, 1993, J BIOL CHEM, V268, P19458; CHOWRIRA BM, 1991, BIOCHEMISTRY-US, V30, P8515; COWAN JA, 1993, J INORG BIOCHEM, V49, P171, DOI 10.1016/0162-0134(93)80002-Q; Earnshaw DJ, 1997, J MOL BIOL, V274, P197, DOI 10.1006/jmbi.1997.1405; Fedor MJ, 1999, BIOCHEMISTRY-US, V38, P11040, DOI 10.1021/bi991069q; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Ferre-D'Amare AR, 2000, J MOL BIOL, V295, P541, DOI 10.1006/jmbi.1999.3398; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; FINDLAY D, 1962, BIOCHEM J, V85, P152, DOI 10.1042/bj0850152; GRASBY JA, 1995, BIOCHEMISTRY-US, V34, P4068, DOI 10.1021/bi00012a025; Hampel A, 1997, CHEM BIOL, V4, P513, DOI 10.1016/S1074-5521(97)90323-9; Hampel KJ, 1998, BIOCHEMISTRY-US, V37, P14672, DOI 10.1021/bi981083n; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P175; MCKAY DB, 1999, RNA WORLD, P265; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Murchie AIH, 1998, MOL CELL, V1, P873, DOI 10.1016/S1097-2765(00)80086-6; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nesbitt S, 1997, CHEM BIOL, V4, P619, DOI 10.1016/S1074-5521(97)90247-7; Nowakowski J, 1999, NAT STRUCT BIOL, V6, P151; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Pinard R, 1999, BIOCHEMISTRY-US, V38, P16035, DOI 10.1021/bi992024s; RICHARDS FM, 1971, COLD SPRING HARB SYM, V36, P35, DOI 10.1101/SQB.1972.036.01.008; ROBERTS GCK, 1969, P NATL ACAD SCI USA, V62, P1151, DOI 10.1073/pnas.62.4.1151; Ryder SP, 1999, J MOL BIOL, V291, P295, DOI 10.1006/jmbi.1999.2959; Saenger W, 2013, PRINCIPLES NUCL ACID; Schmidt S, 1996, NUCLEIC ACIDS RES, V24, P573, DOI 10.1093/nar/24.4.573; Shin C, 1996, NUCLEIC ACIDS RES, V24, P2685, DOI 10.1093/nar/24.14.2685; Shippy R, 1998, BIOCHEMISTRY-US, V37, P564, DOI 10.1021/bi9721288; Siwkowski A, 1997, BIOCHEMISTRY-US, V36, P3930, DOI 10.1021/bi9628735; VANTOL H, 1990, NUCLEIC ACIDS RES, V18, P1971, DOI 10.1093/nar/18.8.1971; Walter F, 1998, BIOCHEMISTRY-US, V37, P14195, DOI 10.1021/bi981513+; Walter F, 1998, BIOCHEMISTRY-US, V37, P17629, DOI 10.1021/bi9821115; Walter NG, 1998, EMBO J, V17, P2378, DOI 10.1093/emboj/17.8.2378; Walter NG, 1999, NAT STRUCT BIOL, V6, P544; Walter NG, 2000, J MOL BIOL, V298, P539, DOI 10.1006/jmbi.2000.3691; Wu M, 1998, P NATL ACAD SCI USA, V95, P11555, DOI 10.1073/pnas.95.20.11555; Young KJ, 1999, J MOL BIOL, V288, P853, DOI 10.1006/jmbi.1999.2748; Young KJ, 1997, NUCLEIC ACIDS RES, V25, P3760, DOI 10.1093/nar/25.19.3760	50	377	388	1	34	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					780	786		10.1038/35071009	http://dx.doi.org/10.1038/35071009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298439				2022-12-01	WOS:000168021900045
J	Bossuyt, F; Milinkovitch, MC				Bossuyt, F; Milinkovitch, MC			Amphibians as indicators of early tertiary "out-of-India" dispersal of vertebrates	SCIENCE			English	Article							BOUNDARY; VOLCANISM; EVOLUTION	Sixty-five million years ago, massive volcanism produced on the India-Seychelles Landmass the largest continental Lava deposit (Deccan Traps) of the past 200 million years. Using a molecular clock-independent approach for inferring dating information from molecular phylogenies, we show that multiple Lineages of frogs survived Deccan Traps volcanism after millions of years of isolation on drifting India. The collision between the Indian and Eurasian plates was followed by wide dispersal of several of these lineages. This "out-of-India" scenario reveals a zoogeographical pattern that might reconcile paleontological and molecular data in other vertebrate groups.	Free Univ Brussels, Inst Mol Biol & Med, Unit Evolutionary Genet, CP 300, B-6041 Gosselies, Belgium		Milinkovitch, MC (corresponding author), Free Univ Brussels, Inst Mol Biol & Med, Unit Evolutionary Genet, CP 300, Rue Jeener & Brachet 12, B-6041 Gosselies, Belgium.	mcmilink@ulb.ac.be		Milinkovitch, Michel/0000-0002-2553-0724; Bossuyt, Franky/0000-0001-6804-9271				BECK RA, 1995, NATURE, V373, P55, DOI 10.1038/373055a0; BHANDARI N, 1995, GEOPHYS RES LETT, V22, P433, DOI 10.1029/94GL03271; Bossuyt F, 2000, P NATL ACAD SCI USA, V97, P6585, DOI 10.1073/pnas.97.12.6585; Bromham L, 1999, TRENDS ECOL EVOL, V14, P113, DOI 10.1016/S0169-5347(98)01507-9; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Duellman W. E., 1994, BIOL AMPHIBIANS; Duellman WE, 1999, PATTERNS DISTRIBUTIO; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; HILDEBRAND AR, 1991, GEOLOGY, V19, P867, DOI 10.1130/0091-7613(1991)019<0867:CCAPCT>2.3.CO;2; JAEGER JJ, 1989, GEOLOGY, V17, P316, DOI 10.1130/0091-7613(1989)017<0316:PVOTAO>2.3.CO;2; Krause D.W., 1999, GSA TODAY, V9, P1; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Maas M. C., 1990, GEOL SOC AM SPEC PAP, V243, P71; Macey JR, 2000, SYST BIOL, V49, P233, DOI 10.1093/sysbio/49.2.233; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OFFICER CB, 1987, NATURE, V326, P143, DOI 10.1038/326143a0; Pethiyagoda R, 1998, OCC PAP WILDL HERITA, V2, P1; Richards CM, 1998, HERPETOL J, V8, P41; SAVAGE JM, 1973, BIOL ANURANS CONT RE, P351; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; THEWISSEN JGM, 1992, SYST BIOL, V41, P248, DOI 10.2307/2992525; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892	23	188	202	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					93	95		10.1126/science.1058875	http://dx.doi.org/10.1126/science.1058875			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292870				2022-12-01	WOS:000167995200044
J	Clancy, DJ; Gems, D; Harshman, LG; Oldham, S; Stocker, H; Hafen, E; Leevers, SJ; Partridge, L				Clancy, DJ; Gems, D; Harshman, LG; Oldham, S; Stocker, H; Hafen, E; Leevers, SJ; Partridge, L			Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein	SCIENCE			English	Article							BODY-SIZE; PHOSPHOINOSITIDE 3-KINASE; GROWTH-HORMONE; ORGAN GROWTH; DWARF MICE; HOMOLOG; CELL; REPRODUCTION; RESTRICTION; PATHWAYS	The Drosophila melanogaster gene chico encodes an insulin receptor substrate that functions in an insulin/insulin-like growth factor (IGF) signaling pathway. in the nematode Caenorhabditis elegans, insulin/IGF signaling regulates adult longevity. We found that mutation of chico extends fruit fly median Life-span by up to 48% in homozygotes and 36% in heterozygotes. Extension of Life-span was not a result of impaired oogenesis in chico females, nor was it consistently correlated with increased stress resistance. The dwarf phenotype of chico homozygotes was also unnecessary for extension of Life-span. The role of insulin/IGF signaling in regulating animal aging is therefore evolutionarily conserved.	UCL, Dept Biol, London NW1 2HE, England; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Ludwig Inst Canc Res, London W1W 7BS, England; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	University of London; University College London; University of Nebraska System; University of Nebraska Lincoln; University of Zurich; Ludwig Institute for Cancer Research; University of London; University College London	Gems, D (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	david.gems@ucl.ac.uk	Stoecker, Horst/F-8382-2012; Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015; Clancy, David J/F-4882-2011	Stoecker, Horst/0000-0002-3282-3664; Clancy, David John/0000-0002-0299-7946; Partridge, Linda/0000-0001-9615-0094; Gems, David/0000-0002-6653-4676				Bartke A, 2000, RES PRO CEL, V29, P181; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Burks DJ, 2000, NATURE, V407, P377, DOI 10.1038/35030105; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; EIGENMANN JE, 1984, ACTA ENDOCRINOL-COP, V106, P448, DOI 10.1530/acta.0.1060448; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; KRZLSNIK C, 1999, J ENDOCR GENET, V1, P9; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Miller RA, 2000, J GERONTOL A-BIOL, V55, pB455, DOI 10.1093/gerona/55.9.B455; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; Riddle DL, 1997, C ELEGANS, P739; SAMARAS TT, 1992, B WORLD HEALTH ORGAN, V70, P259; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sonntag WE, 1999, J GERONTOL A-BIOL, V54, pB521, DOI 10.1093/gerona/54.12.B521; STOCKER H, UNPUB; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 2000, CURR OPIN GENET DEV, V10, P75, DOI 10.1016/S0959-437X(99)00042-8; Weinkove D, 1997, J BIOL CHEM, V272, P14606, DOI 10.1074/jbc.272.23.14606; [No title captured]	26	1068	1108	2	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					104	106		10.1126/science.1057991	http://dx.doi.org/10.1126/science.1057991			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292874	Green Published			2022-12-01	WOS:000167995200048
J	Harada, Y; Ohara, O; Takatsuki, A; Itoh, H; Shimamoto, N; Kinosita, K				Harada, Y; Ohara, O; Takatsuki, A; Itoh, H; Shimamoto, N; Kinosita, K			Direct observation of DNA rotation during transcription by Escherichia coli RNA polymerase	NATURE			English	Article							SINGLE MOLECULES; MOTOR	Helical filaments driven by linear molecular motors are anticipated to rotate around their axis, but rotation consistent with the helical pitch has not been observed. 14S dynein(1) and non-claret disjunctional protein (ncd)(2) rotated a microtubule more efficiently than expected for its helical pitch, and myosin rotated an actin filament only poorly(3). For DNA-based motors such as RNA polymerase, transcription-induced supercoiling of DNA(4) supports the general picture of tracking along the DNA helix(5). Here we report direct and real-time optical microscopy measurements of rotation rate that are consistent with high-fidelity tracking. Single RNA polymerase molecules attached to a glass surface rotated DNA for >100 revolutions around the right-handed screw axis of the double helix with a rotary torque of >5 pN nm. This real-time observation of rotation opens the possibility of resolving individual transcription steps.	Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; CREST, Genet Programming, Miyamae Ku, Kawasaki, Kanagawa 2160001, Japan; Kazusa DNA Res Inst, Kisarazu 2920812, Japan; Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan; Natl Inst Genet, Struct Biol Ctr, Mishima, Shizuoka 4118540, Japan	Keio University; Japan Science & Technology Agency (JST); Kazusa DNA Research Institute; Hamamatsu Photonics; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Harada, Y (corresponding author), Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Hiyoshi 3-14-1, Yokohama, Kanagawa 2238522, Japan.		Shimamoto, Nobuo/AAJ-4999-2020; Ohara, Osamu/G-5448-2015; Ohara, Osamu/A-9119-2012	Shimamoto, Nobuo/0000-0001-7579-0084; Ohara, Osamu/0000-0002-3328-9571; 				Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DeRosier DJ, 1998, CELL, V93, P17, DOI 10.1016/S0092-8674(00)81141-1; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0; Harada Y, 1999, BIOPHYS J, V76, P709, DOI 10.1016/S0006-3495(99)77237-1; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Sase I, 1997, P NATL ACAD SCI USA, V94, P5646, DOI 10.1073/pnas.94.11.5646; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Strick T, 1999, PHYSICA A, V263, P392, DOI 10.1016/S0378-4371(98)00540-8; STRYER I, 1995, BIOCHEMISTRY; STUDIER FW, 1975, J MOL BIOL, V94, P283, DOI 10.1016/0022-2836(75)90083-2; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; VALE RD, 1988, CELL, V52, P459, DOI 10.1016/S0092-8674(88)80038-2; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; WANG JC, 1993, CURR OPIN GENET DEV, V3, P764, DOI 10.1016/S0959-437X(05)80096-6; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7	22	179	188	0	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					113	115		10.1038/35051126	http://dx.doi.org/10.1038/35051126			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343125				2022-12-01	WOS:000166175600051
J	Chittka, L; Schurkens, S				Chittka, L; Schurkens, S			Successful invasion of a floral market - An exotic Asian plant has moved in on Europe's river-banks by bribing pollinators.	NATURE			English	Article							IMPATIENS-GLANDULIFERA; INSECT VISITS; COMPETITION; FLOWERS		Biozentrum, D-97074 Wurzburg, Germany	University of Wurzburg	Chittka, L (corresponding author), Biozentrum, D-97074 Wurzburg, Germany.	chittka@biozentrum.uni-wuerzburg.de	Chittka, Lars/C-3110-2012	Chittka, Lars/0000-0001-8153-1732				BEERLING DJ, 1993, J ECOL, V81, P367, DOI 10.2307/2261507; CAMPBELL DR, 1985, ECOLOGY, V66, P554, DOI 10.2307/1940404; Comba L, 1999, ANN BOT-LONDON, V83, P73, DOI 10.1006/anbo.1998.0798; Comba L, 1999, ANN BOT-LONDON, V83, P369, DOI 10.1006/anbo.1998.0835; Corbet SA, 2001, ANN BOT-LONDON, V87, P219, DOI 10.1006/anbo.2000.1322; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; Schurkens S, 2001, ENTOMOL GEN, V25, P115; Toney JC, 1998, NORTHWEST SCI, V72, P198; Waser N.M., 1983, P277; WASER NM, 1978, ECOLOGY, V59, P934, DOI 10.2307/1938545	10	338	362	10	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					653	653		10.1038/35079676	http://dx.doi.org/10.1038/35079676			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395755				2022-12-01	WOS:000169112500029
J	Dye, MJ; Proudfoot, NJ				Dye, MJ; Proudfoot, NJ			Multiple transcript cleavage precedes polymerase release in termination by RNA polymerase II	CELL			English	Article							REPLICATION; ELONGATION; INITIATION; MECHANISM; PATHWAY; SIGNALS; SITES; HIV-1	The requirement of poly(A) signals to elicit transcription termination of RNA polymerase II (pol II) is firmly established. However, little else is known about the actual process of pol II transcription termination. Evidence presented in this paper, based on analysis of nascent transcripts of the human beta- and epsilon -globin genes, demonstrates that pol II transcription termination involves two distinct and temporally separate events. The first event, termed pretermination cleavage (PTC), is mediated by sequence tracts located downstream of the poly(A) site which appear to promote heterogeneous cleavage of the nascent transcript. The second event, in which pol II disengages from the DNA template, requires that polymerase has transcribed both a PTC sequence tract and a functional poly(A) site.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk		Proudfoot, Nicholas/0000-0001-8646-3222				Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Birse CE, 1997, EMBO J, V16, P3633, DOI 10.1093/emboj/16.12.3633; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; CULLEN BR, 1993, CELL, V73, P417, DOI 10.1016/0092-8674(93)90126-B; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; DYE MJ, 1999, THESIS OXFORD U OXFO; GIARDINA C, 1993, J BIOL CHEM, V268, P23806; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; LABHART P, 1986, CELL, V45, P431, DOI 10.1016/0092-8674(86)90329-6; Mitchell P, 2000, CURR OPIN GENET DEV, V10, P193, DOI 10.1016/S0959-437X(00)00063-0; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Platt T, 1998, COLD SPRING HARBOR M, P541; PROUDFOOT NJ, 1992, NEW BIOL, V4, P369; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; PROUDFOOT NJ, 2000, TRENDS BIOCHEM SCI, V25, P105; REEDER RH, 1994, MOL MICROBIOL, V12, P11, DOI 10.1111/j.1365-2958.1994.tb00989.x; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; TANTRAVAHI J, 1993, MOL CELL BIOL, V13, P578, DOI 10.1128/MCB.13.1.578; TREISMAN R, 1983, P NATL ACAD SCI-BIOL, V80, P7428, DOI 10.1073/pnas.80.24.7428; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	26	89	92	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					669	681		10.1016/S0092-8674(01)00372-5	http://dx.doi.org/10.1016/S0092-8674(01)00372-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389836	Bronze			2022-12-01	WOS:000169123200013
J	Reimann, JDR; Freed, E; Hsu, JY; Kramer, ER; Peters, JM; Jackson, PK				Reimann, JDR; Freed, E; Hsu, JY; Kramer, ER; Peters, JM; Jackson, PK			Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex	CELL			English	Article							CHECKPOINT PROTEIN MAD2; F-BOX PROTEINS; SPINDLE CHECKPOINT; CELL-CYCLE; BUDDING YEAST; MITOSIS; PROTEOLYSIS; UBIQUITIN; FAMILY; PHOSPHORYLATION	We have discovered an early mitotic inhibitor, Emi1, which regulates mitosis by inhibiting the anaphase promoting complex/cyclosome (APC). Emi1 is a conserved F box protein containing a zinc binding region essential for APC inhibition. Emi1 accumulates before mitosis and is ubiquitylated and destroyed in mitosis, independent of the APC. Emi1 immunodepletion from cycling Xenopus extracts strongly delays cyclin B accumulation and mitotic entry, whereas nondestructible Emi1 stabilizes APC substrates and causes a mitotic block. Emi1 binds the APC activator Cdc20, and Cdc20 can rescue an Emi1-induced block to cyclin B destruction. Our results suggest that Emi1 regulates progression through early mitosis by preventing premature APC activation, and may help explain the well-known delay between cyclin B/Cdc2 activation and cyclin B destruction.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Canc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biophys, Stanford, CA 94305 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	Stanford University; Stanford University; Stanford University; Stanford University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Jackson, PK (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.		Kramer, Edgar/A-9288-2012	Kramer, Edgar/0000-0002-4882-4143; Jackson, Peter/0000-0002-1742-2539	NCI NIH HHS [CA09302] Funding Source: Medline; NIGMS NIH HHS [GM54811, GM60439, GM07365] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060439, R01GM054811, T32GM007365] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kallio M, 1998, J CELL BIOL, V141, P1393, DOI 10.1083/jcb.141.6.1393; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Pfleger CM, 2000, GENE DEV, V14, P655; Regan-Reimann JD, 1999, CURR BIOL, V9, pR762, DOI 10.1016/S0960-9822(00)80006-8; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shteinberg M, 1999, BIOCHEM BIOPH RES CO, V260, P193, DOI 10.1006/bbrc.1999.0884; Straight AF, 1997, METHOD ENZYMOL, V283, P425; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721	48	306	313	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					645	655		10.1016/S0092-8674(01)00361-0	http://dx.doi.org/10.1016/S0092-8674(01)00361-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389834	Bronze			2022-12-01	WOS:000169123200011
J	Zhao, C; Takita, J; Tanaka, Y; Setou, M; Nakagawa, T; Takeda, S; Yang, HW; Terada, S; Nakata, T; Takei, Y; Saito, M; Tsuji, S; Hayashi, Y; Hirokawa, N				Zhao, C; Takita, J; Tanaka, Y; Setou, M; Nakagawa, T; Takeda, S; Yang, HW; Terada, S; Nakata, T; Takei, Y; Saito, M; Tsuji, S; Hayashi, Y; Hirokawa, N			Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B beta	CELL			English	Article							LEFT-RIGHT ASYMMETRY; SYNAPTIC VESICLE; MONOMERIC MOTOR; NMDA RECEPTOR; KINESIN; PROTEIN; TRANSPORT; GENE; MICE; MITOCHONDRIA	The kinesin superfamily motor protein KIF1B has been shown to transport mitochondria. Here, we describe an isoform of KIF1B, KIF1B beta, that is distinct from KIF1B in its cargo binding domain. KIF1B knockout mice die at birth from apnea due to nervous system defects. Death of knockout neurons in culture can be rescued by expression of the beta isoform. The KIF1B heterozygotes have a defect in transporting synaptic vesicle precursors and suffer from progressive muscle weakness similar to human neuropathies. Charcot-Marie-Tooth disease type 2A was previously mapped to an interval containing KIF1B. We show that CMT2A patients contain a loss-of-function mutation in the motor domain of the KIF1B gene. This is clear indication that defects in axonal transport due to a mutated motor protein can underlie human peripheral neuropathy.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Pediat, Tokyo 1130033, Japan; Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 9518585, Japan	University of Tokyo; University of Tokyo; Niigata University	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan.		Takei, Yosuke/I-1828-2015; Takeda, Sen/I-8462-2012	Takei, Yosuke/0000-0002-5026-8027; Takeda, Sen/0000-0001-7090-2139; Tanaka, Yosuke/0000-0001-5376-5726				BENOTHMANE K, 1993, GENOMICS, V17, P370; Conforti L, 1999, MAMM GENOME, V10, P617, DOI 10.1007/s003359901056; Gong TWL, 1996, MAMM GENOME, V7, P790, DOI 10.1007/s003359900237; Gong TWL, 1999, GENE, V239, P117, DOI 10.1016/S0378-1119(99)00370-4; Goslin K., 1991, CULTURING NERVE CELL, P251; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HIROKAWA N, 1990, J CELL BIOL, V111, P1027, DOI 10.1083/jcb.111.3.1027; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; Kukita Y, 1997, HUM MUTAT, V10, P400, DOI 10.1002/(SICI)1098-1004(1997)10:5<400::AID-HUMU11>3.3.CO;2-1; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; Meyer O A, 1979, Neurobehav Toxicol, V1, P233; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; ROBERTSON A, 1993, ACTA NEUROPATHOL, V86, P163, DOI 10.1007/BF00334883; Saito M, 1997, NEUROLOGY, V49, P1630, DOI 10.1212/WNL.49.6.1630; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SHY ME, 1999, ANN NY ACAD SCI, V883, P34; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431	29	561	598	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					587	597		10.1016/S0092-8674(01)00363-4	http://dx.doi.org/10.1016/S0092-8674(01)00363-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389829	Bronze			2022-12-01	WOS:000169123200006
J	Schlesinger, WH; Lichter, J				Schlesinger, WH; Lichter, J			Limited carbon storage in soil and litter of experimental forest plots under increased atmospheric CO2	NATURE			English	Article							C-13 NATURAL-ABUNDANCE; UNITED-STATES; PINE FOREST; US FORESTS; ENRICHMENT; ACCUMULATION; ECOSYSTEMS; TURNOVER; BIOMASS; CLIMATE	The current rise in atmospheric CO2 concentration is thought to be mitigated in part by carbon sequestration within forest ecosystems(1,2), where carbon can be stored in vegetation or soils. The storage of carbon in soils is determined by the fraction that is sequestered in persistent organic materials, such as humus. In experimental forest plots of loblolly pine (Pinus taeda) exposed to high CO2 concentrations(3,4), nearly half of the carbon uptake is allocated to short-lived tissues, largely foliage. These tissues fall to the ground and decompose, normally contributing only a small portion of their carbon content to refractory soil humic materials(5). Such findings call into question the role of soils as long-term carbon sinks, and show the need for a better understanding of carbon cycling in forest soils. Here we report a significant accumulation of carbon in the litter layer of experimental forest plots after three years of growth at increased CO2 concentrations (565 mul l(-1)). But fast turnover times of organic carbon in the litter layer (of about three years) appear to constrain the potential size of this carbon sink. Given the observation that carbon accumulation in the deeper mineral soil layers was absent, we suggest that significant, long-term net carbon sequestration in forest soils is unlikely.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; Bowdoin Coll, Environm Studies Program, Brunswick, ME 04011 USA	Duke University; Bowdoin College; Bowdoin College	Schlesinger, WH (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.							ANDREWS JA, 1999, THESIS DUKE U; BALESDENT J, 1988, SOIL SCI SOC AM J, V52, P118, DOI 10.2136/sssaj1988.03615995005200010021x; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; CAMBARDELLA CA, 1993, GEODERMA, V56, P449, DOI 10.1016/0016-7061(93)90126-6; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Ciais P, 2000, ECOL APPL, V10, P1574, DOI 10.2307/2641225; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DELCOURT HR, 1980, SCIENCE, V210, P321, DOI 10.1126/science.210.4467.321; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Delucia EH, 1997, ANN BOT-LONDON, V79, P111, DOI 10.1006/anbo.1996.0320; Ellsworth DS, 1999, PLANT CELL ENVIRON, V22, P461, DOI 10.1046/j.1365-3040.1999.00433.x; Finzi AC, 2001, ECOLOGY, V82, P470, DOI 10.2307/2679873; FOX TR, 1990, SOIL SCI SOC AM J, V54, P1139, DOI 10.2136/sssaj1990.03615995005400040037x; Gill R, 1999, ECOSYSTEMS, V2, P226; HARRISON K, 1993, GLOBAL BIOGEOCHEM CY, V7, P69, DOI 10.1029/92GB02938; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Jastrow JD, 1996, SOIL SCI SOC AM J, V60, P801, DOI 10.2136/sssaj1996.03615995006000030017x; Jones TH, 1998, SCIENCE, V280, P441, DOI 10.1126/science.280.5362.441; JORGENSEN JR, 1980, SOIL SCI SOC AM J, V44, P1307, DOI 10.2136/sssaj1980.03615995004400060036x; Lichter J, 2000, BIOGEOCHEMISTRY, V50, P73, DOI 10.1023/A:1006337132631; Matamala R, 2000, GLOB CHANGE BIOL, V6, P967, DOI 10.1046/j.1365-2486.2000.00374.x; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Richter DD, 1999, NATURE, V400, P56, DOI 10.1038/21867; SCHIFFMAN PM, 1989, CAN J FOREST RES, V19, P69, DOI 10.1139/x89-010; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Van Kessel C, 2000, GLOBAL CHANGE BIOL, V6, P435, DOI 10.1046/j.1365-2486.2000.00318.x; Weisberg S, 1985, APPL LINEAR REGRESSI, P114	30	375	436	4	177	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					466	469		10.1038/35078060	http://dx.doi.org/10.1038/35078060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373676				2022-12-01	WOS:000168858700045
J	Jiggins, CD; Naisbit, RE; Coe, RL; Mallet, J				Jiggins, CD; Naisbit, RE; Coe, RL; Mallet, J			Reproductive isolation caused by colour pattern mimicry	NATURE			English	Article							HELICONIUS BUTTERFLIES; NATURAL-SELECTION; RACE FORMATION; WARNING-COLOR; SPECIATION; REINFORCEMENT; EVOLUTION; CONSEQUENCES; DIVERGENCE	Speciation is facilitated if ecological adaptation directly causes assortative mating(1), but few natural examples are known. Here we show that a shift in colour pattern mimicry was crucial in the origin of two butterfly species. The sister species Heliconius melpomene and Heliconius cydno recently diverged to mimic different model taxa, and our experiments show that their mimetic coloration is also important in choosing mates. Assortative mating between the sister species means that hybridization is rare in nature, and the few hybrids that are produced are nonmimetic, poorly adapted intermediates. Thus, the mimetic shift has caused both pre-mating and post-mating isolation. In addition, individuals from a population of H. melpomene allopatric to H. cydno court and mate with H. cydno more readily than those from a sympatric population. This suggests that assortative mating has been enhanced in sympatry.	UCL, Galton Lab, London NW1 2HE, England; Smithsonian Trop Res Inst, Balboa, Panama; Univ Cambridge Downing Coll, Cambridge CB2 1DQ, England	University of London; University College London; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Cambridge	Jiggins, CD (corresponding author), UCL, Galton Lab, 4 Stephenson Way, London NW1 2HE, England.	jigginsc@naos.si.edu	mallet, james L.B./B-5114-2008; Naisbit, Russell E/B-9658-2011; Jiggins, Chris/T-4296-2019; Jiggins, Chris D/B-9960-2008	Naisbit, Russell E/0000-0003-0190-9323; Jiggins, Chris/0000-0002-7809-062X; Jiggins, Chris D/0000-0002-7809-062X; Mallet, James/0000-0002-3370-0367				Bates HW, 1862, T LINN SOC LONDON, V23, P495, DOI [10.1111/j.1096-3642.1860.tb00146.x, DOI 10.1111/J.1096-3642.1860.TB00146.X]; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; BUTLIN R, 1987, TRENDS ECOL EVOL, V2, P8, DOI 10.1016/0169-5347(87)90193-5; CRAIG TP, 1993, EVOLUTION, V47, P1696, DOI 10.1111/j.1558-5646.1993.tb01262.x; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; Edwards A.W.F., 1972, LIKELIHOOD; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; GILBERT LE, IN PRESS ECOLOGY EVO; Kirkpatrick M, 2000, P ROY SOC B-BIOL SCI, V267, P1649, DOI 10.1098/rspb.2000.1191; LINARES M, 1989, ADAPTIVE MICROEVOLUT; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1111/j.1095-8312.1995.tb01057.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Mallet J, 1998, ENDLESS FORMS, P390; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; MAYNARD SMITH J., 1966, AMER NATUR, V100, P637; McMillan WO, 1997, P NATL ACAD SCI USA, V94, P8628, DOI 10.1073/pnas.94.16.8628; Noor MAF, 1999, HEREDITY, V83, P503, DOI 10.1038/sj.hdy.6886320; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; TURNER JRG, 1981, ANNU REV ECOL SYST, V12, P99, DOI 10.1146/annurev.es.12.110181.000531; TURNER JRG, 1976, ZOOL J LINN SOC-LOND, V58, P297, DOI 10.1111/j.1096-3642.1976.tb01000.x; VANEWRIGHT RI, 1978, DIVERSITY INSECT FAU, P56	23	490	508	4	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					302	305		10.1038/35077075	http://dx.doi.org/10.1038/35077075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357131	Green Submitted			2022-12-01	WOS:000168710000046
J	Martinez-Perez, E; Shaw, P; Moore, G				Martinez-Perez, E; Shaw, P; Moore, G			The Ph1 locus is needed to ensure specific somatic and meiotic centromere association	NATURE			English	Article							DROSOPHILA-MELANOGASTER; CHIASMA FORMATION; WHEAT; ORGANIZATION; CHROMOSOMES; HYBRIDS; COMPLEX; MEIOSIS; NUCLEI	The correct pairing and segregation of chromosomes during meiosis is essential for genetic stability and subsequent fertility. This is more difficult to achieve in polyploid species, such as wheat, because they possess more than one diploid set of similar chromosomes. In wheat, the Ph1 locus ensures correct homologue pairing and recombination(1). Although clustering of telomeres into a bouquet early in meiosis has been suggested to facilitate homologue pairing(2,3), centromeres associate in pairs in polyploid cereals early during floral development(4). We can now extend this observation to root development. Here we show that the Ph1 locus acts both meiotically and somatically by reducing non-homologous centromere associations. This has the effect of promoting true homologous association when centromeres are induced to associate. In fact, non-homologously associated centromeres separate at the beginning of meiosis in the presence, but not the absence, of Ph1. This permits the correction of homologue association during the telomere-bouquet stage in meiosis. We conclude that the Ph1 locus is not responsible for the induction of centromere association, but rather for its specificity.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Moore, G (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.		shaw, peter j/E-5511-2011	shaw, peter j/0000-0003-1076-2669				Abranches R, 1998, J CELL BIOL, V143, P5, DOI 10.1083/jcb.143.1.5; Ananiev EV, 1998, P NATL ACAD SCI USA, V95, P13073, DOI 10.1073/pnas.95.22.13073; AragonAlcaide L, 1997, CURR BIOL, V7, P905, DOI 10.1016/S0960-9822(06)00383-6; DHALIWAL HS, 1977, J HERED, V68, P206; Dvorak J, 2000, CHROMOSOMA, V109, P410, DOI 10.1007/s004120000093; DVORAK J, 1977, CAN J GENET CYTOL, V19, P549; FELDMAN M, 1966, P NATL ACAD SCI USA, V55, P1447, DOI 10.1073/pnas.55.6.1447; Gemkow MJ, 1998, DEVELOPMENT, V125, P4541; GILLIES CB, 1987, THEOR APPL GENET, V74, P430, DOI 10.1007/BF00289817; Henikoff S, 1997, CURR OPIN CELL BIOL, V9, P388, DOI 10.1016/S0955-0674(97)80012-9; HOLM PB, 1988, CARLSBERG RES COMMUN, V53, P191, DOI 10.1007/BF02907179; HOLM PB, 1986, CARLSBERG RES COMMUN, V51, P239, DOI 10.1007/BF02906837; HOLM PB, 1988, CARLSBERG RES COMMUN, V53, P91, DOI 10.1007/BF02907175; Langdon T, 2000, GENETICS, V156, P313; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Martinez-Perez E, 1999, J CELL SCI, V112, P1761; Martinez-Perez E, 2000, J CELL BIOL, V148, P233, DOI 10.1083/jcb.148.2.233; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; RILEY R, 1970, NATURE, V227, P82, DOI 10.1038/227082a0; Roberts MA, 1999, GENETICS, V153, P1909; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; WALL AM, 1971, GENET RES, V18, P329, DOI 10.1017/S0016672300012726; WANG XZ, 1988, CARLSBERG RES COMMUN, V53, P167, DOI 10.1007/BF02907178; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481	25	130	144	2	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					204	207		10.1038/35075597	http://dx.doi.org/10.1038/35075597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346798				2022-12-01	WOS:000168563000053
J	Ostrowsky, BE; Trick, WE; Sohn, AH; Quirk, SB; Holt, S; Carson, LA; Hill, BC; Arduino, MJ; Kuehnert, MJ; Jarvis, WR				Ostrowsky, BE; Trick, WE; Sohn, AH; Quirk, SB; Holt, S; Carson, LA; Hill, BC; Arduino, MJ; Kuehnert, MJ; Jarvis, WR			Control of vancomycin-resistant enterococcus in health care facilities in a region.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONIZATION; EPIDEMIOLOGY; FAECIUM; RISK	Background: In late 1996, vancomycin-resistant enterococci were first detected in the Siouxland region of Iowa, Nebraska, and South Dakota. A task force was created, and in 1997 the assistance of the Centers for Disease Control and Prevention was sought in assessing the prevalence of vancomycin-resistant enterococci in the region's facilities and implementing recommendations for screening, infection control, and education at all 32 health care facilities in the region. Methods: The infection-control intervention was evaluated in October 1998 and October 1999. We performed point-prevalence surveys, conducted a case-control study of gastrointestinal colonization with vancomycin-resistant enterococci, and compared infection-control practices and screening policies for vancomycin-resistant enterococci at the acute care and long-term care facilities in the Siouxland region. Results: Perianal-swab samples were obtained from 1954 of 2196 eligible patients (89 percent) in 1998 and 1820 of 2049 eligible patients (89 percent) in 1999. The overall prevalence of vancomycin-resistant enterococci at 30 facilities that participated in all three years of the study decreased from 2.2 percent in 1997 to 1.4 percent in 1998 and to 0.5 percent in 1999 (P<0.001 by chi-square test for trend). The number of facilities that had had at least one patient with vancomycin-resistant enterococci declined from 15 in 1997 to 10 in 1998 to 5 in 1999. At both acute care and long-term care facilities, the risk factors for colonization with vancomycin-resistant enterococci were prior hospitalization and treatment with antimicrobial agents. Most of the long-term care facilities screened for vancomycin-resistant enterococci (26 of 28 in 1998 [93 percent] and 23 of 25 in 1999 [92 percent]) and had infection-control policies to prevent the transmission of vancomycin-resistant enterococci (22 of 25 [88 percent] in 1999). All four acute care facilities had screening and infection-control policies for vancomycin-resistant enterococci in 1998 and 1999. Conclusions: An active infection-control intervention, which includes the obtaining of surveillance cultures and the isolation of infected patients, can reduce or eliminate the transmission of vancomycin-resistant enterococci in the health care facilities of a region. (N Engl J Med 2001;344:1427-33.) Copyright (C) 2001 Massachusetts Medical Society.	Ctr Dis Control & Prevent, Hosp Infect Program, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA USA; Siouxland Dist Hlth Dept, Sioux City, IA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Ostrowsky, BE (corresponding author), Virginia Commonwealth Univ, Epidemiol & Infect Control Unit, W Hosp, Med Coll Virginia Campus,1200 E Broad St,E Wing,R, Richmond, VA 23298 USA.		Arduino, Matthew/C-1461-2012	Arduino, Matthew/0000-0001-7072-538X; Trick, William/0000-0002-3243-5098				[Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P597; Bonilla HF, 1997, INFECT CONT HOSP EP, V18, P333, DOI 10.1086/647621; Bonten MJM, 1996, LANCET, V348, P1615, DOI 10.1016/S0140-6736(96)02331-8; EDMOND MB, 1995, CLIN INFECT DIS, V20, P1126, DOI 10.1093/clinids/20.5.1126; Eliopoulos G M, 1996, Curr Clin Top Infect Dis, V16, P21; Eliopoulos GM, 1997, INFECT DIS CLIN N AM, V11, P851, DOI 10.1016/S0891-5520(05)70393-7; Facklam Richard R., 1995, P308; Farr BM, 1998, CRIT CARE MED, V26, P1942, DOI 10.1097/00003246-199812000-00008; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; *HOSP INF CONTR PR, 1995, MMWR-MORBID MORTAL W, V44, P1; LAI E, 1989, BIOTECHNIQUES, V7, P34; MOELLERING RC, 1992, CLIN INFECT DIS, V14, P1173, DOI 10.1093/clinids/14.6.1173; MORRIS JG, 1995, ANN INTERN MED, V123, P250, DOI 10.7326/0003-4819-123-4-199508150-00002; *NAT COMM CLIN LAB, 1998, M100S8 NCCLS; SHAY DK, 1995, J INFECT DIS, V172, P993, DOI 10.1093/infdis/172.4.993; *SIOUXL VRE TASK F, 1998, GUID MAN PAT VANC RE; Trick WE, 1999, J INFECT DIS, V180, P391, DOI 10.1086/314898; Weinstein JT, 1996, INFECT CONT HOSP EP, V17, P36	19	228	232	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1427	1433		10.1056/NEJM200105103441903	http://dx.doi.org/10.1056/NEJM200105103441903			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	430BQ	11346807	Green Published			2022-12-01	WOS:000168554000003
J	Tarricone, C; Xiao, B; Justin, N; Walker, PA; Rittinger, K; Gamblin, SJ; Smerdon, SJ				Tarricone, C; Xiao, B; Justin, N; Walker, PA; Rittinger, K; Gamblin, SJ; Smerdon, SJ			The structural basis of Arfaptin-mediated cross-talk between Rac and Arf signalling pathways	NATURE			English	Article							ADP-RIBOSYLATION FACTOR; RAC1-INTERACTING PROTEIN; CRYSTAL-STRUCTURE; BINDING PROTEIN; PHOSPHOLIPASE-D; RHO PROTEINS; COMPLEX; CDC42; ACTIVATION; DOMAIN	Small G proteins are GTP-dependent molecular switches that regulate numerous cellular functions(1). They can be classified into homologous subfamilies that are broadly associated with specific biological processes. Cross-talk between small G-protein families has an important role in signalling, but the mechanism by which it occurs is poorly understood(2). The coordinated action of Arf and Rho family GTPases is required to regulate many cellular processes including lipid signalling(3), cell motility(4) and Golgi function(5). Arfaptin is a ubiquitously expressed protein implicated in mediating cross-talk between Rac (a member of the Rho family) and Arf small GTPases. Here we show that Arfaptin binds specifically to GTP-bound Arf1 and Arf6, but binds to Rac.GTP and Rac.GDP with similar affinities. The X-ray structure of Arfaptin reveals an elongated, crescent-shaped dimer of three-helix coiled-coils. Structures of Arfaptin with Rac bound to either GDP or the slowly hydrolysable analogue GMPPNP show that the switch regions adopt similar conformations in both complexes. Our data highlight fundamental differences between the molecular mechanisms of Rho and Ras family signalling, and suggest a model of Arfaptin-mediated synergy between the Arf and Rho family signalling pathways.	Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England	MRC National Institute for Medical Research	Gamblin, SJ (corresponding author), Natl Inst Med Res, Div Prot Struct, Mill Hill, London NW7 1AA, England.	sgambli@nimr.mrc.ac.uk	Justin, Neil/E-1774-2011; Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Smerdon, Stephen/0000-0001-5688-8465	Medical Research Council [MC_U117565398] Funding Source: Medline; MRC [MC_U117565398] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; Fensome A, 1998, J BIOL CHEM, V273, P13157, DOI 10.1074/jbc.273.21.13157; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Walker SJ, 2000, J BIOL CHEM, V275, P15665, DOI 10.1074/jbc.M000076200; Williger BT, 1999, FEBS LETT, V443, P197, DOI 10.1016/S0014-5793(98)01707-4; Wittinghofer A, 1998, BIOL CHEM, V379, P933; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	26	196	209	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					215	219		10.1038/35075620	http://dx.doi.org/10.1038/35075620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346801				2022-12-01	WOS:000168563000056
J	Veen, T; Borge, T; Griffith, SC; Saetre, GP; Bures, S; Gustafsson, L; Sheldon, BC				Veen, T; Borge, T; Griffith, SC; Saetre, GP; Bures, S; Gustafsson, L; Sheldon, BC			Hybridization and adaptive mate choice in flycatchers	NATURE			English	Article							COLLARED FLYCATCHERS; SEXUAL SELECTION; REPRODUCTIVE SUCCESS; PREMATING ISOLATION; FICEDULA-HYPOLEUCA; CONSPECIFIC SPERM; SEASONAL DECLINE; PATERNAL EFFORT; OFFSPRING SEX; HYBRID ZONE	Hybridization in natural populations is strongly selected against when hybrid offspring have reduced fitness. Here we show that, paradoxically, pairing with another species may offer the best fitness return for an individual, despite reduced fitness of hybrid offspring. Two mechanisms reduce the costs to female collared flycatchers of pairing with male pied flycatchers. A large proportion of young are sired by conspecific male collared flycatchers through extra-pair copulations, and there is a bias in favour of male offspring (which, unlike females, are fertile) within hybrid pairs. In combination with temporal variation in breeding success, these cost-reducing mechanisms yield quantitative predictions about when female collared flycatchers should accept a male pied flycatcher as a mate; empirical data agree with these predictions. Apparent hybridization may thus represent adaptive mate choice under some circumstances.	Univ Oxford, Dept Zool, EGI, Oxford OX1 3PS, England; Uppsala Univ, Dept Anim Ecol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden; Univ Groningen, Dept Biol, NL-9750 Haren, Netherlands; Uppsala Univ, Evolutionary Biol Ctr, Dept Evolutionary Biol, SE-75236 Uppsala, Sweden; Palacky Univ, Ornithol Lab, Olomouc 77146, Czech Republic	University of Oxford; Uppsala University; University of Groningen; Uppsala University; Palacky University Olomouc	Sheldon, BC (corresponding author), Univ Oxford, Dept Zool, EGI, S Parks Rd, Oxford OX1 3PS, England.		Gustafsson, Lars/O-8056-2019; Griffith, Simon/A-1996-2010; Gustafsson, Lars/A-7634-2012; Sheldon, Ben C/A-8056-2010; Griffith, Simon/AAH-3706-2021	Gustafsson, Lars/0000-0001-6566-2863; Griffith, Simon/0000-0001-7612-4999; Gustafsson, Lars/0000-0001-6566-2863; Sheldon, Ben C/0000-0002-5240-7828; Griffith, Simon/0000-0001-7612-4999				ALATALO RV, 1990, J EVOLUTION BIOL, V3, P375, DOI 10.1046/j.1420-9101.1990.3050375.x; ARNOLD ML, 1997, NATURAL HYBRIDIZATIO, P7; CRAWLEY MJ, 1993, GLIM ECOLOGISTS, P279; DAAN S, 1990, BEHAVIOUR, V114, P83, DOI 10.1163/156853990X00068; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; GELTER HP, 1992, IBIS, V134, P62, DOI 10.1111/j.1474-919X.1992.tb07231.x; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Grant PR, 1997, AM NAT, V149, P1, DOI 10.1086/285976; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gustafsson L., 1989, P75; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; Higashi M, 1999, NATURE, V402, P523, DOI 10.1038/990087; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; LUNDBERG A, 1992, PIED FLYCATCHER, P121; Merila J, 2000, AM NAT, V155, P301, DOI 10.1086/303330; Mild Krister, 1994, Birding World, V7, P231; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; Moller AP, 1998, BEHAV ECOL SOCIOBIOL, V43, P345, DOI 10.1007/s002650050501; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Price CSC, 1997, NATURE, V388, P663, DOI 10.1038/41753; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Przybylo R, 2000, J ANIM ECOL, V69, P395, DOI 10.1046/j.1365-2656.2000.00401.x; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Saetre GP, 1997, J AVIAN BIOL, V28, P259, DOI 10.2307/3676978; Saetre GP, 2000, HEREDITAS, V132, P171, DOI 10.1111/j.1601-5223.2000.00171.x; Saetre GP, 1999, J ZOOL, V247, P53, DOI 10.1111/j.1469-7998.1999.tb00192.x; Saetre GP, 2001, MOL ECOL, V10, P737, DOI 10.1046/j.1365-294x.2001.01208.x; Saetre GP, 1997, NATURE, V387, P589; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Sheldon BC, 1996, P ROY SOC B-BIOL SCI, V263, P1017, DOI 10.1098/rspb.1996.0150; Sheldon BC, 1999, ANIM BEHAV, V57, P285, DOI 10.1006/anbe.1998.0968; Sheldon BC, 1997, BEHAV ECOL, V8, P421, DOI 10.1093/beheco/8.4.421; Sheldon BC, 1998, P ROY SOC B-BIOL SCI, V265, P1737, DOI 10.1098/rspb.1998.0496; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; WIGGINS DA, 1994, OIKOS, V70, P359, DOI 10.2307/3545773	43	223	230	0	56	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					45	50		10.1038/35075000	http://dx.doi.org/10.1038/35075000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333971				2022-12-01	WOS:000168432800037
J	Fishman, MC				Fishman, MC			The genomic cosmos	NATURE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Fishman, MC (corresponding author), Harvard Univ, Sch Med, Fruit St, Boston, MA 02114 USA.							Borges J. L., 1962, LABYRINTHS; Eco Umberto, 1998, SERENDIPITIES LANGUA; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fishman MC, 1997, CELL, V91, P153, DOI 10.1016/S0092-8674(00)80397-9; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0	5	3	3	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1033	1033		10.1038/35074219	http://dx.doi.org/10.1038/35074219			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323648				2022-12-01	WOS:000168285500026
J	Goldin, DS; Dahl, CA; Olsen, KL; Ostrach, LH; Klausner, RD				Goldin, DS; Dahl, CA; Olsen, KL; Ostrach, LH; Klausner, RD			Biomedicine - The NASA-NCI collaboration on biomolecular sensors	SCIENCE			English	Editorial Material									NCI, Off Technol & Ind Relat, Bethesda, MD 20892 USA; NASA, Off Biol & Phys Res, Washington, DC 20546 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Aeronautics & Space Administration (NASA)	Dahl, CA (corresponding author), NCI, Off Technol & Ind Relat, Bethesda, MD 20892 USA.							HOCH HC, 1996, INTEGRATING MAT SCI; Lawler A, 2000, SCIENCE, V288, P415; SARIKAYA M, 1995, DESIGN PROCESSING MA	3	8	8	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					443	444		10.1126/science.1059744	http://dx.doi.org/10.1126/science.1059744			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11330296				2022-12-01	WOS:000168187300025
J	Jaakkola, P; Mole, DR; Tian, YM; Wilson, MI; Gielbert, J; Gaskell, SJ; von Kriegsheim, A; Hebestreit, HF; Mukherji, M; Schofield, CJ; Maxwell, PH; Pugh, CW; Ratcliffe, PJ				Jaakkola, P; Mole, DR; Tian, YM; Wilson, MI; Gielbert, J; Gaskell, SJ; von Kriegsheim, A; Hebestreit, HF; Mukherji, M; Schofield, CJ; Maxwell, PH; Pugh, CW; Ratcliffe, PJ			Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O-2-regulated prolyl hydroxylation	SCIENCE			English	Article							TUMOR-SUPPRESSOR PROTEIN; INDUCIBLE FACTOR 1-ALPHA; UBIQUITIN-LIGASE COMPLEX; DEPENDENT PROTEOLYSIS; ERYTHROPOIETIN GENE; FACTOR-I; HYPOXIA; HIF-1-ALPHA; ACTIVATION; BINDING	Hypoxia-inducible factor (HIF) is a transcriptional complex that plays a central role in the regulation of gene expression by oxygen. In oxygenated and iron replete cells, HIF-alpha subunits are rapidly destroyed by a mechanism that involves ubiquitylation by the von Hippel-Lindau tumor suppressor (pVHL) E3 Ligase complex. This process is suppressed by hypoxia and iron chelation, allowing transcriptional activation. Here we show that the interaction between human pVHL and a specific domain of the HIF-1 alpha subunit is regulated through hydroxylation of a proline residue (HIF-1 alpha P564) by an enzyme we have termed HIF-alpha prolyl-hydroxylase (HIF-PH). An absolute requirement for dioxygen as a cosubstrate and iron as cofactor suggests that HIF-PH functions directly as a cellular oxygen sensor.	Univ Oxford, Oxford OX3 7BN, England; Univ Manchester, Inst Sci & Technol, Dept Chem, Michael Barber Ctr Mass Spectrometry, Manchester M60 1QD, Lancs, England; Univ Oxford, Glycobiol Inst, Oxford OX1 3QU, England; Univ Oxford, Dyson Perrins Lab, Oxford Ctr Mol Sci, Oxford OX1 3QY, England	University of Oxford; University of Manchester; University of Oxford; University of Oxford	Maxwell, PH (corresponding author), Univ Oxford, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.		von Kriegsheim, Alex/C-2371-2016; Maxwell, Patrick H/C-5557-2008; Jaakkola, Panu M/B-4355-2012; Gielbert, Adriana/C-5188-2011	von Kriegsheim, Alex/0000-0002-4952-8573; Maxwell, Patrick H/0000-0002-0338-2679; Gielbert, Adriana/0000-0003-1597-9373; Schofield, Christopher/0000-0002-0290-6565; Jaakkola, Panu/0000-0002-2365-4985; Pugh, Chris/0000-0002-5170-1662; Ratcliffe, Peter/0000-0002-2853-806X; Mole, David/0000-0002-0984-300X				Bacon NCM, 1998, BIOCHEM BIOPH RES CO, V249, P811, DOI 10.1006/bbrc.1998.9234; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; CUNLIFFE CJ, 1992, J MED CHEM, V35, P2652, DOI 10.1021/jm00092a016; Ehleben W, 1997, KIDNEY INT, V51, P483, DOI 10.1038/ki.1997.67; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jansen GA, 1999, J LIPID RES, V40, P2244; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; KIVIRIKKO KI, 1980, ENZYMOLOGY POST TRAN, P53; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; MASSON N, UNPUB; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MUKHERJI M, UNPUB; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268	32	4233	4407	16	449	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					468	472		10.1126/science.1059796	http://dx.doi.org/10.1126/science.1059796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11292861				2022-12-01	WOS:000168187300036
J	McComb, K; Moss, C; Durant, SM; Baker, L; Sayialel, S				McComb, K; Moss, C; Durant, SM; Baker, L; Sayialel, S			Matriarchs as repositories of social knowledge in African elephants	SCIENCE			English	Article							AGE	Despite widespread interest in the evolution of social intelligence, Little is known about how wild animals acquire and store information about social companions or whether individuals possessing enhanced social knowledge derive biological fitness benefits. Using playback experiments on African elephants (Loxodonta africana), we demonstrated that the possession of enhanced discriminatory abilities by the oldest individual in a group can influence the social knowledge of the group as a whole. These superior abilities for social discrimination may result in higher per capita reproductive success for female groups led by older individuals. Our findings imply that the removal of older, more experienced individuals, which are often targets for hunters because of their large size, could have serious consequences for endangered populations of advanced social mammals such as elephants and whales.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; African Wildlife Fdn, Amboseli Elephant Res Project, Nairobi, Kenya; Zool Soc London, Inst Zool, London NW1 4RY, England	University of Sussex; Zoological Society of London	McComb, K (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.		Durant, Sarah M/AAB-9659-2019	Durant, Sarah M/0000-0003-0724-0878				Cheney D.L., 1990, MONKEYS SEE WORLD IN; Connor RC, 2000, CETACEAN SOCIETIES, P199; Dobson A, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P193; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Durant SM, 2000, ANIM BEHAV, V60, P121, DOI 10.1006/anbe.2000.1433; Gigerenzer G., 1997, MACHIAVELLIAN INTELL, V2, P264; Humphrey N., 1976, GROWING POINTS ETHOL, P303; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; McConway KJ, 1999, STAT MODELLING USING; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Moss Cynthia, 1996, P58; NISHIDA T, 1986, PRIMATE SOC, P165; Payne R. W., 1987, GENSTAT 5 REFERENCE; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Ratcliffe N, 1998, J ANIM ECOL, V67, P853, DOI 10.1046/j.1365-2656.1998.6760853.x; Spinage C.A., 1994, ELEPHANTS; Stevick PT, 1999, MAR MAMMAL SCI, V15, P725, DOI 10.1111/j.1748-7692.1999.tb00839.x	17	392	406	2	213	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					491	494		10.1126/science.1057895	http://dx.doi.org/10.1126/science.1057895			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313492				2022-12-01	WOS:000168187300043
J	Hansel, DE; Eipper, BA; Ronnett, GV				Hansel, DE; Eipper, BA; Ronnett, GV			Neuropeptide Y functions as a neuroproliferative factor	NATURE			English	Article							NERVOUS-SYSTEM; MAP KINASE; STEM-CELLS; PEPTIDE YY; RECEPTORS; RAT; EXPRESSION; NEURONS; TUBULIN	Neuropeptide Y (NPY) has a number of functions in mammalian physiology(1-6). Here we identify a role for NPY in promoting proliferation of postnatal neuronal precursor cells. NPY is synthesized in the postnatal olfactory epithelium by sustentacular cells, previously proposed to function only in structural support(7). Mice with a targeted deletion of NPY8 contain half as many dividing olfactory neuronal precursor cells as do controls. Furthermore, NPY-deficient mice develop significantly fewer olfactory neurons by adulthood. NPY acts on multipotent neuronal precursor or basal cells to activate rapidly and transiently the extracellular signal-regulated kinase (ERK)1/2 subgroup of mitogen-activated protein kinases. The NPY Y1 receptor subtype appears to mediate this effect. The ability of NPY to induce neuronal precursor proliferation is mediated by protein kinase C (PKC), indicating an upstream PKC-dependent activation of ERK1/2. These results indicate that NPY may regulate neuronal precursor proliferation in the adult mammal.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Univ Vermont, Hlth Sci Ctr, Dept Physiol, Burlington, VT 05405 USA	Johns Hopkins University; Johns Hopkins University; University of Vermont	Ronnett, GV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.							ADRIAN TE, 1983, LANCET, V2, P540; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Balasubramaniam A, 1997, PEPTIDES, V18, P445, DOI 10.1016/S0196-9781(96)00347-6; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; DANGER JM, 1990, FUNDAM CLIN PHARM, V4, P307, DOI 10.1111/j.1472-8206.1990.tb00497.x; Davis JA, 1996, J NEUROSCI, V16, P5082; DICKERSON IM, 1990, ENDOCRINOLOGY, V127, P133, DOI 10.1210/endo-127-1-133; ELITSUR Y, 1994, NEUROPEPTIDES, V26, P289, DOI 10.1016/0143-4179(94)90113-9; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goldberg Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1207, DOI 10.1152/ajpcell.1998.275.5.C1207; Hokfelt T, 1998, BRAIN RES REV, V26, P154, DOI 10.1016/S0165-0173(97)00052-0; Huard JMT, 1998, J COMP NEUROL, V400, P469; Keffel S, 1999, J PHARMACOL EXP THER, V291, P1172; Lopez-Ilasaca M, 1998, BIOCHEM PHARMACOL, V56, P269, DOI 10.1016/S0006-2952(98)00059-8; Mannon PJ, 1998, BIOCHEM BIOPH RES CO, V246, P91, DOI 10.1006/bbrc.1998.8577; MEMBERG SP, 1995, J NEUROBIOL, V27, P26, DOI 10.1002/neu.480270104; Michel MC, 1998, PHARMACOL REV, V50, P143; MORRISON EE, 1995, HDB OLFACTION GUSTAT, P79; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Pellieux C, 2000, P NATL ACAD SCI USA, V97, P1595, DOI 10.1073/pnas.030533197; RIJZEWIJK JJ, 1989, ACTA DERM-VENEREOL, V69, P512; RONNETT GV, 1991, J NEUROSCI, V11, P1243; Roskams AJI, 1998, NEUROSCIENCE, V83, P191, DOI 10.1016/S0306-4522(97)00344-8; SHIGERI Y, 1993, NEUROSCI LETT, V149, P19, DOI 10.1016/0304-3940(93)90337-K; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; UBINK R, 1994, NEUROSCIENCE, V60, P709, DOI 10.1016/0306-4522(94)90499-5	30	288	298	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					940	944		10.1038/35073601	http://dx.doi.org/10.1038/35073601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309620				2022-12-01	WOS:000168152300049
J	Blackmer, T; Larsen, EC; Takahashi, M; Martin, TFJ; Alford, S; Hamm, HE				Blackmer, T; Larsen, EC; Takahashi, M; Martin, TFJ; Alford, S; Hamm, HE			G protein beta gamma subunit-mediated presynaptic inhibition: Regulation of exocytotic fusion downstream of Ca2+ entry	SCIENCE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; DEPENDENT CALCIUM CHANNELS; MOTOR-NERVE ENDINGS; SENSORY NEURONS; DIRECT BINDING; K+ CHANNEL; RAT-BRAIN; MODULATION; ACTIVATION; MECHANISM	The nervous system can modulate neurotransmitter release by neurotransmitter activation of heterotrimeric GTP-binding protein (G protein)-coupled receptors. We found that microinjection of G protein beta gamma subunits (G beta gamma) mimics serotonin's inhibitory effect on neurotransmission. Release of free G beta gamma was critical for this effect because a G beta gamma scavenger blocked serotonin's effect. G beta gamma bad no effect on fast, action potential-evoked intracellular Ca2+ release that triggered neurotransmission. Inhibition of neurotransmitter release by serotonin was still seen after blockade of all classical G beta gamma effector pathways. Thus, G beta gamma blocked neurotransmitter release downstream of Ca2+ entry and may directly target the exocytotic fusion machinery at the presynaptic terminal.	Northwestern Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Inst Neurosci, Chicago, IL 60611 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60608 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Northwestern University; Northwestern University; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Wisconsin System; University of Wisconsin Madison	Alford, S (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg, Nashville, TN 37232 USA.		Hamm, Heidi E/G-2374-2014	Alford, Simon/0000-0002-0454-4246				ALFORD S, 1991, J NEUROSCI, V11, P3718; Betty M, 1998, NEUROSCIENCE, V85, P475, DOI 10.1016/S0306-4522(97)00623-4; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BUCHANAN JT, 1991, NEUROSCI LETT, V122, P71, DOI 10.1016/0304-3940(91)90196-Z; Cochilla AJ, 1998, NEURON, V20, P1007, DOI 10.1016/S0896-6273(00)80481-X; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DOLPHIN AC, 1993, BIOCHEM SOC T, V21, P391, DOI 10.1042/bst0210391; ECCLES JC, 1963, J NEUROPHYSIOL, V26, P506, DOI 10.1152/jn.1963.26.3.506; ElManira A, 1997, J NEUROSCI, V17, P1786; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; HOLZ GG, 1989, J NEUROSCI, V9, P657; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarvis SE, 2000, J BIOL CHEM, V275, P6388, DOI 10.1074/jbc.275.9.6388; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LUINI A, 1990, J NEUROCHEM, V54, P30, DOI 10.1111/j.1471-4159.1990.tb13279.x; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Mirotznik RR, 2000, J NEUROSCI, V20, P7614; Nicoll R A, 1979, Int Rev Neurobiol, V21, P217; Qin N, 1997, P NATL ACAD SCI USA, V94, P8866, DOI 10.1073/pnas.94.16.8866; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SILINSKY EM, 1984, J PHYSIOL-LONDON, V346, P243, DOI 10.1113/jphysiol.1984.sp015019; SILINSKY EM, 1992, J PHYSIOL-LONDON, V457, P315, DOI 10.1113/jphysiol.1992.sp019380; Singer JH, 1996, SLEEP, V19, pS146; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; Takahashi M, 2001, J PHYSIOL-LONDON, V532, P323, DOI 10.1111/j.1469-7793.2001.0323f.x; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; UMEMIYA M, 1995, J NEUROPHYSIOL, V73, P1192, DOI 10.1152/jn.1995.73.3.1192; WICKELGREN WO, 1977, J PHYSIOL-LONDON, V270, P89, DOI 10.1113/jphysiol.1977.sp011940	34	195	199	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					293	297		10.1126/science.1058803	http://dx.doi.org/10.1126/science.1058803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303105				2022-12-01	WOS:000168074000049
J	Schreiber, K; Crawford, JD; Fetter, M; Tweed, D				Schreiber, K; Crawford, JD; Fetter, M; Tweed, D			The motor side of depth vision	NATURE			English	Article							LISTINGS PLANE; EYE POSITION; STEREOPSIS; ROTATION; VERGENCE; LAW; CYCLOVERGENCE; CONVERGENCE; DISPARITY	To achieve stereoscopic vision, the brain must search for corresponding image features on the two retinas(1). As long as the eyes stay still, corresponding features are confined to narrow bands called epipolar lines(2,3). But when the eyes change position, the epipolar lines migrate on the retinas(4-6). To rnd the matching features, the brain must either search different retinal bands depending on current eye position, or search retina-fixed zones that are large enough to cover all usual locations of the epipolar lines. Here we show, using a new type of stereogram in which the depth image vanishes at certain gaze elevations, that the search zones are retina-fixed. This being the case, motor control acquires a crucial function in depth vision: we show that the eyes twist about their lines of sight in a way that reduces the motion of the epipolar lines, allowing stereopsis to get by with smaller search zones and thereby lightening its computational load.	Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Canadian Inst Hlth Res, Grp Act & Percept, Toronto, ON, Canada; York Univ, Ctr Vis Res, Toronto, ON M3J 1P3, Canada; Univ Tubingen Hosp, Dept Neurol, D-72072 Tubingen, Germany	University of Toronto; University of Toronto; Institute for Work & Health; York University - Canada; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Tweed, D (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.		Schreiber, Kai/A-1832-2009	Crawford, Doug/0000-0003-2288-1286				ALLEN M J, 1954, Am J Optom Arch Am Acad Optom, V31, P297; Carpenter RHS, 1988, MOVEMENTS EYES; CRONE RA, 1975, A GRAEF ARCH KLIN EX, V195, P231, DOI 10.1007/BF00414936; Farell B, 1998, NATURE, V395, P689, DOI 10.1038/27192; GARDING J, 1995, VISION RES, V35, P703, DOI 10.1016/0042-6989(94)00162-F; HEPP K, 1990, COMMUN MATH PHYS, V132, P285, DOI 10.1007/BF02278012; HEPP K, 1995, VISION RES, V35, P3237, DOI 10.1016/0042-6989(95)00104-M; Hooge ITC, 2000, J NEUROPHYSIOL, V83, P2757, DOI 10.1152/jn.2000.83.5.2757; HOOTEN K, 1979, A GRAEF ARCH KLIN EX, V210, P65, DOI 10.1007/BF00414790; HOWARD IP, 1993, EXP BRAIN RES, V97, P349; JULESZ B, 1960, BELL SYST TECH J, V39, P1152; Kapoula Z, 1999, EXP BRAIN RES, V126, P175, DOI 10.1007/s002210050727; KERTESZ AE, 1978, VISION RES, V18, P567, DOI 10.1016/0042-6989(78)90204-3; MINKEN AWH, 1994, EXP BRAIN RES, V101, P331, DOI 10.1007/BF00228754; MOK D, 1992, VISION RES, V32, P2055, DOI 10.1016/0042-6989(92)90067-S; NIELSEN KRK, 1984, VISION RES, V24, P1133, DOI 10.1016/0042-6989(84)90167-6; Ogle K. N., 1950, RES BINOCULAR VISION; PRAZDNY K, 1985, B PSYCHONOMIC SOC, V23, P413; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROGERS BJ, 1996, INVEST OPHTHALMOL  S, V37, P31; Steffen H, 2000, INVEST OPHTH VIS SCI, V41, P715; Stevenson SB, 1997, VISION RES, V37, P2717, DOI 10.1016/S0042-6989(97)00097-7; TWEED D, 1990, VISION RES, V30, P97, DOI 10.1016/0042-6989(90)90130-D; Tweed D, 1997, VISION RES, V37, P1939, DOI 10.1016/S0042-6989(97)00002-3; VANRIJN LJ, 1993, VISION RES, V33, P691, DOI 10.1016/0042-6989(93)90189-4; von Helmholtz H., 1967, HDB PHYSL OPTIK	26	67	71	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					819	822		10.1038/35071081	http://dx.doi.org/10.1038/35071081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298450				2022-12-01	WOS:000168021900056
J	Aspden, RM; Scheven, BAA; Hutchison, JD				Aspden, RM; Scheven, BAA; Hutchison, JD			Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism	LANCET			English	Article							TRABECULAR BONE; FEMORAL-HEAD; CHOLESTEROL; PHENOTYPE; PLATE; WOMEN; SERUM; GENE; HIP	For many years articular cartilage has been the focus of research aimed at improving understanding of and treatment for osteoarthritis. Although much Is known about the tissue, research has had little success In elucidating the pathogenesis of generalised osteoarthritis. A new hypothesis is required. Substantial changes in many tissues, including bone, muscle, ligaments, and joint capsule, as well as cartilage, are Increasingly recognised in this disease, and not all these changes are localised to the affected joints. There is also a well established link with obesity. These observations, the common origins of the mesenchymal cells that maintain these tissues, and the possible role of neuroendocrine factors that can regulate bone mass, result in the hypothesis that systemic factors that include altered lipid metabolism could explain the diversity of physiological changes in generalised osteoarthritis. If proven, this hypothesis could have important implications for a new approach to pharmacological intervention in the early stages of the disease.	Univ Aberdeen, Dept Orthopaed Surg, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Aspden, RM (corresponding author), Univ Aberdeen, Dept Orthopaed Surg, Aberdeen AB25 2ZD, Scotland.	r.aspden@abdn.ac.uk		Aspden, Richard/0000-0002-0693-1194				Anderson-MacKenzie JM, 1999, BIOCHEM BIOPH RES CO, V258, P763, DOI 10.1006/bbrc.1999.0713; Cooper C, 1996, J RHEUMATOL, V23, P1938; Curtis CL, 2000, J BIOL CHEM, V275, P721, DOI 10.1074/jbc.275.2.721; DEDRICK DK, 1993, ARTHRITIS RHEUM, V36, P1460, DOI 10.1002/art.1780361019; DEQUEKER J, 1995, J RHEUMATOL, V22, P98; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Duplus E, 2000, J BIOL CHEM, V275, P30749, DOI 10.1074/jbc.R000015200; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X; Hurley Michael V., 1998, Current Opinion in Rheumatology, V10, P246, DOI 10.1097/00002281-199805000-00015; Hurley MV, 1999, RHEUM DIS CLIN N AM, V25, P283, DOI 10.1016/S0889-857X(05)70068-5; Li BH, 1997, J BONE MINER RES, V12, P641, DOI 10.1359/jbmr.1997.12.4.641; Li BH, 1999, J ANAT, V195, P101, DOI 10.1046/j.1469-7580.1999.19510101.x; LIPPIELLO L, 1990, P SOC EXP BIOL MED, V195, P282, DOI 10.3181/00379727-195-43149; LIPPIELLO L, 1991, METABOLISM, V40, P571, DOI 10.1016/0026-0495(91)90046-Y; Madsen OR, 1997, CLIN RHEUMATOL, V16, P39, DOI 10.1007/BF02238761; NEVITT MC, 1995, ARTHRITIS RHEUM-US, V38, P907, DOI 10.1002/art.1780380706; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RADIN EL, 1991, SEMIN ARTHRITIS RHEU, V21, P12, DOI 10.1016/0049-0172(91)90036-Y; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Sturmer T, 1998, J RHEUMATOL, V25, P1827; Vogel G, 1999, SCIENCE, V286, P1825; Watkins BA, 1996, P SOC EXP BIOL MED, V212, P153, DOI 10.3181/00379727-212-44003	26	125	136	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2001	357	9262					1118	1120		10.1016/S0140-6736(00)04264-1	http://dx.doi.org/10.1016/S0140-6736(00)04264-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297982				2022-12-01	WOS:000167996200032
J	Choi, HJ; Kim, SJ; Mukhopadhyay, P; Cho, S; Woo, JR; Storz, G; Ryu, SE				Choi, HJ; Kim, SJ; Mukhopadhyay, P; Cho, S; Woo, JR; Storz, G; Ryu, SE			Structural basis of the redox switch in the OxyR transcription factor	CELL			English	Article							CRYSTAL-STRUCTURE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; ESCHERICHIA-COLI; REVERSIBLE INACTIVATION; SALMONELLA-TYPHIMURIUM; SIGNAL-TRANSDUCTION; MUTATIONAL ANALYSIS; REGIONS IMPORTANT; INDUCIBLE GENES	The Escherichia coli OxyR transcription factor senses H2O2 and is activated through the formation of an intramolecular disulfide bond. Here we present the crystal structures of the regulatory domain of OxyR in its reduced and oxidized forms, determined at 2.7 Angstrom and 2.3 Angstrom resolutions, respectively. In the reduced form, the two redox-active cysteines are separated by approximately 17 Angstrom. Disulfide bond formation in the oxidized form results in a significant structural change in the regulatory domain. The structural remodeling, which leads to different oligomeric associations, accounts for the redox-dependent switch in OxyR and provides a novel example of protein regulation by "fold editing" through a reversible disulfide bond formation within a folded domain.	Korea Res Inst Biosci & Biotechnol, Ctr Cellular Switch Prot Struct, Taejon 305600, South Korea; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ryu, SE (corresponding author), Korea Res Inst Biosci & Biotechnol, Ctr Cellular Switch Prot Struct, POB 115, Taejon 305600, South Korea.		MUKHOPADHYAY, PARTHA/G-3890-2010	MUKHOPADHYAY, PARTHA/0000-0002-1178-1274; Storz, Gisela/0000-0001-6698-1241	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001608] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Choi HJ, 1998, NAT STRUCT BIOL, V5, P400, DOI 10.1038/nsb0598-400; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Cordes MHJ, 1999, SCIENCE, V284, P325, DOI 10.1126/science.284.5412.325; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; ESNOUF RM, 1997, J MOL GRAPH MODEL, V15, P32; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; KULLIK I, 1995, J BACTERIOL, V177, P1285, DOI 10.1128/jb.177.5.1285-1291.1995; Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lin K, 1996, SCIENCE, V273, P1539, DOI 10.1126/science.273.5281.1539; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Muse WB, 1999, J BACTERIOL, V181, P934, DOI 10.1128/JB.181.3.934-940.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; TAO K, 1993, MOL MICROBIOL, V7, P859, DOI 10.1111/j.1365-2958.1993.tb01176.x; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P2038; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tyrrell R, 1997, STRUCTURE, V5, P1017, DOI 10.1016/S0969-2126(97)00254-2; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; [No title captured]	39	409	422	0	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					103	113		10.1016/S0092-8674(01)00300-2	http://dx.doi.org/10.1016/S0092-8674(01)00300-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301006	Bronze			2022-12-01	WOS:000168063300011
J	Mason, AC; Oshinsky, ML; Hoy, RR				Mason, AC; Oshinsky, ML; Hoy, RR			Hyperacute directional hearing in a microscale auditory system	NATURE			English	Article							FLY ORMIA-OCHRACEA; PARASITOID FLY; TEMPORAL HYPERACUITY; ELECTRIC FISH; TACHINIDAE; NEURONS; DIPTERA	The physics of sound propagation imposes fundamental constraints on sound localization: for a given frequency, the smaller the receiver, the smaller the available cues(1). Thus, the creation of nanoscale acoustic microphones with directional sensitivity is very difficult. The fly Ormia ochracea possesses an unusual 'ear' that largely overcomes these physical constraints(2-5); attempts to exploit principles derived from O. ochracea for improved hearing aids are now in progress(6). Here we report that O. ochracea can behaviourally localize a salient sound source with a precision equal to that of humans(7). Despite its small size and minuscule interaural cues, the fly localizes sound sources to within 2 degrees azimuth. As the fly's eardrums are less than 0.5 mm apart, localization cues are around 50 ns. Directional information is represented in the auditory system by the relative timing of receptor responses in the two ears. Low-jitter, phasic receptor responses are pooled to achieve hyperacute timecoding(8,9). These results demonstrate that nanoscale/microscale directional microphones patterned after O. ochracea have the potential for highly accurate directional sensitivity, independent of their size. Notably, in the fly itself this performance is dependent on a newly discovered set of specific coding strategies employed by the nervous system.	Cornell Univ, Ithaca, NY 14853 USA	Cornell University	Mason, AC (corresponding author), Univ Toronto, Div Life Sci, 1265 Mil Trail, Scarborough, ON M1C 1A4, Canada.			Oshinsky, Michael/0000-0002-0976-1047; Mason, Andrew/0000-0001-7719-8500				Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; BATSCHELET E., 1981, CIRCULAR STAT BIOL M; Cade WH, 1996, CAN J ZOOL, V74, P393, DOI 10.1139/z96-046; CARR CE, 1986, J NEUROSCI, V6, P107; Fay R. R., 1988, HEARING VERTEBRATES; GIBBONS C, 2000, P IMECE ASME ORL FLO, P5; KAWASAKI M, 1988, NATURE, V336, P173, DOI 10.1038/336173a0; Marsalek PR, 1997, P NATL ACAD SCI USA, V94, P735, DOI 10.1073/pnas.94.2.735; MICHELSEN A, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P61; Miles RN, 1995, J ACOUST SOC AM, V98, P3059, DOI 10.1121/1.413830; RAMSAUER N, 1999, THESIS U ZURICH; Rieke F, 1997, SPIKES; Robert D, 2000, CELL TISSUE RES, V301, P447, DOI 10.1007/s004410000257; Robert D, 1996, CELL TISSUE RES, V284, P435, DOI 10.1007/s004410050604; ROBERT D, 1992, SCIENCE, V258, P1135, DOI 10.1126/science.1439820; Robert D, 1998, J COMP PHYSIOL A, V183, P443, DOI 10.1007/s003590050270; ROSE G, 1985, NATURE, V318, P178, DOI 10.1038/318178a0; WALKER TJ, 1993, J INSECT BEHAV, V6, P389, DOI 10.1007/BF01048119	18	153	160	1	62	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					686	690		10.1038/35070564	http://dx.doi.org/10.1038/35070564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287954				2022-12-01	WOS:000167875400046
J	Jaenisch, R; Wilmut, I				Jaenisch, R; Wilmut, I			Developmental biology - Don't clone humans!	SCIENCE			English	Editorial Material							NUCLEAR TRANSFER; SOMATIC-CELLS; ADULT; FETAL		MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute	Jaenisch, R (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.							Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Daniels R, 2000, BIOL REPROD, V63, P1034, DOI 10.1095/biolreprod63.4.1034; De Sousa P A, 1999, Cloning, V1, P63, DOI 10.1089/15204559950020102; JANEISCH R, UNPUB; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; *NBAC, 1997, CLON HUM BEINGS, pR2; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; STERN A, 2001, BOSTON GLOBE    0127, pA7; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	14	80	81	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2552	2552		10.1126/science.1060463	http://dx.doi.org/10.1126/science.1060463			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11286275				2022-12-01	WOS:000167861000023
J	Pellman, D				Pellman, D			Cancer - A CINtillating new job for the APC tumor suppressor	SCIENCE			English	Editorial Material							PROTEIN		Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu						Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; Barth AI, 1997, CURR OPIN CELL BIOL, V9, P683, DOI 10.1016/S0955-0674(97)80122-6; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Miller RK, 2000, MOL BIOL CELL, V11, P2949, DOI 10.1091/mbc.11.9.2949; MIRNORIKIYOSUE Y, 2000, CURR BIOL, V10, P865; MIRNORIKIYOSUE Y, 2000, J CELL BIOL, V148, P505; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Schuyler SC, 2001, J CELL SCI, V114, P247; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309	16	20	22	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2555	2556		10.1126/science.1057337	http://dx.doi.org/10.1126/science.1057337			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11286276				2022-12-01	WOS:000167861000025
J	Kawakami, Y; Capdevila, J; Buscher, D; Itoh, T; Esteban, CR; Belmonte, JCI				Kawakami, Y; Capdevila, J; Buscher, D; Itoh, T; Esteban, CR; Belmonte, JCI			WNT signals control FGF-dependent limb initiation and AER induction in the chick embryo	CELL			English	Article							FIBROBLAST GROWTH-FACTORS; APICAL ECTODERMAL RIDGE; PATTERN-FORMATION; VERTEBRATE LIMB; ADDITIONAL LIMB; EXPRESSION; BUD; GENE; OUTGROWTH; INVOLVEMENT	A regulatory loop between the fibroblast growth factors FGF-8 and FGF-10 plays a key role in limb initiation and AER induction in vertebrate embryos. Here, we show that three WNT factors signaling through beta -catenin act as key regulators of the FGF-8/FGF-10 loop. The Wnt-2b gene is expressed in the intermediate mesoderm and the lateral plate mesoderm in the presumptive chick forelimb region. Cells expressing Wnt-2b are able to induce Fgf-10 and generate an extra limb when implanted into the flank. In the presumptive hindlimb region, another Wnt gene, Wnt-8c, controls Fgf-10 expression, and is also capable of inducing ectopic limb formation in the flank. Finally, we also show that the induction of Fgf-8 in the limb ectoderm by FGF-10 is mediated by the induction of Wnt-3a. Thus, three WNT signals mediated by beta -catenin control both limb initiation and AER induction in the vertebrate embryo.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Itoh, Tohru/GYQ-8698-2022	Itoh, Tohru/0000-0002-6579-1638				Altabef M, 1997, DEVELOPMENT, V124, P4547; BALINSKY BI, 1965, INTRO EMBRYOLOGY, P405; Capdevila J, 1998, DEV BIOL, V193, P182, DOI 10.1006/dbio.1997.8806; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; Cohn MJ, 1996, TRENDS GENET, V12, P253, DOI 10.1016/0168-9525(96)10030-5; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Esteve P, 2000, MECH DEVELOP, V97, P217, DOI 10.1016/S0925-4773(00)00421-4; FernandezTeran M, 1997, DEV BIOL, V189, P246, DOI 10.1006/dbio.1997.8680; GAVIN BJ, 1990, GENE DEV, V4, P2319, DOI 10.1101/gad.4.12b.2319; GEDUSPAN JS, 1992, DEV BIOL, V151, P212; Grieshammer U, 1996, DEVELOPMENT, V122, P3851; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HUME CR, 1993, DEVELOPMENT, V119, P1147; Isaac A, 2000, MECH DEVELOP, V93, P41, DOI 10.1016/S0925-4773(00)00261-6; Jasoni C, 1999, DEV DYNAM, V215, P215, DOI 10.1002/(SICI)1097-0177(199907)215:3<215::AID-AJA4>3.0.CO;2-W; Katoh M, 1996, ONCOGENE, V13, P873; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; KIENY M, 1969, CR ACAD SCI D NAT, V268, P3183; Kimmel RA, 2000, GENE DEV, V14, P1377; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Ohuchi H, 1999, CELL TISSUE RES, V296, P45, DOI 10.1007/s004410051265; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; OHUCHI H, 1995, BIOCHEM BIOPH RES CO, V209, P809, DOI 10.1006/bbrc.1995.1572; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PINOT M, 1970, Journal of Embryology and Experimental Morphology, V23, P109; Ros MA, 1996, DEVELOPMENT, V122, P2319; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; SHIMIZU H, 1997, CELL GROWTH DIFFER, V8, P349; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; STEPHENS TD, 1993, PROG CLIN BIOL RES, V383, P317; STEPHENS TD, 1989, DEV BIOL, V133, P1, DOI 10.1016/0012-1606(89)90290-X; Szebenyi G, 1999, INT REV CYTOL, V185, P45; TANDA N, 1995, DNA SEQUENCE, V5, P277, DOI 10.3109/10425179509030981; Tickle C, 1999, SEMIN CELL DEV BIOL, V10, P345, DOI 10.1006/scdb.1999.0294; Vogel A, 1996, DEVELOPMENT, V122, P1737; WILKINSON DG, 1993, IN SITU HYBRIDIZATIO; Zakin LDJ, 1998, MECH DEVELOP, V73, P107, DOI 10.1016/S0925-4773(98)00040-9	45	265	276	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					891	900		10.1016/S0092-8674(01)00285-9	http://dx.doi.org/10.1016/S0092-8674(01)00285-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290326	Bronze			2022-12-01	WOS:000167869200011
J	Omacini, M; Chaneton, EJ; Ghersa, CM; Muller, CB				Omacini, M; Chaneton, EJ; Ghersa, CM; Muller, CB			Symbiotic fungal endophytes control insect host-parasite interaction webs	NATURE			English	Article							APPARENT COMPETITION; PRODUCTIVITY; DIVERSITY; HERBIVORES	Symbiotic microorganisms that live intimately associated with terrestrial plants affect both the quantity and quality of resources(1,2), and thus the energy supply to consumer populations at higher levels in the food chain. Empirical evidence on resource limitation of food webs points to primary productivity as a major determinant of consumer abundance and trophic structure(3-6). Prey quality plays a critical role in community regulation(7,8). Plants infected by endophytic fungi are known to be chemically protected against herbivore consumption(9-11). However, the influence of this microbe-plant association on multi-trophic interactions remains largely unexplored. Here we present the effects of fungal endophytes on insect food webs that reflect limited energy transfer to consumers as a result of low plant quality, rather than low productivity. Herbivore-parasite webs on endophyte-free grasses show enhanced insect abundance at alternate trophic levels, higher rates of parasitism, and increased dominance by a few trophic links. These results mirror predicted effects of increased productivity on food-web dynamics(12). Thus 'hidden' microbial symbionts can have community-wide impacts on the pattern and strength of resource-consumer interactions.	Univ Buenos Aires, Fac Agron, IFEVA, Dept Recursos Nat & Ambiente, RA-1417 Buenos Aires, DF, Argentina; Imperial Coll, Dept Biol, Ascot SL5 7PY, Berks, England; Imperial Coll, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Zool Soc London, Inst Zool, London NW1 4RY, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Zoological Society of London	Omacini, M (corresponding author), Univ Buenos Aires, Fac Agron, IFEVA, Dept Recursos Nat & Ambiente, Av San Martin 4453, RA-1417 Buenos Aires, DF, Argentina.	omacini@ifeva.edu.ar; christine.mueller@ioz.ac.uk		Omacini, Marina/0000-0003-1460-262X				ABRAMS PA, 1993, AM NAT, V141, P351, DOI 10.1086/285478; ALATALO RV, 1981, OIKOS, V37, P199, DOI 10.2307/3544465; Barker GM, 1996, BIOL CONTROL, V7, P281, DOI 10.1006/bcon.1996.0095; BREEN JP, 1994, ANNU REV ENTOMOL, V39, P401, DOI 10.1146/annurev.en.39.010194.002153; Bultman TL, 1997, OIKOS, V78, P170, DOI 10.2307/3545812; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; CLAY K, 1990, ANNU REV ECOL SYST, V21, P275, DOI 10.1146/annurev.es.21.110190.001423; Dahlman D.L., 1991, MICROBIAL MEDIATION, P227; DeAngelis D. L., 1992, DYNAMICS NUTR CYCLIN; DOBSON A, 1994, TRENDS ECOL EVOL, V9, P393, DOI 10.1016/0169-5347(94)90062-0; GEHRING CA, 1994, TRENDS ECOL EVOL, V9, P251, DOI 10.1016/0169-5347(94)90290-9; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; HOLT RD, 1993, AM NAT, V142, P623, DOI 10.1086/285561; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Hulot FD, 2000, NATURE, V405, P340, DOI 10.1038/35012591; HUNTER MD, 1992, ECOLOGY, V73, P724; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; LATCH GCM, 1988, NEW ZEAL J AGR RES, V31, P57, DOI 10.1080/00288233.1988.10421364; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; Magurran A.E., 1988, ECOLOGICAL DIVERSITY, DOI DOI 10.1007/978-94-015-7358-0; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Mikola J, 1998, OIKOS, V82, P158, DOI 10.2307/3546926; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Osenberg Craig W., 1996, P134; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; WOOTTON JT, 1993, P NATL ACAD SCI USA, V90, P1384, DOI 10.1073/pnas.90.4.1384	30	245	272	5	129	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					78	81		10.1038/35051070	http://dx.doi.org/10.1038/35051070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343116				2022-12-01	WOS:000166175600042
J	Santagata, S; Boggon, TJ; Baird, CL; Gomez, CA; Zhao, J; Shan, WS; Myszka, DG; Shapiro, L				Santagata, S; Boggon, TJ; Baird, CL; Gomez, CA; Zhao, J; Shan, WS; Myszka, DG; Shapiro, L			G-protein signaling through tubby proteins	SCIENCE			English	Article							MOLECULAR CHARACTERIZATION; PLASMA-MEMBRANE; RECESSIVE MUTATIONS; STRUCTURAL BASIS; PHOSPHOLIPASE-C; GENE FAMILY; OBESITY; MOUSE; MICE; SEROTONIN	Dysfunction of the tubby protein results in maturity-onset obesity in mice. Tubby has been implicated as a transcription regulator, but details of the molecular mechanism underlying its function remain unclear. Here we show that tubby functions in signal transduction from heterotrimeric GTP-binding protein (G protein)-coupled receptors. Tubby Localizes to the plasma membrane by binding phosphatidylinositol 4,5-bisphosphate through its carboxyl terminal "tubby domain." X-ray crystallography reveals the atomic-level basis of this interaction and implicates tubby domains as phosphorylated-phosphatidylinositol binding factors. Receptor-mediated activation of G protein alpha (q) (G alpha (q)) releases tubby from the plasma membrane through the action of phospholipase C-beta, triggering translocation of tubby to the cell nucleus. The localization of tubby-like protein 3 (TULP3) is similarly regulated. These data suggest that tubby proteins function as membrane-bound transcription regulators that translocate to the nucleus in response to phosphoinositide hydrolysis, providing a direct link between G-protein signaling and the regulation of gene expression.	NYU, Mt Sinai Sch Med, Struct Biol Program, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Ruttenberg Canc Ctr, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Biochem & Mol Biol, New York, NY 10029 USA; Univ Utah, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA	Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; Utah System of Higher Education; University of Utah	Shapiro, L (corresponding author), NYU, Mt Sinai Sch Med, Struct Biol Program, Room 16-20,1425 Madison Ave, New York, NY 10029 USA.	shapiro@inka.mssm.edu	Baird, Cheryl/AGM-0065-2022; Santagata, Sandro/A-7714-2009; Baird, Cheryl L/F-6569-2011	Santagata, Sandro/0000-0002-7528-9668				Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Banerjee P, 1998, NAT GENET, V18, P177, DOI 10.1038/ng0298-177; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR VRSION 3 1 SYS; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hartman JL, 1996, J BIOL CHEM, V271, P22591, DOI 10.1074/jbc.271.37.22591; He W, 2000, MOL BRAIN RES, V81, P109, DOI 10.1016/S0169-328X(00)00164-9; Horvath CM, 1997, CURR OPIN CELL BIOL, V9, P233, DOI 10.1016/S0955-0674(97)80067-1; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jian XY, 1999, J BIOL CHEM, V274, P11573, DOI 10.1074/jbc.274.17.11573; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; Kapeller R, 1999, J BIOL CHEM, V274, P24980, DOI 10.1074/jbc.274.35.24980; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kretzschmar M, 2000, BREAST CANCER RES, V2, P107, DOI 10.1186/bcr42; Kutateladze T, 2001, SCIENCE, V291, P1793, DOI 10.1126/science.291.5509.1793; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leibowitz SF, 1998, BIOL PSYCHIAT, V44, P851, DOI 10.1016/S0006-3223(98)00186-3; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mehrotra B, 2000, BIOCHEMISTRY-US, V39, P9679, DOI 10.1021/bi000487o; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISHINA PM, 1994, METABOLISM, V43, P549, DOI 10.1016/0026-0495(94)90194-5; Nishina PM, 1998, GENOMICS, V54, P215, DOI 10.1006/geno.1998.5567; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; North MA, 1997, P NATL ACAD SCI USA, V94, P3128, DOI 10.1073/pnas.94.7.3128; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; OhkiHamazaki H, 1997, NATURE, V390, P165, DOI 10.1038/36568; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Sargent PA, 1997, PSYCHOPHARMACOLOGY, V133, P309, DOI 10.1007/s002130050407; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; Stevens J, 2000, NUTR REV, V58, P129, DOI 10.1111/j.1753-4887.2000.tb01847.x; Stubdal H, 2000, MOL CELL BIOL, V20, P878, DOI 10.1128/MCB.20.3.878-882.2000; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VICKERS JD, 1993, J PHARMACOL EXP THER, V266, P1156; Wang HY, 1995, MOL PHARMACOL, V48, P988; WHO Consultation, 2000, WHO TECH REP SER, V894, P1	58	267	276	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2001	292	5524					2041	2050		10.1126/science.1061233	http://dx.doi.org/10.1126/science.1061233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11375483				2022-12-01	WOS:000169284700038
J	Hannan, EL; Magaziner, J; Wang, JJ; Eastwood, EA; Silberzweig, SB; Gilbert, M; Morrison, RS; McLaughlin, MN; Orosz, GM; Siu, AL				Hannan, EL; Magaziner, J; Wang, JJ; Eastwood, EA; Silberzweig, SB; Gilbert, M; Morrison, RS; McLaughlin, MN; Orosz, GM; Siu, AL			Mortality and locomotion 6 months after hospitalization for hip fracture - Risk factors and risk-adjusted hospital outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FUNCTIONAL STATUS; PROXIMAL FEMUR; SURVIVAL; WOMEN; OLDER; CARE; EXPERIENCE; PREDICTORS; MOBILITY; RECOVERY	Context Hip fracture is a common clinical problem that leads to considerable mortality and disability. A need exists for a practical means to monitor and improve outcomes, including function, for patients with hip fracture, Objectives To identify and compare the importance of significant prefracture predictors of functional status and mortality at 6 months for patients hospitalized with hip fracture and to compare risk-adjusted outcomes for hospitals providing initial care. Design Prospective study with data obtained from medical records and through structured interviews with patients and proxies. Setting and Participants A total of 571 adults aged 50 years or older with hip fracture who were admitted to 4 New York, NY, metropolitan hospitals between August 1997 and August 1998. Main Outcome Measures In-hospital and 6-month mortality; locomotion at 6 months; and adverse outcomes at 6 months, defined as death or needing assistance to ambulate, compared by hospital, adjusting for patient risk factors. Results The in-hospital mortality rate was 1.6%. At 6 months, the mortality rate was 13.5%, and another 12.8% needed total assistance to ambulate. Laboratory values were strong predictors of mortality but were not significantly associated with locomotion. Age and prefracture residence at a nursing home were significant predictors of locomotion (P=.02 for both) but were not significantly associated with mortality. Adjustment for baseline characteristics either substantially augmented or diminished interhospital differences in outcomes. Two hospitals had 1 outcome (functional status or mortality) that was significantly worse than the overall mean while the other outcome was nonsignificantly better than average. Conclusions Mortality and functional status ideally should be considered both together and individually to distinguish effects limited to one or the other outcome. Hospital performance for these 2 measures may differ substantially after adjustment, probably because different processes of care are important to each outcome.	SUNY Albany, Dept Hlth Policy Management & Behav, Sch Publ Hlth, Rensselaer, NY 12144 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Mt Sinai Sch Med, Dept Hlth Policy, New York, NY USA; Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; Mt Sinai Sch Med, Dept Orthopaed, New York, NY USA; Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA; Mt Sinai Sch Med, Dept Med, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University System of Maryland; University of Maryland Baltimore; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Hannan, EL (corresponding author), SUNY Albany, Dept Hlth Policy Management & Behav, Sch Publ Hlth, 1 Univ Pl, Rensselaer, NY 12144 USA.				AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS009459] Funding Source: NIH RePORTER; AHRQ HHS [U18HS09459-0] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HLTH CAR POL R, 1999, AHCPR PUBL; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1572, DOI 10.1056/NEJM199005313222205; Carson JL, 1998, JAMA-J AM MED ASSOC, V279, P199, DOI 10.1001/jama.279.3.199; CEDER L, 1980, CLIN ORTHOP RELAT R, P173; COBEY JC, 1976, CLIN ORTHOP RELAT R, P258; Diamond TH, 1997, MED J AUSTRALIA, V167, P412, DOI 10.5694/j.1326-5377.1997.tb126646.x; DOLK T, 1989, UPSALA J MED SCI, V94, P209, DOI 10.3109/03009738909178565; FINSEN V, 1995, ANN CHIR GYNAECOL FE, V84, P291; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOLT EM, 1994, INJURY, V25, P91, DOI 10.1016/0020-1383(94)90109-0; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; JENSEN JS, 1984, INJURY, V15, P411; JETTE AM, 1987, ARCH PHYS MED REHAB, V68, P735; Kane RL, 1998, J AM GERIATR SOC, V46, P1525, DOI 10.1111/j.1532-5415.1998.tb01537.x; Kane RL, 1996, J AM GERIATR SOC, V44, P242, DOI 10.1111/j.1532-5415.1996.tb00909.x; KENNIE DC, 1988, BRIT MED J, V297, P1083, DOI 10.1136/bmj.297.6656.1083; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Koval KJ, 1998, CLIN ORTHOP RELAT R, P22; KOVAL KJ, 1995, CLIN ORTHOP RELAT R, P150; Koval KJ, 1996, J ORTHOP TRAUMA, V10, P531, DOI 10.1097/00005131-199611000-00004; KYO T, 1993, CLIN ORTHOP RELAT R, P215; LUYAO GL, 1994, AM J PUBLIC HEALTH, V84, P1287, DOI 10.2105/AJPH.84.8.1287; Lyons Anthony R., 1997, American Journal of Medicine, V103, p51S, DOI 10.1016/S0002-9343(97)90027-9; Magaziner J, 1997, AM J EPIDEMIOL, V146, P418, DOI 10.1093/oxfordjournals.aje.a009295; Magaziner J, 1997, AM J PUBLIC HEALTH, V87, P1630, DOI 10.2105/AJPH.87.10.1630; Magaziner J, 1996, AM J EPIDEMIOL, V143, P283; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; MAGAZINER J, 1989, AM J PUBLIC HEALTH, V79, P274, DOI 10.2105/AJPH.79.3.274; Magaziner J, 1990, J GERONTOL, V45, P101; MAROTTOLI RA, 1994, AM J PUBLIC HEALTH, V84, P1807, DOI 10.2105/AJPH.84.11.1807; Morrison RS, 1998, ANN INTERN MED, V128, P1010, DOI 10.7326/0003-4819-128-12_Part_1-199806150-00010; MULLEN JO, 1992, CLIN ORTHOP RELAT R, P214; Nettleman MD, 1996, J GEN INTERN MED, V11, P765, DOI 10.1007/BF02598997; PITTO RP, 1994, INT ORTHOP, V18, P109, DOI 10.1007/BF02484420; Svensson O, 1996, J BONE JOINT SURG BR, V78B, P115, DOI 10.1302/0301-620X.78B1.0780115; TODD CJ, 1995, BRIT MED J, V310, P904, DOI 10.1136/bmj.310.6984.904; TURCOTTE R, 1990, CLIN ORTHOP RELAT R, P132; WEATHERALL M, 1994, NEW ZEAL MED J, V107, P308; Young Y, 1997, J AM GERIATR SOC, V45, P288, DOI 10.1111/j.1532-5415.1997.tb00942.x	39	316	334	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2736	2742		10.1001/jama.285.21.2736	http://dx.doi.org/10.1001/jama.285.21.2736			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386929	Bronze			2022-12-01	WOS:000168985800026
J	Lewis, PM; Dunn, MP; McMahon, JA; Logan, M; Martin, JF; St-Jacques, B; McMahon, AP				Lewis, PM; Dunn, MP; McMahon, JA; Logan, M; Martin, JF; St-Jacques, B; McMahon, AP			Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1	CELL			English	Article							DEVELOPING CHICK LIMB; MOUSE PATCHED GENE; VERTEBRATE LIMB; FEEDBACK LOOP; TRANSDUCING HEDGEHOG; POLARIZING ACTIVITY; PATTERNING ACTIVITY; HEPARAN-SULFATE; NEURAL-TUBE; TOUT-VELU	Sonic hedgehog (Shh) signaling from the posterior zone of polarizing activity (ZPA) is the primary determinant of anterior-posterior polarity in the vertebrate limb field. An active signal is produced by an autoprocessing reaction that covalently links cholesterol to the N-terminal signaling moiety (N-Shh(p)), tethering N-Shh(p) to the cell membrane. We have addressed the role played by this lipophilic modification in Shh-mediated patterning of mouse digits. Both the distribution and activity of N-Shh(p) indicate that N-Shh(p) acts directly over a few hundred microns. In contrast, N-Shh, a form that lacks cholesterol, retains similar biological activity to N-Shh(p), but signaling is posteriorly restricted. Thus, cholesterol modification is essential for the normal range of signaling. It also appears to be necessary for appropriate modulation of signaling by the Shh receptor, Ptc1.	Harvard Univ, Dept Mol & Cellular Biol, Biolabs, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75235 USA	Harvard University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Biolabs, 16 Divin Ave, Cambridge, MA 02138 USA.		McMahon, Andrew P/ABE-7520-2020	Dunn, Matthew/0000-0002-1320-4235	NINDS NIH HHS [NS 33642] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033642, R37NS033642] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Charite J, 2000, DEVELOPMENT, V127, P2461; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Duprez DM, 1996, DEVELOPMENT, V122, P1821; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gruneberg H, 1963, PATHOLOGY DEV; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; HINCHLIFFE JR, 1983, DEV EVOLUTION, P99; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; HONIG LS, 1981, NATURE, V291, P72, DOI 10.1038/291072a0; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Lee J, 1997, DEVELOPMENT, V124, P2537; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Lin X, 1998, BIOCHEM BIOPH RES CO, V248, P738, DOI 10.1006/bbrc.1998.9050; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; MARTI E, 1995, DEVELOPMENT, V121, P2537; Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.3.CO;2-6; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/ng0298-104; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Osborne TF, 1998, CURR OPIN LIPIDOL, V9, P137, DOI 10.1097/00041433-199804000-00010; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; SMITH JC, 1978, NATURE, V272, P612, DOI 10.1038/272612a0; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Stickens D, 1997, BIOCHEM MOL MED, V61, P16, DOI 10.1006/bmme.1997.2588; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; Tabin CJ, 1997, TRENDS CELL BIOL, V7, P442, DOI 10.1016/S0962-8924(97)01159-8; TAYLOR AM, 1993, MECH DEVELOP, V42, P89, DOI 10.1016/0925-4773(93)90101-3; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Theil T, 1999, CELL TISSUE RES, V296, P75, DOI 10.1007/s004410051268; TICKLE C, 1981, NATURE, V289, P295, DOI 10.1038/289295a0; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; Vervoort M, 2000, BIOESSAYS, V22, P460, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;460::AID-BIES8&gt;3.0.CO;2-G; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; WOLPERT L, 1989, CELL TO CELL SIGNALLING : FROM EXPERIMENTS TO THEORETICAL MODELS, P133; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	69	387	399	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 1	2001	105	5					599	612		10.1016/S0092-8674(01)00369-5	http://dx.doi.org/10.1016/S0092-8674(01)00369-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389830	Bronze			2022-12-01	WOS:000169123200007
J	Carroll, KS; Hanna, J; Simon, I; Krise, J; Barbero, P; Pfeffer, SR				Carroll, KS; Hanna, J; Simon, I; Krise, J; Barbero, P; Pfeffer, SR			Role of Rab9 GTPase in facilitating receptor recruitment by TIP47	SCIENCE			English	Article							ENDOSOMES; BIOGENESIS; TRANSPORT	Mannose 6-phosphate receptors (MPRs) deliver lysosomal hydrolases from the Golgi to endosomes and then return to the Golgi complex. TIP47 recognizes the cytoplasmic domains of MPRs and is required for endosome-to-Golgi transport. Here we show that TIP47 also bound directly to the Rab9 guanosine triphosphatase (GTPase) in its active, GTP-bound conformation. Moreover, Rab9 increased the affinity of TIP47 for its cargo. A functional Rab9 binding site was required for TIP47 stimulation of MPR transport in vivo. Thus, a cytosolic cargo selection device may be selectively recruited onto a specific organelle, and vesicle budding might be coupled to the presence of an active Rab GTPase.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	pfeffer@cmgm.stanford.edu		Carroll, Kate/0000-0002-7624-9617	NIDDK NIH HHS [DK37332] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037332, R56DK037332, R37DK037332] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Itin C, 1997, J BIOL CHEM, V272, P27737, DOI 10.1074/jbc.272.44.27737; Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Krise JP, 2000, J BIOL CHEM, V275, P25188, DOI 10.1074/jbc.M001138200; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425	15	192	200	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1373	1376		10.1126/science.1056791	http://dx.doi.org/10.1126/science.1056791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11359012				2022-12-01	WOS:000168862900045
J	Szathmary, E; Jordan, F; Pal, C				Szathmary, E; Jordan, F; Pal, C			Molecular biology and evolution - Can genes explain biological complexity?	SCIENCE			English	Editorial Material									Coll Budapest, Inst Adv Study, H-1014 Budapest, Hungary		Szathmary, E (corresponding author), Coll Budapest, Inst Adv Study, 2 Szentharomsag, H-1014 Budapest, Hungary.		Jordan, Ferenc/A-9940-2009; Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021	Jordan, Ferenc/0000-0002-0224-6472; Szathmary, Eors/0000-0001-5227-2997				ATLAN H, 1990, B MATH BIOL, V52, P335, DOI 10.1007/BF02458575; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Bork P, 2001, NATURE, V409, P818, DOI 10.1038/35057274; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Harary F., 1969, GRAPH THEORY; HIGASHI M, 1991, THEORETICAL STUDIES; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011	14	87	91	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1315	1316		10.1126/science.1060852	http://dx.doi.org/10.1126/science.1060852			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360989				2022-12-01	WOS:000168862900030
J	Krishnan, B; Levine, JD; Lynch, MKS; Dowse, HB; Funes, P; Hall, JC; Hardin, PE; Dryer, SE				Krishnan, B; Levine, JD; Lynch, MKS; Dowse, HB; Funes, P; Hall, JC; Hardin, PE; Dryer, SE			A new role for cryptochrome in a Drosophila circadian oscillator	NATURE			English	Article							LIGHT; CLOCK; PHOTORECEPTOR; RHYTHMS; CRY; TRANSCRIPTION; MELANOGASTER; MUTATION	Cryptochromes are flavin/pterin-containing proteins that are involved in circadian clock function in Drosophila and mice. In mice, the cryptochromes Cry1 and Cry2 are integral components of the circadian oscillator within the brain(1-6) and contribute to circadian photoreception in the retina(7). In Drosophila, cryptochrome (CRY) acts as a photoreceptor that mediates light input to circadian oscillators in both brain and peripheral tissue(8-12). A Drosophila cry mutant, cry(b), leaves circadian oscillator function intact in central circadian pacemaker neurons but renders peripheral circadian oscillators largely arrhythmic. Although this arrhythmicity could be caused by a loss of light entrainment, it is also consistent with a role for CRY in the oscillator. A peripheral oscillator drives circadian olfactory responses in Drosophila antennae(13). Here we show that CRY contributes to oscillator function and physiological output rhythms in the antenna during and after entrainment to light-dark cycles and after photic input is eliminated by entraining flies to temperature cycles. These results demonstrate a photoreceptor-independent role for CRY in the periphery and imply fundamental differences between central and peripheral oscillator mechanisms in Drosophila.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Univ Houston, Biol Clocks Program, Houston, TX 77204 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, NSF, Ctr Biol Timing, Waltham, MA 02454 USA; Univ Maine, Dept Biol Sci, Orono, ME 04469 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Brandeis University; Brandeis University; National Science Foundation (NSF); NSF - Center for Biological Timing; University of Maine System; University of Maine Orono	Hardin, PE (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.		Krishnan, Balaji/C-7572-2009; Krishnan, Balaji/M-9914-2019	Krishnan, Balaji/0000-0003-2074-4165; Hardin, Paul/0000-0002-3370-9011				Brandes C, 1996, NEURON, V16, P687, DOI 10.1016/S0896-6273(00)80088-4; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chatfield C., 1999, ANAL TIME SERIES; Dowse H, 1995, J NEUROGENET, V10, P153, DOI 10.3109/01677069509083461; DOWSE HB, 1991, J THEOR BIOL, V148, P139, DOI 10.1016/S0022-5193(05)80468-0; DOWSE HB, 1989, J THEOR BIOL, V139, P487, DOI 10.1016/S0022-5193(89)80067-0; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; Johnson E, 1998, J NEUROGENET, V12, P1, DOI 10.3109/01677069809108552; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; POWER J, 1995, J NEUROGENET, V9, P227, DOI 10.3109/01677069509084159; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106	26	185	195	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					313	317		10.1038/35077094	http://dx.doi.org/10.1038/35077094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357134				2022-12-01	WOS:000168710000049
J	Tong, F; Engel, SA				Tong, F; Engel, SA			Interocular rivalry revealed in the human cortical blind-spot representation	NATURE			English	Article							PRIMARY VISUAL-CORTEX; BINOCULAR-RIVALRY; PERCEPTION	To understand conscious vision, scientists must elucidate how the brain selects specific visual signals for awareness. When different monocular patterns are presented to the two eyes, they rival for conscious expression such that only one monocular image is perceived at a time(1,2). Controversy surrounds whether this binocular rivalry reflects neural competition among pattern representations or monocular channels(3,4). Here we show that rivalry arises from interocular competition, using functional magnetic resonance imaging of activity in a monocular region of primary visual cortex corresponding to the blind spot. This cortical region greatly prefers stimulation of the ipsilateral eye to that of the blind-spot eye. Subjects reported their dominant percept while viewing rivalrous orthogonal gratings in the visual location corresponding to the blind spot and its surround. As predicted by interocular rivalry, the monocular blind-spot representation was activated when the ipsilateral grating became perceptually dominant and suppressed when the blind-spot grating became dominant. These responses were as large as those observed during actual alternations between the gratings, indicating that rivalry may be fully resolved in monocular visual cortex. Our findings provide the first physiological evidence, to our knowledge, that interocular competition mediates binocular rivalry, and indicate that V1 may be important in the selection and expression of conscious visual information.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	Princeton University; University of California System; University of California Los Angeles	Tong, F (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	ftong@princeton.edu						Andrews TJ, 1997, P NATL ACAD SCI USA, V94, P9905, DOI 10.1073/pnas.94.18.9905; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Brown RJ, 1997, VISION RES, V37, P2401, DOI 10.1016/S0042-6989(97)00045-X; COBB WA, 1967, NATURE, V216, P1123, DOI 10.1038/2161123b0; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; FOX R, 1969, PERCEPT PSYCHOPHYS, V5, P215, DOI 10.3758/BF03210542; Friston KJ., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; LANSING RW, 1964, SCIENCE, V146, P1325, DOI 10.1126/science.146.3649.1325; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Levelt W., 1965, BINOCULAR RIVALRY; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; STENSAAS SS, 1974, J NEUROSURG, V40, P747, DOI 10.3171/jns.1974.40.6.0747; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; von Helmholtz H., 1924, HELMHOLTZS TREATISE; WADE NJ, 1975, PERCEPTION, V4, P85, DOI 10.1068/p040085; WALLS G L, 1954, Am J Optom Arch Am Acad Optom, V31, P329	24	336	342	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					195	199		10.1038/35075583	http://dx.doi.org/10.1038/35075583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346796				2022-12-01	WOS:000168563000051
J	Kondro, W				Kondro, W			Canada needs better drug reporting, says inquest	LANCET			English	News Item																			0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1424	1424		10.1016/S0140-6736(00)04637-7	http://dx.doi.org/10.1016/S0140-6736(00)04637-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356458				2022-12-01	WOS:000168478200031
J	Montaner, J; Hill, A; Acosta, E				Montaner, J; Hill, A; Acosta, E			Practical implications for the interpretation of minimum plasma concentration/inhibitory concentration ratios	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITORS; ANTIVIRAL ACTIVITY; DRUG-RESISTANCE; THERAPY; PHARMACOKINETICS; ADULTS		Univ British Columbia, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England; Univ Alabama, Birmingham, AL USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Roche Holding; University of Alabama System; University of Alabama Birmingham	Montaner, J (corresponding author), Univ British Columbia, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada.							Barry M, 1997, CLIN PHARMACOKINET, V32, P194, DOI 10.2165/00003088-199732030-00003; Condra JH, 2000, J INFECT DIS, V182, P758, DOI 10.1086/315782; Cooper D, 1999, LANCET, V353, P2061, DOI 10.1016/S0140-6736(98)10391-4; Drusano GL, 1998, ANTIMICROB AGENTS CH, V42, P2153, DOI 10.1128/AAC.42.9.2153; Durant J, 2000, AIDS, V14, P1333, DOI 10.1097/00002030-200007070-00005; Falloon J, 2000, CLIN INFECT DIS, V30, P313, DOI 10.1086/313667; Gieschke R, 1999, CLIN PHARMACOKINET, V37, P75, DOI 10.2165/00003088-199937010-00005; Hennessy M, 2000, AIDS, V14, pS97; Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984; HSU A, 2000, 40 INT C ANT AG CHEM; HSYU PH, 2000, 13 INT AIDS C DURB; Kilby JM, 2000, ANTIMICROB AGENTS CH, V44, P2672, DOI 10.1128/AAC.44.10.2672-2678.2000; Levison ME, 2000, INFECT DIS CLIN N AM, V14, P281, DOI 10.1016/S0891-5520(05)70248-8; Molla A, 1998, VIROLOGY, V250, P255, DOI 10.1006/viro.1998.9383; Nascimbeni M, 1999, ANTIMICROB AGENTS CH, V43, P2629, DOI 10.1128/AAC.43.11.2629; OBRIEN WA, 1999, 39 INT C ANT AG CHEM; SAAH A, 1999, 6 C RETR OPP INF CHI; SADLER BM, 2000, 7 C RETR OPP INF JAN; ZHANG K, 1997, 6 EUR ISSX M GOTH SW	19	20	20	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1438	1440		10.1016/S0140-6736(00)04577-3	http://dx.doi.org/10.1016/S0140-6736(00)04577-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356471				2022-12-01	WOS:000168478200043
J	Ziauddin, J; Sabatini, DM				Ziauddin, J; Sabatini, DM			Microarrays of cells expressing defined cDNAs	NATURE			English	Article							PEPTIDYL-PROLYL ISOMERASE; IMMUNOSUPPRESSANT FK506; GENE-EXPRESSION; RECEPTOR; PROTEIN; IDENTIFICATION	Genome and expressed sequence tag projects are rapidly cataloguing and cloning the genes of higher organisms, including humans. An emerging challenge is to rapidly uncover the functions of genes and to identify gene products with desired properties. We have developed a microarray-driven gene expression system for the functional analysis of many gene products in parallel. Mammalian cells are cultured on a glass slide printed in defined locations with different DNAs. Cells growing on the printed areas take up the DNA, creating spots of localized transfection within a lawn of non-transfected cells. By printing sets of complementary DNAs cloned in expression vectors, we make microarrays whose features are clusters of live cells that express a defined cDNA at each location. Here we demonstrate two uses for our approach: as an alternative to protein microarrays for the identification of drug targets, and as an expression cloning system for the discovery of gene products that alter cellular physiology. By screening transfected cell microarrays expressing 192 different cDNAs, we identified proteins involved in tyrosine kinase signalling, apoptosis and cell adhesion, and with distinct subcellular distributions.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.			/0000-0002-1446-7256				de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lueking A, 1999, ANAL BIOCHEM, V270, P103, DOI 10.1006/abio.1999.4063; MacBeath G, 2000, SCIENCE, V289, P1760; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Sabatini DM, 1999, SCIENCE, V284, P1161, DOI 10.1126/science.284.5417.1161; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SIMONSEN H, 1994, TRENDS PHARMACOL SCI, V15, P437, DOI 10.1016/0165-6147(94)90052-3; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wiemann S, 2001, GENOME RES, V11, P422, DOI 10.1101/gr.GR1547R; Yudate HT, 2001, NUCLEIC ACIDS RES, V29, P185, DOI 10.1093/nar/29.1.185	21	767	884	1	75	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					107	110		10.1038/35075114	http://dx.doi.org/10.1038/35075114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333987				2022-12-01	WOS:000168432800053
J	Dember, LM; Sanchorawala, V; Seldin, DC; Wright, DG; LaValley, M; Berk, JL; Falk, RH; Skinner, M				Dember, LM; Sanchorawala, V; Seldin, DC; Wright, DG; LaValley, M; Berk, JL; Falk, RH; Skinner, M			Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY SYSTEMIC AMYLOIDOSIS; LABORATORY FEATURES; SUPPORT; PREDNISONE; COLCHICINE; SURVIVAL; TRIAL	Background: Dose-intensive intravenous melphalan with autologous blood stem-cell transplantation induces remission of the plasma cell dyscrasia in a substantial proportion of patients with AL amyloidosis. The impact of this treatment on associated renal disease is not known. Objective: To determine the effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on AL amyloidosis-associated renal disease. Design: Prospective cohort study. Setting: Academic medical center. Patients: 65 patients with AL amyloidosis and urinary protein excretion greater than 1 g/24 h who received dose-intensive intravenous melphalan and autologous blood stem-cell transplantation between 1 July 1994 and 30 June 1998, Measurements: 24-hour urinary protein excretion, serum cholesterol level, serum albumin level, creatinine clearance, urine and serum immunoelectrophoresis, and bone marrow biopsy. Renal response was defined as a greater than 50% reduction in urinary protein excretion in the absence of a 25% or greater reduction in creatinine clearance. Complete hematologic response was defined as absence of detectable monoclonal protein in serum and urine and a bone marrow specimen containing less than 5% plasma cells without clonal dominance of kappa or lambda isotype. Results: Among the 50 patients who survived for at least 12 months, proteinuria, hypoalbuminemia, and hypercholesterolemia improved during follow-up; 36% met criteria for a renal response. Median 24-hour urinary protein excretion decreased from a baseline value of 9.6 g/24 h to 1.6 g/24 h at 12 months among patients with complete hematologic response, and 71% met criteria for a renal response. Twenty-hour urinary protein excretion did not decrease during follow-up among patients with persistent plasma cell disease, and only 11% had a renal response at 12 months (P < 0.001 for hematologic responders vs, nonresponders). Conclusion: Dose-intensive intravenous melphalan with autologous blood stem-cell transplantation improves the nephrotic syndrome In patients with AL amyloidosis-associated renal disease. The benefit is largely limited to patients achieving eradication of the underlying plasma cell dyscrasia.	Boston Univ, Med Ctr, Sch Med, EBRC 504,Renal Sect, Boston, MA 02118 USA	Boston University	Dember, LM (corresponding author), Boston Univ, Med Ctr, Sch Med, EBRC 504,Renal Sect, 650 Albany St, Boston, MA 02118 USA.	ldember@bu.edu	LaValley, Michael/AAA-2030-2020	Seldin, David C/0000-0003-0168-2333; Sanchorawala, Vaishali/0000-0002-6307-2445; Berk, John/0000-0002-1768-2373; LaValley, Michael/0000-0002-8488-5170				Comenzo RL, 1999, BRIT J HAEMATOL, V104, P553, DOI 10.1046/j.1365-2141.1999.01216.x; Comenzo RL, 1996, BLOOD, V88, P2801, DOI 10.1182/blood.V88.7.2801.bloodjournal8872801; Comenzo RL, 1998, BLOOD, V91, P3662; Falk RH, 1997, NEW ENGL J MED, V337, P898, DOI 10.1056/NEJM199709253371306; GERTZ MA, 1992, ARCH INTERN MED, V152, P2245, DOI 10.1001/archinte.152.11.2245; GERTZ MA, 1991, BLOOD, V77, P257; Hahn GJ., 1991, STAT INTERVALS GUIDE; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; KYLE RA, 1983, MAYO CLIN PROC, V58, P665; KYLE RA, 1982, ARCH INTERN MED, V142, P1445, DOI 10.1001/archinte.142.8.1445; OGG CS, 1981, CLIN NEPHROL, V15, P9; Perna A, 1996, AM J KIDNEY DIS, V27, P34, DOI 10.1016/S0272-6386(96)90028-1; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; REMUZZI A, 1990, J CLIN INVEST, V85, P541, DOI 10.1172/JCI114470; Ruggenenti P, 1997, CURR OPIN NEPHROL HY, V6, P489, DOI 10.1097/00041552-199709000-00014; Skinner M, 1996, AM J MED, V100, P290, DOI 10.1016/S0002-9343(97)89487-9	19	86	87	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9					746	753		10.7326/0003-4819-134-9_Part_1-200105010-00011	http://dx.doi.org/10.7326/0003-4819-134-9_Part_1-200105010-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428PU	11329232				2022-12-01	WOS:000168470700004
J	Berry, N; Davis, C; Jenkins, A; Wood, D; Minor, P; Schild, G; Bottiger, M; Holmes, H; Almond, N				Berry, N; Davis, C; Jenkins, A; Wood, D; Minor, P; Schild, G; Bottiger, M; Holmes, H; Almond, N			Vaccine safety - Analysis of oral polio vaccine CHAT stocks	NATURE			English	Article							ORIGIN; AIDS		Natl Inst Biol Stand & Controls, Div Retrovirol, Potters Bar EN6 3QG, Herts, England; Natl Inst Biol Stand & Controls, Div Virol, Potters Bar EN6 3QG, Herts, England; Karolinska Inst, S-17177 Stockholm, Sweden	National Institute for Biological Standards & Control; National Institute for Biological Standards & Control; Karolinska Institutet	Berry, N (corresponding author), Natl Inst Biol Stand & Controls, Div Retrovirol, Blanche Lane, Potters Bar EN6 3QG, Herts, England.			Almond, Neil/0000-0001-6105-0616				Berry N, 1998, J Hum Virol, V1, P457; Dickson D, 2000, NATURE, V407, P117, DOI 10.1038/35025249; GARRETT AJ, 1993, LANCET, V342, P932, DOI 10.1016/0140-6736(93)91982-R; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hooper E., 1999, RIVER JOURNEY SOURCE; OSMANOV S, 1994, AIDS RES HUM RETROV, V10, P1327, DOI 10.1089/aid.1994.10.1327; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	7	19	20	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1046	1047		10.1038/35074176	http://dx.doi.org/10.1038/35074176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323658	Bronze			2022-12-01	WOS:000168285500034
J	Shankaran, V; Ikeda, H; Bruce, AT; White, JM; Swanson, PE; Old, LJ; Schreiber, RD				Shankaran, V; Ikeda, H; Bruce, AT; White, JM; Swanson, PE; Old, LJ; Schreiber, RD			IFN gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity	NATURE			English	Article							TARGETED DISRUPTION; IN-VIVO; MICE; SURVEILLANCE; CELLS; SPECIFICITY; RECEPTOR	Lymphocytes were originally thought to form the basis of a 'cancer immunosurveillance' process that protects immunocompetent hosts against primary tumour development(1,2), but this idea was largely abandoned when no differences in primary tumour development were found between athymic nude mice and syngeneic wild-type mice(3-5). However, subsequent observations that nude mice do not completely lack functional T cells(6,7) and that two components of the immune system-IFN gamma (8,9) and perforin(10-12)-help to prevent tumour formation in mice have led to renewed interest in a tumour-suppressor role for the immune response. Here we show that lymphocytes and IFN gamma collaborate to protect against development of carcinogen-induced sarcomas and spontaneous epithelial carcinomas and also to select for tumour cells with reduced immunogenicity. The immune response thus functions as an effective extrinsic tumour-suppressor system. However, this process also leads to the immunoselection of tumour cells that are more capable of surviving in an immunocompetent host, which explains the apparent paradox of tumour formation in immunologically intact individuals.	Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA; Mem Sloan Kettering Canc Ctr, New York Branch, Ludwig Inst Canc Res, New York, NY 10021 USA	Washington University (WUSTL); Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, 660 S Euclid Ave, St Louis, MO 63110 USA.		Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019	Schreiber, Robert D/0000-0001-6311-0432; Schreiber, Robert/0000-0003-1590-2341; White, James Michael/0000-0001-5110-6567				Alimonti J, 2000, NAT BIOTECHNOL, V18, P515, DOI 10.1038/75373; BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; HUNIG T, 1983, IMMUNOL TODAY, V4, P84, DOI 10.1016/0167-5699(83)90125-1; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; MALECKAR JR, 1987, J IMMUNOL, V138, P3873; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Marusina K, 1997, J IMMUNOL, V158, P5251; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; OLD LJ, 1977, ANNU REV GENET, V11, P127, DOI 10.1146/annurev.ge.11.120177.001015; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; STUTMAN O, 1979, EXP CELL BIOL, V47, P129; STUTMAN O, 1974, SCIENCE, V183, P534, DOI 10.1126/science.183.4124.534; STUTMAN O, 1979, J NATL CANCER I, V2, P353; Thomas L, 1959, CELLULAR HUMORAL ASP, P529; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781	21	1929	2030	5	170	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1107	1111		10.1038/35074122	http://dx.doi.org/10.1038/35074122			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323675				2022-12-01	WOS:000168285500051
J	Renault, L; Kuhlmann, J; Henkel, A; Wittinghofer, A				Renault, L; Kuhlmann, J; Henkel, A; Wittinghofer, A			Structural basis for guanine nucleotide exchange on Ran by the regulator of chromosome condensation (RCC1)	CELL			English	Article							NUCLEAR EXPORT SIGNAL; GTP-BINDING PROTEINS; XENOPUS EGG EXTRACTS; GDP-BOUND FORM; EF-TS COMPLEX; CRYSTAL-STRUCTURE; MOLECULAR MECHANISM; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; RAN/TC4 GTPASE	RCC1 (regulator of chromosome condensation), a beta propeller chromatin-bound protein, is the guanine nucleotide exchange factor (GEF) for the nuclear GTP binding protein Ran. We report here the 1.8 Angstrom crystal structure of a Ran . RCC1 complex in the absence of nucleotide, an intermediate in the multistep GEF reaction. In contrast to previous structures, the phosphate binding region of the nucleotide binding site is perturbed only marginally, possibly due to the presence of a polyvalent anion in the P loop. Biochemical experiments show that a sulfate ion stabilizes the Ran . RCC1 complex and inhibits dissociation by guanine nucleotides. Based on the available structural and biochemical evidence, we present a unified scenario for the GEF mechanism where interaction of the P loop lysine with an acidic residue is a crucial element for the overall reaction.	Max Planck Inst Mol Physiol, D-44202 Dortmund, Germany	Max Planck Society	Wittinghofer, A (corresponding author), Max Planck Inst Mol Physiol, Postfach 50 02 47, D-44202 Dortmund, Germany.	alfred.wittinghofer@mpl-dortmund.mpg.de						Azuma Y, 1999, J MOL BIOL, V289, P1119, DOI 10.1006/jmbi.1999.2820; Azuma Y, 1996, J BIOCHEM-TOKYO, V120, P82; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chaillan-Huntington C, 2000, J BIOL CHEM, V275, P5874, DOI 10.1074/jbc.275.8.5874; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; DREUSICKE D, 1986, FEBS LETT, V208, P301, DOI 10.1016/0014-5793(86)81037-7; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1997, J CELL BIOL, V138, P65, DOI 10.1083/jcb.138.1.65; HALL A, 1986, J BIOL CHEM, V261, P963; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hieda M, 1999, J CELL BIOL, V144, P645, DOI 10.1083/jcb.144.4.645; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1993, J BIOL CHEM, V268, P923; JOHN J, 1988, J BIOL CHEM, V263, P11792; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kawashima T, 1996, NATURE, V379, P511, DOI 10.1038/379511a0; KLEBE C, 1993, BIOCHEMISTRY-US, V32, P11923, DOI 10.1021/bi00095a023; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kuhlmann J, 1997, BIOCHEMISTRY-US, V36, P12027, DOI 10.1021/bi970524k; Kunzler M, 2000, MOL CELL BIOL, V20, P4295, DOI 10.1128/MCB.20.12.4295-4308.2000; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; MISTOU MY, 1992, EMBO J, V11, P2391, DOI 10.1002/j.1460-2075.1992.tb05303.x; Muegge I, 1996, STRUCTURE, V4, P475, DOI 10.1016/S0969-2126(96)00052-4; Mueller L, 1998, FEBS LETT, V427, P330, DOI 10.1016/S0014-5793(98)00459-1; Murphy GA, 1997, MOL BIOL CELL, V8, P2591, DOI 10.1091/mbc.8.12.2591; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Noguchi E, 1997, MOL CELL BIOL, V17, P2235, DOI 10.1128/MCB.17.4.2235; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; Pasquinelli AE, 1997, P NATL ACAD SCI USA, V94, P14394, DOI 10.1073/pnas.94.26.14394; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; RENSLAND H, 1995, BIOCHEMISTRY-US, V34, P593, DOI 10.1021/bi00002a026; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; RICHARDS SA, 1995, J BIOL CHEM, V270, P14405, DOI 10.1074/jbc.270.24.14405; Richards SA, 1996, J CELL BIOL, V134, P1157, DOI 10.1083/jcb.134.5.1157; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; SCHEFFZEK K, 1994, ACTA CRYSTALLOGR D, V50, P521, DOI 10.1107/S0907444994001253; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schlenstedt G, 1997, EMBO J, V16, P6237, DOI 10.1093/emboj/16.20.6237; Seki T, 1996, J BIOCHEM, V120, P207; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; Smith A, 1998, CURR BIOL, V8, P1403, DOI 10.1016/S0960-9822(98)00023-2; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Stewart M, 1998, J MOL BIOL, V277, P635, DOI 10.1006/jmbi.1997.1602; Taura T, 1998, P NATL ACAD SCI USA, V95, P7427, DOI 10.1073/pnas.95.13.7427; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wang Y, 1997, NAT STRUCT BIOL, V4, P650, DOI 10.1038/nsb0897-650; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wittinghofer F, 1998, NATURE, V394, P317, DOI 10.1038/28492; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamada M, 1998, CURR BIOL, V8, P1339, DOI 10.1016/S0960-9822(07)00566-0; YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zolotukhin AS, 1997, J BIOL CHEM, V272, P11356, DOI 10.1074/jbc.272.17.11356	71	189	196	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					245	255		10.1016/S0092-8674(01)00315-4	http://dx.doi.org/10.1016/S0092-8674(01)00315-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336674	Bronze			2022-12-01	WOS:000168384300011
J	Marder, E				Marder, E			Moving rhythms	NATURE			English	Article									Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Marder, E (corresponding author), Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA.							Delcomyn F., 1998, FDN NEUROBIOLOGY, P648; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Stein P. S. G., 1997, NEURONS NETWORKS MOT	3	22	22	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					755	755		10.1038/35071196	http://dx.doi.org/10.1038/35071196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298422				2022-12-01	WOS:000168021900031
J	Schatz, IJ				Schatz, IJ			Treatment of severe autonomic orthostatic hypotension	LANCET			English	Editorial Material									Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96813 USA	University of Hawaii System	Schatz, IJ (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96813 USA.							Bradbury S, 1925, AM HEART J, V1, P75; DANIEL SE, 2000, AUTONOMIC FAILURE, pCH33; Oldenburg O, 2001, J AM COLL CARDIOL, V37, P219, DOI 10.1016/S0735-1097(00)01062-7; POLINSKY RJ, 1983, LANCET, V1, P901; Schatz IJ, 1996, ANN INTERN MED, V125, P74, DOI 10.7326/0003-4819-125-1-199607010-00012; SCHATZ IJ, 1996, CLIN AUTON RES, V6, P125; SHY GM, 1960, ARCH NEUROL-CHICAGO, V2, P511, DOI 10.1001/archneur.1960.03840110025004	7	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1060	1061		10.1016/S0140-6736(00)04307-5	http://dx.doi.org/10.1016/S0140-6736(00)04307-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297954				2022-12-01	WOS:000167996200005
J	Low-Zeddies, SS; Takahashi, JS				Low-Zeddies, SS; Takahashi, JS			Chimera analysis of the Clock mutation in mice shows that complex cellular integration determines circadian behavior	CELL			English	Article							RAT SUPRACHIASMATIC NUCLEUS; BETA-GALACTOSIDASE; NEURAL TRANSPLANT; LOCOMOTOR RHYTHMS; ENU-MUTAGENESIS; MOUSE CHIMERAS; MUTANT MICE; IN-VITRO; NEURONS; GENE	The Clock mutation lengthens periodicity and reduces amplitude of circadian rhythms in mice. The effects of Clock are cell intrinsic and can be observed at the level of single neurons in the suprachiasmatic nucleus. To address how cells of contrasting genotype functionally interact in vivo to control circadian behavior, we have analyzed a series of Clock mutant mouse aggregation chimeras. Circadian behavior in Clock! Clock - wild-type chimeric individuals was determined by the proportion of mutant versus normal cells. Significantly, a number of intermediate phenotypes, including Clock/+ phenocopies and novel combinations of the parental behavioral characteristics, were seen in balanced chimeras. Multivariate statistical techniques were used to quantitatively analyze relationships among circadian period, amplitude, and suprachiasmatic nucleus composition. Together, our results demonstrate that complex integration of cellular phenotypes determines the generation and expression of coherent circadian rhythms at the organismal level.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Howard Hughes Medical Institute; Northwestern University	Low-Zeddies, SS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 N Campus Dr, Evanston, IL 60208 USA.		Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019; Jansen, Heiko T./A-5770-2008	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Jansen, Heiko T./0000-0003-0178-396X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AGUILARROBLERO R, 1994, EXP NEUROL, V130, P250, DOI 10.1006/exnr.1994.1203; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balling R, 2000, MAMM GENOME, V11, P471, DOI 10.1007/s003350010091; BOUSKILA Y, 1995, BRAIN RES, V670, P333, DOI 10.1016/0006-8993(94)01356-M; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Challet E, 2000, BRAIN RES, V859, P398, DOI 10.1016/S0006-8993(00)02040-0; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; DECOURSEY PJ, 1989, BRAIN RES, V500, P263, DOI 10.1016/0006-8993(89)90322-3; DEWEY MJ, 1976, DEV BIOL, V50, P68, DOI 10.1016/0012-1606(76)90068-3; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; EWER J, 1992, J NEUROSCI, V12, P3321; FALCONER DS, 1978, J EMBRYOL EXP MORPH, V43, P195; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; FRIEDRICH VL, 1993, J NEUROSCI RES, V36, P88, DOI 10.1002/jnr.490360110; GARDNER RL, 1984, CHIMAERAS DEV BIOL, P431; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GOLDOWITZ D, 1987, DEV BRAIN RES, V35, P1, DOI 10.1016/0165-3806(87)90002-2; GRUVAEUS G, 1972, BRIT J MATH STAT PSY, V25, P200, DOI 10.1111/j.2044-8317.1972.tb00491.x; HARRINGTON ME, 1993, BRAIN RES BULL, V30, P655, DOI 10.1016/0361-9230(93)90097-U; HARTIGANS JA, 1975, CLUSTERING ALGORITHM; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Herzog ED, 2000, J COMP NEUROL, V424, P86, DOI 10.1002/1096-9861(20000814)424:1<86::AID-CNE7>3.0.CO;2-W; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hogan B., 2014, MANIPULATING MOUSE E; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; HURD MW, 1995, AM J PHYSIOL-REG I, V269, pR958, DOI 10.1152/ajpregu.1995.269.5.R958; Ingram CD, 1998, PROG BRAIN RES, V119, P351; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; King DP, 1997, GENETICS, V146, P1049; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KONOPKA R, 1983, MOL GEN GENET, V190, P284, DOI 10.1007/BF00330652; Kuhlman SJ, 2000, NEUROREPORT, V11, P1479, DOI 10.1097/00001756-200005150-00023; Leak RK, 1999, BRAIN RES, V819, P23, DOI 10.1016/S0006-8993(98)01317-1; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; LeSauter J, 1999, J NEUROSCI, V19, P5574; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; LIU X, 1991, NEURON, V6, P753, DOI 10.1016/0896-6273(91)90172-V; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Meijer JH, 1998, J NEUROSCI, V18, P9078; MINTZ B, 1962, AM J ZOOL, V4, P432; Moore RY, 1996, PROG BRAIN RES, V111, P103, DOI 10.1016/S0079-6123(08)60403-3; MULLEN RJ, 1971, J EXP ZOOL, V178, P165, DOI 10.1002/jez.1401780203; MULLEN RJ, 1979, NEUROGENETICS GENETI, P173; MUSCI TS, 1992, DEV BIOL, V152, P133, DOI 10.1016/0012-1606(92)90163-B; NONAN PM, 2000, NAT GENET, V25, P440; OSTERGRANITE ML, 1981, DEV BIOL, V85, P199, DOI 10.1016/0012-1606(81)90251-7; PAGE TL, 1983, J COMP PHYSIOL, V153, P353, DOI 10.1007/BF00612589; Pennartz CMA, 1998, J PHYSIOL-LONDON, V506, P775, DOI 10.1111/j.1469-7793.1998.775bv.x; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SIDMAN RL, 1982, MOL GENETIC NEUROSCI, P389; Silver R, 1999, NEUROREPORT, V10, P3165, DOI 10.1097/00001756-199910190-00008; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; SILVER R, 1990, BRAIN RES, V525, P45, DOI 10.1016/0006-8993(90)91319-C; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Steeves TDL, 1999, GENOMICS, V57, P189, DOI 10.1006/geno.1998.5675; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; TAKAHASHI JS, 1982, J NEUROSCI, V2, P815; VANDENPOL AN, 1979, BRAIN RES, V160, P307, DOI 10.1016/0006-8993(79)90427-X; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; VOGELBAUM MA, 1992, J NEUROSCI, V12, P3619; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; ZHANG LM, 1995, NEUROREPORT, V6, P537, DOI 10.1097/00001756-199502000-00032	72	119	124	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					25	42		10.1016/S0092-8674(01)00294-X	http://dx.doi.org/10.1016/S0092-8674(01)00294-X			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301000	Green Accepted, Bronze			2022-12-01	WOS:000168063300005
J	Lu, Q; Sun, EE; Klein, RS; Flanagan, JG				Lu, Q; Sun, EE; Klein, RS; Flanagan, JG			Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction	CELL			English	Article							RECEPTOR TYROSINE KINASES; DOMAIN-CONTAINING PROTEIN; CENTRAL-NERVOUS-SYSTEM; CELL-MIGRATION; CARDIOVASCULAR DEVELOPMENT; CAENORHABDITIS-ELEGANS; CEREBELLAR DEVELOPMENT; TRANSMEMBRANE LIGANDS; CYTOPLASMIC DOMAIN; AXON GUIDANCE	Transmembrane B ephrins and their Eph receptors signal bidirectionally. However, neither the cell biological effects nor signal transduction mechanisms of the reverse signal are well understood. We describe a cytoplasmic protein, PDZ-RGS3, which binds B ephrins through a PDZ domain, and has a regulator of heterotrimeric G protein signaling (RGS) domain. PDZ-RGS3 can mediate signaling from the ephrin-B cytoplasmic tail. SDF-1, a chemokine with a G protein-coupled receptor, or BDNF, act as chemoattractants for cerebellar granule cells, with SDF-1 action being selectively inhibited by soluble EphB receptor. This study reveals a pathway that links reverse signaling to cellular guidance, uncovers a novel mode of control for G proteins, and demonstrates a mechanism for selective regulation of responsiveness to neuronal guidance cues.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.		Flanagan, John/AAM-2995-2020		NICHD NIH HHS [HD29417] Funding Source: Medline; NINDS NIH HHS [NS40043] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417, R01HD029417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040043] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; BENNETT BD, 1995, P NATL ACAD SCI USA, V92, P1866, DOI 10.1073/pnas.92.6.1866; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Cai HB, 1999, J NEUROSCI, V19, P6519; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CIOSSEK T, 1995, ONCOGENE, V11, P2085; Corset V, 2000, NATURE, V407, P747, DOI 10.1038/35037600; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; De Vries L, 1999, TRENDS CELL BIOL, V9, P138, DOI 10.1016/S0962-8924(99)01515-9; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holder N, 1999, DEVELOPMENT, V126, P2033; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Huai JS, 2001, J BIOL CHEM, V276, P6689, DOI 10.1074/jbc.M008127200; Jones TL, 1998, P NATL ACAD SCI USA, V95, P576, DOI 10.1073/pnas.95.2.576; Karam SD, 2000, J NEUROSCI, V20, P6488, DOI 10.1523/JNEUROSCI.20-17-06488.2000; Kehrl JH, 1998, IMMUNITY, V8, P1, DOI 10.1016/S1074-7613(00)80453-7; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Melchers F, 1999, CELL, V99, P351, DOI 10.1016/S0092-8674(00)81521-4; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Moepps B, 1997, EUR J IMMUNOL, V27, P2102, DOI 10.1002/eji.1830270839; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; PFEFFER S, 1985, NATURE, V313, P184, DOI 10.1038/313184a0; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Suzuki G, 1999, J IMMUNOL, V162, P5981; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Vancura KL, 1998, SEMIN NEUROSCI, V9, P209, DOI 10.1006/smns.1997.0118; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Watson S., 1994, G PROTEIN LINKED REC; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Zheng B, 1999, TRENDS BIOCHEM SCI, V24, P411, DOI 10.1016/S0968-0004(99)01474-7; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	63	317	323	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					69	79		10.1016/S0092-8674(01)00297-5	http://dx.doi.org/10.1016/S0092-8674(01)00297-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301003	Bronze			2022-12-01	WOS:000168063300008
J	Howell, CY; Bestor, TH; Ding, F; Latham, KE; Mertineit, C; Trasler, JM; Chaillet, JR				Howell, CY; Bestor, TH; Ding, F; Latham, KE; Mertineit, C; Trasler, JM; Chaillet, JR			Genomic imprinting disrupted by a maternal effect mutation in the Dnmt1 gene	CELL			English	Article							PARENTAL-SPECIFIC METHYLATION; DNA METHYLTRANSFERASE; PARTHENOGENETIC DEVELOPMENT; PREIMPLANTATION DEVELOPMENT; EPIGENETIC MODIFICATIONS; PATERNAL METHYLATION; OOCYTE GROWTH; MOUSE EMBRYOS; ANNEXIN-V; DE-NOVO	Maintenance of genomic methylation patterns in mammalian somatic cells depends on DNA methyltransferase-1 (Dnmt1). Mouse oocytes and preimplantation embryos lack Dnmt1 but express a variant of this protein called Dnmt1o. We eliminated Dnmt1o by deletion of the oocyte-specific promoter and first exon from the Dnmt1 locus. Homozygous animals were normal, but most heterozygous fetuses of homozygous females died during the last third of gestation. Although genomic methylation patterns were established normally in Dnmt1o-deficient oocytes, embryos derived from such oocytes showed a loss of allele-specific expression and methylation at certain imprinted loci. Transient nuclear localization of Dnmt1o in 8-cell embryos suggests that this variant of Dnmt1 provides maintenance methyltransferase activity specifically at imprinted loci during the fourth embryonic S phase.	Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Temple Univ, Sch Med, Dept Biochem, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA; McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Pediat, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Pharmacol & Therapeut, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal Childrens Hosp, Res Inst, Dept Therapeut, Montreal, PQ H3H 1P3, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; McGill University; McGill University; McGill University; McGill University	Chaillet, JR (corresponding author), Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA.	chaillet@pitt.edu	Ding, Feng/E-5112-2012; Ding, Feng/AAH-7335-2019					Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bao SQ, 2000, BIOL REPROD, V62, P616, DOI 10.1095/biolreprod62.3.616; Barwise JL, 1996, FEBS LETT, V394, P213, DOI 10.1016/0014-5793(96)00950-7; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; CARLSON LL, 1992, GENE DEV, V6, P2536, DOI 10.1101/gad.6.12b.2536; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COLLEDGE WH, 1994, NATURE, V370, P65, DOI 10.1038/370065a0; Dong AP, 2001, NUCLEIC ACIDS RES, V29, P439, DOI 10.1093/nar/29.2.439; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HASHIMOTO N, 1994, NATURE, V370, P68, DOI 10.1038/370068a0; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Hogan B., 2014, MANIPULATING MOUSE E; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Latham KE, 2000, METH MOL B, V136, P405; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li LL, 2000, GENOMICS, V63, P333, DOI 10.1006/geno.1999.6103; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; MCGRATH J, 1983, J EXP ZOOL, V228, P355, DOI 10.1002/jez.1402280218; Mertineit C, 1998, DEVELOPMENT, V125, P889; MONK M, 1987, DEVELOPMENT, V99, P371; Ohsawa K, 1996, J NEUROCHEM, V67, P89, DOI 10.1046/j.1471-4159.1996.67010089.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Patkin EL, 1998, ZYGOTE, V6, P351, DOI 10.1017/S0967199498000318; Rankin T, 1996, DEVELOPMENT, V122, P2903; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; SINGERSAM J, 1994, PCR METH APPL, V3, pS48; Szabo PE, 1995, GENE DEV, V9, P3097, DOI 10.1101/gad.9.24.3097; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Trasler JM, 1996, DEV DYNAM, V206, P239, DOI 10.1002/(SICI)1097-0177(199607)206:3<239::AID-AJA2>3.3.CO;2-M; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yoder JA, 1998, HUM MOL GENET, V7, P279, DOI 10.1093/hmg/7.2.279	49	518	550	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2001	104	6					829	838		10.1016/S0092-8674(01)00280-X	http://dx.doi.org/10.1016/S0092-8674(01)00280-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290321	Bronze			2022-12-01	WOS:000167869200006
J	Clement, S; Krause, U; Desmedt, F; Tanti, JF; Behrends, J; Pesesse, X; Sasaki, T; Penninger, J; Doherty, M; Malaisse, W; Dumont, JE; Le Marchand-Brustel, Y; Erneux, C; Hue, L; Schurmans, S				Clement, S; Krause, U; Desmedt, F; Tanti, JF; Behrends, J; Pesesse, X; Sasaki, T; Penninger, J; Doherty, M; Malaisse, W; Dumont, JE; Le Marchand-Brustel, Y; Erneux, C; Hue, L; Schurmans, S			The lipid phosphatase SHIP2 controls insulin sensitivity	NATURE			English	Article							PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; PHOSPHOINOSITIDE 3-KINASE; 5-PHOSPHATASE SHIP2; GLUCOSE-TRANSPORT; SKELETAL-MUSCLE; PROTEIN; METABOLISM; CELLS; GENE	Insulin is the primary hormone involved in glucose homeostasis, and impairment of insulin action and/or secretion has a critical role in the pathogenesis of diabetes mellitus. Type-II SH2-domain-containing inositol 5-phosphatase, or 'SHIP2', is a member of the inositol polyphosphate 5-phosphatase family(1). In vitro studies have shown that SHIP2, in response to stimulation by numerous growth factors and insulin, is closely linked to signalling events mediated by both phosphoinositide-3-OH kinase and Ras/mitogen-activated protein kinase(2-5). Here we report the generation of mice lacking the SHIP2 gene. Loss of SHIP2 leads to increased sensitivity to insulin, which is characterized by severe neonatal hypoglycaemia, deregulated expression of the genes involved in gluconeogenesis, and perinatal death. Adult mice that are heterozygous for the SHIP2 mutation have increased glucose tolerance and insulin sensitivity associated with an increased recruitment of the GLUT4 glucose transporter and increased glycogen synthesis in skeletal muscles. Our results show that SHIP2 is a potent negative regulator of insulin signalling and insulin sensitivity in vivo.	IBMM, IRIBHN, B-6041 Gosselies, Belgium; ICP, Hormone & Metab Res Unit, B-1200 Brussels, Belgium; IRIBHN, B-1070 Brussels, Belgium; Fac Med Nice, INSERM, E9911, F-06107 Nice 02, France; Univ Toronto, Ontario Canc Inst, Amgen Inst, Dept Med Biophys & Immunol, Toronto, ON M5G 2C1, Canada; Free Univ Brussels, Expt Med Lab, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Schurmans, S (corresponding author), IBMM, IRIBHN, Rue Professeurs Jeener & Brachet 12, B-6041 Gosselies, Belgium.		Penninger, Josef M/I-6860-2013	Penninger, Josef M/0000-0002-8194-3777; Sasaki, Takehiko/0000-0003-1837-3748; Tanti, Jean-Francois/0000-0003-1782-1318				BENVENISTY N, 1984, LESSONS ANIMAL DIABE, P717; Bruyns C, 1999, BIOL CHEM, V380, P969, DOI 10.1515/BC.1999.120; Corvera S, 1998, TRENDS CELL BIOL, V8, P442, DOI 10.1016/S0962-8924(98)01366-X; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Girard J, 1998, BIOCHEM SOC T, V26, P69, DOI 10.1042/bst0260069; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; GIRARD JR, 1973, ENZYME, V15, P272; Habib T, 1998, J BIOL CHEM, V273, P18605, DOI 10.1074/jbc.273.29.18605; HANSON RW, 1973, ENZYME, V15, P97, DOI 10.1159/000481055; Higaki Y, 1999, J BIOL CHEM, V274, P20791, DOI 10.1074/jbc.274.30.20791; Ishihara H, 1999, BIOCHEM BIOPH RES CO, V260, P265, DOI 10.1006/bbrc.1999.0888; JONES CT, 1982, DEV METABOLISM FETAL; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Lteif AN, 1999, ENDOCRIN METAB CLIN, V28, P619, DOI 10.1016/S0889-8529(05)70091-8; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; Pesesse X, 1998, FEBS LETT, V437, P301, DOI 10.1016/S0014-5793(98)01255-1; Pesesse X, 1997, BIOCHEM BIOPH RES CO, V239, P697, DOI 10.1006/bbrc.1997.7538; Schurmans S, 1999, GENOMICS, V62, P260, DOI 10.1006/geno.1999.5995; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Stenbit AE, 1996, J CLIN INVEST, V98, P629, DOI 10.1172/JCI118833; WARRAM JH, 1995, JOSLINS DIABETES MEL, P201; Wisniewski D, 1999, BLOOD, V93, P2707, DOI 10.1182/blood.V93.8.2707.408k17_2707_2720; YEUNG D, 1968, BIOCHEM J, V108, P325, DOI 10.1042/bj1080325	25	280	290	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					92	97		10.1038/35051094	http://dx.doi.org/10.1038/35051094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343120				2022-12-01	WOS:000166175600046
J	Tafuri, A; Shahinian, A; Bladt, F; Yoshinaga, SK; Jordana, M; Wakeham, A; Boucher, LM; Bouchard, D; Chan, VSF; Duncan, G; Odermatt, B; Ho, A; Itie, A; Horan, T; Whoriskey, JS; Pawson, T; Penninger, JM; Ohashi, PS; Mak, TW				Tafuri, A; Shahinian, A; Bladt, F; Yoshinaga, SK; Jordana, M; Wakeham, A; Boucher, LM; Bouchard, D; Chan, VSF; Duncan, G; Odermatt, B; Ho, A; Itie, A; Horan, T; Whoriskey, JS; Pawson, T; Penninger, JM; Ohashi, PS; Mak, TW			ICOS is essential for effective T-helper-cell responses	NATURE			English	Article							DEFICIENT MICE; CD40 LIGAND; IMMUNE-RESPONSES; CO-STIMULATION; CD28; INTERLEUKIN-4	The outcome of T-cell responses after T-cell encounter with specific antigens is modulated by co-stimulatory signals, which are required for both lymphocyte activation and development of adaptive immunity(1-3). ICOS4,5, an inducible co-stimulator with homology to CD28, is expressed on activated, but not resting T cells, and shows T-cell co-stimulatory function in vitro. ICOS binds specifically to its counter-receptor B7RP-1 (refs 5-7), but not to B7-1 or B7-2. Here we provide in vivo genetic evidence that ICOS delivers a co-stimulatory signal that is essential both for efficient interaction between T and B cells and for normal antibody responses to T-cell-dependent antigens. To determine the physiological function of ICOS, we generated and characterized gene-targeted ICOS-deficient mice. In vivo, a lack of ICOS results in severely deficient T-cell-dependent B-cell responses. Germinal centre formation is impaired and immunoglobulin class switching, including production of allergy-mediating IgE, is defective. ICOS-deficient T cells primed in in vivo and restimulated in vitro with specific antigen produce only low levels of interleukin-4, but remain fully competent to produce interferon-gamma.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Amgen Inc, Thousand Oaks, CA 91320 USA; McMaster Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Amgen; McMaster University; University of Zurich; University Zurich Hospital	Mak, TW (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		Tafuri, Agostino/AAC-2186-2019; Pawson, Tony J/E-4578-2013; Penninger, Josef M/I-6860-2013; /B-3419-2011	Tafuri, Agostino/0000-0001-7911-9263; Penninger, Josef M/0000-0002-8194-3777; Ohashi, Pamela S./0000-0003-2915-9317; Boucher, Louis-Martin/0000-0003-2802-2124; /0000-0001-6985-6227				Aicher A, 2000, J IMMUNOL, V164, P4689, DOI 10.4049/jimmunol.164.9.4689; BUNCHER CR, 1994, STAT METHODS PHARM I, P517; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Ferguson SE, 1996, J IMMUNOL, V156, P4576; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; Grewal IS, 1997, IMMUNOL RES, V16, P59, DOI 10.1007/BF02786323; GRUSBY MJ, 1995, ANNU REV IMMUNOL, V13, P417, DOI 10.1146/annurev.iy.13.040195.002221; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.immunol.13.1.655; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.iy.07.040189.001045; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ohkawara Y, 1997, AM J RESP CELL MOL, V16, P510, DOI 10.1165/ajrcmb.16.5.9160833; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1988, IMMUNOL REV, V102, P51, DOI 10.1111/j.1600-065X.1988.tb00741.x; Stampfli MR, 1999, AM J RESP CELL MOL, V21, P317; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Watts TH, 1999, CURR OPIN IMMUNOL, V11, P286, DOI 10.1016/S0952-7915(99)80046-6; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	29	542	591	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					105	109		10.1038/35051113	http://dx.doi.org/10.1038/35051113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343123				2022-12-01	WOS:000166175600049
J	Franklin, MC; Wang, JM; Steitz, TA				Franklin, MC; Wang, JM; Steitz, TA			Structure of the replicating complex of a pol alpha family DNA polymerase	CELL			English	Article							I KLENOW FRAGMENT; CRYSTAL-STRUCTURE; KINETIC CHARACTERIZATION; ACTIVE-SITE; REVERSE-TRANSCRIPTASE; ANGSTROM RESOLUTION; MUTATIONAL ANALYSIS; TERNARY COMPLEXES; B-DNA; BACTERIOPHAGE-T4	We describe the 2.6 Angstrom resolution crystal structure of RB69 DNA polymerase with primer-template DNA and dTTP, capturing the step just before primer extension. This ternary complex structure in the human DNA polymerase alpha family shows a 60 degrees rotation of the fingers domain relative to the ape-protein structure, similar to the fingers movement in pol I family polymerases. Minor groove interactions near the primer 3' terminus suggest a common fidelity mechanism for pol I and pol alpha family polymerases. The duplex product DNA orientation differs by 40 degrees between the polymerizing mode and editing mode structures. The role of the thumb in this DNA motion provides a model for editing in the pol alpha family.	Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA; Yale Univ, Dept Chem, New Haven, CT 06511 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06511 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009		NIGMS NIH HHS [GM57510] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bankier A T, 1983, Mol Biol Med, V1, P21; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; BEESE LS, 1993, SCIENCE, V260, P352, DOI 10.1126/science.8469987; Berdis AJ, 1996, P NATL ACAD SCI USA, V93, P12822, DOI 10.1073/pnas.93.23.12822; BHAT TN, 1988, J APPL CRYSTALLOGR, V21, P279, DOI 10.1107/S0021889887012755; BLASCO MA, 1995, J BIOL CHEM, V270, P2735, DOI 10.1074/jbc.270.6.2735; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; BRAITHWAITE DK, 1993, NUCLEIC ACIDS RES, V21, P787, DOI 10.1093/nar/21.4.787; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; COWART M, 1989, BIOCHEMISTRY-US, V28, P1975, DOI 10.1021/bi00431a004; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Dressman HK, 1997, P NATL ACAD SCI USA, V94, P8042, DOI 10.1073/pnas.94.15.8042; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; EPSTEIN RH, 1963, COLD SPRING HARB SYM, V28, P375, DOI 10.1101/SQB.1963.028.01.053; Frey B, 1995, BIOCHEMICA, V2, P34; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gardner AF, 1999, NUCLEIC ACIDS RES, V27, P2545, DOI 10.1093/nar/27.12.2545; Hopfner KP, 1999, P NATL ACAD SCI USA, V96, P3600, DOI 10.1073/pnas.96.7.3600; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; HUGHES MB, 1987, GENETICS, V115, P393; HUNTER WN, 1987, NUCLEIC ACIDS RES, V15, P6589, DOI 10.1093/nar/15.16.6589; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; Jang SB, 1998, BIOCHEMISTRY-US, V37, P11726, DOI 10.1021/bi980758j; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karam JD, 2000, PROG NUCLEIC ACID RE, V64, P65, DOI 10.1016/S0079-6603(00)64002-3; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kool ET, 1998, BIOPOLYMERS, V48, P3, DOI 10.1002/(SICI)1097-0282(1998)48:1<3::AID-BIP2>3.0.CO;2-7; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; LIN TC, 1994, J BIOL CHEM, V269, P19286; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan BC, 1999, BIOCHEMISTRY-US, V38, P2826, DOI 10.1021/bi982122y; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Pavlov AR, 2000, NUCLEIC ACIDS RES, V28, P4657, DOI 10.1093/nar/28.23.4657; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; REHAKRANTZ LJ, 1989, J VIROL, V63, P4762, DOI 10.1128/JVI.63.11.4762-4766.1989; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Saturno J, 1995, J BIOL CHEM, V270, P31235, DOI 10.1074/jbc.270.52.31235; Saturno J, 1998, J MOL BIOL, V283, P633, DOI 10.1006/jmbi.1998.2121; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; STOCKI SA, 1995, J MOL BIOL, V254, P15, DOI 10.1006/jmbi.1995.0595; TUERK C, 1990, J MOL BIOL, V213, P749, DOI 10.1016/S0022-2836(05)80261-X; WANG CC, 1995, J BIOL CHEM, V270, P26558, DOI 10.1074/jbc.270.44.26558; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Wu P, 1998, BIOCHEMISTRY-US, V37, P14748, DOI 10.1021/bi980835a; Yang GW, 1999, BIOCHEMISTRY-US, V38, P8094, DOI 10.1021/bi990653w; Zhao YX, 1999, STRUCTURE, V7, P1189, DOI 10.1016/S0969-2126(00)80053-2; [No title captured]	69	469	481	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 1	2001	105	5					657	667		10.1016/S0092-8674(01)00367-1	http://dx.doi.org/10.1016/S0092-8674(01)00367-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	439NL	11389835	Bronze			2022-12-01	WOS:000169123200012
J	Schliekelman, P; Garner, C; Slatkin, M				Schliekelman, P; Garner, C; Slatkin, M			Natural selection and resistance to HIV	NATURE			English	Article							HAPLOTYPES; PREVALENCE		Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schliekelman, P (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.							ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Charlesworth B., 1994, EVOLUTION AGE STRUCT; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; *UN, 2000, JOINT UN PROGR HIV A; United States Census Bureau, 2000, CENS; Wilkinson D, 2000, J ACQ IMMUN DEF SYND, V23, P405	8	49	51	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					545	546		10.1038/35079176	http://dx.doi.org/10.1038/35079176			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385558				2022-12-01	WOS:000168982500037
J	He, S; MacLeod, DIA				He, S; MacLeod, DIA			Orientation-selective adaptation and tilt after-effect from invisible patterns	NATURE			English	Article							PRIMARY VISUAL-CORTEX; GRATINGS; VISION	Exposure to visual patterns of high contrast (for example, gratings formed by alternating white and black bars) creates after-effects in perception. We become temporarily insensitive to faint test patterns that resemble the pre-exposed pattern (such as gratings of the same orientation), and we require more contrast to detect them(1). Moreover, if the test pattern is slightly tilted relative to the pre-exposed one, this tilt may be perceptually exaggerated: we experience a tilt after-effect(2,3). Here we show that these visual after-effects occur even if the pre-exposed grating is too fine to be perceptually resolved. After looking at a very fine grating, so high in spatial frequency that it was perceptually indistinguishable from a uniform field, observers required more contrast to detect a test grating presented at the same orientation than one presented at the orthogonal orientation. They also experienced a tilt aftereffect that depended on the relation of the test pattern's tilt to the unseen orientation of the pre-exposed pattern. Because these after-effects are due to changes in orientation-sensitive mechanisms in visual cortex(4-6), our observations imply that extremely fine details, even those too fine to be seen, can penetrate the visual system as far as the cortex, where they are represented neurally without conscious awareness.	Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	He, S (corresponding author), Univ Minnesota, Dept Psychol, 75 E River Rd, Minneapolis, MN 55455 USA.							Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V186, P558, DOI 10.1113/jphysiol.1966.sp008056; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; COLTHEART M, 1971, PSYCHOL REV, V78, P114, DOI 10.1037/h0030639; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; He S, 1996, J OPT SOC AM A, V13, P1139, DOI 10.1364/JOSAA.13.001139; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; LEGRAND Y, 1937, REV OPT, V16, P201; LEVI DM, 1979, SCIENCE, V206, P852, DOI 10.1126/science.493988; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; McMahon MJ, 2000, J NEUROSCI, V20, P2043; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; RATLIFF F, 1965, MACH BANDS QUANTITAT, P1; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SEKIGUCHI N, 1993, J OPT SOC AM A, V10, P2118, DOI 10.1364/JOSAA.10.002118; Smallman HS, 1996, J NEUROSCI, V16, P1852; WOLFE JM, 1984, VISION RES, V24, P1959, DOI 10.1016/0042-6989(84)90030-0	19	119	123	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					473	476		10.1038/35078072	http://dx.doi.org/10.1038/35078072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373679				2022-12-01	WOS:000168858700048
J	Oren, R; Ellsworth, DS; Johnsen, KH; Phillips, N; Ewers, BE; Maier, C; Schafer, KVR; McCarthy, H; Hendrey, G; McNulty, SG; Katul, GG				Oren, R; Ellsworth, DS; Johnsen, KH; Phillips, N; Ewers, BE; Maier, C; Schafer, KVR; McCarthy, H; Hendrey, G; McNulty, SG; Katul, GG			Soil fertility limits carbon sequestration by forest ecosystems in a CO2-enriched atmosphere	NATURE			English	Article							TERRESTRIAL ECOSYSTEMS; NITROGEN LIMITATION; ELEVATED CO2; GROWTH; AIR; ENRICHMENT; FEEDBACKS; BIOSPHERE; BALANCE; BUDGET	Northern mid-latitude forests are a large terrestrial carbon sink(1-4). Ignoring nutrient limitations, large increases in carbon sequestration from carbon dioxide (CO2) fertilization are expected in these forests(5). Yet, forests are usually relegated to sites of moderate to poor fertility, where tree growth is often limited by nutrient supply, in particular nitrogen(6,7). Here we present evidence that estimates of increases in carbon sequestration of forests, which is expected to partially compensate for increasing CO2 in the atmosphere, are unduly optimistic(8). In two forest experiments on maturing pines exposed to elevated atmospheric CO2, the CO2-induced biomass carbon increment without added nutrients was undetectable at a nutritionally poor site, and the stimulation at a nutritionally moderate site was transient, stabilizing at a marginal gain after three years. However, a large synergistic gain from higher CO2 and nutrients was detected with nutrients added. This gain was even larger at the poor site (threefold higher than the expected additive effect) than at the moderate site (twofold higher). Thus, fertility can restrain the response of wood carbon sequestration to increased atmospheric CO2. Assessment of future carbon sequestration should consider the limitations imposed by soil fertility, as well as interactions with nitrogen deposition.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; Brookhaven Natl Lab, Dept Environm Sci, Upton, NY 11973 USA; US Forest Serv, So Res Stn, Res Triangle Pk, NC 27709 USA; Boston Univ, Dept Geog, Boston, MA 02215 USA; US Forest Serv, So Global Climate Change Program, Raleigh, NC 27606 USA	Duke University; University of Michigan System; University of Michigan; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Agriculture (USDA); United States Forest Service; Boston University; United States Department of Agriculture (USDA); United States Forest Service	Oren, R (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.	ramoren@duke.edu	McCarthy, Heather/Q-9347-2019; Ewers, Brent E/A-9696-2008; Katul, Gabriel G/A-7210-2008; Oren, Ram/AAC-5326-2019	Katul, Gabriel G/0000-0001-9768-3693; Oren, Ram/0000-0002-5654-1733; McNulty, Steven/0000-0003-4518-5646; Ellsworth, David/0000-0002-9699-2272; McCarthy, Heather R/0000-0002-2219-5182; Ewers, Brent/0000-0001-6647-7475				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Albaugh TJ, 1998, FOREST SCI, V44, P317; BAZZAZ FA, 1993, OECOLOGIA, V96, P478, DOI 10.1007/BF00320504; Berntson GM, 1996, PLANT SOIL, V187, P119, DOI 10.1007/BF00017085; Bolin B, 1999, SCIENCE, V285, P1851; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; COMINS HN, 1993, ECOL APPL, V3, P666, DOI 10.2307/1942099; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; ELLSWORTH DS, 1995, OECOLOGIA, V104, P139, DOI 10.1007/BF00328578; Field CB, 1999, SCIENCE, V285, P544, DOI 10.1126/science.285.5427.544; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Houghton RA, 1998, GLOBAL BIOGEOCHEM CY, V12, P25, DOI 10.1029/97GB02729; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; IDSO SB, 1993, GLOBAL BIOGEOCHEM CY, V7, P537, DOI 10.1029/93GB01164; Kicklighter DW, 1999, TELLUS B, V51, P343, DOI 10.1034/j.1600-0889.1999.00017.x; KORNER C, 1995, PLANT CELL ENVIRON, V18, P1101, DOI 10.1111/j.1365-3040.1995.tb00622.x; Linder S, 1995, ECOL B COPENHAGEN, V44, P178, DOI DOI 10.2307/20113161; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Naidu SL, 1998, CAN J FOREST RES, V28, P1116, DOI 10.1139/cjfr-28-8-1116; Norby RJ, 1998, NATURE, V396, P17, DOI 10.1038/23812; Oren R, 1998, ECOL APPL, V8, P990, DOI 10.1890/1051-0761(1998)008[0990:WBDTSL]2.0.CO;2; Oren R., 1996, P75; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sokal Robert R., 1969, BIOMETRY; Tans PP, 1998, SCIENCE, V281, P183, DOI 10.1126/science.281.5374.183; Tissue DT, 1996, TREE PHYSIOL, V16, P49; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Wullschleger S., 1995, BIOTIC FEEDBACKS GLO, P85	30	794	843	8	425	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					469	472		10.1038/35078064	http://dx.doi.org/10.1038/35078064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373677	Green Published			2022-12-01	WOS:000168858700046
J	Bradley, EH; Holmboe, ES; Mattera, JA; Roumanis, SA; Radford, MJ; Krumholz, HM				Bradley, EH; Holmboe, ES; Mattera, JA; Roumanis, SA; Radford, MJ; Krumholz, HM			A qualitative study of increasing beta-blocker use after myocardial infarction - Why do some hospitals succeed?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE GUIDELINES; OF-CARE; MEDICARE PATIENTS; MANAGEMENT; IMPROVEMENT; IMPACT; OUTCOMES	Context Based on evidence that beta -blockers can reduce mortality in patients with acute myocardial infarction (AMI), many hospitals have initiated performance improvement efforts to increase prescription of beta -blockers at discharge, Determination of the factors associated with such improvements may provide guidance to hospitals that have been less successful in increasing beta -blocker use, Objectives To identify factors that may influence the success of improvement efforts to increase beta -blocker use after AMI and to develop a taxonomy for classifying such efforts. Design, Setting, and Participants Qualitative study in which data were gathered from in-depth interviews conducted in March-June 2000 with 45 key physician, nursing, quality management, and administrative participants at 8 US hospitals chosen to represent a range of hospital sizes, geographic regions, and changes in beta -blocker use rates between October 1996 and September 1999. Main Outcome Measures initiatives, strategies, and approaches to improve care for patients with AMI. Results The interviews revealed 6 broad factors that characterized hospital-based improvement efforts: goals of the efforts, administrative support, support among clinicians, design and implementation of improvement initiatives, use of data, and modifying variables. Hospitals with greater improvements in beta -blocker use over time demonstrated 4 characteristics not found in hospitals with less or no improvement: shared goals for improvement, substantial administrative support, strong physician leadership advocating beta -blocker use, and use of credible data feedback, Conclusions This study provides a context for understanding efforts to improve care in the hospital setting by describing a taxonomy for classifying and evaluating such efforts. In addition, the study suggests possible elements of successful efforts to increase beta -blocker use for patients with AMI.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010407] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS10407] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		AGUSTI A, 1994, EUR J CLIN PHARMACOL, V46, P95; [Anonymous], 1990, CURING HLTH CARE NEW; AUDET AM, 1990, ANN INTERN MED, V113, P709, DOI 10.7326/0003-4819-113-9-709; Blumenthal D, 1998, MILBANK Q, V76, P625, DOI 10.1111/1468-0009.00108; BLUMENTHAL D, 1995, IMPROVING CLIN PRACT; Bogardus ST, 1998, J GEN INTERN MED, V13, P675, DOI 10.1046/j.1525-1497.1998.00203.x; BRAND DA, 1995, J AM COLL CARDIOL, V26, P1432, DOI 10.1016/0735-1097(95)00362-2; Carman JM, 1996, HEALTH CARE MANAGE R, V21, P48; CONSTAS MA, 1992, AM EDUC RES J, V29, P253, DOI 10.2307/1163368; Crabtree B.F, 1999, ANN N AM PRIM CAR RE; CRECO PJ, 1993, NEW ENGL J MED, V329, P1271; CROCKETT SE, 1998, BETA BLOCKER PROPHYL; DAVIS DA, 1992, JAMA-J AM MED ASSOC, V268, P1111, DOI 10.1001/jama.268.9.1111; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; French WJ, 2000, AM J CARDIOL, V85, p5B; Glaser B. G., 1978, THEORETICAL SENSITIV; GURWITZ JH, 1992, AM J MED, V93, P605, DOI 10.1016/0002-9343(92)90192-E; KARLSON BW, 1994, CLIN CARDIOL, V17, P311, DOI 10.1002/clc.4960170608; KOSECOFF J, 1987, JAMA-J AM MED ASSOC, V258, P2708, DOI 10.1001/jama.258.19.2708; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McCracken G, 1988, LONG INTERVIEW QUALI, V13; Miles M., 2019, QUALITATIVE DATA ANA, V4th; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Shortell SM, 2000, MED CARE, V38, P207, DOI 10.1097/00005650-200002000-00010; Shortell SM, 1998, MILBANK Q, V76, P593, DOI 10.1111/1468-0009.00107; SIAL SH, 1994, J GEN INTERN MED, V9, P599, DOI 10.1007/BF02600301; Soumerai SB, 1998, JAMA-J AM MED ASSOC, V279, P1358, DOI 10.1001/jama.279.17.1358; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; Weiner BJ, 1997, HEALTH SERV RES, V32, P491; Weiner BJ, 1996, MED CARE RES REV, V53, P397, DOI 10.1177/107755879605300402; WHITFORD DL, 1994, BMJ-BRIT MED J, V309, P1268, DOI 10.1136/bmj.309.6964.1268; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	35	226	227	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2604	2611		10.1001/jama.285.20.2604	http://dx.doi.org/10.1001/jama.285.20.2604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433LY	11368734	Bronze			2022-12-01	WOS:000168761900027
J	Grohskopf, LA; Roth, VR; Feikin, DR; Arduino, MJ; Carson, LA; Tokars, JI; Holt, SC; Jensen, BJ; Hoffman, RE; Jarvis, WR				Grohskopf, LA; Roth, VR; Feikin, DR; Arduino, MJ; Carson, LA; Tokars, JI; Holt, SC; Jensen, BJ; Hoffman, RE; Jarvis, WR			Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BACTERIAL-CONTAMINATION; TRANSFUSION; BLOOD; SEPSIS	Background: In one month, 10 Serratia liquefaciens bloodstream infections and 6 pyrogenic reactions occurred in outpatients at a hemodialysis center. Methods: We performed a cohort study of all hemodialysis sessions on days that staff members reported S. liquefaciens bloodstream infections or pyrogenic reactions. We reviewed procedures and cultured samples of water, medications, soaps, and hand lotions and swabs from the hands of personnel. Results: We analyzed 208 sessions involving 48 patients. In 12 sessions, patients had S. liquefaciens bloodstream infections, and in 8, patients had pyrogenic reactions without bloodstream infection. Sessions with infections or reactions were associated with higher median doses of epoetin alfa than the 188 other sessions (6500 vs. 4000 U, P = 0.03) and were more common during afternoon or evening shifts than morning shifts (P = 0.03). Sessions with infections or reactions were associated with doses of epoetin alfa of more than 4000 U (multivariate odds ratio, 4.0; 95 percent confidence interval, 1.3 to 12.3). A review of procedures revealed that preservative-free, single-use vials of epoetin alfa were punctured multiple times, and residual epoetin alfa from multiple vials was pooled and administered to patients. S. liquefaciens was isolated from pooled epoetin alfa, empty vials of epoetin alfa, antibacterial soap, and hand lotion. All the isolates were identical by pulsed-field gel electrophoresis. After the practice of pooling epoetin alfa was discontinued and the contaminated soap and lotion were replaced, no further S. liquefaciens bloodstream infections or pyrogenic reactions occurred at this hemodialysis facility. Conclusions: Puncturing single-use vials multiple times and pooling preservative-free epoetin alfa caused this outbreak of bloodstream infections in a hemodialysis unit. To prevent similar outbreaks, dialysis units should use medication vials containing the doses most appropriate to their clinical needs. (N Engl J Med 2001;344:1491-7.) Copyright (C) 2001 Massachusetts Medical Society.	CDCP, Hosp Infect Program, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; CDCP, Prevent Med Residency, Div Appl Publ Hlth Training, Epidemiol Program Off, Atlanta, GA 30333 USA; Colorado Dept Publ Hlth & Environm, Denver, CO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Colorado Department of Public Health & Environment	Grohskopf, LA (corresponding author), CDCP, Hosp Infect Program, 1600 Clifton Rd NE,Mailstop E-69, Atlanta, GA 30333 USA.		Arduino, Matthew/C-1461-2012	Arduino, Matthew/0000-0001-7072-538X				Association for the Advancement of Medical Instrumentation, 1992, AM NAT STAND HEM SYS; Boulton FE, 1998, TRANSFUSION MED, V8, P15; *DHHS, 1997, A019700509 DHHS; DUNCAN KL, 1994, TRANSFUSION, V34, P738, DOI 10.1046/j.1537-2995.1994.34894353473.x; FAVERO FS, 1998, HOSP INFECT, P357; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; *HLTH CAR FIN ADM, 1999, PROGR MEM INT; JEPPSSON B, 1984, ACTA CHIR SCAND, V150, P489; Maslow Joel N., 1993, P563; PETERSEN NJ, 1973, HEALTH LAB SCI, V10, P18; PUCKETT A, 1986, MED LAB SCI, V43, P252; *REN DAT SUST, 1994, SRDS 1994 ANN DAT RE; *REN DAT SYST, 1999, USRDS 199 ANN DAT RE; Roth VR, 2000, TRANSFUSION, V40, P931, DOI 10.1046/j.1537-2995.2000.40080931.x; SERRUYSSCHOUTENS E, 1984, EUR J CLIN MICROBIOL, V3, P316, DOI 10.1007/BF01977480; Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426; WOLF CFW, 1993, TRANSFUSION S, V33, pS151; WOODFIELD DG, 1991, NEW ZEAL MED J, V104, P141	19	96	97	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1491	1497		10.1056/NEJM200105173442001	http://dx.doi.org/10.1056/NEJM200105173442001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357151				2022-12-01	WOS:000168677200001
J	Zhang, D; Penttila, TL; Morris, PL; Teichmann, M; Roeder, RG				Zhang, D; Penttila, TL; Morris, PL; Teichmann, M; Roeder, RG			Spermiogenesis deficiency in mice lacking the Trf2 gene	SCIENCE			English	Article							TBP-LIKE FACTOR; POLYMERASE-II TRANSCRIPTION; TATA-BINDING PROTEIN; SPERMATOGENIC CELLS; C-ELEGANS; MOUSE; EXPRESSION; CREM; IDENTIFICATION; ACTIVATION	The discovery of TATA-binding protein-related factors (TRFs) has suggested alternative mechanisms for gene-specific transcriptional regulation and raised interest in their biological functions. In contrast to recent observations of an embryonic Lethal phenotype for TRF2 inactivation in Caenorhabditis elegans and Xenopus laevis, we found that Trf2-deficient mice are viable. However, Trf2(-/-) mice are sterile because of a severe defect in spermiogenesis. Postmeiotic round spermatids advance at most to step 7 of differentiation but fail to progress to the elongated form, and gene-specific transcription deficiencies were identified. We speculate that mammals may have evolved more specialized TRF2 functions in the testis that involve transcriptional regulation of genes essential for spermiogenesis.	Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, New York, NY 10021 USA; Populat Council, New York, NY 10021 USA	Rockefeller University; Population Council	Roeder, RG (corresponding author), Biochem & Mol Biol Lab, New York, NY 10021 USA.		Teichmann, Martin/M-7407-2014	Teichmann, Martin/0000-0002-5257-0510				Behr R, 2000, BIOL REPROD, V62, P1344, DOI 10.1095/biolreprod62.5.1344; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Blendy JA, 1996, NATURE, V380, P162, DOI 10.1038/380162a0; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dantonel JC, 1999, TRENDS BIOCHEM SCI, V24, P335, DOI 10.1016/S0968-0004(99)01436-X; Diemer T, 1999, HUM REPROD UPDATE, V5, P120, DOI 10.1093/humupd/5.2.120; Drabent B, 1996, HISTOCHEM CELL BIOL, V106, P247; Eddy EM, 1998, SEMIN CELL DEV BIOL, V9, P451, DOI 10.1006/scdb.1998.0201; Fimia GM, 2000, MOL CELL BIOL, V20, P8613, DOI 10.1128/MCB.20.22.8613-8622.2000; Fimia GM, 1999, NATURE, V398, P165, DOI 10.1038/18237; FULCHER KD, 1995, BIOL REPROD, V52, P41, DOI 10.1095/biolreprod52.1.41; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; KASHIWABARA S, 1990, BIOCHEM BIOPH RES CO, V173, P240, DOI 10.1016/S0006-291X(05)81047-2; KLEENE KC, 1990, DEV BIOL, V137, P395, DOI 10.1016/0012-1606(90)90263-I; MATSUMOTO M, 1990, BIOCHEM BIOPH RES CO, V166, P43, DOI 10.1016/0006-291X(90)91909-C; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Takada S, 2000, CELL, V101, P459, DOI 10.1016/S0092-8674(00)80857-0; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; WELCH JE, 1992, BIOL REPROD, V46, P869, DOI 10.1095/biolreprod46.5.869; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; ZAKERI ZF, 1988, MOL CELL BIOL, V8, P2925, DOI 10.1128/MCB.8.7.2925; ZHANG D, UNPUB	28	153	157	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1153	1155		10.1126/science.1059188	http://dx.doi.org/10.1126/science.1059188			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352070				2022-12-01	WOS:000168609200057
J	Patek, SN				Patek, SN			Spiny lobsters stick and slip to make sound - These crustaceans can scare off predators even when their usual armour turns soft.	NATURE			English	Article									Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Patek, SN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.			Patek, S. N./0000-0001-9738-882X				Aiken D.E., 1980, P91; Benade A., 1990, FUNDAMENTALS MUSICAL; Ewing AW, 1989, ARTHROPOD BIOACOUSTI; Fletcher N. H., 1992, ACOUSTIC SYSTEMS BIO; LINDBERG ROBERT G., 1955, UNIV CALIFORNIA PUBL ZOOL, V59, P157; MASTERS WM, 1979, BEHAV ECOL SOCIOBIOL, V5, P187; MEYERROCHOW VB, 1976, J EXP MAR BIOL ECOL, V23, P191, DOI 10.1016/0022-0981(76)90141-6; MOULTON JM, 1957, BIOL BULL, V113, P286, DOI 10.2307/1539086; MULLIGAN BE, 1977, CRUSTACEANA, V32, P185, DOI 10.1163/156854077X00575; PATERSON N F, 1968, Annals of the South African Museum, V51, P1; Phillips B.F., 1980, P1	11	73	78	1	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					153	154		10.1038/35075656	http://dx.doi.org/10.1038/35075656			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346780				2022-12-01	WOS:000168563000035
J	Liphardt, J; Onoa, B; Smith, SB; Tinoco, I; Bustamante, C				Liphardt, J; Onoa, B; Smith, SB; Tinoco, I; Bustamante, C			Reversible unfolding of single RNA molecules by mechanical force	SCIENCE			English	Article							RIBOZYME DOMAIN; DNA; COOPERATIVITY; SEPARATION; STABILITY; FOLDS	Here we use mechanical force to induce the unfolding and refolding of single RNA molecules: a simple RNA hairpin, a molecule containing a three-helix junction, and the P5abc domain of the Tetrahymena thermophila ribozyme. All three molecules (P5abc only in the absence of Mg2+) can be mechanically unfolded at equilibrium, and when kept at constant force within a critical force range. are bi-stable and hop between folded and-unfolded states. We determine the force-dependent equilibrium constants for folding/unfolding these single RNA molecules and the positions of their transition states along the reaction coordinate.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA.		Liphardt, Jan/A-5906-2012	Liphardt, Jan/0000-0003-2835-5025; Bustamante, Carlos/0000-0002-2970-0073	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032543, R01GM010840, R37GM010840, R01GM032543] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-10840, R01 GM010840, GM-32543, R01 GM010840-43, R01 GM010840-42] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bockelmann U, 1998, PHYS REV E, V58, P2386, DOI 10.1103/PhysRevE.58.2386; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cate JH, 1997, NAT STRUCT BIOL, V4, P553, DOI 10.1038/nsb0797-553; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Ferre-d'Amare AR, 1999, ANNU REV BIOPH BIOM, V28, P57, DOI 10.1146/annurev.biophys.28.1.57; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; MA CL, 1995, BIOPOLYMERS, V35, P211, DOI 10.1002/bip.360350209; Misra VK, 1998, BIOPOLYMERS, V48, P113, DOI 10.1002/(SICI)1097-0282(1998)48:2<113::AID-BIP3>3.0.CO;2-Y; Pan J, 1999, P NATL ACAD SCI USA, V96, P6149, DOI 10.1073/pnas.96.11.6149; PYLE AM, 1993, SCIENCE, V261, P709, DOI 10.1126/science.7688142; Ralston CY, 2000, NAT STRUCT BIOL, V7, P371; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Wu M, 1998, P NATL ACAD SCI USA, V95, P11555, DOI 10.1073/pnas.95.20.11555; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	17	722	742	0	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					733	737		10.1126/science.1058498	http://dx.doi.org/10.1126/science.1058498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326101				2022-12-01	WOS:000168478300053
J	Wakayama, T; Tabar, V; Rodriguez, I; Perry, ACF; Studer, L; Mombaerts, P				Wakayama, T; Tabar, V; Rodriguez, I; Perry, ACF; Studer, L; Mombaerts, P			Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer	SCIENCE			English	Article							MICE; PRECURSORS; CLONING	Embryonic stem (ES) cells are fully pluripotent in that they can differentiate into all cell types, including gametes. We have derived 35 ES cell lines via nuclear transfer (ntES cell lines) from adult mouse somatic cells of inbred, hybrid, and mutant strains. ntES cells contributed to an extensive variety of cell types, including dopaminergic and serotonergic neurons in vitro and germ cells in vivo. Cloning by transfer of ntES cell nuclei could result in normal development of fertile adults. These studies demonstrate the full pluripotency of ntES cells.	Rockefeller Univ, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Lab Stem Cell & Tumor Biol, New York, NY 10021 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	Wakayama, T (corresponding author), Adv Cell Technol, 1 Innovat Dr, Worcester, MA 01605 USA.		Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Perry, Tony/0000-0003-3136-5355; rodriguez, ivan/0000-0002-6468-0565				Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; DIETRICH W, 1992, GENETICS, V131, P423; Gurdon JB, 1999, NATURE, V402, P743, DOI 10.1038/45429; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kawase E, 2000, GENESIS, V28, P156, DOI 10.1002/1526-968X(200011/12)28:3/4<156::AID-GENE100>3.0.CO;2-T; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; MATISE MP, 1993, GENE TARGETING PRACT, P129; McKay R, 2000, NATURE, V406, P361, DOI 10.1038/35019186; METZGER JM, 1994, J CELL BIOL, V126, P701, DOI 10.1083/jcb.126.3.701; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; WAKAYAMA T, UNPUB	19	423	484	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					740	743		10.1126/science.1059399	http://dx.doi.org/10.1126/science.1059399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326103				2022-12-01	WOS:000168478300055
J	Ji, Q; Norell, MA; Gao, KQ; Ji, SA; Ren, D				Ji, Q; Norell, MA; Gao, KQ; Ji, SA; Ren, D			The distribution of integumentary structures in a feathered dinosaur	NATURE			English	Article							YIXIAN FORMATION; THEROPOD; EVOLUTION	Non-avian theropod dinosaurs with preserved integumentary coverings are becoming more common(1-6); but apart from the multiple specimens of Caudipteryx, which have true feathers(2,7), animals that are reasonably complete and entirely articulated that show these structures in relation to the body have not been reported. Here we report on an enigmatic small theropod dinosaur that is covered with filamentous feather-like structures over its entire body.	Amer Museum Nat Hist, New York, NY 10024 USA; Chinese Acad Geol Sci, Beijing 100037, Peoples R China	American Museum of Natural History (AMNH); Chinese Academy of Geological Sciences	Norell, MA (corresponding author), Amer Museum Nat Hist, Cent Pk W & 79th St, New York, NY 10024 USA.	norell@amnh.org						Barsbold R, 1999, ACTA PALAEONTOL POL, V44, P189; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Currie PJ, 1995, J VERTEBR PALEONTOL, V15, P576, DOI 10.1080/02724634.1995.10011250; Gao Ke-Qin, 1999, Vertebrata Palasiatica, V37, P1; Gao KQ, 2000, J VERTEBR PALEONTOL, V20, P417, DOI 10.1671/0272-4634(2000)020[0417:EFMOAS]2.0.CO;2; Gauthier J., 1986, ORIGIN BIRDS EVOLUTI, V8, P1; Holtz Jr T. R., 2000, GAIA, V15, P5; Hou L., 1997, MESOZOIC BIRDS CHINA; Hou LH, 1999, CHINESE SCI BULL, V44, P2113, DOI 10.1007/BF03182691; HOUCK MA, 1990, SCIENCE, V247, P195, DOI 10.1126/science.247.4939.195; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Q, 1999, NATURE, V398, P326; Ji Q., 1996, CHINESE GEOL, V233, P30; Ji Qiang, 1999, Professional Papers of Stratigraphy and Palaeontology, V27, P74; LO CH, 1999, JEHOL BIOTA, P328; Norell MA, 2000, J VERTEBR PALEONTOL, V20, P7, DOI 10.1671/0272-4634(2000)020[0007:ANTTFU]2.0.CO;2; Norell Mark A., 1999, American Museum Novitates, V3282, P1; Norell Mark A., 1997, American Museum Novitates, V3215, P1; Ostrom J.H., 1990, P269; Prum RO, 1999, J EXP ZOOL, V285, P291; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SIMMONS LM, 2000, NAT GEOGR MAG    OCT, P128; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Varricchio D. J, 1997, ENCY DINOSAURS, P749; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	29	119	135	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1084	1088		10.1038/35074079	http://dx.doi.org/10.1038/35074079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323669				2022-12-01	WOS:000168285500045
J	Dammai, V; Subramani, S				Dammai, V; Subramani, S			The human peroxisomal targeting signal receptor, Pex5p, is translocated into the peroxisomal matrix and recycled to the cytosol	CELL			English	Article							PROTEIN IMPORT; PTS1 RECEPTOR; 3-KETOACYL-COA THIOLASE; DOCKING SITE; RAT-LIVER; MEMBRANE; COMPLEX; BIOGENESIS; INTERACTS; DISORDERS	Peroxisomal targeting signals (PTSs) are recognized by predominantly cytosolic receptors, Pex5p and Pex7p. The fate of these PTS receptors following their interactions on the peroxisomal membrane with components of docking and putative translocation complexes is unknown. Using both novel and multiple experimental approaches, we show that human Pex5p does not just bind cargo and deliver it to the peroxisome membrane, but participates in multiple rounds of entry into the peroxisome matrix and export to the cytosol independent of the PTS2 import pathway. This unusual shuttling mechanism for the PTS1 receptor distinguishes protein import into peroxisomes from that into most other organelles, with the exception of the nucleus.	Univ Calif San Diego, Div Biol, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Subramani, S (corresponding author), Univ Calif San Diego, Div Biol, Mol Biol Sect, Room 3230 Bonner Hall,9500 Gilman Dr, La Jolla, CA 92093 USA.				NIDDK NIH HHS [DK41737] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK041737, R37DK041737, R01DK041737] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chang CC, 1999, J CELL BIOL, V147, P761, DOI 10.1083/jcb.147.4.761; Chen K, 2000, BIOCHEM SOC T, V28, P485, DOI 10.1042/0300-5127:0280485; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Elgersma Y, 1996, J CELL BIOL, V135, P97, DOI 10.1083/jcb.135.1.97; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gould SJ, 1996, J CELL BIOL, V135, P85, DOI 10.1083/jcb.135.1.85; Gouveia AMM, 2000, J BIOL CHEM, V275, P32444, DOI 10.1074/jbc.M004366200; HIJIKATA M, 1987, J BIOL CHEM, V262, P8151; JOHNSON MA, 2001, IN PRESS YEAST; Lithgow T, 2000, FEBS LETT, V476, P22, DOI 10.1016/S0014-5793(00)01663-X; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Potter MD, 2000, J BIOL CHEM, V275, P33828, DOI 10.1074/jbc.M005294200; RACHUBINSKI RA, 1995, CELL, V83, P525, DOI 10.1016/0092-8674(95)90091-8; Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307; Subramani S, 2000, ANNU REV BIOCHEM, V69, P399, DOI 10.1146/annurev.biochem.69.1.399; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; SZILARD RK, 1995, J CELL BIOL, V131, P1453, DOI 10.1083/jcb.131.6.1453; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; WIEMER EAC, 1995, J CELL BIOL, V130, P51, DOI 10.1083/jcb.130.1.51; WILCKE M, 1995, J BIOL CHEM, V270, P6949, DOI 10.1074/jbc.270.12.6949; Zhang JW, 1996, J CELL BIOL, V132, P325, DOI 10.1083/jcb.132.3.325	25	188	191	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					187	196		10.1016/S0092-8674(01)00310-5	http://dx.doi.org/10.1016/S0092-8674(01)00310-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336669	Bronze, Green Submitted			2022-12-01	WOS:000168384300006
J	Fabrizio, P; Pozza, F; Pletcher, SD; Gendron, CM; Longo, VD				Fabrizio, P; Pozza, F; Pletcher, SD; Gendron, CM; Longo, VD			Regulation of longevity and stress resistance by Sch9 in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; STATIONARY-PHASE; CAENORHABDITIS-ELEGANS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; IN-VIVO; EXTENSION; SURVIVAL; ACONITASE	The protein kinase Akt/protein kinase B (PKB) is implicated in insulin signaling in mammals and functions in a pathway that regulates Longevity and stress resistance in Caenorhabditis elegans. We screened for Long-Lived mutants in nondividing yeast Saccharomyces cerevisiae and identified mutations in adenylate cyclase and SCH9, which is homologous to Akt/PKB, that increase resistance to oxidants and extend Life-span by up to threefold. Stress-resistance transcription factors Msn2/Msn4 and protein kinase Rim15 were required for this life-span extension. These results indicate that Longevity is associated with increased investment in maintenance and show that highly conserved genes play similar roles in Life-span regulation in S. cerevisiae and higher eukaryotes.	Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Div Biogerontol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Max Planck Inst Demog Res, D-18057 Rostock, Germany	University of Southern California; University of Southern California; Max Planck Society	Longo, VD (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Div Biogerontol, Los Angeles, CA 90089 USA.			fabrizio, paola/0000-0002-1144-7727	NIA NIH HHS [AG 08761-10, AG09793] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG008761, P01AG009793] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		EGILMEZ NK, 1989, J BACTERIOL, V171, P37, DOI 10.1128/jb.171.1.37-42.1989; Finch CE., 1990, LONGEVITY SENESCENCE; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FlatteryOBrien JA, 1997, MOL MICROBIOL, V23, P303, DOI 10.1046/j.1365-2958.1997.2121581.x; GARDNER PR, 1992, J BIOL CHEM, V267, P8757; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; LIOU LL, 1999, THESIS U CALIFORNIA; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; Longo VD, 1999, NEUROBIOL AGING, V20, P479, DOI 10.1016/S0197-4580(99)00089-5; Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Morano KA, 1999, EMBO J, V18, P5953, DOI 10.1093/emboj/18.21.5953; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Ross-Macdonald P, 1999, METHOD ENZYMOL, V303, P512; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sun JT, 1999, MOL CELL BIOL, V19, P216; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	28	651	683	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					288	290		10.1126/science.1059497	http://dx.doi.org/10.1126/science.1059497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11292860				2022-12-01	WOS:000168074000047
J	Agovino, T				Agovino, T			Democracy and health care in Serbia	LANCET			English	Article											Agovino, T (corresponding author), 230 Garth Rd, Scarsdale, NY 10583 USA.								0	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1121	1122		10.1016/S0140-6736(00)04265-3	http://dx.doi.org/10.1016/S0140-6736(00)04265-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297983				2022-12-01	WOS:000167996200033
J	Schmidt, WA				Schmidt, WA			Value of sonography in diagnosis of rheumatoid arthritis	LANCET			English	Editorial Material							FINGER JOINTS; SCINTIGRAPHY; RADIOGRAPHY		Med Ctr Rheumatol, D-13125 Berlin, Germany		Schmidt, WA (corresponding author), Med Ctr Rheumatol, D-13125 Berlin, Germany.		Schmidt, Wolfgang/W-5599-2019	Schmidt, Wolfgang/0000-0001-7831-8738				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Backhaus M, 1999, ARTHRITIS RHEUM-US, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO;2-3; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Goupille P, 2001, J RHEUMATOL, V28, P35; Grassi W, 2001, ANN RHEUM DIS, V60, P98, DOI 10.1136/ard.60.2.98; Klarlund M, 2000, ANN RHEUM DIS, V59, P521, DOI 10.1136/ard.59.7.521; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Wakefield RJ, 2000, ARTHRITIS RHEUM-US, V43, P2762, DOI 10.1002/1529-0131(200012)43:12<2762::AID-ANR16>3.0.CO;2-#; WOLFE F, 1994, ARTHRITIS RHEUM-US, V37, P481, DOI 10.1002/art.1780370408	9	73	76	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 7	2001	357	9262					1056	1057		10.1016/S0140-6736(00)04304-X	http://dx.doi.org/10.1016/S0140-6736(00)04304-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297951				2022-12-01	WOS:000167996200002
J	Klironomos, JN; Hart, MM				Klironomos, JN; Hart, MM			Food-web dynamics - Animal nitrogen swap for plant carbon	NATURE			English	Article									Univ Guelph, Dept Bot, Guelph, ON N1G 2W1, Canada	University of Guelph	Klironomos, JN (corresponding author), Univ Guelph, Dept Bot, Guelph, ON N1G 2W1, Canada.		Hart, Miranda m/D-1562-2011					BARRON GL, 1987, CAN J BOT, V65, P774, DOI 10.1139/b87-103; Fitter A. H., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P333; MOORE JC, 1988, ANNU REV ENTOMOL, V33, P419, DOI 10.1146/annurev.en.33.010188.002223; Schlesinger WH., 1998, BIOGEOCHEMISTRY ANAL, V73, P353, DOI 10.1016/0016-7037(92)90106-s; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; Smith S. E., 2010, MYCORRHIZAL SYMBIOSI	6	98	101	5	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					651	652		10.1038/35070643	http://dx.doi.org/10.1038/35070643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287942				2022-12-01	WOS:000167875400034
J	Akhmanova, A; Hoogenraad, CC; Drabek, K; Stepanova, T; Dortland, B; Verkerk, T; Vermeulen, W; Burgering, BM; De Zeeuw, CI; Grosveld, F; Galjart, N				Akhmanova, A; Hoogenraad, CC; Drabek, K; Stepanova, T; Dortland, B; Verkerk, T; Vermeulen, W; Burgering, BM; De Zeeuw, CI; Grosveld, F; Galjart, N			CLASPs are CLIP-115 and-170 associating proteins involved in the regional regulation of microtubule dynamics in motile fibroblasts	CELL			English	Article							MITOTIC SPINDLE; DISTAL ENDS; LOCALIZATION; YEAST; COLOCALIZATION; STABILIZATION; MORPHOGENESIS; ORGANIZATION; DROSOPHILA; DYNACTIN	CLIP-170 and CLIP-115 are cytoplasmic linker proteins that associate specifically with the ends of growing microtubules and may act as anti-catastrophe factors. Here, we have isolated two CLIP-associated proteins (CLASPs), which are homologous to the Drosophila Orbit/Mast microtubule-associated protein. CLASPs bind CLIPs and microtubules, colocalize with the CLIPs at microtubule distal ends, and have microtubule-stabilizing effects in transfected cells. After serum induction, CLASPs relocalize to distal segments of microtubules at the leading edge of motile fibroblasts. We provide evidence that this asymmetric CLASP distribution is mediated by PI3-kinase and GSK-3 beta. Antibody injections suggest that CLASP2 is required for the orientation of stabilized microtubules toward the leading edge. We propose that CLASPs are involved in the local regulation of microtubule dynamics in response to positional cues.	Erasmus Univ, MGC Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, MGC Dept Anat, NL-3000 DR Rotterdam, Netherlands; Univ Utrecht, Physiol Chem Lab, NL-3584 CG Utrecht, Netherlands; Univ Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Utrecht University; Utrecht University	Galjart, N (corresponding author), Erasmus Univ, MGC Dept Cell Biol & Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Galjart, Niels/D-1146-2010; Akhmanova, Anna S/B-8896-2011; Hoogenraad, Casper/B-8866-2011; Vermeulen, Wim/W-8708-2019	Galjart, Niels/0000-0003-1964-3607; Akhmanova, Anna S/0000-0002-9048-8614; Hoogenraad, Casper/0000-0002-2666-0758; Vermeulen, Wim/0000-0003-3616-734X				Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; De Zeeuw CI, 1997, NEURON, V19, P1187, DOI 10.1016/S0896-6273(00)80411-0; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; DiPaolo G, 1997, J BIOL CHEM, V272, P5175, DOI 10.1074/jbc.272.8.5175; Dujardin D, 1998, J CELL BIOL, V141, P849, DOI 10.1083/jcb.141.4.849; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Gavet O, 1998, J CELL SCI, V111, P3333; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Hoogenraad CC, 2000, J CELL SCI, V113, P2285; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Ishikawa K, 1998, DNA Res, V5, P169, DOI 10.1093/dnares/5.3.169; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Liao GJ, 1999, FASEB J, V13, pS257, DOI 10.1096/fasebj.13.9002.S257; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PIERRE P, 1992, CELL, V70, P887, DOI 10.1016/0092-8674(92)90240-D; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Sambrook J., 1989, MOL CLONING LAB MANU; Scheel J, 1999, J BIOL CHEM, V274, P25883, DOI 10.1074/jbc.274.36.25883; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; van Weeren PC, 1998, J BIOL CHEM, V273, P13150, DOI 10.1074/jbc.273.21.13150; VANVUUREN AJ, 1994, EMBO J, V13, P1645, DOI 10.1002/j.1460-2075.1994.tb06428.x; Vaughan KT, 1999, J CELL SCI, V112, P1437; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Wolthuis RMF, 1996, ONCOGENE, V13, P353	36	362	382	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					923	935		10.1016/S0092-8674(01)00288-4	http://dx.doi.org/10.1016/S0092-8674(01)00288-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290329	Bronze			2022-12-01	WOS:000167869200014
J	Luo, ZX; Cifelli, RL; Kielan-Jaworowska, Z				Luo, ZX; Cifelli, RL; Kielan-Jaworowska, Z			Dual origin of tribosphenic mammals	NATURE			English	Article							SOUTH-AMERICA; EVOLUTION; DISCOVERY; AUSTRALIA; PLATYPUS; ENGLAND; CHINA	Marsupials, placentals and their close therian relatives possess complex (tribosphenic) molars that are capable of versatile occlusal functions. This functional complex is widely thought to be a key to the early diversification and evolutionary success of extant therians and their close relatives (tribosphenidans). Long thought to have arisen on northern continents, tribosphenic mammals have recently been reported from southern landmasses. The great age and advanced morphology of these new mammals has led to the alternative suggestion of a Gondwanan origin for the group. Implicit in both biogeographic hypotheses is the assumption that tribosphenic molars evolved only once in mammalian evolutionary history. Phylogenetic and morphometric analyses including these newly discovered taxa suggest a different interpretation: that mammals with tribosphenic molars are not monophyletic. Tribosphenic molars evolved independently in two ancient (holotherian) mammalian groups with different geographic distributions during the Jurassic/Early Cretaceous: an australosphenidan clade endemic to Gondwanan landmasses, survived by extant monotremes; and a boreosphenidan clade of Laurasian continents, including extant marsupials, placentals and their relatives.	Oklahoma Museum Nat Hist, Norman, OK 73072 USA; Carnegiw Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Polish Acad Sci, Inst Paleobiol, PL-00818 Warsaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences	Cifelli, RL (corresponding author), Oklahoma Museum Nat Hist, 2401 Chautauqua, Norman, OK 73072 USA.	rlc@uo.edu	Self, Casey J/B-6871-2011; Luo, Zhe-XI/AAU-2263-2021					ARCHER M, 1985, NATURE, V318, P363, DOI 10.1038/318363a0; ARCHER M, 1993, MAMMAL PHYLOGENY; Archer Michael, 1999, Australian Mammalogy, V21, P1; BONAPARTE JF, 1990, NATL GEOGR RES, V6, P63; Butler PM, 1939, P ZOOL SOC LOND B-SY, V109, P329; BUTLER PM, 1990, BIOL REV, V65, P529, DOI 10.1111/j.1469-185X.1990.tb01237.x; CHOW M, 1982, Australian Mammalogy, V5, P127; Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; Cifelli RL, 1999, NATURE, V401, P363, DOI 10.1038/43861; CLEMENS W A, 1971, Bulletin of the British Museum (Natural History) Geology, V20, P89; Crompton A., 1971, EARLY MAMMALS, P65; deMuizon C, 1997, NATURE, V389, P486, DOI 10.1038/39029; Flynn JJ, 1999, NATURE, V401, P57, DOI 10.1038/43420; Griffiths M, 1978, BIOL MONOTREMES; HOPSON JA, 1994, MAJOR FEATURES VERTE, P190; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; JACOBS LL, 1989, P NATL ACAD SCI USA, V86, P4992, DOI 10.1073/pnas.86.13.4992; Janke A, 1997, P NATL ACAD SCI USA, V94, P1276, DOI 10.1073/pnas.94.4.1276; Ji Q, 1999, NATURE, V398, P326; Kielan-Jaworowska Z, 1998, LETHAIA, V31, P267; KIELANJAWOROWSKA Z, 1987, NATURE, V326, P871, DOI 10.1038/326871a0; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Krebs B., 1991, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V133, P1; Lillegraven J.A., 1974, Annual Rev Ecol Syst, V5, P263, DOI 10.1146/annurev.es.05.110174.001403; McKenna MC, 1975, PHYLOGENY PRIMATES, P2146, DOI [10.1007/978-1-4684-2166-8_2, DOI 10.1007/978-1-4684-2166-8_2]; McKenna MC, 1997, CLASSIFICATION MAMMA; Musser AM, 1998, PHILOS T R SOC B, V353, P1063, DOI 10.1098/rstb.1998.0266; PASCUAL R, 1992, NATURE, V356, P704, DOI 10.1038/356704a0; Pascual Rosendo, 2000, Geodiversitas, V22, P395; PATTERSON BRUAN, 1956, FIELDIANA GEOL, V13, P1; Penny D, 1997, NATURE, V387, P549, DOI 10.1038/42352; Prothero DR, 1981, B AM MUS NAT HIST, V167, P277; Rich TH, 1997, SCIENCE, V278, P1438, DOI 10.1126/science.278.5342.1438; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Sigogneau-Russell D, 1998, CR ACAD SCI II A, V327, P571, DOI 10.1016/S1251-8050(99)80040-8; SIGOGNEAURUSSELL D, 1994, CR ACAD SCI II, V319, P833; SIGOGNEAURUSSELL D, 1991, CR ACAD SCI II, V313, P1635; Wang YQ, 1998, J VERTEBR PALEONTOL, V18, P777, DOI 10.1080/02724634.1998.10011106; Wible John R., 1995, American Museum Novitates, V3149, P1; Zeller U., 1989, ABHANDLUNGEN SENCKEN, V545, P1	44	185	202	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					53	57		10.1038/35051023	http://dx.doi.org/10.1038/35051023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343108				2022-12-01	WOS:000166175600034
J	Stokroos, I; Litinetsky, L; van der Want, JJL; Ishay, JS				Stokroos, I; Litinetsky, L; van der Want, JJL; Ishay, JS			Magnetic minerals - Keystone-like crystals in cells of hornet combs	NATURE			English	Article									Univ Groningen, Fac Med Sci, Dept Cell Biol, Grad Sch Brain Cognit & Neurosci, NL-9713 EZ Groningen, Netherlands; Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel	University of Groningen; Tel Aviv University; Sackler Faculty of Medicine	Stokroos, I (corresponding author), Univ Groningen, Fac Med Sci, Dept Cell Biol, Grad Sch Brain Cognit & Neurosci, Oostersingel 69-2, NL-9713 EZ Groningen, Netherlands.	physio7@post.tau.ac.il	van der Want, Johannes/AAA-8058-2019	van der Want, Johannes/0000-0002-7485-4434				Ishay Jacob S., 1996, Scanning Microscopy, V10, P187; ISHAY JS, 1982, INSECT SOC, V29, P34, DOI 10.1007/BF02224526; Jongebloed WL, 1999, J ELECTRON MICROSC, V48, P63, DOI 10.1093/oxfordjournals.jmicro.a023652; SPRADBERY JP, 1973, WASPS; Welham NJ, 1998, J MATER SCI, V33, P1795, DOI 10.1023/A:1004388818110; Wilson GS, 1999, GEOL SOC SPEC PUBL, V151, P95, DOI 10.1144/GSL.SP.1999.151.01.10	6	16	16	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					654	654		10.1038/35079679	http://dx.doi.org/10.1038/35079679			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395756				2022-12-01	WOS:000169112500030
J	Shu, DG; Chen, L; Han, J; Zhang, XL				Shu, DG; Chen, L; Han, J; Zhang, XL			An early Cambrian tunicate from China	NATURE			English	Article							EVOLUTIONARY HISTORY; VERTEBRATES; FOSSIL	Like the Burgess Shales of Canada, the Chengjiang Lagerstatte from the Lower Cambrian of China is renowned for the detailed preservation as fossils of delicate, soft-bodied creatures(1-9), providing an insight into the Cambrian explosion. The fossils of possible hemichordate chordates(5-7) and vertebrates(9) have attracted particular attention. Tunicates, or urochordates, comprise the most basal chordate clade(10), and details of their evolution could be important in understanding the sequence of character acquisition that led to the emergence of chordates and vertebrates(11-18). However, definitive fossils of tunicates from the Cambrian are scarce or debatable(4,9,19-24). Here we report a probable tunicate Cheungkongella ancestralis from the Chengjiang fauna. It resembles the extant ascidian tunicate genus Styela whose morphology could be useful in understanding the origin of the vertebrates.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Dept Geol, Xian 710069, Peoples R China	Northwest University Xi'an; Northwest University Xi'an	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.	dgshu@sein.sxgb.com.cn						[Anonymous], 1994, FOSSILS BURGESS SHAL; Berrill N.J., 1955, ORIGIN VERTEBRATES; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; CARTER GS, 1957, SYST ZOOL, V6, P187; CHEN JY, 1995, NATURE, V377, P720, DOI 10.1038/377720a0; Conway Morris S, 1982, ATLAS BURGESS SHALE, P26; Degan Shu, 1995, Beringeria Special Issue, V2, P203; Di Gregorio A, 1998, CURR OPIN GENET DEV, V8, P457, DOI 10.1016/S0959-437X(98)80118-4; GARSTANG WALTER, 1928, QUART JOUR MICROS SCI, V72, P51; Gee H., 1996, BACKBONE VIEWS ORIGI; Hou Xianguang, 1997, Fossils and Strata, V45, P1; JOLLIE M, 1982, ZOOL J LINN SOC-LOND, V75, P167, DOI 10.1111/j.1096-3642.1982.tb01946.x; Lehnert Oliver, 1999, Acta Universitatis Carolinae Geologica, V43, P447; LOHMANN H, 1922, MITT ZOOL MUS HAMBUR, V38, P69; MEGLITSCH PA, 1991, INVERTEBRATE ZOOLOGY, P576; MUELLER K J, 1977, Lethaia, V10, P107; Nielsen C., 1997, ANIMAL EVOLUTION INT; Ogasawara M, 1999, ZOOL SCI, V16, P559, DOI 10.2108/zsj.16.559; ROMER AS, 1971, VERTEBRATE STORY; Satoh N., 1994, DEV BIOL ASCIDIANS; Shu D, 1996, NATURE, V380, P428, DOI 10.1038/380428a0; Shu D, 1999, NATURE, V400, P746, DOI 10.1038/23445; Shu DG, 1995, ALCHERINGA, V19, P333, DOI 10.1080/03115519508619512; Shu DG, 1996, NATURE, V384, P157, DOI 10.1038/384157a0; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Swalla BJ, 2000, SYST BIOL, V49, P52, DOI 10.1080/10635150050207384; Wada H, 1998, MOL BIOL EVOL, V15, P1189, DOI 10.1093/oxfordjournals.molbev.a026026; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; ZHANG AY, 1987, SCI CHINA SER B, V30, P888; Zhang XL, 2001, J GEOL SOC LONDON, V158, P211, DOI 10.1144/jgs.158.2.211	30	83	100	2	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					472	473		10.1038/35078069	http://dx.doi.org/10.1038/35078069			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373678				2022-12-01	WOS:000168858700047
J	Johnston, WK; Unrau, PJ; Lawrence, MS; Glasner, ME; Bartel, DP				Johnston, WK; Unrau, PJ; Lawrence, MS; Glasner, ME; Bartel, DP			RNA-catalyzed RNA polymerization: Accurate and general RNA-templated primer extension	SCIENCE			English	Article							NONTEMPLATED NUCLEOTIDE ADDITION; FIDELITY; RIBOZYME; REPLICATION; ORIGIN; SITES	The RNA world hypothesis regarding the early evolution of Life relies on the premise that some RNA sequences can catalyze RNA replication. In support of this conjecture, we describe here an RNA molecule that catalyzes the type of polymerization needed for RNA replication. The ribozyme uses nucleoside triphosphates and the coding information of an RNA template to extend an RNA primer by the successive addition of up to 14 nucleotides-more than a complete turn of an RNA helix. Its polymerization activity is general in terms of the sequence and the Length of the primer and template RNAs, provided that the 3' terminus of the primer pairs with the template. Its polymerization is also quite accurate: when primers extended by 11 nucleotides were cloned and sequenced, 1088 of 1100 sequenced nucleotides matched the template.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Glasner, Margaret/0000-0003-1818-1965				Bartel D.P, 1999, RNA WORLD 2 NAT MOD, V37, P143; Bartel David P., 1999, Trends in Cell Biology, V9, pM9, DOI 10.1016/S0962-8924(99)01669-4; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; BAUSCH JN, 1983, J BIOL CHEM, V258, P1978; Bergman NH, 2000, BIOCHEMISTRY-US, V39, P3115, DOI 10.1021/bi992654u; CECH TR, 1986, P NATL ACAD SCI USA, V83, P4360, DOI 10.1073/pnas.83.12.4360; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; DOUDNA JA, 1991, SCIENCE, V251, P1605, DOI 10.1126/science.1707185; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; EKLAND EH, 1995, NUCLEIC ACIDS RES, V23, P3231, DOI 10.1093/nar/23.16.3231; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; Glasner ME, 2000, BIOCHEMISTRY-US, V39, P15556, DOI 10.1021/bi002174z; GREEN R, 1992, SCIENCE, V258, P1910, DOI 10.1126/science.1470913; Hager AJ, 1996, CHEM BIOL, V3, P717, DOI 10.1016/S1074-5521(96)90246-X; Joyce G. F., 1993, COLD SPRING HARB SYM, V24, P49; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; KUNKEL TA, 1992, BIOESSAYS, V14, P303, DOI 10.1002/bies.950140503; LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; ORGEL LE, 1986, J THEOR BIOL, V123, P127, DOI 10.1016/S0022-5193(86)80149-7; PACE NR, 1985, ORIGINS LIFE EVOL B, V16, P97, DOI 10.1007/BF01809465; SHARP PA, 1985, CELL, V42, P397, DOI 10.1016/0092-8674(85)90092-3; STEINHAUER DA, 1986, J VIROL, V57, P219, DOI 10.1128/JVI.57.1.219-228.1986; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; TUSCHL T, 1993, BIOCHEMISTRY-US, V32, P11658, DOI 10.1021/bi00094a023; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; UNRAU PJ, UNPUB; WARD CD, 1992, J VIROL, V66, P3784, DOI 10.1128/JVI.66.6.3784-3793.1992; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835	31	434	455	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1319	1325		10.1126/science.1060786	http://dx.doi.org/10.1126/science.1060786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11358999	Green Submitted			2022-12-01	WOS:000168862900032
J	Schwechheimer, C; Serino, G; Callis, J; Crosby, WL; Lyapina, S; Deshaies, RJ; Gray, WM; Estelle, M; Deng, XW				Schwechheimer, C; Serino, G; Callis, J; Crosby, WL; Lyapina, S; Deshaies, RJ; Gray, WM; Estelle, M; Deng, XW			Interactions of the COP9 signalosome with the E3 ubiquitin ligase SCFTIR1 in mediating auxin response	SCIENCE			English	Article							ARABIDOPSIS-THALIANA DEFINE; GENE; COMPLEX; MUTATIONS; PROTEIN; MUTANTS; DEGRADATION; EXPRESSION; REGULATOR; ENCODES	The COP9 signalosome is an evolutionary conserved multiprotein complex of unknown function that acts as a negative regulator of photomorphogenic seedling development in Arabidopsis. Here, we show that plants with reduced COP9 signalosome levels had decreased auxin response similar to loss-of-function mutants of the E3 ubiquitin ligase SCFTIR1. Furthermore, we found that the COP9 signalosome and SCFTIR1 interacted in vivo and that the COP9 signalosome was required for efficient degradation of PSIAA6, a candidate substrate of SCFTIR1. Thus, the COP9 signalosome may play an important role in mediating E3 ubiquitin ligase-mediated responses.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Texas, Sect Mol Cellular & Dev Biol, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Yale University; University of California System; University of California Davis; National Research Council Canada; California Institute of Technology; University of Texas System; University of Texas Austin	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.		Gray, William M/F-9402-2010; Deshaies, Raymond/B-8354-2014; Estelle, Mark/ABD-6742-2021; Serino, Giovanna/W-4683-2019; Ding, Cheng-Qiang/B-6287-2011; Deng, Xing Wang/ABF-4107-2020; Schwechheimer, Claus/Q-7907-2016	Gray, William M/0000-0002-1320-290X; Deshaies, Raymond/0000-0002-3671-9354; Serino, Giovanna/0000-0001-8689-6132; Schwechheimer, Claus/0000-0003-0269-2330; Callis, Judy/0000-0002-0622-078X				ABEL S, 1995, J MOL BIOL, V251, P533, DOI 10.1006/jmbi.1995.0454; ABEL S, 1994, P NATL ACAD SCI USA, V91, P326, DOI 10.1073/pnas.91.1.326; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; del Pozo JC, 1998, SCIENCE, V280, P1760, DOI 10.1126/science.280.5370.1760; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; GIL P, 1994, PLANT PHYSIOL, V104, P777, DOI 10.1104/pp.104.2.777; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gray WM, 2000, TRENDS BIOCHEM SCI, V25, P133, DOI 10.1016/S0968-0004(00)01544-9; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hobbie L, 2000, DEVELOPMENT, V127, P23; HOBBIE L, 1995, PLANT J, V7, P211, DOI 10.1046/j.1365-313X.1995.7020211.x; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Leyser HMO, 1996, PLANT J, V10, P403, DOI 10.1046/j.1365-313x.1996.10030403.x; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mayer R, 1996, PLANT CELL, V8, P1951, DOI 10.1105/tpc.8.11.1951; Napoli CA, 1999, CURR TOP DEV BIOL, V44, P127; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Schwechheimer C, 2000, SEMIN CELL DEV BIOL, V11, P495, DOI 10.1006/scdb.2000.0203; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Staub JM, 1996, PLANT CELL, V8, P2047, DOI 10.1105/tpc.8.11.2047; TIMPTE CS, 1992, PLANTA, V188, P271, DOI 10.1007/BF00216824; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wei N, 1999, TRENDS GENET, V15, P98, DOI 10.1016/S0168-9525(98)01670-9; Worley CK, 2000, PLANT J, V21, P553, DOI 10.1046/j.1365-313x.2000.00703.x; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200	28	379	411	5	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1379	1382		10.1126/science.1059776	http://dx.doi.org/10.1126/science.1059776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11337587				2022-12-01	WOS:000168862900047
J	Gillman, MW; Rifas-Shiman, SL; Camargo, CA; Berkey, CS; Frazier, AL; Rockett, HRH; Field, AE; Colditz, GA				Gillman, MW; Rifas-Shiman, SL; Camargo, CA; Berkey, CS; Frazier, AL; Rockett, HRH; Field, AE; Colditz, GA			Risk of overweight among adolescents who were breastfed as infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; NUTRITION EXAMINATION SURVEYS; CHILDHOOD OBESITY; FOLLOW-UP; ENDOCRINE RESPONSES; FEEDING PRACTICES; YOUNG ADULTHOOD; NATIONAL-HEALTH; CHILDREN; GROWTH	Context Overweight during adolescence predicts short- and long-term morbidity as well as obesity in adulthood. The prevalence of overweight among adolescents is high and continues to increase. Physiological and behavioral mechanisms and preliminary epidemiologic data suggest that breastfeeding could lower the risk of subsequent obesity in adolescence. Objective To examine the extent to which overweight status among adolescents is associated with the type of infant feeding (breast milk vs infant formula) and duration of breastfeeding. Design, Setting, and Subjects Survey of 8186 girls and 7155 boys, aged 9 to 14 years, who are participants in the Growing Up Today Study, a nationwide cohort study of diet, activity, and growth. In the fall of 1996 we mailed a questionnaire to each of the subjects, and in the spring of 1997, we mailed a supplemental questionnaire to their mothers, who are participants in the Nurses' Health Study II. Main Outcome Measure Overweight status defined as body mass index exceeding the 95th percentile for age and sex from US national data. Results In the first 6 months of life, 9553 subjects (62%) were only or mostly fed breast milk, and 4744 (31%) were only or mostly fed infant formula. A total of 7186 subjects (48%) were breastfed for at least 7 months while 4613 (31%) were breastfed for 3 months or less. At ages 9 to 14 years, 404 girls (5%) and 635 boys (9%) were overweight. Among subjects who had been only or mostly fed breast milk, compared with those only or mostly fed formula, the odds ratio (OR) for being overweight was 0.78 (95% confidence interval [CI], 0.66-0.91), after adjustment for age, sex, sexual maturity, energy intake, time watching television, physical activity, mother's body mass index, and other variables reflecting social, economic, and lifestyle factors. Compared with subjects who had been breastfed for 3 months or less, those who had been breastfed for at least 7 months had an adjusted OR for being overweight of 0.80 (95% CI, 0.67-0.96). Timing of introduction of solid foods, infant formula, or cow's milk was not related to risk of being overweight, Conclusion Infants who were fed breast milk more than infant formula, or who were breastfed for longer periods, had a lower risk of being overweight during older childhood and adolescence.	Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care, Dept Amulatory Care & Prevent, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Gillman, MW (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care, Dept Amulatory Care & Prevent, 126 Brookline Ave,Suite 200, Boston, MA 02215 USA.		Camargo, Carlos A./C-2145-2008; Field, Alison/AAA-4508-2021; Colditz, Graham/A-3963-2009	Camargo, Carlos A./0000-0002-5071-7654; Colditz, Graham/0000-0002-7307-0291	NCI NIH HHS [CA 50385] Funding Source: Medline; NIDDK NIH HHS [DK 46834] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046834] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGRAS WS, 1990, J PEDIATR-US, V116, P805, DOI 10.1016/S0022-3476(05)82677-0; Barker DJP, 1998, MOTHERS BABIES DIS L; Baughcum AE, 1998, ARCH PEDIAT ADOL MED, V152, P1010; Berkey CS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e56; Birch LL, 1998, PEDIATRICS, V101, P539; Butte NF, 1998, J NUTR, V128, p381S, DOI 10.1093/jn/128.2.381S; *CDC, 2001, CDC GROWTH CHARTS US; *COMM NUTR AM AC P, 1998, PED NUTR HDB; DEWEY KG, 1991, J PEDIATR-US, V119, P538, DOI 10.1016/S0022-3476(05)82401-1; DEWEY KG, 1995, PEDIATRICS, V96, P495; Elliott KG, 1997, OBES RES, V5, P538, DOI 10.1002/j.1550-8528.1997.tb00574.x; Ellis KJ, 1999, AM J EPIDEMIOL, V150, P939, DOI 10.1093/oxfordjournals.aje.a010102; FORD K, 1990, AM J CLIN NUTR, V52, P451, DOI 10.1093/ajcn/52.3.451; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; FRENCH SA, 1995, OBES RES, V3, P479, DOI 10.1002/j.1550-8528.1995.tb00179.x; Goodman E, 2000, PEDIATRICS, V106, P52, DOI 10.1542/peds.106.1.52; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HAAGA JG, 1988, DEMOGRAPHY, V25, P307, DOI 10.2307/2061296; HAMOSH M, 1988, J PEDIATR GASTR NUTR, V7, P10, DOI 10.1097/00005176-198801000-00004; HAUNER H, 1995, EUR J CLIN INVEST, V25, P90, DOI 10.1111/j.1365-2362.1995.tb01532.x; Hilson JA, 1997, AM J CLIN NUTR, V66, P1371, DOI 10.1093/ajcn/66.6.1371; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Institute of Medicine, 1991, NUTR LACT; KARK JD, 1984, J EPIDEMIOL COMMUN H, V38, P218, DOI 10.1136/jech.38.3.218; KRAMER MS, 1981, J PEDIATR-US, V98, P883, DOI 10.1016/S0022-3476(81)80579-3; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; LANTING CI, 1994, LANCET, V344, P1319, DOI 10.1016/S0140-6736(94)90692-0; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; LUCAS A, 1980, LANCET, V1, P1267; LUCAS A, 1981, ACTA PAEDIATR SCAND, V70, P195, DOI 10.1111/j.1651-2227.1981.tb05541.x; MCGILL HC, 1996, NUTR REV, V54, P531; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; NEWCOMB PA, 1994, NEW ENGL J MED, V330, P81, DOI 10.1056/NEJM199401133300201; OCallaghan MJ, 1997, J PAEDIATR CHILD H, V33, P311, DOI 10.1111/j.1440-1754.1997.tb01607.x; RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; RUTISHAUSER IHE, 1992, J EPIDEMIOL COMMUN H, V46, P559, DOI 10.1136/jech.46.6.559; SAMUELS SE, 1985, AM J CLIN NUTR, V42, P504, DOI 10.1093/ajcn/42.3.504; SHANNON B, 1991, J AM DIET ASSOC, V91, P675; Strauss RS, 1999, INT J OBESITY, V23, P904, DOI 10.1038/sj.ijo.0800971; Strbak V, 1991, Endocr Regul, V25, P53; Thorogood M, 1979, J R Coll Gen Pract, V29, P427; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Troiano RP, 1998, PEDIATRICS, V101, P497; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; VOBECKY JS, 1988, J CLIN EPIDEMIOL, V41, P261, DOI 10.1016/0895-4356(88)90130-8; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; ZIVE MM, 1992, AM J CLIN NUTR, V55, P1104, DOI 10.1093/ajcn/55.6.1104	52	482	509	3	48	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2461	2467		10.1001/jama.285.19.2461	http://dx.doi.org/10.1001/jama.285.19.2461			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368698	Bronze			2022-12-01	WOS:000168547600027
J	Levin, BR; Antia, R				Levin, BR; Antia, R			Why we don't get sick: The within-host population dynamics of bacterial infections	SCIENCE			English	Editorial Material							LYMPHOCYTE MEMORY; IN-VIVO; SELECTION; COMPETITION; HOMEOSTASIS; RESPONSES; MODEL; HIV; REPERTOIRE; EVOLUTION	To pathogenic microparasites (viruses, bacteria, protozoa, or fungi), we and other mammals (Living organisms at large) are Little more than soft, thin-walled flasks of culture media. Almost every time we eat, brush our teeth, scrape our skin, have sex, get bitten by insects, and inhale, we are confronted with populations of microbes that are capable of colonizing the mucosa lining our orifices and alimentary tract and proliferating in fluids and cells within us. Nevertheless, we rarely get sick, much Less succumb to these infections. The massive numbers of bacteria and other micro- and not-mo-micro organisms that abound and replicate in our alimentary tract and cover our skin and the mucosa Lining our orifices normally maintain their communities in seemingly peaceful coexistence with the somatic cells that define us. Why don't these microbes invade and proliferate in the culture media within the soft, thin-walled flask that envelops us? Why don't they cause disease and Lead to our rapid demise?	Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Levin, BR (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.				NIAID NIH HHS [AI40662] Funding Source: Medline; NIGMS NIH HHS [GM33782, GM 54268] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040662] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUR Z, 1991, P ROY SOC B-BIOL SCI, V245, P147, DOI 10.1098/rspb.1991.0101; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Antia R, 1998, P NATL ACAD SCI USA, V95, P14926, DOI 10.1073/pnas.95.25.14926; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; Craig W., 1993, European Journal of Clinical Microbiology and Infectious Diseases, V12, pS6, DOI 10.1007/BF02389870; DeBoer RJ, 1997, INT IMMUNOL, V9, P779, DOI 10.1093/intimm/9.5.779; Detours V, 1999, P NATL ACAD SCI USA, V96, P5153, DOI 10.1073/pnas.96.9.5153; DEVRIES FP, 1996, INFECT IMMUN, V64, P2999; Drusano GL, 1997, J CHEMOTHERAPY, V9, P38; Falk PG, 2000, TRENDS MICROBIOL, V8, P321, DOI 10.1016/S0966-842X(00)01780-7; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; FISHMAN MA, 1995, J THEOR BIOL, V173, P241, DOI 10.1016/S0022-5193(95)80003-4; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; FREITAS AA, 1993, IMMUNOL TODAY, V14, P25, DOI 10.1016/0167-5699(93)90320-K; GERNE JWS, 1991, INFECT IMMUN, V59, P1325; GRAVENOR MB, 1995, PARASITOLOGY, V110, P115, DOI 10.1017/S0031182000063861; Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013; KEPLER TB, 1993, J THEOR BIOL, V164, P37, DOI 10.1006/jtbi.1993.1139; Kerksiek KM, 1999, CURR OPIN IMMUNOL, V11, P400, DOI 10.1016/S0952-7915(99)80067-3; Kesmir C, 1999, J IMMUNOL, V163, P2463; Krakauer DC, 1999, P ROY SOC B-BIOL SCI, V266, P1069, DOI 10.1098/rspb.1999.0745; Levin Bruce R., 1994, Trends in Microbiology, V2, P76, DOI 10.1016/0966-842X(94)90538-X; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; McLean AR, 1997, P NATL ACAD SCI USA, V94, P5792, DOI 10.1073/pnas.94.11.5792; MEHR R, 1995, J THEOR BIOL, V175, P103, DOI 10.1006/jtbi.1995.0124; MEYNELL GG, 1957, J GEN MICROBIOL, V16, P396, DOI 10.1099/00221287-16-2-396; MEYNELL GG, 1957, J GEN MICROBIOL, V16, P38, DOI 10.1099/00221287-16-1-38; MOXON ER, 1978, P NATL ACAD SCI USA, V75, P1534, DOI 10.1073/pnas.75.3.1534; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nowak M. A, 2000, VIRUS DYNAMICS; Ochman H, 2001, SCIENCE, V292, P1096, DOI 10.1126/science.1058543; Oprea M, 1996, J THEOR BIOL, V181, P215, DOI 10.1006/jtbi.1996.0127; PAUL WE, 1989, FUNDAMENTALS IMMUNOL; Segel LA, 1999, J IMMUNOL, V163, P1342; SPITZNAGEL JK, 1993, MECH MICROBIAL DIS, P90; Wick D, 2000, MATH BIOSCI, V165, P115, DOI 10.1016/S0025-5564(00)00013-4; Wodarz D, 2000, PHILOS T R SOC B, V355, P329, DOI 10.1098/rstb.2000.0570; Wodarz D, 1999, IMMUNOL TODAY, V20, P220, DOI 10.1016/S0167-5699(99)01446-2; ZEIGLER HK, 1993, MECH MICROBIAL DIS, P114; 1997, ANTIMICROB AGENTS CH, V41, P365	42	78	83	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1112	1115		10.1126/science.1058879	http://dx.doi.org/10.1126/science.1058879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352067				2022-12-01	WOS:000168609200045
J	Oliet, SHR; Piet, R; Poulain, DA				Oliet, SHR; Piet, R; Poulain, DA			Control of glutamate clearance and synaptic efficacy by glial coverage of neurons	SCIENCE			English	Article							HYPOTHALAMIC MAGNOCELLULAR NEURONS; RAT-BRAIN; DIFFERENTIAL EXPRESSION; OXYTOCIN NEURONS; TRANSPORTERS; RECEPTORS; PLASTICITY; SYNAPSES; INHIBITION; INPUTS	Analysis of excitatory synaptic transmission in the rat hypothalamic supraoptic nucleus revealed that glutamate clearance and, as a consequence, glutamate concentration and diffusion in the extracellular space, is associated with the degree of astrocytic coverage of its neurons. Reduction in glutamate clearance, whether induced pharmacologically or associated with a relative decrease of glial coverage in the vicinity of synapses, affected transmitter release through modulation of presynaptic metabotropic glutamate receptors, Astrocytic wrapping of neurons, therefore, contributes to the regulation of synaptic efficacy in the central nervous system.	Univ Bordeaux 2, INSERM, U378, F-33077 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Oliet, SHR (corresponding author), Univ Bordeaux 2, INSERM, U378, F-33077 Bordeaux, France.		Piet, Richard/H-7958-2019	Piet, Richard/0000-0001-5160-6027; Oliet, Stephane/0000-0003-0595-9029				ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bergles DE, 1998, J NEUROSCI, V18, P7709; Brussaard AB, 1997, NEURON, V19, P1103, DOI 10.1016/S0896-6273(00)80401-8; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Diamond JS, 1997, J NEUROSCI, V17, P4672; El Majdoubi M, 2000, BIOCHEM CELL BIOL, V78, P317; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; Hatton GI, 1997, ANNU REV NEUROSCI, V20, P375, DOI 10.1146/annurev.neuro.20.1.375; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; JOHNSTON GAR, 1979, J NEUROCHEM, V32, P121, DOI 10.1111/j.1471-4159.1979.tb04518.x; Jourdain P, 1998, J NEUROSCI, V18, P6641; Laming PR, 2000, NEUROSCI BIOBEHAV R, V24, P295, DOI 10.1016/S0149-7634(99)00080-9; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Oliet SHR, 1999, J PHYSIOL-LONDON, V520, P815, DOI 10.1111/j.1469-7793.1999.00815.x; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schrader LA, 1997, J NEUROPHYSIOL, V77, P527, DOI 10.1152/jn.1997.77.2.527; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; TORP R, 1994, EUR J NEUROSCI, V6, P936, DOI 10.1111/j.1460-9568.1994.tb00587.x	24	458	475	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					923	926		10.1126/science.1059162	http://dx.doi.org/10.1126/science.1059162			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340204				2022-12-01	WOS:000168514900042
J	Dragoi, V; Rivadulla, C; Sur, M				Dragoi, V; Rivadulla, C; Sur, M			Foci of orientation plasticity in visual cortex	NATURE			English	Article							CAT AREA 17; OCULAR DOMINANCE; ADAPTATION; SELECTIVITY; CONNECTIONS; INHIBITION; CONTRAST	Cortical areas are generally assumed to be uniform in their capacity for adaptive changes or plasticity(1-4). Here we demonstrate, however, that neurons in the cat striate cortex (V1) show pronounced adaptation-induced short-term plasticity of orientation tuning primarily at specific foci. V1 neurons are clustered according to their orientation preference in iso-orientation domains(5) that converge at singularities or pinwheel centres(6,7). Although neurons in pinwheel centres have similar orientation tuning and responses to those in iso-orientation domains, we rnd that they differ markedly in their capacity for adaptive changes. Adaptation with an oriented drifting grating stimulus alters responses of neurons located at and near pinwheel centres to a broad range of orientations, causing repulsive shifts in orientation preference and changes in response magnitude. In contrast, neurons located in iso-orientation domains show minimal changes in their tuning properties after adaptation. The anisotropy of adaptation-induced orientation plasticity is probably mediated by inhomogeneities in local intracortical interactions that are overlaid on the map of orientation preference in V1.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Dragoi, V (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	vdragoi@ai.mit.edu	RIVADULLA, CASTO/K-8425-2012	RIVADULLA, CASTO/0000-0001-5580-3917				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; Dragoi V, 2000, J NEUROPHYSIOL, V83, P1019, DOI 10.1152/jn.2000.83.2.1019; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V., 1999, Society for Neuroscience Abstracts, V25, P1548; Eysel UT, 1999, CEREB CORTEX, V9, P101, DOI 10.1093/cercor/9.2.101; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Fregnac Y, 1999, J NEUROBIOL, V41, P69; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HAMMOND P, 1989, VISION RES, V29, P1671, DOI 10.1016/0042-6989(89)90149-1; HATA Y, 1991, J PHYSIOL-LONDON, V441, P593, DOI 10.1113/jphysiol.1991.sp018769; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hubener M, 1997, J NEUROSCI, V17, P9270; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SOMERS DC, CEREBRAL CORTEX CAT; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665	30	128	129	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2001	411	6833					80	86		10.1038/35075070	http://dx.doi.org/10.1038/35075070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333981	Green Submitted			2022-12-01	WOS:000168432800047
J	Jeong, H; Mason, SP; Barabasi, AL; Oltvai, ZN				Jeong, H; Mason, SP; Barabasi, AL; Oltvai, ZN			Lethality and centrality in protein networks	NATURE			English	Article							ORGANIZATION; DATABASE; GENOME		Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	University of Notre Dame	Jeong, H (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	alb@nd.edu; zno008@nwu.edu	Jeong, Hawoong/AAR-2524-2021; Jeong, Hawoong/C-1587-2011; Barabasi, Albert-Laszlo/S-6474-2017; Jeong, Hawoong/A-2469-2009	Jeong, Hawoong/0000-0002-2491-8620; Jeong, Hawoong/0000-0002-2491-8620; Barabasi, Albert/0000-0002-4028-3522				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; FELL DA, ANIMATING CELLULAR M, P79; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289	13	3527	3711	7	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2001	411	6833					41	42		10.1038/35075138	http://dx.doi.org/10.1038/35075138			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333967	Green Submitted			2022-12-01	WOS:000168432800033
J	Kates, RW; Clark, WC; Corell, R; Hall, JM; Jaeger, CC; Lowe, I; McCarthy, JJ; Schellnhuber, HJ; Bolin, B; Dickson, NM; Faucheux, S; Gallopin, GC; Grubler, A; Huntley, B; Jager, J; Jodha, NS; Kasperson, RE; Mabogunje, A; Matson, P; Mooney, H; Moore, B; O'Riordan, T; Svedin, U				Kates, RW; Clark, WC; Corell, R; Hall, JM; Jaeger, CC; Lowe, I; McCarthy, JJ; Schellnhuber, HJ; Bolin, B; Dickson, NM; Faucheux, S; Gallopin, GC; Grubler, A; Huntley, B; Jager, J; Jodha, NS; Kasperson, RE; Mabogunje, A; Matson, P; Mooney, H; Moore, B; O'Riordan, T; Svedin, U			Environment and development - Sustainability science	SCIENCE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Amer Meteorol Soc, Washington, DC 20005 USA; NOAA, Silver Spring, MD 20910 USA; Potsdam Inst Climate Imapct Res, D-14412 Potsdam, Germany; Griffith Univ, Nathan, Qld 4111, Australia; Stockholm Univ, S-18451 Stockholm, Sweden; Univ Versailles, Ctr Econ & Eth Environm & Dev, F-78047 Guyancourt, France; Comis Econ Amer Latina & Carib, Santiago, Chile; Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; Natl Bot Inst, ZA-7735 Cape Town, South Africa; Int Human Dimens Programme Global Environm Change, D-53113 Bonn, Germany; Int Ctr Integrated Mt Dev, Kathmandu, Nepal; Stockholm Environm Inst, S-10314 Stockholm, Sweden; Stanford Univ, Stanford, CA 94305 USA; Univ New Hampshire, Inst Earth Oceans & Space, Durham, NH 03824 USA; Univ E Anglia, Ctr Social & Econ Res Global Environm, Norwich NR4 7TJ, Norfolk, England; Swedish Council Planning & Coordinat Res FRN, S-10387 Stockholm, Sweden; Dev Policy Ctr, Ibadan, Nigeria	Harvard University; National Oceanic Atmospheric Admin (NOAA) - USA; Potsdam Institut fur Klimafolgenforschung; Griffith University; Stockholm University; UDICE-French Research Universities; Universite Paris Saclay; International Institute for Applied Systems Analysis (IIASA); Stockholm Environment Institute; Stanford University; University System Of New Hampshire; University of New Hampshire; University of East Anglia	Clark, WC (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	william_clark@harvard.edu	Schellnhuber, Hans Joachim/B-2607-2012; Clark, William C/A-4832-2008; Schellnhuber, Hans Joachim/O-3873-2019; Lowe, Ian/AAH-7449-2019	Schellnhuber, Hans Joachim/0000-0001-7453-4935; Schellnhuber, Hans Joachim/0000-0001-7453-4935; O'Riordan, Timothy/0000-0002-0492-8477; Grubler, Arnulf/0000-0002-6225-7712				Annan Kofi A., 2000, WE PEOPLE ROLE UN 21; BOLIN B, 2000, UNEP ENCY GLOBAL ENV; BRANDOM R, 1988, MAKING IT EXPLICIT R; Cash DW, 2000, GLOBAL ENVIRON CHANG, V10, P109, DOI 10.1016/S0959-3780(00)00017-0; Dixon J., 1998, PROTECTING OUR PLANE; Faucheux S., 2000, NATURE SCI SOC, V8, P31; Faucheux S., 2000, FUTURIBLES, V251, P29; GALLOPIN G, IN PRESS INT SOC SCI; German Advisory Council on Global Change, 1997, WORLD TRANS RES CHAL; Gibson CC, 2000, ECOL ECON, V32, P217, DOI 10.1016/S0921-8009(99)00092-0; Grubler A, 1999, ANNU REV ENERG ENV, V24, P545, DOI 10.1146/annurev.energy.24.1.545; JAGER J, 1999, EFIEA WORKSH UNC EUR; Jodha N.S., 1998, LINKING SOCIAL ECOLO; Matson PA, 1998, SCIENCE, V280, P112, DOI 10.1126/science.280.5360.112; *NAT RES COUNC BOA, 1999, OUR COMMON JOURNEY T; *NAT RES COUNC COM, 2000, SCI REG GLOB CHANG P; Parson Edward A., 1995, BARRIERS BRIDGES REN, P428; Petschel-Held G., 1999, Environmental Modeling & Assessment, V4, P295, DOI 10.1023/A:1019080704864; Petschel- Held G, 1999, CLIMATIC CHANGE, V41, P303, DOI 10.1023/A:1005487123751; Schellnhuber HJ, 1999, NATURE, V402, pC19, DOI 10.1038/35011515; Tuinstra W, 1999, ENVIRONMENT, V41, P33, DOI 10.1080/00139159909605536; *U SO CAL, SUST CIT PROGR ENV S; Varis O, 1997, CLIMATIC CHANGE, V37, P539, DOI 10.1023/A:1005358216361; Wilbanks TJ, 1999, CLIMATIC CHANGE, V43, P601, DOI 10.1023/A:1005418924748; 2000, TRANSITION SUSTAINAB	25	1620	1817	36	773	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2001	292	5517					641	642		10.1126/science.1059386	http://dx.doi.org/10.1126/science.1059386			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11330321				2022-12-01	WOS:000168478300024
J	Wei, MC; Zong, WX; Cheng, EHY; Lindsten, T; Panoutsakopoulou, V; Ross, AJ; Roth, KA; MacCregor, GR; Thompson, CB; Korsmeyer, SJ				Wei, MC; Zong, WX; Cheng, EHY; Lindsten, T; Panoutsakopoulou, V; Ross, AJ; Roth, KA; MacCregor, GR; Thompson, CB; Korsmeyer, SJ			Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death	SCIENCE			English	Article							BCL-2 FAMILY MEMBERS; CYTOCHROME-C RELEASE; ENDOPLASMIC-RETICULUM; CELL-DEATH; APOPTOTIC PATHWAYS; PROTEIN; ACTIVATION; MEMBRANE; CASPASE-9; SURVIVAL	Multiple death signals influence mitochondria during apoptosis, yet the critical initiating event for mitochondrial dysfunction in vivo has been unclear. tBID, the caspase-activated form of a "BH3-domain-only" BCL-2 family member, triggers the homooligomerization of "multidomain" conserved proapoptotic family members BAK or BAX, resulting in the release of cytochrome c from mitochondria. We find that cells lacking both Bax and Bak, but not cells lacking only one of these components, are completely resistant to tBID-induced cytochrome c release and apoptosis. Moreover, doubly deficient cells are resistant to multiple apoptotic stimuli that act through disruption of mitochondrial function: staurosporine, ultraviolet radiation, growth factor deprivation, etoposide, and the endoplasmic reticulum stress stimuli thapsigargin and tunicamycin. Thus, activation of a "multidomain" proapoptotic member, BAX or BAK, appears to be an essential gateway to mitochondrial dysfunction required for cell death in response to diverse stimuli.	Univ Penn, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med,Dana Farber Canc Inst, Dept Pathol,Howard Huges Med Inst, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Dana Farber Canc Inst, Boston, MA 02115 USA; Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA; Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Washington University (WUSTL); Emory University; Washington University (WUSTL)	Thompson, CB (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA.			Roth, Kevin/0000-0002-0643-995X; Panoutsakopoulou, Vily/0000-0002-1569-1508	NCCIH NIH HHS [5T32AT09361] Funding Source: Medline; NCI NIH HHS [R37CA4802, R01CA50239] Funding Source: Medline; NICHD NIH HHS [R01 HD036437-04, R01 HD036437-02, R01 HD036437-05, R01 HD036437-03] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036437] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA050239] Funding Source: NIH RePORTER	NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; He HL, 1997, J CELL BIOL, V138, P1219, DOI 10.1083/jcb.138.6.1219; Hsu SY, 1997, P NATL ACAD SCI USA, V94, P12401, DOI 10.1073/pnas.94.23.12401; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; WEI M, UNPUB; Wei MC, 2000, GENE DEV, V14, P2060; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	33	3178	3295	4	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					727	730		10.1126/science.1059108	http://dx.doi.org/10.1126/science.1059108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326099	Green Accepted			2022-12-01	WOS:000168478300051
J	Puertollano, R; Aguilar, RC; Gorshkova, I; Crouch, RJ; Bonifacino, JS				Puertollano, R; Aguilar, RC; Gorshkova, I; Crouch, RJ; Bonifacino, JS			Sorting of mannose 6-phosphate receptors mediated by the GGAs	SCIENCE			English	Article							FACTOR-II RECEPTOR; CYTOPLASMIC DOMAIN; GAMMA-ADAPTIN; TRANS-GOLGI; SIGNALS; PROTEINS; BINDING; FAMILY; RECOGNITION; TRAFFICKING	The delivery of soluble hydrolases to lysosomes is mediated by the cation-independent and cation-dependent mannose 6-phosphate receptors. The cytosolic tails of both receptors contain acidic-cluster-dileucine signals that direct sorting from the trans-Golgi network to the endosomal-lysosomal system. We found that these signals bind to the VHS domain of the Golgi-localized, gamma -ear-containing, ARF-binding proteins (GGAs). The receptors and the GGAs left the trans-Golgi network on the same tubulo-vesicular carriers. A dominant-negative GGA mutant blocked exit of the receptors from the trans-Golgi, network. Thus, the GGAs appear to mediate sorting of the mannose 6-phosphate receptors at the trans-Golgi network.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NICHHD, Genet Mol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bonifacino, JS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.			Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000068, ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607, Z01HD000068] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; Heilker R, 1999, BIOESSAYS, V21, P558, DOI 10.1002/(SICI)1521-1878(199907)21:7<558::AID-BIES4>3.0.CO;2-R; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; HONING S, 1997, J BIOL CHEM, V272, P1984; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KOMFELD S, 1992, ANNU REV BIOCHEM, V61, P307; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Mauxion F, 1996, J BIOL CHEM, V271, P2171, DOI 10.1074/jbc.271.4.2171; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	17	316	329	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1712	1716		10.1126/science.1060750	http://dx.doi.org/10.1126/science.1060750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387475				2022-12-01	WOS:000169031800044
J	Chen, Y; Schier, AF				Chen, Y; Schier, AF			The zebrafish Nodal signal Squint functions as a morphogen	NATURE			English	Article							LONG-RANGE ACTION; ONE-EYED PINHEAD; TGF-BETA FAMILY; ACTIVIN; INDUCTION; MESODERM; GRADIENT; GASTRULATION; ORGANIZER; ENDODERM	Secreted morphogens induce distinct cellular responses in a concentration-dependent manner and act directly at a distance(1-7). The existence of morphogens during mesoderm induction and patterning in vertebrates has been highly controversial, and it remains unknown whether endogenous mesoderm inducers act directly as morphogens(8-10), function locally(9) or act through relay mechanisms(11-12). Here we test the morphogen properties of Cyclops and Squint-two Nodal-related transforming growth factor-beta signals required for mesoderm formation and patterning in zebrafish(13-16). Whereas different levels of both Squint and Cyclops can induce different downstream genes(14,17-19), we rnd that only Squint can function directly at a distance. These results indicate that Squint acts as a secreted morphogen that does not require a relay mechanism.	NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Schier, AF (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Dev Genet Program, New York, NY 10016 USA.			Schier, Alexander Franz/0000-0001-7645-5325				Agius E, 2000, DEVELOPMENT, V127, P1173; Erter CE, 1998, DEV BIOL, V204, P361, DOI 10.1006/dbio.1998.9097; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gritsman K, 2000, DEVELOPMENT, V127, P921; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; GURDON JB, 1994, NATURE, V371, P487, DOI 10.1038/371487a0; Jones CM, 1996, CURR BIOL, V6, P1468, DOI 10.1016/S0960-9822(96)00751-8; JONES CM, 1995, DEVELOPMENT, V121, P3651; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Reilly KM, 1996, CELL, V86, P743, DOI 10.1016/S0092-8674(00)80149-X; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Strahle U, 1997, Genes Funct, V1, P131; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vogel AM, 1999, MECH DEVELOP, V85, P133, DOI 10.1016/S0925-4773(99)00104-5; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	28	236	243	1	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					607	610		10.1038/35079121	http://dx.doi.org/10.1038/35079121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385578				2022-12-01	WOS:000168982500057
J	Ungless, MA; Whistler, JL; Malenka, RC; Bonci, A				Ungless, MA; Whistler, JL; Malenka, RC; Bonci, A			Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; EXCITATORY AMINO-ACIDS; BEHAVIORAL SENSITIZATION; AMPA RECEPTORS; SILENT SYNAPSES; GLUTAMATE; AMPHETAMINE; ADDICTION; LTP; RAT	How do drugs of abuse modify neural circuitry and thereby lead to addictive behaviour? As for many forms of experience-dependent plasticity, modifications in glutamatergic synaptic transmission have been suggested to be particularly important(1-4). Evidence of such changes in response to in vivo administration of drugs of abuse is lacking, however. Here we show that a single in vivo exposure to cocaine induces long-term potentiation of AMPA (alpha -amino-3-hydroxy-5-methyl-isoxazole propionic acid)-receptor-mediated currents at excitatory synapses onto dopamine cells in the ventral tegmental area. Potentiation is still observed 5 but not 10 days after cocaine exposure and is blocked when an NMDA (N-methyl-D-aspartate) receptor antagonist is administered with cocaine. Furthermore, long-term potentiation at these synapses is occluded and long-term depression is enhanced by in vivo cocaine exposure. These results show that a prominent form of synaptic plasticity can be elicited by a single in vivo exposure to cocaine and therefore may be involved in the early stages of the development of drug addiction.	Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94134 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Stanford University	Bonci, A (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA.		Jansen, Heiko T./A-5770-2008; Ungless, Mark/A-1985-2009	Jansen, Heiko T./0000-0003-0178-396X; Ungless, Mark/0000-0002-1730-3353				Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bonci A, 1999, J NEUROSCI, V19, P3723; Carlezon WA, 1997, SCIENCE, V277, P812, DOI 10.1126/science.277.5327.812; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Clark D, 1998, ADDICT BIOL, V3, P109, DOI 10.1080/13556219872191; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JACKSON HC, 1993, PHARMACOL BIOCHEM BE, V45, P733, DOI 10.1016/0091-3057(93)90533-Y; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; KALIVAS PW, 1995, J NEUROSCI, V15, P5379, DOI 10.1523/jneurosci.15-07-05379.1995; KALIVAS PW, 1995, DRUG ALCOHOL DEPEN, V37, P95, DOI 10.1016/0376-8716(94)01063-Q; KALIVAS PW, 1993, J PHARMACOL EXP THER, V267, P486; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; THOMAS MJ, 2000, SOC NEUR ABSTR; WHITE FJ, 1984, BRAIN RES, V309, P283; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Zhang XF, 1997, J PHARMACOL EXP THER, V281, P699	30	870	896	2	114	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					583	587		10.1038/35079077	http://dx.doi.org/10.1038/35079077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385572				2022-12-01	WOS:000168982500051
J	Batista, FD; Iber, D; Neuberger, MS				Batista, FD; Iber, D; Neuberger, MS			B cells acquire antigen from target cells after synapse formation	NATURE			English	Article							FOLLICULAR DENDRITIC CELLS; REACTIVE LYMPHOCYTES-B; PEPTIDE-MHC COMPLEXES; T-CELLS; SURFACE MOLECULES; PRESENTING CELLS; CLASS-II; RECEPTOR; AFFINITY; INTERNALIZATION	Soluble antigen binds to the B-cell antigen receptor and is internalized for subsequent processing and the presentation of antigen-derived peptides to T cells(1). Many antigens are not soluble, however, but are integral components of membrane; furthermore, soluble antigens will usually be encountered in vivo in a membrane-anchored form, tethered by Fc or complement receptors(2-4). Here we show that B-cell interaction with antigens that are immobilized on the surface of a target cell leads to the formation of a synapse and the acquisition, even, of membrane-integral antigens from the target. B-cell antigen receptor accumulates at the synapse, segregated from the CD45 co-receptor which is excluded from the synapse, and there is a corresponding polarization of cytoplasmic effectors in the B cell. B-cell antigen receptor mediates the gathering of antigen into the synapse and its subsequent acquisition, thereby potentiating antigen processing and presentation to T cells with high efficacy. Synapse formation and antigen acquisition will probably enhance the activation of B cells at low antigen concentration, allow context-dependent antigen recognition and enhance the linking of B- and T-cell epitopes.	Med Res Lab Mol Biol, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Batista, FD (corresponding author), Med Res Lab Mol Biol, Hills Rd, Cambridge CB2 2QH, England.		Iber, Dagmar/V-2846-2019	Iber, Dagmar/0000-0001-8051-1035				Aluvihare VR, 1997, EMBO J, V16, P3553, DOI 10.1093/emboj/16.12.3553; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; Batista FD, 1998, IMMUNITY, V8, P751, DOI 10.1016/S1074-7613(00)80580-4; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; CASTEN LA, 1985, P NATL ACAD SCI USA, V82, P5890, DOI 10.1073/pnas.82.17.5890; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Dustin ML, 1997, J BIOL CHEM, V272, P30889, DOI 10.1074/jbc.272.49.30889; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GREEN SM, 1989, ONCOGENE, V4, P737; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; KLAUS GGB, 1980, IMMUNOL REV, V53, P3, DOI 10.1111/j.1600-065X.1980.tb01038.x; KOSCOVILBOIS MH, 1993, J EXP MED, V178, P2055, DOI 10.1084/jem.178.6.2055; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Leupin O, 2000, CURR BIOL, V10, P277, DOI 10.1016/S0960-9822(00)00362-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; SCHREINER GF, 1977, J IMMUNOL, V119, P1549; Serre K, 1998, J IMMUNOL, V161, P6059; Siemasko K, 1998, J IMMUNOL, V160, P5203; TAYLOR RB, 1971, NATURE-NEW BIOL, V233, P225, DOI 10.1038/newbio233225a0; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Weintraub BC, 2000, J EXP MED, V191, P1443, DOI 10.1084/jem.191.8.1443; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	30	468	482	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					489	494		10.1038/35078099	http://dx.doi.org/10.1038/35078099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373683				2022-12-01	WOS:000168858700052
J	Milkereit, P; Gadal, O; Podtelejnikov, A; Trumtel, S; Gas, N; Petfalski, E; Tollervey, D; Mann, M; Hurt, E; Tschochner, H				Milkereit, P; Gadal, O; Podtelejnikov, A; Trumtel, S; Gas, N; Petfalski, E; Tollervey, D; Mann, M; Hurt, E; Tschochner, H			Maturation and intranuclear transport of pre-ribosomes requires Noc proteins	CELL			English	Article							MESSENGER-RNA EXPORT; NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION; BINDING PROTEIN; POLYMERASE I; MEX67P; NUCLEOPORINS; BIOGENESIS; NUCLEOLUS	How pre-ribosomes temporally and spatially mature during intranuclear biogenesis is not known. Here, we report three nucleolar proteins, Noc1p to Noc3p, that are required for ribosome maturation and transport. They can be isolated in two distinct complexes: Noc1p/Noc2p associates with 90S and 66S pre-ribosomes and is enriched in the nucleolus, and Noc2p/Noc3p associates with 66S pre-ribosomes and is mainly nucleoplasmic. Mutation of each Noc protein impairs intranuclear transport of 60S subunits at different stages and inhibits pre-rRNA processing. Overexpression of a conserved domain common to Noc1p and Noc3p is dominant-negative for cell growth, with a defect int nuclear 60S subunit transport, but no inhibition of pre-RNA processing. We propose that the dynamic interaction of Noc proteins is crucial for intranuclear movement of ribosomal precursor particles, and, thereby represent a prerequisite for proper maturation.	Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany; Odense Univ, Prot Interact Lab, DK-5230 Odense M, Denmark; Lab Biol Mol Eucaryote, F-32062 Toulouse, France; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland	Ruprecht Karls University Heidelberg; University of Southern Denmark; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Edinburgh	Tschochner, H (corresponding author), Biochem Zentrum Heidelberg, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz.uni-heidelberg.de; IM4@ix.urz.uni-heidelberg.de	Gadal, Olivier/A-4731-2008; Podtelejnikov, Alexandre/B-6120-2017; Ed Hurt, Dr./AAE-8874-2019; Mann, Matthias/A-3454-2013; Tollervey, David/AAR-6662-2020	Gadal, Olivier/0000-0001-9421-0831; Podtelejnikov, Alexandre/0000-0002-8124-6584; Ed Hurt, Dr./0000-0002-4535-8255; Mann, Matthias/0000-0003-1292-4799; Tollervey, David/0000-0003-2894-2772				AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; DOYE V, 1995, TRENDS GENET, V11, P235, DOI 10.1016/S0168-9525(00)89057-5; Edskes HK, 1998, J BIOL CHEM, V273, P28912, DOI 10.1074/jbc.273.44.28912; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; KADOWAKI T, 1992, P NATL ACAD SCI USA, V89, P2312, DOI 10.1073/pnas.89.6.2312; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Leger-Silvestre I, 1999, CHROMOSOMA, V108, P103, DOI 10.1007/s004120050357; LegerSilvestre I, 1997, EUR J CELL BIOL, V72, P13; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Maniatis T, 1982, MOL CLONING; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Moy TI, 1999, GENE DEV, V13, P2118, DOI 10.1101/gad.13.16.2118; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; Sarkar S, 1999, P NATL ACAD SCI USA, V96, P14366, DOI 10.1073/pnas.96.25.14366; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; TRAPMAN J, 1975, EXP CELL RES, V90, P95, DOI 10.1016/0014-4827(75)90361-4; Trumtel S, 2000, MOL BIOL CELL, V11, P2175, DOI 10.1091/mbc.11.6.2175; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Williams M., 1977, QUANTITATIVE METHODS; WOOLFORD JL, 1991, ADV GENET, V29, P63, DOI 10.1016/S0065-2660(08)60107-8	33	156	160	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					499	509		10.1016/S0092-8674(01)00358-0	http://dx.doi.org/10.1016/S0092-8674(01)00358-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371346	Bronze			2022-12-01	WOS:000168840700009
J	Hediger, ML; Overpeck, MD; Kuczmarski, RJ; Ruan, WJ				Hediger, ML; Overpeck, MD; Kuczmarski, RJ; Ruan, WJ			Association between infant breastfeeding and overweight in young children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GESTATIONAL-AGE; PRESCHOOL-CHILDREN; UNITED-STATES; BIRTH-WEIGHT; BORN SMALL; OBESITY; GROWTH; ADIPOSITY; PREVALENCE; CHILDHOOD	Context it has been suggested that breastfeeding is protective against children becoming overweight, and that there is a dose-dependent effect of its duration. Objective To determine whether breastfeeding and its duration are associated with a reduced risk of being overweight among young children in the United States. Design and Setting Data on infant feeding and child overweight status were taken from the third National Health and Nutrition Examination Survey (NHANES iii), a cross-sectional health examination survey conducted from 1988-1994. Subjects Sample of 2685 US-born children between the ages of 3 and 5 years, with birth certificates, height and weight measures, and information on infant feeding. Main Outcome Measures A body mass index (BMI) between the 85th and 94th percentile was considered at risk of overweight and a BMI in the 95th percentile or higher was considered being overweight. Results After adjusting for potential confounders, there was a reduced risk of being at risk of overweight for ever breastfed children (adjusted odds ratio [AOR], 0.63; 95% confidence interval [CI], 0.41-0.96) compared with those never breastfed. There was no reduced risk of being overweight (AOR, 0.84; 95% CI, 0.62-1.13), There was no clear dose-dependent effect of the duration of full breastfeeding on being at risk of overweight or overweight and no threshold effect. The strongest predictor of child overweight status was the mother's concurrent weight. The rate of children being overweight nearly tripled with maternal overweight status (BMI, 25.0-29.9 kg/m(2); AOR, 2.95; 95% CI, 1.35-6.42) and more than quadrupled with maternal obesity status (BMI greater than or equal to 30.0 kg/m(2); AOR, 4.34; 95% CI, 2.50-7.54). Conclusions There are inconsistent associations among breastfeeding, its duration, and the risk of being overweight in young children, Breastfeeding continues to be strongly recommended, but may not be as effective as moderating familial factors, such as dietary habits and physical activity, in preventing children from becoming overweight.	NICHD, Div Epidemiol Stat & Prevent Res, NIH, Bethesda, MD 20892 USA; US Hlth Resources & Serv Adm, Maternal & Child Hlth Bur, Rockville, MD 20857 USA; Ctr Dis Control & Prevent, Div Hlth Examinat Stat, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); United States Health Resources & Service Administration (HRSA); Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Hediger, ML (corresponding author), NICHD, Div Epidemiol Stat & Prevent Res, NIH, Bldg 6100,Room 7B03,9000 Rockville Pike, Bethesda, MD 20892 USA.	hedigerm@exchange.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002512] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anderson JW, 1999, AM J CLIN NUTR, V70, P525; [Anonymous], 2000, ADV DATA VITAL HLTH; BARANOWSKI T, 1990, J DEV BEHAV PEDIATR, V11, P234; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Butte NF, 2000, PEDIATRICS, V106, P1355, DOI 10.1542/peds.106.6.1355; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Hediger ML, 1998, ARCH PEDIAT ADOL MED, V152, P1225; Hediger ML, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.3.e33; Hediger ML, 2000, AM J CLIN NUTR, V72, P159; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; HUTTLY SRA, 1990, AM J EPIDEMIOL, V132, P572, DOI 10.1093/oxfordjournals.aje.a115693; Lohman TG, 1988, ANTROPOMETRIC STANDA; Mehta KC, 1998, PEDIATRICS, V102, P569, DOI 10.1542/peds.102.3.569; Mei ZG, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e12; *NAT CTR HLTH STAT, 1997, 1994 NAT DAT SET 21, V4; National Center for Health Statistics, 1996, NHANES 3 REF MAN REP; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; OCallaghan MJ, 1997, J PAEDIATR CHILD H, V33, P311, DOI 10.1111/j.1440-1754.1997.tb01607.x; Oddy WH, 1999, BMJ-BRIT MED J, V319, P815, DOI 10.1136/bmj.319.7213.815; Ogden CL, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e1; Overpeck MD, 2000, J PEDIATR-US, V137, P205, DOI 10.1067/mpd.2000.107163; Overpeck MD, 1999, OBSTET GYNECOL, V93, P943, DOI 10.1016/S0029-7844(98)00553-5; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Raisler J, 1999, AM J PUBLIC HEALTH, V89, P25, DOI 10.2105/AJPH.89.1.25; ROLLANDCACHERA MF, 1987, ANN HUM BIOL, V14, P219, DOI 10.1080/03014468700008991; Ryan AS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.4.e12; RYAN AS, 1991, PEDIATRICS, V88, P719; RYAN AS, 1991, AM J PUBLIC HEALTH, V81, P1049, DOI 10.2105/AJPH.81.8.1049; SHAH BV, 1997, SUDAAN USERS MANUAL; Tulldahl J, 1999, OBES RES, V7, P431, DOI 10.1002/j.1550-8528.1999.tb00430.x; *US DEPT HHS, 1996, NHANES 3 ANTHR PROC; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Wadsworth M, 1999, BRIT MED J, V319, P1576, DOI 10.1136/bmj.319.7224.1576; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; ZHANG J, 1995, OBSTET GYNECOL, V86, P200, DOI 10.1016/0029-7844(95)00142-E; ZIVE MM, 1992, AM J CLIN NUTR, V55, P1104, DOI 10.1093/ajcn/55.6.1104	38	262	277	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2453	2460		10.1001/jama.285.19.2453	http://dx.doi.org/10.1001/jama.285.19.2453			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429ZC	11368697	Bronze			2022-12-01	WOS:000168547600026
J	Fearon, P; Hotopf, M				Fearon, P; Hotopf, M			Relation between headache in childhood and physical and psychiatric symptoms in adulthood: national birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							ABDOMINAL-PAIN; CHILDREN; SCHOOLCHILDREN; PREVALENCE; ADOLESCENTS; MIGRAINE; AGE; POPULATION; COMMUNITY; PARENTS	Objective To elucidate the associations between frequent headache and psychosocial factors in childhood and to determine whether such children are at an increased risk of headache, multiple physical symptoms, and psychiatric symptoms in adulthood. Design Population based birth cohort study. Setting General population. Participants People participating in the national child development study, a population based birth cohort study established in 1958. Main outcome measures Headache, multiple physical symptoms, and psychiatric morbidity at age 33. Results Headache in childhood was associated with several psychosocial factors. Prospectively, children with frequent headache had an increased risk in adulthood of headache (odds ratio 2.22, 95% confidence interval 1.62 to 3.06), multiple physical symptoms (1.75, 1.46 to 2.10), and psychiatric morbidity (1.41, 1.20 to 1.66). The outcomes of headache and multiple physical symptoms were not accounted for by psychiatric morbidity. Conclusion Children with headache are at an increased risk of recurring headache in adulthood and may complain of other physical and psychiatric symptoms. Strategies for coping with psychosocial adversity in childhood may improve the prognosis in adulthood.	Inst Psychiat, London SE5 8AF, England; Guys Kings & St Thomass Sch Med, London SE5 8AF, England	University of London; King's College London; University of London; King's College London	Fearon, P (corresponding author), Inst Psychiat, London SE5 8AF, England.		Hotopf, Matthew/E-4971-2010	Hotopf, Matthew/0000-0002-3980-4466				ANDRASIK F, 1988, PAIN, V34, P43, DOI 10.1016/0304-3959(88)90180-7; BILLE B, 1981, CEPHALALGIA, V1, P71, DOI 10.1111/j.1468-2982.1981.tb00012.x; BORGE AIH, 1994, ACTA PAEDIATR, V83, P433, DOI 10.1111/j.1651-2227.1994.tb18137.x; Carlsson J, 1996, ACTA PAEDIATR, V85, P692, DOI 10.1111/j.1651-2227.1996.tb14128.x; CUNNINGHAM SJ, 1987, HEADACHE, V27, P16, DOI 10.1111/j.1526-4610.1987.hed2701016.x; ECOB R, 1993, SOC SCI MED, V36, P1017, DOI 10.1016/0277-9536(93)90119-O; EGERMARKERIKSSON I, 1982, ACTA PAEDIATR SCAND, V71, P135, DOI 10.1111/j.1651-2227.1982.tb09384.x; Egger HL, 1998, J AM ACAD CHILD PSY, V37, P951, DOI 10.1097/00004583-199809000-00015; ESCOBAR JI, 1987, AM J PUBLIC HEALTH, V77, P837, DOI 10.2105/AJPH.77.7.837; Hotopf M, 1998, BRIT MED J, V316, P1196, DOI 10.1136/bmj.316.7139.1196; KROENKE K, 1989, AM J MED, V86, P262, DOI 10.1016/0002-9343(89)90293-3; LARSSON BS, 1991, J CHILD PSYCHOL PSYC, V32, P821, DOI 10.1111/j.1469-7610.1991.tb01905.x; OSTER J, 1972, PEDIATRICS, V50, P429; PASSCHIER J, 1985, CEPHALALGIA, V5, P167, DOI 10.1046/j.1468-2982.1985.0503167.x; POWER C, 1991, HLTH CLASS EARLY YEA; Rutter Michael, 1970, ED HLTH BEHAV; Scott SC, 1997, J CLIN EPIDEMIOL, V50, P45, DOI 10.1016/S0895-4356(96)00312-5; Sillanpaa M, 1996, HEADACHE, V36, P466, DOI 10.1046/j.1526-4610.1996.3608466.x; SILLANPAA M, 1991, CEPHALALGIA, V11, P239, DOI 10.1046/j.1468-2982.1991.1105239.x; Stott D. H., 1969, SOCIAL ADJUSTMENT CH; Sweeting H, 1998, ARCH DIS CHILD, V78, P427, DOI 10.1136/adc.78.5.427; WATERS W E, 1970, Headache, V9, P178, DOI 10.1111/j.1526-4610.1970.hed0904178.x; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; ZUCKERMAN B, 1987, PEDIATRICS, V79, P677	24	167	170	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2001	322	7295					1145	1148A		10.1136/bmj.322.7295.1145	http://dx.doi.org/10.1136/bmj.322.7295.1145			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	433HH	11348907	Green Published, Bronze, Green Submitted			2022-12-01	WOS:000168748900013
J	Guss, KA; Nelson, CE; Hudson, A; Kraus, ME; Carroll, SB				Guss, KA; Nelson, CE; Hudson, A; Kraus, ME; Carroll, SB			Control of a genetic regulatory network by a selector gene	SCIENCE			English	Article							LONG-RANGE ACTION; DORSAL-VENTRAL BOUNDARY; SPLIT COMPLEX GENES; WING FORMATION; SYNERGISTIC ACTIVATION; DROSOPHILA; EXPRESSION; NOTCH; DPP; TRANSCRIPTION	The formation of many complex structures is controlled by a special class of transcription factors encoded by selector genes. it is shown that SCALLOPED, the DNA binding component of the selector protein complex for the Drosophila wing field, binds to and directly regulates the cis-regulatory elements of many individual target genes within the genetic regulatory network controlling wing development. Furthermore, combinations of binding sites for SCALLOPED and transcriptional effecters of signaling pathways are necessary and sufficient to specify wing-specific responses to different signaling pathways. The obligate integration of selector and signaling protein inputs on cis-regulatory DNA may be a general mechanism by which selector proteins control extensive genetic regulatory networks during development.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	sbcarrol@facstaff.wisc.edu						BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Certel K, 2000, DEVELOPMENT, V127, P3173; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; deCelis JF, 1996, DEVELOPMENT, V122, P359; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; Gilbert SF, 1996, DEV BIOL, V173, P357, DOI 10.1006/dbio.1996.0032; Goodman RH, 2000, GENE DEV, V14, P1553; Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402; Halder G, 1998, GENE DEV, V12, P3900, DOI 10.1101/gad.12.24.3900; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; Hudson JB, 1998, DEVELOPMENT, V125, P1407; JACK J, 1991, DEVELOPMENT, V113, P735; Jacquemin P, 1997, TRENDS CARDIOVAS MED, V7, P192, DOI 10.1016/S1050-1738(97)00052-2; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Kuhnlein RP, 1997, MECH DEVELOP, V66, P107, DOI 10.1016/S0925-4773(97)00103-2; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Liu XF, 2000, DEV BIOL, V228, P287, DOI 10.1006/dbio.2000.9939; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Nellesen DT, 1999, DEV BIOL, V213, P33, DOI 10.1006/dbio.1999.9324; NELSON CE, UNPUB; NELSON HB, 1993, ROUX ARCH DEV BIOL, V202, P341, DOI 10.1007/BF00188733; Neumann CJ, 1996, DEVELOPMENT, V122, P3477; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815; Vaudin P, 1999, DEVELOPMENT, V126, P4807; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	35	101	103	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1164	1167		10.1126/science.1058312	http://dx.doi.org/10.1126/science.1058312			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11303087				2022-12-01	WOS:000168609200060
J	Go, AS; Hylek, EM; Phillips, KA; Chang, YC; Henault, LE; Selby, JV; Singer, DE				Go, AS; Hylek, EM; Phillips, KA; Chang, YC; Henault, LE; Selby, JV; Singer, DE			Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described. Objective To estimate prevalence of atrial fibrillation and US national projections of the numbers of persons with atrial fibrillation through the year 2050, Design, Setting, and Patients Cross-sectional study of adults aged 20 years or older who were enrolled in a large health maintenance organization in California and who had atrial fibrillation diagnosed between July 1, 1996, and December 31, 1997, Main Outcome Measures Prevalence of atrial fibrillation in the study population of 1.89 million; projected number of persons in the United States with atrial fibrillation between 1995-2050. Results A total of 17974 adults with diagnosed atrial fibrillation were identified during the study period; 45% were aged 75 years or older. The prevalence of atrial fibrillation was 0.95% (95% confidence interval, 0.94%-0.96%). Atrial fibrillation was more common in men than in women (1.1% vs 0.8%; P<.001). Prevalence increased from 0.1% among adults younger than 55 years to 9.0% in persons aged 80 years or older. Among persons aged 50 years or older, prevalence of atrial fibrillation was higher in whites than in blacks (2.2% vs 1.5%; P<.001). We estimate approximately 2.3 million US adults currently have atrial fibrillation. We project that this will increase to more than 5.6 million (lower bound, 5.0; upper bound, 6.3) by the year 2050, with more than 50% of affected individuals aged 80 years or older. Conclusions Our study confirms that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Coordinated efforts are needed to face the increasing challenge of optimal stroke prevention and rhythm management in patients with atrial fibrillation.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94611 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Massachusetts Gen Hosp, Dept Med, Div Gen Med, Clin Epidemiol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 3505 Boradway,12th Floor, Oakland, CA 94611 USA.	axg@dor.kaiser.org	Go, Alan S./AAE-7745-2019	Hylek, Elaine/0000-0001-8263-8304	NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER; NIA NIH HHS [AG15478] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Fleiss J.L., 1981, STAT METHODS RATES P; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; HOLLMAN FW, 2000, 38 US CENS BUR DEP C; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; Langenberg M, 1996, BRIT MED J, V313, P1534, DOI 10.1136/bmj.313.7071.1534; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; LIP GYH, 1994, BRIT HEART J, V71, P92; PAGE RL, 1994, CIRCULATION, V89, P224, DOI 10.1161/01.CIR.89.1.224; PHILLIPS SJ, 1990, MAYO CLIN PROC, V65, P344, DOI 10.1016/S0025-6196(12)62535-X; Psaty BM, 1997, CIRCULATION, V96, P2455; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; *US CENS BUR, 2000, PROJ TOT RES POP 5 Y; *US CENS BUR, 1999, RES POP EST US AG SE; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wolk R, 1996, INT J CARDIOL, V54, P207, DOI 10.1016/0167-5273(96)02631-9	17	4553	4806	3	179	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2370	2375		10.1001/jama.285.18.2370	http://dx.doi.org/10.1001/jama.285.18.2370			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NB	11343485	Bronze			2022-12-01	WOS:000168411200029
J	Ramtoola, S; Home, P; Damry, H; Husnoo, A; Ah-Kion, S				Ramtoola, S; Home, P; Damry, H; Husnoo, A; Ah-Kion, S			Gestational impaired glucose tolerance does not increase perinatal mortality in a developing country: cohort study	BRITISH MEDICAL JOURNAL			English	Article									Univ Newcastle Upon Tyne, Human Diabet & Metab Res Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Dr AG Jeetoo Hosp, Port Louis, Mauritius	Newcastle University - UK	Ramtoola, S (corresponding author), Dr AG Jeetoo Hosp, Port Louis, Mauritius.							Alberti KG, 1999, DEFINITION DIAGNOS 1; Deerochanawong C, 1996, DIABETOLOGIA, V39, P1070; *INT DIAB I AUSTR, 1993, MAUR NONC DIS INT PR; ROBERTS RN, 1993, DIABETIC MED, V10, P438, DOI 10.1111/j.1464-5491.1993.tb00095.x; *WHO STUD GROUP, 1985, WHO TECHN REP SER, V727	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2001	322	7293					1025	1026		10.1136/bmj.322.7293.1025	http://dx.doi.org/10.1136/bmj.322.7293.1025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325766	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000168478700020
J	de Vegt, F; Dekker, JM; Jager, A; Hienkens, E; Kostense, PJ; Stehouwer, CDA; Nijpels, G; Bouter, LM; Heine, RJ				de Vegt, F; Dekker, JM; Jager, A; Hienkens, E; Kostense, PJ; Stehouwer, CDA; Nijpels, G; Bouter, LM; Heine, RJ			Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAUCASIAN POPULATION; NATURAL-HISTORY; HIGH-RISK; TOLERANCE; NIDDM; PROGRESSION; CONVERSION; MELLITUS; HYPERGLYCEMIA; DETERMINANTS	Context Persons with impaired glucose tolerance (IGT) are known to have an elevated risk of developing diabetes mellitus. Less is known about diabetes risk among persons with impaired fasting glucose (IFG) or with normal glucose levels. Objective To determine the incidence of diabetes in relation to baseline fasting and postload glucose levels and other risk factors. Design, Setting, and Participants Population-based cohort study conducted from October 1989 to February 1992 among 1342 nondiabetic white residents of Hoorn, the Netherlands, aged 50 to 75 years at baseline, in whom fasting plasma glucose (FPG) levels and glucose levels 2 hours after a 75-g oral glucose tolerance test were measured at baseline and at follow-up in 1996-1998. Main outcome Measures Cumulative incidence of diabetes, defined according to the diagnostic criteria of the World Health Organization (WHO-1985 and WHO-1999) and the American Diabetes Association (ADA-1997), during a mean follow-up of 6.4 years, compared among participants with IFG, IGT, and normal glucose levels at baseline. Results The cumulative incidence of diabetes was 6.1%, 8.3%, and 9.9% according to the WHO-1985, ADA, and WHO-1999 criteria, respectively. The cumulative incidence of diabetes (WHO-1999 criteria) for participants with both IFG and IGT was 64.5% compared with 4.5% for those with normal glucose levels at baseline. The odds ratios for diabetes (WHO-1999 criteria), adjusted for age, sex, and follow-up duration, were 10.0 (95% confidence interval [CI], 6.1-16.5), 10.9 (95% CI, 6.0-19.9), and 39.5 (95% CI, 17.0-92.1), respectively, for those having isolated IFG, isolated IGT, and both IFG and IGT. In addition to FPG and 2-hour postload glucose levels (P<.001 for both), the waist-hip ratio also was an important risk factor for developing diabetes (P=.002). Conclusion In this study, the cumulative incidence of diabetes was strongly related to both IFG and IGT at baseline and, in particular, to the combined presence of IFG and IGT.	Free Univ Amsterdam, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; Free Univ Amsterdam, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands; Free Univ Amsterdam, Univ Hosp, Dept Internal Med, Amsterdam, Netherlands; Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen	Dekker, JM (corresponding author), Free Univ Amsterdam, Inst Res Extramural Med, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.		de Vegt, F./L-4704-2015; jager, agnes/V-6381-2017; Stehouwer, Coen/AAB-3435-2021	de Vegt, F./0000-0001-8728-3397; jager, agnes/0000-0002-7713-1450; Bouter, Lex/0000-0002-2659-5482				Alberti KGMM, 1996, DIABETIC MED, V13, P927, DOI 10.1002/(SICI)1096-9136(199611)13:11<927::AID-DIA279>3.0.CO;2-E; Chou PS, 1998, DIABETES CARE, V21, P1183, DOI 10.2337/diacare.21.7.1183; de Vegt F, 2000, DIABETES CARE, V23, P40, DOI 10.2337/diacare.23.1.40; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; Dinneen SF, 1998, DIABETES CARE, V21, P1408, DOI 10.2337/diacare.21.9.1408; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; FESKENS EJM, 1991, J CLIN EPIDEMIOL, V44, P947, DOI 10.1016/0895-4356(91)90058-H; Gavin JR, 1997, DIABETES CARE, V20, P1183; Haffner SM, 1997, DIABETOLOGIA, V40, P62, DOI 10.1007/s001250050643; Harrison A, 1996, FAM PRACT, V13, P59, DOI 10.1093/fampra/13.1.59; Hosmer DW, 2000, APPL LOGISTIC REGRES, V2nd; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; MARSHALL JA, 1994, DIABETES CARE, V17, P50, DOI 10.2337/diacare.17.1.50; Mooy JM, 1996, DIABETOLOGIA, V39, P298, DOI 10.1007/BF00418345; MOOY JM, 1995, DIABETES CARE, V18, P1270, DOI 10.2337/diacare.18.9.1270; MOTALA AA, 1993, DIABETES, V42, P556, DOI 10.2337/diabetes.42.4.556; Nijpels G, 1996, DIABETOLOGIA, V39, P113; Nijpels G, 1998, EUR J CLIN INVEST, V28, P8; NORUSIS MJ, 1990, SPSS WINDOWS; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; Sinclair AJ, 1997, DIABETIC MED, V14, P639, DOI 10.1002/(SICI)1096-9136(199708)14:8<639::AID-DIA433>3.0.CO;2-C; Vaccaro O, 1999, DIABETES CARE, V22, P1490, DOI 10.2337/diacare.22.9.1490; Warram JH, 1996, DIABETIC MED, V13, pS40; *WHO, 1985, WHO TECHNICAL REPORT, V727; *WHO, 1999, PUBL WHO NCD NCS	29	431	442	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2001	285	16					2109	2113		10.1001/jama.285.16.2109	http://dx.doi.org/10.1001/jama.285.16.2109			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	422QW	11311100	Bronze, Green Published			2022-12-01	WOS:000168131600031
J	Dismukes, GC				Dismukes, GC			Photosynthesis - Splitting water	SCIENCE			English	Editorial Material							PHOTOSYSTEM-II; EARLY EVOLUTION; OXIDATION; ORIGIN		Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University	Dismukes, GC (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.		Dismukes, Gerard C/I-4905-2012	Dismukes, Gerard C/0000-0003-0155-0541				Ananyev GM, 2001, BBA-BIOENERGETICS, V1503, P52, DOI 10.1016/S0005-2728(00)00215-2; BABCOCK GT, 1996, OXYGENIC PHOTOSYNTHE, P213; Blankenship RE, 1998, TRENDS BIOCHEM SCI, V23, P94, DOI 10.1016/S0968-0004(98)01186-4; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; Des Marais DJ, 2000, SCIENCE, V289, P1703; Diner BA, 1998, BIOCHEMISTRY-US, V37, P17931, DOI 10.1021/bi981894r; Dismukes GC, 2001, P NATL ACAD SCI USA, V98, P2170, DOI 10.1073/pnas.061514798; DISMUKES GC, 1988, CHEM SCRIPTA, V28A, P99; Dole F, 1997, J AM CHEM SOC, V119, P11540, DOI 10.1021/ja9717727; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; Limburg J, 2001, J AM CHEM SOC, V123, P423, DOI 10.1021/ja001090a; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Rhee KH, 1998, NATURE, V396, P283, DOI 10.1038/24421; Ruettinger W, 2000, J AM CHEM SOC, V122, P10353, DOI 10.1021/ja0005587; RUETTINGER W, 1997, CHEM REV, V97, P1; Rutherford A. W., 1996, P143; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Westphal KL, 2000, CURR OPIN PLANT BIOL, V3, P236, DOI 10.1016/S1369-5266(00)80071-0; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Yagi M, 2001, CHEM REV, V101, P21, DOI 10.1021/cr980108l; YAGI M, UNPUB; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	22	28	29	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					447	448		10.1126/science.1060222	http://dx.doi.org/10.1126/science.1060222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11330297				2022-12-01	WOS:000168187300028
J	Jha, P; Nagelkerke, NJD; Ngugi, EN; Rao, JVRP; Willbond, B; Moses, S; Plummer, FA				Jha, P; Nagelkerke, NJD; Ngugi, EN; Rao, JVRP; Willbond, B; Moses, S; Plummer, FA			Public health - Reducing HIV transmission in developing countries	SCIENCE			English	Editorial Material							SEXUALLY-TRANSMITTED DISEASES; COST-EFFECTIVENESS; CONDOM PROMOTION; INFECTION; TANZANIA; AFRICA; TRIAL; PREVENTION; IMPACT		Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3E 0W3, Canada; Univ Manitoba, Dept Med, Winnipeg, MB R3E 0W3, Canada; WHO, Econ Advisory Serv, CH-1211 Geneva, Switzerland; Univ Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; Natl Inst Publ Hlth & Environm, Amsterdam, Netherlands; Univ Nairobi, Dept Community Hlth, Nairobi, Kenya; Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; Hlth Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; World Health Organization; Erasmus University Rotterdam; Netherlands National Institute for Public Health & the Environment; University of Nairobi; Health Canada	Plummer, FA (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0W3, Canada.							Gilson L, 1997, LANCET, V350, P1805, DOI 10.1016/S0140-6736(97)08222-6; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Investing in Health Research and Development, 1996, REP AD HOC COMM HLTH; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; MACHEKANO R, 1998, 5 C RETR OPP INF CHI; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; MOSES S, 1991, AIDS, V5, P407, DOI 10.1097/00002030-199104000-00008; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Tarantola D, 2000, B WORLD HEALTH ORGAN, V78, P236; World Bank, 1999, INT ACT HIV AIDS AFR; *WORLD BANK, 1998, CONFR AIDS PUBL PRIO	15	56	57	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					224	225		10.1126/science.1058187	http://dx.doi.org/10.1126/science.1058187			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305312				2022-12-01	WOS:000168074000026
J	Oram, RJ; Daum, RS; Seal, JB; Lauderdale, DS				Oram, RJ; Daum, RS; Seal, JB; Lauderdale, DS			Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNIZATION; PEDIATRICIANS; VACCINATION; PREVENTION; INFANTS	Context In July 1999, due to concerns about thimerosal content, the American Academy of Pediatrics (AAP) and the Public Health Service (PHS) recommended suspending hepatitis B virus (HBV) Vaccination at birth except for mothers who had positive or unknown hepatitis B surface antigen (HBsAg) status. In September 1999, the Centers for : Disease Control and Prevention recommended that hospitals resume HBV vaccination at birth with a new thimerosal-free vaccine. Whether the 2 changes in recommendations within 3 months led to less-than-optimal compliance in hospital nurseries is unknown. Objective To determine hospital HBV vaccination policy before the recommendation for delay of HBV Vaccination and 1 year later, Design, Setting, and Participants Survey of aff 46 hospitals with obstetric services and neonatal nurseries in Cook County. Illinois. Main Outcome Measures Hepatitis B virus immunization practices before July 1999 and in August 2000; hospital factors associated with routine HBV immunization and compliance with AAP and PHS recommendations. Results Before July 1999, 74% of surveyed hospital nurseries offered HBV vaccine to all neonates; only 39% did so in August 2000. Being located in the Chicago city-limits (88 % vs 57%, P = .02) and having an academic affiliation (93% vs 66%; P = .05) were positively associated with routine neonatal immunization before July 1999. Both academic affiliation and city location were associated with routine immunization in August: 2000 (71% vs 25% [P = .003] and 60% vs 14% [P = .002], respectively) and with:compliance with recommendations for suspension (57% vs 25% [P = .03] and 56% vs 10% [P = .001]). Conclusions We documented a 35% decrease in hospital nurseries that routinely offered HBV immunization 1 year after the AAP and PHS recommendations were made. Special efforts may be required to make at-birth administration of HBV vaccination universal.	Univ Chicago, Pediat Immunizat Program, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Oram, RJ (corresponding author), Univ Chicago, Pediat Immunizat Program, 5841 S Maryland Ave,MC 6054, Chicago, IL 60637 USA.	roram@peds.bsd.uchicago.edu						Abramson JS, 1999, PEDIATRICS, V104, P570, DOI 10.1542/peds.104.3.570; *AM AC PED, 1999, PEDC AAP MEMB A 0715; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; BALL LK, IN PRESS PEDIATRICS; BEASLEY RP, 1983, LANCET, V2, P1099; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P94; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P563; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P996; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P780; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P651; *CHIC DEP PUBL HLT, 1999, THIM FREE HEP B VACC; *COOK COUNT DEP PU, 1999, COMM BIRTH HOSP SUB; *COTH MEMB CRIT, 2000, COUNC TEACH HOSP HLT; FREED GL, 1993, PEDIATRICS, V91, P699; Freed GL, 1998, ARCH PEDIAT ADOL MED, V152, P285; FREED GL, 1993, J FAM PRACTICE, V36, P153; FREED GL, 1994, PEDIATRICS, V93, P747; HALL CB, 1993, PEDIATRICS, V91, P841; HALL CB, 1992, PEDIATRICS, V89, P795; *HEALTHC INF INC, 2000, AM HOSP ASS GUID HLT; *HLTH CAR FIN ADM, 2000, PROSP PAYM SYST PPS; HURIE MB, 1995, PEDIATRICS, V96, P875; *IL DEP UBL HLTH, 2000, ILL PROJ LOC ASS NEE; Lauderdale DS, 1999, JAMA-J AM MED ASSOC, V282, P1725, DOI 10.1001/jama.282.18.1725; PICKERING LK, 2000, AAP NEWS, V16, P1; SEAL JB, IN PRESS PEDIATRICS; Takayama JI, 1999, PREV MED, V28, P160, DOI 10.1006/pmed.1998.0390; WATSON B, 1999, UNPUB NAT VACC ADV C; XU ZY, 1985, PEDIATRICS, V76, P713; Yusuf HR, 2000, JAMA-J AM MED ASSOC, V284, P978, DOI 10.1001/jama.284.8.978	30	25	25	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1874	1879		10.1001/jama.285.14.1874	http://dx.doi.org/10.1001/jama.285.14.1874			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308401	Bronze			2022-12-01	WOS:000167876700028
J	Paassilta, P; Lohiniva, J; Goring, HHH; Perala, M; Raina, SS; Karppinen, J; Hakala, M; Palm, T; Kroger, H; Kaitila, I; Vanharanta, H; Ott, J; Ala-Kokko, L				Paassilta, P; Lohiniva, J; Goring, HHH; Perala, M; Raina, SS; Karppinen, J; Hakala, M; Palm, T; Kroger, H; Kaitila, I; Vanharanta, H; Ott, J; Ala-Kokko, L			Identification of a novel common genetic risk factor for lumbar disk disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; IX COLLAGEN; FAMILIAL PREDISPOSITION; MUTATIONS; DEGENERATION; COL9A2; CARTILAGE; ALLELE; CHAIN; SPINE	Context Lumbar disk disease (LDD) is one of the most common musculoskeletal diseases, with a prevalence of about 5%, A tryptophan (Trp) allele (Trp2) was recently discovered in the COL9A2 gene that is associated with dominantly inherited LDD but is only present in about 4% of Finnish patients with LDD. Objective To determine if other collagen IX gene sequence variations play a role in the pathogenesis of LDD. Design and Setting Case-control study conducted from February 1997 to May 1998 at university hospitals in Finland. Participants A total of 171 individuals with LDD (evaluated clinically and by magnetic resonance imaging or computed tomography) and 321 controls without LDD (186 healthy individuals, 83 patients with primary osteoarthritis, 31 with rheumatoid arthritis, and 21 with chondrodysplasias). Main Outcome Measures Frequencies of sequence variations covering the entire coding sequences and exon boundaries of the collagen IX genes, COL9A1, COL9A2, and COL9A3, which code for the alpha1, alpha2, and alpha3 chains of the protein, detected by conformation-sensitive gel electrophoresis and confirmed by sequencing, compared between individuals with and without LDD, Results Mutation analysis of all 3 collagen IX genes resulted in identification of an Arg103 --> Trp (arginine --> tryptophan) substitution in the alpha3 chain (Trp3 allele). The frequency of the Trp3 allele was 12.2% in LDD cases, excluding 7 individuals who were carriers of the previously identified Gln326 --> Trp (glutamine --> tryptophan) substitution in the a2 chain (Trp2 allele), and was 4.7% among controls. The difference in the frequency was statistically significant (P = .000013). Presence of at least 1 Trp3 allele increases risk of LDD about 3-fold. Conclusion This study led to the identification of a novel common genetic risk factor for LDD, confirming that genetic risk factors likely play a significant role in LDD.	Univ Oulu, Dept Med Biochem, SF-90220 Oulu, Finland; Univ Oulu, Bioctr, Collagen Res Unit, SF-90220 Oulu, Finland; Univ Oulu, Dept Phys Med & Rehabil, SF-90220 Oulu, Finland; Univ Oulu, Dept Internal Med, SF-90220 Oulu, Finland; Columbia Univ, Dept Genet & Dev, New York, NY USA; Univ Kuopio, Dept Surg, SF-70210 Kuopio, Finland; Univ Helsinki Hosp, Dept Clin Genet, Helsinki, Finland; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Med Coll Penn & Hahnemann Univ, Ctr Gene Therapy, Philadelphia, PA USA	University of Oulu; University of Oulu; University of Oulu; University of Oulu; Columbia University; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital; Rockefeller University; Drexel University	Paassilta, P (corresponding author), Univ Oulu, Dept Med Biochem, Aapistie 7, SF-90220 Oulu, Finland.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045982] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00008] Funding Source: Medline; NIAMS NIH HHS [AR45982] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Battie MC, 1995, SPINE, V20, P2601, DOI 10.1097/00007632-199512150-00001; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; BREWTON RG, 1994, EXTRACELLULAR MATRIX, P129; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; CHERKIN DC, 1994, SPINE, V19, P1201, DOI 10.1097/00007632-199405310-00001; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DERBY R, 1992, SPINE, V17, pS176, DOI 10.1097/00007632-199206001-00020; Fairbank J C, 1980, Physiotherapy, V66, P271; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Frymoyer J W, 1992, Instr Course Lect, V41, P217; Frymoyer John W., 1996, P8; Guillausseau PJ, 1997, DIABETES METAB, V23, P14; HANKE M, 1994, BIOTECHNIQUES, V17, P858; HELIOVAARA M, 1989, ANN MED, V21, P254, DOI 10.3109/07853898909149202; HELIOVAARA M, 1987, J EPIDEMIOL COMMUN H, V41, P251, DOI 10.1136/jech.41.3.251; Holden P, 1999, AM J HUM GENET, V65, P31, DOI 10.1086/302440; HUNT SM, 1981, SOC SCI MED-MED SOC, V15, P221, DOI 10.1016/0271-7123(81)90005-5; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; KARPPINEN J, IN PRESS SPINE; KEEGAN JJ, 1948, ANAT REC, V102, P409, DOI 10.1002/ar.1091020403; Kimura T, 1996, INT ORTHOP, V20, P177, DOI 10.1007/s002640050058; KORKKO J, 1993, AM J HUM GENET, V53, P55; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; MATSUI H, 1992, SPINE, V17, P1323, DOI 10.1097/00007632-199211000-00011; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; NAKATA K, 1993, P NATL ACAD SCI USA, V90, P2870, DOI 10.1073/pnas.90.7.2870; Nelson C L, 1972, Clin Orthop Relat Res, V88, P142, DOI 10.1097/00003086-197210000-00025; Paassilta P, 1999, AM J HUM GENET, V64, P1036, DOI 10.1086/302328; Paassilta P, 1999, J BIOL CHEM, V274, P22469, DOI 10.1074/jbc.274.32.22469; Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464; Pihlajamaa T, 1998, MATRIX BIOL, V17, P237, DOI 10.1016/S0945-053X(98)90063-4; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rimoin DL, 1998, AM J MED GENET, V79, P376; Scapinelli R, 1993, Acta Orthop Belg, V59, P371; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; Tiller GE, 1998, CYTOGENET CELL GENET, V81, P205, DOI 10.1159/000015031; Tilley L, 1998, J CLIN PATHOL-MOL PA, V51, P293, DOI 10.1136/mp.51.6.293; VARLOTTA GP, 1991, J BONE JOINT SURG AM, V73A, P124, DOI 10.2106/00004623-199173010-00016; VIKKULA M, 1994, ANN MED, V26, P107; WARMAN ML, 1993, GENOMICS, V17, P694, DOI 10.1006/geno.1993.1391; WARMAN ML, 1994, GENOMICS, V23, P158, DOI 10.1006/geno.1994.1472; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; Weishaupt D, 1998, RADIOLOGY, V209, P661, DOI 10.1148/radiology.209.3.9844656	51	169	187	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2001	285	14					1843	1849		10.1001/jama.285.14.1843	http://dx.doi.org/10.1001/jama.285.14.1843			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	418DY	11308397	Bronze			2022-12-01	WOS:000167876700024
J	Marquardt, T; Ashery-Padan, R; Andrejewski, N; Scardigli, R; Guillemot, F; Gruss, P				Marquardt, T; Ashery-Padan, R; Andrejewski, N; Scardigli, R; Guillemot, F; Gruss, P			Pax6 is required for the multipotent state of retinal progenitor cells	CELL			English	Article							XENOPUS-RETINA; EYE DEVELOPMENT; AMACRINE CELLS; DEVELOPING CNS; HOMEOBOX GENE; BHLH GENES; NEURONAL DIFFERENTIATION; MAMMALIAN RETINA; NERVOUS-SYSTEM; GANGLION-CELLS	The molecular mechanisms mediating the retinogenic potential of multipotent retinal progenitor cells (RPCs) are poorly defined. Prior to initiating retinogenesis, RPCs express a limited set of transcription factors implicated in the evolutionary ancient genetic network that initiates eye development. We elucidated the function of one of these factors, Pax6, in the RPCs of the intact developing eye by conditional gene targeting. Upon Pax6 inactivation, the potential of RPCs becomes entirely restricted to only one of the cell fates normally available to RPCs, resulting in the exclusive generation of amacrine interneurons. Our findings demonstrate furthermore that Pax6 directly controls the transcriptional activation of retinogenic bHLH factors that bias subsets of RPCs toward the different retinal cell fates, thereby mediating the full retinogenic potential of RPCs.	Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; Univ Strasbourg 1, CNRS, INSERM, IGBMC, F-67404 Illkirch, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gruss, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Cell Biol, Fassberg 11, D-37077 Gottingen, Germany.		Guillemot, Francois/AAV-1482-2021	Scardigli, Raffaella/0000-0003-1369-0496				Alexiades MR, 1997, DEVELOPMENT, V124, P1119; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bernier G, 2000, MECH DEVELOP, V93, P59, DOI 10.1016/S0925-4773(00)00271-9; Brown NL, 1998, DEVELOPMENT, V125, P4821; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chow RL, 1999, DEVELOPMENT, V126, P4213; Collinson JM, 2000, DEVELOPMENT, V127, P945; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Fode C, 2000, GENE DEV, V14, P67; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; GalliResta L, 1997, J NEUROSCI, V17, P7831; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Hogan B., 2014, MANIPULATING MOUSE E; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Jensen AM, 1997, DEV BIOL, V188, P267, DOI 10.1006/dbio.1997.8645; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; LILLIEN L, 1995, NATURE, V377, P158, DOI 10.1038/377158a0; Lillien L, 1998, CURR OPIN NEUROBIOL, V8, P37, DOI 10.1016/S0959-4388(98)80006-8; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; Morrow EM, 1999, DEVELOPMENT, V126, P23; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Oliver G, 1997, TRENDS NEUROSCI, V20, P415, DOI 10.1016/S0166-2236(97)01082-5; Oliver G, 1995, DEVELOPMENT, V121, P4045; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Porter FD, 1997, DEVELOPMENT, V124, P2935; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Sears S, 2000, INVEST OPHTH VIS SCI, V41, P971; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; StOnge L, 1997, NATURE, V387, P406, DOI 10.1038/387406a0; Strettoi E, 1996, P NATL ACAD SCI USA, V93, P14906, DOI 10.1073/pnas.93.25.14906; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Verma-Kurvari S, 1998, DEV BIOL, V197, P106, DOI 10.1006/dbio.1998.8873; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; WETTS R, 1989, DEV BIOL, V136, P245; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; ZernickaGoetz M, 1997, DEVELOPMENT, V124, P1133; Zuber ME, 1999, CELL, V98, P341, DOI 10.1016/S0092-8674(00)81963-7	71	701	708	1	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 6	2001	105	1					43	55		10.1016/S0092-8674(01)00295-1	http://dx.doi.org/10.1016/S0092-8674(01)00295-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301001	hybrid, Green Published			2022-12-01	WOS:000168063300006
J	Pierce-Shimomura, JT; Faumont, S; Gaston, MR; Pearson, BJ; Lockery, SR				Pierce-Shimomura, JT; Faumont, S; Gaston, MR; Pearson, BJ; Lockery, SR			The homeobox gene lim-6 is required for distinct chemosensory representations in C-elegans	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; NEURONS; CHEMOTAXIS; EXPRESSION; SYSTEM	The ability to discriminate between different chemical stimuli is crucial for food detection, spatial orientation and other adaptive behaviours in animals. In the nematode Caenorhabditis elegans, spatial orientation in gradients of soluble chemoattractants (chemotaxis) is controlled mainly by a single pair of chemosensory neurons(1). These two neurons, ASEL and ASER, are left-right homologues in terms of the disposition of their somata and processes, morphology of specialized sensory endings, synaptic partners and expression profile of many genes(2,3). However, recent gene-expression studies have revealed unexpected asymmetries between ASEL and ASER. ASEL expresses the putative receptor guanylyl cyclase genes gcy-6 and gcy-7, whereas ASER expresses gcy-5 (ref. 4). In addition, only ASEL expresses the homeobox gene lim-6, an orthologue of the human LMX1 subfamily of homeobox genes(5). Here we show, using laser ablation of neurons and whole-cell patch-clamp electrophysiology, that the asymmetries between ASEL and ASER extend to the functional level. ASEL is primarily sensitive to sodium, whereas ASER is primarily sensitive to chloride and potassium. Furthermore, we rnd that lim-6 is required for this functional asymmetry and for the ability to distinguish sodium from chloride. Thus, a homeobox gene increases the representational capacity of the nervous system by establishing asymmetric functions in a bilaterally symmetrical neuron pair.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Lockery, SR (corresponding author), Univ Oregon, Inst Neurosci, 1254, Eugene, OR 97403 USA.			Pearson, Bret/0000-0002-3473-901X				BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1990, COLD SH Q B, V55, P529; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; DUSENBER.DB, 1974, J EXP ZOOL, V188, P41, DOI 10.1002/jez.1401880105; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Hobert O, 1999, DEVELOPMENT, V126, P1547; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Lockery SR, 1998, METHOD ENZYMOL, V293, P201; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	20	136	143	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					694	698		10.1038/35070575	http://dx.doi.org/10.1038/35070575			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287956				2022-12-01	WOS:000167875400048
J	[Anonymous]				[Anonymous]			Gathering the evidence on medical marijuana	NATURE			English	Editorial Material																		2001, NATURE, V410, P505	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					613	613						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287904				2022-12-01	WOS:000167875400001
J	Schwetz, BA				Schwetz, BA			Labeling changes for Orlaam	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2705	2705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386912				2022-12-01	WOS:000168985800006
J	Lee, AL; Wand, AJ				Lee, AL; Wand, AJ			Microscopic origins of entropy, heat capacity and the glass transition in proteins	NATURE			English	Article							INELASTIC NEUTRON-SCATTERING; SIDE-CHAIN DYNAMICS; ORDER PARAMETERS; RIBONUCLEASE-A; NMR; RELAXATION; MYOGLOBIN; BINDING; H-2; MOTIONS	Internal motion is central to protein folding(1), to protein stability through the resulting residual entropy(2), and to protein function(1,3-7). Despite its importance, the precise nature of the internal motions of protein macromolecules remains a mystery. Here we report a survey of the temperature dependence of the fast dynamics of methyl-bearing side chains in a calmodulin-peptide complex using site-specific deuterium NMR relaxation methods. The amplitudes of motion had a markedly heterogeneous spectrum and segregated into three largely distinct classes. Other proteins studied at single temperatures tend to segregate similarly. Furthermore, a large variability in the degree of thermal activation of the dynamics in the calmodulin complex indicates a heterogeneous distribution of residual entropy and hence reveals the microscopic origins of heat capacity in proteins. These observations also point to an unexpected explanation for the low-temperature 'glass transition' of proteins. It is this transition that has been ascribed to the creation of protein motional modes that are responsible for biological activity(5-7).	Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), Univ N Carolina, Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA.		Lee, Andrew/GVU-2817-2022					AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Constantine KL, 1998, BIOCHEMISTRY-US, V37, P7965, DOI 10.1021/bi980203o; Diehl M, 1997, BIOPHYS J, V73, P2726, DOI 10.1016/S0006-3495(97)78301-2; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Feher VA, 1999, NATURE, V400, P289, DOI 10.1038/22357; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRAUENFELDER H, 1985, SCIENCE, V229, P337, DOI 10.1126/science.4012322; HARTMANN H, 1982, P NATL ACAD SCI-BIOL, V79, P4967, DOI 10.1073/pnas.79.16.4967; KARPLUS M, 1987, BIOPHYS J, V52, P1083, DOI 10.1016/S0006-3495(87)83303-9; Kay LE, 1996, BIOCHEMISTRY-US, V35, P361, DOI 10.1021/bi9522312; Lee AL, 1999, J AM CHEM SOC, V121, P2891, DOI 10.1021/ja983758f; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; LeMaster DM, 1999, J AM CHEM SOC, V121, P1726, DOI 10.1021/ja982988r; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mittermaier A, 1999, J BIOMOL NMR, V13, P181, DOI 10.1023/A:1008387715167; MUHANDIRAM DR, 1995, J AM CHEM SOC, V117, P11536, DOI 10.1021/ja00151a018; NICHOLSON LK, 1992, BIOCHEMISTRY-US, V31, P5253, DOI 10.1021/bi00138a003; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; Reat V, 2000, P NATL ACAD SCI USA, V97, P9961, DOI 10.1073/pnas.97.18.9961; Sokolov AP, 1996, SCIENCE, V273, P1675, DOI 10.1126/science.273.5282.1675; TILTON RF, 1992, BIOCHEMISTRY-US, V31, P2469, DOI 10.1021/bi00124a006; Wand AJ, 1996, BIOCHEMISTRY-US, V35, P6116, DOI 10.1021/bi9530144; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yang DW, 1998, J MOL BIOL, V276, P939, DOI 10.1006/jmbi.1997.1588; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	28	267	268	0	85	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					501	504		10.1038/35078119	http://dx.doi.org/10.1038/35078119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373686				2022-12-01	WOS:000168858700055
J	Olson, A; Stenlid, J				Olson, A; Stenlid, J			Plant pathogens - Mitochondrial control of fungal hybrid virulence	NATURE			English	Article							HETEROBASIDION-ANNOSUM; M-MEDUSAE; HYBRIDIZATION		Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences	Olson, A (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Pathol, SE-75007 Uppsala, Sweden.	ake.olson@mykopat.slu.se	Stenlid, Jan/K-5909-2019					Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Brasier CM, 1998, MYCOL RES, V102, P45, DOI 10.1017/S0953756297004541; ERESK T, 1995, PHYTOPATHOLOGY, V85, P1343; Garbelotto M, 1996, PHYTOPATHOLOGY, V86, P543, DOI 10.1094/Phyto-86-543; GARBELOTTO M, 1996, PHYTOPATHOLOGY S, V86, P28; Garbelotto MM, 1997, MYCOLOGIA, V89, P92, DOI 10.2307/3761177; Korhonen K, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P43; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; SHARMA P, 1993, PHYSIOL MOL PLANT P, V43, P57, DOI 10.1006/pmpp.1993.1040; SPIERS AG, 1994, MYCOL RES, V98, P889, DOI 10.1016/S0953-7562(09)80260-8; t Veld VAMI, 1998, PHYTOPATHOLOGY, V88, P922, DOI 10.1094/PHYTO.1998.88.9.922	12	69	69	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					438	438		10.1038/35078147	http://dx.doi.org/10.1038/35078147			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373666	Bronze			2022-12-01	WOS:000168858700035
J	Beier, M				Beier, M			Visiting the sadness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2001	285	19					2425	2426		10.1001/jama.285.19.2425	http://dx.doi.org/10.1001/jama.285.19.2425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429ZC	11368675				2022-12-01	WOS:000168547600001
J	Sasieni, P; Adams, J				Sasieni, P; Adams, J			Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England	LANCET			English	Article							CANCER MORTALITY; CELL CARCINOMAS; TRENDS; WALES; RISK	Background A recent analysis showed little or no effect of screening on the incidence of adenocarcinoma of the cervix between 1971 and 1992. We have used additional data on cancers diagnosed in 1993-94 in England and up to 1997 in five English cancer registries to investigate more recent trends. Methods After imputing the number of adenocarcinomas in women with unknown histology, we fitted an age-cohort model to 8062 adenocarcinomas of the cervix diagnosed in England between 1971 and 1987. Predictions from this model were applied to the more recent data on 5854 cases. Residual effects were plotted against year of diagnosis in each of four age-groups. Findings We estimated the underlying risk of cervical adenocarcinoma to be 14 times (95% CI 11-19) greater in women born in the early 1960s than in cohorts born before 1935. An age-cohort model fitted the data for England well up to 1987, but substantially overestimated the numbers of adenocarcinomas in young women from 1990 onwards. In 1996-97 the incidence rate in women aged 25-54 years was less than 40% of that predicted from the age-cohort model. Interpretation The substantial increase in cervical adenocarcinoma in recent years is largely a birth-cohort effect presumably associated with greater exposure to human papillomavirus after the sexual revolution in the 1960s. The relative decline in younger women observed in more recent years suggests an effect of cervical screening.	Imperial Canc Res Fund, Dept Math Stat & Epidemiol, London WC2A 3PX, England	Cancer Research UK	Sasieni, P (corresponding author), Imperial Canc Res Fund, Dept Math Stat & Epidemiol, 61 Lincolns Inn Fields, London WC2A 3PX, England.	p.sasieni@icrf.icnet.uk		Sasieni, Peter/0000-0003-1509-8744				BERAL V, 1974, LANCET, V1, P1037; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; *INT AG RES CANC, 1995, IARC MON EV CARC RIS; Lacey JV, 1999, CANCER EPIDEM BIOMAR, V8, P1079; McCann J, 1998, J MED SCREEN, V5, P42, DOI 10.1136/jms.5.1.42; MCCULLAGH P, 1989, GEN LINEAR MODELS, P324; *OFF NAT STAT, 1999, SERIES MBI, V26; *OFF NAT STAT, 2000, STAT B; PARKIN DM, 1985, BRIT J OBSTET GYNAEC, V92, P150, DOI 10.1111/j.1471-0528.1985.tb01067.x; Sasieni P, 1999, BRIT MED J, V318, P1244; Sasieni PD, 2000, J ROY STAT SOC A STA, V163, P191, DOI 10.1111/1467-985X.00165; Sasieni PD, 1999, AM J EPIDEMIOL, V149, P869; URSIN G, 1994, LANCET, V344, P1390, DOI 10.1016/S0140-6736(94)90567-3; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.3.CO;2-E	15	138	143	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2001	357	9267					1490	1493		10.1016/S0140-6736(00)04646-8	http://dx.doi.org/10.1016/S0140-6736(00)04646-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377601				2022-12-01	WOS:000168614300013
J	Kamermans, M; Fahrenfort, I; Schultz, K; Janssen-Bienhold, U; Sjoerdsma, T; Weiler, R				Kamermans, M; Fahrenfort, I; Schultz, K; Janssen-Bienhold, U; Sjoerdsma, T; Weiler, R			Hemichannel-mediated inhibition in the outer retina	SCIENCE			English	Article							GAP-JUNCTION CHANNELS; HORIZONTAL CELLS; GOLDFISH RETINA; FEEDBACK; NEUROTRANSMITTER; SYNAPSE; CONES	An essential feature of the first synapse in the retina is a negative feedback pathway from horizontal cells to cones. Here we show that at this synapse, connexin26 forms hemichannels on horizontal cell dendrites near the glutamate release site of the cones. Blocking these hemichannels hyperpolarizes horizontal cells, modulates the Ca2+ channels of the cones, and abolishes all feedback-mediated responses. We propose a feedback mechanism in which the activity of the Ca2+ channels and the subsequent glutamate release of the cones are modulated by a current through these hemichannels. Because the current through the hemichannels depends on the polarization of the horizontal cells, their activity modulates the output of the cones.	Netherlands Ophthalm Res Inst, Res Unit Retinal Signal Proc, NL-1105 BA Amsterdam, Netherlands; Univ Oldenburg, Dept Biol, D-26111 Oldenburg, Germany	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Carl von Ossietzky Universitat Oldenburg	Kamermans, M (corresponding author), Netherlands Ophthalm Res Inst, Res Unit Retinal Signal Proc, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.							BYZOV AL, 1986, VISION RES, V26, P33, DOI 10.1016/0042-6989(86)90069-6; DEVRIES SH, 1992, J PHYSIOL-LONDON, V445, P201, DOI 10.1113/jphysiol.1992.sp018920; Fahrenfort I, 1999, J GEN PHYSIOL, V114, P511, DOI 10.1085/jgp.114.4.511; Janssen-Bienhold U, 2001, VISUAL NEUROSCI, V18, P169, DOI 10.1017/S0952523801182015; Janssen-Bienhold U, 1998, J COMP NEUROL, V396, P310, DOI 10.1002/(SICI)1096-9861(19980706)396:3<310::AID-CNE3>3.0.CO;2-5; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; Klooster J, 2001, INVEST OPHTH VIS SCI, V42, pS727; Kraaij DA, 2000, J NEUROPHYSIOL, V84, P1256, DOI 10.1152/jn.2000.84.3.1256; Lu CB, 1996, VISUAL NEUROSCI, V13, P1049, DOI 10.1017/S0952523800007707; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Oh S, 1999, J GEN PHYSIOL, V114, P339, DOI 10.1085/jgp.114.3.339; Osborne PB, 1996, J NEUROPHYSIOL, V76, P1559, DOI 10.1152/jn.1996.76.3.1559; SCHULTZ K, IN PRESS J COMP NEUR; Suchyna TM, 1999, BIOPHYS J, V77, P2968, DOI 10.1016/S0006-3495(99)77129-8; TOYODA JI, 1982, S POTENTIAL, P151; Vandenbranden CAV, 1996, VISION RES, V36, P3859, DOI 10.1016/S0042-6989(96)00134-4; Vaney DI, 1998, J NEUROSCI, V18, P10594; WEILER R, 1984, BRAIN RES, V298, P1, DOI 10.1016/0006-8993(84)91141-7; WITKOVSKY P, 1995, P NATL ACAD SCI USA, V92, P3556, DOI 10.1073/pnas.92.8.3556; WU SM, 1994, ANNU REV PHYSIOL, V56, P141	20	301	305	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1178	1180		10.1126/science.1060101	http://dx.doi.org/10.1126/science.1060101			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11349152				2022-12-01	WOS:000168609200064
J	del Campo, ML; Miles, CI; Schroeder, FC; Mueller, C; Booker, R; Renwick, JA				del Campo, ML; Miles, CI; Schroeder, FC; Mueller, C; Booker, R; Renwick, JA			Host recognition by the tobacco hornworm is mediated by a host plant compound	NATURE			English	Article							MANDUCA-SEXTA; FOOD DISCRIMINATION; CHEMOSENSORY ORGANS; CHEMORECEPTORS; SPECIFICITY; SENSITIVITY; LEPIDOPTERA; SPHINGIDAE; INSECT; SYSTEM	It is generally believed that animals make decisions about the selection of mates, kin or food on the basis of pre-constructed recognition templates. These templates can be innate or acquired through experience(1). An example of an acquired template is the feeding preference exhibited by larvae of the moth, Manduca sexta. Naive hatchlings will feed and grow successfully on many different plants or artificial diets, but once they have fed on a natural host they become specialist feeders(2-6). Here we show that the induced feeding preference of M. sexta involves the formation of a template to a steroidal glycoside, indioside D, that is present in solanaceous foliage. This compound is both necessary and sufficient to maintain the induced feeding preference. The induction of host plant specificity is at least partly due to a tuning of taste receptors to indioside D. The taste receptors of larvae fed on host plants show an enhanced response to indioside D as compared with other plant compounds tested.	Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; Cornell Univ, Dept Chem & Biol Chem, Ithaca, NY 14853 USA; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; Cornell University; Cornell University; Cornell University; Boyce Thompson Institute for Plant Research	del Campo, ML (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	moliva@binghamton.edu	Muller, Caroline/G-5073-2011; Schroeder, Frank/H-5026-2012	Muller, Caroline/0000-0002-8447-534X; Schroeder, Frank/0000-0002-4420-0237				ABISGOLD JD, 1988, J EXP BIOL, V135, P215; Bell RA., 1981, USDA TECH B, P599; Bernays EA, 1996, ENTOMOL EXP APPL, V80, P125, DOI 10.1007/BF00194741; CROASMUM WA, 1994, 2 DIMENSIONAL NMR SP; DEBOER G, 1993, J INSECT PHYSIOL, V39, P17, DOI 10.1016/0022-1910(93)90013-H; DEBOER G, 1991, ENTOMOL EXP APPL, V61, P159, DOI 10.1007/BF00191746; DEBOER G, 1991, J INSECT PHYSIOL, V37, P763, DOI 10.1016/0022-1910(91)90111-C; DETHIER VG, 1982, J GEN PHYSIOL, V79, P549, DOI 10.1085/jgp.79.4.549; FLOWERS RW, 1992, FLA ENTOMOL, V75, P89, DOI 10.2307/3495484; Glendinning JI, 1999, J EXP BIOL, V202, P2091; GOTHILF S, 1994, ENTOMOL EXP APPL, V72, P305, DOI 10.1007/BF02383819; JERMY T, 1968, ENTOMOL EXP APPL, V11, P211, DOI 10.1007/BF00305230; Mechaber WL, 2000, ANN ENTOMOL SOC AM, V93, P447, DOI 10.1603/0013-8746(2000)093[0447:NNSHRF]2.0.CO;2; ROTHSCHILD M, 1979, NATURE, V280, P487, DOI 10.1038/280487a0; Schoonhoven L. M., 1966, ARCH NEERL ZOOL, V16, P497, DOI DOI 10.1163/036551666X00057; SCHOONHOVEN LM, 1969, P K NED AKAD C BIOL, V72, P491; SCHOONHOVEN LM, 1967, ENTOMOL EXP APPL, V10, P270, DOI 10.1007/BF00302248; Sherman Paul W., 1997, P69; Stadler E., 1976, Symposia Biologica Hungarica, V16, P267; WALDBAUER G. P., 1961, ANN ENT SOC AMER, V54, P477, DOI 10.1093/aesa/54.4.477; YAJARA S, 1996, PHYTOCHEMISTRY, V43, P1319; YAMAMOTO ROBERT T., 1960, ANN ENT SOC AMER, V53, P503, DOI 10.1093/aesa/53.4.503; YAMAMOTO RT, 1974, J INSECT PHYSIOL, V20, P641, DOI 10.1016/0022-1910(74)90185-1	23	78	83	1	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 10	2001	411	6834					186	189		10.1038/35075559	http://dx.doi.org/10.1038/35075559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346793				2022-12-01	WOS:000168563000048
J	Calvert, PD; Govardovskii, VI; Krasnoperova, N; Anderson, RE; Lem, J; Makino, CL				Calvert, PD; Govardovskii, VI; Krasnoperova, N; Anderson, RE; Lem, J; Makino, CL			Membrane protein diffusion sets the speed of rod phototransduction	NATURE			English	Article							PHOTORECEPTOR LIGHT ADAPTATION; LATERAL DIFFUSION; OUTER SEGMENT; LIPID BILAYERS; RETINAL RODS; IN-VIVO; RHODOPSIN; TRANSDUCIN; PHOTORESPONSE; ACTIVATION	Retinal rods signal the activation of a single receptor molecule by a photon(1). To ensure efficient photon capture, rods maintain about 10(9) copies of rhodopsin densely packed into membranous disks(2). But a high packing density of rhodopsin may impede other steps in phototransduction that take place on the disk membrane(3), by restricting the lateral movement of, and hence the rate of encounters between, the molecules involved(4-6). Although it has been suggested that lateral diffusion of proteins on the membrane sets the rate of onset of the photoresponse(7), it was later argued that the subsequent processing of the complexes was the main determinant of this rate(8,9). The effects of protein density on response shut-off have not been reported. Here we show that a roughly 50% reduction in protein crowding achieved by the hemizygous knockout of rhodopsin in transgenic mice accelerates the rising phases and recoveries of flash responses by about 1.7-fold in vivo. Thus, in rods the rates of both response onset and recovery are set by the diffusional encounter frequency between proteins on the disk membrane.	Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; New England Med Ctr, Dept Ophthalmol, Mol Cardiol Res Inst, Boston, MA 02111 USA; New England Med Ctr, Dept Genet, Mol Cardiol Res Inst, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Tufts Medical Center; Tufts Medical Center; Tufts University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Calvert, PD (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA.		Govardovskii, Victor I/K-2655-2018; Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069				BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BRUCKERT F, 1992, BIOPHYS J, V63, P616, DOI 10.1016/S0006-3495(92)81650-8; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; DODD RL, 1995, INVEST OPHTH VIS SCI, V36, pS641; HECK M, 1993, BIOCHEMISTRY-US, V32, P8220, DOI 10.1021/bi00083a024; KAHLERT M, 1991, BIOPHYS J, V59, P375, DOI 10.1016/S0006-3495(91)82231-7; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; NAQVI KR, 1974, CHEM PHYS LETT, V28, P280; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317; PINK DA, 1985, BIOCHIM BIOPHYS ACTA, V818, P200, DOI 10.1016/0005-2736(85)90562-0; POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; SAXTON MJ, 1989, BIOCHIM BIOPHYS ACTA, V979, P27, DOI 10.1016/0005-2736(89)90519-1; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; SMITH HG, 1975, EXP EYE RES, V20, P211, DOI 10.1016/0014-4835(75)90134-7; SUNG CH, 1994, J NEUROSCI, V14, P5818; TANK DW, 1982, BIOPHYS J, V40, P129, DOI 10.1016/S0006-3495(82)84467-6; TILTON RD, 1990, BIOPHYS J, V58, P1321, DOI 10.1016/S0006-3495(90)82473-5; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0; Yuan C, 1998, COMP BIOCHEM PHYS B, V120, P785, DOI 10.1016/S0305-0491(98)10079-2	30	143	145	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					90	94		10.1038/35075083	http://dx.doi.org/10.1038/35075083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333983				2022-12-01	WOS:000168432800049
J	Moshous, D; Callebaut, I; de Chasseval, R; Corneo, B; Cavazzana-Calvo, M; Le Deist, F; Tezcan, I; Sanal, O; Bertrand, Y; Philippe, N; Fischer, A; de Villartay, JP				Moshous, D; Callebaut, I; de Chasseval, R; Corneo, B; Cavazzana-Calvo, M; Le Deist, F; Tezcan, I; Sanal, O; Bertrand, Y; Philippe, N; Fischer, A; de Villartay, JP			Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency	CELL			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; V(D)J RECOMBINATION; SCID MUTATION; LIGASE-IV; SACCHAROMYCES-CEREVISIAE; INCREASED SENSITIVITY; CATALYTIC SUBUNIT; CHROMOSOME 10P; GENOMIC DNA; GENE	The V(D)J recombination process insures the somatic diversification of immunoglobulin and antigen T cell receptor encoding genes. This reaction is initiated by a DNA double-strand break (dsb), which is resolved by the ubiquitously expressed DNA repair machinery. Human T-B-severe combined immunodeficiency associated with increased cellular radiosensitivity (RS-SCID) is characterized by a defect in the V(D)J recombination leading to an early arrest of both B and T cell maturation. We previously mapped the disease-related locus to the short arm of chromosome 10. We herein describe the cloning of the gene encoding a novel protein involved in V(D)J recombination/DNA repair, Artemis, whose mutations cause human RS-SCID. Protein sequence analysis strongly suggests that Artemis belongs to the metallo-beta -lactamase superfamily.	Hop Necker Enfants Malad, INSERM, U429, F-75015 Paris, France; Univ Paris 06, LMCP, CNRS, UMR C7590, F-75005 Paris, France; Univ Paris 07, F-75005 Paris, France; Hacettepe Univ, Ihsan Dogramaci Childrens Hosp, Div Immunol, Ankara, Turkey; Hop Debrousse, Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Hacettepe University; CHU Lyon	Moshous, D (corresponding author), Hop Necker Enfants Malad, INSERM, U429, 149 Rue Sevres, F-75015 Paris, France.		de Villartay, jean pierre/H-9353-2017; Moshous, Despina/B-7507-2017	de Villartay, jean pierre/0000-0001-5987-0463; Moshous, Despina/0000-0001-6719-3693; Corneo, Barbara/0000-0001-5189-6749; Cavazzana, Marina/0000-0002-0264-0891				ARAVIND L, 1997, SILICO BIOL, V1, P5; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Blunt T, 1996, P NATL ACAD SCI USA, V93, P10285, DOI 10.1073/pnas.93.19.10285; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; CAVAZZANACALVO M, 1993, J CLIN INVEST, V91, P1214, DOI 10.1172/JCI116282; Corneo B, 2000, J BIOL CHEM, V275, P12672, DOI 10.1074/jbc.275.17.12672; Danska JS, 1996, MOL CELL BIOL, V16, P5507; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Fischer A, 1997, ANNU REV IMMUNOL, V15, P93, DOI 10.1146/annurev.immunol.15.1.93; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; GOTTLIEB TM, 1993, CELL, V72, P132; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; HENRIQUES JAP, 1980, GENETICS, V95, P273; HU DC, 1988, PEDIATR RES, V24, P239; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Jhappan C, 1997, NAT GENET, V17, P483, DOI 10.1038/ng1297-483; Li LY, 1998, AM J HUM GENET, V62, P136, DOI 10.1086/301688; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moshous D, 2000, HUM MOL GENET, V9, P583, DOI 10.1093/hmg/9.4.583; Nicolas N, 1996, EUR J IMMUNOL, V26, P1118, DOI 10.1002/eji.1830260524; Nicolas N, 1998, J EXP MED, V188, P627, DOI 10.1084/jem.188.4.627; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Shin EK, 1997, J IMMUNOL, V158, P3565; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Wilson TE, 1997, NATURE, V388, P495, DOI 10.1038/41365; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	45	666	688	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 20	2001	105	2					177	186		10.1016/S0092-8674(01)00309-9	http://dx.doi.org/10.1016/S0092-8674(01)00309-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336668	Bronze			2022-12-01	WOS:000168384300005
J	Simmonds, AJ; dosSantos, G; Livne-Bar, I; Krause, HM				Simmonds, AJ; dosSantos, G; Livne-Bar, I; Krause, HM			Apical localization of wingless transcripts is required for wingless signaling	CELL			English	Article							SEGMENT-POLARITY GENE; DEPENDENT LOCALIZATION; UBIQUITOUS EXPRESSION; PATTERN-FORMATION; RNA LOCALIZATION; MESSENGER-RNAS; WNT GENE; DROSOPHILA; PROTEIN; ENCODES	Many developing and adult tissues are comprised of polarized epithelia. Proteins that are asymmetrically distributed in these cells are thought to be localized by protein trafficking. Here we show that the distribution and function of the signaling protein Wingless is predetermined by the subcellular localization of its mRNA. High-resolution in situ hybridization reveals apical transcript localization in the majority of tissues examined. This localization is mediated by two independently acting elements in the 3' UTR. Replacement of these elements with non- or basolaterally localizing elements yields proteins with altered intracellular and extracellular distributions and reduced signaling activities. This novel aspect of the wingless signaling pathway is conserved and may prove to be a mechanism used commonly for establishing epithelial cell polarity.	Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Program Dev Biol, Toronto, ON, Canada	University of Toronto; University of Toronto	Krause, HM (corresponding author), Univ Toronto, Charles H Best Inst, Banting & Best Dept Med Res, Room 312,112 Coll St, Toronto, ON M5G 1L6, Canada.	h.krause@utoronto.ca	Simmonds, Andrew J/D-3675-2009	Simmonds, Andrew/0000-0001-7165-9302; Krause, Henry/0000-0002-6182-7074				Baeg GH, 2000, CURR OPIN CELL BIOL, V12, P575, DOI 10.1016/S0955-0674(00)00134-4; BAKER NE, 1988, DEVELOPMENT, V102, P489; BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Bocchinfuso WP, 1999, CANCER RES, V59, P1869; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Brook WJ, 1996, ANNU REV CELL DEV BI, V12, P161, DOI 10.1146/annurev.cellbio.12.1.161; Christian JL, 2000, CURR OPIN CELL BIOL, V12, P244, DOI 10.1016/S0955-0674(99)00082-4; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; CUI YZ, 1995, DEVELOPMENT, V121, P2177; Dubowy J, 1998, MECH DEVELOP, V70, P193, DOI 10.1016/S0925-4773(97)00185-8; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; FESSLER JH, 1989, ANNU REV CELL BIOL, V5, P309, DOI 10.1146/annurev.cb.05.110189.001521; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; GONZALEZ F, 1991, MECH DEVELOP, V35, P43, DOI 10.1016/0925-4773(91)90040-D; GULLBERG D, 1994, DEV DYNAM, V199, P116, DOI 10.1002/aja.1001990205; Hacker U, 1997, DEVELOPMENT, V124, P3565; Hays R, 1997, DEVELOPMENT, V124, P3727; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; Hughes SC, 1996, BIOTECHNIQUES, V20, P748; Hughes SC, 1999, METH MOL B, V122, P93; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; KU M, 1993, DEVELOPMENT, V119, P1161; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; LIN JJC, 1981, P NATL ACAD SCI-BIOL, V78, P2335, DOI 10.1073/pnas.78.4.2335; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lindsley D.L., 1992, GENOME DROSOPHILA ME; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Manoukian AS, 1995, DEVELOPMENT, V121, P4037; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; MOON RT, 1993, DEVELOPMENT, V119, P97; Mostov KE, 2000, CURR OPIN CELL BIOL, V12, P483, DOI 10.1016/S0955-0674(00)00120-4; Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X; MURRAY MA, 1995, DEV BIOL, V168, P150, DOI 10.1006/dbio.1995.1068; NEUMANSILBERBERG FS, 1994, DEVELOPMENT, V120, P2457; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; NOORDERMEER J, 1992, DEVELOPMENT, V116, P711; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; PARK WJ, 1994, MECH DEVELOP, V45, P127, DOI 10.1016/0925-4773(94)90026-4; Pfeiffer S, 2000, CURR BIOL, V10, P321, DOI 10.1016/S0960-9822(00)00381-X; Raj L, 2000, CURR BIOL, V10, P1265, DOI 10.1016/S0960-9822(00)00745-4; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; ROBERTSON HM, 1988, GENETICS, V118, P461; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sasakura Y, 1998, INT J DEV BIOL, V42, P573; Saulier-Le Drean B, 1998, DEVELOPMENT, V125, P4851; Selleck SB, 2000, TRENDS GENET, V16, P206, DOI 10.1016/S0168-9525(00)01997-1; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Strigini M, 1999, SEMIN CELL DEV BIOL, V10, P335, DOI 10.1006/scdb.1999.0293; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; WOODS DF, 1993, J CELL SCI, P171; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243; Yu X, 1999, MECH DEVELOP, V84, P69, DOI 10.1016/S0925-4773(99)00072-6; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	72	97	97	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 20	2001	105	2					197	207		10.1016/S0092-8674(01)00311-7	http://dx.doi.org/10.1016/S0092-8674(01)00311-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	427BE	11336670	Bronze			2022-12-01	WOS:000168384300007
J	Dettmer, K; Saunders, B; Strang, J				Dettmer, K; Saunders, B; Strang, J			Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes	BRITISH MEDICAL JOURNAL			English	Article							HEROIN		Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England; Maudsley Hosp, London SE5 8AF, England; Alcohol & Drug Serv, St Saviour JE2 7LB, Jersey, England; Fixpunkt eV Mobilix, D-10967 Berlin, Germany	University of London; King's College London; South London & Maudsley NHS Trust	Strang, J (corresponding author), Inst Psychiat, Natl Addict Ctr, London SE5 8AF, England.		Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725				Darke S, 1997, ADDICTION, V92, P1195; Strang J, 1996, BRIT MED J, V312, P1435, DOI 10.1136/bmj.312.7044.1435; Strang J, 1999, ADDICTION, V94, P199, DOI 10.1046/j.1360-0443.1999.9421993.x; Wanger K, 1998, ACAD EMERG MED, V5, P293, DOI 10.1111/j.1553-2712.1998.tb02707.x	4	109	113	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					895	896		10.1136/bmj.322.7291.895	http://dx.doi.org/10.1136/bmj.322.7291.895			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302902	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000168311300020
J	Reich, PB; Knops, J; Tilman, D; Craine, J; Ellsworth, D; Tjoelker, M; Lee, T; Wedin, D; Naeem, S; Bahauddin, D; Hendrey, G; Jose, S; Wrage, K; Goth, J; Bengston, W				Reich, PB; Knops, J; Tilman, D; Craine, J; Ellsworth, D; Tjoelker, M; Lee, T; Wedin, D; Naeem, S; Bahauddin, D; Hendrey, G; Jose, S; Wrage, K; Goth, J; Bengston, W			Plant diversity enhances ecosystem responses to elevated CO2 and nitrogen deposition	NATURE			English	Article							CARBON-DIOXIDE ENRICHMENT; ATMOSPHERIC CO2; LONG-TERM; CALCAREOUS GRASSLAND; SPECIES COMPOSITION; BIOMASS; MONOCULTURES; PRODUCTIVITY; BIODIVERSITY; COMPETITION	Human actions are causing declines in plant biodiversity, increases in atmospheric CO2 concentrations and increases in nitrogen deposition; however, the interactive effects of these factors on ecosystem processes are unknown(1,2). Reduced biodiversity has raised numerous concerns, including the possibility that ecosystem functioning may be affected negatively(1-4), which might be particularly important in the face of other global changes(5,6). Here we present results of a grassland field experiment in Minnesota, USA, that tests the hypothesis that plant diversity and composition influence the enhancement of biomass and carbon acquisition in ecosystems subjected to elevated atmospheric CO2 concentrations and nitrogen deposition. The study experimentally controlled plant diversity (1, 4, 9 or 16 species), soil nitrogen (unamended versus deposition of 4 g of nitrogen per m(2) per yr) and atmospheric CO2 concentrations using free-air CO2 enrichment (ambient, 368 mu mol mol(-1), versus elevated, 560 mu mol mol(-1)). We found that the enhanced biomass accumulation in response to elevated levels of CO2 or nitrogen, or their combination, is less in species-poor than in species-rich assemblages.	Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Brookhaven Natl Lab, Div Environm Biol, Upton, NY 11973 USA; Univ Nebraska, Sch Nat Resource Sci, Lincoln, NE 68583 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Nebraska System; University of Nebraska Lincoln	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.		Craine, Joseph/D-4569-2009; Tilman, David/ABD-5309-2021; Tjoelker, Mark G/M-2413-2016; Wedin, David A/K-4093-2012; Knops, Johannes/AAA-8546-2020	Craine, Joseph/0000-0001-6561-3244; Tjoelker, Mark G/0000-0003-4607-5238; Reich, Peter/0000-0003-4424-662X; Ellsworth, David/0000-0002-9699-2272; Lee, Tali/0000-0002-3933-6607				BOLKER BM, 1995, GLOB CHANGE BIOL, V1, P373, DOI 10.1111/j.1365-2486.1995.tb00035.x; Cannell MGR, 1998, GLOBAL CHANGE BIOL, V4, P431, DOI 10.1046/j.1365-2486.1998.00167.x; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; Hebeisen T, 1997, GLOB CHANGE BIOL, V3, P149, DOI 10.1046/j.1365-2486.1997.00073.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hu SJ, 1999, TRENDS ECOL EVOL, V14, P433, DOI 10.1016/S0169-5347(99)01682-1; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; KORNER C, 1996, CARBON DIOXIDE POPUL; Leadley PW, 1999, OECOLOGIA, V118, P39, DOI 10.1007/s004420050701; LEWIN KF, 1994, AGR FOREST METEOROL, V70, P15, DOI 10.1016/0168-1923(94)90045-0; Luscher A, 1998, OECOLOGIA, V113, P37, DOI 10.1007/s004420050351; Navas ML, 1999, NEW PHYTOL, V143, P323, DOI 10.1046/j.1469-8137.1999.00443.x; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schenk U, 1997, NEW PHYTOL, V135, P67, DOI 10.1046/j.1469-8137.1997.00615.x; Schimel D, 2000, SCIENCE, V287, P2004, DOI 10.1126/science.287.5460.2004; SCHMID B, IN PRESS FUNCTIONAL; Stocker R, 1999, GLOBAL CHANGE BIOL, V5, P95, DOI 10.1046/j.1365-2486.1998.00198.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Warwick KR, 1998, GLOB CHANGE BIOL, V4, P375, DOI 10.1046/j.1365-2486.1998.00159.x; ZAK DR, 1993, PLANT SOIL, V151, P105, DOI 10.1007/BF00010791; Zak DR, 2000, ECOL APPL, V10, P34, DOI 10.2307/2640984; Zanetti S, 1997, OECOLOGIA, V112, P17, DOI 10.1007/s004420050278	29	436	476	5	315	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					809	812		10.1038/35071062	http://dx.doi.org/10.1038/35071062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298447	Green Published			2022-12-01	WOS:000168021900053
J	Aronow, HD; Topol, EJ; Roe, MT; Houghtaling, PL; Wolski, KE; Lincoff, AM; Harrington, RA; Califf, RM; Ohman, EM; Kleiman, NS; Keltai, M; Wilcox, RG; Vahanian, A; Armstrong, PW; Lauer, MS				Aronow, HD; Topol, EJ; Roe, MT; Houghtaling, PL; Wolski, KE; Lincoff, AM; Harrington, RA; Califf, RM; Ohman, EM; Kleiman, NS; Keltai, M; Wilcox, RG; Vahanian, A; Armstrong, PW; Lauer, MS			Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; INTERNATIONAL TRIAL; ACC/AHA GUIDELINES; UNSTABLE ANGINA; HEART-DISEASE; CHOLESTEROL; PREVENTION; STATINS; MEN; ENDOTHELIUM	Background Lipid-lowering agents are known to reduce longterm mortality in patients with stable coronary disease or significant risk factors. However, the effect of lipid-lowering therapy on short-term mortality immediately after an acute coronary syndrome has not been determined. We did an observational study using data from two randomised trials to investigate this issue. Methods We used data from the GUSTO IIb and PURSUIT trials to compare ail-cause mortality among patients with acute coronary syndromes who were discharged on lipid-lowering agents (n=3653) with those who were not (n=17 156). A propensity analysis was done to adjust for presumed selection biases in the prescription of lipid-lowering agents. Findings Lipid-lowering therapy was associated with a smaller proportion of deaths at 30 days (17 [0.5%] vs 179 [1.0%], hazard ratio 0.44 [95% CI 0.27-0.73], p=0.001) and at 6 months (63 [1.7%] vs 605 [3.5%], 0.48 [0.37-0.63], p<0.0001). After adjustment for the propensity to be prescribed lipid-lowering agents and other potential confounders, prescription of a lipid-lowering agent at discharge remained associated with a reduced risk of death at 6 months (0.67 [0.48-0.95], p=0.023). Interpretation Prescription of a lipid-lowering drug at hospital discharge was independently associated with reduced short-term mortality among patients after an acute coronary syndrome.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Duke Clin Res Inst, Durham, NC USA; Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA; Hungarian Inst Cardiol, Budapest, Hungary; Univ Nottingham Hosp, Queens Med Ctr, Nottingham NG7 2UH, England; Hop Bichat Claude Bernard, Serv Cardiol, F-75877 Paris, France; Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB, Canada	Cleveland Clinic Foundation; Duke University; Baylor College of Medicine; University of Nottingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Alberta	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiol, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	lauerm@ccf.org	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177; Armstrong, Paul/0000-0002-0460-3445; Topol, Eric/0000-0002-1478-4729				Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; Harrington RA, 1997, AM J CARDIOL, V80, pB34, DOI 10.1016/S0002-9149(97)00575-4; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kalblleisch JD, 1980, COMPETING RISKS STAT, P163; Kluft C, 1999, LANCET, V353, P1274, DOI 10.1016/S0140-6736(05)66951-6; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Krumholz HM, 1999, ANN INTERN MED, V131, P648, DOI 10.7326/0003-4819-131-9-199911020-00003; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; LACOSTE L, 1995, CIRCULATION, V92, P3172, DOI 10.1161/01.CIR.92.11.3172; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; NOTARBARTOLO A, 1995, ARTERIOSCL THROM VAS, V15, P247, DOI 10.1161/01.ATV.15.2.247; PEDERSEN TR, 1994, LANCET, V344, P1383; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schwartz GG, 1998, AM J CARDIOL, V81, P578, DOI 10.1016/S0002-9149(97)00963-6; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Siegel D, 2000, AM J MED, V108, P496, DOI 10.1016/S0002-9343(00)00319-3; Stenestrand U, 2001, JAMA-J AM MED ASSOC, V285, P430, DOI 10.1001/jama.285.4.430; Strandberg TE, 1999, LANCET, V353, P118, DOI 10.1016/S0140-6736(05)76154-7; STROES ESG, 1995, LANCET, V346, P467, DOI 10.1016/S0140-6736(95)91322-X; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Weber C, 1997, J AM COLL CARDIOL, V30, P1212, DOI 10.1016/S0735-1097(97)00324-0	33	232	242	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2001	357	9262					1063	1068		10.1016/S0140-6736(00)04257-4	http://dx.doi.org/10.1016/S0140-6736(00)04257-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420GA	11297956				2022-12-01	WOS:000167996200007
J	Liu, JG; Linderman, M; Ouyang, ZY; An, L; Yang, J; Zhang, HM				Liu, JG; Linderman, M; Ouyang, ZY; An, L; Yang, J; Zhang, HM			Ecological degradation in protected areas: The case of Wolong Nature Reserve for giant pandas	SCIENCE			English	Article							CONSERVATION TARGETS; BIODIVERSITY; HURRICANE	It is generally perceived that biodiversity is better protected from human activities after an area is designated as a protected area. However, we found that this common perception was not true in Wolong Nature Reserve (southwestern China), which was established in 1975 as a "flagship" protected area for the world-renowned endangered giant pandas. Analyses of remote sensing data from pre- and post-establishment periods indicate that the reserve has become more fragmented and less suitable for giant panda habitation. The rate of Loss of high-quality habitat after the reserve's establishment was much higher than before the reserve was created, and the fragmentation of high-quality habitat became far more severe. After the creation of the reserve, rates of habitat loss and fragmentation inside the reserve unexpectedly increased to levels that were;similar to or higher than those outside the reserve, in contrast to the situation before the reserve was created.	Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Dept Syst Ecol, Beijing, Peoples R China; Chinas Ctr Giant Panda Res & Conservat, Wolong Nat Reserve, Wenchuan Cty, Sichuan Provinc, Peoples R China	Michigan State University; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Liu, JG (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, 13 Nat Resources Bldg, E Lansing, MI 48824 USA.		Liu, Jianguo/G-5211-2015	Liu, Jianguo/0000-0001-6344-0087				Armesto JJ, 1998, SCIENCE, V282, P1271, DOI 10.1126/science.282.5392.1271; BASNET K, 1992, J TROP ECOL, V8, P47, DOI 10.1017/S0266467400006076; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Caro TM, 1998, AFR J ECOL, V36, P303, DOI 10.1046/j.1365-2028.1998.00147.x; *CHIN MIN FOR WWF, 1989, CONS MAN PLAN GIANT; Dompka V, 1996, HUMAN POPULATION BIO; Forman R.T.T., 1995, LAND MOSAICS ECOLOGY; Giant Panda Expedition of the Wanglang Nature Reserve, 1974, ACTA ZOOL SINICA, V20, P162; *INT UN CONS NAT N, 1998, UN LIST PROT AR; Jensen, 2015, INTRO DIGITAL IMAGE; Kiefer R.W., 1994, REMOTE SENSING IMAGE; LIU J, IN PRESS ECOL MODEL; Liu JG, 1999, POPUL ENVIRON, V21, P45, DOI 10.1007/BF02436120; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; McGarigal Kevin, 1994, FRAGSTATS SPATIAL PA; Morrison ML, 2007, WILDLIFE HABITAT REL; Noss Reed F., 1996, P91; Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068; Sanchez-Azofeifa GA, 1999, CONSERV BIOL, V13, P407, DOI 10.1046/j.1523-1739.1999.013002407.x; Schaller G.B., 1985, GIANT PANDAS WOLONG; Schaller GB, 1994, LAST PANDA; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; STOW D, 1990, GEOCARTO INT, V3, P3; Sullivan NH, 1999, BIOTROPICA, V31, P382, DOI 10.1111/j.1744-7429.1999.tb00380.x; van Schaik Carel P., 1997, P64; van Schaik Carel P., 1997, P212	26	502	594	23	428	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					98	101		10.1126/science.1058104	http://dx.doi.org/10.1126/science.1058104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292872				2022-12-01	WOS:000167995200046
J	Hu, YL; Baud, V; Oga, T; Kim, KII; Yoshida, K; Karin, M				Hu, YL; Baud, V; Oga, T; Kim, KII; Yoshida, K; Karin, M			IKK alpha controls formation of the epidermis independently of NF-kappa B	NATURE			English	Article							DEFICIENT MICE; KINASE COMPLEX; INCONTINENTIA PIGMENTI; SIGNAL-TRANSDUCTION; BETA SUBUNIT; ACTIVATION; SKIN; PHOSPHORYLATION; DIFFERENTIATION; APOPTOSIS	The IKK alpha and IKK beta catalytic subunits of I kappaB kinase (IKK) share 51% amino-acid identity and similar biochemical activities: they both phosphorylate I kappaB proteins at serines that trigger their degradation(1-4). IKK alpha and IKK beta differ, however, in their physiological functions. IKK beta and the IKK gamma /NEMO regulatory subunit are required for activating NF-kappaB by pro-inflammatory stimuli and preventing apoptosis induced by tumour necrosis factor-alpha (refs 5-11). IKK alpha is dispensable for these functions, but is essential for developing the epidermis and its derivatives(12-15). The mammalian epidermis is composed of the basal, spinous, granular and cornified layers(16). Only basal keratinocytes can proliferate and give rise to differentiated derivatives, which on full maturation undergo enucleation to generate the cornified layer. Curiously, keratinocyte-specific inhibition of NF-kappaB, as in Ikk alpha (-/-) mice(12-15), results in epidermal thickening but does not block terminal differentiation(17,18). It has been proposed(19,20) that the epidermal defect in Ikk alpha (-/-) mice may be due to the failed activation of NF-kappaB. Here we show that the unique function of IKK alpha in control of keratinocyte differentiation is not exerted through its I kappaB kinase activity or through NF-kappaB. Instead, IKK alpha controls production of a soluble factor that induces keratinocyte differentiation.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Baud, Veronique/AAL-3950-2020; KIM, KEUN IL/D-2959-2011; Hu, Yinling/G-5682-2015; Baud, Veronique/F-7699-2013	Baud, Veronique/0000-0002-4090-718X; Hu, Yinling/0000-0002-4795-8537; Baud, Veronique/0000-0002-4090-718X				Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FISHER C, 1987, J CELL BIOL, V105, P1807, DOI 10.1083/jcb.105.4.1807; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; KNUCHEL R, 1990, VERH DEUT G, V74, P275; Li QT, 2000, GENE DEV, V14, P1729; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Makris C, 2000, MOL CELL, V5, P969, DOI 10.1016/S1097-2765(00)80262-2; May MJ, 1999, SCIENCE, V284, P271, DOI 10.1126/science.284.5412.271; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MOCK BA, 1995, GENOMICS, V27, P348, DOI 10.1006/geno.1995.1054; OETTINGER MA, 1992, TRENDS GENET, V8, P413, DOI 10.1016/0168-9525(92)90323-V; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; ROTHWARF DM, 1999, SCI STKE        1026; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630; SUN TT, 1976, CELL, V9, P511, DOI 10.1016/0092-8674(76)90033-7; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tomic-Canic M, 1998, J DERMATOL SCI, V17, P167, DOI 10.1016/S0923-1811(98)00016-4; van Hogerlinden M, 1999, CANCER RES, V59, P3299; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yoshida K, 2000, INVEST OPHTH VIS SCI, V41, P3665; YUSPA SH, 1981, NATURE, V293, P72, DOI 10.1038/293072a0; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7	30	291	307	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					710	714		10.1038/35070605	http://dx.doi.org/10.1038/35070605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287960				2022-12-01	WOS:000167875400052
J	Yue, LX; Peng, JB; Hediger, MA; Clapham, DE				Yue, LX; Peng, JB; Hediger, MA; Clapham, DE			CaT1 manifests the pore properties of the calcium-release-activated calcium channel	NATURE			English	Article							INTRACELLULAR CA2+ STORES; JURKAT T-LYMPHOCYTES; MAST-CELLS; I-CRAC; DEPLETION; TRANSPORTER; PERMEATION; INFLUX	The calcium-release-activated Ca2+ channel, I-CRAC(1-3), is a highly Ca2+-selective ion channel that is activated on depletion of either intracellular Ca2+ levels or intracellular Ca2+ stores. The unique gating of I-CRAC has made it a favourite target of investigation for new signal transduction mechanisms; however, without molecular identification of the channel protein, such studies have been inconclusive. Here we show that the protein CaT1 (ref. 4), which has six membrane-spanning domains, exhibits the unique biophysical properties of I-CRAC when expressed in mammalian cells. Like I-CRAC, expressed CaT1 protein is Ca2+ selective, activated by a reduction in intracellular Ca2+ concentration, and inactivated by higher intracellular concentrations of Ca2+. The channel is indistinguishable from I-CRAC in the following features: sequence of selectivity to divalent cations; an anomalous mole fraction effect; whole-cell current kinetics; block by lanthanum; loss of selectivity in the absence of divalent cations; and single-channel conductance to Na+ in divalent-ion-free conditions. CaT1 is activated by both passive and active depletion of calcium stores. We propose that CaT1 comprises all or part of the I-CRAC pore.	Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Membrane Biol Program, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.		Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Hediger, Matthias/0000-0003-1946-027X				CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Fasolato C, 1998, PFLUG ARCH EUR J PHY, V436, P69, DOI 10.1007/s004240050605; Fierro L, 2000, J PHYSIOL-LONDON, V522, P247, DOI 10.1111/j.1469-7793.2000.t01-1-00247.x; Fomina AF, 2000, J CELL BIOL, V150, P1435, DOI 10.1083/jcb.150.6.1435; Hille B., 1992, IONIC CHANNELS EXCIT; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kerschbaum HH, 1998, J GEN PHYSIOL, V111, P521, DOI 10.1085/jgp.111.4.521; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; LEWIS RR, 1989, WETLAND CREATION RES, V2, P1; Lewis RS, 1999, ADV SEC MESS PHOSPH, V33, P279; MONTERO M, 1990, BIOCHEM J, V271, P535, DOI 10.1042/bj2710535; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Peng JB, 2000, BIOCHEM BIOPH RES CO, V278, P326, DOI 10.1006/bbrc.2000.3716; Peng JB, 2000, J BIOL CHEM, V275, P28186; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; PUTNEY JW, 1977, J PHYSIOL-LONDON, V268, P139, DOI 10.1113/jphysiol.1977.sp011851; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	22	271	295	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					705	709		10.1038/35070596	http://dx.doi.org/10.1038/35070596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287959				2022-12-01	WOS:000167875400051
J	Muhr, J; Andersson, E; Persson, M; Jessell, TM; Ericson, J				Muhr, J; Andersson, E; Persson, M; Jessell, TM; Ericson, J			Groucho-mediated transcriptional repression establishes progenitor cell pattern and neuronal fate in the ventral neural tube	CELL			English	Article							SONIC HEDGEHOG; DROSOPHILA-ENHANCER; GENE-EXPRESSION; NERVOUS-SYSTEM; DEVELOPING CNS; HOMEODOMAIN; IDENTITY; SPECIFICATION; CLONING; MOUSE	The pattern of neuronal specification in the ventral neural tube is controlled by homeodomain transcription factors expressed by neural progenitor cells, but no general logic has emerged to explain how these proteins determine neuronal fate. We show that most of these homeodomain proteins possess a conserved ehl motif that mediates the recruitment of Gro/TLE corepressors. The ehl motif underlies the function of these proteins as repressors during neural patterning in vivo. Inhibition of Gro/TLE-mediated repression in vivo results in a deregulation of cell pattern in the neural tube. These results imply that the pattern of neurogenesis in the neural tube is achieved through the spatially controlled repression of transcriptional repressors-a derepression strategy of neuronal fate specification.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA	Karolinska Institutet; Columbia University; Howard Hughes Medical Institute	Ericson, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	johan.ericson@cmb.ki.se	Lek, Madelen/AGZ-3906-2022	andersson, elisabet/0000-0003-3095-465X; Ericson, Johan/0000-0002-8019-7127				Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Choi CY, 1999, J BIOL CHEM, V274, P31543, DOI 10.1074/jbc.274.44.31543; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; EPSTEIN J, 1994, J BIOL CHEM, V269, P8355; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; Jensen J, 1996, J BIOL CHEM, V271, P18749, DOI 10.1074/jbc.271.31.18749; Jimenez G, 1997, GENE DEV, V11, P3072, DOI 10.1101/gad.11.22.3072; Jorgensen MC, 1999, FEBS LETT, V461, P287, DOI 10.1016/S0014-5793(99)01436-2; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Leon C, 1997, DEV DYNAM, V208, P11, DOI 10.1002/(SICI)1097-0177(199701)208:1<11::AID-AJA2>3.0.CO;2-4; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Ma QF, 1997, J NEUROSCI, V17, P3644; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; Mirmira RG, 2000, J BIOL CHEM, V275, P14743, DOI 10.1074/jbc.275.19.14743; MIYASAKA H, 1993, EUR J BIOCHEM, V216, P343, DOI 10.1111/j.1432-1033.1993.tb18151.x; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pabst O, 2000, DEV GENES EVOL, V210, P47, DOI 10.1007/PL00008188; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Smith ST, 1996, DEVELOPMENT, V122, P3141; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sugiyama S, 2000, DEV BIOL, V221, P168, DOI 10.1006/dbio.2000.9643; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591; Zhang HL, 1996, P NATL ACAD SCI USA, V93, P1764, DOI 10.1073/pnas.93.5.1764	46	313	316	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2001	104	6					861	873		10.1016/S0092-8674(01)00283-5	http://dx.doi.org/10.1016/S0092-8674(01)00283-5			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290324	Bronze			2022-12-01	WOS:000167869200009
J	Gnatt, AL; Cramer, P; Fu, JH; Bushnell, DA; Kornberg, RD				Gnatt, AL; Cramer, P; Fu, JH; Bushnell, DA; Kornberg, RD			Structural basis of transcription: An RNA polymerase II elongation complex at 3.3 angstrom resolution	SCIENCE			English	Article							CRYSTAL-STRUCTURE; DNA-POLYMERASE; TERNARY COMPLEXES; INITIATION; MECHANISM; PROMOTER; HYBRID; REPLICATION; TRANSITIONS; SUBUNITS	The crystal structure of RNA polymerase II in the act of transcription was determined at 3.3 Angstrom resolution. Duplex DNA is seen entering the main cleft of the enzyme and unwinding before the active site. Nine base pairs of DNA-RNA hybrid extend from the active center at nearly right angles to the entering DNA, with the 3' end of the RNA in the nucleotide addition site. The 3' end is positioned above a pore, through which nucleotides may enter and through which RNA may be extruded during back-tracking. The 5'-most residue of the RNA is close to the point of entry to an exit groove. Changes in protein structure between the transcribing complex and free enzyme include closure of a clamp over the DNA and RNA and ordering of a series of "switches" at the base of the clamp to create a binding site complementary to the DNA-RNA hybrid. Protein-nucleic acid contacts help explain DNA and RNA strand separation, the specificity of RNA synthesis, "abortive cycling" during transcription initiation, and RNA and DNA translocation during transcription elongation.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.				NIGMS NIH HHS [GM49985] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTHOLOME K, 1982, J INHERIT METAB DIS, V5, P7, DOI 10.1007/BF01799747; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Conaway RC, 1997, PROG NUCLEIC ACID RE, V56, P327, DOI 10.1016/S0079-6603(08)61009-0; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; CRAMER P, 2001, SCIENCE, V292, P1882; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Gnatt A, 1997, J BIOL CHEM, V272, P30799, DOI 10.1074/jbc.272.49.30799; GRZESKOWIAK K, 1993, BIOCHEMISTRY-US, V32, P8923, DOI 10.1021/bi00085a025; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; JIN DJ, 1994, J MOL BIOL, V236, P72, DOI 10.1006/jmbi.1994.1119; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KINSELLA L, 1982, BIOCHEMISTRY-US, V21, P2719, DOI 10.1021/bi00540a022; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; NUDLER E, 1997, CELL, V89, P38; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poglitsch CL, 1999, CELL, V98, P791, DOI 10.1016/S0092-8674(00)81513-5; Rodriguez AC, 2000, J MOL BIOL, V299, P447, DOI 10.1006/jmbi.2000.3728; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; TINTUT Y, 1995, J BIOL CHEM, V270, P24392, DOI 10.1074/jbc.270.41.24392; Wooddell CI, 2000, BIOCHEMISTRY-US, V39, P13405, DOI 10.1021/bi0014249; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	40	717	746	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2001	292	5523					1876	1882		10.1126/science.1059495	http://dx.doi.org/10.1126/science.1059495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	440WY	11313499	Green Published			2022-12-01	WOS:000169200700040
J	Thomas, CD; Bodsworth, EJ; Wilson, RJ; Simmons, AD; Davies, ZG; Musche, M; Conradt, L				Thomas, CD; Bodsworth, EJ; Wilson, RJ; Simmons, AD; Davies, ZG; Musche, M; Conradt, L			Ecological and evolutionary processes at expanding range margins	NATURE			English	Article							BUTTERFLY HESPERIA-COMMA; METAPOPULATION MODELS; FRAGMENTED LANDSCAPES; FLIGHT MORPHOLOGY; CONSERVATION; DYNAMICS; HABITATS; BRITAIN; CLIMATE	Many animals are regarded as relatively sedentary and specialized in marginal parts of their geographical distributions(1,2). They are expected to be slow at colonizing new habitats. Despite this, the cool margins of many species' distributions have expanded rapidly in association with recent climate warming(3-10). We examined four insect species that have expanded their geographical ranges in Britain over the past 20 years. Here we report that two butterfly species have increased the variety of habitat types that they can colonize, and that two bush cricket species show increased fractions of longer-winged (dispersive) individuals in recently founded populations. Both ecological and evolutionary processes are probably responsible for these changes. Increased habitat breadth and dispersal tendencies have resulted in about 3- to 15-fold increases in expansion rates, allowing these insects to cross habitat disjunctions that would have represented major or complete barriers to dispersal before the expansions started. The emergence of dispersive phenotypes will increase the speed at which species invade new environments, and probably underlies the responses of many species to both past(11) and future climate change.	Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Thomas, CD (corresponding author), Univ Leeds, Sch Biol, Ctr Biodivers & Conservat, Leeds LS2 9JT, W Yorkshire, England.		Wilson, Robert J/I-8726-2014; Thomas, Chris D/A-1460-2014; Musche, Martin/Z-5662-2019; Conradt, Larissa/H-6309-2011; Thomas, Chris D/A-1894-2012	Wilson, Robert J/0000-0003-4477-7068; Thomas, Chris D/0000-0003-2822-1334; Musche, Martin/0000-0002-9999-0838; Thomas, Chris D/0000-0003-2822-1334				Asher J., 2001, MILLENNIUM ATLAS BUT; BOURN NAD, 1993, BIOL CONSERV, V63, P67, DOI 10.1016/0006-3207(93)90075-C; Coope G. R., 1995, P55; CWYNAR LC, 1987, AM NAT, V129, P463, DOI 10.1086/284651; Doebeli M, 1997, EVOLUTION, V51, P1730, DOI 10.1111/j.1558-5646.1997.tb05097.x; Haes ECM, 1997, ATLAS GRASSHOPPERS C; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Heath J., 1984, ATLAS BUTTERFLIES BR; Hill JK, 1999, OECOLOGIA, V121, P165, DOI 10.1007/s004420050918; Hill JK, 1999, BIOL CONSERV, V87, P277, DOI 10.1016/S0006-3207(98)00091-3; Hill JK, 1999, P ROY SOC B-BIOL SCI, V266, P1197, DOI 10.1098/rspb.1999.0763; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Marshall JA, 1988, GRASSHOPPERS ALLIED; Moilanen A, 2000, J ANIM ECOL, V69, P143, DOI 10.1046/j.1365-2656.2000.00381.x; NIEMELA J, 1991, OIKOS, V62, P351, DOI 10.2307/3545500; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Perring F.H., 1976, ATLAS BRIT FLORA; Ratnieks F.L.W., 1991, P119; THOMAS CD, 1992, OECOLOGIA, V92, P563, DOI 10.1007/BF00317850; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; THOMAS CD, 1993, J ANIM ECOL, V62, P472, DOI 10.2307/5196; Thomas Chris D., 1997, P359, DOI 10.1016/B978-012323445-2/50020-1; THOMAS JA, 1993, ECOGRAPHY, V16, P278, DOI 10.1111/j.1600-0587.1993.tb00217.x; THOMAS JA, 1986, J APPL ECOL, V23, P365, DOI 10.2307/2404023; Thomas V, 1999, J NURS CARE QUAL, V13, P1, DOI 10.1097/00001786-199906000-00003; Wahlberg N, 1996, SCIENCE, V273, P1536, DOI 10.1126/science.273.5281.1536; WIDGERY J, 2000, ORTHOPTERA RECORDING, P26; Williamson M, 1996, BIOL INVASIONS; WILSON RJ, 1999, SPATIOTEMPORAL DYNAM; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	30	637	663	1	368	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					577	581		10.1038/35079066	http://dx.doi.org/10.1038/35079066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385570	Green Accepted			2022-12-01	WOS:000168982500049
J	Coulson, T; Catchpole, EA; Albon, SD; Morgan, BJT; Pemberton, JM; Clutton-Brock, TH; Crawley, MJ; Grenfell, BT				Coulson, T; Catchpole, EA; Albon, SD; Morgan, BJT; Pemberton, JM; Clutton-Brock, TH; Crawley, MJ; Grenfell, BT			Age, sex, density, winter weather, and population crashes in Soay sheep	SCIENCE			English	Article							DYNAMICS; TRENDS; CYCLES	Quantifying the impact of density, extrinsic climatic fluctuations, and demography on population fluctuations is a persistent challenge in ecology. We analyzed the effect of these processes on the irregular pattern of population crashes of Soay sheep on the St. Kilda archipelago, United Kingdom. Because the age and sex structure of the population fluctuates independently of population size, and because animals of different age and sex respond in different ways to density and weather, identical weather conditions can result in different dynamics in populations of equal size. In addition, the strength of density-dependent processes is a function of the distribution of weather events. Incorporating demographic heterogeneities into population models can influence dynamics and their response to climate change.	Zool Soc London, Inst Zool, London NW1 4RY, England; Univ New S Wales, Univ Coll, Australian Def Force Acad, Sch Math & Stat, Canberra, ACT 2600, Australia; Hill Brathens, Ctr Ecol & Hydrol, Banchory AB31 4BY, Kincardine, Scotland; Univ Kent, Inst Math & Stat, Canterbury CT2 7NF, Kent, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ London Imperial Coll Sci Technol & Med, Ascot SL5 7PY, Berks, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Zoological Society of London; Australian Defense Force Academy; University of New South Wales Sydney; UK Centre for Ecology & Hydrology (UKCEH); University of Kent; University of Edinburgh; Imperial College London; University of Cambridge	Coulson, T (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	tnc20@cam.ac.uk	Pemberton, Josephine M/F-3100-2010; Coulson, Tim/AAL-8148-2021; ALBON, Stephen D/C-6304-2011	Coulson, Tim/0000-0001-9371-9003; ALBON, Stephen D/0000-0002-0811-1333				Bjornstad ON, 1999, P NATL ACAD SCI USA, V96, P5066, DOI 10.1073/pnas.96.9.5066; Catchpole EA, 2000, J R STAT SOC C-APPL, V49, P453, DOI 10.1111/1467-9876.00205; Caughley G., 1977, ANAL VERTEBRATE POPU; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Coulson T, 1999, J ANIM ECOL, V68, P658, DOI 10.1046/j.1365-2656.1999.00298.x; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; GRENFELL BT, 1992, NATURE, V355, P823, DOI 10.1038/355823a0; GULLAND FMD, 1992, PARASITOLOGY, V105, P493, DOI 10.1017/S0031182000074679; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; Hilborn Ray, 1997, V28; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Stearns S.C., 1992, pi; Tuljapurkar S., 1997, STRUCTURED POPULATIO; [No title captured]	17	700	715	8	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1528	1531		10.1126/science.292.5521.1528	http://dx.doi.org/10.1126/science.292.5521.1528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375487				2022-12-01	WOS:000168963800040
J	Brown, MG; Dokun, AO; Heusel, JW; Smith, HRC; Beckman, DL; Blattenberger, EA; Dubbelde, CE; Stone, LR; Scalzo, AA; Yokoyama, WM				Brown, MG; Dokun, AO; Heusel, JW; Smith, HRC; Beckman, DL; Blattenberger, EA; Dubbelde, CE; Stone, LR; Scalzo, AA; Yokoyama, WM			Vital involvement of a natural killer cell activation receptor in resistance to viral infection	SCIENCE			English	Article							GENE-COMPLEX; MOUSE CHROMOSOME-6; PHYSICAL MAP; LOCUS CMV1; IN-VIVO; LY49; MOUSE-CHROMOSOME-6; DEPLETION; SUBSETS; CONTIG	Natural killer (NK) cells are lymphocytes that can be distinguished from T and B cells through their involvement in innate immunity and their lack of rearranged antigen receptors. Although NK cells and their receptors were initially characterized in terms of tumor killing in vitro, we have determined that the NK cell activation receptor, Ly-49H, is critically involved in resistance to murine cytomegalovirus in vivo. Ly-49H requires an immunoreceptor tyrosine-based activation motif (ITAM)-containing transmembrane molecule for expression and signal transduction. Thus, NK cells use receptors functionally resembling ITAM-coupled T and B cell antigen receptors to provide vital innate host defense.	Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA; Mt Sinai Sch Med, Immunobiol Grad Program, New York, NY 10029 USA; Univ Western Australia, Dept Microbiol, Nedlands, WA 6907, Australia	Howard Hughes Medical Institute; Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; University of Western Australia	Yokoyama, WM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Div Rheumatol, St Louis, MO 63110 USA.		Brown, Michael G/AAX-5569-2021; Heusel, Jon/AAC-8050-2021	Brown, Michael G/0000-0003-2872-7685; 				Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Bakker ABH, 2000, HUM IMMUNOL, V61, P18, DOI 10.1016/S0198-8859(99)00160-3; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Brown MG, 1999, J IMMUNOL, V163, P1991; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Depatie C, 1999, INT IMMUNOL, V11, P1541, DOI 10.1093/intimm/11.9.1541; Depatie C, 2000, GENOMICS, V66, P161, DOI 10.1006/geno.2000.6186; Farrell HE, 1997, NATURE, V386, P510, DOI 10.1038/386510a0; Forbes CA, 1997, GENOMICS, V41, P406, DOI 10.1006/geno.1997.4667; Idris AH, 1999, P NATL ACAD SCI USA, V96, P6330, DOI 10.1073/pnas.96.11.6330; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Karre K, 1985, MECHANISMS CYTOTOXIC, P81; McQueen KL, 1999, IMMUNOGENETICS, V49, P685, DOI 10.1007/s002510050665; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Smith HRC, 2000, J EXP MED, V191, P1341, DOI 10.1084/jem.191.8.1341; Tay CH, 1999, J IMMUNOL, V162, P718; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Yokoyama WM, 2000, NAT IMMUNOL, V1, P95, DOI 10.1038/77878	25	487	495	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					934	937		10.1126/science.1060042	http://dx.doi.org/10.1126/science.1060042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340207				2022-12-01	WOS:000168514900045
J	Tapon, N; Ito, N; Dickson, BJ; Treisman, JE; Hariharan, IK				Tapon, N; Ito, N; Dickson, BJ; Treisman, JE; Hariharan, IK			The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation	CELL			English	Article							EKER RAT MODEL; TSC2 GENE; CYCLIN-E; S-PHASE; PHOSPHOINOSITIDE 3-KINASE; IMAGINAL DISC; PRODUCT; SIZE; HAMARTIN; EYE	The inherited human disease tuberous sclerosis, characterized by hamartomatous tumors, results from mutations in either TSC1 or TSC2. We have characterized mutations in the Drosophila Tsc1 and Tsc2/gigas genes. Inactivating mutations in either gene cause an identical phenotype characterized by enhanced growth and increased cell sire with no change in ploidy. Overall, mutant cells spend less time in G1. Coexpression of both Tsc1 and Tsc2 restricts tissue growth and reduces cell size and cell proliferation. This phenotype is modulated by manipulations in cyclin levels. In postmitotic mutant cells, levels of Cyclin E and Cyclin A are elevated. This correlates with a tendency for these cells to reenter the cell cycle inappropriately as is observed in the human lesions.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Mol Neurogenet Unit, Charlestown, MA 02129 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA	Harvard University; Massachusetts General Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); New York University; New York University	Hariharan, IK (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.		Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X; Tapon, Nicolas/0000-0001-5267-6510; Treisman, Jessica/0000-0002-7453-107X	NEI NIH HHS [EY11632] Funding Source: Medline; NIGMS NIH HHS [GM61672] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061672] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avedisov SN, 2000, MOL CELL BIOL, V20, P8220, DOI 10.1128/MCB.20.21.8220-8229.2000; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Edgar BA, 1999, NAT CELL BIOL, V1, pE191, DOI 10.1038/70217; FERRUS A, 1976, NATURE, V260, P425, DOI 10.1038/260425a0; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gomez MR, 1988, TUBEROUS SCLEROSIS; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Henry KW, 1998, J BIOL CHEM, V273, P20535, DOI 10.1074/jbc.273.32.20535; Huang H, 1999, DEVELOPMENT, V126, P5365; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Kobayashi T, 1999, CANCER RES, V59, P1206; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Miloloza A, 2000, HUM MOL GENET, V9, P1721, DOI 10.1093/hmg/9.12.1721; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Plank TL, 1998, CANCER RES, V58, P4766; Polymenis M, 1997, GENE DEV, V11, P2522, DOI 10.1101/gad.11.19.2522; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Soucek T, 1997, J BIOL CHEM, V272, P29301, DOI 10.1074/jbc.272.46.29301; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Tsuchiya H, 1996, CANCER RES, V56, P429; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; WIENECKE R, 1995, J BIOL CHEM, V270, P16409, DOI 10.1074/jbc.270.27.16409; Xiao GH, 1997, J BIOL CHEM, V272, P6097, DOI 10.1074/jbc.272.10.6097; XU T, 1993, DEVELOPMENT, V117, P1223; YEUNG RS, 1994, P NATL ACAD SCI USA, V91, P11413, DOI 10.1073/pnas.91.24.11413; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	46	429	440	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 4	2001	105	3					345	355		10.1016/S0092-8674(01)00332-4	http://dx.doi.org/10.1016/S0092-8674(01)00332-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348591	Bronze			2022-12-01	WOS:000168515900004
J	Fischbacher, C; Bhopal, R; Patel, S; White, M; Unwin, N; Alberti, KGMM				Fischbacher, C; Bhopal, R; Patel, S; White, M; Unwin, N; Alberti, KGMM			Anaemia in Chinese, South Asian, and European populations in Newcastle upon Tyne: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; RISK-FACTORS		Univ Newcastle Upon Tyne, Sch Med, Div Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Dept Diabet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Edinburgh, Dept Publ Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland	Newcastle University - UK; Newcastle University - UK; University of Edinburgh	Fischbacher, C (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Div Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		White, Martin J. R./G-2410-2010	Fischbacher, Colin/0000-0003-3090-1857; Patel, Sheila/0000-0002-0626-1899; Unwin, Nigel/0000-0002-1368-1648				Bhopal R, 1999, BRIT MED J, V319, P215, DOI 10.1136/bmj.319.7204.215; BRITT RP, 1983, POSTGRAD MED J, V59, P645, DOI 10.1136/pgmj.59.696.645; Harland JO, 1997, J EPIDEMIOL COMMUN H, V51, P636, DOI 10.1136/jech.51.6.636; *HLTH ED AUTH, 2000, BLACK ETHN MIN GROUP; *NHS CTR REV DISS, 1996, ETHN HLTH REV LIT GU	5	12	12	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					958	959		10.1136/bmj.322.7292.958	http://dx.doi.org/10.1136/bmj.322.7292.958			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312228	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000168345100018
J	Fricke, C; Lee, JS; Geiger-Rudolph, S; Bonhoeffer, F; Chien, CB				Fricke, C; Lee, JS; Geiger-Rudolph, S; Bonhoeffer, F; Chien, CB			astray, a zebrafish roundabout homolog required for retinal axon guidance	SCIENCE			English	Article							OPTIC CHIASM; C-ELEGANS; RECEPTORS; REPELLENT; MIDLINE; GENES; DISC; SLIT; MAP	As growing retinotectal axons navigate from the eye to the tectum, they sense guidance molecules distributed along the optic pathway. Mutations in the zebrafish astray gene severely disrupt retinal axon guidance, causing anterior-posterior pathfinding defects, excessive midline crossing, and defasciculation of the retinal projection, Eye transplantation experiments show that astray function is required in the eye, We identify astray as zebrafish robo2, a member of the Roundabout family of axon guidance receptors. Retinal ganglion cells express robo2 as they extend axons. Thus, robo2 is required for multiple axon guidance decisions during establishment of the Vertebrate visual projection.	Univ Utah, Med Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany; Max Planck Inst Entwicklungsbiol, Abt Phys Biol, D-72076 Tubingen, Germany	Utah System of Higher Education; University of Utah; Max Planck Society; Max Planck Society	Chien, CB (corresponding author), Univ Utah, Med Ctr, Dept Neurobiol & Anat, 401 MREB,50 N Med Dr, Salt Lake City, UT 84132 USA.				NEI NIH HHS [R01-EY12873] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012873] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baier H, 1996, DEVELOPMENT, V123, P415; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; BURRILL JD, 1995, J NEUROSCI, V15, P2935; Chien C. C., UNPUB; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Erskine L, 2000, J NEUROSCI, V20, P4975; Geisler R, 1999, NAT GENET, V23, P86, DOI 10.1038/12692; Haffter P, 1996, DEVELOPMENT, V123, P1; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; HUTSON L, UNPUB; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kruger K, 1998, J NEUROSCI, V18, P5692; LEE JS, IN PRESS DEV DYN; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Niclou SP, 2000, J NEUROSCI, V20, P4962; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	27	152	155	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					507	510		10.1126/science.1059496	http://dx.doi.org/10.1126/science.1059496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313496				2022-12-01	WOS:000168187300048
J	McCarron, P; Okasha, M; McEwen, J; Smith, GD				McCarron, P; Okasha, M; McEwen, J; Smith, GD			Changes in blood pressure among students attending Glasgow University between 1948 and 1968: analyses of cross sectional surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTH-WEIGHT; TRENDS; ADULTHOOD; MORTALITY; PATTERNS	Objectives To examine the changes in blood pressure over time in a cohort of young adults attending university between 1948 and 1968. Design Cross sectional study. Setting Glasgow University. Participants 12 414 students aged 16-25 years-9248 men (mean age 19.9 years) and 3164 women (19.2 years)-who participated in health screening on entering university between 1948 and 1968. Main outcome measures Systolic and diastolic blood pressure. Results in male students mean systolic blood pressure adjusted for age decreased from 134.5 (95% confidence interval 133.8 to 135.2) mm Hg in those born before 1929 to 125.7 (125.0 to 126.3) mm Hg in those born after 1945, and diastolic blood pressure dropped from 80.3 (79.8 to 80.8) mm Hg to 74.7 (74.2 to 75.1) nlm Hg. For female students the corresponding declines were from 129.0 (127.5 to 130.5) mm Hg to 120.6 (119.8 to 121.4) mm Hg and from 79.7 78.7 to 80.6) mm Hg to 77.0 (76.5 to 77.5) mm Hg. Adjustment for potential confounding factors made little difference to these findings. The proportion of students with hypertension declined substantially in both sexes. Conclusions Substantial declines in systolic and diastolic blood pressure over time were occurring up to 50 years ago in young adults who were not taking antihypertensive medication. Since blood pressure tracks into adult life, the results of the cross sectional comparisons suggest that factors acting in early life may be important in determining population risk of cardiovascular disease. Changes in such factors may have made important contributions to the decline in rates of cardiovascular diseases, particularly stroke, seen in developed countries during the past century.	NCI, Surveillance Res Program, Div Canc Control & Populat, Bethesda, MD 20892 USA; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bristol; University of Glasgow	McCarron, P (corresponding author), NCI, Surveillance Res Program, Div Canc Control & Populat, 6130 Execut Blvd,Execut Plaza N,Suite 4097, Bethesda, MD 20892 USA.	mccarrop@mail.nih.gov	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.157.21.2413; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; BAINES A H, 1963, Nutr Abstr Rev, V33, P653; BENNETT S, 1994, J CLIN EPIDEMIOL, V47, P293, DOI 10.1016/0895-4356(94)90010-8; Berkey CS, 1998, OBES RES, V6, P187, DOI 10.1002/j.1550-8528.1998.tb00336.x; BONITA R, 1990, STROKE, V21, P989, DOI 10.1161/01.STR.21.7.989; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Charlton J, 1997, HLTH ADULT BRITAIN 1; Ebrahim S, 1998, J PUBLIC HEALTH MED, V20, P441, DOI 10.1093/oxfordjournals.pubmed.a024800; Falkner B, 1998, HYPERTENSION, V31, P145, DOI 10.1161/01.HYP.31.1.145; Geleijnse JM, 1997, HYPERTENSION, V29, P913, DOI 10.1161/01.HYP.29.4.913; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Harland R W, 1980, Ulster Med J, V49, P37; JOHNSTON W, 1962, BRIT J PREV SOC MED, V16, P76; Law CM, 1996, J HYPERTENS, V14, P935; McCarron P, 2000, LANCET, V355, P1430, DOI 10.1016/S0140-6736(00)02146-2; McCarron P, 1999, PUBLIC HEALTH, V113, P265, DOI 10.1016/S0033-3506(99)00178-X; *MIN FOOD, 1951, URB WORK CLASS HOUS; *MIN FOOD, 1952, DOM FOOD CONS EXP 19; Montgomery SM, 2000, ARCH DIS CHILD, V82, P358, DOI 10.1136/adc.82.5.358; NELSON MJ, 1992, AM J EPIDEMIOL, V136, P633, DOI 10.1093/oxfordjournals.aje.a116543; Orr J.B., 1936, FOOD HLTH INCOME; POWER C, 1994, BRIT MED J, V308, P1270, DOI 10.1136/bmj.308.6939.1270; *STAT, 1998, STATS STAT SOFTW REL; THOMAS CB, 1969, B NEW YORK ACAD MED, V45, P831; WARD W, 1993, BIRTH WEIGHT EC GROW	26	39	41	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 14	2001	322	7291					885	888		10.1136/bmj.322.7291.885	http://dx.doi.org/10.1136/bmj.322.7291.885			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302898	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000168311300015
J	Cunningham, ML; Titus, RG; Turco, SJ; Beverley, SM				Cunningham, ML; Titus, RG; Turco, SJ; Beverley, SM			Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin	SCIENCE			English	Article							DIHYDROFOLATE-REDUCTASE; PTERIDINE REDUCTASE-1; THYMIDYLATE SYNTHASE; GENE REPLACEMENT; PROMASTIGOTES; LOCUS; RESISTANCE; PTR1; IDENTIFICATION; TARENTOLAE	A critical step in the infectious cycle of Leishmania is the differentiation of parasites within the sand fly vector to the highly infective metacyclic promastigote stage, Here, we establish tetrahydrobiopterin (H4B) levels as an important factor controlling the extent of metacyclogenesis, H4B Levels decline substantially during normal development, and genetic or nutritional manipulations showed that Low H4B caused elevated metacyclogenesis. Mutants Lacking pteridine reductase 1 (PTR1) had Low Levels of H4B, remained infectious to mice, and induced Larger cutaneous Lesions (hypervirulence), Thus, the control of pteridine metabolism has relevance to the mechanism of Leishmania differentiation and the Limitation of virulence during evolution.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Pathol, Ft Collins, CO 80523 USA; Univ Kentucky, Dept Biochem, Lexington, KY 40536 USA	Washington University (WUSTL); Colorado State University; University of Kentucky	Beverley, SM (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.			Beverley, Stephen/0000-0001-5319-0811	NIAID NIH HHS [AI31078, AI21903] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021903, R01AI031078, R37AI021903] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; BLAKLEY RL, 1985, FOLATES PTERINS, V2; COULSON RMR, 1990, MOL BIOCHEM PARASIT, V40, P63, DOI 10.1016/0166-6851(90)90080-6; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; CUNNINGHAM ML, IN PRESS MOL BIOCH P; GUILLAMON JJ, 1988, BIOCHEM BIOPH RES CO, V152, P49, DOI 10.1016/S0006-291X(88)80678-8; HADWIGER JA, 1994, P NATL ACAD SCI USA, V91, P10566, DOI 10.1073/pnas.91.22.10566; Hardy LW, 1997, EXP PARASITOL, V87, P157, DOI 10.1006/expr.1997.4207; IVANETICH KM, 1990, EXP PARASITOL, V70, P367, DOI 10.1016/0014-4894(90)90119-W; Kaufman S., 1997, TETRAHYDROBIOPTERIN; KNUEPFER E, IN PRESS BIOCH J; Kundig C, 1999, NUCLEIC ACIDS RES, V27, P3653, DOI 10.1093/nar/27.18.3653; Lemley C, 1999, MOL BIOCHEM PARASIT, V104, P93, DOI 10.1016/S0166-6851(99)00132-2; Levin BR, 1996, EMERG INFECT DIS, V2, P93, DOI 10.3201/eid0202.960203; MIWA S, 1992, FOLIA PHARMACOL JPN, V100, P367, DOI 10.1254/fpj.100.367; MOORE JS, UNPUB; Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883; Nare B, 1997, PARASITOLOGY, V114, pS101, DOI 10.1017/S0031182097001133; PAPADOPOULOU B, 1994, J BIOL CHEM, V269, P7310; PEIXOTO MP, 1987, ANTIMICROB AGENTS CH, V31, P1575, DOI 10.1128/AAC.31.10.1575; PUENTES SM, 1990, J IMMUNOL, V145, P4311; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; TITUS RG, 1995, P NATL ACAD SCI USA, V92, P10267, DOI 10.1073/pnas.92.22.10267; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; TIWARI M, UNPUB; Wang JY, 1997, ARCH BIOCHEM BIOPHYS, V342, P197, DOI 10.1006/abbi.1997.0126	26	101	108	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					285	287		10.1126/science.1057740	http://dx.doi.org/10.1126/science.1057740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303103				2022-12-01	WOS:000168074000046
J	del Portillo, HA; Fernandez-Becerra, C; Bowman, S; Oliver, K; Preuss, M; Sanchez, CP; Schneider, NK; Villalobos, JM; Rajandream, MA; Harris, D; da Silva, LHP; Barrell, B; Lanzer, M				del Portillo, HA; Fernandez-Becerra, C; Bowman, S; Oliver, K; Preuss, M; Sanchez, CP; Schneider, NK; Villalobos, JM; Rajandream, MA; Harris, D; da Silva, LHP; Barrell, B; Lanzer, M			A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax	NATURE			English	Article							ANTIGENIC VARIATION; HUMAN-ERYTHROCYTES; FALCIPARUM; MALARIA; SURFACE; SEQUENCE; FAMILY; EXPRESSION; RIF; DNA	The malarial parasite Plasmodium vivax causes disease in humans, including chronic infections and recurrent relapses, but the course of infection is rarely fatal(1,2), unlike that caused by Plasmodium falciparum. To investigate differences in pathogenicity between P. vivax and P. falciparum, we have compared the subtelomeric domains in the DNA of these parasites. In P. falciparum, subtelomeric domains are conserved and contain ordered arrays of members of multigene families, such as var(3-5), rif(6,7) and stevor(8), encoding virulence determinants of cytoadhesion and antigenic variation. Here we identify, through the analysis of a continuous 155,711-base-pair sequence of a P. vivax chromosome end, a multigene family called vir, which is specific to P. vivax. The vir genes are present at about 600-1,000 copies per haploid genome and encode proteins that are immunovariant in natural infections, indicating that they may have a functional role in establishing chronic infection through antigenic variation.	Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508900 Sao Paulo, Brazil; Sanger Ctr, Pathogen Sequencing Unit, Hinxton CB10 1SA, England; Heidelberg Univ, Inst Hyg, Abt Parasitol, INF 324, D-69120 Heidelberg, Germany; Ctr Pesquisa Med Trop, BR-78900000 Porto Velho, Rondonia, Brazil	Universidade de Sao Paulo; Wellcome Trust Sanger Institute; Ruprecht Karls University Heidelberg	del Portillo, HA (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Av Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.	hernando@icb.usp.br	Fernandez Becerra, Carmen/L-2069-2014; Lanzer, Michael/E-9752-2013; del Portillo, Hernando A/L-2131-2014	Fernandez Becerra, Carmen/0000-0001-5154-0013; Lanzer, Michael/0000-0002-0220-6526; del Portillo, Hernando A/0000-0002-5278-3452				Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Camargo AA, 1997, GENOMICS, V42, P467, DOI 10.1006/geno.1997.4758; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; DAVID PH, 1988, BIOL CELL, V64, P251, DOI 10.1016/0248-4900(88)90084-6; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Galinski MR, 1996, PARASITOL TODAY, V12, P20, DOI 10.1016/0169-4758(96)80641-7; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Golenda CF, 1997, P NATL ACAD SCI USA, V94, P6786, DOI 10.1073/pnas.94.13.6786; HALL R, 1984, NATURE, V311, P379, DOI 10.1038/311379a0; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; LEVITUS G, 1994, AM J TROP MED HYG, V51, P68, DOI 10.4269/ajtmh.1994.51.68; MCCUTCHAN TF, 1984, SCIENCE, V225, P808, DOI 10.1126/science.6382604; MENDIS KN, 1988, AM J TROP MED HYG, V38, P42, DOI 10.4269/ajtmh.1988.38.42; OLIVEIRA CI, 1999, VACCINE, V17, P2959; Persson B, 2000, EXS, V88, P215; PONZI M, 1985, EMBO J, V4, P2991, DOI 10.1002/j.1460-2075.1985.tb04034.x; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; VAUDIN M, 1995, NUCLEIC ACIDS RES, V23, P670, DOI 10.1093/nar/23.4.670; VERNICK KD, 1988, MOL BIOCHEM PARASIT, V28, P85, DOI 10.1016/0166-6851(88)90055-2; VOLLER A, 1971, B WORLD HEALTH ORGAN, V45, P524	26	179	183	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					839	842		10.1038/35071118	http://dx.doi.org/10.1038/35071118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298455				2022-12-01	WOS:000168021900061
J	Hippisley-Cox, J; Pringle, M; Crown, N; Meal, A; Wynn, A				Hippisley-Cox, J; Pringle, M; Crown, N; Meal, A; Wynn, A			Sex inequalities in ischaemic heart disease in general practice: cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANGINA; WOMEN; ACCESS; MEN	Objective To study differences in treatment for men and women with ischaemic heart disease by using. standards defined in England's national service framework for coronary artery disease. Design Cross sectional survey using routinely collected data. Setting 18 practices in 18 primary care groups in Trent Region. Subjects 5891 men and women aged over 35 years with a diagnosis of ischaemic hart disease or prescription for nitrates recorded on computer. Min outcome measure Difference in the proportion of men and women with ischaemic heart disease and taking lipid lowering treatment. Results Women were less likely than men to have a recording of body mass index (79% (2197/2783) v 82% (2552/3102), P = 0.002), smoking (86% (2386) v 89% (2779), P<0.0001), and blood pressure (95% (2643) v 96% (2986), P=0.04). Women were also less likely to have a recording of fasting cholesterol concentration (35% (968) v 50% (1550), P < 0.0001) but were more likely to be obese (25% (558/2197) v 20% (514/2552), P < 0.0001) and have their most recently recorded blood pressure value over the recommended 140/85 mm Hg (60% (1598/2643) v 52% (1553/2986), P < 0.0001). Although a higher proportion of women had a raised serum cholesterol concentration (77% (749/968) v 67% (1043/1550), P<0.0001), men were more likely to take aspirin (76% (2358) v 71% (1979), P<0.0001), have a recorded diagnosis of hyperlipidaemia, (13% (418) v 10% (274), P<0.0001), and be prescribed lipid lowering drugs (31% (973) v 21% (596), P<0.0001). These differences remained despite adjustments for the practice where the patient is registered, age, smoking status, obesity, diabetes, and hypertension. Conclusion The results suggest a systematic bias towards men compared with women in terms of secondary prevention of ischaemic heart disease.	Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England; Collingham Med Ctr, Collingham NG23 7LB, England; Queens Med Ctr, Sch Med, Sch Nursing, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020; Meal, Andy/B-9083-2008	Hippisley-Cox, Julia/0000-0002-2479-7283; 				Bouvy ML, 1999, BRIT J GEN PRACT, V49, P299; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; CANNON PJ, 1988, LANCET, V1, P979; *DEP HLTH, 1998, OUR HLTH NAT; Department of Health, 2000, NAT SERV FRAM COR AR; HAMMERSLEY V, 1998, J INF PRIMARY CARE, V1, P3; Hippisley-Cox J, 2000, BRIT J GEN PRACT, V50, P449; KEE F, 1993, BRIT MED J, V307, P1305, DOI 10.1136/bmj.307.6915.1305; MCLAUGHLIN T, 1996, ARCH INTERN MED, P156; PEDERSEN TR, 1994, LANCET, V344, P1383; Royal College of General Practitioners Office of Population Consensus & Survey. Department of Health, 1995, MORB STAT GEN PRACT; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SPENCER I, 1995, BRIT MED J, V310, P1576, DOI 10.1136/bmj.310.6994.1576; Vogels EA, 1999, BRIT J GEN PRACT, V49, P963; Whitelaw FG, 1996, BRIT J GEN PRACT, V46, P181	15	98	98	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2001	322	7290					832	834A		10.1136/bmj.322.7290.832	http://dx.doi.org/10.1136/bmj.322.7290.832			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290638	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000168063000025
J	Kiesecker, JM; Blaustein, AR; Belden, LK				Kiesecker, JM; Blaustein, AR; Belden, LK			Complex causes of amphibian population declines	NATURE			English	Article							UV-B PENETRATION; EL-NINO; CLIMATE-CHANGE; CONSEQUENCES; RADIATION; ACIDIFICATION; VARIABILITY; MORTALITY; AMERICA; TRENDS	Amphibian populations have suffered widespread declines and extinctions in recent decades. Although climatic changes, increased exposure to ultraviolet-B (UV-B) radiation and increased prevalence of disease have all been implicated at particular localities(1-6), the importance of global environmental change remains unclear. Here we report that pathogen outbreaks in amphibian populations in the western USA are linked to climate-induced changes in UV-B exposure. Using long-term observational data and a field experiment, we examine patterns among interannual variability in precipitation, UV-B exposure and infection by a pathogenic oomycete, Saprolegnia ferax. Our findings indicate that climate-induced reductions in water depth at oviposition sites have caused high mortality of embryos by increasing their exposure to UV-B radiation and, consequently, their vulnerability to infection(1). Precipitation, and thus water depth/UV-B exposure, is strongly linked to El Nino/Southern Oscillation cycles, underscoring the role of large-scale climatic patterns involving the tropical Pacific(7). Elevated sea-surface temperatures in this region since the mid-1970s, which have affected the climate over much of the world(8), could be the precursor for pathogen-mediated amphibian declines in many regions(1,3,4,9).	Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Oregon State University	Kiesecker, JM (corresponding author), Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA.			Belden, Lisa/0000-0002-3514-3920				[Anonymous], 1997, NATURAL HIST AMPHIBI; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; BLAUSTEIN AR, 1994, BIOL CONSERV, V67, P251, DOI 10.1016/0006-3207(94)90616-5; BLAUSTEIN AR, 1994, P NATL ACAD SCI USA, V91, P1791, DOI 10.1073/pnas.91.5.1791; BLAUSTEIN AR, 1997, EFFECTS OZONE DEPLET, P175; BLUMTHALER M, 1990, SCIENCE, V248, P206, DOI 10.1126/science.2326634; Epstein PR, 1999, SCIENCE, V285, P347, DOI 10.1126/science.285.5426.347; GRAHAM NE, 1995, SCIENCE, V267, P661; Guilderson TP, 1998, SCIENCE, V281, P240, DOI 10.1126/science.281.5374.240; Hader DP, 1999, PHOTOCHEM PHOTOBIOL, V69, p23S; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; KERR JB, 1993, SCIENCE, V262, P1032, DOI 10.1126/science.262.5136.1032; Kiesecker JM, 1997, CONSERV BIOL, V11, P214, DOI 10.1046/j.1523-1739.1997.95509.x; Kiesecker JM, 1999, ECOLOGY, V80, P2442, DOI 10.1890/0012-9658(1999)080[2442:PRCBLA]2.0.CO;2; KIESECKER JM, 1995, P NATL ACAD SCI USA, V92, P11049, DOI 10.1073/pnas.92.24.11049; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lima M, 1999, AM NAT, V153, P476, DOI 10.1086/303191; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Meehl GA, 1996, NATURE, V382, P56, DOI 10.1038/382056a0; NUSSBAUM RA, 1983, AMPHIBIAN REPTILES P; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; REDMOND KT, 1991, WATER RESOUR RES, V27, P2381, DOI 10.1029/91WR00690; Schindler DW, 1996, NATURE, V379, P705, DOI 10.1038/379705a0; STOLARSKI R, 1992, SCIENCE, V256, P342, DOI 10.1126/science.256.5055.342; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Yan ND, 1996, NATURE, V381, P141, DOI 10.1038/381141a0	30	512	603	3	199	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					681	684		10.1038/35070552	http://dx.doi.org/10.1038/35070552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287952				2022-12-01	WOS:000167875400044
J	Pockley, P				Pockley, P			Climate change transforms island ecosystem	NATURE			English	News Item																			0	5	6	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 5	2001	410	6829					616	616		10.1038/35070741	http://dx.doi.org/10.1038/35070741			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287909	Bronze			2022-12-01	WOS:000167875400006
J	Balmford, A; Moore, JL; Brooks, T; Burgess, N; Hansen, LA; Williams, P; Rahbek, C				Balmford, A; Moore, JL; Brooks, T; Burgess, N; Hansen, LA; Williams, P; Rahbek, C			Conservation conflicts across Africa	SCIENCE			English	Article							PATTERNS; DISTRIBUTIONS; PRODUCTIVITY; ENDEMISM	There is increasing evidence that areas of outstanding conservation importance may coincide with dense human settlement or impact. We tested the generality of these findings using 1 degrees -resolution data for sub-Saharan Africa. We find that human population density is positively correlated with species richness of birds, mammals, snakes, and amphibians. This association holds for widespread, narrowly endemic, and threatened species and looks set to persist in the face of foreseeable population growth. Our results contradict earlier expectations of low conflict based on the idea that species richness decreases and human impact increases with primary productivity. We find that across Africa, both variables instead exhibit unimodal relationships with productivity. Modifying priority-setting to take account of human density shows that, at this scale, conflicts between conservation and development are not easily avoided, because many densely inhabited grid cells contain species found nowhere else.	Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England; Univ Copenhagen, Museum Zool, DK-2100 Copenhagen O, Denmark; Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20036 USA; Wildlife Conservat Soc Tanzania, Morogoro, Tanzania; Nat Hist Museum, Biogeog & Conservat Lab, London SW7 5BD, England	University of Cambridge; University of Copenhagen; Conservation International; Natural History Museum London	Balmford, A (corresponding author), Univ Cambridge, Dept Zool, Conservat Biol Grp, Downing St, Cambridge CB2 3EJ, England.	a.balmford@zoo.cam.ac.uk	Rahbek, Carsten/D-9372-2013; Rahbek, Carsten/L-1129-2013; Moore, Joslin/AAE-3819-2020; Moore, Joslin L/C-5270-2009	Rahbek, Carsten/0000-0003-4585-0300; Moore, Joslin/0000-0001-9809-5092; Moore, Joslin L/0000-0001-9809-5092; Balmford, Andrew/0000-0002-0144-3589; Brooks, Thomas/0000-0001-8159-3116				Abbitt RJF, 2000, BIOL CONSERV, V96, P169, DOI 10.1016/S0006-3207(00)00064-1; Adams Jonathan S., 1992, MYTH WILD AFRICA; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; BALMFORD A, 1994, NATURE, V372, P623, DOI 10.1038/372623a0; Bell R.H.V., 1987, P79; BROOKS T, IN PRESS BIOSCIENCE; Burgess N. D., 1998, SPECIES, V30, P16; *CIESIN IFPRI WRI, 2000, GRIDD POP WORLD GPW; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Cliff A., 1981, SPATIAL PROCESSES MO; DEICHMANN U, 1997, POPULATION DENSITY A; DEKLERK H, 1998, THESIS U CAPE TOWN C; Diamond J, 1997, GUNS GERMS STEEL; FJELDSA J, 1997, TROPICAL FOREST REMN; Gaston Kevin J., 1996, P202; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; HUSTON M, 1994, SCIENCE, V265, P458, DOI 10.1126/science.265.5171.458; IUCN, 2000, 2000 IUCN RED LIST T; Lan DY, 2000, ORYX, V34, P275, DOI 10.1017/S0030605300031343; LARSEN JB, 1997, THESIS U COPENHAGEN; LEGENDRE P, PERMUTE VERSION 3 4; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Musters CJM, 2000, SCIENCE, V287, P1759, DOI 10.1126/science.287.5459.1759; Nantel P, 1998, BIOL CONSERV, V84, P223, DOI 10.1016/S0006-3207(97)00133-X; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; PAGEL MD, 1991, AM NAT, V137, P791, DOI 10.1086/285194; Rahbek C, 2000, P ROY SOC B-BIOL SCI, V267, P2259, DOI 10.1098/rspb.2000.1277; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; SCOTT JM, 1993, WILDLIFE MONOGR, P1; *UN, 2000, REV WORLD POP EST PR; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wessels KJ, 2000, ANIM CONSERV, V3, P67, DOI 10.1017/S1367943000000755; WILLIAMS PH, 1996, WORLDMAP 4 WINDOWS S; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432; Wright David H., 1993, P66; [No title captured]	36	395	416	2	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2616	2619		10.1126/science.291.5513.2616	http://dx.doi.org/10.1126/science.291.5513.2616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283376				2022-12-01	WOS:000167861000046
J	Sacco, RL; Benson, RT; Kargman, DE; Boden-Albala, B; Tuck, C; Lin, IF; Cheng, JF; Paik, MC; Shea, S; Berglund, L				Sacco, RL; Benson, RT; Kargman, DE; Boden-Albala, B; Tuck, C; Lin, IF; Cheng, JF; Paik, MC; Shea, S; Berglund, L			High-density lipoprotein cholesterol and ischemic stroke in the elderly - The northern Manhattan stroke study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; SERUM-CHOLESTEROL; CARDIOVASCULAR-DISEASE; CEREBRAL INFARCTION; HDL CHOLESTEROL; ARTERY-DISEASE; RACE-ETHNICITY; PLASMA-LIPIDS	Context Elevated high-density lipoprotein cholesterol (HDL-C) levels have been shown to be protective against cardiovascular disease. However, the association of specific lipoprotein classes and ischemic stroke has not been well defined, particularly in higher risk minority populations. Objective To evaluate the association between HDL-C and ischemic stroke in an elderly, racially or ethnically diverse population. Design Population-based, incident case-control study conducted July 1993 through June 1997. Setting A multiethnic community in northern Manhattan, New York, NY. Participants Cases (n = 539) of first ischemic stroke (67% aged greater than or equal to 65 years; 55% women; 53% Hispanic, 28% black, and 19% white) were enrolled and matched by age, sex, and race or ethnicity to stroke-free community residents (controls; n=905). Main Outcome Measure Independent association of fasting HDL-C levels, determined at enrollment, with ischemic stroke, including atherosclerotic and nonatherosclerotic ischemic stroke subtypes. Results After risk factor adjustment, a protective effect was observed for HDL-C levels of at least 35 mg/dL (0.91 mmol/L) (odds ratio [OR], 0.53; 95% confidence interval [CI], 0.39-0.72). A dose-response relationship was observed (OR, 0.65; 95% CI, 0.47-0.90 and OR, 0.31; 95% CI,0.21-0.46) for HDL-C levels of 35 to 49 mg/dL (0.91-1.28 mmol/L) and at least 50 mg/dL (1.29 mmol/L), respectively. The protective effect of a higher HDL-C level was significant among participants aged 75 years or older (OR, 0.51;95% CI,0.27-0.94), was more potent for the atherosclerotic stroke subtype (OR, 0.20; 95% CI, 0.08-0.50), and was present in all 3 racial or ethnic groups studied. Conclusions Increased HDL-C levels are associated with reduced risk of ischemic stroke in the elderly and among different racial or ethnic groups. These data add to the evidence relating lipids to stroke and support HDL-C as an important modifiable stroke risk factor.	Columbia Univ, Mailman Sch Publ Hlth, Dept Neurol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Gertrude H Sergievsky Ctr, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Med, Div Gen Med, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Med, Div Prevent Med & Nutr, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Irving Ctr Clin Res, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Coll Phys & Surg, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Div Epidemiol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Div Sociomed Sci, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Div Biostat, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Sacco, RL (corresponding author), Neurol Inst, 710 W 168th St, New York, NY 10032 USA.	rsl1@columbia.edu	Sacco, Ralph/Y-9278-2019; Albala, Bernadette Boden/J-5703-2013	Albala, Bernadette Boden/0000-0001-5664-2342; Boden-Albala, Bernadette/0000-0002-3752-329X; Berglund, Lars/0000-0001-6705-1791	NCRR NIH HHS [2 M01 RR00645] Funding Source: Medline; NIA NIH HHS [AG15294] Funding Source: Medline; NINDS NIH HHS [R01 NS29993, T32 NS07153, R01 NS27517] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029993, R01NS027517, T32NS007153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG015294] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ballantyne CM, 1999, CIRCULATION, V99, P736, DOI 10.1161/01.CIR.99.6.736; BENFANTE R, 1994, STROKE, V25, P814, DOI 10.1161/01.STR.25.4.814; BIHARIVARGA M, 1981, ATHEROSCLEROSIS, V40, P337, DOI 10.1016/0021-9150(81)90144-1; Blauw GJ, 1997, STROKE, V28, P946, DOI 10.1161/01.STR.28.5.946; Bureau of the Census, 1990, 1990 CENS POP HOUS; Casper ML, 1997, ANN EPIDEMIOL, V7, P146, DOI 10.1016/S1047-2797(96)00113-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; CORTI MC, 1995, JAMA-J AM MED ASSOC, V274, P539, DOI 10.1001/jama.274.7.539; Crouse JR, 1999, AM J CARDIOL, V83, P1476, DOI 10.1016/S0002-9149(99)00153-8; DEMPSEY RJ, 1990, NEUROSURGERY, V27, P343, DOI 10.1227/00006123-199009000-00001; FINEEDELSTEIN JS, 1994, NEUROLOGY, V44, P1046, DOI 10.1212/WNL.44.6.1046; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gan R, 1997, NEUROLOGY, V48, P1204, DOI 10.1212/WNL.48.5.1204; GENEST JJ, 1991, AM J CARDIOL, V67, P1185, DOI 10.1016/0002-9149(91)90924-A; GOLDBOURT U, 1977, AM J EPIDEMIOL, V105, P75, DOI 10.1093/oxfordjournals.aje.a112358; Goldbourt U, 1997, ARTERIOSCL THROM VAS, V17, P107, DOI 10.1161/01.ATV.17.1.107; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; Gorelick PB, 1997, NEUROEPIDEMIOLOGY, V16, P107, DOI 10.1159/000109679; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; HOWARD G, 1994, STROKE, V25, P2120, DOI 10.1161/01.STR.25.11.2120; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kargman DE, 1998, ATHEROSCLEROSIS, V139, P391, DOI 10.1016/S0021-9150(98)00085-9; KITTNER SJ, 1990, JAMA-J AM MED ASSOC, V264, P1267, DOI 10.1001/jama.264.10.1267; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; LINDENSTROM E, 1994, BMJ-BRIT MED J, V309, P11, DOI 10.1136/bmj.309.6946.11; MACKNESS MI, 1993, BIOCHEM J, V294, P829, DOI 10.1042/bj2940829; MENDEZ I, 1987, NEUROLOGY, V37, P507, DOI 10.1212/WNL.37.3.507; MILLER GJ, 1975, LANCET, V1, P16; MURAI A, 1981, STROKE, V12, P167, DOI 10.1161/01.STR.12.2.167; NUBIOLA AR, 1981, ARCH NEUROL-CHICAGO, V38, P468, DOI 10.1001/archneur.1981.00510070102026; OLEARY DH, 1992, STROKE, V23, P1752, DOI 10.1161/01.STR.23.12.1752; Packard CJ, 1998, CIRCULATION, V97, P1440; PEDERSEN TR, 1995, LANCET, V345, P1274; QIZILBASH N, 1991, BRIT MED J, V303, P605, DOI 10.1136/bmj.303.6803.605; Qizilbash N, 1995, LANCET, V346, P1647; QIZILBASH N, 1992, CEREBROVASC DIS, V2, P127, DOI 10.1159/000109004; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Rosenson RS, 1998, JAMA-J AM MED ASSOC, V279, P1643, DOI 10.1001/jama.279.20.1643; RUBINS HB, 1995, AM J CARDIOL, V75, P1196, DOI 10.1016/S0002-9149(99)80761-9; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacco RL, 1998, STROKE, V29, P380, DOI 10.1161/01.STR.29.2.380; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Sacco RL, 1997, STROKE, V28, P929, DOI 10.1161/01.STR.28.5.929; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SAGIV M, 1994, INT J SPORTS MED, V15, P261, DOI 10.1055/s-2007-1021057; SALONEN R, 1988, ARTERIOSCLEROSIS, V8, P788, DOI 10.1161/01.ATV.8.6.788; SRIDHARAN R, 1992, NEUROEPIDEMIOLOGY, V11, P24, DOI 10.1159/000110903; Tanne David, 1997, Stroke, V28, P250; TASKINEN MR, 1987, AM HEART J, V113, P458, DOI 10.1016/0002-8703(87)90614-4; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; White HD, 2000, NEW ENGL J MED, V343, P317, DOI 10.1056/NEJM200008033430502; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOO J, 1990, STROKE, V21, P1407, DOI 10.1161/01.STR.21.10.1407; WOOD PD, 1988, NEW ENGL J MED, V319, P1173, DOI 10.1056/NEJM198811033191801; YAARI S, 1981, LANCET, V1, P1011; ZIMETBAUM P, 1992, ARTERIOSCLER THROMB, V12, P416, DOI 10.1161/01.ATV.12.4.416	61	210	222	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2729	2735		10.1001/jama.285.21.2729	http://dx.doi.org/10.1001/jama.285.21.2729			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386928	Bronze			2022-12-01	WOS:000168985800025
J	Liu, T; DeCostanzo, AJ; Liu, XX; Wang, HY; Hallagan, S; Moon, RT; Malbon, CC				Liu, T; DeCostanzo, AJ; Liu, XX; Wang, HY; Hallagan, S; Moon, RT; Malbon, CC			G protein signaling from activated rat Frizzled-1 to the beta-catenin-Lef-Tcf pathway	SCIENCE			English	Article							F9 TERATOCARCINOMA CELLS; ADRENERGIC RECEPTORS; WNT; DIFFERENTIATION; MEMBER; FAMILY; XWNT-8	The frizzled receptors, which mediate development and display seven hydrophobic, membrane-spanning segments, are cell membrane-localized. We constructed a chimeric receptor with the ligand-binding and transmembrane segments from the beta (2)-adrenergic receptor (beta (2)AR) and the cytoplasmic domains from rat Frizzled-1 (Rfz1). Stimulation of mouse F9 clones expressing the chimera (beta (2)AR-Rfz1) with the beta -adrenergic agonist isoproterenol stimulated stabilization of beta -catenin, activation. of a beta -catenin-sensitive promoter, and formation of primitive endoderm. The response was blocked by inactivation of pertussis toxin-sensitive, heterotrimeric guanine nucleotide-binding proteins (G proteins) and by depletion of G alphaq and G alphao. Thus, G proteins are elements of Wnt/Frizzled-1 signaling to the beta -catenin-lymphoid-enhancer factor (LEF)-T cell factor (Tcf) pathway.	SUNY Stony Brook, Univ Med Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Univ Med Ctr, Dept Physiol, Diabet & Metab Dis Res Ctr, Stony Brook, NY 11794 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Ctr Dev Biol, Seattle, WA 98195 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Malbon, CC (corresponding author), SUNY Stony Brook, Univ Med Ctr, Dept Mol Pharmacol, Stony Brook, NY 11794 USA.		malbon, craig/ABF-3604-2020; Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408				Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CHAN SDH, 1992, J BIOL CHEM, V267, P25202; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu T, 1999, J BIOL CHEM, V274, P33539, DOI 10.1074/jbc.274.47.33539; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; MAGUIRE ME, 1976, MOL PHARMACOL, V12, P335; MALBAN CC, UNPUB; MALBON CC, 1980, J BIOL CHEM, V255, P8692; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MOON RT, 1993, DEVELOPMENT, V119, P97; Polakis P, 2000, GENE DEV, V14, P1837; ROS M, 1988, J BIOL CHEM, V263, P4362; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; WANG H, UNPUB; WANG HY, 1992, NATURE, V358, P334, DOI 10.1038/358334a0; Wu CL, 2000, DEVELOPMENT, V127, P2773; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	20	203	209	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1718	1722		10.1126/science.1060100	http://dx.doi.org/10.1126/science.1060100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387477				2022-12-01	WOS:000169031800046
J	Natelson, BH				Natelson, BH			Chronic fatigue syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; COGNITIVE-BEHAVIOR THERAPY; ORTHOSTATIC INTOLERANCE; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS; SUBSTANCE-P; FIBROMYALGIA; DEPRESSION; HYPOTENSION; DEFINITION		Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurosci, Chron Fatigue Syndrome Cooperat Res Ctr, Newark, NJ 07103 USA; Vet Affairs Med Ctr, E Orange, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Natelson, BH (corresponding author), New Jersey Med Sch, Fatigue Res Ctr, 88 Ross St, E Orange, NJ 07018 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI032246] Funding Source: NIH RePORTER; NIAID NIH HHS [AI32246] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOUHOLAIGAH I, 1995, JAMA-J AM MED ASSOC, V274, P961, DOI 10.1001/jama.274.12.961; BUCHWALD D, 1994, ARCH INTERN MED, V154, P2049, DOI 10.1001/archinte.154.18.2049; Christodoulou C, 1998, J NEUROL NEUROSUR PS, V64, P431, DOI 10.1136/jnnp.64.4.431; Cook DB, 2001, INT J NEUROSCI, V107, P1, DOI 10.3109/00207450109149754; De Meirleir K, 2000, AM J MED, V108, P99, DOI 10.1016/S0002-9343(99)00300-9; Deale A, 1997, AM J PSYCHIAT, V154, P408; DELUCA J, 1995, J NEUROL NEUROSUR PS, V58, P38, DOI 10.1136/jnnp.58.1.38; DeLuca J, 1997, J NEUROL NEUROSUR PS, V62, P151, DOI 10.1136/jnnp.62.2.151; Evengard B, 1998, PAIN, V78, P153, DOI 10.1016/S0304-3959(98)00134-1; FRIEDBERG F, 1994, CLIN INFECT DIS, V18, pS105, DOI 10.1093/clinids/18.Supplement_1.S105; FRIEDBERG F, 2000, J CHRONIC FATIGUE SY, V5, P149; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GOLD D, 1990, JAMA-J AM MED ASSOC, V264, P48, DOI 10.1001/jama.264.1.48; HICKIE I, 1995, PSYCHOL MED, V25, P925, DOI 10.1017/S0033291700037417; HOLMES GP, 1988, ANN INTERN MED, V108, P387, DOI 10.7326/0003-4819-108-3-387; Hotopf M, 1996, J NEUROL NEUROSUR PS, V60, P504, DOI 10.1136/jnnp.60.5.504; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Johnson SK, 1996, PSYCHOSOM MED, V58, P50, DOI 10.1097/00006842-199601000-00008; Johnson SK, 1996, J AFFECT DISORDERS, V39, P21, DOI 10.1016/0165-0327(96)00015-8; JOHNSON SK, 1996, J PSYCHIAT RES, V31, P9; KATON W, 1992, ARCH INTERN MED, V152, P1604, DOI 10.1001/archinte.152.8.1604; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; LaManca JJ, 1999, CLIN PHYSIOL, V19, P111; Lange G, 1999, J NEUROL SCI, V171, P3, DOI 10.1016/S0022-510X(99)00243-9; Lerner AM, 1997, INFECT DIS CLIN PRAC, V6, P327; LLOYD AR, 1993, AM J MED, V94, P197, DOI 10.1016/0002-9343(93)90183-P; Natelson BH, 1999, J AFFECT DISORDERS, V53, P179, DOI 10.1016/S0165-0327(98)00118-9; Natelson BH., 1998, FACING FIGHTING FATI; Parker J C, 1993, Arthritis Care Res, V6, P207, DOI 10.1002/art.1790060407; Poole J, 2000, ARCH INTERN MED, V160, P3461, DOI 10.1001/archinte.160.22.3461; Rowe PC, 2001, JAMA-J AM MED ASSOC, V285, P52, DOI 10.1001/jama.285.1.52; RUSSELL IJ, 1994, ARTHRITIS RHEUM-US, V37, P1593, DOI 10.1002/art.1780371106; Schondorf R, 1999, J AUTONOM NERV SYST, V75, P192, DOI 10.1016/S0165-1838(98)00177-5; Scott LV, 1999, FUNCT NEUROL, V14, P3; Sharpe M, 1996, BRIT MED J, V312, P22, DOI 10.1136/bmj.312.7022.22; Stewart JM, 1999, PEDIATRICS, V103, P116, DOI 10.1542/peds.103.1.116; STRAYER DR, 1994, CLIN INFECT DIS, V18, pS88, DOI 10.1093/clinids/18.Supplement_1.S88; Streeten D. H., 1998, J CHRONIC FATIGUE SY, V4, P3, DOI 10.1300/J092v04n01_02; Streeten DHP, 1998, CLIN AUTON RES, V8, P119, DOI 10.1007/BF02267822; STROBER W, 1994, CHRONIC FATIGUE SYND, P207; Thompson D, 1998, AM J PSYCHIAT, V155, P824; vonMikecz A, 1997, ARTHRITIS RHEUM-US, V40, P295; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Wessely S, 1998, CHRONIC FATIGUE ITS; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475; Zhang QW, 1999, CLIN DIAGN LAB IMMUN, V6, P6, DOI 10.1128/CDLI.6.1.6-13.1999; Zhang QW, 2000, CHRONOBIOL INT, V17, P95, DOI 10.1081/CBI-100101035	47	23	26	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2001	285	20					2557	2559		10.1001/jama.285.20.2557	http://dx.doi.org/10.1001/jama.285.20.2557			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433LY	11368714				2022-12-01	WOS:000168761900002
J	Brown, DWG				Brown, DWG			Foot and mouth disease in human beings	LANCET			English	Editorial Material									Cent Publ Hlth Lab, Enter Resp & Neurol Virus Lab, London NW9 5HT, England	Public Health England	Brown, DWG (corresponding author), Cent Publ Hlth Lab, Enter Resp & Neurol Virus Lab, London NW9 5HT, England.							ARMSTRONG R, 1967, BMJ-BRIT MED J, V4, P529, DOI 10.1136/bmj.4.5578.529; BAUER K, 1997, ARCH VIROL, V13, P95; PILZ W, 1965, ZENTBL BAKTERIOLOG P, V198, P154; SELLERS R F, 1970, Journal of Hygiene, V68, P565; SELLERS RF, 1971, VET REC, V89, P447, DOI 10.1136/vr.89.16.447-a; 1967, LANCET, V1, P961; 2001, CDR WEEKLY      0503, P3	7	4	4	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 12	2001	357	9267					1463	1463		10.1016/S0140-6736(00)04670-5	http://dx.doi.org/10.1016/S0140-6736(00)04670-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431CL	11377592				2022-12-01	WOS:000168614300004
J	Chen, J; Rathore, SS; Radford, MJ; Wang, Y; Krumholz, HM				Chen, J; Rathore, SS; Radford, MJ; Wang, Y; Krumholz, HM			Racial differences in the use of cardiac catheterization after acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-VETERANS-AFFAIRS; HOSPITAL DISCHARGE SURVEY; HEART-DISEASE; UNITED-STATES; RACE; BLACK; MANAGEMENT; MORTALITY; OUTCOMES; CARE	Background: Several studies have reported that black patients are less likely than white patients to undergo cardiac catheterization after acute myocardial infarction. The role of the race of the physician in this pattern is unknown. Methods: We analyzed data from the Cooperative Cardiovascular Project, a study of Medicare beneficiaries hospitalized for acute myocardial infarction in 1994 and 1995, to evaluate whether differences between black patients and white patients in the use of cardiac catheterization within 60 days after acute myocardial infarction varied according to the race of their attending physician. Results: Our study cohort consisted of 35,676 white and 4039 black patients with acute myocardial infarction who were treated by 17,550 white and 588 black physicians. Black patients had lower rates of cardiac catheterization than white patients, regardless of whether their attending physician was white (rate of catheterization, 38.4 percent vs. 45.7 percent; P<0.001) or black (38.2 percent vs. 49.6 percent, P<0.001). We did not find a significant interaction between the race of the patients and the race of the physicians in the use of cardiac catheterization. The adjusted mortality rate among black patients was lower than or similar to that among white patients for up to three years after the infarction. Conclusions: Racial differences in the use of cardiac catheterization are similar among patients treated by white physicians and those treated by black physicians, suggesting that this pattern of care is independent of the race of the physician. (N Engl J Med 2001;344:1443-9.) Copyright (C) 2001 Massachusetts Medical Society.	Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Chron Dis Epidemiol, New Haven, CT 06510 USA; Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Qualidigm, Middletown, CT USA	Yale University; Yale University; Yale University	Chen, J (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.		, Harlan/AAI-2875-2020	Radford, Martha/0000-0001-7503-9557	PHS HHS [500-96-P549] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM HOSP ASS, 1994, ANN SURV HOSP DAT DO; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; *BUR CENS, 1991, STAT METR AR DAT BOO; CASTANER A, 1988, ANN INTERN MED, V109, P33, DOI 10.7326/0003-4819-109-1-33; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; *DEP HLTH HUM SERV, 1999, SOC SEC ADM DEATH MA; Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156; EISENBERG JM, 1979, ANN INTERN MED, V90, P957, DOI 10.7326/0003-4819-90-6-957; Ferguson JA, 1997, J AM COLL CARDIOL, V30, P1707, DOI 10.1016/S0735-1097(97)00365-3; GILES WH, 1995, ARCH INTERN MED, V155, P318, DOI 10.1001/archinte.155.3.318; *HLTH CAR FIN ADM, 1997, ICD9CM HLTH CAR FIN; HOOPER EM, 1982, MED CARE, V20, P630, DOI 10.1097/00005650-198206000-00009; IEZZONI LI, 1994, RISK ADJUSTMENT MEAS, P119; KEIL JE, 1985, AM HEART J, V109, P776, DOI 10.1016/0002-8703(85)90638-6; Kenward K, 1996, AM J PUBLIC HEALTH, V86, P1481, DOI 10.2105/AJPH.86.10.1481; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1994, CIRCULATION, V89, P2015, DOI 10.1161/01.CIR.89.5.2015; MIRVIS DM, 1994, J AM COLL CARDIOL, V24, P1297, DOI 10.1016/0735-1097(94)90112-0; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; PETERSON ED, 1994, JAMA-J AM MED ASSOC, V271, P1175, DOI 10.1001/jama.271.15.1175; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; RACZYNSKI JM, 1994, AM J PUBLIC HEALTH, V84, P951, DOI 10.2105/AJPH.84.6.951; RICE T, 1985, INQUIRY-J HEALTH CAR, V22, P188; ROIG E, 1987, CIRCULATION, V76, P280, DOI 10.1161/01.CIR.76.2.280; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Sedlis SP, 1997, J CLIN EPIDEMIOL, V50, P899, DOI 10.1016/S0895-4356(97)00089-9; Stone PH, 1996, JAMA-J AM MED ASSOC, V275, P1104, DOI 10.1001/jama.275.14.1104; Summers RL, 1999, AM J MED SCI, V318, P142, DOI 10.1097/00000441-199909000-00008; Taylor HA, 1998, AM J CARDIOL, V82, P1019, DOI 10.1016/S0002-9149(98)00547-5; TOFLER GH, 1987, J AM COLL CARDIOL, V9, P473, DOI 10.1016/S0735-1097(87)80038-4; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; WENNEKER MB, 1989, JAMA-J AM MED ASSOC, V261, P253, DOI 10.1001/jama.261.2.253; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Whittle J, 1997, J GEN INTERN MED, V12, P267, DOI 10.1007/s11606-006-5062-0; WHITTLE J, 1993, NEW ENGL J MED, V329, P621, DOI 10.1056/NEJM199308263290907; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	39	218	219	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2001	344	19					1443	1449		10.1056/NEJM200105103441906	http://dx.doi.org/10.1056/NEJM200105103441906			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	430BQ	11346810				2022-12-01	WOS:000168554000006
J	Elbert, T; Heim, S				Elbert, T; Heim, S			A light and a dark side	NATURE			English	Editorial Material									Univ Konstanz, Dept Psychol, D-78457 Constance, Germany	University of Konstanz	Elbert, T (corresponding author), Univ Konstanz, Dept Psychol, Box D25, D-78457 Constance, Germany.		Elbert, Thomas/C-8556-2009	Elbert, Thomas/0000-0003-1332-4939				Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Elbert T, 2001, HDB DEV COGNITIVE NE; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Nudo RJ, 1999, CURR OPIN NEUROBIOL, V9, P740, DOI 10.1016/S0959-4388(99)00027-6; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	5	24	25	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					139	139		10.1038/35075678	http://dx.doi.org/10.1038/35075678			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346769	Bronze, Green Published			2022-12-01	WOS:000168563000026
J	Lake, JA; Quick, WP; Beerling, DJ; Woodward, FI				Lake, JA; Quick, WP; Beerling, DJ; Woodward, FI			Plant development - Signals from mature to new leaves	NATURE			English	Article							STOMATAL RESPONSES; ATMOSPHERIC CO2		Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Lake, JA (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Western Bank, Sheffield S10 2TN, S Yorkshire, England.		Woodward, Frank Ian/P-4530-2019; Beerling, David J/C-2840-2009; Woodward, Ian F/B-7762-2008	Beerling, David J/0000-0003-1869-4314; 				Beerling DJ, 1998, J EXP BOT, V49, P1603, DOI 10.1093/jexbot/49.326.1603; BERRYMAN CA, 1994, J EXP BOT, V45, P539, DOI 10.1093/jxb/45.5.539; Buchmann N, 1996, GLOBAL CHANGE BIOL, V2, P421, DOI 10.1111/j.1365-2486.1996.tb00092.x; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5857, DOI 10.1029/96JD02360; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Douville H, 2000, J GEOPHYS RES-ATMOS, V105, P14841, DOI 10.1029/1999JD901086; EAMUS D, 1993, AUST J PLANT PHYSIOL, V20, P741, DOI 10.1071/PP9930741; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; JACKSON D, 1994, DEVELOPMENT, V120, P405; Muraoka H, 2000, PLANT CELL ENVIRON, V23, P235, DOI 10.1046/j.1365-3040.2000.00547.x; TICHA I, 1982, PHOTOSYNTHETICA, V16, P375; WOODWARD FI, 1987, NATURE, V327, P617, DOI 10.1038/327617a0; WOODWARD FI, 1988, J EXP BOT, V39, P1771, DOI 10.1093/jxb/39.12.1771	13	282	317	5	132	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					154	154		10.1038/35075660	http://dx.doi.org/10.1038/35075660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346781	Bronze			2022-12-01	WOS:000168563000036
J	Boppana, SB; Rivera, LB; Fowler, KB; Mach, M; Britt, WJ				Boppana, SB; Rivera, LB; Fowler, KB; Mach, M; Britt, WJ			Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DNA-POLYMERASE GENE; GLYCOPROTEIN-H; ANTIBODY-RESPONSES; NEWBORN-INFANTS; CELL RESPONSE; INFECTION; MOTHERS; VIRUS; GANCICLOVIR; RESISTANCE	Background: Preconceptional immunity against cytomegalovirus (CMV) provides only partial protection against intrauterine transmission of the virus. Whether congenital CMV infection in the offspring of women who are seropositive for CMV can occur after maternal reinfection with a different strain of CMV is unknown. Methods: Serum specimens from 46 women with preconceptional immunity against CMV that were obtained during the previous pregnancy and the current pregnancy were analyzed for antibodies against the strain-specific epitopes of CMV glycoprotein H. Virus-neutralizing activity in maternal serum samples was measured against the AD169 laboratory strain of CMV and the CMV isolates available from seven infected infants. In addition, the nucleotide sequences of the glycoprotein H gene from the seven CMV isolates were determined. Results: Eleven of the 16 mothers with infected infants (69 percent) had antibodies against the glycoprotein H epitopes present on two laboratory strains of CMV, AD169 and Towne. Ten of the 16 mothers with infected children (62 percent) acquired new antibody specificities against glycoprotein H, as compared with only 4 of the 30 mothers of uninfected infants (13 percent, P<0.001). The samples obtained at the time of the current delivery from four of the seven mothers contained at least twice as many neutralizing antibodies against the CMV isolated from their infants as were present in the samples obtained at the previous delivery. The specificity of the newly acquired maternal antibodies reflected the amino acid sequence of the glycoprotein H epitope of CMV from these four infants. Conclusions: In women who are seropositive for CMV, reinfection with a different strain of CMV can lead to intrauterine transmission and symptomatic congenital infection. (N Engl J Med 2001;344:1366-71.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Alabama, Dept Pediat, Birmingham, AL 35233 USA; Univ Alabama, Dept Epidemiol, Birmingham, AL 35233 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35233 USA; Univ Erlangen Nurnberg, Inst Clin & Mol Virol, Erlangen, Germany	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Erlangen Nuremberg	Boppana, SB (corresponding author), Univ Alabama, Dept Pediat, 1600 7th Ave S,Suite 752, Birmingham, AL 35233 USA.				NCRR NIH HHS [M01 RR000032] Funding Source: Medline; NIAID NIH HHS [P01 AI043681, P01 AI43681] Funding Source: Medline; NIDCD NIH HHS [R01 DC004163, R01 DC04163] Funding Source: Medline; PHS HHS [M01 R00032] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI043681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004163] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahlfors K, 1999, SCAND J INFECT DIS, V31, P443, DOI 10.1080/00365549950163969; ANDREONI M, 1989, J VIROL METHODS, V23, P157, DOI 10.1016/0166-0934(89)90129-8; BALCAREK KB, 1993, J INFECT DIS, V167, P1433, DOI 10.1093/infdis/167.6.1433; BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366; Beninga J, 1996, J INFECT DIS, V173, P1051, DOI 10.1093/infdis/173.5.1051; BENINGA J, 1995, J GEN VIROL, V76, P153, DOI 10.1099/0022-1317-76-1-153; BOPPANA SB, 1995, J INFECT DIS, V171, P1115, DOI 10.1093/infdis/171.5.1115; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; BOPPANA SB, 1993, J INFECT DIS, V167, P72, DOI 10.1093/infdis/167.1.72; BRITT WJ, 1996, FIELDS VIROLOGY, V2, P2493; CHOU SW, 1995, J INFECT DIS, V172, P239, DOI 10.1093/infdis/172.1.239; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003; HUANG ES, 1980, NEW ENGL J MED, V303, P958, DOI 10.1056/NEJM198010233031702; Klein M, 1999, J VIROL, V73, P878, DOI 10.1128/JVI.73.2.878-886.1999; LI L, 1995, J VIROL, V69, P6047, DOI 10.1128/JVI.69.10.6047-6053.1995; LITTLER E, 1992, NATURE, V358, P160, DOI 10.1038/358160a0; LURAIN NS, 1992, J VIROL, V66, P7146, DOI 10.1128/JVI.66.12.7146-7152.1992; MORRIS DJ, 1994, PEDIATR INFECT DIS J, V13, P61, DOI 10.1097/00006454-199401000-00013; PASS RF, 1982, J INFECT DIS, V146, P1, DOI 10.1093/infdis/146.1.1; PECKHAM CS, 1983, LANCET, V1, P1352; SCHOPFER K, 1978, ARCH DIS CHILD, V53, P536, DOI 10.1136/adc.53.7.536; SIMPSON JA, 1993, J VIROL, V67, P489, DOI 10.1128/JVI.67.1.489-496.1993; SMITH KL, 1993, TRANSFUSION, V33, P497, DOI 10.1046/j.1537-2995.1993.33693296813.x; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; STAGNO S, 1982, Clinical Obstetrics and Gynecology, V25, P563, DOI 10.1097/00003081-198209000-00014; Stagno S., 1995, INFECT DIS FETUS NEW, P312; SULLIVAN V, 1993, ANTIMICROB AGENTS CH, V37, P19, DOI 10.1128/AAC.37.1.19; Urban M, 1996, J GEN VIROL, V77, P1537, DOI 10.1099/0022-1317-77-7-1537; URBAN M, 1992, J VIROL, V66, P1303, DOI 10.1128/JVI.66.3.1303-1311.1992; WIRTSCHAFTER D D, 1982, Journal of Medical Systems, V6, P277, DOI 10.1007/BF00992804	31	498	531	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2001	344	18					1366	1371		10.1056/NEJM200105033441804	http://dx.doi.org/10.1056/NEJM200105033441804			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427NY	11333993				2022-12-01	WOS:000168413500004
J	Park, PW; Pier, GB; Hinkes, MT; Bernfield, M				Park, PW; Pier, GB; Hinkes, MT; Bernfield, M			Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence	NATURE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ACUTE PULMONARY INFECTION; HOST-DEFENSE; LUNG INFECTIONS; BINDING; ELASTASE; MICE; RECEPTORS; ADHERENCE; MODEL	Cell-surface heparan sulphate proteoglycans (HSPGs) are ubiquitous and abundant receptors/co-receptors of extracellular ligands(1,2), including many microbes(3-10). Their role in microbial infections is poorly defined, however, because no cell-surface HSPG has been clearly connected to the pathogenesis of a particular microbe. We have previously shown that Pseudomonas aeruginosa, through its virulence factor LasA, enhances the in vitro shedding of syndecan-1-the predominant cell-surface HSPG of epithelia(11). Here we show that shedding of syndecan-1 is also activated by P. aeruginosa in vivo, and that the resulting syndecan-1 ectodomains enhance bacterial virulence in newborn mice. Newborn mice deficient in syndecan-1 resist P. aeruginosa lung infection but become susceptible when given purified syndecan-1 ectodomains or heparin, but not when given ectodomain core protein, indicating that the ectodomain's heparan sulphate chains are the effectors. In wild-type newborn mice, inhibition of syndecan-1 shedding or inactivation of the shed ectodomain's heparan sulphate chains prevents lung infection. Our findings uncover a pathogenetic mechanism in which a host response to tissue injury-syndecan-1 shedding-is exploited to enhance microbial virulence apparently by modulating host defences.	Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bernfield, M (corresponding author), Childrens Hosp, Dept Pediat, Div Newborn Med, Boston, MA 02115 USA.		Pier, Gerald/AAO-2692-2021	Pier, Gerald/0000-0002-9112-2331; Park, Pyong Woo/0000-0002-7979-4979				Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Allewelt M, 2000, INFECT IMMUN, V68, P3998, DOI 10.1128/IAI.68.7.3998-4004.2000; Bals R, 1999, J CLIN INVEST, V103, P303, DOI 10.1172/JCI6277; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BLACKWOOD LL, 1983, INFECT IMMUN, V39, P198, DOI 10.1128/IAI.39.1.198-201.1983; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Crouch EC, 1998, AM J RESP CELL MOL, V19, P177, DOI 10.1165/ajrcmb.19.2.140; Grassme H, 1997, CELL, V91, P605, DOI 10.1016/S0092-8674(00)80448-1; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Kainulainen V, 1998, J BIOL CHEM, V273, P11563, DOI 10.1074/jbc.273.19.11563; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kuschert GSV, 1999, BIOCHEMISTRY-US, V38, P12959, DOI 10.1021/bi990711d; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; ORTEGABARRIA E, 1991, CELL, V67, P411, DOI 10.1016/0092-8674(91)90192-2; PANCAKE SJ, 1992, J CELL BIOL, V117, P1351, DOI 10.1083/jcb.117.6.1351; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Park PW, 2000, J BIOL CHEM, V275, P3057, DOI 10.1074/jbc.275.5.3057; Pearson JP, 2000, INFECT IMMUN, V68, P4331, DOI 10.1128/IAI.68.7.4331-4334.2000; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; Rostand KS, 1997, INFECT IMMUN, V65, P1; ROSTAND KS, 1993, J BIOL CHEM, V268, P24053; Schmidtchen A, 2001, MOL MICROBIOL, V39, P708, DOI 10.1046/j.1365-2958.2001.02251.x; SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; TANG H, 1995, INFECT IMMUN, V63, P1278, DOI 10.1128/IAI.63.4.1278-1285.1995; WOODS DE, 1982, INFECT IMMUN, V36, P1223, DOI 10.1128/IAI.36.3.1223-1228.1982	29	192	196	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					98	102		10.1038/35075100	http://dx.doi.org/10.1038/35075100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333985				2022-12-01	WOS:000168432800051
J	Tramere, A				Tramere, A			Cell biology - Asymmetry in action	NATURE			English	Editorial Material																		Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; WILKIE GS, 2001, NATURE, V105, P209	2	4	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					33	33		10.1038/35075187	http://dx.doi.org/10.1038/35075187			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333960	Bronze			2022-12-01	WOS:000168432800028
J	Douglas, S; Zauner, S; Fraunholz, M; Beaton, M; Penny, S; Deng, LT; Wu, XN; Reith, M; Cavalier-Smith, T; Maier, UG				Douglas, S; Zauner, S; Fraunholz, M; Beaton, M; Penny, S; Deng, LT; Wu, XN; Reith, M; Cavalier-Smith, T; Maier, UG			The highly reduced genome of an enslaved algal nucleus	NATURE			English	Article							EUKARYOTIC GENOME; PLASTID GENOME; RED ALGAE; NUCLEOMORPH; EVOLUTION; CRYPTOMONADS; CHLOROPLASTS; TRANSPORT; CHIMERAS; PROTEIN	Chromophyte algae differ fundamentally from plants in possessing chloroplasts that contain chlorophyll c and that have a more complex bounding-membrane topology(1). Although chromophytes are known to be evolutionary chimaeras of a red alga and a non-photosynthetic host(1), which gave rise to their exceptional membrane complexity, their cell biology is poorly understood. Cryptomonads are the only chromophytes that still retain the enslaved red algal nucleus as a minute nucleomorph(2-4). Here we report complete sequences for all three nucleomorph chromosomes from the cryptomonad Guillardia theta. This tiny 551-kilobase eukaryotic genome is the most gene-dense known, with only 17 diminutive spliceosomal introns and 44 overlapping genes. Marked evolutionary compaction hundreds of millions of years ago(1,4,5) eliminated nearly all the nucleomorph genes for metabolic functions, but left 30 for chloroplast-located proteins. To allow expression of these proteins, nucleomorphs retain hundreds of genetic-housekeeping genes(5). Nucleomorph DNA replication and periplastid protein synthesis require the import of many nuclear gene products across endoplasmic reticulum and periplastid membranes. The chromosomes have centromeres, but possibly only one loop domain, offering a means for studying eukaryotic chromosome replication, segregation and evolution.	Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Program Evolutionary Biol, Vancouver, BC V6T 1Z4, Canada; Univ Marburg, D-35032 Marburg, Germany; Natl Res Council Canada, Inst Marine Biosci, Halifax, NS B3H 3Z1, Canada; Canadian Inst Adv Res, Program Evolutionary Biol, Halifax, NS B3H 3Z1, Canada	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Philipps University Marburg; International Business Machines (IBM); National Research Council Canada; Canadian Institute for Advanced Research (CIFAR)	Cavalier-Smith, T (corresponding author), Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Program Evolutionary Biol, Vancouver, BC V6T 1Z4, Canada.	tom.cavalier-smith@zoo.ox.ac.uk		Fraunholz, Martin/0000-0002-4581-6244				Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Cavalier-Smith T, 2000, TRENDS PLANT SCI, V5, P174, DOI 10.1016/S1360-1385(00)01598-3; Cavalier-Smith T, 1999, GENETICA, V106, P3, DOI 10.1023/A:1003701925110; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Cavalier-Smith T., 1986, Progress phycol. Res., V4, P309; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; DOUGLAS SE, 1991, NATURE, V350, P148, DOI 10.1038/350148a0; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; DOUGLAS SE, 1988, CURR GENET, V14, P591, DOI 10.1007/BF00434085; ESCHBACH S, 1991, NUCLEIC ACIDS RES, V19, P1779, DOI 10.1093/nar/19.8.1779; Gaasterland T, 1996, BIOCHIMIE, V78, P302, DOI 10.1016/0300-9084(96)84761-4; Gilson PR, 1996, P NATL ACAD SCI USA, V93, P7737, DOI 10.1073/pnas.93.15.7737; HEGEMANN JH, 1993, BIOESSAYS, V15, P451, DOI 10.1002/bies.950150704; Kawahara H, 2000, J CELL SCI, V113, P2659; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; LUDWIG M, 1987, ANN NY ACAD SCI, V503, P198, DOI 10.1111/j.1749-6632.1987.tb40609.x; Maier UG, 2000, MOL BIOL EVOL, V17, P576, DOI 10.1093/oxfordjournals.molbev.a026337; Maier UG, 2000, PROTIST, V151, P103, DOI 10.1078/1434-4610-00011; McFadden G.I., 2000, GENOME BIOL, V1; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; MEYER SR, 1987, S AFR J BOT, V53, P129, DOI 10.1016/S0254-6299(16)31447-8; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; Paul AL, 1999, PLANT MOL BIOL, V41, P713, DOI 10.1023/A:1006323222693; Poole A, 1999, BIOESSAYS, V21, P880, DOI 10.1002/(SICI)1521-1878(199910)21:10<880::AID-BIES11>3.0.CO;2-P; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Wastl J, 2000, J BIOL CHEM, V275, P23194, DOI 10.1074/jbc.M003125200; WHATLEY JM, 1979, PROC R SOC SER B-BIO, V204, P165, DOI 10.1098/rspb.1979.0020; Zauner S, 2000, P NATL ACAD SCI USA, V97, P200, DOI 10.1073/pnas.97.1.200	30	343	374	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1091	1096		10.1038/35074092	http://dx.doi.org/10.1038/35074092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323671	Bronze			2022-12-01	WOS:000168285500047
J	Rambaut, A; Robertson, DL; Pybus, OG; Peeters, M; Holmes, EC				Rambaut, A; Robertson, DL; Pybus, OG; Peeters, M; Holmes, EC			Human immunodeficiency virus - Phylogeny and the origin of HIV-1	NATURE			English	Article									Univ Oxford, Dept Zool, Oxford OX1 3PS, England; IRD, Retrovirus Lab, F-34032 Montpellier, France	University of Oxford; Institut de Recherche pour le Developpement (IRD)	Rambaut, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.		Pybus, Oliver G/B-2640-2012; Rambaut, Andrew/B-2481-2009	Pybus, Oliver G/0000-0002-8797-2667; Rambaut, Andrew/0000-0003-4337-3707; Holmes, Edward/0000-0001-9596-3552				Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hooper E., 1999, RIVER JOURNEY SOURCE; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Pybus OG, 2000, GENETICS, V155, P1429; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000	6	121	126	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1047	1048		10.1038/35074179	http://dx.doi.org/10.1038/35074179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323659				2022-12-01	WOS:000168285500035
J	Suarez-Lopez, P; Wheatley, K; Robson, F; Onouchi, H; Valverde, F; Coupland, G				Suarez-Lopez, P; Wheatley, K; Robson, F; Onouchi, H; Valverde, F; Coupland, G			CONSTANS mediates between the circadian clock and the control of flowering in Arabidopsis	NATURE			English	Article							CONTROLLED GENE; PROTEIN; RHYTHMS; THALIANA; ENCODES; RNA; EXPRESSION; GIGANTEA; ROLES; TIME	Flowering is often triggered by exposing plants to appropriate day lengths. This response requires an endogenous timer called the circadian clock to measure the duration of the day or night(1). This timer also controls daily rhythms in gene expression and behavioural patterns such as leaf movements. Several Arabidopsis mutations affect both circadian processes and flowering time(2-10); but how the effect of these mutations on the circadian clock is related to their influence on flowering remains unknown. Here we show that expression of CONSTANS (CO), a gene that accelerates flowering in response to long days(11), is modulated by the circadian clock and day length. Expression of a CO target gene, called FLOWERING LOCUS T (FT), is restricted to a similar time of day as expression of CO. Three mutations that affect circadian rhythms and flowering time alter CO and FT expression in ways that are consistent with their effects on flowering. In addition, the late flowering phenotype of such mutants is corrected by overexpressing CO. Thus, CO acts between the circadian clock and the control of flowering, suggesting mechanisms by which day length regulates flowering time.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Max Planck Society	Coupland, G (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk,Colney Lane, Norwich NR4 7UH, Norfolk, England.	george.coupland@bbsrc.ac.uk	Coupland, George/AAP-8609-2020; Suárez-López, Paula/D-4894-2012; Valverde, Federico/K-1248-2014	Coupland, George/0000-0001-6988-4172; Suárez-López, Paula/0000-0001-5748-9263; Valverde, Federico/0000-0001-8063-0974				Blazquez MA, 1999, PLANT PHYSIOL, V120, P1025, DOI 10.1104/pp.120.4.1025; CARPENTER CD, 1994, PLANT PHYSIOL, V104, P1015, DOI 10.1104/pp.104.3.1015; Chon ML, 1999, PLANT CELL PHYSIOL, V40, P702, DOI 10.1093/oxfordjournals.pcp.a029596; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; SOMERS DE, 1998, BIOL RHYTHMS PHOTOPE, P81; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Thomas B., 1996, PHOTOPERIODISM PLANT; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x	31	999	1110	12	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2001	410	6832					1116	1120		10.1038/35074138	http://dx.doi.org/10.1038/35074138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323677				2022-12-01	WOS:000168285500053
J	Gray, RH; Wawer, MJ; Brookmeyer, R; Sewankambo, NK; Serwadda, D; Wabwire-Mangen, F; Lutalo, T; Li, XB; vanCott, T; Quinn, TC				Gray, RH; Wawer, MJ; Brookmeyer, R; Sewankambo, NK; Serwadda, D; Wabwire-Mangen, F; Lutalo, T; Li, XB; vanCott, T; Quinn, TC		Rakal Project Team	Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL TRANSMISSION; TYPE-1; FEMALE; RELIABILITY; BEHAVIORS; PARTNERS; AFRICA; AIDS	Background The probability of HIV-1 transmission per coital act in representative African populations is unknown. We aimed to calculate this probability overall, and to estimate how it is affected by various factors thought to influence infectivity. Methods 174 monogamous couples, in which one partner was HIV-1 positive, were retrospectively identified from a population cohort in Rakai, Uganda. Frequency of intercourse and reliability of reporting within couples was assessed prospectively, HIV-1 seroconversion was determined in the uninfected partners, and HIV-1 viral load was measured in the infected partners. Adjusted rate ratios of transmission per coital act were estimated by Poisson regression. Probabilities of transmission per act were estimated by log-log binomial regression for quartiles of age and HIV-1 viral load, and for symptoms or diagnoses of sexually transmitted diseases (STDs) in the HIV-1-infected partners. Results The mean frequency of intercourse was 8.9 per month, which declined with age and HIV-1 viral load. Members of couples reported similar frequencies of intercourse. The overall unadjusted probability of HIV-1 transmission per coital act was 0.0011 (95% CI 0.0008-0.0015). Transmission probabilities increased from 0.0001 per act at viral loads of less than 1700 copies/mL to 0.0023 per act at 38 500 copies/mL or more (p=0.002), and were 0.0041 with genital ulceration versus 0.0011 without (p=0.02). Transmission probabilities per act did not differ significantly by HIV-1 subtypes A and D, sex, STDs, or symptoms of discharge or dysuria in the HIV-l-positive partner. Interpretation Higher viral load and genital ulceration are the main determinants of HIV-1 transmission per coital act in this Ugandan population.	Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Med, Baltimore, MD 21205 USA; Columbia Univ, Heilbrun Ctr Populat & Family Hlth, Joseph L Mailman Sch Publ Hlth, New York, NY USA; Makerere Univ, Dept Med, Kampala, Uganda; Makerere Univ, Clin Epidemiol Unit, Kampala, Uganda; Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Uganda Virus Res Inst, Rakai Project, Entebbe, Uganda; Walter Reed Army Inst Res, Rockville, MD USA; NIAID, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Columbia University; Makerere University; Makerere University; Makerere University; Uganda Virus Research Institute; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gray, RH (corresponding author), Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Populat & Family Hlth Sci, Suite 4030,615 N Wolfe St, Baltimore, MD 21205 USA.		Quinn, Thomas/A-2494-2010	Sewankambo, Nelson/0000-0001-9362-053X	FIC NIH HHS [5D43TW00010, D43 TW001508] Funding Source: Medline; NIAID NIH HHS [R01 AI34826, R01 AI3426S] Funding Source: Medline; NICHD NIH HHS [5P30HD06826] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW001508, D43TW000010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, R01AI034826] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*AIDS CONTR PROGR, 1992, HIV TEST POL, P1; BLANC AK, 1991, STUD FAMILY PLANN, V22, P162, DOI 10.2307/1966643; Breslow NE, 1987, STAT METHODS CANC RE, VII; BROOKMEYER R, 1994, AIDS EPIDEMIOLOGY QU, P36; CAMERON DW, 1989, LANCET, V2, P403; Cohen MS, 2000, NEW ENGL J MED, V342, P970, DOI 10.1056/NEJM200003303421311; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; DUERR A, 1994, 10 INT C AIDS YOK JA; JEWELL NP, 1990, BIOMETRICS, V46, P1133, DOI 10.2307/2532454; LAGARDE E, 1995, AM J EPIDEMIOL, V141, P1194, DOI 10.1093/oxfordjournals.aje.a117393; Lutalo T, 2000, STUD FAMILY PLANN, V31, P217, DOI 10.1111/j.1728-4465.2000.00217.x; MASTRO TD, 1994, LANCET, V343, P204, DOI 10.1016/S0140-6736(94)90990-3; Mastro TD, 1998, AIDS RES HUM RETROV, V14, pS223; Mayer KH, 1995, INFECT AGENT DIS, V4, P273; MCCUTCHAN F, 2000, 13 INT AIDS C DURB S; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; O'Farrell N, 2001, SEX TRANSM DIS, V28, P84, DOI 10.1097/00007435-200102000-00005; OBRIEN TR, 1994, J ACQ IMMUN DEF SYND, V7, P705; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; RENZULLO P, 2000, 13 INT AIDS C DURB S; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; SANCHEZMARTINEZ D, 1991, J INFECT DIS, V164, P1196, DOI 10.1093/infdis/164.6.1196; SCHOPPER D, 1993, SOC SCI MED, V37, P401, DOI 10.1016/0277-9536(93)90270-E; Schwartlander B, 2000, SCIENCE, V289, P64, DOI 10.1126/science.289.5476.64; SERWADDA D, 1995, AIDS, V9, P745, DOI 10.1097/00002030-199507000-00012; UPCHURCH DM, 1991, AM J EPIDEMIOL, V134, P1159, DOI 10.1093/oxfordjournals.aje.a116019; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3	28	941	971	1	45	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 14	2001	357	9263					1149	1153		10.1016/S0140-6736(00)04331-2	http://dx.doi.org/10.1016/S0140-6736(00)04331-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	423RX	11323041				2022-12-01	WOS:000168192100008
J	Rebello, G; Hallam, N; Smart, G; Farquharson, D; McCafferty, J				Rebello, G; Hallam, N; Smart, G; Farquharson, D; McCafferty, J			Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study	BRITISH MEDICAL JOURNAL			English	Article							NEOPLASIA		Lothian Univ Hosp NHS Trust, Reg Clin Virol Lab, City Hosp, Edinburgh EH10 5SB, Midlothian, Scotland; Lothian Univ Hosp NHS Trust, Royal Infirm Edinburgh, Colposcopy Clin, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Hallam, N (corresponding author), Lothian Univ Hosp NHS Trust, Reg Clin Virol Lab, City Hosp, Edinburgh EH10 5SB, Midlothian, Scotland.							Cuzick J, 1999, BRIT J CANCER, V81, P554, DOI 10.1038/sj.bjc.6690730; CUZICK J, 1999, HLTH TECHNOL ASSESS, V3; Kinney WK, 1998, OBSTET GYNECOL, V91, P973, DOI 10.1016/S0029-7844(98)00080-5; Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605	5	30	31	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 14	2001	322	7291					893	894		10.1136/bmj.322.7291.893	http://dx.doi.org/10.1136/bmj.322.7291.893			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	425VA	11302900	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000168311300018
J	LaDeau, SL; Clark, JS				LaDeau, SL; Clark, JS			Rising CO2 levels and the fecundity of forest trees	SCIENCE			English	Article							ELEVATED ATMOSPHERIC CO2; RECRUITMENT LIMITATION; PINUS-TAEDA; GROWTH; PHOTOSYNTHESIS; PLANTS; REPRODUCTION; ENRICHMENT; RESPONSES; FIELD	We determined the reproductive response of 19-year-old loblolly pine (Pinus taeda) to 4 years of carbon dioxide (CO2) enrichment (ambient concentration plus 200 microliters per liter) in an intact forest. After 3 years of CO2 fumigation, trees were twice as likely to be reproductively mature and produced three times as many cones and seeds as trees at ambient CO2 concentration. A disproportionate carbon allocation to reproduction under CO2 enrichment results in trees reaching maturity sooner and at a smaller size. This reproductive response to future increases in atmospheric CO2 concentration is expected to change Loblolly dispersal and recruitment patterns.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Univ Program Ecol, Durham, NC 27708 USA	Duke University; Duke University	LaDeau, SL (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.			LaDeau, Shannon/0000-0003-4825-5435				CEULEMANS R, 1994, NEW PHYTOL, V127, P425, DOI 10.1111/j.1469-8137.1994.tb03961.x; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; CLARK JS, 1995, AM NAT, V146, P72, DOI 10.1086/285788; CONNER KF, 1998, PRODUCTIVITY SUSTAIN, V128, P103; Curtis PS, 1998, OECOLOGIA, V113, P299, DOI 10.1007/s004420050381; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; FARNSWORTH EJ, 1995, OECOLOGIA, V104, P454, DOI 10.1007/BF00341343; Fischer M, 1997, J ECOL, V85, P681, DOI 10.2307/2960538; Fiscus EL, 1997, J EXP BOT, V48, P307, DOI 10.1093/jxb/48.2.307; GARBUTT K, 1984, NEW PHYTOL, V98, P433, DOI 10.1111/j.1469-8137.1984.tb04136.x; Grunzweig JM, 2000, GLOB CHANGE BIOL, V6, P631, DOI 10.1046/j.1365-2486.2000.00346.x; Hendrey GR, 1999, GLOBAL CHANGE BIOL, V5, P293, DOI 10.1046/j.1365-2486.1999.00228.x; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; IDSO SB, 1992, AGR FOREST METEOROL, V60, P145, DOI 10.1016/0168-1923(92)90080-N; LAWLOR W, 1991, IMPACT GLOBAL CLIMAT, P431; Lee HSJ, 1995, J BIOGEOGR, V22, P323, DOI 10.2307/2845927; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lovelock CE, 1999, PLANT CELL ENVIRON, V22, P49, DOI 10.1046/j.1365-3040.1999.00370.x; Naumburg E, 2000, OECOLOGIA, V122, P163, DOI 10.1007/PL00008844; Reid CD, 1998, J EXP BOT, V49, P885, DOI 10.1093/jexbot/49.322.885; RIBBENS E, 1994, ECOLOGY, V75, P1794, DOI 10.2307/1939638; Schappi B, 1996, OECOLOGIA, V106, P93, DOI 10.1007/BF00334411; SCHULTZ RP, 1997, LOBLOLLY PINE; SHMIDA A, 1984, VEGETATIO, V58, P29; Thomas SC, 1996, EVOL ECOL, V10, P517, DOI 10.1007/BF01237882; Tissue DT, 1996, TREE PHYSIOL, V16, P49; Tissue DT, 1997, PLANT CELL ENVIRON, V20, P1123, DOI 10.1046/j.1365-3040.1997.d01-140.x; Ward JK, 1997, PLANT CELL ENVIRON, V20, P254, DOI 10.1046/j.1365-3040.1997.d01-59.x; Zamski E., 1995, SEED DEV GERMINATION, P25	31	140	153	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2001	292	5514					95	98		10.1126/science.1057547	http://dx.doi.org/10.1126/science.1057547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292871				2022-12-01	WOS:000167995200045
J	Keefe, AD; Szostak, JW				Keefe, AD; Szostak, JW			Functional proteins from a random-sequence library	NATURE			English	Article							IN-VITRO SELECTION; RNA; BINDING; FUSIONS	Functional primordial proteins presumably originated from random sequences, but it is not known how frequently functional, or even folded, proteins occur in collections of random sequences. Here we have used in vitro selection of messenger RNA displayed proteins, in which each protein is covalently linked through its carboxy terminus to the 3' end of its encoding mRNA(1), to sample a large number of distinct random sequences. Starting from a library of 6 x 10(12) proteins each containing 80 contiguous random amino acids, we selected functional proteins by enriching for those that bind to ATP. This selection yielded four new ATP-binding proteins that appear to be unrelated to each other or to anything found in the current databases of biological proteins. The frequency of occurrence of functional proteins in random-sequence libraries appears to be similar to that observed for equivalent RNA libraries(2,3).	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital	Szostak, JW (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu	lu, zhenghui/N-2903-2014		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Cho G, 2000, J MOL BIOL, V297, P309, DOI 10.1006/jmbi.2000.3571; CONSIDINE DM, 1989, VANNOSTRANDS SCI ENC, P3067; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; Keefe A. D., 2001, CURRENT PROTOCOLS MO; Liu RH, 2000, METHOD ENZYMOL, V318, P268; McCafferty DG, 1997, BIOCHEMISTRY-US, V36, P10498, DOI 10.1021/bi970543u; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; SASSANFAR M, 1993, NATURE, V364, P550, DOI 10.1038/364550a0; WANG Y, 1993, J BIOL CHEM, V268, P13947; WILSON D, 2000, CURRENT PROTOCOLS MO; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; WILSON DS, IN PRESS P NATL ACAD	15	395	458	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					715	718		10.1038/35070613	http://dx.doi.org/10.1038/35070613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287961	Green Accepted			2022-12-01	WOS:000167875400053
J	Dong, C; Juedes, AE; Temann, UA; Shresta, S; Allison, JP; Ruddle, NH; Flavell, RA				Dong, C; Juedes, AE; Temann, UA; Shresta, S; Allison, JP; Ruddle, NH; Flavell, RA			ICOS co-stimulatory receptor is essential for T-cell activation and function	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN MONOCYTES; TNF-ALPHA; COSTIMULATION; IL-13; INFLAMMATION; EXPRESSION; PHENOTYPE; CTLA-4; CD28	T-lymphocyte activation and immune function are regulated by co-stimulatory molecules. CD28, a receptor for B7 gene products, has a chief role in initiating T-cell immune responses(1,2). CTLA4, which binds B7 with a higher affinity, is induced after T-cell activation and is involved in downregulating T-cell responses(3,4). The inducible co-stimulatory molecule (ICOS), a third member of the CD28/CTLA4 family, is expressed on activated T cells(5,6). Its ligand B7H/B7RP-1 is expressed on B cells and in non-immune tissues after injection of lipopolysaccharide into animals(6,7). To understand the role of ICOS in T-cell activation and function, we generated and analysed ICOS-deficient mice. Here we show that T-cell activation and proliferation are defective in the absence of ICOS. In addition, ICOS-/- T cells fail to produce interleukin-4 when differentiated in vitro or when primed in vivo. ICOS is required for humoral immune responses after immunization with several antigens. ICOS-/- mice showed greatly enhanced susceptibility to experimental autoimmune encephalomyelitis, indicating that ICOS has a protective role in inflammatory autoimmune diseases.	Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; Yale University; Yale University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Flavell, RA (corresponding author), Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA.		dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Allison, James/0000-0001-8980-5697				CASH E, 1994, J IMMUNOL, V153, P4258; Chambers CA, 1999, CURR OPIN CELL BIOL, V11, P203, DOI 10.1016/S0955-0674(99)80027-1; Chang TT, 1999, J EXP MED, V190, P733, DOI 10.1084/jem.190.5.733; COSENTINO G, 1995, J IMMUNOL, V155, P3145; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Girvin AR, 2000, J IMMUNOL, V164, P136, DOI 10.4049/jimmunol.164.1.136; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Juedes AE, 2000, J IMMUNOL, V164, P419, DOI 10.4049/jimmunol.164.1.419; KIM C, 1995, ARCH SURG-CHICAGO, V130, P1330; Kopf M, 2000, J EXP MED, V192, P53, DOI 10.1084/jem.192.1.53; KUNG TT, 1994, INT ARCH ALLERGY IMM, V105, P83, DOI 10.1159/000236807; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; LIU Y, 1992, EUR J IMMUNOL, V22, P2855, DOI 10.1002/eji.1830221115; LIU Y, 1993, EUR J IMMUNOL, V23, P780; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; Oliveira-dos-Santos AJ, 1999, J IMMUNOL, V162, P4490; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Suen WE, 1997, J EXP MED, V186, P1233, DOI 10.1084/jem.186.8.1233; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Thompson CB, 1997, IMMUNITY, V7, P445, DOI 10.1016/S1074-7613(00)80366-0; VIALE G, 1995, INT ARCH ALLERGY IMM, V107, P176, DOI 10.1159/000236969; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582	25	707	773	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					97	101		10.1038/35051100	http://dx.doi.org/10.1038/35051100			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343121				2022-12-01	WOS:000166175600047
J	Tuffnell, DJ; Wilkinson, K; Beresford, N				Tuffnell, DJ; Wilkinson, K; Beresford, N			Interval between decision and delivery by caesarean section - are current standards achievable? Observational case series	BRITISH MEDICAL JOURNAL			English	Article							ANESTHESIA	Objectives To audit interval from decision to delivery in urgent caesarean section to determine whether the current standard of 30 minutes is achievable routinely; to determine whether delay leads to an excess of admissions to special care. Design Three audit cycles over four years followed by a continuous audit over 32 months. Setting Large district general hospital delivering 5500 women each year. Participants All women delivered by urgent caesarean section for abnormal fetal heart rate patterns, cord prolapse, failed instrumental delivery, or suspected placental abruption. Main outcome measures Proportion of women delivered within 30 and 40 minutes of decision. Admission rates to special care by length of interval between decision and delivery Results In the continuous audit 478 of 721 (66.3%) women were delivered in 30 minutes and 637 (88.3%) within 40 minutes; 29 (4.0%) were undelivered at 50 minutes. If the woman was taken to theatre in 10 minutes, 409 of 500 (81.8%) were delivered in 30 minutes and 495 (97%) in 40 minutes. There was no significant difference in the proportion of babies born at 36 weeks or later who were admitted to special care, when analysed by interval from decision to delivery. 36/449 (8%) babies with an interval, from decision to delivery of less than 30 minutes were admitted to special care and 3/23 (13%) with an interval of more than 50 minutes were admitted. Conclusions The current recommendations for the interval between decision and delivery are not being achieved in routine practice. Failure to meet the recommendations does not seem to increase neonatal morbidity.	Bradford NHS Trust, Matern Unit, Bradford BD9 6RJ, W Yorkshire, England		Tuffnell, DJ (corresponding author), Bradford NHS Trust, Matern Unit, Bradford BD9 6RJ, W Yorkshire, England.							*ASS AN GREAT BRIT, 1998, GUID OBST AN SERV; Brown G W, 1995, Int J Obstet Anesth, V4, P214, DOI 10.1016/0959-289X(95)82913-U; CHADWICK HS, 1991, ANESTHESIOLOGY, V74, P242, DOI 10.1097/00000542-199102000-00009; *CLIN NEGL SCHEM T, 1999, CLIN RISK MAN STAND; DWYER JP, 1999, 4 INT SCI M ROYAL CO, P13; *FOC GROUP, 2000, CONF ENQ STILLB DEAT, P41; Hawkins JL, 1997, ANESTHESIOLOGY, V86, P277, DOI 10.1097/00000542-199702000-00002; Johnson RV, 2000, ANAESTHESIA, V55, P179, DOI 10.1046/j.1365-2044.2000.055002179.x; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; Madej T H, 1993, Qual Health Care, V2, P31, DOI 10.1136/qshc.2.1.31; *OYAL COLL OBST GY, 1995, ORG STAND MAT SERV, P36; *ROYAL COLL OBST G, 1999, SAF CHILDB, P17; 1997, WHY MOTHERS DIE CONF, P91	14	96	98	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1330	1333		10.1136/bmj.322.7298.1330	http://dx.doi.org/10.1136/bmj.322.7298.1330			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387177	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000169167900016
J	Frankel, MS; Chapman, AR				Frankel, MS; Chapman, AR			Genetic technologies - Facing inheritable genetic modifications	SCIENCE			English	Article									Amer Assoc Advancement Sci, Sci Program, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Policy Program, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Sci Freedom Responsibil & Law, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Dialogue Sci Eth & Relig Program, Washington, DC 20005 USA; Amer Assoc Advancement Sci, Sci & Human Rights Program, Washington, DC 20005 USA		Frankel, MS (corresponding author), Amer Assoc Advancement Sci, Sci Program, Washington, DC 20005 USA.							Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Couzin J, 1998, SCIENCE, V282, P27, DOI 10.1126/science.282.5386.27; Frankel MS., 2000, HUMAN INHERITABLE GE; *NIH, 1995, FED REG         0427, V60, P20737; *NY STAT TASK FORC, 1998, LAW ASS REPR TECHN A; Parens E, 2001, SCIENCE, V292, P397, DOI 10.1126/science.292.5516.397; 1994, GENE TECHNOLOGY 0712	7	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1303	1303		10.1126/science.1057712	http://dx.doi.org/10.1126/science.1057712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360984				2022-12-01	WOS:000168862900022
J	Lumelsky, N; Blondel, O; Laeng, P; Velasco, I; Ravin, R; McKay, R				Lumelsky, N; Blondel, O; Laeng, P; Velasco, I; Ravin, R; McKay, R			Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets	SCIENCE			English	Article							IN-VITRO; HUMAN BLASTOCYSTS; MICE; NEURONS; EXPRESSION; LINES; TRANSCRIPTION; CULTURE; PDX-1; GENE	Although the source of embryonic stem (ES) cells presents ethical concerns, their use may lead to many clinical benefits if differentiated cell types can be derived from them and used to assemble functional organs. in pancreas, insulin is produced and secreted by specialized structures, islets of Langerhans. Diabetes, which affects 16 million people in the United States, results from abnormal function of pancreatic islets. We have generated cells expressing insulin and other pancreatic endocrine hormones from mouse ES cells. The cells self-assemble to form three-dimensional clusters similar in topology to normal pancreatic islets where pancreatic cell types are in close association with neurons. Glucose triggers insulin release from these cell clusters by mechanisms similar to those employed in vivo. When injected into diabetic mice, the insulin-producing cells undergo rapid vascularization and maintain a clustered, islet-like organization.	NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NIMH, Lab Syst Neurosci, NIH, Bethesda, MD 20892 USA; Human Genome Sci, Rockville, MD 20850 USA; Psychiat Genom, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); GlaxoSmithKline; Human Genome Sciences Inc	McKay, R (corresponding author), NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	mckay@codon.nih.gov	Velasco, Ivan/AAE-4249-2019; Velasco, Iván/D-3593-2014	Velasco, Ivan/0000-0002-8953-6578; Velasco, Iván/0000-0002-8953-6578				AHREN B, 1990, PROG BRAIN RES, V84, P209; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Csernus VJ, 1998, CELL MOL LIFE SCI, V54, P733, DOI 10.1007/s000180050201; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HALBAN PA, 1987, DIABETES, V36, P783, DOI 10.2337/diabetes.36.7.783; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kim SK, 1997, DEVELOPMENT, V124, P4243; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li H, 1999, NAT GENET, V23, P67; McClenaghan NH, 1999, J MOL MED, V77, P235, DOI 10.1007/s001090050344; MONTAGUE W, 1971, BIOCHEM J, V122, P115, DOI 10.1042/bj1220115; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Offield MF, 1996, DEVELOPMENT, V122, P983; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; ORKIN SH, 2000, NAT MED, V16, P1212; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Ramiya VK, 2000, NAT MED, V6, P278; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; ROJAS E, 1990, FEBS LETT, V261, P265, DOI 10.1016/0014-5793(90)80568-4; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; SHAPIRO AM, 2000, NEW ENGL J MED, V27, P2308; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Stoffers DA, 1999, ENDOCRINOLOGY, V140, P5374, DOI 10.1210/en.140.11.5374; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Vinik A, 1997, HORM METAB RES, V29, P278, DOI 10.1055/s-2007-979037; WOLLHEIM CB, 1990, METHOD ENZYMOL, V192, P188; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	39	1093	1378	1	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1389	1394		10.1126/science.1058866	http://dx.doi.org/10.1126/science.1058866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11326082				2022-12-01	WOS:000168862900050
J	Smit, AB; Syed, NI; Schaap, D; van Minnen, J; Klumperman, J; Kits, KS; Lodder, H; van der Schors, RC; van Elk, R; Sorgedrager, B; Brejc, K; Sixma, TK; Geraerts, WPM				Smit, AB; Syed, NI; Schaap, D; van Minnen, J; Klumperman, J; Kits, KS; Lodder, H; van der Schors, RC; van Elk, R; Sorgedrager, B; Brejc, K; Sixma, TK; Geraerts, WPM			A glia-derived acetylcholine-binding protein that modulates synaptic transmission	NATURE			English	Article							IDENTIFIED LYMNAEA NEURONS; CULTURED HIPPOCAMPAL-NEURONS; FROG NEUROMUSCULAR-JUNCTION; PERISYNAPTIC SCHWANN-CELLS; ASTROCYTES IN-SITU; INTRACELLULAR CALCIUM; NICOTINIC RECEPTORS; SUBUNIT; SYNAPTOGENESIS; COMMUNICATION	There is accumulating evidence that glial cells actively modulate neuronal synaptic transmission. We identified a glia-derived soluble acetylcholine-binding protein (AChBP), which is a naturally occurring analogue of the ligand-binding domains of the nicotinic acetylcholine receptors (nAChRs). Like the nAChRs, it assembles into a homopentamer with ligand-binding characteristics that are typical for a nicotinic receptor; unlike the nAChRs, however, it lacks the domains to form a transmembrane ion channel. Presynaptic release of acetylcholine induces the secretion of AChBP through the glial secretory pathway. We describe a molecular and cellular mechanism by which glial cells release AChBP in the synaptic cleft, and propose a model for how they actively regulate cholinergic transmission between neurons in the central nervous system.	Free Univ Amsterdam, Fac Biol, Neurosci Res Inst, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; Univ Utrecht, Med Ctr, Dept Cell Biol, Inst Biomembranes, NL-3584 CX Utrecht, Netherlands; Ctr Biogenet, NL-3584 CX Utrecht, Netherlands; Organon Teknika BV, Biosci Res Unit, Boxtel, Netherlands	Vrije Universiteit Amsterdam; Netherlands Cancer Institute; University of Calgary; Utrecht University	Smit, AB (corresponding author), Free Univ Amsterdam, Fac Biol, Neurosci Res Inst, Dept Mol & Cellular Neurobiol, De Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	absmit@bio.vu.nl	Smit, August B/E-8410-2011	Sixma, Titia K/0000-0001-6180-0632				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; BADIO B, 1994, MOL PHARMACOL, V45, P563; Betz H, 1999, ANN NY ACAD SCI, V868, P667, DOI 10.1111/j.1749-6632.1999.tb11343.x; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Corringer PJ, 1998, J NEUROSCI, V18, P648; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DEVILLERSTHIERY A, 1993, J MEMBRANE BIOL, V136, P97, DOI 10.1007/BF02505755; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Edelstein SJ, 1997, J MOL BIOL, V267, P10, DOI 10.1006/jmbi.1996.0861; Feng ZP, 1997, J NEUROSCI, V17, P7839; GARDNER D, 1977, J NEUROPHYSIOL, V40, P349, DOI 10.1152/jn.1977.40.2.349; Green WN, 1999, J GEN PHYSIOL, V113, P163, DOI 10.1085/jgp.113.2.163; GROEBE DR, 1995, J BIOL CHEM, V270, P281, DOI 10.1074/jbc.270.1.281; Hamakawa T, 1999, J NEUROSCI, V19, P9306; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KUFFLER SW, 1975, J PHYSL, V1, P465; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; MURPHY TH, 1993, J NEUROSCI, V13, P2672, DOI 10.1523/JNEUROSCI.13-06-02672.1993; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 1998, J NEUROSCI, V18, P4022; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; PASTI L, 1995, J BIOL CHEM, V270, P15203, DOI 10.1074/jbc.270.25.15203; Pasti L, 1997, J NEUROSCI, V17, P7817; Porter JT, 1996, J NEUROSCI, V16, P5073; Robitaille R, 1997, J PHYSIOL-LONDON, V504, P337, DOI 10.1111/j.1469-7793.1997.337be.x; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; SLOT JW, 1988, METHOD MICROBIOL, V20, P211, DOI 10.1016/S0580-9517(08)70053-9; SMITH SJ, 1992, PROG BRAIN RES, V94, P119; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; VANMINNEN J, 1988, CELL TISSUE RES, V251, P477, DOI 10.1007/BF00215857; Verbitsky M, 2000, NEUROPHARMACOLOGY, V39, P2515, DOI 10.1016/S0028-3908(00)00124-6; VERRALL S, 1992, CELL, V68, P23, DOI 10.1016/0092-8674(92)90203-O; Wang ZZ, 1996, J BIOL CHEM, V271, P27575, DOI 10.1074/jbc.271.44.27575; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; Wells GB, 1998, J BIOL CHEM, V273, P964, DOI 10.1074/jbc.273.2.964; Woodin MA, 1999, LEARN MEMORY, V6, P307; YEOMAN MS, 1993, J NEUROPHYSIOL, V70, P37, DOI 10.1152/jn.1993.70.1.37; Zwart R, 1997, MOL PHARMACOL, V52, P886, DOI 10.1124/mol.52.5.886	50	435	456	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2001	411	6835					261	268		10.1038/35077000	http://dx.doi.org/10.1038/35077000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357121				2022-12-01	WOS:000168710000036
J	Wilson, SI; Rydstrom, A; Trimborn, T; Willert, K; Nusse, R; Jessell, TM; Edlund, T				Wilson, SI; Rydstrom, A; Trimborn, T; Willert, K; Nusse, R; Jessell, TM; Edlund, T			The status of Wnt signalling regulates neural and epidermal fates in the chick embryo	NATURE			English	Article							BETA-CATENIN; NONNEURAL ECTODERM; SOX3 GENES; INDUCTION; EXPRESSION; XENOPUS; CELLS; FGF; GASTRULATION; REQUIREMENT	The acquisition of neural fate by embryonic ectodermal cells is a fundamental step in the formation of the vertebrate nervous system. Neural induction seems to involve signalling by fibroblast growth factors (FGFs) and attenuation of the activity of bone morphogenetic protein (BMP)(1-4). But FGFs, either alone or in combination with BMP antagonists, are not sufficient to induce neural fate in prospective epidermal ectoderm of amniote embryos(1,3,4). These findings suggest that additional signals are involved in the specification of neural fate. Here we show that the state of Wnt signalling is a critical determinant of neural and epidermal fates in the chick embryo. Continual Wnt signalling blocks the response of epiblast cells to FGF signals, permitting the expression and signalling of BMP to direct an epidermal fate. Conversely, a lack of exposure of epiblast cells to Wnt signals permits FGFs to induce a neural fate.	Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; Stanford Univ, Beckman Ctr, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Umea University; Howard Hughes Medical Institute; Stanford University; Columbia University; Howard Hughes Medical Institute	Edlund, T (corresponding author), Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.			Rydstrom, Anna/0000-0002-3404-7195				Dufort D, 1998, DEVELOPMENT, V125, P3015; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; GUGER KA, 1995, DEV BIOL, V172, P115, DOI 10.1006/dbio.1995.0009; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; KELLY GM, 1995, MECH DEVELOP, V53, P261, DOI 10.1016/0925-4773(95)00442-4; Kishi M, 2000, DEVELOPMENT, V127, P791; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Mallamaci A, 1996, MECH DEVELOP, V58, P165, DOI 10.1016/S0925-4773(96)00571-0; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; Pera E, 1999, DEVELOPMENT, V126, P63; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Read EM, 1998, INT J DEV BIOL, V42, P763; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Roeser T, 1999, DEVELOPMENT, V126, P2955; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sheng GJ, 1999, MECH DEVELOP, V87, P213, DOI 10.1016/S0925-4773(99)00150-1; Shibamoto S, 1998, GENES CELLS, V3, P659; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	29	215	223	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					325	330		10.1038/35077115	http://dx.doi.org/10.1038/35077115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357137				2022-12-01	WOS:000168710000052
J	Sethi, AA; Tybjaerg-Hansen, A; Gronholdt, MLM; Steffensen, R; Schnohr, P; Nordestgaard, BG				Sethi, AA; Tybjaerg-Hansen, A; Gronholdt, MLM; Steffensen, R; Schnohr, P; Nordestgaard, BG			Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease - Six case-control studies from the Copenhagen City Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACE GENE POLYMORPHISM; ESSENTIAL-HYPERTENSION; CARDIOVASCULAR-DISEASE; LIPOPROTEIN-LIPASE; CONVERTING ENZYME; BLOOD-PRESSURE; T235 VARIANT; ASSOCIATION; POPULATION; M235T	Background: The M235T and T174M angiotensinogen mutations have been linked to increased risk for ischemic heart and cerebrovascular disease. Objective: To determine whether angiotensinogen mutations are associated with ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Design: Six case-control studies from the Copenhagen City Heart Study. Setting: Copenhagen, Denmark. Participants: Participants in the Copenhagen City Heart Study and patients from the same hospital with ischemic heart disease (n = 866 and n = 943, respectively), myocardial infarction (n = 519 and n = 493, respectively), or ischemic cerebrovascular disease (n = 489 and n = 434, respectively) and 7975 controls without these conditions. Measurements: Genotypes for the M235T and T174M angiotensinogen mutations were compared between controls and Copenhagen City Heart Study participants with ischemic heart disease, myocardial infarction, and cerebrovascular disease (studies 1a, 1b, and 1c) and patients from Copenhagen University Hospital with the same conditions (studies 2a, 2b, and 2c). Results: Relative allele frequencies of 235T and 174M in the general population were 0.41 and 0.12, respectively. Genotype was not associated with increased risk for ischemic heart or ischemic cerebrovascular disease in studies of either mutation alone or combined in women or men. Among compound heterozygotes (235MT/174TM), women in case-control study 2a had decreased risk for ischemic heart disease in age-adjusted analysis; however, this decreased risk was not seen in multifactorial-adjusted or matched analyses, in men, or in case-control study 1a. Among double homozygotes (235TT/174MM), women in case-control study 2b had increased risk for myocardial infarction in matched analysis; however, this increased risk was not seen in age- or multifactorial-adjusted analyses, in men, or in case-control study 1b. Among single homozygotes (235TT/174TT), men in case-control study 2b had increased risk for myocardial infarction in multifactorial-adjusted and matched analyses. This risk was not present in age-adjusted analysis, in women, or in case-control study 1b. In addition, male single homozygotes had decreased risk for ischemic cerebrovascular disease in case-control study 2c in age- and multifactorial-adjusted analyses, but this finding was not seen in matched analysis, in women, or in case-control study 1c. Conclusions: In six large case-control studies, the M235T and T174M angiotensinogen mutations were not consistently associated with increased (or decreased) risk for ischemic heart disease, myocardial infarction, or ischemic cerebrovascular disease. Statistically significant associations may represent chance findings rather than real phenomena.	Herlev Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Copenhagen Univ Hosp, Copenhagen, Denmark; Herlev Univ Hosp, Copenhagen, Denmark; Bispebjerg Hosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital	Nordestgaard, BG (corresponding author), Herlev Univ Hosp, Dept Clin Biochem, Herlev Ringvej 75, DK-2730 Herlev, Denmark.	brno@herlevhosp.kbhamt.dk	Nordestgaard, Borge Gronne/ABF-1310-2020					Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; AgerholmLarsen B, 1997, ANN INTERN MED, V127, P346, DOI 10.7326/0003-4819-127-5-199709010-00002; AgerholmLarsen B, 1997, CIRCULATION, V95, P2358, DOI 10.1161/01.CIR.95.10.2358; BARLEY R, 1995, J HUM HYPERTENS, V9, P681; BLOEM LJ, 1995, J CLIN INVEST, V95, P948, DOI 10.1172/JCI117803; CAULFIELD M, 1994, NEW ENGL J MED, V330, P1629, DOI 10.1056/NEJM199406093302301; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fauci A, 1998, HARRISONS PRINCIPLES; FORNAGE M, 1995, HUM GENET, V96, P295; FUKAMIZU A, 1990, J BIOL CHEM, V265, P7576; Gardemann A, 1999, ATHEROSCLEROSIS, V145, P309, DOI 10.1016/S0021-9150(99)00082-9; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Julian DG, 1997, EUR HEART J, V18, P394; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Ludwig EH, 1997, ANN EPIDEMIOL, V7, P3, DOI 10.1016/S1047-2797(96)00105-6; Nakata Y, 1997, AM J HYPERTENS, V10, P1391, DOI 10.1016/S0895-7061(97)00315-4; *NOR MJ SPSS INC, 1998, SPSS WIND BAS SYST U; Nordestgaard BG, 1997, CIRCULATION, V96, P1737, DOI 10.1161/01.CIR.96.6.1737; Schunkert H, 1997, HYPERTENSION, V29, P628, DOI 10.1161/01.HYP.29.2.628; Sethi AA, 2001, HYPERTENSION, V37, P875, DOI 10.1161/01.HYP.37.3.875; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; TIRET L, 1995, J HYPERTENS, V13, P311; Tiret L, 1998, J HYPERTENS, V16, P37, DOI 10.1097/00004872-199816010-00007; Tybjaerg-Hansen A, 1998, NEW ENGL J MED, V338, P1577, DOI 10.1056/NEJM199805283382203; Winkelmann BR, 1999, AM HEART J, V137, P698, DOI 10.1016/S0002-8703(99)70226-7; Wittrup HH, 1997, J CLIN INVEST, V99, P1606, DOI 10.1172/JCI119323; YAMAKAWAKOBAYASHI K, 1995, LANCET, V346, P515, DOI 10.1016/S0140-6736(95)91369-6	28	54	59	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2001	134	10					941	954		10.7326/0003-4819-134-10-200105150-00008	http://dx.doi.org/10.7326/0003-4819-134-10-200105150-00008			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432FX	11352695				2022-12-01	WOS:000168682500002
J	Ferguson, NM; Donnelly, CA; Anderson, RM				Ferguson, NM; Donnelly, CA; Anderson, RM			The foot-and-mouth epidemic in Great Britain: Pattern of spread and impact of interventions	SCIENCE			English	Article							EMERGENCY VACCINATION; DISEASE; PROTECTION; REDUCTION	We present an analysis of the current foot-and-mouth disease epidemic in Great Britain over the first 2 months of the spread of the virus. The net transmission potential of the pathogen and the increasing impact of control measures are estimated over the course of the epidemic to date. These results are used to parameterize a,mathematical model of disease transmission that captures the differing spatial contact patterns between farms before and after the imposition of movement restrictions. The model is used to make predictions of future incidence and to simulate the impact of additional control strategies. Hastening the slaughter of animals with suspected infection is predicted to slow the epidemic, but more drastic action, such as "ring" culling or vaccination around;infection foci, is necessary for more rapid control. Culling is predicted to be more effective than vaccination.	Imperial Coll Sch Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Ferguson, NM (corresponding author), Imperial Coll Sch Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	Neil.Ferguson@ic.ac.uk	Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Anderson, Roy/0000-0002-9528-3175; Donnelly, Christl/0000-0002-0195-2463				ANDERSON R M, 1991; Cox SJ, 1999, VACCINE, V17, P1858, DOI 10.1016/S0264-410X(98)00486-1; DOEL TR, 1994, VACCINE, V12, P592, DOI 10.1016/0264-410X(94)90262-3; DONALDSON AI, 1992, VET REC, V131, P114, DOI 10.1136/vr.131.6.114; GLOSTER J, 1981, VET REC, V108, P370, DOI 10.1136/vr.108.17.370; Haydon DT, 1997, IMA J MATH APPL MED, V14, P1; HMSO (Her Majesty's Stationery Office), 1968, NORTHUMBERLAND REPOR; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; HUGHJONES ME, 1970, J HYG-CAMB, V68, P253, DOI 10.1017/S0022172400028722; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; *MIN AGR FISH FOOD, 2001, JUN 2000 AGR HORT CE; Salt JS, 1998, VACCINE, V16, P746, DOI 10.1016/S0264-410X(97)86180-4; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250	13	501	512	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2001	292	5519					1155	1160		10.1126/science.1061020	http://dx.doi.org/10.1126/science.1061020			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11303090				2022-12-01	WOS:000168609200058
J	Bulavin, DV; Higashimoto, Y; Popoff, IJ; Gaarde, WA; Basrur, V; Potapova, O; Appella, E; Fornace, AJ				Bulavin, DV; Higashimoto, Y; Popoff, IJ; Gaarde, WA; Basrur, V; Potapova, O; Appella, E; Fornace, AJ			Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase	NATURE			English	Article							DNA-DAMAGE CHECKPOINT; CELL-CYCLE; CDC25 PHOSPHATASE; PROTEIN-KINASE; PHOSPHORYLATION; CHK1; MITOSIS; P53	Response to genotoxic stress can be considered as a multistage process involving initiation of cell-cycle arrest and maintenance of arrest during DNA repair(1). Although maintenance of G2/M checkpoints is known to involve Chk1, Chk2/Rad53 and upstream components, the mechanisms involved in its initiation are less well defined(1-4). Here we report that p38 kinase has a critical role in the initiation of a G2 delay after ultraviolet radiation. Inhibition of p38 blocks the rapid initiation of this checkpoint in both human and murine cells after ultraviolet radiation. In vitro, p38 binds and phosphorylates Cdc25B at serines 309 and 361, and Cdc25C at serine 216; phosphorylation of these residues is required for binding to 14-3-3 proteins. In vivo, inhibition of p38 prevents both phosphorylation of Cdc25B at serine 309 and 14-3-3 binding after ultraviolet radiation, and mutation of this site is sufficient to inhibit the checkpoint initiation. In contrast, in vivo Cdc25C binding to 14-3-3 is not affected by p38 inhibition after ultraviolet radiation. We propose that regulation of Cdc25B phosphorylation by p38 is a critical event for initiating the G2/M checkpoint after ultraviolet radiation.	NCI, Div Basic Sci, NIH, Bethesda, MD 20892 USA; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; ISIS Pharmaceut, Carlsbad, CA 92008 USA; NIA, Biol Chem Lab, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Isis Pharmaceuticals Inc; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Fornace, AJ (corresponding author), NCI, Div Basic Sci, NIH, Bethesda, MD 20892 USA.		Fornace, Albert J/A-7407-2008	Fornace, Albert J/0000-0001-9695-085X; Higashimoto, Yuichiro/0000-0003-1382-8598	DIVISION OF BASIC SCIENCES - NCI [Z01BC007184] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander MR, 2001, MOL BIOL CELL, V12, P53, DOI 10.1091/mbc.12.1.53; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Gabrielli BG, 1997, ONCOGENE, V15, P749, DOI 10.1038/sj.onc.1201254; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Lammer C, 1998, J CELL SCI, V111, P2445; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Liu F, 1999, MOL CELL BIOL, V19, P5113; Liu QH, 2000, GENE DEV, V14, P1448; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Lopez JB, 1999, INT J BIOL MARKER, V14, P172, DOI 10.1177/172460089901400309; Morris MC, 2000, J BIOL CHEM, V275, P28849, DOI 10.1074/jbc.M002942200; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	23	446	476	1	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					102	107		10.1038/35075107	http://dx.doi.org/10.1038/35075107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333986				2022-12-01	WOS:000168432800052
J	Davies, R; Cartwright, J; Pike, J; Line, C				Davies, R; Cartwright, J; Pike, J; Line, C			Early Oligocene initiation of North Atlantic Deep Water formation	NATURE			English	Article								Dating the onset of deep-water flow between the Arctic and North Atlantic oceans is critical for modelling climate change in the Northern Hemisphere(1,2) and for explaining changes in global ocean circulation throughout the Cenozoic era(3) (from about 65 million years ago to the present). In the early Cenozoic era, exchange between these two ocean basins was inhibited by the Greenland-Scotland ridge(3,4), but a gateway through the Faeroe-Shetland basin has been hypothesized(3,5). Previous estimates of the date marking the onset of deep-water circulation through this basin-on the basis of circumstantial evidence from neighbouring basins-have been contradictory(5-9), ranging from about 35 to 15 million years ago. Here we describe the newly discovered Southeast Faeroes drift, which extends for 120 km parallel to the basin axis. The onset of deposition in this drift has been dated to the early Oligocene epoch (similar to 35 million years ago) from a petroleum exploration borehole. We show that the drift was deposited under a southerly flow regime, and conclude that the initiation of deep-water circulation from the Norwegian Sea into the North Atlantic Ocean took place much earlier than is currently assumed in most numerical models of ancient ocean circulation.	ExxonMobil Int Ltd, London WC2B 6WF, England; Univ Cardiff, Dept Earth Sci, Cardiff CF10 3YE, S Glam, Wales	Exxon Mobil Corporation; Cardiff University	Davies, R (corresponding author), ExxonMobil Int Ltd, St Catherines House,2 Kingsway,POB 393, London WC2B 6WF, England.	richard_davies@email.mobil.com; cartwrightja@cardiff.ac.uk	Pike, Jennifer/D-2589-2009	Pike, Jennifer/0000-0001-9415-6003				Berggren W., 1983, STRUCTURE DEV GREENL, P495; Berggren W. A., 1974, SPEC PUBLS SOC ECON, V20, P126; Blow W.H., 1979, CENOZOIC GLOBIGERINI, V3, P1; BOLDREEL IO, 1995, TECTONICS SEDIMENTAT, P145; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI [DOI 10.5670/0CEAN0G.1991.07, 10.5670/oceanog.1991.07, DOI 10.5670/OCEANOG.1991.07]; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Davies R, 1999, GEOLOGY, V27, P907, DOI 10.1130/0091-7613(1999)027<0907:GHIDWM>2.3.CO;2; Dean K., 1999, PETROLEUM GEOLOGY NW, V5, P533, DOI [DOI 10.1144/0050533, 10.1144/0050533]; Eldholm O., 1990, MEM GEOL ITAL, V44, P13; Faugeres JC, 1999, MAR GEOL, V162, P1, DOI 10.1016/S0025-3227(99)00068-7; Harland W.B., 1990, GEOLOGIC TIME SCALE; HEIN JR, 1978, SEDIMENTOLOGY, V25, P155, DOI 10.1111/j.1365-3091.1978.tb00307.x; HEINRICH R, 1989, P OCEAN DRILLING PRO, V104, P75; Hollister C.D., 1972, STUDIES PHYSICAL OCE, V2, P37; KIDD RB, 1987, INITIAL REP DEEP SEA, V94, P1217; Martini E., 1971, P 2 PLANKT C ROM 197, V2, P739; Miller K. G., 1983, STRUCTURE DEV GREENL, P549, DOI DOI 10.1007/978-1-4613-3485-9_27; MITCHELL SM, 1993, PETROLEUM GEOLOGY OF NORTHWEST EUROPE: PROCEEDINGS OF THE 4TH CONFERENCE, P1011, DOI 10.1144/0041011; NILSEN TH, 1983, STRUCTURE DEV GREENL, P457; SCHNITKER D, 1980, NATURE, V284, P615, DOI 10.1038/284615a0; SCHNITKER D, 1980, EARTH-SCI REV, V16, P1, DOI 10.1016/0012-8252(80)90002-1; SHOR AN, 1907, INIT REP DSDP, V49, P859; Stoker MS, 1998, GEOL SOC SPEC PUBL, V129, P229, DOI 10.1144/GSL.SP.1998.129.01.15; STOW DAV, 1984, INITIAL REP DEEP SEA, V81, P695; Thiede J., 1983, STRUCTURE DEV GREENL, P445; VOGT PR, 1972, NATURE, V239, P79, DOI 10.1038/239079a0; WOLD CN, 1994, PALEOCEANOGRAPHY, V9, P917, DOI 10.1029/94PA01438; WOLD CN, 1995, TECTONICS SEDIMENTAT, P271; Wright JD, 1996, PALEOCEANOGRAPHY, V11, P157, DOI 10.1029/95PA03696	29	107	112	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					917	920		10.1038/35073551	http://dx.doi.org/10.1038/35073551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309613				2022-12-01	WOS:000168152300042
J	Egger, M; Juni, P; Bartlett, C				Egger, M; Juni, P; Bartlett, C		CONSORT Grp	Value of flow diagrams in reports of randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONSORT STATEMENT; QUALITY	Context Diagrams of the flow of participants through a clinical trial are recommended in the Consolidated Standards for Reporting of Trials (CONSORT) statement, but it is unclear whether such flow diagrams improve the quality of trial reports. Objective To examine the information contributed by flow diagrams and the completeness of reporting overall in reports of randomized controlled trials (RCTs) published in 5 general and internal medicine journals. Design and Setting Analysis of 270 reports of RCTs published in 1998 in the Annals of Internal Medicine (AIM; n = 19), BMJ (n = 42), JAMA (n = 45), The Lancet (n = 81), and The New England Journal of Medicine (NEJM; n = 83). Main Outcome Measures Proportion of reports that included a flow diagram, information provided in flow diagrams, and completeness of reporting about flow of published in 5 general and internal medicine journals. participants overall in flow diagrams or text. Results A total of 139 reports (51.5%) of RCTs included a flow diagram, but this varied widely among journals (AIM, 21.0%; BMJ, 38.1%; JAMA, 80.0%; The Lancet, 93.8%; and NEJM, 8.4%). Diagrams generally provided useful information, but only 73 (52.5%) included the number of participants who received allocated interventions and only 32 (23.0%) included the number of participants included in the analysis. In logistic regression analysis, overall completeness of reporting about flow of study participants was associated with publication of a flow diagram. Conclusions Flow diagrams are associated with improved quality of reporting of randomized controlled trials. However, the structure of current flow diagrams is less than ideal. We propose a revised flow diagram that includes all important counts through participants overall in flow diagrams or text. the stages of parallel group trials.	Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England; Univ Bern, Dept Social & Prevent Med, Bern, Switzerland	University of Bristol; University of Bern	Egger, M (corresponding author), Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.		Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Egger, Matthias/0000-0001-7462-5132				Altman DG, 1996, BRIT MED J, V313, P570; Ausejo M, 1998, Aten Primaria, V21, P351; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; *CONSORT, 1998, NED TIJDSCHR GENEESK, V142, P1089; Deeks JJ, 1998, LANCET, V352, P1908, DOI 10.1016/S0140-6736(05)60399-6; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Huston P, 1996, CAN MED ASSOC J, V155, P1277; JUNI P, 2001, SYSTEMATIC REV HLTH; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Meinert CL, 1998, JAMA-J AM MED ASSOC, V279, P1487, DOI 10.1001/jama.279.18.1487; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 1998, JAMA-J AM MED ASSOC, V279, P1489, DOI 10.1001/jama.279.18.1489; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987	13	241	254	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2001	285	15					1996	1999		10.1001/jama.285.15.1996	http://dx.doi.org/10.1001/jama.285.15.1996			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	420FY	11308437				2022-12-01	WOS:000167995900029
J	Geleziunas, R; Xu, WD; Takeda, K; Ichijo, H; Greene, WC				Geleziunas, R; Xu, WD; Takeda, K; Ichijo, H; Greene, WC			HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell	NATURE			English	Article							FAS LIGAND EXPRESSION; HUMAN-IMMUNODEFICIENCY-VIRUS; TUMOR-NECROSIS-FACTOR; CD4 DOWN-REGULATION; T-LYMPHOCYTES; DILEUCINE MOTIF; LYMPH-NODES; SH3 DOMAIN; IN-VIVO; APOPTOSIS	In vivo infection of lymphatic tissues by the human immunodeficiency virus type 1 (HIV-1) leads to enhanced apoptosis, which prominently involves uninfected bystander cells(1-3). Increased killing of such bystander cells is mediated in part through Nef induction of Fas ligand (FasL) expression(4-6) on the surface of the virally infected T cells. The subsequent interaction of FasL with Fas (CD95) displayed on neighbouring cells, including HIV-1-specific cytotoxic T lymphocytes, may lead to bystander cell killing and thus forms an important mechanism of immune evasion. As HIV-1 also enhances Fas expression on virally infected cells(7-9), it is unclear how these hosts avoid rapid cell-autonomous apoptosis mediated through cis ligation of Fas by FasL. Here we show that HIV-1 Nef associates with and inhibits apoptosis signal-regulating kinase 1 (ASK1), a serine/threonine kinase that forms a common and key signalling intermediate in the Fas and tumour-necrosis factor-alpha (TNF alpha) death-signalling pathways(10-12). The interaction of Nef with ASK1 inhibits both Fas- and TNF alpha -mediated apoptosis, as well as the activation of the downstream c-Jun amino-terminal kinase. Our findings reveal a strategy by which HIV-1 Nef promotes the killing of bystander cells through the induction of FasL, while simultaneously protecting the HIV-1-infected host cell from these same pro-apoptotic signals through its interference with ASK1 function.	Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Tokyo Med & Dent Univ, Grad Sch, Lab Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; Japan Sci & Technol, CREST, Chiyoda Ku, Tokyo 1020081, Japan; Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greene, WC (corresponding author), Gladstone Inst Virol & Immunol, POB 419100, San Francisco, CA 94141 USA.			Ichijo, Hidenori/0000-0002-5005-6438; Takeda, Kohsuke/0000-0002-8359-8399				Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Badley AD, 1997, J EXP MED, V185, P55, DOI 10.1084/jem.185.1.55; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; CHANG CF, 1981, P S QINGHAI XIZANG T, V1, P1; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; DEBATIN KM, 1994, BLOOD, V83, P3101, DOI 10.1182/blood.V83.10.3101a.3101a; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Hodge S, 1998, VIROLOGY, V252, P354, DOI 10.1006/viro.1998.9477; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jaworowski A, 1999, IMMUNOL CELL BIOL, V77, P90, DOI 10.1046/j.1440-1711.1999.00798.x; KATSIKIS PD, 1995, J EXP MED, V181, P2029, DOI 10.1084/jem.181.6.2029; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Mitra D, 1996, IMMUNOLOGY, V87, P581, DOI 10.1046/j.1365-2567.1996.510589.x; MUROCACHO CA, 1995, J IMMUNOL, V154, P5555; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; SAWAI ET, 1995, J BIOL CHEM, V270, P15307, DOI 10.1074/jbc.270.25.15307; Sloand EM, 1997, BLOOD, V89, P1357, DOI 10.1182/blood.V89.4.1357; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Xu XN, 1997, J EXP MED, V186, P7, DOI 10.1084/jem.186.1.7; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	30	265	278	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 12	2001	410	6830					834	838		10.1038/35071111	http://dx.doi.org/10.1038/35071111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298454				2022-12-01	WOS:000168021900060
J	Colvin, JS; Green, RP; Schmahl, J; Capel, B; Ornitz, DM				Colvin, JS; Green, RP; Schmahl, J; Capel, B; Ornitz, DM			Male-to-female sex reversal in mice lacking fibroblast growth factor 9	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; ANTI-MULLERIAN HORMONE; TARGETED DISRUPTION; SERTOLI-CELLS; TESTIS DIFFERENTIATION; PERITUBULAR CELLS; MOUSE TESTIS; GENE; EXPRESSION; SRY	Fgfs direct embryogenesis of several organs, including the lung, limb, and anterior pituitary. Here we report male-to-female sex reversal in mice lacking Fibroblast growth factor 9 (Fgf9), demonstrating a novel role for FGF signaling in testicular embryogenesis. Fgf9(/-) mice also exhibit lung hypoplasia and die at birth. Reproductive system phenotypes range from testicular hypoplasia to complete sex reversal, with most Fgf9(-/-) reproductive systems appearing grossly female at birth. Fgf9 appears to act downstream of Sly to stimulate mesenchymal proliferation, mesonephric cell migration, and Sertoli cell differentiation in the embryonic testis. While Sry is found only in some mammals, Fgfs are highly conserved. Thus, Fgfs may function in sex determination and reproductive system development in many species.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Washington University (WUSTL); Duke University	Ornitz, DM (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Campus Box 8103,660 S Euclid Ave, St Louis, MO 63110 USA.	domitz@pcg.wustl.edu		Ornitz, David/0000-0003-1592-7629	NCI NIH HHS [CA60673] Funding Source: Medline; NICHD NIH HHS [HD33688, HD35692] Funding Source: Medline; NIGMS NIH HHS [GM56757, 5-T32-GM07200-25] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035692, P30HD033688] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA060673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200, R01GM056757] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; AGELOPOULOU R, 1984, J EMBRYOL EXP MORPH, V83, P15; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; Bellusci S, 1997, DEVELOPMENT, V124, P4867; Birk OS, 2000, NATURE, V403, P909, DOI 10.1038/35002622; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; BUEHR M, 1993, DEVELOPMENT, V117, P273; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; BURGOYNE PS, 1989, NATURE, V342, P860, DOI 10.1038/342860a0; Capel B, 1998, ANNU REV PHYSIOL, V60, P497, DOI 10.1146/annurev.physiol.60.1.497; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; Clark AM, 2000, BIOL REPROD, V63, P1825, DOI 10.1095/biolreprod63.6.1825; Colvin JS, 1999, DEV DYNAM, V216, P72; COLVIN JS, 2001, IN PRESS DEVELOPMENT; DAVIS AP, 1994, DEVELOPMENT, V120, P2187; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; FOX N, 1981, DEV BIOL, V83, P391, DOI 10.1016/0012-1606(81)90487-5; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; Johnston CM, 1995, PHILOS T R SOC B, V350, P297, DOI 10.1098/rstb.1995.0165; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koopman P, 1999, CELL MOL LIFE SCI, V55, P839; LovellBadge R, 1995, PHILOS T R SOC B, V350, P205, DOI 10.1098/rstb.1995.0153; LOVELLBADGE R, 1990, DEVELOPMENT, V109, P635; MAGRE S, 1991, J ELECTRON MICR TECH, V19, P172, DOI 10.1002/jemt.1060190205; Martineau J, 1997, CURR BIOL, V7, P958, DOI 10.1016/S0960-9822(06)00415-5; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Mishina Y, 1996, GENE DEV, V10, P2577, DOI 10.1101/gad.10.20.2577; MITTWOCH U, 1992, HUM GENET, V89, P467, DOI 10.1007/BF00219168; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; MULLER J, 1991, HORM RES, V36, P203, DOI 10.1159/000182162; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; Naski MC, 1998, DEVELOPMENT, V125, P4977; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Oreal E, 1998, DEV DYNAM, V212, P522, DOI 10.1002/(SICI)1097-0177(199808)212:4<522::AID-AJA5>3.0.CO;2-J; Ornitz DM, 2001, GENOME BIOL, V2; Orth JM., 1993, CELL MOL BIOL TESTIS, P3; PALMER SJ, 1991, DEVELOPMENT, V113, P709; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Partanen J, 1998, GENE DEV, V12, P2332, DOI 10.1101/gad.12.15.2332; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Rey R, 1996, AM J PATHOL, V148, P1689; ROBERTS MM, 1993, NEUROENDOCRINOLOGY, V57, P388, DOI 10.1159/000126384; SantosOcampo S, 1996, J BIOL CHEM, V271, P1726, DOI 10.1074/jbc.271.3.1726; Scherer G, 1999, CELL MOL LIFE SCI, V55, P821, DOI 10.1007/s000180050335; Schmahl J, 2000, DEVELOPMENT, V127, P65; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Sinclair AH, 1998, J EXP ZOOL, V281, P501, DOI 10.1002/(SICI)1097-010X(19980801)281:5<501::AID-JEZ15>3.0.CO;2-B; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Song JW, 1996, DEV DYNAM, V206, P427, DOI 10.1002/(SICI)1097-0177(199608)206:4<427::AID-AJA8>3.0.CO;2-K; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Szebenyi G, 1999, INT REV CYTOL, V185, P45; Tilmann C, 1999, DEVELOPMENT, V126, P2883; TUNG PS, 1987, DEV BIOL, V120, P139, DOI 10.1016/0012-1606(87)90112-6; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu JS, 1999, MECH DEVELOP, V83, P165, DOI 10.1016/S0925-4773(99)00034-9; Xu XL, 1998, DEVELOPMENT, V125, P753; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032	69	434	450	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2001	104	6					875	889		10.1016/S0092-8674(01)00284-7	http://dx.doi.org/10.1016/S0092-8674(01)00284-7			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290325	Bronze			2022-12-01	WOS:000167869200010
J	Bode, F; Sachs, F; Franz, MR				Bode, F; Sachs, F; Franz, MR			Tarantula peptide inhibits atrial fibrillation - A peptide from spider venom can prevent the heartbeat from losing its rhythm.	NATURE			English	Article							ACTIVATED ION CHANNELS; STRETCH; MYOCYTES		Georgetown Univ, Dept Pharmacol, Washington, DC 20007 USA; SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	Georgetown University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bode, F (corresponding author), Univ Klinikum Luebeck, Med Klin 2, Ratzeburger Allee 160, D-23538 Lubeck, Germany.		Bode, Frank/A-6395-2015					Bode F, 2000, CIRCULATION, V101, P2200, DOI 10.1161/01.CIR.101.18.2200; Caldwell RA, 1998, AM J PHYSIOL-CELL PH, V275, pC619, DOI 10.1152/ajpcell.1998.275.2.C619; HAGIWARA N, 1992, J PHYSIOL-LONDON, V456, P285, DOI 10.1113/jphysiol.1992.sp019337; KIM D, 1992, J GEN PHYSIOL, V100, P1021, DOI 10.1085/jgp.100.6.1021; NAZIR SA, 1996, J PHYSL P, V494, P111; Ravelli F, 1997, CIRCULATION, V96, P1686, DOI 10.1161/01.CIR.96.5.1686; RUKNUDIN A, 1993, AM J PHYSIOL, V264, pH960, DOI 10.1152/ajpheart.1993.264.3.H960; SACHS F, 1994, CELL MECHANICS AND CELLULAR ENGINEERING, P308; Sato R, 1998, J MEMBRANE BIOL, V163, P67, DOI 10.1007/s002329900371; SMALL DL, 1995, BRIT J PHARMACOL, V114, P180, DOI 10.1111/j.1476-5381.1995.tb14923.x; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; Zabel M, 1996, CARDIOVASC RES, V32, P120, DOI 10.1016/0008-6363(96)00089-2	12	237	247	0	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					35	36		10.1038/35051165	http://dx.doi.org/10.1038/35051165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343101				2022-12-01	WOS:000166175600027
J	Lindroth, AM; Cao, XF; Jackson, JP; Zilberman, D; McCallum, CM; Henikoff, S; Jacobsen, SE				Lindroth, AM; Cao, XF; Jackson, JP; Zilberman, D; McCallum, CM; Henikoff, S; Jacobsen, SE			Requirement of CHROMOMETHYLASE3 for maintenance of CpXpG methylation	SCIENCE			English	Article							DNA METHYLATION; EPIGENETIC ALLELES; PLANT DNA; ARABIDOPSIS; METHYLTRANSFERASES; HYPERMETHYLATION; RETROTRANSPOSONS; SEQUENCES; MUTANTS; DOMAIN	Epigenetic silenced alleles of the Arabidopsis SUPERMAN locus (the clark kent alleles) are associated with dense hypermethylation at noncanonical cytosines (CpXpG and asymmetric sites, where X = A, T, C, or G). A genetic screen for suppressors of a hypermethylated clark kent mutant identified nine loss-of-function alleles of CHROMOMETHYLASE3 (CMT3), a novel cytosine methyltransferase homolog. These cmt3 mutants display a wild-type morphology but exhibit decreased CpXpG methylation of the SUP gene and of other sequences throughout the genome. They also show reactivated expression of endogenous retrotransposon sequences. These results show that a non-CpG DNA methyltransferase is responsible for maintaining epigenetic gene silencing.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Seattle, WA 98109 USA	University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.		Lindroth, Anders M/C-7744-2015	Lindroth, Anders M/0000-0002-8291-2745; Zilberman, Daniel/0000-0002-0123-8649; Henikoff, Steven/0000-0002-7621-8685	NIGMS NIH HHS [GM07104, GM60398, GM07185, GM29009] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398, R01GM029009, T32GM007185] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; Henikoff S, 1998, GENETICS, V149, P307; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; KISHIMOTO N, IN PRESS PLANT MOL B; KONIECZNY A, 1991, GENETICS, V127, P801; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; PAPA CM, UNPUB; Pelissier T, 1996, GENETICA, V97, P141, DOI 10.1007/BF00054621; PRADHAN S, 1995, PLANT J, V7, P471, DOI 10.1046/j.1365-313X.1995.7030471.x; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(00)00078-2; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832	22	639	695	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2001	292	5524					2077	2080		10.1126/science.1059745	http://dx.doi.org/10.1126/science.1059745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	442KP	11349138				2022-12-01	WOS:000169284700048
J	MacKenzie, IZ; Cooke, I				MacKenzie, IZ; Cooke, I			Prospective 12 month study of 30 minute decision to delivery intervals for "emergency" caesarean section	BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England	University of Oxford	MacKenzie, IZ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.							[Anonymous], 2000, 7 MAT CHILD HLTH RES, P41; DENNIS J, 1989, AM J OBSTET GYNECOL, V161, P213, DOI 10.1016/0002-9378(89)90269-X; DUNPHY, 1991, J OBSTET GYNAECOL, V11, P241; HANNAH WJ, 1986, CAN MED ASSOC J, V134, P1348; Okunwobi-Smith Y, 2000, BRIT J OBSTET GYNAEC, V107, P467, DOI 10.1111/j.1471-0528.2000.tb13263.x	5	48	48	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2001	322	7298					1334	1335		10.1136/bmj.322.7298.1334	http://dx.doi.org/10.1136/bmj.322.7298.1334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	440GQ	11387178	Bronze, Green Published, Green Submitted			2022-12-01	WOS:000169167900017
J	Cho, H; Mu, J; Kim, JK; Thorvaldsen, JL; Chu, QW; Crenshaw, EB; Kaestner, KH; Bartolomei, MS; Shulman, GI; Birnbaum, MJ				Cho, H; Mu, J; Kim, JK; Thorvaldsen, JL; Chu, QW; Crenshaw, EB; Kaestner, KH; Bartolomei, MS; Shulman, GI; Birnbaum, MJ			Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)	SCIENCE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; GLUT4 TRANSLOCATION; 3T3-L1 ADIPOCYTES; GLUCOSE-UPTAKE; C-LAMBDA; EXPRESSION; ACTIVATION; TRANSCRIPTION; HEPATOCYTES; INHIBITION	Glucose homeostasis depends on insulin responsiveness in target tissues, most importantly, muscle and Liver. The critical initial steps in insulin action include phosphorylation of scaffolding proteins and activation of phosphatidylinositol 3-kinase. These early events Lead to activation of the serine-threonine protein kinase Akt, also known as protein kinase B. We show that mice deficient in Akt2 are impaired in the ability of insulin to Lower blood glucose because of defects in the action of the hormone on Liver and skeletal muscle. These data establish Akt2 as an essential gene in the maintenance of normal glucose homeostasis.	Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Yale University; University of Pennsylvania	Birnbaum, MJ (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.		Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Kim, Jason/0000-0002-7185-042X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886, P30DK050306, R01DK040936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK56886, P30 DK50306, R01 DK040936] Funding Source: Medline; NIGMS NIH HHS [GM07229] Funding Source: Medline; PHS HHS [P30 19525] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Agati JM, 1998, J BIOL CHEM, V273, P18751, DOI 10.1074/jbc.273.30.18751; Altomare DA, 1996, CYTOGENET CELL GENET, V74, P248, DOI 10.1159/000134426; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; BELLACOSA A, 1993, ONCOGENE, V8, P745; BIRNBAUM MJ, 1992, INT REV CYTOL, V137A, P239; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Brozinick JT, 1998, J BIOL CHEM, V273, P14679, DOI 10.1074/jbc.273.24.14679; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Cherrington AD, 1998, DIABETOLOGIA, V41, P987, DOI 10.1007/s001250051021; Cho H.-G., UNPUB; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Iynedjian PB, 2000, BIOCHEM J, V351, P621, DOI 10.1042/0264-6021:3510621; Kadowaki T, 2000, J CLIN INVEST, V106, P459, DOI 10.1172/JCI10830; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kotani K, 1999, J BIOL CHEM, V274, P21305, DOI 10.1074/jbc.274.30.21305; Kotani K, 1998, MOL CELL BIOL, V18, P6971, DOI 10.1128/MCB.18.12.6971; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Murthy SS, 2000, CYTOGENET CELL GENET, V88, P38, DOI 10.1159/000015481; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Summers SA, 1999, J BIOL CHEM, V274, P23858, DOI 10.1074/jbc.274.34.23858; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	33	1441	1520	5	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1728	1731		10.1126/science.292.5522.1728	http://dx.doi.org/10.1126/science.292.5522.1728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387480				2022-12-01	WOS:000169031800049
J	Dubois, M; Deme, B; Gulik-Krzywicki, T; Dedieu, JC; Vautrin, C; Desert, S; Perez, E; Zemb, T				Dubois, M; Deme, B; Gulik-Krzywicki, T; Dedieu, JC; Vautrin, C; Desert, S; Perez, E; Zemb, T			Self-assembly of regular hollow icosahedra in salt-free catanionic solutions	NATURE			English	Article							VESICLES	Self-assembled structures having a regular hollow icosahedral form (such as those observed for proteins of virus capsids) can occur as a result of biomineralization processes(1), but are extremely rare in mineral crystallites(2). Compact icosahedra made from a boron oxide have been reported(3), but equivalent structures made of synthetic organic components such as surfactants have not hitherto been observed. It is, however, well known that lipids, as well as mixtures of anionic and cationic single chain surfactants, can readily form bilayers(4,5) that can adopt a variety of distinct geometric forms: they can fold into soft vesicles or random bilayers (the so-called sponge phase) or form ordered stacks of flat or undulating membranes(6). Here we show that in salt-free mixtures of anionic and cationic surfactants, such bilayers can self-assemble into hollow aggregates with a regular icosahedral shape. These aggregates are stabilized by the presence of pores located at the vertices of the icosahedra. The resulting structures have a size of about one micrometre and mass of about 10(10) daltons, making them larger than any known icosahedral protein assembly(7) or virus capsid(8). We expect the combination of wall rigidity and holes at vertices of these icosahedral aggregates to be of practical value for controlled drug or DNA release.	CEA Saclay, Serv Chim Mol, F-91191 Gif Sur Yvette, France; Inst Max Von Laue Paul Langevin, F-38042 Grenoble 09, France; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; IMRCP, CNRS, URA 470, F-31062 Toulouse, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut Laue-Langevin (ILL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Dubois, M (corresponding author), CEA Saclay, Serv Chim Mol, F-91191 Gif Sur Yvette, France.	duboism@scm.saclay.cea.fr	Demé, Bruno/AAG-1620-2021; ZEMB, Thomas N/E-5958-2010	Demé, Bruno/0000-0002-9523-7662; 				CRICK FHC, 1956, NATURE, V177, P473, DOI 10.1038/177473a0; Donath E, 1998, ANGEW CHEM INT EDIT, V37, P2202, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2201::AID-ANIE2201>3.0.CO;2-E; Dubois M, 2000, PROG COLL POL SCI S, V115, P238; Dubois M, 1998, CR ACAD SCI II C, V1, P567, DOI 10.1016/S1387-1609(98)80012-1; Dubois M, 2000, CURR OPIN COLLOID IN, V5, P27, DOI 10.1016/S1359-0294(00)00032-7; Fogden A, 1997, J PHYS II, V7, P229, DOI 10.1051/jp2:1997121; Fogden A, 1997, COLLOID SURFACE A, V129, P157, DOI 10.1016/S0927-7757(97)00034-4; GRACIAA A, 1989, J PHYS CHEM-US, V93, P4167, DOI 10.1021/j100347a055; Hubert H, 1998, NATURE, V391, P376, DOI 10.1038/34885; Hyde ST, 1997, COLLOID SURFACE A, V129, P207, DOI 10.1016/S0927-7757(97)00038-1; KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283; KIMOTO K, 1966, J APPL PHYS, V16, P941; KLUG A, 1959, BIOCHIM BIOPHYS ACTA, V32, P203, DOI 10.1016/0006-3002(59)90570-0; KLUG A., 1960, ADVANCES IN VIRUS RES, V7, P225; NELSON DR, 1989, SOLID STATE PHYS, V42, P1; PARENTE RA, 1985, BIOCHIM BIOPHYS ACTA, V812, P493, DOI 10.1016/0005-2736(85)90324-4; Radtchenko IL, 2000, J COLLOID INTERF SCI, V230, P272, DOI 10.1006/jcis.2000.7068; Regev O, 1999, LANGMUIR, V15, P642, DOI 10.1021/la9803474; SACKMANN E, 1995, HDB BIOL PHYSICS B, V1; SCAMEHORN JF, 1989, SURFACTANT SCI SERIE, V33, pCH10; SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669; Spector MS, 1996, LANGMUIR, V12, P4704, DOI 10.1021/la960218s; THOMAS BN, 1995, SCIENCE, V267, P1635, DOI 10.1126/science.267.5204.1635; Thompson D.W., 1961, GROWTH FORM; WALS J, 1997, MOL CELL, V1, P59; Zemb T, 1999, SCIENCE, V283, P816, DOI 10.1126/science.283.5403.816	26	302	311	5	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN	2001	411	6838					672	675		10.1038/35079541	http://dx.doi.org/10.1038/35079541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395764				2022-12-01	WOS:000169112500038
J	Sturm, M; Racine, C; Tape, K				Sturm, M; Racine, C; Tape, K			Climate change - Increasing shrub abundance in the Arctic	NATURE			English	Article									USA, Cold Reg Res & Engn Lab, Ft Wainwright, AK 99703 USA; USA, Cold Reg Res & Engn Lab, Hanover, NH 03755 USA; Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); Cold Regions Research & Engineering Laboratory (CRREL); University of Alaska System; University of Alaska Fairbanks	Sturm, M (corresponding author), USA, Cold Reg Res & Engn Lab, POB 35170, Ft Wainwright, AK 99703 USA.		Sturm, Matthew/GXF-6926-2022					Anderson Patricia M., 1993, P386; BILLINGS WD, 1987, QUATERNARY SCI REV, V6, P155; BLISS L C, 1992, P59; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chapin FS, 2000, J CLIMATE, V13, P2002, DOI 10.1175/1520-0442(2000)013<2002:SDAAEI>2.0.CO;2; Epstein HE, 2000, ECOL APPL, V10, P824, DOI 10.1890/1051-0761(2000)010[0824:ATNBMO]2.0.CO;2; McGuire AD, 2000, GLOBAL CHANGE BIOL, V6, P141, DOI 10.1046/j.1365-2486.2000.06017.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; REED JC, 1958, 302 US GEOL SURV; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Sturm M, 2001, J CLIMATE, V14, P336, DOI 10.1175/1520-0442(2001)014<0336:SSIIAT>2.0.CO;2	13	952	1010	10	356	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					546	547		10.1038/35079180	http://dx.doi.org/10.1038/35079180			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385559				2022-12-01	WOS:000168982500038
J	Cowley, MA; Smart, JL; Rubinstein, M; Cordan, MG; Diano, S; Horvath, TL; Cone, RD; Low, MJ				Cowley, MA; Smart, JL; Rubinstein, M; Cordan, MG; Diano, S; Horvath, TL; Cone, RD; Low, MJ			Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus	NATURE			English	Article							CENTRAL MELANOCORTIN SYSTEM; NEUROPEPTIDE-Y RECEPTOR; HYPOTHALAMIC NEURONS; OBESE GENE; MOUSE; MICE; INNERVATION; CHANNELS; RATS; AREA	The administration of leptin(1) to leptin-deficient humans, and the analogous Lep(ob)/Lep(ob) mice, effectively reduces hyperphagia and obesity(2,3). But common obesity is associated with elevated leptin, which suggests that obese humans are resistant to this adipocyte hormone. In addition to regulating long-term energy balance, leptin also rapidly affects neuronal activity(4-6). Proopiomelanocortin (POMC) and neuropeptide-Y types of neurons in the arcuate nucleus of the hypothalamus(7) are both principal sites of leptin receptor expression and the source of potent neuropeptide modulators, melanocortins and neuropeptide Y, which exert opposing effects on feeding and metabolism(8,9). These neurons are therefore ideal for characterizing leptin action and the mechanism of leptin resistance; however, their diffuse distribution makes them difficult to study. Here we report electrophysiological recordings on POMC neurons, which we identified by targeted expression of green fluorescent protein in transgenic mice. Leptin increases the frequency of action potentials in the anorexigenic POMC neurons by two mechanisms: depolarization through a nonspecific cation channel; and reduced inhibition by local orexigenic neuropeptide-Y/GABA (gamma -aminobutyric acid) neurons. Furthermore, we show that melanocortin peptides have an autoinhibitory effect on this circuit. On the basis of our results, we propose an integrated model of leptin action and neuronal architecture in the arcuate nucleus of the hypothalamus.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Buenos Aires, Sch Sci, Dept Biol, RA-1428 Buenos Aires, DF, Argentina; CONICET, Inst Invest Ingn Genet & Biol Mol, RA-1428 Buenos Aires, DF, Argentina; Yale Univ, Sch Med, Dept Obstet & Gynecol, Reprod Neurosci Unit, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA	Oregon Health & Science University; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Yale University; Yale University	Cone, RD (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.		Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X; Low, Malcolm/0000-0002-9900-3708				BAGNOL D, 1999, J NEUROSCI      0825; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; CSIFFARY A, 1990, BRAIN RES, V506, P215, DOI 10.1016/0006-8993(90)91253-D; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA; Glaum SR, 1996, MOL PHARMACOL, V50, P230; Grieco P, 2000, J MED CHEM, V43, P4998, DOI 10.1021/jm000211e; Hakansson ML, 1998, J NEUROSCI, V18, P559; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Haynes WG, 1999, HYPERTENSION, V33, P542, DOI 10.1161/01.HYP.33.1.542; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; HORVATH TL, 1992, NEUROSCIENCE, V51, P391, DOI 10.1016/0306-4522(92)90323-T; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; KELLY MJ, 1990, NEUROENDOCRINOLOGY, V52, P268, DOI 10.1159/000125597; Kim MS, 2000, J CLIN INVEST, V105, P1005, DOI 10.1172/JCI8857; King PJ, 1999, J NEUROCHEM, V73, P641, DOI 10.1046/j.1471-4159.1999.0730641.x; Lee K, 1999, J PHYSIOL-LONDON, V515, P439, DOI 10.1111/j.1469-7793.1999.439ac.x; Powis JE, 1998, AM J PHYSIOL-REG I, V274, pR1468, DOI 10.1152/ajpregu.1998.274.5.R1468; Shiraishi T, 1999, NUTRITION, V15, P576, DOI 10.1016/S0899-9007(99)00088-X; Slugg RM, 2000, NEUROENDOCRINOLOGY, V72, P208, DOI 10.1159/000054589; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Young JI, 1998, J NEUROSCI, V18, P6631; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	1658	1702	1	142	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					480	484		10.1038/35078085	http://dx.doi.org/10.1038/35078085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373681	Green Published, Green Submitted			2022-12-01	WOS:000168858700050
J	Alexandru, G; Uhlmann, F; Mechtler, K; Poupart, MA; Nasmyth, K				Alexandru, G; Uhlmann, F; Mechtler, K; Poupart, MA; Nasmyth, K			Phosphorylation of the cohesin subunit Scc1 by Polo/Cdc5 kinase regulates sister chromatid separation in yeast	CELL			English	Article							CELL-CYCLE REGULATION; POLO-LIKE KINASES; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PROTEOLYTIC CLEAVAGE; DNA-REPLICATION; PROTEIN-KINASES; ANAPHASE; CHROMOSOME; METAPHASE	At the onset of anaphase, a caspase-related protease (separase) destroys the link between sister chromatids by cleaving the cohesin subunit Scc1. During most of the cell cycle, separase is kept inactive by binding to an inhibitory protein called securin. Separase activation requires proteolysis of securin, which is mediated by an ubiquitin protein ligase called the anaphase-promoting complex. Cells regulate anaphase entry by delaying securin ubiquitination until all chromosomes have attached to the mitotic spindle. Though no longer regulated by this mitotic surveillance mechanism, sister separation remains tightly cell cycle regulated in yeast mutants lacking securin. We show here that the Polo/Cdc5 kinase phosphorylates serine residues adjacent to Scc1 cleavage sites and strongly enhances their cleavage. Phosphorylation of separase recognition sites may be highly conserved and regulates sister chromatid separation independently of securin.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Boehringer Ingelheim Canada Ltd, Laval, PQ H7S 2G5, Canada	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim	Nasmyth, K (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	nasmyth@nt.imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019	Mechtler, Karl/0000-0002-3392-9946; Uhlmann, Frank/0000-0002-3527-6619; Nasmyth, Kim/0000-0001-7030-4403; Alexandru, Gabriela/0000-0002-7058-5644				Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bae SS, 2000, FASEB J, V14, P1083, DOI 10.1096/fasebj.14.9.1083; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Darwiche N, 1999, GENE, V233, P39, DOI 10.1016/S0378-1119(99)00160-2; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; EPSTEIN CB, 1992, GENE DEV, V6, P1695, DOI 10.1101/gad.6.9.1695; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Funabiki H, 1996, EMBO J, V15, P6617, DOI 10.1002/j.1460-2075.1996.tb01052.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; He XW, 2000, CELL, V101, P763, DOI 10.1016/S0092-8674(00)80888-0; Hoque MT, 2001, J BIOL CHEM, V276, P5059, DOI 10.1074/jbc.M007809200; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Leismann O, 2000, GENE DEV, V14, P2192, DOI 10.1101/gad.176700; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Losada A, 2000, J CELL BIOL, V150, P405, DOI 10.1083/jcb.150.3.405; Mayor T, 1999, FEBS LETT, V452, P92, DOI 10.1016/S0014-5793(99)00534-7; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; PRINGLE JR, 1981, MOL BIOL YEAST SACCH; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Stratmann R, 1996, CELL, V84, P25, DOI 10.1016/S0092-8674(00)80990-3; Sumara I, 2000, J CELL BIOL, V151, P749, DOI 10.1083/jcb.151.4.749; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	54	305	311	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					459	472		10.1016/S0092-8674(01)00362-2	http://dx.doi.org/10.1016/S0092-8674(01)00362-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371343	Bronze			2022-12-01	WOS:000168840700006
J	Ganguly, K; Schinder, AF; Wong, ST; Poo, M				Ganguly, K; Schinder, AF; Wong, ST; Poo, M			GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition	CELL			English	Article							K-CL COTRANSPORTER; CA3 HIPPOCAMPAL-NEURONS; POSTNATAL RAT BRAINS; DORSAL HORN NEURONS; IN-VITRO; CREB PHOSPHORYLATION; CALCIUM CURRENTS; SENSORY NEURONS; ACTIVATION; EXPRESSION	GABA is the main inhibitory neurotransmitter in the adult brain. Early in development, however, GABAergic synaptic transmission is excitatory and can exert widespread trophic effects. During the postnatal period, GABAergic responses undergo a switch from being excitatory to inhibitory. Here, we show that the switch is delayed by chronic blockade of GABA(A) receptors, and accelerated by increased GABA(A) receptor activation. In contrast, blockade of glutamatergic transmission or action potentials has no effect. Furthermore, GABAergic activity modulated the mRNA levels of KCC2, a K+-Cl- cotransporter whose expression correlates with the switch. Finally, we report that GABA can alter the properties of depolarization-induced Ca2+ influx. Thus, GABA acts as a self-limiting trophic factor during neural development.	Univ Calif San Diego, Program Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Poo, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Schinder, Alejandro/0000-0003-4863-8348	NINDS NIH HHS [NS 36999, NS 37831] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037831, R01NS036999] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; Boukhaddaoui H, 2000, EUR J NEUROSCI, V12, P2068, DOI 10.1046/j.1460-9568.2000.00105.x; Caillard O, 1999, J PHYSIOL-LONDON, V518, P109, DOI 10.1111/j.1469-7793.1999.0109r.x; Chameu P, 1999, NEUROSCIENCE, V90, P383, DOI 10.1016/S0306-4522(98)00457-6; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; CHERUBINI E, 1990, INT J DEV NEUROSCI, V8, P481, DOI 10.1016/0736-5748(90)90080-L; CONNOR JA, 1987, J NEUROSCI, V7, P1384; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Desmadryl G, 1998, EUR J NEUROSCI, V10, P545, DOI 10.1046/j.1460-9568.1998.00055.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GRUOL DL, 1992, J NEUROSCI, V12, P2838; Hilaire C, 1996, NEUROSCIENCE, V75, P1219, DOI 10.1016/0306-4522(96)00347-8; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Ikeda Y, 1997, DEV BRAIN RES, V98, P253, DOI 10.1016/S0165-3806(96)00183-6; Jarolimek W, 1999, J NEUROSCI, V19, P4695; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 1997, J PHYSIOL-LONDON, V498, P763, DOI 10.1113/jphysiol.1997.sp021900; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kneussel M, 2000, TRENDS NEUROSCI, V23, P429, DOI 10.1016/S0166-2236(00)01627-1; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lamsa K, 2000, J NEUROPHYSIOL, V83, P359, DOI 10.1152/jn.2000.83.1.359; LEE JJ, 1987, METHOD ENZYMOL, V152, P633; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Li YX, 1998, J PHYSIOL-LONDON, V509, P847, DOI 10.1111/j.1469-7793.1998.847bm.x; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.3.CO;2-X; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; MUELLER AL, 1984, J NEUROSCI, V4, P860; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Obrietan K, 1997, J NEUROSCI, V17, P4785; OBRIETAN K, 1995, J NEUROSCI, V15, P5065; Owens DF, 1996, J NEUROSCI, V16, P6414; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Plotkin MD, 1997, J NEUROBIOL, V33, P781, DOI 10.1002/(SICI)1097-4695(19971120)33:6<781::AID-NEU6>3.0.CO;2-5; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rosenstein JM, 1998, CELL TRANSPLANT, V7, P121, DOI 10.1016/S0963-6897(98)00006-2; Schierle GS, 1997, CEREB CORTEX, V7, P130, DOI 10.1093/cercor/7.2.130; STALEY KJ, 1995, SCIENCE, V269, P977, DOI 10.1126/science.7638623; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van den Pol AN, 1998, J NEUROSCI, V18, P10749; Vu TQ, 2000, J NEUROSCI, V20, P1414; WANG J, 1994, EUR J NEUROSCI, V6, P1275, DOI 10.1111/j.1460-9568.1994.tb00317.x; YUSTE R, 1991, NEURON, V6, P334	51	513	526	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 18	2001	105	4					521	532		10.1016/S0092-8674(01)00341-5	http://dx.doi.org/10.1016/S0092-8674(01)00341-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371348	Bronze			2022-12-01	WOS:000168840700011
J	Paterson, ICM				Paterson, ICM			Consent to cancer registration - an unnecessary burden	BRITISH MEDICAL JOURNAL			English	Editorial Material									Velindre Hosp, Cardiff, S Glam, Wales	Velindre Hospital	Paterson, ICM (corresponding author), Velindre Hosp, Cardiff, S Glam, Wales.			Paterson, Ian/0000-0001-9156-401X					0	8	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2001	322	7294					1130	1130		10.1136/bmj.322.7294.1130	http://dx.doi.org/10.1136/bmj.322.7294.1130			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	431JP	11337454	Green Published			2022-12-01	WOS:000168628300056
J	Hunot, S; Flavell, RA				Hunot, S; Flavell, RA			Apoptosis - Death of a monopoly?	SCIENCE			English	Editorial Material							CELL-DEATH; CASPASE		Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Hunot, S (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.		Hunot, Stephane/ABE-4204-2021	Hunot, Stephane/0000-0002-8266-5211				Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Exley GE, 1999, BIOL REPROD, V61, P231, DOI 10.1095/biolreprod61.1.231; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; LIK, 2000, CELL, V101, P389; Lorenzo HK, 1999, CELL DEATH DIFFER, V6, P516, DOI 10.1038/sj.cdd.4400527; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zheng TS, 1999, CELL DEATH DIFFER, V6, P1043, DOI 10.1038/sj.cdd.4400593	15	58	66	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					865	866		10.1126/science.1060885	http://dx.doi.org/10.1126/science.1060885			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341280				2022-12-01	WOS:000168514900027
J	Von Korff, M; Moore, JC				Von Korff, M; Moore, JC			Stepped care for back pain: Activating approaches for primary care	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIAL; CHRONIC ILLNESS; BED REST; MANAGEMENT; DISABILITY; OUTCOMES; INTERVENTION; INFORMATION; ADVICE; FEAR	Interventions that encourage return to normal function and reduce fear of physical activity have been shown to improve outcomes for patients with back pain, but routine medical care for back pain often does not provide such interventions. This paper proposes a stepped-care approach that addresses the functional outcomes of back pain. Step 1, which is relevant to most patients, addresses the common fears of patients with back pain and encourages patients to resume normal activities. Step 2, which targets the substantial minority of patients who require more than simple advice to resume activities, provides brief, structured interventions that support physical exercise and return to normal activities. Step 3 targets patients who require more intensive interventions, including treatment of psychological illness when present, before they can return to normal activities in work and family life. Patient needs relevant to these three levels of care are delineated. This stepped-care approach provides a framework for sequencing progressively more intensive interventions and coordinating the efforts of primary care physicians, allied health professionals, behavioral health clinicians, and patients to improve functional outcomes in patients with back pain.	Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	Group Health Cooperative	Von Korff, M (corresponding author), Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	vonkorff.m@ghc.org		VonKorff, Michael/0000-0001-5386-8477	NIDCR NIH HHS [P01 DE08773] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE008773] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abenhaim L, 2000, SPINE, V25, p1S, DOI 10.1097/00007632-200002151-00001; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Crombez G, 1999, PAIN, V80, P329, DOI 10.1016/S0304-3959(98)00229-2; Davison GC, 2000, J CONSULT CLIN PSYCH, V68, P580, DOI 10.1037/0022-006X.68.4.580; Haaga DAF, 2000, J CONSULT CLIN PSYCH, V68, P547, DOI 10.1037/0022-006X.68.4.547; INDAHL A, 1995, SPINE, V20, P473, DOI 10.1097/00007632-199502001-00011; KOES BW, 1994, J CLIN EPIDEMIOL, V47, P851, DOI 10.1016/0895-4356(94)90188-0; Linton SJ, 2000, SPINE, V25, P2825, DOI 10.1097/00007632-200011010-00017; MALMIVAARA A, 1995, NEW ENGL J MED, V332, P351, DOI 10.1056/NEJM199502093320602; Moffett JK, 1999, BRIT MED J, V319, P279, DOI 10.1136/bmj.319.7205.279; Moore JE, 2000, PAIN, V88, P145, DOI 10.1016/S0304-3959(00)00314-6; Ritvo P G, 1997, Cancer Prev Control, V1, P289; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rossignol M, 2000, SPINE, V25, P251, DOI 10.1097/00007632-200001150-00018; Turk DC, 1983, PAIN BEHAV MED; Turner JA, 1998, SPINE, V23, P463, DOI 10.1097/00007632-199802150-00011; Turner JA, 1996, SPINE, V21, P2851, DOI 10.1097/00007632-199612150-00010; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Von Korff M, 1998, SPINE, V23, P2608, DOI 10.1097/00007632-199812010-00016; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Von Korff M, 2000, WESTERN J MED, V172, P133, DOI 10.1136/ewjm.172.2.133; VONKORFF M, 1993, SPINE, V18, P855, DOI 10.1097/00007632-199306000-00008; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; VONKORFF M, 1999, PSYCHOSOCIAL FACTORS, P360; Waddell G, 1997, BRIT J GEN PRACT, V47, P647; Waddell G., 1998, BACK PAIN REVOLUTION; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391	27	89	90	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			911	917		10.7326/0003-4819-134-9_Part_2-200105011-00016	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00016			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	429XK	11346328				2022-12-01	WOS:000168543100016
J	Eriksson, JG; Forsen, T; Tuomilehto, J; Osmond, C; Barker, DJP				Eriksson, JG; Forsen, T; Tuomilehto, J; Osmond, C; Barker, DJP			Early growth and coronary heart disease in later life: longitudinal study	BRITISH MEDICAL JOURNAL			English	Article							REDUCED FETAL GROWTH; ADULT LIFE; IN-UTERO; CARDIOVASCULAR-DISEASE; BIRTH-WEIGHT; FACTOR-VII; FOLLOW-UP; DEATH; WOMEN; CHOLESTEROL	Objective To determine how growth during infancy and childhood modifies the increased risk of coronary heart disease associated with small body size at birth. Design Longitudinal study. Setting Helsinki, Finland. Subjects 4630 men who were born in the Helsinki University Hospital during 1934-44 and who attended child welfare clinics in the city. Each man had on average 18.0 (SD 9.5) measurements of height and weight between birth and age 12 years. Main outcome measures Hospital admission or death from coronary heart disease. Results Low birth weight and low ponderal index (birth weight/length(3)) were associated with increased risk of coronary heart disease. Low height, weight, and body mass index (weight/height(2)) at age 1 year also increased the risk. Hazard ratios fell progressively from 1.83 (95% confidence interval 1.28 to 2.60) in men whose body mass index at age 1 year was below 16 kg/m(2) to 1.00 in those whose body mass index was > 19 (P for trend = 0.0004). After age 1 year, rapid gain in weight and body mass index increased the risk of coronary heart disease. This effect was confined, however, to men with a ponderal index < 26 at birth. In these men the hazard ratio associated with a one unit increase in standard deviation score for body mass index between ages 1 and 12 years was 1.27 (1.10 to 1.47; P = 0.001). Conclusion Irrespective of size at birth, low weight gain during infancy is associated with increased risk of coronary heart disease. After age 1 year, rapid weight gain is associated with further increase in risk, but only among boys who were thin at birth. In these boys the adverse effects of rapid weight gain on later coronary heart disease are already apparent at age 3 years. Improvements in fetal, infant, and child growth could lead to substantial reductions in the incidence of coronary heart disease.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, FIN-00300 Helsinki, Finland; Univ Southampton, Southampton Gen Hosp, MRC, Environm Epidemiol Unit, Southampton SO16 6YD, Hants, England	Finland National Institute for Health & Welfare; University of Southampton	Eriksson, JG (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Diabet & Genet Epidemiol Unit, Mannerheimintie 166, FIN-00300 Helsinki, Finland.			Osmond, Clive/0000-0002-9054-4655				BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1992, BMJ-BRIT MED J, V304, P148, DOI 10.1136/bmj.304.6820.148; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; BARKER DJP, 1995, BRIT MED J, V310, P703, DOI 10.1136/bmj.310.6981.703; BARKER DJP, 1989, LANCET, V2, P557; BATESON P, 1999, DESIGN LIFE BEHAV DE; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; COX DR, 1972, J R STAT SOC B, V34, P187; DESAI M, 1995, BIOCHEM SOC T, V23, P331, DOI 10.1042/bst0230331; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; FALL CHD, 1992, BRIT MED J, V304, P801, DOI 10.1136/bmj.304.6830.801; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Gunnell DJ, 1998, J EPIDEMIOL COMMUN H, V52, P142, DOI 10.1136/jech.52.3.142; HOOPER L, BMJ, V322, P737; Kind KL, 1999, AM J PHYSIOL-REG I, V277, pR1675, DOI 10.1152/ajpregu.1999.277.6.R1675; Kuh D, 1997, LIFE COURSE APPROACH; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; MARMOT MG, 1984, LANCET, V1, P1003; Martyn CN, 1996, LANCET, V348, P1264, DOI 10.1016/S0140-6736(96)04257-2; MARTYN CN, 1995, BRIT J HAEMATOL, V89, P142, DOI 10.1111/j.1365-2141.1995.tb08920.x; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; ROYSTON P, 1991, STAT MED, V10, P675, DOI 10.1002/sim.4780100502; Stein CE, 1996, LANCET, V348, P1269, DOI 10.1016/S0140-6736(96)04547-3; Tanner JM, 1989, FOETUS INTO MAN; WIDDOWSON EM, 1972, ARCH DIS CHILD, V47, P652, DOI 10.1136/adc.47.254.652	30	710	738	0	31	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 21	2001	322	7292					949	953		10.1136/bmj.322.7292.949	http://dx.doi.org/10.1136/bmj.322.7292.949			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	426JB	11312225	Bronze, Green Submitted, Green Accepted, Green Published			2022-12-01	WOS:000168345100015
J	Doring, V; Mootz, HD; Nangle, LA; Hendrickson, TL; de Crecy-Lagard, V; Schimmel, P; Marliere, P				Doring, V; Mootz, HD; Nangle, LA; Hendrickson, TL; de Crecy-Lagard, V; Schimmel, P; Marliere, P			Enlarging the amino acid set of Escherichia coli by infiltration of the valine coding pathway	SCIENCE			English	Article							TRANSFER-RNA-SYNTHETASES; THYMIDYLATE SYNTHASE; GENETIC-CODE; BIOSYNTHESIS; EVOLUTION; CYSTEINE; ERRORS	Aminoacyl transfer RNA (tRNA) synthetases establish the rules of the genetic code by catalyzing the aminoacylation of tRNAs. For some synthetases, accuracy depends critically on an editing function at a site distinct from the aminoacylation site. Mutants of Escherichia coli that incorrectly charge tRNA(Val) with cysteine were selected after random mutagenesis of the whole chromosome. All mutations obtained were located in the editing site of valyl-tRNA synthetase. More than 20% of the valine in cellular proteins from such an editing mutant organism could be replaced with the noncanonical aminobutyrate, sterically similar to cysteine, Thus, the editing function may have played a central role in restricting the genetic code to 20 amino acids. Disabling this editing function offers a powerful approach for diversifying the chemical composition of proteins and for emulating evolutionary stages of ambiguous translation.	Scripps Res Inst, Res Inst, La Jolla, CA 92037 USA; Evolog SA, F-91000 Evry, France; Genoscope, UMR8030, F-91057 Evry, France; Univ Marburg, Biochem Fachbereich Chem, D-35032 Marburg, Germany	Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Philipps University Marburg	Schimmel, P (corresponding author), Scripps Res Inst, Res Inst, BCC-379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		de Crecy-Lagard, Valerie/AAN-8995-2020		NIGMS NIH HHS [GM23562] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ansaldi M, 1996, ANAL BIOCHEM, V234, P110, DOI 10.1006/abio.1996.0060; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; BELFORT M, 1983, P NATL ACAD SCI-BIOL, V80, P4914, DOI 10.1073/pnas.80.16.4914; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; DEFELICE M, 1977, J MOL BIOL, V156, P1; DEV IK, 1988, P NATL ACAD SCI USA, V85, P1472, DOI 10.1073/pnas.85.5.1472; Doring V, 1998, GENETICS, V150, P543; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; FERSHT A, 1999, STRUCTURE MECH PROTE, P347; Fotheringham IG, 1999, BIOORGAN MED CHEM, V7, P2209, DOI 10.1016/S0968-0896(99)00153-4; Gevaert K, 2000, ELECTROPHORESIS, V21, P1145, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1145::AID-ELPS1145>3.0.CO;2-Z; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hendrickson TL, 2000, BIOCHEMISTRY-US, V39, P8180, DOI 10.1021/bi0004798; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1981, NUCLEIC ACIDS RES, V9, P3105, DOI 10.1093/nar/9.13.3105; Kowal AK, 2001, P NATL ACAD SCI USA, V98, P2268, DOI 10.1073/pnas.031488298; LEMEIGNAN B, 1993, J MOL BIOL, V231, P161, DOI 10.1006/jmbi.1993.1269; LEMEIGNAN B, 1995, THESIS U PARIS 6; Lin L, 1996, BIOCHEMISTRY-US, V35, P5596, DOI 10.1021/bi960011y; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Liu DR, 1999, P NATL ACAD SCI USA, V96, P4780, DOI 10.1073/pnas.96.9.4780; LOFTFIELD RB, 1972, BIOCHEM J, V128, P1353, DOI 10.1042/bj1281353; MUSLERFORSYTH K, 2000, NAT STRUCT BIOL, V7, P435; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; PINE MJ, 1978, ANTIMICROB AGENTS CH, V13, P676, DOI 10.1128/AAC.13.4.676; RAJBHANDARY UL, 1994, J BACTERIOL, V176, P547, DOI 10.1128/jb.176.3.547-552.1994; RICHAUD C, 1993, J BIOL CHEM, V268, P26827; SCHMIDT E, 1995, BIOCHEMISTRY-US, V34, P11204, DOI 10.1021/bi00035a028; SUSSMAN AJ, 1971, ANNU REV BIOCHEM, V40, P397, DOI 10.1146/annurev.bi.40.070171.002145; WEBER AL, 1981, J MOL EVOL, V17, P273, DOI 10.1007/BF01795749	30	157	202	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					501	504		10.1126/science.1057718	http://dx.doi.org/10.1126/science.1057718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11313495				2022-12-01	WOS:000168187300046
J	Rao, H; Uhlmann, F; Nasmyth, K; Varshavsky, A				Rao, H; Uhlmann, F; Nasmyth, K; Varshavsky, A			Degradation of a cohesin subunit by the N-end rule pathway is essential for chromosome stability	NATURE			English	Article							SISTER-CHROMATID SEPARATION; PROTEIN; CENTROMERES; PROTEOLYSIS; CLEAVAGE	Cohesion between sister chromatids is established during DNA replication and depends on a protein complex called cohesin(1-7). At the metaphase-anaphase transition in the yeast Saccharomyces cerevisiae, the ESP1-encoded protease separin cleaves SCC1, a subunit of cohesin with a relative molecular mass of 63,000 (M-r 63K)(8). The resulting 33K carboxy-terminal fragment of SCC1 bears an amino-terminal arginine-a destabilizing residue in the N-end rule(9). Here we show that the SCC1 fragment is short-lived (t(1/2) approximate to 2 min), being degraded by the ubiquitin/proteasome-dependent N-end rule pathway. Overexpression of a long-lived derivative of the SCC1 fragment is lethal. In ubr1 Delta cells, which lack the N-end rule pathway(9), we found a highly increased frequency of chromosome loss. The bulk of increased chromosome loss in ubr1 Delta cells is caused by metabolic stabilization of the ESP1-produced SCC1 fragment. This fragment is the first physiological substrate of the N-end rule pathway that is targeted through its N-terminal residue. A number of yeast proteins bear putative cleavage sites for the ESP1 separin, suggesting other physiological substrates and functions of the N-end rule pathway.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Imperial Canc Res Fund, London WC2A 3PX, England; Res Inst Mol Pathol, A-1030 Vienna, Austria	California Institute of Technology; Cancer Research UK; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Nasmyth, Kim/0000-0001-7030-4403; RAO, HAI/0000-0002-4235-2210; Uhlmann, Frank/0000-0002-3527-6619				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Biggins S, 1999, CURR OPIN GENET DEV, V9, P230, DOI 10.1016/S0959-437X(99)80034-3; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Dej KJ, 2000, TRENDS CELL BIOL, V10, P392, DOI 10.1016/S0962-8924(00)01821-3; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; Koshland DE, 2000, CURR OPIN CELL BIOL, V12, P297, DOI 10.1016/S0955-0674(00)00092-2; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Pidoux AL, 2000, CURR OPIN CELL BIOL, V12, P308, DOI 10.1016/S0955-0674(00)00094-6; Sijts AJAM, 1997, J BIOL CHEM, V272, P19261, DOI 10.1074/jbc.272.31.19261; SPENCER F, 1990, GENETICS, V124, P237; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x	26	222	229	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					955	959		10.1038/35073627	http://dx.doi.org/10.1038/35073627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309624				2022-12-01	WOS:000168152300053
J	DeFalco, J; Tomishima, M; Liu, HY; Zhao, C; Cai, XL; Marth, JD; Enquist, L; Friedman, JM				DeFalco, J; Tomishima, M; Liu, HY; Zhao, C; Cai, XL; Marth, JD; Enquist, L; Friedman, JM			Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus	SCIENCE			English	Article							PSEUDORABIES VIRUS; AFFERENT CONNECTIONS; GENE-EXPRESSION; MOUSE-BRAIN; LEPTIN; RAT; PROJECTIONS; NEURONS; TYPE-1; LOCALIZATION	We report the development of a pseudorabies virus that can be used for retrograde tracing from selected neurons. This virus encodes a green fluorescent protein marker and replicates only in neurons that express the Cre recombinase and in neurons in synaptic contact with the originally infected cells. The virus was injected into the arcuate nucleus of mice that express Cre only in those neurons that express neuropeptide Y or the leptin receptor. Sectioning of the brains revealed that these neurons receive inputs from neurons in other regions of the hypothalamus, as well as the amygdala, cortex, and other brain regions. These data suggest that higher cortical centers modulate leptin signaling in the hypothalamus. This method of neural tracing may prove useful in studies of other complex neural circuits.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Rockefeller University; Princeton University; Rockefeller University; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Friedman, JM (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	friedj@mail.rockefeller.edu	Friedman, Jeffrey M/E-5784-2011		NIDDK NIH HHS [R01DK41096, DK48247] Funding Source: Medline; PHS HHS [R01133506] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247, R01DK041096] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARONE FC, 1981, BRAIN RES BULL, V7, P75, DOI 10.1016/0361-9230(81)90101-5; Bester H, 1997, J COMP NEUROL, V383, P245, DOI 10.1002/(SICI)1096-9861(19970707)383:3<245::AID-CNE1>3.0.CO;2-3; CARD JP, 1990, J NEUROSCI, V10, P1974; Card JP, 1999, J COMP NEUROL, V407, P438, DOI 10.1002/(SICI)1096-9861(19990510)407:3<438::AID-CNE11>3.0.CO;2-2; DEFALCO J, UNPUB; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Enquist LW, 1999, ADV VIRUS RES, V51, P237; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GEHLERT DR, 1987, SYNAPSE, V1, P25, DOI 10.1002/syn.890010106; GORDON Y, 1983, ARCH VIROL, V76, P39, DOI 10.1007/BF01315702; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; HEFFNER S, 1993, J VIROL, V67, P1529, DOI 10.1128/JVI.67.3.1529-1537.1993; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; HIGUCHI H, 1988, J BIOL CHEM, V263, P6288; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Knapp AC, 1997, J VIROL, V71, P2731, DOI 10.1128/JVI.71.4.2731-2739.1997; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Loewy AD, 1998, NEUROSCI BIOBEHAV R, V22, P679, DOI 10.1016/S0149-7634(98)00006-2; Logvinoff C, 2000, J VIROL, V74, P8402, DOI 10.1128/JVI.74.18.8402-8412.2000; Petrovich GD, 1996, J COMP NEUROL, V374, P387, DOI 10.1002/(SICI)1096-9861(19961021)374:3<387::AID-CNE6>3.0.CO;2-Y; ROBBINS AK, 1986, J VIROL, V58, P339, DOI 10.1128/JVI.58.2.339-347.1986; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Standish A, 1995, J NEUROVIROL, V1, P359, DOI 10.3109/13550289509111025; Yang M, 1999, J VIROL, V73, P4350, DOI 10.1128/JVI.73.5.4350-4359.1999; ZABORSZKY L, 1982, ADV ANAT EMBRYOL CEL, V69, P1; ZHU Y, COMMUNICATION	29	295	315	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2001	291	5513					2608	2613		10.1126/science.1056602	http://dx.doi.org/10.1126/science.1056602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283374				2022-12-01	WOS:000167861000044
J	Tsai, B; Rodighiero, C; Lencer, WI; Rapoport, TA				Tsai, B; Rodighiero, C; Lencer, WI; Rapoport, TA			Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin	CELL			English	Article							ENDOPLASMIC-RETICULUM; DEGRADATION PATHWAY; SECRETORY PROTEIN; MAMMALIAN-CELLS; QUALITY-CONTROL; BOND FORMATION; LABILE TOXIN; HSP70; TRANSLOCATION; REDUCTION	Cholera toxin is assembled from two subunits in the periplasm of Vibrio cholerae and disassembled in the analogous compartment of target cells, the lumen of the endoplasmic reticulum (ER), before a fragment of it, the Al chain, is transported into the cytosol. We show that protein disulfide isomerase (PDI) in the ER lumen functions to disassemble and unfold the toxin once its A chain has been cleaved. PDI acts as a redox-driven chaperone; in the reduced state, it binds to the A chain and in the oxidized state it releases it. Our results explain the pathway of cholera toxin, suggest a role for PDI in retrograde protein transport into the cytosol, and indicate that PDI can act as a novel type of chaperone, whose binding and release of substrates is regulated by a redox, rather than an ATPase, cycle.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Combined Program Pediat Gastroenterol & Nutr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.			Lencer, Wayne/0000-0001-7346-2730	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048106, R37DK048106, P30DK034854] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK34854, DK48106] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADLER S, 1983, J BIOL CHEM, V258, P6956; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Courageot J, 1999, EUR J BIOCHEM, V260, P482, DOI 10.1046/j.1432-1327.1999.00193.x; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; HIRSCH PM, 1995, IEEE COMPUT APPL POW, V8, P8; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; LENCER WI, 1995, J CELL BIOL, V131, P951, DOI 10.1083/jcb.131.4.951; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; Orlandi PA, 1997, J BIOL CHEM, V272, P4591; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Rodighiero C, 1999, J BIOL CHEM, V274, P3962, DOI 10.1074/jbc.274.7.3962; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Sears CL, 1996, MICROBIOL REV, V60, P167, DOI 10.1128/MMBR.60.1.167-215.1996; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; Thyberg J, 2000, LAB INVEST, V80, P915, DOI 10.1038/labinvest.3780095; Wainwright LJ, 1997, BIOCHEM J, V321, P655, DOI 10.1042/bj3210655; WALTER P, 1981, J CELL BIOL, V91, P545, DOI 10.1083/jcb.91.2.545; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; YOUNG J, 1993, J BIOL CHEM, V268, P19810; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	34	386	399	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 23	2001	104	6					937	948		10.1016/S0092-8674(01)00289-6	http://dx.doi.org/10.1016/S0092-8674(01)00289-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	418BD	11290330	Bronze			2022-12-01	WOS:000167869200015
J	Zhu, YX; Doray, B; Poussu, A; Lehto, VP; Kornfeld, S				Zhu, YX; Doray, B; Poussu, A; Lehto, VP; Kornfeld, S			Binding of GGA2 to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor	SCIENCE			English	Article							FACTOR-II RECEPTOR; GAMMA-ADAPTIN; MUTATIONAL ANALYSIS; CYTOPLASMIC DOMAIN; TRANS-GOLGI; PROTEINS; FAMILY; VHS	The GGAs are a multidomain protein family implicated in protein trafficking between the Golgi and endosomes. Here, the VHS domain of GGA2 was shown to bind to the acidic cluster-dileucine motif in the cytoplasmic tail of the cation-independent mannose 6-phosphate receptor (CI-MPR). Receptors with mutations in this motif were defective in lysosomal enzyme sorting. The hinge domain of GGA2 bound clathrin, suggesting that GGA2 could be a link between cargo molecules and clathrin-coated vesicle assembly. Thus, GGA2 binding to the Cl-MPR is important for lysosomal enzyme targeting.	Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Univ Oulu, Dept Pathol, FIN-90410 Oulu, Finland	Washington University (WUSTL); University of Oulu	Kornfeld, S (corresponding author), Washington Univ, Sch Med, Dept Internal Med, 660 S Euclid Ave, St Louis, MO 63110 USA.			Doray, Balraj/0000-0003-3347-5013	NATIONAL CANCER INSTITUTE [R01CA008759] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-08759] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; CHEN HJ, 1993, J BIOL CHEM, V268, P22338; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; DORAY B, IN PRESS MOL BIOL CE; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; JOHNSON KF, 1992, J CELL BIOL, V119, P249, DOI 10.1083/jcb.119.2.249; KLUMPERMAN J, 1993, J CELL BIOL, V121, P997, DOI 10.1083/jcb.121.5.997; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5	16	224	230	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1716	1718		10.1126/science.1060896	http://dx.doi.org/10.1126/science.1060896			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387476				2022-12-01	WOS:000169031800045
J	Cronin, TW; Caldwell, RL; Marshall, J				Cronin, TW; Caldwell, RL; Marshall, J			Sensory adaptation - Tunable colour vision in a mantis shrimp	NATURE			English	Article							SYSTEM		Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Queensland, Vis Touch & Hearing Res Ctr, Brisbane, Qld 4072, Australia	University System of Maryland; University of Maryland Baltimore County; University of California System; University of California Berkeley; University of Queensland	Cronin, TW (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA.			Marshall, Justin/0000-0001-9006-6713				CRONIN TW, 1994, VISION RES, V34, P2639, DOI 10.1016/0042-6989(94)90221-6; Cronin TW, 2000, PHILOS T ROY SOC B, V355, P1263, DOI 10.1098/rstb.2000.0680; CRONIN TW, 1989, NATURE, V339, P137, DOI 10.1038/339137a0; CRONIN TW, 1994, VISION RES, V34, P279, DOI 10.1016/0042-6989(94)90087-6; HAWRYSHYN CW, 1989, VISUAL NEUROSCI, V2, P247, DOI 10.1017/S0952523800001164; Marshall J, 1999, NATURE, V401, P873, DOI 10.1038/44751; MARSHALL NJ, 1988, NATURE, V333, P557, DOI 10.1038/333557a0; MCFARLAND WN, 1975, VISION RES, V15, P1063, DOI 10.1016/0042-6989(75)90002-4; SUZUKI T, 1985, ZOOL SCI, V2, P455; TSIN ATC, 1977, SCIENCE, V195, P1358, DOI 10.1126/science.841335	10	60	65	24	101	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					547	548		10.1038/35079184	http://dx.doi.org/10.1038/35079184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385560				2022-12-01	WOS:000168982500039
J	Ohtaki, T; Shintani, Y; Honda, S; Matsumoto, H; Hori, A; Kanehashi, K; Terao, Y; Kumano, S; Takatsu, Y; Masuda, Y; Ishibashi, Y; Watanabe, T; Asada, M; Yamada, T; Suenaga, M; Kitada, C; Usuki, S; Kurokawa, T; Onda, H; Nishimura, O; Fujino, M				Ohtaki, T; Shintani, Y; Honda, S; Matsumoto, H; Hori, A; Kanehashi, K; Terao, Y; Kumano, S; Takatsu, Y; Masuda, Y; Ishibashi, Y; Watanabe, T; Asada, M; Yamada, T; Suenaga, M; Kitada, C; Usuki, S; Kurokawa, T; Onda, H; Nishimura, O; Fujino, M			Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor	NATURE			English	Article							IDENTIFICATION; CELLS; MOTILITY; CLONING; BINDING; SITES	Metastasis is a major cause of death in cancer patients and involves a multistep process including detachment of cancer cells from a primary cancer, invasion of surrounding tissue, spread through circulation, re-invasion and proliferation in distant organs. KiSS-1 is a human metastasis suppressor gene(1), that suppresses metastases of human melanomas(2) and breast carcinomas(3) without affecting tumorigenicity. However, its gene product and functional mechanisms have not been elucidated. Here we show that KiSS-1 (refs 1, 4) encodes a carboxy-terminally amidated peptide with 54 amino-acid residues, which we have isolated from human placenta as the endogenous ligand of an orphan G-protein-coupled receptor (hOT7T175) and have named 'metastin'. Metastin inhibits chemotaxis and invasion of hOT7T175-transfected CHO cells in vitro and attenuates pulmonary metastasis of hOT7T175-transfected B16-BL6 melanomas in vivo. The results suggest possible mechanisms of action for KiSS-1 and a potential new therapeutic approach.	Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Tsukuba, Ibaraki 3004293, Japan; Univ Tsukuba, Inst Clin Med, Dept Obstet & Gynecol, Tsukuba, Ibaraki 3058575, Japan	Takeda Chemical Industries; University of Tsukuba	Ohtaki, T (corresponding author), Takeda Chem Ind Ltd, Pharmaceut Discovery Res Div, Wadai 10, Tsukuba, Ibaraki 3004293, Japan.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051				Bischof P, 2000, PLACENTA, V21, pS55, DOI 10.1053/plac.2000.0521; Bloomquist BT, 1998, BIOCHEM BIOPH RES CO, V243, P474, DOI 10.1006/bbrc.1998.8133; Fujii R, 2000, J BIOL CHEM, V275, P21068, DOI 10.1074/jbc.M001546200; Lee DK, 1999, FEBS LETT, V446, P103, DOI 10.1016/S0014-5793(99)00009-5; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1997, INT J CANCER, V71, P1035, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1035::AID-IJC20>3.0.CO;2-B; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; LEE JH, 1997, JNCI-J NATL CANCER I, V89, P1549; LINDEN J, 1982, J CYCLIC NUCL PROT, V8, P163; Masuda Y, 1996, J PHARMACOL EXP THER, V279, P675; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishimura O, 1998, CHEM PHARM BULL, V46, P1490; Ohtaki T, 1999, J BIOL CHEM, V274, P37041, DOI 10.1074/jbc.274.52.37041; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; West A, 1998, GENOMICS, V54, P145, DOI 10.1006/geno.1998.5566; Yamamura S, 2000, ANN NY ACAD SCI, V905, P301	18	1105	1206	0	59	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					613	617		10.1038/35079135	http://dx.doi.org/10.1038/35079135			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385580				2022-12-01	WOS:000168982500059
J	Perraud, AL; Fleig, A; Dunn, CA; Bagley, LA; Launay, P; Schmitz, C; Stokes, AJ; Zhu, QQ; Bessman, MJ; Penner, R; Kinet, JP; Scharenberg, AM				Perraud, AL; Fleig, A; Dunn, CA; Bagley, LA; Launay, P; Schmitz, C; Stokes, AJ; Zhu, QQ; Bessman, MJ; Penner, R; Kinet, JP; Scharenberg, AM			ADP-ribose gating of the calcium-permeable LTRPC2 channel revealed by Nudix motif homology	NATURE			English	Article							MITOCHONDRIA; ENZYMES	Free ADP-ribose (ADPR), a product of NAD hydrolysis and a breakdown product of the calcium-release second messenger cyclic ADPR (cADPR), has no defined role as an intracellular signalling molecule in vertebrate systems. Here we show that a 350-amino-acid protein (designated NUDT9) and a homologous domain (NUDT9 homology domain) near the carboxy terminus of the LTRPC2/TrpC7 putative cation channel(1) both function as specific ADPR pyrophosphatases. Whole-cell and single-channel analysis of HEK-293 cells expressing LTRPC2 show that LTRPC2 functions as a calcium-permeable cation channel that is specifically gated by free ADPR. The expression of native LTRPC2 transcripts is detectable in many tissues including the U937 monocyte cell line, in which ADPR induces large cation currents (designated I-ADPR) that closely match those mediated by recombinant LTRPC2. These results indicate that intracellular ADPR regulates calcium entry into cells that express LTRPC2.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Hawaii, Queens Med Ctr, Biomed Res Ctr, Lab Cell & Mol Signaling, Honolulu, HI 96813 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; The Queen's Medical Center; University of Hawaii System; University of Hawaii System; Johns Hopkins University	Scharenberg, AM (corresponding author), Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA.		Launay, Pierre/AAH-7076-2019; Stokes, Alexander/B-1086-2015	Stokes, Alexander/0000-0002-3526-4685; Fleig, Andrea/0000-0001-8396-7249; Dunn, Christopher/0000-0001-7899-0110; Penner, Reinhold/0000-0002-5366-1537				AMES BN, 1960, J BIOL CHEM, V235, P769; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Chakraborti T, 1999, CELL SIGNAL, V11, P77, DOI 10.1016/S0898-6568(98)00025-4; Dousa TP, 1996, AM J PHYSIOL-CELL PH, V271, pC1007, DOI 10.1152/ajpcell.1996.271.4.C1007; Guse AH, 2000, J MOL MED, V78, P26, DOI 10.1007/s001090000076; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; KochNolte F, 1997, ADV EXP MED BIOL, V419, P1; Liang M, 1999, ARCH BIOCHEM BIOPHYS, V371, P317, DOI 10.1006/abbi.1999.1463; McConkey DJ, 1996, STEM CELLS, V14, P619, DOI 10.1002/stem.140619; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Okazaki IJ, 1998, J BIOL CHEM, V273, P23617, DOI 10.1074/jbc.273.37.23617; Wilding M, 1998, AM J PHYSIOL-CELL PH, V275, pC1277, DOI 10.1152/ajpcell.1998.275.5.C1277	13	694	725	0	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					595	599		10.1038/35079100	http://dx.doi.org/10.1038/35079100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385575				2022-12-01	WOS:000168982500054
J	Dubnau, J; Grady, L; Kitamoto, T; Tully, T				Dubnau, J; Grady, L; Kitamoto, T; Tully, T			Disruption of neurotransmission in Drosophila mushroom body blocks retrieval but not acquisition of memory	NATURE			English	Article							EXPRESSION; DYNAMIN; SHIBIRE; MELANOGASTER; NEURONS; BODIES; BRAIN; ORGANIZATION; MUTATIONS; ANATOMY	Surgical, pharmacological and genetic lesion studies have revealed distinct anatomical sites involved with different forms of learning. Studies of patients with localized brain damage and work in rodent model systems, for example, have shown that the hippocampal formation participates in acquisition of declarative tasks but is not the site of their long-term storage(1,2). Such lesions are usually irreversible, however, which has limited their use for dissecting the temporal processes of acquisition, storage and retrieval of memories(3,4). Studies in bees and flies have similarly revealed a distinct anatomical region of the insect brain, the mushroom body, that is involved specifically in olfactory associative learning(5,6). We have used a temperature-sensitive dynamin transgene, which disrupts synaptic transmission reversibly and on the time-scale of minutes(7), to investigate the temporal requirements for ongoing neural activity during memory formation. Here we show that synaptic transmission from mushroom body neurons is required during memory retrieval but not during acquisition or storage. We propose that the hebbian processes underlying olfactory associative learning reside in mushroom body dendrites or upstream of the mushroom body and that the resulting alterations in synaptic strength modulate mushroom body output during memory retrieval.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; City Hope Natl Med Ctr, Beckman Res Inst, Div Neurosci, Duarte, CA 91010 USA	Cold Spring Harbor Laboratory; City of Hope; Beckman Research Institute of City of Hope	Dubnau, J (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	dubnau@cshl.org		Dubnau, Josh/0000-0002-9285-7444; Kitamoto, Toshihiro/0000-0003-0863-8466				BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, CURR BIOL, V11, pR240, DOI 10.1016/S0960-9822(01)00115-4; DUDAI Y, 1988, J COMP PHYSIOL A, V162, P101, DOI 10.1007/BF01342707; Grant D, 1998, GENETICS, V149, P1019; Hammer M, 1998, LEARN MEMORY, V5, P146; Ito K, 1998, LEARN MEMORY, V5, P52; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; RAMASWAMI M, 1993, J NEUROGENET, V9, P73, DOI 10.3109/01677069309083451; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Strausfeld NJ, 1999, J COMP NEUROL, V409, P603; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; YANG MY, 1995, NEURON, V15, P45; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	30	315	326	0	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2001	411	6836					476	480		10.1038/35078077	http://dx.doi.org/10.1038/35078077			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373680				2022-12-01	WOS:000168858700049
J	O'Connell, KF; Caron, C; Kopish, KR; Hurd, DD; Kemphues, KJ; Li, YJ; White, JG				O'Connell, KF; Caron, C; Kopish, KR; Hurd, DD; Kemphues, KJ; Li, YJ; White, JG			The C-elegans zyg-1 gene encodes a regulator of centrosome duplication with distinct maternal and paternal roles in the embryo	CELL			English	Article							XENOPUS EGG EXTRACTS; HAMSTER OVARY CELLS; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS; BODY DUPLICATION; MITOTIC SPINDLE; CYCLIN-E; REPRODUCTION; KINASE; MICROTUBULES	Centrosome duplication is a critical step in assembly of the bipolar mitotic spindle, but the molecular mechanisms regulating this process during the cell cycle and during animal development are poorly understood. Here, we report that the zyg-1 gene of Caenorhabditis elegans is an essential regulator of centrosome duplication. ZYG-1 is a protein kinase specifically required for daughter centriole formation that localizes transiently to centrosomes and acts at least one cell cycle prior to each spindle assembly event. In the embryo, ZYG-1 participates in a unique regulatory scheme whereby paternal ZYG-1 regulates duplication and bipolar spindle assembly during the first cell cycle, and maternal ZYG-1 regulates these processes thereafter. ZYG-1 is therefore a key molecular component of the centrosome/centriole duplication process.	Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; Univ Wisconsin, Dept Anat, Madison, WI 53706 USA; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Cornell Univ, Genet & Dev Sect, Ithaca, NY 14853 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; Cornell University	O'Connell, KF (corresponding author), Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA.	kfoconne@facstaff.wisc.edu		O'Connell, Kevin/0000-0002-9789-288X	NIGMS NIH HHS [GM-54454] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Albertson DG, 1993, CHROMOSOME RES, V1, P15, DOI 10.1007/BF00710603; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; KEMPHUES KJ, 1988, GENETICS, V120, P977; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kimble J, 1988, NEMATODE CAENORHABDI, P191; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; MAZIA D, 1960, J BIOPHYS BIOCHEM CY, V7, P1, DOI 10.1083/jcb.7.1.1; Mello C, 1995, METHOD CELL BIOL, V48, P451; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Middendorp S, 2000, J CELL BIOL, V148, P405, DOI 10.1083/jcb.148.3.405; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; O'Connell KF, 1998, GENETICS, V149, P1303; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; PHILLIPS SG, 1976, J CELL BIOL, V70, P9, DOI 10.1083/jcb.70.1.9; Ruiz F, 1999, CURR BIOL, V9, P43, DOI 10.1016/S0960-9822(99)80045-1; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; SLUDER G, 1990, J CELL BIOL, V110, P2025, DOI 10.1083/jcb.110.6.2025; SLUDER G, 1985, J CELL BIOL, V100, P887, DOI 10.1083/jcb.100.3.887; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; Sluder G, 1997, J CELL SCI, V110, P421; STJOHNSTON D, 1992, CELL, V68, P201; Strausfeld UP, 1996, J CELL SCI, V109, P1555; SWOFFORD DL, 1998, PAUP ASTERISK PHYLOG; Tabara H, 1999, DEVELOPMENT, V126, P1; Urbani L, 1999, CURR BIOL, V9, pR315, DOI 10.1016/S0960-9822(99)80201-2; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; WOLF N, 1978, J ULTRA MOL STRUCT R, V63, P155, DOI 10.1016/S0022-5320(78)80071-9; WOOD WB, 1980, DEV BIOL, V74, P446, DOI 10.1016/0012-1606(80)90445-5; WOOD WB, 1994, TRENDS GENET, V10, P49, DOI 10.1016/0168-9525(94)90148-1; Wu XY, 1999, P NATL ACAD SCI USA, V96, P1397, DOI 10.1073/pnas.96.4.1397	46	232	240	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					547	558		10.1016/S0092-8674(01)00338-5	http://dx.doi.org/10.1016/S0092-8674(01)00338-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371350	Bronze			2022-12-01	WOS:000168840700013
J	Dubilier, N; Mulders, C; Ferdelman, T; de Beer, D; Pernthaler, A; Klein, M; Wagner, M; Erseus, C; Thiermann, F; Krieger, J; Giere, O; Amann, R				Dubilier, N; Mulders, C; Ferdelman, T; de Beer, D; Pernthaler, A; Klein, M; Wagner, M; Erseus, C; Thiermann, F; Krieger, J; Giere, O; Amann, R			Endosymbiotic sulphate-reducing and sulphide-oxidizing bacteria in an oligochaete worm	NATURE			English	Article							SULFATE REDUCTION; SEDIMENTS; ANNELIDA; SULFUR; TUBIFICIDAE; DIVERSITY; SYMBIONTS; ECOLOGY; OXYGEN; COAST	Stable associations of more than one species of symbiont within a single host cell or tissue are assumed to be rare in metazoans because competition for space and resources between symbionts can be detrimental to the host(1). In animals with multiple endosymbionts, such as mussels from deep-sea hydrothermal vents(2) and reef-building corals(3), the costs of competition between the symbionts are outweighed by the ecological and physiological flexibility gained by the hosts. A further option for the coexistence of multiple symbionts within a host is if these benefit directly from one another, but such symbioses have not been previously described. Here we show that in the gutless marine oligochaete Olavius algarvensis, endosymbiotic sulphate-reducing bacteria produce sulphide that can serve as an energy source for sulphide-oxidizing symbionts of the host. Thus, these symbionts do not compete for resources but rather share a mutalistic relationship with each other in an endosymbiotic sulphur cycle, in addition to their symbiotic relationship with the oligochaete host.	Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; Tech Univ Munich, Dept Microbiol, D-85350 Freising, Germany; Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden; Univ Hamburg, Inst Zool, D-20146 Hamburg, Germany; Univ Hamburg, Museum Zool, D-20146 Hamburg, Germany	Max Planck Society; Technical University of Munich; Swedish Museum of Natural History; University of Hamburg; University of Hamburg	Dubilier, N (corresponding author), Max Planck Inst Marine Microbiol, Celsiusstr 1, D-28359 Bremen, Germany.		de Beer, Dirk/L-4840-2013; Wagner, Michael/A-7801-2011; Ferdelman, Timothy G/A-3758-2013; Dubilier, Nicole/I-8203-2018; Amann, Rudolf I/C-6534-2014	de Beer, Dirk/0000-0001-5274-1781; Wagner, Michael/0000-0002-9778-7684; Ferdelman, Timothy G/0000-0002-9701-3793; Dubilier, Nicole/0000-0002-9394-825X; Amann, Rudolf I/0000-0002-0846-7372				Barton LL., 1995, SULFATE REDUCING BAC; BUSSMANN I, 1991, MAR ECOL PROG SER, V78, P97, DOI 10.3354/meps078097; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3971, DOI 10.1016/0016-7037(93)90347-Y; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Cottrell MT, 1999, APPL ENVIRON MICROB, V65, P1127; Crank J., 1979, MATH DIFFUSION; DISTEL DL, 1995, P NATL ACAD SCI USA, V92, P9598, DOI 10.1073/pnas.92.21.9598; DUBILIER N, 1995, AM ZOOL, V35, P163; DUBILIER N, 1995, APPL ENVIRON MICROB, V61, P2346, DOI 10.1128/AEM.61.6.2346-2350.1995; Dubilier N, 1999, MAR ECOL PROG SER, V178, P271, DOI 10.3354/meps178271; FENCHEL T, 1992, ARCH MICROBIOL, V158, P394; Ferdelman TG, 1997, GEOCHIM COSMOCHIM AC, V61, P3065, DOI 10.1016/S0016-7037(97)00158-0; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; GIERE O, 1987, MAR BIOL, V93, P641, DOI 10.1007/BF00392801; GIERE O, 1991, MAR ECOL PROG SER, V68, P287; Giere O, 1998, ZOOL ANZ, V237, P209; GIERE O, 1995, ACTA ZOOL-STOCKHOLM, V76, P281, DOI 10.1111/j.1463-6395.1995.tb01000.x; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; JORGENSEN BB, 1978, GEOMICROBIOL J, V1, P49; Krieger J, 2000, MAR BIOL, V137, P239, DOI 10.1007/s002270000355; Kuhnigk T, 1996, SYST APPL MICROBIOL, V19, P139, DOI 10.1016/S0723-2020(96)80039-7; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; Morvan B, 1996, CURR MICROBIOL, V32, P129, DOI 10.1007/s002849900023; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; vandenEnde FP, 1997, FEMS MICROBIOL ECOL, V23, P65, DOI 10.1016/S0168-6496(97)00014-7; Vetter RD, 1998, MAR BIOL, V132, P453, DOI 10.1007/s002270050411; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998	28	159	164	0	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2001	411	6835					298	302		10.1038/35077067	http://dx.doi.org/10.1038/35077067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	432RT	11357130				2022-12-01	WOS:000168710000045
J	Guillebaud, J				Guillebaud, J			Medical-eligibility criteria for contraceptive use	LANCET			English	Editorial Material									UCL, Dept Family Planning & Reprod Hlth, London W1T 4PL, England; Margaret Pyke Family Planning Ctr, London W1T 4PL, England	University of London; University College London	Guillebaud, J (corresponding author), UCL, Dept Family Planning & Reprod Hlth, London W1T 4PL, England.	j.guillebaud@lineone.net						GRAHAMSMITH F, 1994, POPULATION COMPLEX R; GUILLEBAUD J, 1995, BRIT MED J, V311, P1111, DOI 10.1136/bmj.311.7013.1111; GUILLEBAUD J, 1999, CONTRACEPTION YOUR Q, P195; Hinrichsen D., 2000, POPULATION REPORTS M, V15; Kubba A, 2000, LANCET, V356, P1913, DOI 10.1016/S0140-6736(00)03269-4; Potts M, 1999, BRIT MED J, V319, P933, DOI 10.1136/bmj.319.7215.933; ROBEY B, 2000, POPULATION REPORTS J, V43; *WHO, 2001, IMPR ACC QUAL CAR FA	8	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1378	1379		10.1016/S0140-6736(00)04615-8	http://dx.doi.org/10.1016/S0140-6736(00)04615-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356428				2022-12-01	WOS:000168478200002
J	Ding, ZL; Fong, RB; Long, CJ; Stayton, PS; Hoffman, AS				Ding, ZL; Fong, RB; Long, CJ; Stayton, PS; Hoffman, AS			Size-dependent control of the binding of biotinylated proteins to streptavidin using a polymer shield	NATURE			English	Article								Many medical and biotechnological processes rely on controlling and manipulating the molecular-recognition capabilities of proteins(1-4). This can be achieved using small molecules capable of competing for protein binding or by changing environmental parameters that affect protein structure and hence binding. An alternative is provided by stimuli-responsive polymers that change reversibly from a water-soluble expanded coil to a water-insoluble collapsed globule upon small changes in temperature, pH or light intensity: when attached to proteins in the vicinity of their binding sites, they reversibly block and release small ligands(1,5-7). Here we show how this approach can be extended to achieve size-selective binding of large, macromolecular ligands. We use the thermally responsive polymer poly(N,N-diethylacrylamide) (PDEAAm), and attach it to the protein streptavidin approximately 20 Angstrom from the binding site for biotinylated proteins. Below the lower critical solution temperature of PDEAAm, the polymer is in its extended state and acts as a 'shield' to block the binding of large biotinylated proteins; above this temperature, it collapses and exposes the binding site, thereby allowing binding. We rnd that the degree of shielding depends on both the size of the biotinylated protein and the size of PDEAAm, suggesting that 'smart' polymer shields could be tailored to achieve a wide range of size-dependent ligand discrimination for use in affinity separations, biosensors and diagnostics technologies.	Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hoffman, AS (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.		Stayton, Patrick/C-1975-2018	Stayton, Patrick/0000-0001-6939-6371				BLOCH B, 1993, J HISTOCHEM CYTOCHEM, V41, P1751, DOI 10.1177/41.12.8245422; Bulmus V, 2000, BIOCONJUGATE CHEM, V11, P78, DOI 10.1021/bc9901043; Ding ZL, 1999, BIOCONJUGATE CHEM, V10, P395, DOI 10.1021/bc980108s; Fong RB, 1999, BIOCONJUGATE CHEM, V10, P720, DOI 10.1021/bc980151f; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Schlosser M, 1997, J IMMUNOASSAY, V18, P289, DOI 10.1080/01971529708005823; SOGAH DY, 1987, MACROMOLECULES, V20, P1473, DOI 10.1021/ma00173a006; STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0; Wilchek M, 1990, AVIDIN BIOTIN TECHNO; Wu C, 1998, PHYS REV LETT, V80, P4092, DOI 10.1103/PhysRevLett.80.4092	10	213	222	0	65	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					59	62		10.1038/35075028	http://dx.doi.org/10.1038/35075028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333975				2022-12-01	WOS:000168432800041
J	Ivan, M; Kondo, K; Yang, HF; Kim, W; Valiando, J; Ohh, M; Salic, A; Asara, JM; Lane, WS; Kaelin, WG				Ivan, M; Kondo, K; Yang, HF; Kim, W; Valiando, J; Ohh, M; Salic, A; Asara, JM; Lane, WS; Kaelin, WG			HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O-2 sensing	SCIENCE			English	Article							TUMOR-SUPPRESSOR PROTEIN; PROLYL 4-HYDROXYLASE; HYPOXIA; COMPLEX; UBIQUITINATION; UBIQUITYLATION; ACCUMULATION; INHIBITION; ACTIVATION; SUBUNIT	HIF (hypoxia-inducible factor) is a transcription factor that plays a pivotal role in cellular adaptation to changes in oxygen availability. In the presence of oxygen, HIF is targeted for destruction by an E3 ubiquitin ligase containing the von Hippel-lindau tumor suppressor protein (pVHL). We found that human pVHL binds to a short HIF-derived peptide when a conserved proline residue at the core of this peptide is hydroxylated. Because proline hydroxylation requires molecular oxygen and Fe2+, this protein modification may play a key role in mammalian oxygen sensing.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University	Kaelin, WG (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	william_kaelin@dfci.harvard.edu	Salic, Adrian/GXG-1611-2022; Ivan, Mircea/A-8109-2012	Ivan, Mircea/0000-0003-3424-6642				Bickel M, 1998, HEPATOLOGY, V28, P404, DOI 10.1002/hep.510280217; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Franklin TJ, 2001, BIOCHEM J, V353, P333, DOI 10.1042/bj3530333; Friedman L, 2000, P NATL ACAD SCI USA, V97, P4736, DOI 10.1073/pnas.97.9.4736; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; IVAN M, UNPUB; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; LEVENE CI, 1976, BIOCHIM BIOPHYS ACTA, V444, P446, DOI 10.1016/0304-4165(76)90388-3; LUDLOW JW, 1989, J VIROL, V63, P2881, DOI 10.1128/JVI.63.6.2881-2884.1989; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Srinivas V, 1999, BIOCHEM BIOPH RES CO, V260, P557, DOI 10.1006/bbrc.1999.0878; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Wenger RH, 2000, J EXP BIOL, V203, P1253; Zhu H, 1999, RESP PHYSIOL, V115, P239, DOI 10.1016/S0034-5687(99)00024-9	26	3652	3818	12	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2001	292	5516					464	468		10.1126/science.1059817	http://dx.doi.org/10.1126/science.1059817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11292862				2022-12-01	WOS:000168187300035
J	Pena, JL; Konishi, M				Pena, JL; Konishi, M			Auditory spatial receptive fields created by multiplication	SCIENCE			English	Article							PARIETAL CORTEX; DIRECTION SELECTIVITY; INFERIOR COLLICULUS; OWL; COMPUTATION; SYSTEM; SPACE; CELLS; TIME	Examples of multiplication by neurons or neural circuits are scarce, although many computational models use this basic operation. The owl's auditory system computes interaural time (ITD) and Level (ILD) differences to create a two-dimensional map of auditory space. Space-specific neurons are selective for combinations of ITD and ILD, which define, respectively, the horizontal and vertical dimensions of their receptive fields. A multiplication of separate postsynaptic potentials tuned to ITD and ILD, rather than an addition, can account for the subthreshold responses of these neurons to ITD-ILD pairs. Other nonlinear processes improve the spatial tuning of the spike output and reduce the fit to the multiplicative model.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology	Pena, JL (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.			Pena, Jose/0000-0001-6773-5640	NIDCD NIH HHS [DC00134] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000134] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; [Anonymous], 1990, ADV NEURAL INFORM PR; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; FELDMAN DE, 1994, J NEUROSCI, V14, P5939; FUJITA I, 1991, J NEUROSCI, V11, P722; Golub G. H., 1989, MATRIX COMPUTATIONS; HATSOPOULOS N, 1995, SCIENCE, V270, P1000, DOI 10.1126/science.270.5238.1000; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1978, SCIENCE, V202, P778, DOI 10.1126/science.715444; Koch C., 1998, BIOPHYSICS COMPUTATI; MOISEFF A, 1983, J NEUROSCI, V3, P2553; Pena JL, 2000, P NATL ACAD SCI USA, V97, P11787, DOI 10.1073/pnas.97.22.11787; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P944; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; SULLIVAN WE, 1984, J NEUROSCI, V4, P1786; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; TAKAHASHI T, 1984, J NEUROSCI, V4, P1781; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347	20	172	172	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					249	252		10.1126/science.1059201	http://dx.doi.org/10.1126/science.1059201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303092				2022-12-01	WOS:000168074000035
J	Tilman, D; Fargione, J; Wolff, B; D'Antonio, C; Dobson, A; Howarth, R; Schindler, D; Schlesinger, WH; Simberloff, D; Swackhamer, D				Tilman, D; Fargione, J; Wolff, B; D'Antonio, C; Dobson, A; Howarth, R; Schindler, D; Schlesinger, WH; Simberloff, D; Swackhamer, D			Forecasting agriculturally driven global environmental change	SCIENCE			English	Article							NITROGEN BUDGETS; INTENSIFICATION; BIODIVERSITY; FOOD	During the next 50 years, which is likely to be the final period of rapid agricultural expansion, demand for food by a wealthier and 50% Larger global population will be a major driver of global environmental change. Should past dependences of the global environmental impacts of agriculture on human population and consumption continue, 10(9) hectares of natural ecosystems would be converted to agriculture by 2050. This would be accompanied by 2.4- to 2.7-fold increases in nitrogen- and phosphorus-driven eutrophication of terrestrial, freshwater, and near-shore marine ecosystems, and comparable increases in pesticide use. This eutrophication and habitat destruction would cause unprecedented ecosystem simplification, Loss of ecosystem services, and species extinctions. Significant scientific advances and regulatory, technological, and policy changes are needed to control the environmental impacts of agricultural expansion.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; Marine Biol Lab, Oceans Program, Woods Hole, MA 02543 USA; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ Alberta, Edmonton, AB T6G 2E9, Canada; Duke Univ, Durham, NC 27708 USA; Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; Univ Minnesota, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; Princeton University; Marine Biological Laboratory - Woods Hole; Marine Biological Laboratory - Woods Hole; University of Alberta; Duke University; University of Tennessee System; University of Tennessee Knoxville; University of Minnesota System; University of Minnesota Twin Cities	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.		Schindler, David/A-3752-2014; Tilman, David/ABD-5309-2021	Howarth, Robert/0000-0001-9531-4288				Alexandratos N, 1999, P NATL ACAD SCI USA, V96, P5908, DOI 10.1073/pnas.96.11.5908; ALEXANDRATOS N., 1995, WORLD AGR 2010; [Anonymous], 1997, NATURES SERVICES; *ARCT MON ASS PROG, 1998, ASS REP ARCT POLL IS; Bouwman AF, 1997, GLOBAL BIOGEOCHEM CY, V11, P561, DOI 10.1029/97GB02266; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Cohen J. E., 1995, MANY PEOPLE CAN EART; Conway G., 1997, DOUBLY GREEN REVOLUT; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; DOWNING JA, 1999, 134 COUNC AGR SCI TE; *FAO UN, 2001, FAOSTAT HOM; GREEN MJB, 1998, PROT AR S ALB W AUST; Groot JJR, 1998, NUTR CYCL AGROECOSYS, V50, P181, DOI 10.1023/A:1009788211315; Holland EA, 1999, BIOGEOCHEMISTRY, V46, P7, DOI 10.1007/BF01007572; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; IPCC,, 1996, CLIMATE CHANGE 1995; Janzen D, 1999, P NATL ACAD SCI USA, V96, P5987, DOI 10.1073/pnas.96.11.5987; KIDD KA, 1995, SCIENCE, V269, P240, DOI 10.1126/science.269.5221.240; Maddison A., 1995, MONITORING WORLD EC; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; *NAT RES COUNC, 2000, CLEAN COAST WAT UND; National Research Council, 1999, OUR COMM JOURN TRANS; National Research Council (USA), 2000, GLOB CHANG EC RES; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Postel S., 1999, PILLAR SAND CAN IRRI; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Ruttan VW, 1999, P NATL ACAD SCI USA, V96, P5960, DOI 10.1073/pnas.96.11.5960; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schindler D, 1999, AMBIO, V28, P350; Schlesinger W.H., 1997, BIOGEOCHEMISTRY ANAL, V2nd Edition; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; UN Department of Economic and Social Affairs, 1999, WORLD POP PROSP 1998; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WALSH J, 1991, PRESERVING OPTIONS F; Woomer P.L., 1994, BIOL MANAG TROP SOIL; *WORLD BANK, 2000, WORLD DEV IND CD ROM; World Health Organization, 1990, PUBL HLTH IMP PEST U; Zhu YY, 2000, NATURE, V406, P718, DOI 10.1038/35021046	41	2396	2568	59	1956	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					281	284		10.1126/science.1057544	http://dx.doi.org/10.1126/science.1057544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303102				2022-12-01	WOS:000168074000045
J	Brewster, DH; Thomson, CS; Hole, DJ; Black, RJ; Stroner, PL; Gillis, CR				Brewster, DH; Thomson, CS; Hole, DJ; Black, RJ; Stroner, PL; Gillis, CR		Scottish Canc Therapy Network	Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies	BRITISH MEDICAL JOURNAL			English	Article							DEPRIVATION; WOMEN		Scottish Canc Intelligence Unit, Informat & Stat Div, Edinburgh EH5 3SQ, Midlothian, Scotland; Univ Glasgow, Dept Publ Hlth, W Scotland Canc Surveillance Unit, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow	Brewster, DH (corresponding author), Scottish Canc Intelligence Unit, Informat & Stat Div, Trin Pk House, Edinburgh EH5 3SQ, Midlothian, Scotland.			Brewster, David/0000-0002-5346-5608				CARNON AG, 1994, BRIT MED J, V309, P1054, DOI 10.1136/bmj.309.6961.1054; Ionescu MV, 1998, LANCET, V352, P1439, DOI 10.1016/S0140-6736(98)00052-X; LAMONT DW, 1993, BRIT J CANCER, V67, P351, DOI 10.1038/bjc.1993.64; Macleod U, 2000, ANN ONCOL, V11, P105, DOI 10.1023/A:1008385321476; McLaren G, 1998, DEPRIVATION HLTH SCO	5	81	81	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2001	322	7290					830	831		10.1136/bmj.322.7290.830	http://dx.doi.org/10.1136/bmj.322.7290.830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290637	Green Submitted, Bronze, Green Published			2022-12-01	WOS:000168063000024
J	Puertollano, R; Randazzo, PA; Presley, JF; Hartnell, LM; Bonifacino, JS				Puertollano, R; Randazzo, PA; Presley, JF; Hartnell, LM; Bonifacino, JS			The GGAs promote ARF-dependent recruitment of clathrin to the TGN	CELL			English	Article							ADP-RIBOSYLATION FACTOR; GTPASE-ACTIVATING PROTEIN; AP-3 ADAPTER COMPLEX; GOLGI MEMBRANES; GAMMA-ADAPTIN; MEDIATED ENDOCYTOSIS; SYNTHETIC LIPOSOMES; BINDING PROTEIN; TRANS-GOLGI; FACTOR-I	The GGAs constitute a family of modular adaptor-related proteins that bind ADP-ribosylation factors (ARFs) and localize to the trans-Golgi network (TGN) via their GAT domains. Here, we show that binding of the GAT domain stabilizes membrane-bound ARF1 . GTP due to interference with the action of GTPase-activating proteins. We also show that the hinge and ear domains of the GGAs interact with clathrin in vitro, and that the GGAs promote recruitment of clathrin to liposomes in vitro and to TGN membranes in vivo. These observations suggest that the GGAs could function to link clathrin to membrane-bound ARF GTP.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NCI, Div Basic Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bonifacino, JS (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	juan@helix.nih.gov		Bonifacino, Juan S./0000-0002-5673-6370	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001607] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001607] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Black MW, 2000, J CELL BIOL, V151, P587, DOI 10.1083/jcb.151.3.587; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Clabecq A, 2000, J BIOL CHEM, V275, P31786, DOI 10.1074/jbc.M003705200; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Drake MT, 2000, MOL BIOL CELL, V11, P3723, DOI 10.1091/mbc.11.11.3723; Ellenberg J, 1999, TRENDS CELL BIOL, V9, P52, DOI 10.1016/S0962-8924(98)01420-2; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Huang KM, 1999, EMBO J, V18, P3897, DOI 10.1093/emboj/18.14.3897; KISHIDA S, 1993, J BIOL CHEM, V268, P22259; Kuai J, 2000, J BIOL CHEM, V275, P4022, DOI 10.1074/jbc.275.6.4022; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; Misra S, 2000, BIOCHEMISTRY-US, V39, P11282, DOI 10.1021/bi0013546; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Ooi CE, 1998, J CELL BIOL, V142, P391, DOI 10.1083/jcb.142.2.391; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; RANDAZZO PA, 1992, METHOD ENZYMOL, V219, P362; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; ROBINSON MS, 1992, CELL, V69, P129, DOI 10.1016/0092-8674(92)90124-U; Roth MG, 1999, CELL, V97, P149, DOI 10.1016/S0092-8674(00)80723-0; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; STAMNES MA, 1993, CELL, V73, P999, DOI 10.1016/0092-8674(93)90277-W; Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; VIRSHUP DM, 1988, J CELL BIOL, V106, P39, DOI 10.1083/jcb.106.1.39; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5; Zhu XJ, 2000, J BIOL CHEM, V275, P13465, DOI 10.1074/jbc.275.18.13465; Zhu YX, 1999, P NATL ACAD SCI USA, V96, P5013, DOI 10.1073/pnas.96.9.5013; Zhu YX, 1999, MOL BIOL CELL, V10, P537, DOI 10.1091/mbc.10.3.537; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	46	212	221	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					93	102		10.1016/S0092-8674(01)00299-9	http://dx.doi.org/10.1016/S0092-8674(01)00299-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301005	Bronze			2022-12-01	WOS:000168063300010
J	Kotiaho, JS; Simmons, LW; Tomkins, JL				Kotiaho, JS; Simmons, LW; Tomkins, JL			Towards a resolution of the lek paradox	NATURE			English	Article							GENETIC-VARIATION; SEXUAL SELECTION; BODY CONDITION; MALE ATTRACTIVENESS; OFFSPRING CONDITION; MATING PREFERENCES; ESTIMATING FITNESS; NATURAL-SELECTION; EVOLUTION; INVESTMENT	Genetic benefits in the shape of 'good genes' have been invoked to explain costly female choice in the absence of direct fitness benefits(1-3). Little genetic variance in fitness traits is expected, however, because directional selection tends to drive beneficial alleles to fixation(4-6). There seems to be little potential, therefore, for female choice to result in genetic benefits, giving rise to the 'lek paradox'(7-9). Nevertheless, evidence shows that genetic variance persists despite directional selection(10,11) and genetic benefits of female choice are frequently reported(12,13). A theoretical solution to the lek paradox has been proposed on the basis of two assumptions(14): that traits are condition-dependent, and that condition shows high genetic variance. The observed genetic variability in sexual traits will be accounted for, because a proportion of the genetic variance in condition will be captured and expressed in the trait(14). Here we report results from experiments showing that male courtship rate in the dung beetle Onthophagus taurus is a condition-dependent trait that is preferred by females. More importantly, male condition has high genetic variance and is genetically correlated with courtship rate. Our results thereby represent a significant step towards a resolution of the lek paradox.	Univ Western Australia, Dept Zool, Evolutionary Biol Res Grp, Nedlands, WA 6907, Australia	University of Western Australia	Kotiaho, JS (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35, FIN-40351 Jyvaskyla, Finland.	jkotiaho@cc.jyu.fi	Simmons, Leigh W/B-1815-2011; Tomkins, Joseph L/A-8091-2011	Simmons, Leigh W/0000-0003-0562-1474; Tomkins, Joseph L/0000-0003-1259-7898; Kotiaho, Janne/0000-0002-4732-784X				Alatalo RV, 1998, P ROY SOC B-BIOL SCI, V265, P2297, DOI 10.1098/rspb.1998.0574; ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; Andersson Malte, 1994; ARNOLD SJ, 1984, EVOLUTION, V38, P709, DOI 10.1111/j.1558-5646.1984.tb00344.x; Borgia G., 1979, SEXUAL SELECTION REP, P19; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Falconer D. S., 1989, Introduction to quantitative genetics.; Fisher R., 2005, TEACHING CHILDREN TH; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; HOULE D, 1992, GENETICS, V130, P195; Hunt J, 1997, BEHAV ECOL SOCIOBIOL, V41, P109, DOI 10.1007/s002650050370; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kotiaho JS, 1999, OIKOS, V87, P399, DOI 10.2307/3546755; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Merila J, 1996, FUNCT ECOL, V10, P465, DOI 10.2307/2389939; Merila J, 1999, GENET RES, V73, P165, DOI 10.1017/S0016672398003656; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Pomiankowski A.N., 1988, Oxford Surveys in Evolutionary Biology, V5, P136; Roff D.A., 2012, EVOLUTIONARY QUANTIT; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; TAYLOR PD, 1982, THEOR POPUL BIOL, V22, P392, DOI 10.1016/0040-5809(82)90052-1; Wilkinson GS, 1999, P ROY SOC B-BIOL SCI, V266, P1685, DOI 10.1098/rspb.1999.0832	30	216	216	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2001	410	6829					684	686		10.1038/35070557	http://dx.doi.org/10.1038/35070557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	418DJ	11287953				2022-12-01	WOS:000167875400045
J	Kusano, K; Johnson-Schlitz, DM; Engels, WR				Kusano, K; Johnson-Schlitz, DM; Engels, WR			Sterility of Drosophila with mutations in the bloom syndrome gene - Complementation by Ku70	SCIENCE			English	Article							STRAND BREAK REPAIR; P-ELEMENT EXCISION; MELANOGASTER; PROTEIN; RECOMBINATION; HELICASES; JUNCTIONS; PRODUCT; HOMOLOG; DAMAGE	The Drosophila Dmblm locus is a homolog of the human Bloom syndrome gene, which encodes a helicase of the RECQ family. We show that Dmblm is identical to mus309, a locus originally identified in a mutagen-sensitivity screen. One mus309 allele, which carries a stop codon between two of the helicase motifs, causes partial male sterility and complete female sterility. Mutant males produce an excess of XY sperm and nullo sperm, consistent with a high frequency of nondisjunction and/or chromosome loss. These phenotypes of mus309 suggest that Dmblm functions in DNA double-strand break repair. The mutant Dmblm phenotypes were partially rescued by an extra copy of the DNA repair gene Ku70, indicating that the two genes functionally interact in vivo.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Engels, WR (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030948, R56GM030948] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30948] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANGA SS, 1991, MUTAT RES, V255, P79, DOI 10.1016/0921-8777(91)90020-P; Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; BOYD JB, 1981, GENETICS, V97, P607; Brodsky MH, 2000, GENE DEV, V14, P666; Cooper MP, 2000, GENE DEV, V14, P907; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; GAUSZ J, 1981, GENETICS, V98, P775; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kooistra R, 1999, MOL CELL BIOL, V19, P6269; Kusano K, 1999, GENETICS, V151, P1027; Li BM, 2000, J BIOL CHEM, V275, P28349, DOI 10.1074/jbc.C000289200; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Ochem AE, 1997, J BIOL CHEM, V272, P29919, DOI 10.1074/jbc.272.47.29919; PASTINK A, 1991, MOL GEN GENET, V229, P213, DOI 10.1007/BF00272158; Preston CR, 1996, GENETICS, V144, P1623; Wang WS, 2000, EMBO J, V19, P3428, DOI 10.1093/emboj/19.13.3428; YU EE, 1996, SCIENCE, V272, P258	22	92	94	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2600	2602		10.1126/science.291.5513.2600	http://dx.doi.org/10.1126/science.291.5513.2600			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283371				2022-12-01	WOS:000167861000041
J	Wood, M				Wood, M			When stool cultures from adult inpatients are appropriate	LANCET			English	Editorial Material							ENTERIC PATHOGENS; DIARRHEA; COST		Birmingham Heartlands Hosp, Dept Infect, Birmingham B9 5SS, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham	Wood, M (corresponding author), Birmingham Heartlands Hosp, Dept Infect, Birmingham B9 5SS, W Midlands, England.							BARBUT F, 1995, EUR J CLIN MICROBIOL, V14, P346, DOI 10.1007/BF02116530; Bauer TH, 2001, JAMA-J AM MED ASSOC, V285, P313, DOI 10.1001/jama.285.3.313; Chitkara YK, 1996, ARCH INTERN MED, V156, P1445, DOI 10.1001/archinte.156.13.1445; Craven D, 1998, PEDIATR INFECT DIS J, V17, P1040, DOI 10.1097/00006454-199811000-00015; FAN K, 1993, J CLIN MICROBIOL, V31, P2233, DOI 10.1128/JCM.31.8.2233-2235.1993; GROSS PA, 1988, INFECT CONT HOSP EP, V9, P497, DOI 10.2307/30146545; Hogenauer C, 1998, CLIN INFECT DIS, V27, P702, DOI 10.1086/514958; KOPLAN JP, 1980, LANCET, V2, P413; MCFARLAND LV, 1993, GASTROENTEROL CLIN N, V22, P563; Morris AJ, 1996, J CLIN MICROBIOL, V34, P1776, DOI 10.1128/JCM.34.7.1776-1778.1996; Ozerek AE, 1999, J HOSP INFECT, V41, P159, DOI 10.1016/S0195-6701(99)90055-5; Rohner P, 1997, J CLIN MICROBIOL, V35, P1427, DOI 10.1128/JCM.35.6.1427-1432.1997; SIEGEL DL, 1990, JAMA-J AM MED ASSOC, V263, P979, DOI 10.1001/jama.263.7.979; Valenstein P, 1996, ARCH PATHOL LAB MED, V120, P206	14	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 24	2001	357	9260					901	902		10.1016/S0140-6736(00)04230-6	http://dx.doi.org/10.1016/S0140-6736(00)04230-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	413RG	11289342				2022-12-01	WOS:000167625300004
J	Lecuit, M; Vandormael-Pournin, S; Lefort, J; Huerre, M; Gounon, P; Dupuy, C; Babinet, C; Cossart, P				Lecuit, M; Vandormael-Pournin, S; Lefort, J; Huerre, M; Gounon, P; Dupuy, C; Babinet, C; Cossart, P			A transgenic model for listeriosis: Role of internalin in crossing the intestinal barrier	SCIENCE			English	Article							CELL-ADHESION MOLECULES; E-CADHERIN; TYROSINE KINASE; SURFACE PROTEIN; L-MONOCYTOGENES; RECEPTOR; ENTRY; EXPRESSION; SYSTEM; GASTROENTERITIS	Listeria monocytogenes is responsible for severe food-borne infections, but the mechanisms by which bacteria cross the intestinal barrier are unknown. Listeria monocytogenes expresses a surface protein, internalin, that interacts with a host receptor, E-cadherin, to promote entry into human epithelial cells. Murine E-cadherin, in contrast to guinea pig E-cadherin, does not interact with internalin, excluding the mouse as a model for addressing internalin function in vivo. In guinea pigs and transgenic mice expressing human E-cadherin, internalin was found to mediate invasion of enterocytes and crossing of the intestinal barrier. These results illustrate how relevant animal models for human infections can be generated.	Inst Pasteur, Unite Interact Bacteries Cellules, CNRS, Unite Rech Associee 1960, F-75724 Paris 15, France; Inst Pasteur, Unite Biol Dev, CNRS, Unite Rech Associee 1960, F-75724 Paris, France; Inst Pasteur, Unite Pharmacol Cellulaire, F-75724 Paris 15, France; Inst Pasteur, Unite Histopathol, F-75724 Paris 15, France; Inst Pasteur, Stn Cent Microscopie Electron, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, CNRS, Unite Rech Associee 1960, F-75724 Paris 15, France.		Lecuit, Marc/M-4126-2019; Lecuit, Marc/J-4073-2013	Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063				Aureli P, 2000, NEW ENGL J MED, V342, P1236, DOI 10.1056/NEJM200004273421702; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Dalton CB, 1997, NEW ENGL J MED, V336, P100, DOI 10.1056/NEJM199701093360204; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; FIGARELLABRANGER D, 1995, ACTA NEUROPATHOL, V89, P248; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; LORBER B, 1996, CLIN INFECT DIS, V24, P1; Marra A, 1997, INFECT IMMUN, V65, P3412, DOI 10.1128/IAI.65.8.3412-3421.1997; Mayhew TM, 1999, HISTOL HISTOPATHOL, V14, P257, DOI 10.14670/HH-14.257; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; Pron B, 1998, INFECT IMMUN, V66, P747, DOI 10.1128/IAI.66.2.747-755.1998; RACZ P, 1972, LAB INVEST, V26, P694; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Schulte R, 2000, CELL MICROBIOL, V2, P173, DOI 10.1046/j.1462-5822.2000.00047.x; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	22	447	469	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1722	1725		10.1126/science.1059852	http://dx.doi.org/10.1126/science.1059852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387478				2022-12-01	WOS:000169031800047
J	Birring, SS; Heartin, E; Williams, TJ; Brightling, CE; Pavord, ID				Birring, SS; Heartin, E; Williams, TJ; Brightling, CE; Pavord, ID			Peak expiratory flow sequence in acute exacerbations of asthma	BRITISH MEDICAL JOURNAL			English	Article							DEEP INHALATION		Gen Hosp Kettering, Dept Resp Med, Kettering NN16 8UZ, Northants, England; Univ Hosp Leicester NHS Trust, Dept Resp Med, Inst Lung Hlth, Leicester LE3 9QP, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester	Birring, SS (corresponding author), Gen Hosp Kettering, Dept Resp Med, Kettering NN16 8UZ, Northants, England.		Birring, Surinder/GWU-6967-2022	Pavord, Ian/0000-0002-4288-5973; brightling, chris/0000-0002-9345-4903				BURNS CB, 1985, J APPL PHYSIOL, V59, P1590, DOI 10.1152/jappl.1985.59.5.1590; LIM TK, 1987, AM REV RESPIR DIS, V135, P591; PELLEGRINO R, 1990, AM REV RESPIR DIS, V142, P822, DOI 10.1164/ajrccm/142.4.822	3	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 26	2001	322	7297					1281	1281		10.1136/bmj.322.7297.1281	http://dx.doi.org/10.1136/bmj.322.7297.1281			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437YW	11375231	Green Submitted, Green Published, Bronze			2022-12-01	WOS:000169027800020
J	DeMaria, CD; Soong, TW; Alseikhan, BA; Alvania, RS; Yue, DT				DeMaria, CD; Soong, TW; Alseikhan, BA; Alvania, RS; Yue, DT			Calmodulin bifurcates the local Ca2+ signal that modulates P/Q-type Ca2+ channels	NATURE			English	Article							PRESYNAPTIC CALCIUM CURRENT; RAT BRAIN-STEM; CA2+-DEPENDENT INACTIVATION; TARGET SEQUENCE; FACILITATION; BINDING; ACTIVATION; DOMAINS; SYNAPSE; SUBUNIT	Acute modulation of P/Q-type (alpha (1A)) calcium channels by neuronal activity-dependent changes in intracellular Ca2+ concentration may contribute to short-term synaptic plasticity(1-3), potentially enriching the neurocomputational capabilities of the brain(4,5). An unconventional mechanism for such channel modulation has been proposed(6,7) in which calmodulin (CaM) may exert two opposing effects on individual channels, initially promoting ('facilitation') and then inhibiting ('inactivation') channel opening. Here we report that such dual regulation arises from surprising Ca2+-transduction capabilities of CaM. First, although facilitation and inactivation are two competing processes, both require Ca2+-CaM binding to a single 'IQ-like' domain on the carboxy tail of alpha (8)(1A); a previously identified 'CBD' CaM-binding site(6,7) has no detectable role. Second, expression of a CaM mutant with impairment of all four of its Ca2+-binding sites (CaM1234) eliminates both forms of modulation. This result confirms that CaM is the Ca2+ sensor for channel regulation, and indicates that CaM may associate with the channel even before local Ca2+ concentration rises. Finally, the bifunctional capability of CaM arises from bifurcation of Ca2+ signalling by the lobes of CaM: Ca2+ binding to the amino-terminal lobe selectively initiates channel inactivation, whereas Ca2+ sensing by the carboxy-terminal lobe induces facilitation. Such lobe-specific detection provides a compact means to decode local Ca2+ signals in two ways, and to separately initiate distinct actions on a single molecular complex.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Program Mol & Cellular Syst Physiol, Baltimore, MD 21205 USA; Natl Inst Neurosci, Singapore 308433, Singapore; Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore	Johns Hopkins University; Johns Hopkins University; National Neuroscience Institute (NNI); National University of Singapore	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@bme.jhu.edu		Alvania, Rebecca/0000-0002-3846-0702; Soong, Tuck Wah/0000-0002-0876-0325				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Barth A, 1998, J BIOL CHEM, V273, P2174, DOI 10.1074/jbc.273.4.2174; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Colecraft HM, 2000, J GEN PHYSIOL, V115, P175, DOI 10.1085/jgp.115.2.175; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Erickson MG, 2001, BIOPHYS J, V80, p196A; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; KINCAID RL, 1988, METHOD ENZYMOL, V159, P605; KINK JA, 1990, CELL, V62, P165, DOI 10.1016/0092-8674(90)90250-I; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; OHYA Y, 1994, SCIENCE, V263, P963, DOI 10.1126/science.8310294; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Song LS, 1998, J PHYSIOL-LONDON, V512, P677, DOI 10.1111/j.1469-7793.1998.677bd.x; Sutton R, 1999, BAKKEN RES, V1, P401; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	30	323	334	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					484	489		10.1038/35078091	http://dx.doi.org/10.1038/35078091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373682				2022-12-01	WOS:000168858700051
J	Huelsken, J; Vogel, R; Erdmann, B; Cotsarelis, G; Birchmeier, W				Huelsken, J; Vogel, R; Erdmann, B; Cotsarelis, G; Birchmeier, W			beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin	CELL			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; HYPOHIDROTIC ECTODERMAL DYSPLASIA; ANTERIOR-POSTERIOR AXIS; ALPHA-CATENIN; MICE LACKING; FUNCTIONAL INTERACTION; EMBRYONIC HEART; COLON-CARCINOMA; HUMAN HOMOLOG; FEATHER BUDS	beta -Catenin is an essential molecule in Wnt/wingless signaling, which controls decisive steps in embryogenesis. To study the role of beta -catenin in skin development, we introduced a conditional mutation of the gene in the epidermis and hair follicles using Cre/loxP technology. When beta -catenin is mutated during embryogenesis, formation of placodes that generate hair follicles is blocked. We show that beta -catenin is required genetically downstream of tabby/downless and upstream of bmp and shh in placode formation. If beta -catenin is deleted after hair follicles have formed, hair is completely lost after the first hair cycle. Further analysis demonstrates that beta -catenin is essential for fate decisions of skin stem cells: in the absence of beta -catenin, stem cells rail to differentiate into follicular keratinocytes, but instead adopt an epidermal fate.	Max Delbrueck Ctr Mol Med, D-13092 Berlin, Germany; Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Pennsylvania	Birchmeier, W (corresponding author), Max Delbrueck Ctr Mol Med, Robert Roessle Str 10, D-13092 Berlin, Germany.	wbirch@mdc-berlin.de	Huelsken, Joerg/AAC-9581-2021	Huelsken, Joerg/0000-0003-3105-9606				Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Akiyama M, 2000, J INVEST DERMATOL, V114, P321, DOI 10.1046/j.1523-1747.2000.00857.x; Barker N, 2000, ADV CANCER RES, V77, P1; Barsh G, 1999, NAT GENET, V22, P315, DOI 10.1038/11876; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Ben-Ze'ev A, 1998, CURR OPIN CELL BIOL, V10, P629, DOI 10.1016/S0955-0674(98)80039-2; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chen CWJ, 1997, DEV BIOL, V188, P181, DOI 10.1006/dbio.1997.8643; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; Chuong CM, 1996, J INVEST DERMATOL, V107, P639, DOI 10.1111/1523-1747.ep12584254; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Crowe R, 1998, DEVELOPMENT, V125, P767; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cellbio.11.1.123; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Hulsken J, 2000, J CELL SCI, V113, P3545; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kishimoto J, 2000, GENE DEV, V14, P1181; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kofron M, 1997, DEVELOPMENT, V124, P1553; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Lyle S, 1998, J CELL SCI, V111, P3179; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nieset JE, 1997, J CELL SCI, V110, P1013; NOCKA K, 1990, EMBO J, V9, P3287, DOI 10.1002/j.1460-2075.1990.tb07528.x; Noramly S, 1999, DEVELOPMENT, V126, P3509; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Oro AE, 1998, CELL, V95, P575, DOI 10.1016/S0092-8674(00)81624-4; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Palka HL, 1997, J CELL SCI, V110, P2359; Panteleyev AA, 1999, AM J PATHOL, V155, P159, DOI 10.1016/S0002-9440(10)65110-3; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Polakis P, 2000, GENE DEV, V14, P1837; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Saitoh A, 1998, EXP CELL RES, V243, P150, DOI 10.1006/excr.1998.4152; SNAITH MR, 1995, GENE, V166, P173, DOI 10.1016/0378-1119(95)00579-8; Song HK, 1996, P NATL ACAD SCI USA, V93, P10246, DOI 10.1073/pnas.93.19.10246; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thorey IS, 1998, MOL CELL BIOL, V18, P3081, DOI 10.1128/MCB.18.5.3081; TOKSOZ D, 1992, P NATL ACAD SCI USA, V89, P7350, DOI 10.1073/pnas.89.16.7350; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wang JW, 1996, ONCOGENE, V13, P1537; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Widelitz RB, 2000, DEV BIOL, V219, P98, DOI 10.1006/dbio.1999.9580; Widelitz RB, 1999, DEVELOPMENT, V126, P2577; Wilson N, 1999, Exp Dermatol, V8, P367; Winter H, 1998, J INVEST DERMATOL, V111, P955, DOI 10.1046/j.1523-1747.1998.00456.x; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	90	1047	1127	10	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					533	545		10.1016/S0092-8674(01)00336-1	http://dx.doi.org/10.1016/S0092-8674(01)00336-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371349	Bronze			2022-12-01	WOS:000168840700012
J	Koenig, F; Knittel, J; Stepp, H				Koenig, F; Knittel, J; Stepp, H			Diagnosing cancer in vivo	SCIENCE			English	Article							5-AMINOLEVULINIC ACID; CONFOCAL MICROSCOPE; BLADDER-CARCINOMA; OPTICAL BIOPSY; FLUORESCENCE		Humboldt Univ, Charite Med Sch, Dept Urol, D-1086 Berlin, Germany; Univ Tubingen, Dept Minimally Invas Surg, D-72074 Tubingen, Germany; Univ Munich Grosshadern, Dept Urol, Laser Forschungslab, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; University of Munich	Koenig, F (corresponding author), Humboldt Univ, Charite Med Sch, Dept Urol, D-1086 Berlin, Germany.	frank.koenig@charite.de	Knittel, Joachim/C-5854-2009; Stepp, Herbert/E-1990-2013					Abulafia O, 1999, Obstet Gynecol Surv, V54, P253, DOI 10.1097/00006254-199904000-00022; Benaron DA, 1997, SCIENCE, V276, P2002, DOI 10.1126/science.276.5321.2002; Bom N, 1998, Eur J Ultrasound, V7, P9, DOI 10.1016/S0929-8266(98)00007-X; DABBS T, 1992, APPL OPTICS, V31, P3030, DOI 10.1364/AO.31.003030; Dickensheets DL, 1996, OPT LETT, V21, P764, DOI 10.1364/OL.21.000764; Dickensheets DL, 1998, J MICROELECTROMECH S, V7, P38, DOI 10.1109/84.661382; Dijkstra J, 1999, INT J CARDIAC IMAG, V15, P513, DOI 10.1023/A:1006334517720; GMITRO AF, 1993, OPT LETT, V18, P565, DOI 10.1364/OL.18.000565; Hamilton PW, 1998, ANAL QUANT CYTOL, V20, P443; Ikeda N, 1998, LUNG CANCER-J IASLC, V19, P161, DOI 10.1016/S0169-5002(97)00095-0; Jichlinski P, 1997, LASER SURG MED, V20, P402, DOI 10.1002/(SICI)1096-9101(1997)20:4<402::AID-LSM5>3.0.CO;2-U; KIEMENEY LALM, 1993, J UROLOGY, V150, P60, DOI 10.1016/S0022-5347(17)35397-1; Knittel J, 2001, OPT COMMUN, V188, P267, DOI 10.1016/S0030-4018(00)01164-0; Koenig F, 1999, BJU INT, V83, P129, DOI 10.1046/j.1464-410X.1999.00917.x; Koenig F, 1999, UROLOGY, V53, P853, DOI 10.1016/S0090-4295(98)00628-1; KORAITIM M, 1995, J UROLOGY, V154, P375, DOI 10.1016/S0022-5347(01)67051-4; Kriegmair M, 1996, J UROLOGY, V155, P105, DOI 10.1016/S0022-5347(01)66559-5; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Spitzer M, 1998, AM J OBSTET GYNECOL, V179, P544, DOI 10.1016/S0002-9378(98)70393-X; Stepp H, 1995, P SOC PHOTO-OPT INS, V2627, P13, DOI 10.1117/12.228884; Tearney GJ, 1998, OPT LETT, V23, P1152, DOI 10.1364/OL.23.001152; Tearney GJ, 1997, J UROLOGY, V157, P1915, DOI 10.1016/S0022-5347(01)64900-0; Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; Uchida K, 1998, Endoscopy, V30 Suppl 1, pA14, DOI 10.1055/s-2007-1001457	24	57	58	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1401	+		10.1126/science.292.5520.1401	http://dx.doi.org/10.1126/science.292.5520.1401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11360991				2022-12-01	WOS:000168862900052
J	Overbaugh, J; Bangham, CRM				Overbaugh, J; Bangham, CRM			Selection forces and constraints on retroviral sequence variation	SCIENCE			English	Editorial Material							CELL LEUKEMIA-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; I HTLV-I; HIV-1 INFECTION; TYPE-1 EVOLUTION; RECEPTOR; CARRIERS; VARIANTS; ESCAPE	All retroviruses possess a highly error-prone reverse transcriptase, but the extent of the consequent sequence diversity and the rate of evolution differ greatly among retroviruses. Because of the high mutability of retroviruses, it is not the generation of new viral variants that Limits the extent of diversity and the rate of evolution of retroviruses, but rather the selection forces that act on these variants. Here, we suggest that two selection forces-the immune response and the limited availability of appropriate target cells during transmission and persistence-are chiefly responsible for the observed sequence diversity in untreated retroviral infections. We illustrate these aspects of positive selection by reference to specific lentiviruses [human and simian immunodeficiency viruses (HIV and SIV)] and oncoviruses [feline Leukemia virus (FeLV) and human T cell Leukemia virus (HTLV)] that differ in their extent of variation and in disease outcomes.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Imperial Coll Sch Med, London W2 1PG, England	Fred Hutchinson Cancer Center; Imperial College London	Overbaugh, J (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.			Bangham, Charles/0000-0003-2624-3599				Anderson MM, 2000, SCIENCE, V287, P1828, DOI 10.1126/science.287.5459.1828; Bangham CRM, 2000, CURR OPIN IMMUNOL, V12, P397, DOI 10.1016/S0952-7915(00)00107-2; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Cavrois M, 1996, ONCOGENE, V12, P2419; COSSET FL, 1995, J VIROL, V69, P6314, DOI 10.1128/JVI.69.10.6314-6322.1995; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; DONAHUE PR, 1988, J VIROL, V62, P722, DOI 10.1128/JVI.62.3.722-731.1988; Hanon E, 2000, BLOOD, V95, P1386, DOI 10.1182/blood.V95.4.1386.004k22_1386_1392; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoffman T L, 1998, AIDS, V12 Suppl A, pS17; HOOVER EA, 1991, J AM VET MED ASSOC, V199, P1392; INA Y, 1990, J MOL EVOL, V31, P493, DOI 10.1007/BF02102076; JARRETT O, 1978, INT J CANCER, V21, P466, DOI 10.1002/ijc.2910210411; KANNAGI M, 1991, INT IMMUNOL, V3, P761, DOI 10.1093/intimm/3.8.761; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kimata JT, 1999, NAT MED, V5, P535, DOI 10.1038/8414; KORBER B, IN PRESS CHANGING FA; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; LUKASHOV VV, 1995, J VIROL, V69, P6911, DOI 10.1128/JVI.69.11.6911-6916.1995; Mansky LM, 2000, J VIROL, V74, P9525, DOI 10.1128/JVI.74.20.9525-9531.2000; MCKNIGHT A, 1995, J VIROL, V69, P3167, DOI 10.1128/JVI.69.5.3167-3170.1995; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; NEI M, 1986, MOL BIOL EVOL, V3, P418; NIEWIESK S, 1995, J VIROL, V69, P2649, DOI 10.1128/JVI.69.4.2649-2653.1995; NIEWIESK S, 1994, J VIROL, V68, P6778, DOI 10.1128/JVI.68.10.6778-6781.1994; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; OVERBAUGH J, 1988, NATURE, V332, P731, DOI 10.1038/332731a0; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Slattery JP, 1999, GENOME RES, V9, P525; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Taylor GP, 1999, J VIROL, V73, P10289, DOI 10.1128/JVI.73.12.10289-10295.1999; TEMIN HM, 1991, TRENDS GENET, V7, P71, DOI 10.1016/0168-9525(91)90048-U; Uchiyama T, 1997, ANNU REV IMMUNOL, V15, P15, DOI 10.1146/annurev.immunol.15.1.15; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Zinkernagel RM, 1997, IMMUNOL TODAY, V18, P258, DOI 10.1016/S0167-5699(97)80017-5; [No title captured]	42	144	147	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2001	292	5519					1106	+		10.1126/science.1059128	http://dx.doi.org/10.1126/science.1059128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	431AF	11352065				2022-12-01	WOS:000168609200043
J	Elul, B; Hajri, S; Nguyen, TNN; Ellertson, C; Ben Slama, C; Pearlman, E; Winikoff, B				Elul, B; Hajri, S; Nguyen, TNN; Ellertson, C; Ben Slama, C; Pearlman, E; Winikoff, B			Can women in less-developed countries use a simplified medical abortion regimen?	LANCET			English	Article							VAGINAL MISOPROSTOL; MIFEPRISTONE; HOME	Background Mifepristpne-misoprostol abortion, consisting of oral pills. is potentially simple and safe enough for use in less-developed countries. But the labour-intensive, costly, clinic-based European protocols are not affordable or feasible in most less-developed countries. Methods We prospectively tested two simplifications to the French mifepristone-misoprostol regimen in Vietnam and Tunisia. Women (n = 315) with amenorrhoea 8 weeks or less since their last menstrual period received 200 mg mifepristone in the clinic and then chose whether to take 400 mug oral misoprostol 2 days later either at home or in the clinic. Findings Despite the two-thirds reduction in mifepristone dose, success rates were high: Vietnam 93%, Tunisia 91%. About 88% of participants chose home administration of misoprostol. Most Vietnamese and Tunisian women were satisfied with their abortions, but efficacy and satisfaction rates were higher among those who used misoprostol at home. Interpretations A simplified medical abortion regimen of 200 mg mifepristone followed by the option of home administration of misoprostol seems feasible.	Populat Council, New York, NY 10021 USA; Tunisian Soc Endocrinol, Tunis, Tunisia; Hung Vuong Hosp, Ho Chi Minh City, Vietnam; Populat Council, Mexico City, DF, Mexico	Population Council	Winikoff, B (corresponding author), Populat Council, 1230 York Ave, New York, NY 10021 USA.							Guengant JP, 1999, CONTRACEPTION, V60, P167, DOI 10.1016/S0010-7824(99)00074-8; Schaff E A, 2000, J Am Med Womens Assoc (1972), V55, P137; Schaff EA, 1999, CONTRACEPTION, V59, P1, DOI 10.1016/S0010-7824(98)00150-4; Schaff EA, 1997, J FAM PRACTICE, V44, P353; Schaff EA, 2000, JAMA-J AM MED ASSOC, V284, P1948, DOI 10.1001/jama.284.15.1948; STEIN K, 1998, ABORPTION EXPANDING; VANLOOK PFA, 1993, BRIT MED J, V307, P532; Winikoff B, 1996, CONTRACEPTION, V54, P323, DOI 10.1016/S0010-7824(96)00206-5; World Health Organization, 1994, AB TAB AV DAT FREQ M; Wu YM, 2000, BRIT J OBSTET GYNAEC, V107, P524	10	70	72	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1402	1405		10.1016/S0140-6736(00)04563-3	http://dx.doi.org/10.1016/S0140-6736(00)04563-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356438				2022-12-01	WOS:000168478200012
J	Greenspan, D; Canchoia, AJ; MacPhail, LA; Cheikh, B; Greenspan, JS				Greenspan, D; Canchoia, AJ; MacPhail, LA; Cheikh, B; Greenspan, JS			Effect of highly active antiretroviral therapy on frequency of oral warts	LANCET			English	Article							MANIFESTATIONS	To investigate changes in the pattern of oral disease associated with highly active antiretroviral therapy (HAART), we assessed the frequency of these lesions in our clinic over 9 years. We retrospectively studied 1280 patients seen between Jury, 1990, and June, 1999, and related oral findings to medication use, immune function, and viral load. We found significant decreases in oral candidosis, hairy leucoplakia, and Kaposi's sarcoma over time, but no change in the occurrence of aphthous ulcers. There was an increase in salivary-gland disease and a striking Increase in warts: three-fold for patients an antiretroviral therapy and six-fold for those an HAART (p = 0.01). This pattern of oral disease in a referral clinic suggests that an increase in oral warts could be occurring as a complication of HAART.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Oral AIDS Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Greenspan, D (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.		Greenspan, John/AAE-9321-2020		NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE007946] Funding Source: NIH RePORTER; NIDCR NIH HHS [P0 1 DE 07946] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Greenspan D, 1996, LANCET, V348, P729, DOI 10.1016/S0140-6736(96)02308-2; GREENSPAN JS, 1992, ORAL SURG ORAL MED O, V73, P142, DOI 10.1016/0030-4220(92)90185-S; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Leigh IM, 1999, J ACQ IMMUN DEF SYND, V21, pS49; Patton LL, 2000, ORAL SURG ORAL MED O, V89, P299, DOI 10.1016/S1079-2104(00)70092-8	5	149	158	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1411	1412		10.1016/S0140-6736(00)04578-5	http://dx.doi.org/10.1016/S0140-6736(00)04578-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356441				2022-12-01	WOS:000168478200015
J	Mucklow, JC				Mucklow, JC			Reporting drug safety in clinical trials: getting the emphasis right	LANCET			English	Editorial Material									N Staffordshire Hosp NHS Trust, Dept Clin Pharmacol, Stoke On Trent ST4 6QG, Staffs, England	University Hospital of North Staffordshire NHS Trust	Mucklow, JC (corresponding author), N Staffordshire Hosp NHS Trust, Dept Clin Pharmacol, Stoke On Trent ST4 6QG, Staffs, England.							Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V285, P437, DOI 10.1001/jama.285.4.437; Kaufman DW, 2000, LANCET, V356, P1339, DOI 10.1016/S0140-6736(00)02826-9	2	9	10	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 5	2001	357	9266					1384	1384		10.1016/S0140-6736(00)04619-5	http://dx.doi.org/10.1016/S0140-6736(00)04619-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428TW	11356432				2022-12-01	WOS:000168478200006
J	Huber, AH; Weis, WI				Huber, AH; Weis, WI			The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin	CELL			English	Article							APC TUMOR-SUPPRESSOR; TYROSINE PHOSPHORYLATION; CELL-ADHESION; FUNCTIONAL INTERACTION; ALPHA-CATENIN; BINDING; REGION; LOCALIZATION; PLAKOGLOBIN; ASSOCIATION	As a component of adherens junctions and the Wnt signaling pathway, beta -catenin binds cadherins, Tcf family transcription factors, and the tumor suppressor APC. We have determined the crystal structures of both unphosphorylated and phosphorylated E-cadherin cytoplasmic domain complexed with the arm repeat region of beta -catenin. The interaction spans all 12 arm repeats, and features quasi-independent binding regions that include helices which interact with both ends of the arm repeat domain and an extended stretch of 14 residues which closely resembles a portion of XTcf-3. Phosphorylation of E-cadherin results in interactions with a hydrophobic patch of beta -catenin that mimics the binding of an amphipathic XTcf-3 helix. APC contains sequences homologous to the phosphorylated region of cadherin, and is likely to bind similarly.	Stanford Univ, Sch Med, Dept Struct Biol & Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol & Mol & Cellular Physiol, 299 Campus Dr W, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56169] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chitaev NA, 1998, J CELL SCI, V111, P1941; Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Finnemann S, 1997, J BIOL CHEM, V272, P11856, DOI 10.1074/jbc.272.18.11856; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HAMAGUCHI M, 1993, EMBO J, V12, P307, DOI 10.1002/j.1460-2075.1993.tb05658.x; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Lickert H, 2000, J BIOL CHEM, V275, P5090, DOI 10.1074/jbc.275.7.5090; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Norvell SM, 1998, J CELL SCI, V111, P1305; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Polakis P, 2000, GENE DEV, V14, P1837; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; RUBINFELD B, 1995, J BIOL CHEM, V270, P5549, DOI 10.1074/jbc.270.10.5549; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542; Takeda H, 1995, J CELL BIOL, V131, P1839, DOI 10.1083/jcb.131.6.1839; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wahl JK, 2000, J CELL SCI, V113, P1737; Witcher LL, 1996, J BIOL CHEM, V271, P10904, DOI 10.1074/jbc.271.18.10904; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0	51	572	592	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					391	402		10.1016/S0092-8674(01)00330-0	http://dx.doi.org/10.1016/S0092-8674(01)00330-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348595	Bronze			2022-12-01	WOS:000168515900008
J	Sanudo-Wilhelmy, SA; Kustka, AB; Gobler, CJ; Hutchins, DA; Yang, M; Lwiza, K; Burns, J; Capone, DG; Raven, JA; Carpenter, EJ				Sanudo-Wilhelmy, SA; Kustka, AB; Gobler, CJ; Hutchins, DA; Yang, M; Lwiza, K; Burns, J; Capone, DG; Raven, JA; Carpenter, EJ			Phosphorus limitation of nitrogen fixation by Trichodesmium in the central Atlantic Ocean	NATURE			English	Article							NORTH PACIFIC-OCEAN; IRON; PHYTOPLANKTON; PHYSIOLOGY; EVOLUTION; TRANSPORT; CADMIUM; COASTAL; CARBON; COPPER	Marine fixation of atmospheric nitrogen is believed to be an important source of biologically useful nitrogen to ocean surface waters(1), stimulating productivity of phytoplankton and so influencing the global carbon cycle(2). The majority of nitrogen fixation in tropical waters is carried out by the marine cyanobacterium Trichodesmium(3), which supplies more than half of the new nitrogen used for primary production(4). Although the factors controlling marine nitrogen fixation remain poorly understood, it has been thought that nitrogen fixation is limited by iron availability in the ocean(2,5). This was inferred from the high iron requirement estimated for growth of nitrogen fixing organisms(6) and the higher apparent densities of Trichodesmium where aeolian iron inputs are plentiful(7). Here we report that nitrogen fixation rates in the central Atlantic appear to be independent of both dissolved iron levels in sea water and iron content in Trichodesmium colonies. Nitrogen fixation was, instead, highly correlated to the phosphorus content of Trichodesmium and was enhanced at higher irradiance. Furthermore, our calculations suggest that the structural iron requirement for the growth of nitrogen-fixing organisms is much lower than previously calculated(6). Although iron deficiency could still potentially limit growth of nitrogen-fixing organisms in regions of low iron availability-for example, in the subtropical North Pacific Ocean-our observations suggest that marine nitrogen fixation is not solely regulated by iron supply.	SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA; Long Isl Univ, Southampton Coll, Div Nat Sci, Southampton, NY 11968 USA; Univ Delaware, Coll Marine Studies, Lewes, DE 19958 USA; Univ So Calif, Wrigley Inst Environm Studies, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ Dundee, Sch Life Sci, Div Environm & Appl Biol, Dundee DD1 4HN, Scotland; San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA 94920 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook; University of Delaware; University of Southern California; University of Southern California; University of Dundee; California State University System; San Francisco State University	Sanudo-Wilhelmy, SA (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.		Hutchins, David A/D-3301-2013	Hutchins, David A/0000-0002-6637-756X; Lwiza, Kamazima/0000-0003-2790-9284				BRAND LE, 1991, LIMNOL OCEANOGR, V36, P1756, DOI 10.4319/lo.1991.36.8.1756; BRULAND KW, 1979, ANAL CHIM ACTA, V105, P233, DOI 10.1016/S0003-2670(01)83754-5; Capone D. G., 1993, HDB METHODS AQUATIC, P621; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARPENTER EJ, 1976, SCIENCE, V191, P1278, DOI 10.1126/science.1257749; CARPENTER EJ, 1995, MAR ECOL PROG SER, V118, P267, DOI 10.3354/meps118267; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Flynn KJ, 1999, J PHYCOL, V35, P1171, DOI 10.1046/j.1529-8817.1999.3561171.x; GIESKES JM, 1991, OCEAN DRILLING PROGR, P46; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Johnson KS, 1999, NATURE, V398, P697, DOI 10.1038/19511; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; KARL DM, 1995, NATURE, V373, P230, DOI 10.1038/373230a0; Lagerloef GSE, 1998, J CLIMATE, V11, P2297, DOI 10.1175/1520-0442(1998)011<2297:PWPTRD>2.0.CO;2; LANDING WM, 1987, GEOCHIM COSMOCHIM AC, V51, P29, DOI 10.1016/0016-7037(87)90004-4; MAGUE TH, 1977, MAR BIOL, V41, P213, DOI 10.1007/BF00394908; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Postgate J., 1998, NITROGEN FIXATION, P1; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; RUETER JG, 1992, NATO ADV SCI I C-MAT, V362, P289; Schmidt MA, 1999, DEEP-SEA RES PT II, V46, P2487, DOI 10.1016/S0967-0645(99)00073-9; SPRENT JI, 1985, P ROY SOC EDINB B, V85, P215, DOI 10.1017/S0269727000004036; VanderLoeff MR, 1997, GEOCHIM COSMOCHIM AC, V61, P47, DOI 10.1016/S0016-7037(96)00333-X; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zehr JP, 1997, FEMS MICROBIOL LETT, V153, P303, DOI 10.1111/j.1574-6968.1997.tb12589.x; Zwiers FW, 1998, J CLIMATE, V11, P2200, DOI 10.1175/1520-0442(1998)011<2200:CITEOT>2.0.CO;2	30	472	496	3	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					66	69		10.1038/35075041	http://dx.doi.org/10.1038/35075041			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333977				2022-12-01	WOS:000168432800043
J	Maurice-Williams, RS				Maurice-Williams, RS			Bedside treatment of chronic subdural haematoma?	LANCET			English	Editorial Material							HEMATOMA		Royal Free Hosp NHS Trust, Dept Surg, London NW3 2QG, England	University of London; University College London	Maurice-Williams, RS (corresponding author), Royal Free Hosp NHS Trust, Dept Surg, London NW3 2QG, England.							KRUPP WF, 1995, BRIT J NEUROSURG, V9, P619, DOI 10.1080/02688699550040909; MARKWALDER TM, 1981, J NEUROSURG, V54, P637, DOI 10.3171/jns.1981.54.5.0637; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P547, DOI 10.1080/02688699943033; MAURICEWILLIAMS RS, 1975, J NEUROSURG, V43, P623, DOI 10.3171/jns.1975.43.5.0623; MAURICEWILLIAMS RS, 1993, AGE AGEING, V22, P337, DOI 10.1093/ageing/22.5.337; NAGANUMA H, 1986, NEUROSURGERY, V19, P794, DOI 10.1227/00006123-198611000-00013; Reinges MHT, 2000, J NEUROL NEUROSUR PS, V69, P40, DOI 10.1136/jnnp.69.1.40; VanHavenbergh T, 1996, BRIT J NEUROSURG, V10, P35	8	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 28	2001	357	9265					1308	1309		10.1016/S0140-6736(00)04528-1	http://dx.doi.org/10.1016/S0140-6736(00)04528-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343731				2022-12-01	WOS:000168411400005
J	Jarillo, JA; Gabrys, H; Capel, J; Alonso, JM; Ecker, JR; Cashmore, AR				Jarillo, JA; Gabrys, H; Capel, J; Alonso, JM; Ecker, JR; Cashmore, AR			Phototropin-related NPL1 controls chloroplast relocation induced by blue light	NATURE			English	Article							LEMNA-TRISULCA L; ARABIDOPSIS-THALIANA; PROTEIN-KINASE; NPH1; PHOTORECEPTORS; RECEPTOR; DOMAINS	In photosynthetic cells, chloroplasts migrate towards illuminated sites to optimize photosynthesis and move away from excessively illuminated areas to protect the photosynthetic machinery(1). Although this movement of chloroplasts in response to light has been known for over a century, the photoreceptor mediating this process has not been identified. The Arabidopsis gene NPL1 (ref. 2) is a paralogue of the NPH1 gene, which encodes phototropin, a photoreceptor for phototropic bending(3). Here we show that NPL1 is required for chloroplast relocation induced by blue light. A loss-of-function npl1 mutant showed no chloroplast avoidance response in strong blue light, whereas the accumulation of chloroplasts in weak light was normal. These results indicate that NPL1 may function as a photoreceptor mediating chloroplast relocation.	Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA; Jagiellonian Univ, Inst Mol Biol, PL-31120 Krakow, Poland; Univ Almeria, Dept Biol Aplicada, Almeria 04120, Spain	University of Pennsylvania; Jagiellonian University; Universidad de Almeria	Cashmore, AR (corresponding author), Univ Penn, Dept Biol, Inst Plant Sci, Philadelphia, PA 19104 USA.		Capel, Juan/M-3772-2018; Alonso, Jose M/K-6826-2014; Ecker, Joseph R/B-9144-2008	Capel, Juan/0000-0002-4327-0604; Alonso, Jose M/0000-0001-7087-1571; Ecker, Joseph R/0000-0001-5799-5895; Jarillo, Jose Antonio/0000-0002-2963-7641				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Jarillo JA., 1998, PLANT PHYSIOL, V117, P719; Kadota A, 2000, PLANTA, V210, P932, DOI 10.1007/s004250050700; Kagawa T, 2000, PLANT CELL PHYSIOL, V41, P84, DOI 10.1093/pcp/41.1.84; Kanegae H, 2000, PLANT CELL PHYSIOL, V41, P415, DOI 10.1093/pcp/41.4.415; LEUTWILER LS, 1986, NUCLEIC ACIDS RES, V14, P4051, DOI 10.1093/nar/14.10.4051; Lin CT, 2000, PLANT PHYSIOL, V123, P39, DOI 10.1104/pp.123.1.39; LISCUM E, 1995, PLANT CELL, V7, P473, DOI 10.1105/tpc.7.4.473; MALEC P, 1994, J THEOR BIOL, V169, P189, DOI 10.1006/jtbi.1994.1140; NOZUE K, 2000, PLANT PHYSIOL, V122, P1457; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; TLALKA M, 1993, PLANTA, V189, P491, DOI 10.1007/BF00198211; Trojan A, 1996, PLANT PHYSIOL, V111, P419, DOI 10.1104/pp.111.2.419; WADA M, 1993, J PHOTOCH PHOTOBIO B, V17, P3, DOI 10.1016/1011-1344(93)85002-P; WALCZAK T, 1980, PHOTOSYNTHETICA, V14, P65; Zacherl M, 1998, PLANT PHYSIOL, V116, P869; ZXURZXYCKI J, 1980, BLUE LIGHT SYNDROME, P50	20	362	373	0	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					952	954		10.1038/35073622	http://dx.doi.org/10.1038/35073622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309623				2022-12-01	WOS:000168152300052
J	Martin, PR; Lee, BB; White, AJR; Soloman, SG; Ruttiger, L				Martin, PR; Lee, BB; White, AJR; Soloman, SG; Ruttiger, L			Chromatic sensitivity of ganglion cells in the peripheral primate retina	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; MACAQUE MONKEY; RHESUS-MONKEY; VISUAL-FIELD; COLOR-VISION; HUMAN EYE; LUMINANCE; CIRCUITS; CONTRAST; NEURONS	Visual abilities change over the visual field. For example, our ability to detect movement is better in peripheral vision than in foveal vision, but colour discrimination is markedly worse(1,2). The deterioration of colour vision has been attributed to reduced colour specificity in cells of the midget, parvocellular (PC) visual pathway in the peripheral retina(3-5). We have measured the colour specificity (red-green chromatic modulation sensitivity) of PC cells at eccentricities between 20 and 50 degrees in the macaque retina. Here we show that most peripheral PC cells have red-green modulation sensitivity close to that of foveal PC cells. This result is incompatible with the view that PC pathway cells in peripheral retina make indiscriminate connections ('random wiring') with retinal circuits devoted to different spectral types of cone photoreceptors(4,6,7). We show that selective cone connections can be maintained by dendritic field anisotropy, consistent with the morphology of PC cell dendritic fields in peripheral retina(8,9). Our results also imply that postretinal mechanisms contribute to the psychophysically demonstrated deterioration of colour discrimination in the peripheral visual field.	Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia; Univ Sydney, Inst Biomed Res, Sydney, NSW 2006, Australia; Max Planck Inst Biophys Chem, Neurobiol Grp, D-37077 Gottingen, Germany; SUNY Coll Optometry, New York, NY 10036 USA	University of Sydney; University of Sydney; Max Planck Society; State University of New York (SUNY) System; SUNY Optometry	Martin, PR (corresponding author), Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia.	paulm@physiol.usyd.edu.au	Solomon, Samuel/C-8779-2009; White, Andrew JR/E-8462-2013; Martin, Paul R/A-4346-2009	Martin, Paul R/0000-0002-5166-9658; Solomon, Samuel/0000-0001-5321-0288				Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; DEMONASTERIO FM, 1975, J PHYSIOL-LONDON, V251, P167, DOI 10.1113/jphysiol.1975.sp011086; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P219, DOI 10.1113/jphysiol.1984.sp015498; DREHER B, 1976, J PHYSIOL-LONDON, V258, P433, DOI 10.1113/jphysiol.1976.sp011429; Goodchild AK, 1996, J COMP NEUROL, V366, P55, DOI 10.1002/(SICI)1096-9861(19960226)366:1<55::AID-CNE5>3.0.CO;2-J; GOURAS P, 1979, SCIENCE, V205, P587, DOI 10.1126/science.109925; KAPLAN E, 1989, NEW VIEWS PRIMATE RE, V9, P273; Lankheet MJM, 1998, VISUAL NEUROSCI, V15, P47, DOI 10.1017/S0952523898151015; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Lennie P., 1991, COMPUTATIONAL MODELS, P71, DOI [10.7551/mitpress/2002.003.0010, DOI 10.7551/MITPRESS/2002.003.0010]; Mullen KT, 1996, VISION RES, V36, P1995, DOI 10.1016/0042-6989(95)00261-8; MULLEN KT, 1991, VISION RES, V31, P119, DOI 10.1016/0042-6989(91)90079-K; NAVARRO R, 1993, J OPT SOC AM A, V10, P201, DOI 10.1364/JOSAA.10.000201; NOORLANDER C, 1983, VISION RES, V23, P1, DOI 10.1016/0042-6989(83)90035-4; Packer OS, 1996, J NEUROSCI, V16, P2251; RODIECK RW, 1991, NATO ADV SCI I A-LIF, V203, P83; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; ROORDA A, IN PRESS VISION RES; SHAPLEY R, 1986, TRENDS NEUROSCI, V9, P229, DOI 10.1016/0166-2236(86)90064-0; SMITH EL, 1990, VISUAL NEUROSCI, V5, P525, DOI 10.1017/S0952523800000699; SMITH VC, 1992, J PHYSIOL-LONDON, V458, P191, DOI 10.1113/jphysiol.1992.sp019413; WASSLE H, 1994, VISION RES, V34, P561, DOI 10.1016/0042-6989(94)90013-2; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; Wong WT, 2000, J NEUROSCI, V20, P5024	27	110	111	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2001	410	6831					933	936		10.1038/35073587	http://dx.doi.org/10.1038/35073587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309618	Green Published			2022-12-01	WOS:000168152300047
J	Pachepsky, E; Crawford, JW; Bown, JL; Squire, G				Pachepsky, E; Crawford, JW; Bown, JL; Squire, G			Towards a general theory of biodiversity	NATURE			English	Article							POPULATION-DYNAMICS; COMMUNITY STRUCTURE; ANNUALS	The study of patterns in living diversity is driven by the desire to rnd the universal rules that underlie the organization of ecosystems(1,2). The relative abundance distribution, which characterizes the total number and abundance of species in a community, is arguably the most fundamental measure in ecology. Considerable effort has been expended in striving for a general theory that can explain the form of the distribution(3,4). Despite this, a mechanistic understanding of the form in terms of physiological and environmental parameters remains elusive(5). Recently, it has been proposed that space plays a central role in generating the patterns of diversity(6,7). Here we show that an understanding of the observed form of the relative abundance distribution requires a consideration of how individuals pack in time. We present a framework for studying the dynamics of communities which generalizes the prevailing species-based approach to one based on individuals that are characterized by their physiological traits. The observed form of the abundance distribution and its dependence on richness and disturbance are reproduced, and can be understood in terms of the trade-off between time to reproduction and fecundity.	Univ Albertay Dundee, Sch Comp, SIMBIOS Ctr, Dundee DD1 1HG, Scotland; Scottish Crop Res Inst, Vegetat Syst Unit, Dundee DD2 5DA, Scotland	University of Abertay Dundee; James Hutton Institute	Crawford, JW (corresponding author), Univ Albertay Dundee, Sch Comp, SIMBIOS Ctr, Dundee DD1 1HG, Scotland.			Crawford, John/0000-0002-7139-0355				CRAWLEY MJ, 1987, J THEOR BIOL, V125, P475, DOI 10.1016/S0022-5193(87)80215-1; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Giplin M, 1991, METAPOPULATION DYNAM; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Kareiva, 1997, SPATIAL ECOLOGY; Legendre L, 1983, NUMERICAL ECOLOGY; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; Magurran A.E, 1995, BIOL DIVERSITY, V32, P668, DOI 10.2307/2404662; PACALA SW, 1986, THEOR POPUL BIOL, V29, P262, DOI 10.1016/0040-5809(86)90011-0; PEARSON TH, 1983, MAR ECOL PROG SER, V12, P237, DOI 10.3354/meps012237; Putman R. J., 1994, COMMUNITY ECOLOGY; ROSENZWEIG ML, 1995, SPACIES DIVERSITY SP; Sole RV, 1999, TRENDS ECOL EVOL, V14, P156, DOI 10.1016/S0169-5347(98)01518-3; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; UGLAND KI, 1982, OIKOS, V39, P171, DOI 10.2307/3544482; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Winkler E, 1999, OIKOS, V85, P217, DOI 10.2307/3546488; [No title captured]	18	69	72	0	28	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					923	926		10.1038/35073563	http://dx.doi.org/10.1038/35073563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309615				2022-12-01	WOS:000168152300044
J	Binswanger, HP				Binswanger, HP			Public health - HIV/AIDS treatment for millions	SCIENCE			English	Editorial Material													Binswanger, Hans/M-6883-2013	Binswanger, Hans/0000-0002-6323-1418				Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; Castro-Leal F, 1999, WORLD BANK RES OBSER, V14, P49, DOI 10.1093/wbro/14.1.49; *MCKINS CO, 2000, INCR ACC ARV TREATM; SCHOOFS M, 2000, WALL STREET J   0307, pA1; SUBBARAO K, 1997, SAFETY NET PROGRAMS, pCH4; *UNAIDS IAS WHO, US ANT TREATM AD PAR; *UNAIDS UNICEF WHO, 2000, SEL DRUGS US CAR PEO; *UNAIDS WHO, 2000, PAT SIT HIV AIDS REL; VONPISCHKE JD, 1991, FINANCES FRONTIER; WEHRWEIN P, 1999, HARVARD PUBL HLTH RE, V32, P32; *WORLD BANK, 2000, AIDS CAMP TEAM AFR A	12	28	29	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					221	+		10.1126/science.1057504	http://dx.doi.org/10.1126/science.1057504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11305311				2022-12-01	WOS:000168074000025
J	Di Marzo, V; Goparaju, SK; Wang, L; Liu, J; Batkai, S; Jarai, Z; Fezza, F; Miura, GI; Palmiter, RD; Sugiura, T; Kunos, G				Di Marzo, V; Goparaju, SK; Wang, L; Liu, J; Batkai, S; Jarai, Z; Fezza, F; Miura, GI; Palmiter, RD; Sugiura, T; Kunos, G			Leptin-regulated endocannabinoids are involved in maintaining food intake	NATURE			English	Article							MELANIN-CONCENTRATING HORMONE; RECEPTOR MESSENGER-RNA; NEUROPEPTIDE-Y; RAT-BRAIN; CB1; ANTAGONIST; 2-ARACHIDONOYLGLYCEROL; IDENTIFICATION; INACTIVATION; ANANDAMIDE	Leptin is the primary signal through which the hypothalamus senses nutritional state and modulates food intake and energy balance(1). Leptin reduces food intake by upregulating anorexigenic (appetite-reducing) neuropeptides, such as a-melanocyte-stimulating hormone(2,3), and downregulating orexigenic (appetite-stimulating) factors, primarily neuropeptide Y-4. Genetic defects in anorexigenic signalling, such as mutations in the melanocortin-4 (ref. 5) or leptin receptors(6), cause obesity. However, alternative orexigenic pathways maintain food intake in mice deficient in neuropeptide Y-7. CB1 cannabinoid receptors(8) and the endocannabinoids anandamide and 2-arachidonoyl glycerol are present in the hypothalamus(9), and marijuana(10) and anandamide(11,12) stimulate food intake. Here we show that following temporary food restriction, CB1 receptor knockout mice eat less than their wild-type littermates, and the CB1 antagonist SR141716A reduces food intake in wild-type but not knockout mice. Furthermore, defective leptin signalling is associated with elevated hypothalamic, but not cerebellar, levels of endocannabinoids in obese db/db and ob/ob mice and Zucker rats. Acute leptin treatment of normal rats and ob/ob mice reduces anandamide and 2-arachidonoyl glycerol in the hypothalamus. These findings indicate that endocannabinoids in the hypothalamus may tonically activate CB1 receptors to maintain food intake and form part of the neural circuitry regulated by leptin.	CNR, Ist Chim Mol Interesse Biol, Endocannabinoid Res Grp, I-80072 Arco Felice Napoli, Naples, Italy; Virginia Commonwealth Univ, Med Coll Virginia, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Teikyo Univ, Fac Pharmaceut Sci, Kanagawa 1990195, Japan	Consiglio Nazionale delle Ricerche (CNR); Virginia Commonwealth University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Teikyo University	Kunos, G (corresponding author), NIAAA, NIH, MSC-8115, Bethesda, MD 20892 USA.	gkunos@mail.nih.gov	Batkai, Sandor/G-3889-2010; Di Marzo, Vincenzo/AAD-7742-2019; Goparaju, Sravan/H-3422-2011; Batkai, Sandor/H-7983-2014	Di Marzo, Vincenzo/0000-0002-1490-3070; 	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000350, Z01AA000350] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Bisogno T, 1999, J NEUROCHEM, V72, P2113, DOI 10.1046/j.1471-4159.1999.0722113.x; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Chaperon F, 1998, PSYCHOPHARMACOLOGY, V135, P324, DOI 10.1007/s002130050518; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Funahashi H, 1999, NEUROSCI LETT, V264, P117, DOI 10.1016/S0304-3940(99)00186-X; Gonzalez S, 1999, NEUROENDOCRINOLOGY, V70, P137, DOI 10.1159/000054468; Hao SZ, 2000, EUR J PHARMACOL, V392, P147, DOI 10.1016/S0014-2999(00)00059-5; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Lopez M, 2000, BIOCHEM BIOPH RES CO, V269, P41, DOI 10.1006/bbrc.2000.2245; Mechoulam R, 1998, PROGR MED CHEM, V35, P199, DOI 10.1016/S0079-6468(08)70037-7; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Sahu A, 1998, ENDOCRINOLOGY, V139, P795, DOI 10.1210/en.139.2.795; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Sugiura T, 1996, EUR J BIOCHEM, V240, P53, DOI 10.1111/j.1432-1033.1996.0053h.x; White R, 1998, BRIT J PHARMACOL, V125, P689, DOI 10.1038/sj.bjp.0702127; WILLIAMS SK, 1999, TIS ENGN INTELL UNIT, V1, P143; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	29	1219	1261	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					822	825		10.1038/35071088	http://dx.doi.org/10.1038/35071088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298451				2022-12-01	WOS:000168021900057
J	Abu-Elheiga, L; Matzuk, MM; Abo-Hashema, KAH; Wakil, SJ				Abu-Elheiga, L; Matzuk, MM; Abo-Hashema, KAH; Wakil, SJ			Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2	SCIENCE			English	Article							COENZYME-A CARBOXYLASE; MALONYL-COA; SKELETAL-MUSCLE; MOLECULAR-CLONING; PROTEIN-KINASE; RAT-LIVER; PHOSPHORYLATION; GENE; IDENTIFICATION; PURIFICATION	Malonyl-coenzyme A (malonyl-CoA), generated by acetyl-CoA carboxylases ACC1 and ACC2, is a key metabolite in the regulation of energy homeostasis. Here, we show that Acc2(-/-) mutant mice have a normal life span, a higher fatty acid oxidation rate, and lower amounts of fat. In comparison to the wild type, Acc2-deficient mice had 10- and 30-fold lower levels of malonyl-CoA in heart and muscle, respectively. The fatty acid oxidation rate in the soleus muscle of the Acc2(-/-) mice was 30% higher than that of wild-type mice and was not affected by addition of insulin; however, addition of insulin to the wild-type muscle reduced fatty acid oxidation by 45%. The mutant mice accumulated 50% less fat in their adipose tissue than did wild-type mice. These results raise the possibility that pharmacological manipulation of ACC2 may lead to loss of body fat in the context of normal caloric intake.	Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Wakil, SJ (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem, Houston, TX 77030 USA.			Abu-Elheiga, Lutfi/0000-0002-7366-3556	NIGMS NIH HHS [GM19091] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; ABUELHEIGA L, 1995, P NATL ACAD SCI USA, V92, P4011, DOI 10.1073/pnas.92.9.4011; AbuElheiga L, 1997, J BIOL CHEM, V272, P10669; ABUELHEIGA L, UNPUB; Alam N, 1998, BIOCHEM J, V334, P233, DOI 10.1042/bj3340233; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; BRESSLER R, 1961, J BIOL CHEM, V236, P1643; CHAUDRY IH, 1969, BIOCHIM BIOPHYS ACTA, V177, P527, DOI 10.1016/0304-4165(69)90315-8; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; EVANS JL, 1989, BIOCHEM J, V259, P821, DOI 10.1042/bj2590821; Ha J, 1996, P NATL ACAD SCI USA, V93, P11466, DOI 10.1073/pnas.93.21.11466; HARDIE DG, 1989, PROG LIPID RES, V28, P117, DOI 10.1016/0163-7827(89)90010-6; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; IVERSON AJ, 1990, BIOCHEM J, V269, P365, DOI 10.1042/bj2690365; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379; LOPASCHUK GD, 1994, CAN J PHYSIOL PHARM, V72, P1101, DOI 10.1139/y94-156; MABROUK GM, 1990, J BIOL CHEM, V265, P6330; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MOHAMED AH, 1994, J BIOL CHEM, V269, P6859; OShea D, 1997, ENDOCRINOLOGY, V138, P196, DOI 10.1210/en.138.1.196; Rasmussen BB, 1997, J APPL PHYSIOL, V83, P1104, DOI 10.1152/jappl.1997.83.4.1104; Rasmussen BB, 1999, ANNU REV NUTR, V19, P463, DOI 10.1146/annurev.nutr.19.1.463; Schwartz MW, 1998, ENDOCRINOLOGY, V139, P2629, DOI 10.1210/en.139.5.2629; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; THAMPY KG, 1988, J BIOL CHEM, V263, P6447; THAMPY KG, 1988, J BIOL CHEM, V263, P6454; THAMPY KG, 1989, J BIOL CHEM, V264, P17631; Vavvas D, 1997, J BIOL CHEM, V272, P13255, DOI 10.1074/jbc.272.20.13255; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WAKIL SJ, 1958, BIOCHIM BIOPHYS ACTA, V29, P225, DOI 10.1016/0006-3002(58)90177-X; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	36	704	756	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 30	2001	291	5513					2613	2616		10.1126/science.1056843	http://dx.doi.org/10.1126/science.1056843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417XP	11283375				2022-12-01	WOS:000167861000045
J	Whittington, AT; Vugrek, O; Wei, KJ; Hasenbein, NG; Sugimoto, K; Rashbrooke, MC; Wasteneys, GO				Whittington, AT; Vugrek, O; Wei, KJ; Hasenbein, NG; Sugimoto, K; Rashbrooke, MC; Wasteneys, GO			MOR1 is essential for organizing cortical microtubules in plants	NATURE			English	Article							MITOTIC SPINDLE; HEAT REPEATS; LIVING CELLS; PROTEIN; XMAP215; ORGANIZATION; CYTOSKELETON; MUTATIONS; COMPONENT; DYNAMICS	Microtubules orchestrate cell division and morphogenesis, but how they disassemble and reappear at different subcellular locations is unknown. Microtubule organizing centres are thought to have an important role, but in higher plants microtubules assemble in ordered configurations even though microtubule organizing centres are inconspicuous or absent. Plant cells generate highly organized microtubule arrays that coordinate mitosis, cytokinesis and expansion. Inhibiting microtubule assembly prevents chromosome separation(1), blocks cell division(2) and impairs growth polarity(3). Microtubules are essential for the formation of cell walls, through an array of plasma-membrane-associated cortical microtubules whose control mechanisms are unknown. Using a genetic strategy to identify microtubule organizing factors in Arabidopsis thaliana, we isolated temperature-sensitive mutant alleles of the MICROTUBULE ORGANIZATION 1 (MOR1) gene. Here we show that MOR1 is the plant version of an ancient family of microtubule-associated proteins(4). Point mutations that substitute single amino-acid residues in an amino-terminal HEAT repeat impart reversible temperature-dependent cortical microtubule disruption, showing that MOR1 is essential for cortical microtubule organization.	Australian Natl Univ, Res Sch Biol Sci, Plant Cell Biol Grp, Canberra, ACT 2601, Australia	Australian National University	Wasteneys, GO (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Plant Cell Biol Grp, GPO Box 475, Canberra, ACT 2601, Australia.	geoffw@rsbs.anu.edu.au	Sugimoto, Keiko/B-3368-2010; Wasteneys, Geoffrey/AGQ-5388-2022	Sugimoto, Keiko/0000-0002-9209-8230; Wasteneys, Geoffrey/0000-0002-8746-7994				Andersen SSL, 1998, CELL MOTIL CYTOSKEL, V41, P202, DOI 10.1002/(SICI)1097-0169(1998)41:3<202::AID-CM2>3.0.CO;2-X; Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; BASKIN TI, 1994, PLANT CELL PHYSIOL, V35, P935; BASKIN TI, 1990, ANNU REV PLANT PHYS, V41, P277, DOI 10.1146/annurev.pp.41.060190.001425; Charrasse S, 1998, J CELL SCI, V111, P1371; Charrasse S, 2000, EXP CELL RES, V254, P249, DOI 10.1006/excr.1999.4740; Cullen CF, 1999, J CELL BIOL, V146, P1005, DOI 10.1083/jcb.146.5.1005; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Graf R, 2000, J CELL SCI, V113, P1747; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200; Lloyd C, 2001, NAT REV MOL CELL BIO, V2, P40, DOI 10.1038/35048005; Matthews LR, 1998, J CELL BIOL, V141, P1159, DOI 10.1083/jcb.141.5.1159; Mayer U, 1999, EUR J CELL BIOL, V78, P100, DOI 10.1016/S0171-9335(99)80011-9; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; Smertenko A, 2000, NAT CELL BIOL, V2, P750, DOI 10.1038/35036390; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Ueda K, 2000, PROTOPLASMA, V213, P28, DOI 10.1007/BF01280502; Ueda K, 1999, PROTOPLASMA, V206, P201, DOI 10.1007/BF01279267; Vasquez RJ, 1999, CELL MOTIL CYTOSKEL, V43, P310, DOI 10.1002/(SICI)1097-0169(1999)43:4<310::AID-CM4>3.0.CO;2-J; Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271; Wasteneys GO, 2000, CURR OPIN PLANT BIOL, V3, P503, DOI 10.1016/S1369-5266(00)00120-5; Wasteneys GO, 1997, J MICROSC-OXFORD, V188, P51, DOI 10.1046/j.1365-2818.1977.2390796.x; Wick S, 2000, NAT CELL BIOL, V2, pE204, DOI 10.1038/35041129	29	342	368	7	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 31	2001	411	6837					610	613		10.1038/35079128	http://dx.doi.org/10.1038/35079128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385579				2022-12-01	WOS:000168982500058
J	Iwata, N; Tsubuki, S; Takaki, Y; Shirotani, K; Lu, B; Gerard, NP; Gerard, C; Hama, E; Lee, HJ; Saido, TC				Iwata, N; Tsubuki, S; Takaki, Y; Shirotani, K; Lu, B; Gerard, NP; Gerard, C; Hama, E; Lee, HJ; Saido, TC			Metabolic regulation of brain A beta by neprilysin	SCIENCE			English	Article							ALZHEIMERS-DISEASE; IDENTIFICATION; PROTEIN; GENE; DEGRADATION; CATABOLISM; PRESENILIN; REGION; MICE	Amyloid beta peptide (A beta) the pathogenic agent of Alzheimer's disease (AD), is a physiological metabolite in the brain. We examined the role of neprilysin, a candidate A beta -degrading peptidase, in the metabolism using neprilysin gene-disrupted mice. Neprilysin deficiency resulted in defects both in the degradation of exogenously administered A beta and in the metabolic suppression of the endogenous A beta Levels in a gene dose-dependent manner. The regional Levels of A beta in the neprilysin-deficient mouse brain were in the distinct order of hippocampus, cortex, thalamus/striatum, and cerebellum, where hippocampus has the highest Level and cerebellum the lowest, correlating with the vulnerability to A beta deposition in brains of humans with AD. Our observations suggest that even partial down-regulation of neprilysin activity, which could be caused by aging, can contribute to AD development by promoting A beta accumulation.	RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	RIKEN; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Saido, TC (corresponding author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan.	saido@brain.riken.go.jp	Saido, Takaomi C/N-5472-2015; Sado, Takaomi/AAN-2759-2021	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903				Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; HAOUAS H, 1995, BIOCHEM BIOPH RES CO, V207, P933, DOI 10.1006/bbrc.1995.1275; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Ikeda K, 1999, J BIOL CHEM, V274, P32469, DOI 10.1074/jbc.274.45.32469; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kiryu-Seo S, 2000, P NATL ACAD SCI USA, V97, P4345, DOI 10.1073/pnas.070509897; LI CW, 1995, J BIOL CHEM, V270, P5723, DOI 10.1074/jbc.270.11.5723; Li CW, 1998, ARCH BIOCHEM BIOPHYS, V358, P189, DOI 10.1006/abbi.1998.0855; LU B, 1995, J EXP MED, V181, P2271, DOI 10.1084/jem.181.6.2271; Nakano Y, 1999, EUR J NEUROSCI, V11, P2577, DOI 10.1046/j.1460-9568.1999.00698.x; Perez A, 2000, NEUROCHEM RES, V25, P247, DOI 10.1023/A:1007527721160; Poduslo SE, 1999, HUM GENET, V105, P32, DOI 10.1007/s004390051060; Saido T.C., 2000, NEUROSCI NEWS, V5, P52; Saido TC, 1998, NEUROBIOL AGING, V19, pS69, DOI 10.1016/S0197-4580(98)00033-5; Saria A, 1997, NEUROSCI LETT, V234, P27, DOI 10.1016/S0304-3940(97)00660-5; Sawamura N, 2000, J BIOL CHEM, V275, P27901; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Shen RQ, 2000, MOL CELL ENDOCRINOL, V170, P131, DOI 10.1016/S0303-7207(00)00326-9; SHIROTANI K, IN PRESS J BIOL CHEM; Takaki Y, 2000, J BIOCHEM-TOKYO, V128, P897, DOI 10.1093/oxfordjournals.jbchem.a022839; Tanzi RE, 1996, NEUROBIOL DIS, V3, P159, DOI 10.1006/nbdi.1996.0016; Tucker HM, 2000, J NEUROSCI, V20, P3937; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X	29	784	833	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1550	1552		10.1126/science.1059946	http://dx.doi.org/10.1126/science.1059946			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375493				2022-12-01	WOS:000168963800046
J	Kawane, K; Fukuyama, H; Kondoh, G; Takeda, J; Ohsawa, Y; Uchiyama, Y; Nagata, S				Kawane, K; Fukuyama, H; Kondoh, G; Takeda, J; Ohsawa, Y; Uchiyama, Y; Nagata, S			Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver	SCIENCE			English	Article							TRANSCRIPTION FACTOR PU.1; DEOXYRIBONUCLEASE-II; MOLECULAR-CLONING; APOPTOTIC CELLS; TGF-BETA; GENE; MACROPHAGES; DIFFERENTIATION; FRAGMENTATION; ABSENCE	Mature erythrocytes in mammals have no nuclei, although they differentiate from nucleated precursor cells. The mechanism by which enucleation occurs is not well understood. Here we show that deoxyribonuclease II (DNase II) is indispensable for definitive erythropoiesis in mouse fetal liver. No live DNase Ii-null mice were born, owing to severe anemia. When mutant fetal liver cells were transferred into Lethally irradiated wild-type mice, mature red blood cells were generated from the mutant cells, suggesting that DNase II functions in a non-cell-autonomous manner. Histochemical analyses indicated that the critical cellular sources of DNase II are macrophages present at the site of definitive erythropoiesis in the fetal Liver. Thus, DNase II in macrophages appears to be responsible for destroying the nuclear DNA expelled from erythroid precursor cells.	Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Cell Biol & Anat, Suita, Osaka 5650871, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Fukuyama, Hidehiro/AAY-6256-2021; Fukuyama, Hidehiro/N-5276-2018; Nagata, Shigekazu/AAG-3203-2019	Fukuyama, Hidehiro/0000-0002-6457-0630; Fukuyama, Hidehiro/0000-0002-6457-0630; Nagata, Shigekazu/0000-0001-9758-8426; Kawane, Kohki/0000-0003-1125-9483				ALTER BP, 1982, HEMOGLOBIN, V6, P517, DOI 10.3109/03630268209083764; Appierto V, 1997, GENE, V188, P119, DOI 10.1016/S0378-1119(96)00794-9; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Baker KP, 1998, GENE, V215, P281, DOI 10.1016/S0378-1119(98)00280-7; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; CROCKER PR, 1985, J EXP MED, V162, P993, DOI 10.1084/jem.162.3.993; DYBEDAL I, 1995, BLOOD, V86, P949; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Kondoh G, 1999, J BIOCHEM BIOPH METH, V39, P137, DOI 10.1016/S0165-022X(99)00008-1; Krieser RJ, 2000, GENE, V252, P155, DOI 10.1016/S0378-1119(00)00209-2; Lichanska AM, 1999, BLOOD, V94, P127, DOI 10.1182/blood.V94.1.127.413k07_127_138; McCall K, 1998, SCIENCE, V279, P230, DOI 10.1126/science.279.5348.230; McIlroy D, 2000, GENE DEV, V14, P549; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; PERKINS AC, 1995, NATURE, V375, P318; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; RUSSELL ES, 1974, ANN NY ACAD SCI, V241, P25, DOI 10.1111/j.1749-6632.1974.tb21864.x; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shiokawa D, 1999, NUCLEIC ACIDS RES, V27, P4083, DOI 10.1093/nar/27.20.4083; TORRIGLIA A, 1995, J BIOL CHEM, V270, P28579, DOI 10.1074/jbc.270.48.28579; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wu YC, 2000, GENE DEV, V14, P536; Yasuda T, 1998, J BIOL CHEM, V273, P2610, DOI 10.1074/jbc.273.5.2610; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	25	282	295	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1546	1549		10.1126/science.292.5521.1546	http://dx.doi.org/10.1126/science.292.5521.1546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375492				2022-12-01	WOS:000168963800045
J	Yamada, K; Ji, JJ; Yuan, HJ; Miki, T; Sato, S; Horimoto, N; Shimizu, T; Seino, S; Inagaki, N				Yamada, K; Ji, JJ; Yuan, HJ; Miki, T; Sato, S; Horimoto, N; Shimizu, T; Seino, S; Inagaki, N			Protective role ob ATP-sensitive potassium channels in hypoxia-induced generalized seizure	SCIENCE			English	Article							NIGRA PARS-RETICULATA; RAT SUBSTANTIA-NIGRA; SULFONYLUREA RECEPTOR; BINDING-SITES; K+ CHANNELS; NEURONS; LOCALIZATION; CONDUCTANCE; DOPAMINE; ANOXIA	Adenosine triphosphate (ATP)-sensitive potassium (K-ATP) channels are activated by various metabolic stresses, including hypoxia. The substantia nigra pars reticulata (SNr), the area with the highest expression of K-ATP channels in the brain, plays a pivotal role in the control of seizures. Mutant mice lacking the Kir6.2 subunit of K-ATP channels [knockout (KO) mice] were susceptible to generalized seizures after brief hypoxia. In normal mice, SNr neuron activity was inactivated during hypoxia by the opening of the postsynaptic K-ATP channels, whereas in KO mice, the activity of these neurons was enhanced. K-ATP channels exert a depressant effect on SNr neuronal activity during hypoxia and may be involved in the nigral protection mechanism against generalized seizures.	Akita Univ, Sch Med, Dept Physiol, Akita 0108543, Japan; Akita Univ, Sch Med, Dept Psychiat, Akita 0108543, Japan; Japan Sci & Technol Corp, CREST, Akita 0108543, Japan; Chiba Univ, Grad Sch Med, Dept Cellular & Mol Biol, Chuo Ku, Chiba 2608670, Japan	Akita University; Akita University; Japan Science & Technology Agency (JST); Chiba University	Inagaki, N (corresponding author), Akita Univ, Sch Med, Dept Physiol, 1-1-1 Hondo, Akita 0108543, Japan.	inagaki@med.akita-u.ac.jp	MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626; Yuan, Hongjie/0000-0002-8127-7145; Inagaki, Nobuya/0000-0001-8261-2593				AMOROSO S, 1990, SCIENCE, V247, P852, DOI 10.1126/science.2305257; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; CHUN J, 1991, BRAIN RES, V568, P159, DOI 10.1016/0006-8993(91)91392-E; DEPAULIS A, 1994, PROG NEUROBIOL, V42, P33, DOI 10.1016/0301-0082(94)90020-5; DESARRO G, 1984, EUR J PHARMACOL, V106, P175, DOI 10.1016/0014-2999(84)90692-7; Dugan Laura L., 1999, P711; FISCH BJ, 1999, FISCH SPEHLMANS EEG, P301; HANSEN AJ, 1982, ACTA PHYSIOL SCAND, V115, P301, DOI 10.1111/j.1748-1716.1982.tb07082.x; HICKS GA, 1994, NEUROSCIENCE, V61, P285, DOI 10.1016/0306-4522(94)90231-3; IADAROLA MJ, 1982, SCIENCE, V218, P1237, DOI 10.1126/science.7146907; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Lamensdorf I, 1999, BRAIN RES, V818, P275, DOI 10.1016/S0006-8993(98)01290-6; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; MOURRE C, 1989, BRAIN RES, V486, P159, DOI 10.1016/0006-8993(89)91288-2; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; OERTEL WH, 1982, BRAIN RES BULL, V9, P463, DOI 10.1016/0361-9230(82)90155-1; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; SCHWANSTECHER C, 1993, N-S ARCH PHARMACOL, V348, P113, DOI 10.1007/BF00168546; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Stanford IM, 1996, NEUROSCIENCE, V74, P499, DOI 10.1016/0306-4522(96)00151-0; TURSKI L, 1990, BRAIN RES, V520, P232, DOI 10.1016/0006-8993(90)91710-X; Wu CW, 1996, NEUROREPORT, V7, P2513, DOI 10.1097/00001756-199611040-00022; Yamada K., UNPUB	24	272	284	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2001	292	5521					1543	1546		10.1126/science.1059829	http://dx.doi.org/10.1126/science.1059829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375491				2022-12-01	WOS:000168963800044
J	Polacek, N; Gaynor, M; Yassin, A; Mankin, AS				Polacek, N; Gaynor, M; Yassin, A; Mankin, AS			Ribosomal peptidyl transferase can withstand mutations at the putative catalytic nucleotide	NATURE			English	Article							TRANSFER-RNA; DOMAIN-V; A-SITES; P-SITES; POSITIONS; BASE; RECONSTITUTION; RESISTANCE	Peptide bond formation is the principal reaction of protein synthesis. It takes place in the peptidyl transferase centre of the large (50S) ribosomal subunit. In the course of the reaction, the polypeptide is transferred from peptidyl transfer RNA to the alpha -amino group of amino acyl-tRNA. The crystallographic structure of the 50S subunit showed no proteins within 18 Angstrom E from the active site, revealing peptidyl transferase as an RNA enzyme(1). Reported unique structural and biochemical features of the universally conserved adenine residue A2451 in 23S ribosomal RNA (Escherichia coli numbering) led to the proposal of a mechanism of rRNA catalysis that implicates this nucleotide as the principal catalytic residue(2,3). In vitro genetics allowed us to test the importance of A2451 for the overall rate of peptide bond formation. Here we report that large ribosomal subunits with mutated A2451 showed significant peptidyl transferase activity in several independent assays. Mutations at another nucleotide, G2447, which is essential to render catalytic properties to A2451 (refs 2, 3), also did not dramatically change the transpeptidation activity. As alterations of the putative catalytic residues do not severely affect the rate of peptidyl transfer the ribosome apparently promotes transpeptidation not through chemical catalysis, but by properly positioning the substrates of protein synthesis.	Univ Illinois, Ctr Pharmaceut Biotechnol MC 870, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mankin, AS (corresponding author), Univ Illinois, Ctr Pharmaceut Biotechnol MC 870, 900 S Ashland Ave, Chicago, IL 60607 USA.		Polacek, Norbert/AAV-7346-2020; Yassin, Aymen/N-8490-2016	Polacek, Norbert/0000-0001-5317-3990; Yassin, Aymen/0000-0002-4423-164X				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barta A., 2001, SCIENCE, V291, p203a, DOI [10.1126/science.291.5502.203a, DOI 10.1126/SCIENCE.291.5502.203A]; Blaha G, 2000, METHOD ENZYMOL, V317, P292; Bocchetta M, 1998, P NATL ACAD SCI USA, V95, P3525, DOI 10.1073/pnas.95.7.3525; CRICK FHC, 1976, ORIGINS LIFE EVOL B, V7, P389, DOI 10.1007/BF00927934; Green J, 1996, AEROSPACE, V23, P2; Green R, 1997, J MOL BIOL, V266, P40, DOI 10.1006/jmbi.1996.0780; Green R, 1999, BIOCHEMISTRY-US, V38, P1772, DOI 10.1021/bi982246a; HART HE, 1979, MOL IMMUNOL, V16, P265, DOI 10.1016/0161-5890(79)90065-8; KEARSEY SE, 1981, NATURE, V290, P607, DOI 10.1038/290607a0; Khaitovich P, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P229; Khaitovich P, 1999, BIOCHEMISTRY-US, V38, P1780, DOI 10.1021/bi9822473; Khaitovich P, 1999, RNA, V5, P605, DOI 10.1017/S1355838299990295; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Krayevsky A A, 1979, Prog Nucleic Acid Res Mol Biol, V23, P1; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MONRO RE, 1967, J MOL BIOL, V25, P347, DOI 10.1016/0022-2836(67)90146-5; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nierhaus K.H., 1990, RIBOSOMES PROTEIN SY, P161; NIERHAUS KH, 1980, BIOCHEM INT, V1, P185; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; OCONNOR M, 1993, P NATL ACAD SCI USA, V90, P9214, DOI 10.1073/pnas.90.19.9214; PORSE BT, 1995, J MOL BIOL, V249, P1, DOI 10.1006/jmbi.1995.0276; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; STEINER G, 1988, EMBO J, V7, P3949, DOI 10.1002/j.1460-2075.1988.tb03281.x; SWANEY SM, 1998, 38 INT C ANT AG CHEM, pC104; Xiong LQ, 2000, J BACTERIOL, V182, P5325, DOI 10.1128/JB.182.19.5325-5331.2000; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhang BL, 1997, NATURE, V390, P96, DOI 10.1038/36375	30	154	165	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					498	501		10.1038/35078113	http://dx.doi.org/10.1038/35078113			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373685				2022-12-01	WOS:000168858700054
J	Plaster, NM; Tawil, R; Tristani-Firouzi, M; Canun, S; Bendahhou, S; Tsunoda, A; Donaldson, MR; Iannaccone, ST; Brunt, E; Barohn, R; Clark, J; Deymeer, F; George, AL; Fish, FA; Hahn, A; Nitu, A; Ozdemir, C; Serdaroglu, P; Subramony, SH; Wolfe, G; Fu, YH; Ptacek, LJ				Plaster, NM; Tawil, R; Tristani-Firouzi, M; Canun, S; Bendahhou, S; Tsunoda, A; Donaldson, MR; Iannaccone, ST; Brunt, E; Barohn, R; Clark, J; Deymeer, F; George, AL; Fish, FA; Hahn, A; Nitu, A; Ozdemir, C; Serdaroglu, P; Subramony, SH; Wolfe, G; Fu, YH; Ptacek, LJ			Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome	CELL			English	Article							HYPOKALEMIC PERIODIC PARALYSIS; RECTIFIER POTASSIUM CHANNEL; LONG QT SYNDROME; FUNCTIONAL EXPRESSION; K+ CHANNEL; CARDIAC-ARRHYTHMIA; MOLECULAR-CLONING; GENE; INACTIVATION; SUBUNITS	Andersen's syndrome is characterized by periodic paralysis, cardiac arrhythmias, and dysmorphic features. We have mapped an Andersen's locus to chromosome 17q23 (maximum LOD = 3.23 at theta = 0) near the inward rectifying potassium channel gene KCNJ2. A missense mutation in KCNJ2 (encoding D71V) was identified in the linked family. Eight additional mutations were identified in unrelated patients. Expression of two of these mutations in Xenopus oocytes revealed loss of function and a dominant negative effect in Kir2.1 current as assayed by voltage-clamp. We conclude that mutations in Kir2.1 cause Andersen's syndrome. These findings suggest that Kir2.1 plays an important role in developmental signaling in addition to its previously recognized function in controlling cell excitability in skeletal muscle and heart.	Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA; Univ Rochester, Sch Med, Rochester, NY 14642 USA; Hosp Gen Dr Manuel Gea Gonzalez, Dept Genet, Mexico City 14000, DF, Mexico; Texas Scottish Rite Hosp Children, Dept Neurol, Dallas, TX 75219 USA; Univ Groningen, Univ Med Ctr Groningen, Acad Ziekenhuis Groningen, Neurol Klin, NL-9700 RB Groningen, Netherlands; Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; Childrens Hosp, Med Ctr, Akron, OH 44308 USA; Istanbul Univ, Tip Fak, Noroloji Anabilim, TR-34390 Istanbul, Turkey; Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA; London Hlth Sci Ctr, Dept Clin & Neurol Sci, London, ON N6A 4GA, Canada; Indiana Univ, Med Ctr, Dept Neurol, Indianapolis, IN 46202 USA; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Rochester; Texas Scottish Rite Hospital for Children; University of Groningen; University of Kansas; University of Kansas Medical Center; Akron Children's Hospital; Istanbul University; Vanderbilt University; London Health Sciences Centre; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ptacek, LJ (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	ptacek@genetics.utah.edu	Wolfe, Gil/AAO-2786-2020	, Piraye/0000-0001-8202-5313	NCRR NIH HHS [M01-RR00064] Funding Source: Medline; NINDS NIH HHS [NS38616] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038616] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Canun S, 1999, AM J MED GENET, V85, P147, DOI 10.1002/(SICI)1096-8628(19990716)85:2<147::AID-AJMG9>3.0.CO;2-0; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Derst C, 1997, BIOCHEM BIOPH RES CO, V230, P641, DOI 10.1006/bbrc.1996.6024; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Fouad G, 1997, NEUROMUSCULAR DISORD, V7, P33, DOI 10.1016/S0960-8966(96)00401-4; HOROWICZ P, 1994, MYOLOGY BASIC CLIN, P405; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; JEN J, 2001, METABOLIC MOL BASES, P5223; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; KANNEL WB, 1987, AM HEART J, V113, P799, DOI 10.1016/0002-8703(87)90722-8; Karschin C, 1997, MOL CELL NEUROSCI, V10, P131, DOI 10.1006/mcne.1997.0655; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARTIN AB, 1995, AM J CARDIOL, V75, P950, DOI 10.1016/S0002-9149(99)80697-3; MCMANIS PG, 1986, MUSCLE NERVE, V9, P704, DOI 10.1002/mus.880090805; MORISHIGE KI, 1994, FEBS LETT, V346, P251, DOI 10.1016/0014-5793(94)00483-8; Nakamura TY, 1998, AM J PHYSIOL-HEART C, V274, pH892, DOI 10.1152/ajpheart.1998.274.3.H892; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; PATIL N, 1995, NAT GENET, V11, P126, DOI 10.1038/ng1095-126; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1994, CELL, V77, P863; RAABGRAHAM KF, 1994, NEUROREPORT, V5, P2501, DOI 10.1097/00001756-199412000-00024; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; Ruff RL, 2000, P NATL ACAD SCI USA, V97, P9832, DOI 10.1073/pnas.170293197; Ruff RL, 1999, NEUROLOGY, V53, P1556, DOI 10.1212/WNL.53.7.1556; Ruff RL, 2000, NEUROLOGY, V54, P2191, DOI 10.1212/WNL.54.11.2191; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 2000, CARDIAC ELECTROPHYSI, P79; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; TAWIL R, 1994, ANN NEUROL, V35, P326, DOI 10.1002/ana.410350313; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Topert C, 1998, J NEUROSCI, V18, P4096; Tricarico D, 1999, J CLIN INVEST, V103, P675, DOI 10.1172/JCI4552; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; Tucker SJ, 1999, J BIOL CHEM, V274, P33393, DOI 10.1074/jbc.274.47.33393; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WIBLE BA, 1995, CIRC RES, V76, P343, DOI 10.1161/01.RES.76.3.343; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	48	686	722	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 18	2001	105	4					511	519		10.1016/S0092-8674(01)00342-7	http://dx.doi.org/10.1016/S0092-8674(01)00342-7			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	434XG	11371347	Bronze			2022-12-01	WOS:000168840700010
J	Barbraud, C; Weimerskirch, H				Barbraud, C; Weimerskirch, H			Emperor penguins and climate change	NATURE			English	Article							SEA-ICE EXTENT; SOUTHERN-OCEAN; APTENODYTES-FORSTERI; MARKED ANIMALS; ANTARCTICA; SURVIVAL; POPULATIONS; TEMPERATURE; TRENDS; WINTER	Variations in ocean-atmosphere coupling over time in the Southern Ocean(1-3) have dominant effects on sea-ice extent and ecosystem structure(4-6), but the ultimate consequences of such environmental changes for large marine predators cannot be accurately predicted because of the absence of long-term data series on key demographic parameters(7,8). Here, we use the longest time series available on demographic parameters of an Antarctic large predator breeding on fast ice(9,10) and relying on food resources from the Southern Ocean(11). We show that over the past 50 years, the population of emperor penguins (Aptenodytes forsteri) in Terre Adelie has declined by 50% because of a decrease in adult survival during the late 1970s. At this time there was a prolonged abnormally warm period with reduced sea-ice extent. Mortality rates increased when warm sea-surface temperatures occurred in the foraging area and when annual sea-ice extent was reduced, and were higher for males than for females. In contrast with survival, emperor penguins hatched fewer eggs when winter sea-ice was extended. These results indicate strong and contrasting effects of large-scale oceanographic processes and sea-ice extent on the demography of emperor penguins, and their potential high susceptibility to climate change.	CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Barbraud, C (corresponding author), CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France.		Barbraud, Christophe/A-5870-2012; Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019	Barbraud, Christophe/0000-0003-0146-212X; Weimerskirch, Henri/0000-0002-0457-586X				AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; ANCEL A, 1992, NATURE, V360, P336, DOI 10.1038/360336a0; Cherel Y, 1998, MAR BIOL, V130, P335, DOI 10.1007/s002270050253; CROXALL JP, 1992, PHILOS T ROY SOC B, V338, P319, DOI 10.1098/rstb.1992.0152; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; *ECMWF WCRP, 1993, GLOB ATM DAT ARCH; Furness R.W., 1993, BIRDS MONITORS ENV C; Isenmann P., 1971, Oiseau, V41, P9; JOUVENTIN P, 1974, BIOL PENGUINS, P435; Kirkwood R, 1997, ECOL MONOGR, V67, P155, DOI 10.1890/0012-9615(1997)067[0155:TFEOFE]2.0.CO;2; Kooyman GL, 2000, MAR ECOL PROG SER, V204, P269, DOI 10.3354/meps204269; KUKLA G, 1981, SCIENCE, V214, P497, DOI 10.1126/science.214.4520.497; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LEBRETON JD, 1991, BIRD POPULATION STUD, P103; LEMAHO Y, 1977, AM SCI, V65, P680; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; NICHOLS JD, 1992, BIOSCIENCE, V42, P94, DOI 10.2307/1311650; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; OFFREDO C, 1986, IBIS, V128, P409, DOI 10.1111/j.1474-919X.1986.tb02690.x; Pakhomov EA, 1996, POLAR BIOL, V16, P271, DOI 10.1007/s003000050054; PARKINSON CL, 1994, J GEOPHYS RES-OCEANS, V99, P16327, DOI 10.1029/94JC01146; PREVOST J, 1965, ECOLOGIE MANCHOT EMP; REYNOLDS RW, 1993, J CLIMATE, V6, P114, DOI 10.1175/1520-0442(1993)006<0114:AIRTGS>2.0.CO;2; Siriwardena GM, 1999, IBIS, V141, P621, DOI 10.1111/j.1474-919X.1999.tb07370.x; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0; Williams T.D., 1995, PENGUINS	29	280	292	14	361	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2001	411	6834					183	186		10.1038/35075554	http://dx.doi.org/10.1038/35075554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	430FC	11346792				2022-12-01	WOS:000168563000047
J	Laine, C; Hauck, WW; Gourevitch, MN; Rothman, J; Cohen, A; Turner, BJ				Laine, C; Hauck, WW; Gourevitch, MN; Rothman, J; Cohen, A; Turner, BJ			Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-EFFECTIVENESS; METHADONE-MAINTENANCE; SUBSTANCE-ABUSE; COMPLICATIONS; PREDICTORS; PROGRESSION; RETENTION; OUTCOMES; ALCOHOL; DISEASE	Context Patients and the public could benefit from identification of factors that prevent drug users' heavy reliance on inpatient care; however, optimal health care delivery models for illicit drug users remain ill-defined. Objective To evaluate associations of outpatient medical and drug abuse care with drug users' subsequent hospitalization rates. Design and Setting Retrospective cohort study of data from longitudinally linked claims for all ambulatory physician/clinic services and drug abuse services covered by the New York State Medicaid program. Subjects A total of 11 556 human immunodeficiency virus (HIV)-positive and 46687 HIV-negative drug users. Main Outcome Measures Hospitalization in federal fiscal year (FFY) 1997 compared by 4 patterns of care in FFY 1996. regular drug abuse care (greater than or equal to6 months in 1 program), regular medical care (>35% of care from 1 clinic, group practice, or individual physician), both, or neither. Results Hospitalization occurred in 55.6% of HIV-positive and 37.5% of HIV-negative drug users, with a mean of 27.5 and 24.5 inpatient days, respectively. In HIV-positive drug users, the adjusted odds ratio (AOR) for hospitalization was lowest among those with both regular medical and drug abuse care (AOR, 0.76; 95% confidence interval [CI], 0.67-0.85) followed by those with regular medical care alone (AOR, 0.82; 95% CI, 0.74-0.91) and regular drug abuse care alone (AOR, 0.85; 95% CI, 0.76-0.96) vs those with neither. In HIV-negative drug users, the AOR of hospitalization was lower for those with regular medical and drug abuse care (AOR, 0.73; 95% CI, 0.68-0.79), regular drug abuse care alone (AOR, 0.71; 95% CI, 0.66-0.76), and regular medical care (AOR, 0.91; 95% CI, 0.86-0.95) vs those with neither. Both types of care showed favorable effects for all but drug abuse-related hospitalizations. Conclusion Our data indicate that regular drug abuse care with regular medical care for drug users is associated with less subsequent hospitalization.	Univ Penn, Div Gen Internal Med, Sch Med, Philadelphia, PA 19104 USA; Thomas Jefferson Univ, Jefferson Med Coll, Div Internal Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Ctr Res Med Educ & Hlth Care, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Div Clin Pharmacol, Philadelphia, PA 19107 USA; New York State Dept Hlth, AIDS Inst, Albany, NY USA; Montefiore Med Ctr, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Div Subst Abuse, Bronx, NY 10467 USA	University of Pennsylvania; Jefferson University; Jefferson University; Jefferson University; State University of New York (SUNY) System; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Turner, BJ (corresponding author), Univ Penn, Div Gen Internal Med, Sch Med, 1122 Blockley Hall 6021,423 Guardian Dr, Philadelphia, PA 19104 USA.	bturner@mail.med.upenn.edu	Cohen, Abigail/K-9180-2013	Cohen, Abigail/0000-0002-7425-7218; Gourevitch, Marc/0000-0001-6865-2126	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011606] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA11606] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aszalos R, 1999, J SUBST ABUSE TREAT, V17, P149, DOI 10.1016/S0740-5472(98)00075-0; Ball J. C., 1991, EFFECTIVENESS METHAD; Barnett PG, 1999, ADDICTION, V94, P479, DOI 10.1046/j.1360-0443.1999.9444793.x; BATKI SL, 1996, 11 INT C AIDS JUL 7; Brettle RP, 1996, INT J STD AIDS, V7, P151, DOI 10.1258/0956462961917483; CHERUBIN CE, 1993, ANN INTERN MED, V119, P1017, DOI 10.7326/0003-4819-119-10-199311150-00009; Chou CP, 1998, SUBST USE MISUSE, V33, P2281, DOI 10.3109/10826089809056258; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Etheridge RM, 1999, DRUG ALCOHOL DEPEN, V57, P99, DOI 10.1016/S0376-8716(99)00087-3; Ettner SL, 1999, MED CARE, V37, P547, DOI 10.1097/00005650-199906000-00004; Fanning TR, 1995, AIDS PUBLIC POLICY J, V10, P39; FLEISHMAN JA, 1994, HEALTH SERV RES, V29, P527; FOX K, 1995, AM J PUBLIC HEALTH, V85, P48, DOI 10.2105/AJPH.85.1.48; French MT, 2000, SOC SCI MED, V50, P1703, DOI 10.1016/S0277-9536(99)00411-6; Gourevitch MN, 1998, INT J TUBERC LUNG D, V2, P531; Hendryx MS, 1998, ADM POLICY MENT HLTH, V25, P437, DOI 10.1023/A:1022248725615; KEYES M, 1991, J ACQ IMMUN DEF SYND, V4, P1015; KOPSTEIN A, 1992, BR J ADDICT, V87, P281; LANGE WR, 1992, POSTGRAD MED, V92, P205; LANGE WR, 1992, POSTGRAD MED, V2, P211; Magura S, 1998, ADDICTION, V93, P51, DOI 10.1046/j.1360-0443.1998.931516.x; MAKOWER RM, 1992, ARCH EMERG MED, V9, P32; MARKSON LE, 1994, HLTH CARE FINANC REV, V15, P1; MOOS RH, 1994, J STUD ALCOHOL, V55, P561, DOI 10.15288/jsa.1994.55.561; NEIMCRYK SJ, 1998, J COMMUNITY HLTH, V23, P137; Newschaffer CJ, 1998, J URBAN HEALTH, V75, P153, DOI 10.1007/BF02344936; Pettinati H M, 1993, Psychiatr Q, V64, P173, DOI 10.1007/BF01065868; RAWLINGS MK, 1998, INTERSCI C ANTIMICRO, V31, P38; RAWSON RA, 1995, J SUBST ABUSE TREAT, V12, P117, DOI 10.1016/0740-5472(94)00080-B; ROSS HE, 1988, ARCH GEN PSYCHIAT, V45, P1023; Samet J. H., 1996, SUBSTANCE ABUSE, V17, P181; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; SELWYN PA, 1992, NEW ENGL J MED, V327, P1697, DOI 10.1056/NEJM199212103272401; Single E, 1999, AM J PUBLIC HEALTH, V89, P385, DOI 10.2105/AJPH.89.3.385; Stein M D, 1993, J Subst Abuse, V5, P187, DOI 10.1016/0899-3289(93)90062-G; STEIN MD, 1994, J ACQ IMMUN DEF SYND, V7, P469; TURNER BJ, 1994, MED CARE, V32, P902, DOI 10.1097/00005650-199409000-00002; Turner BJ, 2000, MED CARE, V38, P911, DOI 10.1097/00005650-200009000-00005; Turner BJ, 1996, J ACQ IMMUN DEF SYND, V12, P259, DOI 10.1097/00042560-199607000-00005; Webber MP, 1998, EPIDEMIOLOGY, V9, P613, DOI 10.1097/00001648-199811000-00008; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100	41	121	121	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2001	285	18					2355	2362		10.1001/jama.285.18.2355	http://dx.doi.org/10.1001/jama.285.18.2355			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	427NB	11343483				2022-12-01	WOS:000168411200027
J	An, ZS; Kutzbach, JE; Prell, WL; Porter, SC				An, ZS; Kutzbach, JE; Prell, WL; Porter, SC			Evolution of Asian monsoons and phased uplift of the Himalayan Tibetan plateau since Late Miocene times	NATURE			English	Article							CHINESE LOESS PLATEAU; NORTHERN-HEMISPHERE; MAGNETOSTRATIGRAPHY; SEQUENCES; DEFORMATION; SENSITIVITY; GLACIATION; ATLANTIC; CLIMATE; ZONE	The climates of Asia are affected significantly by the extent and height of the Himalayan mountains and the Tibetan plateau(1-4). Uplift of this region began about 50 Myr ago, and further significant increases in altitude of the Tibetan plateau are thought to have occurred about 10-8 Myr ago(4,5), or more recently. However, the climatic consequences of this uplift remain unclear. Here we use records of aeolian sediments from China(6,7) and marine sediments from the Indian(8-10) and North Pacific oceans(11) to identify three stages of evolution of Asian climates: first, enhanced aridity in the Asian interior and onset of the Indian and east Asian monsoons, about 9-8 Myr ago; next, continued intensification of the east Asian summer and winter monsoons, together with increased dust transport to the North Pacirc Ocean(11), about 3.6-2.6 Myr ago; and last, increased variability and possible weakening of the Indian and east Asian summer monsoons and continued strengthening of the east Asian winter monsoon since about 2.6 Myr ago. The results of a numerical climate-model experiment, using idealized stepwise increases of mountain-plateau elevation, support the argument that the stages in evolution of Asian monsoons are linked to phases of Himalaya-Tibetan plateau uplift and to Northern Hemisphere glaciation.	Univ Wisconsin, Inst Environm Studies, Ctr Climat Res, Madison, WI 53706 USA; Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian 710054, Peoples R China; Brown Univ, Providence, RI 02912 USA; Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA	University of Wisconsin System; University of Wisconsin Madison; Chinese Academy of Sciences; Institute of Earth Environment, CAS; Brown University; University of Washington; University of Washington Seattle	Kutzbach, JE (corresponding author), Univ Wisconsin, Inst Environm Studies, Ctr Climat Res, 1225 W Dayton St, Madison, WI 53706 USA.	jek@facstaff.wisc.edu		an, zhi sheng/0000-0002-9538-9826				An ZS, 1999, SCI CHINA SER D, V42, P258, DOI 10.1007/BF02878963; BROCCOLI AJ, 1992, J CLIMATE, V5, P1181, DOI 10.1175/1520-0442(1992)005<1181:TEOOOM>2.0.CO;2; BURCHFIEL BC, 1991, TECTONICS, V10, P1091, DOI 10.1029/90TC02685; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chen J, 1999, QUATERNARY RES, V51, P215, DOI 10.1006/qres.1999.2038; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; ENGLAND P, 1986, J GEOPHYS RES-SOLID, V91, P3664, DOI 10.1029/JB091iB03p03664; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Kroon D., 1991, Proceedings of the Ocean Drilling Program Scientific Results, V117, P257, DOI 10.2973/odp.proc.sr.117.126.1991; KUKLA G, 1989, PALAEOGEOGR PALAEOCL, V72, P203, DOI 10.1016/0031-0182(89)90143-0; Kutzbach J.E., 1997, TECTONIC UPLIFT CLIM, P149; KUTZBACH JE, 1993, J GEOL, V101, P177, DOI 10.1086/648215; Li JJ, 1997, GEOL MIJNBOUW, V76, P121, DOI 10.1023/A:1003153717799; Ma YZ., 1998, CHINESE SCI BULL, V43, P301, DOI [10.1360/csb1998-43-3-301, DOI 10.1006/JHGE.2002.0453]; MAHER BA, 1986, PHYS EARTH PLANET IN, V42, P76, DOI 10.1016/S0031-9201(86)80010-3; Metivier F, 1998, TECTONICS, V17, P823, DOI 10.1029/98TC02764; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; PORTER SC, 1995, NATURE, V375, P305, DOI 10.1038/375305a0; Prell W L, 1997, TECTONIC UPLIFT CLIM, P172; PRELL WL, 1992, NATURE, V360, P647, DOI 10.1038/360647a0; PRELL WL, 1992, SYNTHESIS RESULTS SC, P447; QUADE J, 1989, NATURE, V342, P163, DOI 10.1038/342163a0; Ramsey M, 1997, J SOC HIST, V30, P788, DOI 10.1353/jsh/30.3.788; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; Rea DK, 1998, PALEOCEANOGRAPHY, V13, P215, DOI 10.1029/98PA00123; Royden LH, 1997, SCIENCE, V276, P788, DOI 10.1126/science.276.5313.788; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; Sun DG, 1998, GEOPHYS J INT, V134, P207, DOI 10.1046/j.1365-246x.1998.00553.x; Sun DH, 1997, SCI CHINA SER D, V40, P337, DOI 10.1007/BF02877564; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2	31	1953	2446	55	903	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 3	2001	411	6833					62	66		10.1038/35075035	http://dx.doi.org/10.1038/35075035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427XY	11333976				2022-12-01	WOS:000168432800042
J	Kramer, SG; Kidd, T; Simpson, JH; Goodman, CS				Kramer, SG; Kidd, T; Simpson, JH; Goodman, CS			Switching repulsion to attraction: Changing responses to slit during transition in mesoderm migration	SCIENCE			English	Article							AXON GUIDANCE; DROSOPHILA; CELLS; MIDLINE; CHEMOATTRACTANT; RECEPTORS; SELECTION; MUSCLES; PROTEIN	Slit is secreted by cells at the midline of the central nervous system, where it binds to Roundabout (Robo) receptors and functions as a potent repellent. We found that migrating mesodermal cells in vivo respond to Slit as both an attractant and a repellent and that Robe receptors are required for both functions. Mesoderm cells expressing Robe receptors initially migrate away from Slit at the midline. A few hours after migration, these same cells change their behavior and require Robe to extend toward Slit-expressing muscle attachment sites. Thus, Slit functions as a chemoattractant to provide specificity for muscle patterning.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 519 Life Sci Addit, Berkeley, CA 94720 USA.		Kidd, Thomas/AAT-9993-2020	Simpson, Julie/0000-0002-6793-7100; Kidd, Thomas/0000-0001-7190-4208; Kramer, Sunita/0000-0001-8372-5928	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER; NINDS NIH HHS [NS18366] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bagnard D, 1998, DEVELOPMENT, V125, P5043; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; Becker S, 1997, DEVELOPMENT, V124, P2615; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Callahan CA, 1996, DEVELOPMENT, V122, P2761; HO RK, 1983, NATURE, V301, P66, DOI 10.1038/301066a0; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KRAMER SC, UNPUB; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Su MW, 2000, DEVELOPMENT, V127, P585; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Van Vactor D, 1999, NEURON, V22, P649, DOI 10.1016/S0896-6273(00)80723-0; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wong JTW, 1997, DEVELOPMENT, V124, P3597	26	190	198	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 27	2001	292	5517					737	740		10.1126/science.1058766	http://dx.doi.org/10.1126/science.1058766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	428TX	11326102				2022-12-01	WOS:000168478300054
J	Yagita, K; Tamanini, F; van der Horst, GTJ; Okamura, H				Yagita, K; Tamanini, F; van der Horst, GTJ; Okamura, H			Molecular mechanisms of the biological clock in cultured fibroblasts	SCIENCE			English	Article							CIRCADIAN GENE-EXPRESSION; PERIPHERAL-TISSUES; OSCILLATORS; PROTEINS; TIME; DBP	In mammals, the central circadian pacemaker resides in the hypothalamic suprachiasmatic nucleus (SCN), but circadian oscillators also exist in peripheral tissues. Here, using wild-type and cryptochrome (mCry)-deficient cell Lines derived from mCry mutant mice, we show that the peripheral oscillator in cultured fibroblasts is identical to the oscillator in the SCN in (i) temporal expression profiles of all known clock genes, (ii) the phase of the various mRNA rhythms (i.e., antiphase oscillation of Bmal1 and mPer genes), (iii) the delay between maximum mRNA Levels and appearance of nuclear mPER1 and mPER2 protein, (iv) the inability to produce oscillations in the absence of functional mCry genes, and (v) the control of period Length by mCRY proteins.	Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	Kobe University; Erasmus University Rotterdam	Okamura, H (corresponding author), Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci,Chuo Ku, Kobe, Hyogo 6500017, Japan.	okamurah@kobe-u.ac.jp	Jansen, Heiko T./A-5770-2008; van der Horst, Gijsbertus TJ/E-3661-2015	Jansen, Heiko T./0000-0003-0178-396X; van der Horst, Gijsbertus TJ/0000-0002-7773-6396				Akashi M, 2000, GENE DEV, V14, P645; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; ISHIDA Y, IN PRESS J NEUROSCI; Kuwaki T, 1997, PROG NEUROBIOL, V51, P545, DOI 10.1016/S0301-0082(96)00063-9; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yagita K, 2000, GENE DEV, V14, P1353; Yamaguchi S, 2000, MOL CELL BIOL, V20, P4773, DOI 10.1128/MCB.20.13.4773-4781.2000; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Young MW, 2000, SCIENCE, V288, P451, DOI 10.1126/science.288.5465.451	21	348	362	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2001	292	5515					278	281		10.1126/science.1059542	http://dx.doi.org/10.1126/science.1059542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303101				2022-12-01	WOS:000168074000044
J	Fleming, PJ; Blair, PS; Ward, M; Tripp, J; Smith, IJ; Golding, J				Fleming, PJ; Blair, PS; Ward, M; Tripp, J; Smith, IJ; Golding, J		CESDI SUDI Res Grp	The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TETANUS-PERTUSSIS IMMUNIZATION; RISK; VACCINATION	Objectives To investigate whether the accelerated immunisation programme in the United Kingdom is associated after adjustment for potential confounding, with the sudden infant death syndrome. Design Population based case-control study; February 1993 to March 1996. Parental interviews were conducted for each death and for four controls matched fur age, locality; and time of sleep, Immunisation status was taken from records held by the parents. Setting Five regions in England with a combined population of over 17 million, Subjects Immunisation details were available for 93% (303/325) of infants whose deaths were attributed to the sudden infant death syndrome (SIDS): 90% (65/72) of infants with explained sudden deaths; and 95%, (1515//1588) of controls. Results After alt potential confounding factors were controlled for, immunisation uptake was strongly associated with a lower risk of SIDS (odds ratio 0.45 (95% confidence interval 0.24 to 0.85), This difference became non-significant (0.67; (0.31 to 1.43)) after further adjustment for other factors specific to the infant's sleeping environment. Similar proportions of SIDS deaths and reference sleeps (corresponding to the time of day during which the index baby had died) among the controls occurred within 48 hours of the last vaccination (5% (7/149) v 5% (41/822)) and within two weeks (21% (31/149) v 27% (224/822)). No longer term temporal association with immunisation was found (P = 0.78). Of the SIDS infants who died within two weeks of vaccination, 16% (5/31) had signs and symptoms of illness that suggested that medical contact was required, compared with 26% (16/61) of the non-immunised SIDS infants of similar age. The findings for the infants who died suddenly and unexpectedly but of explained causes mirrored those for SIDS infants. Conclusions Immunisation does not lead to sudden unexpected death in infancy, and the direction of the relation is towards protection rather than risk.	Royal Hosp Sick Children, Inst Child Hlth, Bristol BS2 8BJ, Avon, England; Royal Victoria Infirm, Newcastle Neonatal Serv, Ward 35, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Royal Devon & Exeter Hosp, Postgrad Med Sch, Dept Child Hlth, Exeter EX2 5DW, Devon, England; Nuffield Inst Hlth Serv, Leeds LS2 9PL, W Yorkshire, England	Bristol Royal Hospital For Children; University of Bristol; Newcastle University - UK; University of Exeter; University of Leeds	Fleming, PJ (corresponding author), Royal Hosp Sick Children, Inst Child Hlth, Bristol BS2 8BJ, Avon, England.	peter.fleming@bris.ac.uk	Fleming, Peter J/A-9081-2010; Blair, Peter S/C-1213-2009; Platt, Martin Ward/D-4008-2014; Fleming, Peter/O-3231-2019	Fleming, Peter J/0000-0003-2521-5764; Platt, Martin Ward/0000-0003-0536-5749; Fleming, Peter/0000-0003-2521-5764; Golding, Jean/0000-0003-2826-3307; Blair, Peter/0000-0002-7832-8087				BARAFF LJ, 1983, PEDIATR INFECT DIS J, V2, P7, DOI 10.1097/00006454-198301000-00003; Blair PS, 2000, ARCH DIS CHILD, V82, P462, DOI 10.1136/adc.82.6.462; Blair PS, 1999, BRIT MED J, V319, P1457, DOI 10.1136/bmj.319.7223.1457; CAMERON MH, 1986, AUST PAEDIATR J, V22, P37; DWYER T, 1995, JAMA-J AM MED ASSOC, V273, P783, DOI 10.1001/jama.273.10.783; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; FLAHAULT A, 1988, LANCET, V1, P582; Fleming P., 2000, SUDDEN UNEXPECTED DE; GRIFFIN MR, 1988, NEW ENGL J MED, V319, P618, DOI 10.1056/NEJM198809083191006; HOFFMAN HJ, 1987, PEDIATRICS, V79, P598; Hutcheson R, 1979, MMWR-MORBID MORTAL W, V28, P131; JEFFERIES S, 1991, J PUBLIC HEALTH MED, V13, P312; JONVILLEBERA AP, 1995, FUNDAM CLIN PHARM, V9, P263, DOI 10.1111/j.1472-8206.1995.tb00294.x; Leach CEA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e43; MCGLASHAN ND, 1989, SOC SCI MED, V29, P1015, DOI 10.1016/0277-9536(89)90059-2; Mitchell EA, 1995, ARCH DIS CHILD, V73, P498, DOI 10.1136/adc.73.6.498; Platt MJ, 1998, ARCH DIS CHILD, V79, P523, DOI 10.1136/adc.79.6.523; Platt MW, 2000, ARCH DIS CHILD, V82, P98, DOI 10.1136/adc.82.2.98; ROBERTS SC, 1987, ARCH DIS CHILD, V62, P754, DOI 10.1136/adc.62.7.754; *SAS I, 1992, P229 SAS I; Shann F, 1999, BRIT MED J, V319, P4, DOI 10.1136/bmj.319.7201.4; SOLBERG LK, 1985, DTP VACCINATION VISI, P1; TAYLOR EM, 1982, LANCET, V2, P721; TORCH WC, 1982, NEUROLOGY, V32, pA169; WALKER AM, 1987, AM J PUBLIC HEALTH, V77, P945, DOI 10.2105/AJPH.77.8.945	25	45	46	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2001	322	7290					822	825		10.1136/bmj.322.7290.822	http://dx.doi.org/10.1136/bmj.322.7290.822			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	421KF	11290634	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000168063000021
J	de Bruin, D; Zaman, Z; Liberatore, RA; Ptashne, M				de Bruin, D; Zaman, Z; Liberatore, RA; Ptashne, M			Telomere looping permits gene activation by a downstream UAS in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; DROSOPHILA; HETEROCHROMATIN; TRANSCRIPTION; ACETYLATION; EXPRESSION; NUCLEOSOME; PROTEIN; DNA	In yeast (Saccharomyces cerevisiae), transcriptional activators, such as Gal4 and Gal4-VP16, work ordinarily from sites located in the upstream activating sequence (UAS) positioned about 250 base pairs upstream of the transcription start site(1). In contrast to their behaviour in mammalian cells, however, such activators fail to work when positioned at distances greater than similar to 600-700 base pairs upstream(2), or anywhere downstream(3,4) of the gene. Here we show that, in yeast, a gene bearing an enhancer positioned 1-2 kilobases downstream of the gene is activated if the reporter is linked to a telomere, but not if it is positioned at an internal chromosomal locus. These observations are explained by the finding that yeast telomeres form back-folding, or looped, structures. Because yeast telomeric regions resemble the heterochromatin found in higher eukaryotes, these findings might also explain why transcription of some higher eukaryotic genes depends on their location in heterochromatin.	Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Program Mol Biol, New York, NY 10021 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	de Bruin, D (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA.							Alexandre Cyrille, 1993, Methods (Orlando), V5, P147, DOI 10.1006/meth.1993.1019; APARICIO OM, 1994, GENE DEV, V8, P1133, DOI 10.1101/gad.8.10.1133; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Boivin A, 1998, GENETICS, V150, P1539; Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; DEVLIN RH, 1990, GENETICS, V125, P129; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GUARENTE L, 1984, P NATL ACAD SCI-BIOL, V81, P7860, DOI 10.1073/pnas.81.24.7860; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; SANDELL LL, 1994, P NATL ACAD SCI USA, V91, P12061, DOI 10.1073/pnas.91.25.12061; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; STRUHL K, 1984, P NATL ACAD SCI-BIOL, V81, P7865, DOI 10.1073/pnas.81.24.7865; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x	24	118	118	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 4	2001	409	6816					109	113		10.1038/35051119	http://dx.doi.org/10.1038/35051119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343124				2022-12-01	WOS:000166175600050
J	Smith, JB; Lamanna, MC; Lacovara, KJ; Dodson, P; Smith, JR; Poole, JC; Giegengack, R; Attia, Y				Smith, JB; Lamanna, MC; Lacovara, KJ; Dodson, P; Smith, JR; Poole, JC; Giegengack, R; Attia, Y			A giant sauropod dinosaur from an Upper Cretaceous mangrove deposit in Egypt	SCIENCE			English	Article							PREDATORY DINOSAUR; SAHARA	We describe a giant titanosaurid sauropod dinosaur discovered in coastal deposits in the Upper Cretaceous Bahariya Formation of Egypt, a unit that has produced three Tyrannosaurus-sized theropods and numerous other vertebrate taxa, Paralititan stromeri is the first tetrapod reported from Bahariya since 1935. Its 1.69-meter-long humerus is Longer than that of any known Cretaceous sauropod. The autochthonous scavenged skeleton was preserved in mangrove deposits, raising the possibility that titanosaurids and their predators habitually entered such environments.	Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; Drexel Univ, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; Egyptian Geol Survey & Min Author, Egyptian Geol Museum, Cairo, Egypt	University of Pennsylvania; Drexel University; University of Pennsylvania; Drexel University	Smith, JB (corresponding author), Univ Penn, Dept Earth & Environm Sci, 240 S 33rd St, Philadelphia, PA 19104 USA.	smithjb@sas.upenn.edu	Dodson, Peter/A-9544-2009					Andrejeko M.J., 1983, TASKS VEGETATION SCI; Boureau E., 1951, CR SOMM SEANCES SOC, V7, P107; Cridland A.A., 1964, PALAEONTOLOGY, V7, P186; CURTICE BD, 1996, CONTINENTAL JURASSIC, P87; DAVIS RA, 1992, QUATERNARY COASTS US, P193; Dominik W, 1985, BERLINER GEOWISSENSC, V62, P1; Duke, 1992, TROPICAL MANGROVE EC, V41, P63, DOI DOI 10.1029/CE041P0063; Ellison AM, 1999, GLOBAL ECOL BIOGEOGR, V8, P95, DOI 10.1046/j.1466-822X.1999.00126.x; Fassell ML, 1999, GEOL S AM S, P121; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Jain SL, 1997, J VERTEBR PALEONTOL, V17, P114, DOI 10.1080/02724634.1997.10010958; Jianu CM, 1999, GEOL MIJNBOUW, V78, P335, DOI 10.1023/A:1003855416962; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Lavocat R., 1954, C GEOLOGIQUE INT ALG, V15, P65; Lydekker R., 1893, ANALES MUSEO LA PLAT, V2; Paul Gregory S., 1997, P129; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Salgado Leonardo, 1993, Ameghiniana, V30, P265; Salgado Leonardo, 1996, Ameghiniana, V33, P355; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Sampson SD, 2001, NATURE, V409, P504, DOI 10.1038/35054046; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Sereno PC, 1996, SCIENCE, V272, P986, DOI 10.1126/science.272.5264.986; Shinaq R., 1998, FREIBERGER FORSCH, V6, P39; Stromer E., 1932, ABHANDLUNGEN BAYERIS, V10, P1; STROMER E, 1936, ABH BAYER AKAD WISS, V33, P1; Taquet P, 1998, CR ACAD SCI II A, V327, P347, DOI 10.1016/S1251-8050(98)80054-2; THANIKAIMONI G, 1987, MANGROVE PALYNOLOGY, P1; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115	32	114	118	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2001	292	5522					1704	1706		10.1126/science.1060561	http://dx.doi.org/10.1126/science.1060561			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387472				2022-12-01	WOS:000169031800041
J	Szakonyi, G; Guthridge, JM; Li, DW; Young, K; Holers, VM; Chen, XJS				Szakonyi, G; Guthridge, JM; Li, DW; Young, K; Holers, VM; Chen, XJS			Structure of complement receptor 2 in complex with its C3d ligand	SCIENCE			English	Article							EPSTEIN-BARR-VIRUS; CRYSTAL-STRUCTURE; LYMPHOCYTES-B; BINDING-SITE; IMMUNE-RESPONSE; CR-2; CD21; ANTIGEN; CELLS; INFECTION	Complement receptor 2 (CR2/CD21) is an important receptor that amplifies B lymphocyte activation by bridging the innate and adaptive immune systems. CR2 Ligands include complement C3d and Epstein-Barr virus glycoprotein 350/ 220. We describe the x-ray structure of this CR2 domain in complex with C3d at 2.0 angstroms, The structure reveals extensive main chain interactions between C3d and only one short consensus repeat (SCR) of CR2 and substantial SCR side-side packing, These results provide a detailed understanding of receptor-ligand interactions in this protein family and reveal potential target sites for molecular drug design.	Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Med, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Immunol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Chen, XJS (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA.		Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263; Guthridge, Joel/0000-0002-9308-237X	NCI NIH HHS [R0-1 CA53615] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA053615] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahearn JM, 1996, IMMUNITY, V4, P251, DOI 10.1016/S1074-7613(00)80433-1; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; AUBRY JP, 1992, NATURE, V358, P505, DOI 10.1038/358505a0; BARLOW PN, 1993, J MOL BIOL, V232, P268, DOI 10.1006/jmbi.1993.1381; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BRANDEN C, 1999, INTRO PROTEIN STRUCT, P16; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAREL JC, 1990, J BIOL CHEM, V265, P12293; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; Casasnovas JM, 1999, EMBO J, V18, P2911, DOI 10.1093/emboj/18.11.2911; Clemenza L, 2000, J IMMUNOL, V165, P3839, DOI 10.4049/jimmunol.165.7.3839; Fearon DT, 1998, SEMIN IMMUNOL, V10, P355, DOI 10.1006/smim.1998.0137; FINGEROTH JD, 1984, P NATL ACAD SCI-BIOL, V81, P4510, DOI 10.1073/pnas.81.14.4510; GUTHRIDGE JM, IN PRESS BIOCHEMISTR; HEBELL T, 1991, SCIENCE, V254, P102, DOI 10.1126/science.1718035; KALLI KR, 1991, J IMMUNOL, V147, P590; LAW SKA, 1995, FOCUS SERIES; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; MARTIN DR, 1994, J VIROL, V68, P4716, DOI 10.1128/JVI.68.8.4716-4726.1994; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; MOLINA H, 1995, J IMMUNOL, V154, P5426; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; POZNANSKY MC, 1989, J IMMUNOL, V143, P1254; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Prodinger WM, 1998, J IMMUNOL, V161, P4604; RAO PE, 1985, CELL IMMUNOL, V93, P549, DOI 10.1016/0008-8749(85)90159-5; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Wiles AP, 1997, J MOL BIOL, V272, P253, DOI 10.1006/jmbi.1997.1241	29	126	145	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1725	1728		10.1126/science.1059118	http://dx.doi.org/10.1126/science.1059118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11387479				2022-12-01	WOS:000169031800048
J	Turecek, R; Trussell, LO				Turecek, R; Trussell, LO			Presynaptic glycine receptors enhance transmitter release at a mammalian central synapse	NATURE			English	Article							GAMMA-AMINOBUTYRIC ACID; RAT BRAIN-STEM; CALCIUM CURRENTS; GABA(B) RECEPTOR; BIPOLAR CELLS; NEURONS; NEUROTRANSMITTER; FACILITATION; INHIBITION; MODULATION	Glycine and GABA(A) (gamma -aminobutyric acid A) receptors are inhibitory neurotransmitter-gated Cl- channels localized in postsynaptic membranes. In some cases, GABA(A) receptors are also found presynaptically, but they retain their inhibitory effect as their activation reduces excitatory transmitter release(1-4). Here we report evidence for presynaptic ionotropic glycine receptors, using pre- and postsynaptic recordings of a calyceal synapse in the medial nucleus of the trapezoid body (MNTB). Unlike the classical action of glycine, presynaptic glycine receptors triggered a weakly depolarizing Cl- current in the nerve terminal. The depolarization enhanced transmitter release by activating Ca2+ channels and increasing resting intraterminal Ca2+ concentrations. Repetitive activation of glycinergic synapses on MNTB neurons also enhanced glutamatergic synaptic currents, indicating that presynaptic glycine receptors are activated by glycine spillover. These results reveal a novel site of action of the transmitter glycine, and indicate that under certain conditions presynaptic Cl- channels may increase transmitter release.	Oregon Hearing Res Ctr & Vollum Inst, Portland, OR 97201 USA		Trussell, LO (corresponding author), Oregon Hearing Res Ctr & Vollum Inst, L-335A,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.		Turecek, Rostislav/AAL-3523-2020; Turecek, Rostislav/H-2706-2014	Turecek, Rostislav/0000-0003-4978-7556; 				Akaike N, 1996, PROG BIOPHYS MOL BIO, V65, P251, DOI 10.1016/S0079-6107(96)00013-2; Atluri PP, 1998, J NEUROSCI, V18, P8214; BANKS MI, 1992, J NEUROSCI, V12, P2819; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Dittman JS, 1997, J NEUROSCI, V17, P9048; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; Isaacson JS, 1998, J NEUROPHYSIOL, V80, P1571, DOI 10.1152/jn.1998.80.3.1571; ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E; Martin AR, 1977, HDB PHYSL 1, V1, P329, DOI 10.1002/cphy.cp010110; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Pouzat C, 1999, J NEUROSCI, V19, P1675; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; TACHIBANA M, 1987, P NATL ACAD SCI USA, V84, P3501, DOI 10.1073/pnas.84.10.3501; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; Takahashi T, 1998, J NEUROSCI, V18, P3138; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; WU SH, 1992, J NEUROSCI, V12, P3084, DOI 10.1523/JNEUROSCI.12-08-03084.1992; ZHANG SLJ, 1995, J PHYSIOL-LONDON, V483, P583, DOI 10.1113/jphysiol.1995.sp020608	27	231	239	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 31	2001	411	6837					587	590		10.1038/35079084	http://dx.doi.org/10.1038/35079084			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	437GE	11385573				2022-12-01	WOS:000168982500052
J	Pignone, M; Mulrow, CD				Pignone, M; Mulrow, CD			Evidence based management of hypertension - Using cardiovascular risk profiles to individualise hypertensive treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Univ N Carolina, Div Gen Internal Med, Chapel Hill, NC 27599 USA; Univ Texas, Div Gen Internal Med, San Antonio, TX 78249 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System	Pignone, M (corresponding author), Univ N Carolina, Div Gen Internal Med, Chapel Hill, NC 27599 USA.	pignone@med.unc.edu		Pignone, Michael/0000-0002-6657-7342				Mulrow CD, 2001, BMJ-BRIT MED J, V322, P1107, DOI 10.1136/bmj.322.7294.1107; Padwal R, 2001, BMJ-BRIT MED J, V322, P977, DOI 10.1136/bmj.322.7292.977; PIGNONE M, 2001, EVIDENCE BASED HYPER, P117	3	21	22	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 12	2001	322	7295					1164	1166		10.1136/bmj.322.7295.1164	http://dx.doi.org/10.1136/bmj.322.7295.1164			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348913	Green Published, Green Submitted			2022-12-01	WOS:000168748900019
J	Hiraoka, K; Sato, T; Takayama, T				Hiraoka, K; Sato, T; Takayama, T			Interstellar chemistry - Tunneling reactions in interstellar ices	SCIENCE			English	Editorial Material							TEMPERATURES; ATOMS		Univ Yamanashi, Clean Energy Res Ctr, Kofu, Yamanashi 4008511, Japan	University of Yamanashi	Hiraoka, K (corresponding author), Univ Yamanashi, Clean Energy Res Ctr, Takeda 4, Kofu, Yamanashi 4008511, Japan.							Crovisier J, 1998, FARADAY DISCUSS, V109, P437, DOI 10.1039/a800079d; EHRENFREUND P, 2000, IAU S, V197, P135; GALLOWAY ET, 1989, ASTRON ASTROPHYS, V211, P413; GREENBERG JM, 1991, CHEM SPACE; HASEGAWA TI, 1992, ASTROPHYS J SUPPL S, V82, P167, DOI 10.1086/191713; Heller EJ, 1996, PHYS REV LETT, V77, P4122, DOI 10.1103/PhysRevLett.77.4122; Hiraoka K, 2000, ASTROPHYS J, V532, P1029, DOI 10.1086/308612; HIRAOKA K, 2001, RADIAT PHYS CHEM, V60, P1; Mumma MJ, 1996, SCIENCE, V272, P1310, DOI 10.1126/science.272.5266.1310; Pirronello V, 1997, ASTROPHYS J, V483, pL131, DOI 10.1086/310746; TAKAYANAGI T, 1990, J CHEM PHYS, V92, P2862, DOI 10.1063/1.457932; TIELENS AGGM, 1982, ASTRON ASTROPHYS, V114, P245; WILLIAMS DA, 1993, DUST CHEM ASTRONOMY; WOOD DE, 1996, J CHEM PHYS, V105, P9921; YANG K, 1994, J CHEM PHYS, V101, P8205, DOI 10.1063/1.468205	15	17	17	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					869	870		10.1126/science.1060837	http://dx.doi.org/10.1126/science.1060837			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11341283				2022-12-01	WOS:000168514900030
J	Tsujishita, Y; Guo, SL; Stolz, LE; York, JD; Hurley, JH				Tsujishita, Y; Guo, SL; Stolz, LE; York, JD; Hurley, JH			Specificity determinants in phosphoinositide dephosphorylation: Crystal structure of an archetypal inositol polyphosphate 5-phosphatase	CELL			English	Article							MULTIPLE ISOMORPHOUS REPLACEMENT; DNA-REPAIR; LOWE-SYNDROME; SYSTEM; FAMILY; IDENTIFICATION; MECHANISM; PROTEINS; SUGGESTS; PRODUCTS	Inositol polyphosphate 5-phosphatases are central to intracellular processes ranging from membrane trafficking to Ca2+ signaling, and defects in this activity result in the human disease Lowe syndrome. The 1.8 Angstrom resolution structure of the inositol polyphosphate 5-phosphatase domain of SPsynaptojanin bound to Ca2+ and inositol (1,4)-bisphosphate reveals a fold and an active site His and Asp pair resembling those of several Mg2+-dependent nucleases. Additional loops mediate specific inositol polyphosphate contacts. The 4-phosphate of inositol (1,4)-bisphosphate is misoriented by 4.6 Angstrom compared to the reactive geometry observed in the apurinic/apyrimidinic endonuclease 1, explaining the dephosphorylation site selectivity of the 5-phosphatases. Based on the structure, a series of mutants are described that exhibit altered substrate specificity providing general determinants for substrate recognition.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Howard Hughes Med Inst, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Duke University; Howard Hughes Medical Institute	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	jh8e@nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Drayer AL, 1996, BIOCHEM SOC T, V24, P1001, DOI 10.1042/bst0241001; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gorman MA, 1997, EMBO J, V16, P6548, DOI 10.1093/emboj/16.21.6548; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Hurley JH, 2000, CURR OPIN STRUC BIOL, V10, P737; Jefferson AB, 1996, BIOCHEMISTRY-US, V35, P7890, DOI 10.1021/bi9602627; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisseleva MV, 2000, J BIOL CHEM, V275, P20110, DOI 10.1074/jbc.M910119199; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laskowski R. A., 1993, J APPL CRYSTALLOGR, V24, P946; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Matsuo Y, 1996, PROTEIN SCI, V5, P2459, DOI 10.1002/pro.5560051208; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mitchell CA, 1996, BIOCHEM SOC T, V24, P994, DOI 10.1042/bst0240994; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Odom AR, 2000, SCIENCE, V287, P2026, DOI 10.1126/science.287.5460.2026; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; SIKORSKI RS, 1989, GENETICS, V122, P19; Spiegelberg BD, 1999, J BIOL CHEM, V274, P13619, DOI 10.1074/jbc.274.19.13619; Srinivasan S, 1997, EUR J CELL BIOL, V74, P350; Stolz LE, 1998, GENETICS, V148, P1715; SUCHY SF, 1995, HUM MOL GENET, V4, P2245, DOI 10.1093/hmg/4.12.2245; SUCK D, 1986, NATURE, V321, P620, DOI 10.1038/321620a0; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; Whisstock JC, 2000, J BIOL CHEM, V275, P37055, DOI 10.1074/jbc.M006244200; Woscholski R, 1997, TRENDS BIOCHEM SCI, V22, P427, DOI 10.1016/S0968-0004(97)01120-1; ZHANG XL, 1995, P NATL ACAD SCI USA, V92, P4853, DOI 10.1073/pnas.92.11.4853	53	103	105	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 4	2001	105	3					379	389		10.1016/S0092-8674(01)00326-9	http://dx.doi.org/10.1016/S0092-8674(01)00326-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	429KL	11348594	Bronze			2022-12-01	WOS:000168515900007
J	Weiss, SC; Emanuel, LL; Fairclough, DL; Emanuel, EJ				Weiss, SC; Emanuel, LL; Fairclough, DL; Emanuel, EJ			Understanding the experience of pain in terminally ill patients	LANCET			English	Article							COOPERATIVE-ONCOLOGY-GROUP; CANCER PAIN; OPIOID ANALGESICS; FAMILY MEMBERS; HOSPICE; CAREGIVERS; CARE	Background Terminally ill patients commonly experience substantial pain. Unresolved pain has been cited as evidence that end-of-life care is of poor quality. However, the data on which that conclusion is based are limited. We aimed to provide additional data on the experience of pain in such patients. Methods We interviewed 988 terminally ill patients from six randomly selected US sites. We asked them who had treated their pain in the previous 4 weeks (primary-care physician, pain specialist, or both), and whether they wanted more pain medication than they were receiving, or why they did not want more. Findings 496 (50%) terminally ill patients reported moderate or severe pain. 514 (52%) individuals had seen a primary-care physician for treatment of pain in the previous 4 weeks and 198 (20%) saw a pain specialist. Of those who had been treated by their primary-care physician, 287 (29%) wanted more therapy, 613 (62%) wanted their pain therapy to remain the same, and 89 (9%) wanted to reduce or stop their pain therapy. Several reasons for not wanting additional therapy were offered-fear of addiction, dislike of mental or physical side-effects, and not wanting to take more pills or injections. We saw no association between disease and amount of pain between disease and the desire for more treatment. Black patients were more likely to seek additional pain therapy, see a pain specialist, and refuse additional medication because of fear of addiction than other populations. Interpretation Although half of terminally ill patients experienced moderate to severe pain, only 30% of them wanted additional pain treatment from their primary-care physician. The number of patients experiencing pain remains too high. However, the number is not as large as perceived. Additionally, most are willing to tolerate pain. Furthermore, the experience of pain is constant across major terminal diseases.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Northwestern Univ, Sch Med, Chicago, IL USA; AMC Canc Res Ctr, Ctr Res Methodol & Biometr, Denver, CO USA	National Institutes of Health (NIH) - USA; Northwestern University; AMC Cancer Research Center	Weiss, SC (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.							Arnst C, 1999, BUS WEEK, P190; Bonica J. J., 1980, PAIN, P335; BRESCIA FJ, 1992, J CLIN ONCOL, V10, P149, DOI 10.1200/JCO.1992.10.1.149; Cleeland CS, 1997, ANN INTERN MED, V127, P813, DOI 10.7326/0003-4819-127-9-199711010-00006; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; DAUT RL, 1982, CANCER-AM CANCER SOC, V50, P1913, DOI 10.1002/1097-0142(19821101)50:9<1913::AID-CNCR2820500944>3.0.CO;2-R; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; EMANMUEL LL, IN PRESS J PALLIATIV; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Field MJ, 1997, APPROACHING DEATH IM; Foley KM, 1998, OXFORD TXB PALLIATIV, P310; Jacox A., 1994, AHCPR PUBLICATION; Joranson DE, 2000, JAMA-J AM MED ASSOC, V283, P1710, DOI 10.1001/jama.283.13.1710; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; MCKEGNEY FP, 1981, GEN HOSP PSYCHIAT, V3, P95, DOI 10.1016/0163-8343(81)90050-5; MORRIS JN, 1986, J CHRON DIS, V39, P27, DOI 10.1016/0021-9681(86)90104-9; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; OSTER MW, 1978, ARCH INTERN MED, V138, P1801, DOI 10.1001/archinte.138.12.1801; Paice JA, 1998, J PAIN SYMPTOM MANAG, V16, P1, DOI 10.1016/S0885-3924(98)00025-6; Parker RA, 1999, JAMA-J AM MED ASSOC, V281, P1937, DOI 10.1001/jama.281.20.1937; Petrosino B M, 1985, Hosp J, V1, P3; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; PORTENOY RK, 1992, CANCER, V70, P616; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; STEIN WM, 1993, J PAIN SYMPTOM MANAG, V8, P474, DOI 10.1016/0885-3924(93)90190-7; Tay W. K. J., 1994, Annals Academy of Medicine Singapore, V23, P191; TWYCROSS RG, 1982, PAIN, V14, P303, DOI 10.1016/0304-3959(82)90137-3; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; Ward SE, 1996, RES NURS HEALTH, V19, P205, DOI 10.1002/(SICI)1098-240X(199606)19:3<205::AID-NUR4>3.0.CO;2-O	31	148	151	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 28	2001	357	9265					1311	1315		10.1016/S0140-6736(00)04515-3	http://dx.doi.org/10.1016/S0140-6736(00)04515-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427ND	11343734				2022-12-01	WOS:000168411400008
J	Troy, CS; MacHugh, DE; Bailey, JF; Magee, DA; Loftus, RT; Cunningham, P; Chamberlain, AT; Sykes, BC; Bradley, DG				Troy, CS; MacHugh, DE; Bailey, JF; Magee, DA; Loftus, RT; Cunningham, P; Chamberlain, AT; Sykes, BC; Bradley, DG			Genetic evidence for Near-Eastern origins of European cattle	NATURE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; AFRICAN; SEQUENCE; SUGGESTS	The limited ranges of the wild progenitors of many of the primary European domestic species point to their origins further east in Anatolia or the fertile crescent(1,2). The wild ox (Bos primigenius), however, ranged widely(3) and it is unknown whether it was domesticated within Europe as one feature of a local contribution to the farming economy(1,2,4). Here we examine mitochondrial DNA control-region sequence variation from 392 extant animals sampled from Europe, Africa and the Near East, and compare this with data from four extinct British wild oxen. The ancient sequences cluster tightly in a phylogenetic analysis and are clearly distinct from modern cattle. Network analysis of modern Bos taurus identifies four star-like clusters of haplotypes, with intracluster diversities that approximate to that expected from the time depth of domestic history. Notably, one of these clusters predominates in Europe and is one of three encountered at substantial frequency in the Near East. In contrast, African diversity is almost exclusively composed of a separate haplogroup, which is encountered only rarely elsewhere. These data provide strong support for a derived Near-Eastern origin for European cattle.	Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland; Univ Coll Dublin, Fac Agr, Dept Anim Sci & Prod, Dublin 4, Ireland; Univ Sheffield, Dept Archaeol & Prehist, Sheffield S1 4ET, S Yorkshire, England; Univ Oxford, John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England	Trinity College Dublin; University College Dublin; University of Sheffield; University of Oxford	Bradley, DG (corresponding author), Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland.		Bradley, Daniel G/A-3240-2012; Chamberlain, Andrew T/F-2118-2018	MacHugh, David/0000-0002-8112-4704; Bradley, Daniel G/0000-0001-7335-7092				ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Bailey JF, 1996, P ROY SOC B-BIOL SCI, V263, P1467, DOI 10.1098/rspb.1996.0214; BANDELT HJ, 1995, GENETICS, V141, P743; Bokonyi S., 1974, HIST DOMESTIC ANIMAL; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Cymbron T, 1999, P ROY SOC B-BIOL SCI, V266, P597, DOI 10.1098/rspb.1999.0678; Epstein H., 1971, ORIGIN DOMESTIC ANIM; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fu YX, 1997, GENETICS, V147, P915; Harris D. R, 1996, ORIGINS SPREAD AGR P; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Macaulay V.A., 1998, CRED CREDIBLE REGION; MacHugh DE, 1999, PHILOS T ROY SOC B, V354, P99, DOI 10.1098/rstb.1999.0363; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SCHNEIDER SD, 1999, ARLEQUIN VER 2 0 SOF; Smith BD, 1995, EMERGENCE AGR; TROY CS, 1998, THESIS U DUBLIN; Wendorf F, 1998, J ANTHROPOL ARCHAEOL, V17, P97, DOI 10.1006/jaar.1998.0319; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	22	416	447	0	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1088	1091		10.1038/35074088	http://dx.doi.org/10.1038/35074088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323670				2022-12-01	WOS:000168285500046
J	Meldrum, DR				Meldrum, DR			Sequencing genomes and beyond	SCIENCE			English	Article							DNA; AUTOMATION; DEVICE; ARRAY		Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Meldrum, DR (corresponding author), Univ Washington, Dept Elect Engn, Seattle, WA 98195 USA.	deedee@kant.ee.washington.edu						BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BOGUSLAVSKY J, 2001, DRUG DISCOVERY D JAN, P71; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; CANTOR CR, 1999, GENOMICS; Deamer DW, 2000, TRENDS BIOTECHNOL, V18, P147, DOI 10.1016/S0167-7799(00)01426-8; HUNKAPILLER T, 1991, SCIENCE, V254, P59, DOI 10.1126/science.1925562; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Koutny L, 2000, ANAL CHEM, V72, P3388, DOI 10.1021/ac9913614; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; MARZIALI A, IN PRESS ANN REV BIO; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Meldrum D, 2000, GENOME RES, V10, P1081, DOI 10.1101/gr.101400; Meldrum D, 2000, GENOME RES, V10, P1288, DOI 10.1101/gr.157400; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Olson MV, 2001, NATURE, V409, P816, DOI 10.1038/35057271; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shi YN, 1999, ANAL CHEM, V71, P5354, DOI 10.1021/ac990518p; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WEBSTER JR, 1998, MICRO TOTAL ANAL SYS, P249	22	15	15	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2001	292	5516					515	+		10.1126/science.292.5516.515	http://dx.doi.org/10.1126/science.292.5516.515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423QB	11330300				2022-12-01	WOS:000168187300050
J	Smith, CI; Chamberlain, AT; Riley, MS; Cooper, A; Stringer, CB; Collins, MJ				Smith, CI; Chamberlain, AT; Riley, MS; Cooper, A; Stringer, CB; Collins, MJ			Not just old but old and cold?	NATURE			English	Article							NEANDERTHAL DNA; CLIMATE; WESTERN; EUROPE		Newcastle Univ, Fossil Fuel & Environm Geochem Postgrad Inst, NRG, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England; Univ Birmingham, Sch Earth Sci, Birmingham B15 2TT, W Midlands, England; Univ Oxford, Dept Biol Anthropol, Oxford OX2 6QS, England; Univ Oxford, Dept Zool, Oxford OX2 6QS, England; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Newcastle University - UK; University of Sheffield; University of Birmingham; University of Oxford; University of Oxford; Natural History Museum London	Collins, MJ (corresponding author), Newcastle Univ, Fossil Fuel & Environm Geochem Postgrad Inst, NRG, Drummond Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	m.collins@ncl.ac.uk	Chamberlain, Andrew T/F-2118-2018; Cooper, Alan/E-8171-2012; Smith, Colin/A-9150-2008; Riley, Michael S/G-2295-2014	Cooper, Alan/0000-0002-7738-7851; Smith, Colin/0000-0001-5901-8780; Collins, Matthew/0000-0003-4226-5501				Cooper A, 1996, NATURE, V381, P484, DOI 10.1038/381484a0; Cooper A, 1997, SCIENCE, V277, P1021; Elias SA, 2000, QUATERNARY RES, V53, P229, DOI 10.1006/qres.1999.2093; Fleischer RC, 2000, AUK, V117, P1051, DOI 10.1642/0004-8038(2000)117[1051:IOTEHE]2.0.CO;2; GUIOT J, 1993, PALAEOGEOGR PALAEOCL, V103, P73, DOI 10.1016/0031-0182(93)90053-L; HOSS M, 1994, NATURE, V370, P333, DOI 10.1038/370333a0; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Osborne MR, 2000, CHEM RES TOXICOL, V13, P257, DOI 10.1021/tx990182e; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Vandenberghe J, 1998, J QUATERNARY SCI, V13, P361, DOI 10.1002/(SICI)1099-1417(1998090)13:5<361::AID-JQS404>3.0.CO;2-O; Vercauteren M., 1997, ANC BIOMOL, V1, P109; Zhang T, 1997, PERMAFROST PERIGLAC, V8, P45, DOI 10.1002/(SICI)1099-1530(199701)8:1&lt;45::AID-PPP240&gt;3.0.CO;2-K	14	117	120	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2001	410	6830					771	772		10.1038/35071177	http://dx.doi.org/10.1038/35071177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420TT	11298436	Green Accepted, Green Published			2022-12-01	WOS:000168021900042
J	Amara, RR; Villinger, F; Altman, JD; Lydy, SL; O'Neil, SP; Staprans, SI; Montefiori, DC; Xu, Y; Herndon, JG; Wyatt, LS; Candido, MA; Kozyr, NL; Earl, PL; Smith, JM; Ma, HL; Grimm, BD; Hulsey, ML; Miller, J; McClure, HM; McNicholl, JM; Moss, B; Robinson, HL				Amara, RR; Villinger, F; Altman, JD; Lydy, SL; O'Neil, SP; Staprans, SI; Montefiori, DC; Xu, Y; Herndon, JG; Wyatt, LS; Candido, MA; Kozyr, NL; Earl, PL; Smith, JM; Ma, HL; Grimm, BD; Hulsey, ML; Miller, J; McClure, HM; McNicholl, JM; Moss, B; Robinson, HL			Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine	SCIENCE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RHESUS-MONKEYS; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS; PATHOGENIC SIV; INFECTION; REPLICATION; RESPONSES; TYPE-1; ASSAY	Heterologous prime/boost regimens have the potential for raising high Levels of immune responses. Here we report that DNA priming followed by a recombinant modified vaccinia Ankara (rMVA) booster controlled a highly pathogenic immunodeficiency virus challenge in a rhesus macaque model. Both the DNA and rMVA components of the vaccine expressed multiple immunodeficiency virus proteins. Two DNA inoculations at 0 and 8 weeks and a single rMVA booster at 24 weeks effectively controlled an intrarectal challenge administered 7 months after the booster. These findings provide hope that a relatively simple multiprotein DNA/MVA vaccine can help to control the acquired immune deficiency syndrome epidemic.	Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Sch Med, Vaccine Res Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; Ctr Dis Control & Prevent, Div AIDS STD & TB Lab Res, Natl Ctr Infect Dis, Atlanta, GA 30330 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Centers for Disease Control & Prevention - USA	Robinson, HL (corresponding author), Emory Univ, Vaccine Res Ctr, Atlanta, GA 30329 USA.	hrobins@rmy.emory.edu	Amara, Rama/AAO-8136-2021	Moss, Bernard/0000-0002-2154-8564	NCRR NIH HHS [P51 RR000165] Funding Source: Medline; NIAID NIH HHS [P01 AI 43045] Funding Source: Medline; NIDA NIH HHS [P30 DA 12121] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000416, ZIAAI000416, P01AI043045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012121] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Egan MA, 2000, J VIROL, V74, P7485, DOI 10.1128/JVI.74.16.7485-7495.2000; Gorelick RJ, 1999, VIROLOGY, V253, P259, DOI 10.1006/viro.1998.9513; Goulder PJR, 1999, AIDS, V13, pS121; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Karlsson GB, 1997, J VIROL, V71, P4218, DOI 10.1128/JVI.71.6.4218-4225.1997; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; MONTEFIORI DC, 1988, J CLIN MICROBIOL, V26, P231, DOI 10.1128/JCM.26.2.231-235.1988; Montefiori DC, 1998, J VIROL, V72, P3427, DOI 10.1128/JVI.72.4.3427-3431.1998; Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000; Power CA, 1999, J IMMUNOL METHODS, V227, P99, DOI 10.1016/S0022-1759(99)00074-5; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Robinson HL, 1999, NAT MED, V5, P526, DOI 10.1038/8406; Robinson R, 2000, J GEOPHYS RES-SOL EA, V105, P16139, DOI 10.1029/2000JB900012; Sauter MM, 1996, J CELL BIOL, V132, P795, DOI 10.1083/jcb.132.5.795; Staprans Silvija I., 1996, P167; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338	19	971	1036	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					69	74		10.1126/science.1058915	http://dx.doi.org/10.1126/science.1058915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11393868				2022-12-01	WOS:000167995200037
J	Cantor, SB; Bell, DW; Ganesan, S; Kass, EM; Drapkin, R; Grossman, S; Wahrer, DCR; Sgroi, DC; Lane, WS; Haber, DA; Livingston, DM				Cantor, SB; Bell, DW; Ganesan, S; Kass, EM; Drapkin, R; Grossman, S; Wahrer, DCR; Sgroi, DC; Lane, WS; Haber, DA; Livingston, DM			BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; RNA-POLYMERASE-II; DOUBLE-STRAND BREAKS; MAMMALIAN-CELLS; TRANSCRIPTIONAL ACTIVATION; BASAL TRANSCRIPTION; DAMAGE RESPONSE; MEIOTIC CELLS; YEAST RAD3; TFIIH	BRCA1 interacts in vivo with a novel protein, BACH1, a member of the DEAH helicase family. BACH1 binds directly to the BRCT repeats of BRCA1.A BACH1 derivative, bearing a mutation in a residue that was essential for catalytic function in other helicases, interfered with normal double-strand break repair in a manner that was dependent on its BRCA1 binding function. Thus, BACH1/BRCA1 complex formation contributes to a key BRCA1 activity. In addition, germline BACH1 mutations affecting the helicase domain were detected in two early-onset breast cancer patients and not in 200 matched controls. Thus, it is conceivable that, like BRCA1, BACH1 is a target of germline cancer-inducing mutations.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc Risk Anal, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Harvard Univ, Microchem & Proteom Anal Facil, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Livingston, DM (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	david_livingston@dfci.harvard.edu	Sgroi, Dennis/AAV-2487-2021; Drapkin, Ronny/E-9944-2016	Drapkin, Ronny/0000-0002-6912-6977	NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA89393] Funding Source: Medline; NHLBI NIH HHS [T32 HL07627-16] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amann J, 1997, J BIOL CHEM, V272, P3823, DOI 10.1074/jbc.272.6.3823; BADIE C, 1995, RADIAT RES, V144, P26, DOI 10.2307/3579232; BLANAR MA, 1992, SCIENCE, V256, P1014, DOI 10.1126/science.1589769; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Callahan R, 1998, BIOCHEM SOC SYMP, P211; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; Cleaver JE, 2000, J DERMATOL SCI, V23, P1, DOI 10.1016/S0923-1811(99)00088-2; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Deng CX, 2000, BIOESSAYS, V22, P728; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FRIEDBERG EC, 1995, PHILOS T ROY SOC B, V347, P63, DOI 10.1098/rstb.1995.0010; Hoeijmakers JHJ, 1996, CURR OPIN GENET DEV, V6, P26, DOI 10.1016/S0959-437X(96)90006-4; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; Kiltie AE, 1997, NUCLEIC ACIDS RES, V25, P2945, DOI 10.1093/nar/25.14.2945; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; MA LB, 1994, MOL CELL BIOL, V14, P4126, DOI 10.1128/MCB.14.6.4126; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; OHKUMA Y, 1994, NATURE, V368, P160, DOI 10.1038/368160a0; Prakash L, 1989, Ann Ist Super Sanita, V25, P99; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; Schmekel K, 1996, EXP CELL RES, V226, P20, DOI 10.1006/excr.1996.0198; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1996, SCIENCE, V272, P123, DOI 10.1126/science.272.5258.123; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; SERIZAWA H, 1994, J BIOL CHEM, V269, P20750; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Tomlinson GE, 1998, CANCER RES, V58, P3237; Vermeulen W, 1997, BIOCHEM SOC T, V25, P309, DOI 10.1042/bst0250309; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Wang Y, 2000, GENE DEV, V14, P927; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wood RD, 1999, BIOCHIMIE, V81, P39, DOI 10.1016/S0300-9084(99)80036-4; WU X, 2000, SCIENCE, V289, pA11; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zabludoff SD, 1996, ONCOGENE, V13, P649; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	58	510	529	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 6	2001	105	1					149	160		10.1016/S0092-8674(01)00304-X	http://dx.doi.org/10.1016/S0092-8674(01)00304-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	421KJ	11301010	Bronze			2022-12-01	WOS:000168063300015
J	Ernest, SKM; Brown, JH				Ernest, SKM; Brown, JH			Delayed compensation for missing keystone species by colonization	SCIENCE			English	Article							DESERT RODENT COMMUNITY; PLANT-COMMUNITIES; LONG-TERM; ECOSYSTEM; BIODIVERSITY; DIVERSITY; COMPETITION; GRASSLANDS; EXTINCTION; STABILITY	Because individual species can play key roles, the Loss of species through extinction OF their gain through colonization can cause major changes in ecosystems. For almost 20 years after kangaroo rats were experimentally removed from a Chihuahuan desert ecosystem in the United States, other rodent species were unable to compensate and use the available resources. This changed abruptly in 1995, when an alien species of pocket mouse colonized the ecosystem, used most of the available resources, and compensated almost completely for the missing kangaroo rats. These results demonstrate the importance of individual species and of colonization and extinction events in the structure and dynamics of ecosystems.	Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Ernest, SKM (corresponding author), Texas Tech Univ, Dept Biol Sci, Program Ecol, Lubbock, TX 79409 USA.	morgan.ernest@ttu.edu	Ernest, S.K. Morgan/O-2532-2015; Ernest, Morgan/A-4355-2008	Ernest, S.K. Morgan/0000-0002-6026-8530; Ernest, Morgan/0000-0002-6026-8530				[Anonymous], COMMUNITY ECOLOGY; Bond WJ, 1994, BIODIVERSITY ECOSYST, P237, DOI [DOI 10.1890/0012-9658(1997)0781531:EOROSO2.0.CO;2, 10.1007/978-3-642-58001-7_11, DOI 10.1007/978-3-642-58001-7_11]; BROWN JH, 1985, ECOLOGY, V66, P1545, DOI 10.2307/1938017; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; Calder W. A, 1984, SIZE FUNCTION LIFE H; Davis M.B., 1986, COMMUNITY ECOL, P269; FRANK DA, 1991, OIKOS, V62, P360, DOI 10.2307/3545501; GELUSO K, UNPUB; Gilbert L. E., 1980, Conservation biology. An evolutionary-ecological perspective., P11; Guo QF, 1996, OECOLOGIA, V107, P568, DOI 10.1007/BF00333950; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; HESKE EJ, 1994, ECOLOGY, V75, P438, DOI 10.2307/1939547; Hoffmeister D. F., 1986, MAMMALS ARIZONA; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; MITTELBACH GG, 1995, ECOLOGY, V76, P2347, DOI 10.2307/2265812; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; PRICE MV, 1978, ECOLOGY, V59, P910, DOI 10.2307/1938543; PULLIAM HR, 1975, ECOLOGY, V56, P1158, DOI 10.2307/1936155; REICHMAN OJ, 1975, J MAMMAL, V56, P731, DOI 10.2307/1379649; ROSENZWEIG ML, 1969, ECOLOGY, V50, P558, DOI 10.2307/1936246; Schmidt-Neilsen K, 1984, SCALING WHY IS ANIMA; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; VALONE TJ, 1995, SCIENCE, V267, P880, DOI 10.1126/science.7846530; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731	30	70	72	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					101	104						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292873				2022-12-01	WOS:000167995200047
J	Schwetz, BA				Schwetz, BA			Safety of aristolochic acid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	33	33	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2001	285	21					2705	2705						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	437HG	11386912				2022-12-01	WOS:000168985800004
J	Engelhardt, KAM; Ritchie, ME				Engelhardt, KAM; Ritchie, ME			Effects of macrophyte species richness on wetland ecosystem functioning and services	NATURE			English	Article							PLANT DIVERSITY; BIODIVERSITY; PRODUCTIVITY; PHOSPHORUS; PATTERNS; DISTURBANCE; GRASSLANDS; EPIPHYTES; REGIMES; ALGAE	Wetlands provide many important ecosystem services to human society(1-5), which may depend on how plant diversity influences biomass production and nutrient retention(4,6-8). Vascular aquatic plant diversity may not necessarily enhance wetland ecosystem functioning, however, because competition among these plant species can be strong, often resulting in the local dominance of a single species(4,9). Here we have manipulated the species richness of rooted, submerged aquatic plant (macrophyte) communities in experimental wetland mesocosms. We found higher algal and total plant (algal plus macrophyte) biomass, as well as lower loss of total phosphorus, in mesocosms with a greater richness of macrophyte species. Greater plant biomass resulted from a sampling effect; that is, the increased chance in species mixtures that algal production would be facilitated by the presence of a less competitive species-in this case, crisped pondweed. Lower losses of total phosphorus resulted from the greater chance in species mixtures of a high algal biomass and the presence of sago pondweed, which physically filter particulate phosphorus from the water(2,10,11). These indirect and direct effects of macrophyte species richness on algal production, total plant biomass and phosphorus loss suggest that management practices that maintain macrophyte diversity may enhance the functioning and associated services of wetland ecosystems.	Utah State Univ, Dept Fisheries & Wildlife, Logan, UT 84322 USA; Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Engelhardt, KAM (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Soil & Water Conservat Res Lab, 301 Braddock Rd, Frostburg, MD 21532 USA.		Engelhardt, Katharina AM/H-8755-2013					Bedford BL, 1999, ECOLOGY, V80, P2151, DOI 10.1890/0012-9658(1999)080[2151:PINAAP]2.0.CO;2; BUNN SE, 1993, OECOLOGIA, V96, P85, DOI 10.1007/BF00318034; BURKHOLDER JM, 1990, LIMNOL OCEANOGR, V35, P736, DOI 10.4319/lo.1990.35.3.0736; BURKHOLDER JM, 1989, J PHYCOL, V25, P55, DOI 10.1111/j.0022-3646.1989.00055.x; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Fischer JM, 2000, ESTUARIES, V23, P565, DOI 10.2307/1353146; Grace James B., 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P1, DOI 10.1078/1433-8319-00063; HARGEBY A, 1994, HYDROBIOLOGIA, V279, P83, DOI 10.1007/BF00027843; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Jeppesen E, 1999, HYDROBIOLOGIA, V395, P419, DOI 10.1023/A:1017071602549; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Mitsch W. J, 2011, WETLANDS; MITSCH WJ, 1995, ECOL APPL, V5, P830, DOI 10.2307/1941991; MOELLER RE, 1988, AQUAT BOT, V32, P261, DOI 10.1016/0304-3770(88)90120-9; NAEEM S, 1995, PHILOS T R SOC B, V347, P249, DOI 10.1098/rstb.1995.0025; Pollock MM, 1998, ECOLOGY, V79, P94; Robinson GGC, 1997, WETLANDS, V17, P182, DOI 10.1007/BF03161408; Symstad AJ, 1998, OIKOS, V81, P389, DOI 10.2307/3547058; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Troumbis AY, 2000, OIKOS, V90, P549, DOI 10.1034/j.1600-0706.2000.900313.x; Ward JV, 1998, BIOL CONSERV, V83, P269, DOI 10.1016/S0006-3207(97)00083-9; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Wetzel R. G, 1990, VERH INT VEREIN LIMN, V24, P6, DOI DOI 10.1080/03680770.1989.11898687; Wetzel R.G., 2013, LIMNOLOGICAL ANAL; Wilson MA, 1999, ECOL APPL, V9, P772, DOI 10.2307/2641328; Wu XY, 1998, WETLANDS, V18, P9, DOI 10.1007/BF03161438	30	286	339	19	330	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN	2001	411	6838					687	689		10.1038/35079573	http://dx.doi.org/10.1038/35079573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439JC	11395769				2022-12-01	WOS:000169112500043
J	Khan, AA; Bose, C; Yam, LS; Soloski, MJ; Rupp, F				Khan, AA; Bose, C; Yam, LS; Soloski, MJ; Rupp, F			Physiological regulation of the immunological synapse by agrin	SCIENCE			English	Article							NEUROMUSCULAR-JUNCTION; RECEPTOR; COSTIMULATION; THYMOCYTES; MYOTUBES; ANTIGEN; DOMAINS; BINDING; SYSTEM; CELLS	T cell activation is dependent on both a primary signal delivered through the T cell receptor and a secondary costimulatory signal mediated by coreceptors. Although controversial, costimulation is thought to act through the specific redistribution and clustering of membrane and intracellular kinase-rich Lipid raft microdomains at the contact site between T cells and antigen-presenting cells. This site has been termed the immunological synapse. Endogenous mediators of raft clustering in lymphocytes have not been identified, although they are essential for T cell activation. We now demonstrate that agrin, an aggregating protein crucial for formation of the neuromuscular junction, is also expressed in Lymphocytes and is important in reorganization of membrane Lipid microdomains and setting the threshold for T cell signaling. Our data show that agrin induces the aggregation of signaling proteins and the creation of signaling domains in both immune and nervous systems through a common Lipid raft pathway.	Outer Banks Neurosci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Khan, AA (corresponding author), Outer Banks Neurosci, Baltimore, MD 21218 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020922] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI20922] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOCH W, 1994, EMBO J, V13, P2814, DOI 10.1002/j.1460-2075.1994.tb06575.x; KHAN AT, UNPUB; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Luck G, 2000, MOL CELL NEUROSCI, V16, P269, DOI 10.1006/mcne.2000.0873; LUSTIG S, 1983, J CELL PHYSIOL, V115, P87, DOI 10.1002/jcp.1041150113; MALISSEN B, 1993, CURR OPIN IMMUNOL, V5, P324, DOI 10.1016/0952-7915(93)90049-X; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MOSIER DE, 1974, J IMMUNOL, V112, P305; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; PARTON RG, 1995, SCIENCE, V269, P1398, DOI 10.1126/science.7660120; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHON A, 1989, BIOCHEMISTRY-US, V28, P5019, DOI 10.1021/bi00438a017; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266	23	148	160	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2001	292	5522					1681	1686		10.1126/science.1056594	http://dx.doi.org/10.1126/science.1056594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	438AP	11349136				2022-12-01	WOS:000169031800034
J	Luo, ZX; Crompton, AW; Sun, AL				Luo, ZX; Crompton, AW; Sun, AL			A new mammaliaform from the Early Jurassic and evolution of mammalian characteristics	SCIENCE			English	Article							MORGANUCODON; DIVERSITY; ECOLOGY; SKULL	A fossil from the Early Jurassic (Sinemurian, similar to 195 million years ago) represents a new Lineage of mammaliaforms, the extinct groups more closely related to the living mammals than to nonmammaliaform cynodonts. it has an enlarged era nial cavity, but no postdentary trough on the mandible, indicating separation of the middle ear bones from the mandible. This extends the earliest record of these crucial mammalian features by some 45 million years and suggests that separation of the middle ear bones from the mandible and the expanded brain vault could be correlated. It shows that several key mammalian evolutionary innovations in the ear region, the temporomandibular joint, and the brain vault evolved incrementally through mammaliaform evolution and Long before the differentiation of the Living mammal groups. With an estimated body weight of only 2 grams, its coexistence with other Larger mammaliaforms with similar "triconodont-like" teeth for insectivory within the same fauna suggests a great trophic diversity within the mammaliaform insectivore feeding guild, as inferred from the range of body sizes.	Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Harvard University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA.	Luoz@carnegiemuseums.org	Luo, Zhe-XI/AAU-2263-2021					ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; [Anonymous], 1996, INDIA MIN; Bloch JI, 1998, J MAMMAL, V79, P804, DOI 10.2307/1383090; Cifelli RL, 1998, J VERTEBR PALEONTOL, V18, P237, DOI 10.1080/02724634.1998.10011048; Clemens W.A., 1980, Zitteliana, V5, P51; Crompton A.W., 1974, Bulletin Br Mus nat Hist (Geol), V24, P399; CROMPTON AW, 1993, MAMMAL PHYLOGENY, P30; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; FRASER NC, 1985, NATURE, V314, P161, DOI 10.1038/314161a0; Gingerich P.D., 1984, SIZE SCALING PRIMATE, P257; Hahn G., 1988, Palaeovertebrata (Montpellier), V18, P155; HERRING SW, 1993, AM ZOOL, V33, P472; Hopson J.A., 1986, P83; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; JENKINS FA, 1983, SCIENCE, V222, P1233, DOI 10.1126/science.222.4629.1233; JENKINS FA, 1997, NATURE, V385, P315; Jerison HJ., 1973, EVOLUTION BRAIN INTE, DOI 10.4324/9781315787107-3; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; Ji Q, 1999, NATURE, V398, P326; Kemp T.S., 1982, P1; KERMACK DORIS M., 1968, J LINN SOC LONDON ZOOL, V47, P407; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; KIELANJAWOROWSK.Z, 1997, LETHAIA, V29, P249; KielanJaworowska Z, 1997, ACTA PALAEONTOL POL, V42, P201; KIELBOWICZ RB, 1986, CRIT STUD MASS COMM, V3, P21, DOI 10.1080/15295038609366627; Kuhn H. J., 1971, Abh Senckenb Naturf Ges, V528, P1; Lillegraven J.A., 1991, Contributions to Geology University of Wyoming, V28, P39; Lucas Spencer G., 1993, Journal of Vertebrate Paleontology, V13, P309; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; LUO ZX, 1994, IN THE SHADOW OF THE DINOSAURS, P98; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P113, DOI 10.1080/02724634.1995.10011211; Musser AM, 1998, PHILOS T R SOC B, V353, P1063, DOI 10.1098/rstb.1998.0266; Nummela Sirpa, 1997, Comments on Theoretical Biology, V4, P387; PARRINGTON FR, 1978, PHILOS T ROY SOC B, V282, P177, DOI 10.1098/rstb.1978.0012; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Sidor CA, 1998, PALEOBIOLOGY, V24, P254; Sigogneau-Russell Denise, 1995, Acta Palaeontologica Polonica, V40, P245; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.1111/j.1558-5646.1997.tb01489.x; VANVALKENBURGH B, 1995, TRENDS ECOL EVOL, V10, P71, DOI 10.1016/S0169-5347(00)88980-6; VONMAIER W, 1989, Z ZOOL SYST EVOL, V27, P149; VONMAIER W, 1993, MAMMAL PHYLOGENY, P165; WIBLE JR, 1993, MAMMAL PHYLOGENY, P45; Zeller U., 1987, Mammalia Depicta, P17; Zeller U., 1989, ABHANDLUNGEN SENCKEN, V545, P1; Zeller U., 1993, MAMMAL PHYLOGENY, P95	49	172	180	5	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2001	292	5521					1535	1540		10.1126/science.1058476	http://dx.doi.org/10.1126/science.1058476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	436YQ	11375489				2022-12-01	WOS:000168963800042
J	Adam, D				Adam, D			Plans for GM livestock fail the poor	NATURE			English	News Item																		Reichhardt T, 2000, NATURE, V406, P10, DOI 10.1038/35017657; 2001, NATURE, V409, P749	2	0	0	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					403	403		10.1038/35078211	http://dx.doi.org/10.1038/35078211			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373634	Bronze			2022-12-01	WOS:000168858700007
J	Brockie, B				Brockie, B			GM cows face slaughter in multiple sclerosis experiment	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2001	411	6836					402	402		10.1038/35078202	http://dx.doi.org/10.1038/35078202			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435CB	11373631	Bronze			2022-12-01	WOS:000168858700004
J	Garcia, CK; Wilund, K; Arca, M; Zuliani, G; Fellin, R; Maioli, M; Calandra, S; Bertolini, S; Cossu, F; Grishin, N; Barnes, R; Cohen, JC; Hobbs, HH				Garcia, CK; Wilund, K; Arca, M; Zuliani, G; Fellin, R; Maioli, M; Calandra, S; Bertolini, S; Cossu, F; Grishin, N; Barnes, R; Cohen, JC; Hobbs, HH			Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein	SCIENCE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; MOLECULAR CHARACTERIZATION; CYTOSOLIC ADAPTER; SHC; REGION; INTERNALIZATION; DISTINCT; SIGNALS; DOMAIN	Atherogenic low density lipoproteins are cleared from the circulation by hepatic low density lipoprotein receptors (LDLR). Two inherited forms of hypercholesterolemia result from loss of LDLR activity: autosomal dominant familiar hypercholesterolemia (FH), caused by mutations in the LDLR gene, and autosomal recessive hypercholesterolemia (ARH), of unknown etiology. Here we map the ARH Locus to a similar to1-centimorgan interval on chromosome 1p35 and identify six mutations in a gene encoding a putative adaptor protein (ARH). ARH contains a phosphotyrosine binding (PTB) domain, which in other proteins binds NPXY motifs in the cytoplasmic tails of cell-surface receptors, including the LDLR. ARH appears to have a tissue-specific role in LDLR function, as it is required in liver but not in fibroblasts.	Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med & Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Roma La Sapienza, Inst Systemat Med Therapy, I-00161 Rome, Italy; Univ Ferrara, Dept Internal Med, I-44100 Ferrara, Italy; Univ Sassari, Dept Internal Med, Metab Dis Unit, I-07100 Sassari, Italy; Univ Modena & Reggioemilia, Dept Biol Sci, I-41100 Modena, Italy; Univ Genoa, Dept Internal Med, I-16100 Genoa, Italy; Osped Microcitemico Cagliari, Bone Marrow Transplant Unit, I-09121 Cagliari, Italy	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Sapienza University Rome; University of Ferrara; University of Sassari; Universita di Modena e Reggio Emilia; University of Genoa	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	helen.hobbs@UTSouthwestern.edu	ARCA, Marcello/AAC-3883-2022; /V-4899-2019	ARCA, Marcello/0000-0003-3786-0883; Cossu, Fausto/0000-0001-5485-2098	NHLBI NIH HHS [HL07360, P0I-HL2048] Funding Source: Medline; Telethon [E.0565] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARCA M, UNPUB; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BLAIKIE P, 1994, J BIOL CHEM, V269, P32031; BORK P, 1995, CELL, V80, P693, DOI 10.1016/0092-8674(95)90347-X; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Ciccarese M, 2000, AM J HUM GENET, V66, P453, DOI 10.1086/302753; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; Eden ER, 2001, AM J HUM GENET, V68, P653, DOI 10.1086/318795; GOLDSTEIN JL, UNPUB; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; HARADASHIBA M, 1992, ARTERIOSCLER THROMB, V12, P1071, DOI 10.1161/01.ATV.12.9.1071; HE WM, 1995, J BIOL CHEM, V270, P23258, DOI 10.1074/jbc.270.40.23258; JOKINEN EV, 1994, J BIOL CHEM, V269, P26411; KHACHADURIAN AK, 1973, NUTR METAB, V15, P132; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEHRMAN MA, 1987, J BIOL CHEM, V262, P401; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Loudianos G, 1999, HUM MUTAT, V14, P294, DOI 10.1002/(SICI)1098-1004(199910)14:4<294::AID-HUMU4>3.0.CO;2-9; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; MATTER K, 1993, CELL, V74, P1053, DOI 10.1016/0092-8674(93)90727-8; Norman D, 1999, J CLIN INVEST, V104, P619, DOI 10.1172/JCI6677; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PATHAK RK, 1990, J CELL BIOL, V111, P347, DOI 10.1083/jcb.111.2.347; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; Schmidt HHJ, 1998, J CLIN ENDOCR METAB, V83, P2167, DOI 10.1210/jc.83.6.2167; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Zhou MM, 1995, PROG BIOPHYS MOL BIO, V64, P221, DOI 10.1016/S0079-6107(96)00005-3; Zuliani G, 1999, ARTERIOSCL THROM VAS, V19, P802, DOI 10.1161/01.ATV.19.3.802; ZULIANI G, 1995, EUR J CLIN INVEST, V25, P322, DOI 10.1111/j.1365-2362.1995.tb01709.x	34	424	447	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2001	292	5520					1394	1398		10.1126/science.1060458	http://dx.doi.org/10.1126/science.1060458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11326085				2022-12-01	WOS:000168862900051
J	Kang, PJ; Sanson, A; Lee, B; Park, HO				Kang, PJ; Sanson, A; Lee, B; Park, HO			A GDP/GTP exchange factor involved in linking a spatial landmark to cell polarity	SCIENCE			English	Article							BUD-SITE SELECTION; YEAST SACCHAROMYCES-CEREVISIAE; GTPASE-ACTIVATING PROTEIN; GENE-PRODUCT; BUDDING SITE; LOCALIZATION; CYCLE; MORPHOGENESIS; BUD1/RSR1; PATTERN	In both animal and yeast cells, signaling pathways involving small guanosine triphosphatases (GTPases) regulate polarized organization of the actin cytoskeleton. In the budding yeast Saccharomyces cerevisiae, the Ras-like GTPase Bud1/Rsr1 and its guanosine 5'-diphosphate (GDP)/guanosine 5'-triphosphate (GTP) exchange factor Bud5 are involved in the selection of a specific site for growth, thus determining cell polarity. We found that Bud5 is localized at the cell division site and the presumptive bud site. Its localization is dependent on potential cellular landmarks, such as Bud3 and Axl2/Bud10 in haploid cells and Bud8 and Bud9 in diploid cells. Bud5 also physically interacts with Axl2/Bud10, a transmembrane glycoprotein, suggesting that a receptor-like transmembrane protein recruits a GDP/GTP exchange factor to connect an intrinsic spatial signal to oriented cell growth.	Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	Ohio State University	Park, HO (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12th Ave, Columbus, OH 43210 USA.			Park, Hay-Oak/0000-0001-5782-2257	NIGMS NIH HHS [R01 GM056997-02, R01 GM056997] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056997] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; CHANT J, 1991, CELL, V65, P1213, DOI 10.1016/0092-8674(91)90016-R; CHANT J, 1995, J CELL BIOL, V129, P767, DOI 10.1083/jcb.129.3.767; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; FLESCHER EG, 1993, J CELL BIOL, V122, P373, DOI 10.1083/jcb.122.2.373; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; FREIFELDER D, 1960, J BACTERIOL, V80, P567, DOI 10.1128/JB.80.4.567-568.1960; FUJITA A, 1994, NATURE, V372, P567, DOI 10.1038/372567a0; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; Halme A, 1996, CURR BIOL, V6, P570, DOI 10.1016/S0960-9822(02)00543-2; HARKINS HA, IN PRESS MOL BIOL CE; HICKS JB, 1977, GENETICS, V85, P373; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Michelitch M, 1996, CURR BIOL, V6, P446, DOI 10.1016/S0960-9822(02)00512-2; Park HO, 1999, GENE DEV, V13, P1912, DOI 10.1101/gad.13.15.1912; PARK HO, 1993, NATURE, V365, P269, DOI 10.1038/365269a0; Park HO, 1997, P NATL ACAD SCI USA, V94, P4463, DOI 10.1073/pnas.94.9.4463; POWERS S, 1991, CELL, V65, P1225, DOI 10.1016/0092-8674(91)90017-S; Roemer T, 1996, GENE DEV, V10, P777, DOI 10.1101/gad.10.7.777; Sanders SL, 1996, J CELL BIOL, V134, P413, DOI 10.1083/jcb.134.2.413; Taheri N, 2000, EMBO J, V19, P6686, DOI 10.1093/emboj/19.24.6686; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; ZHENG Y, 1995, J BIOL CHEM, V270, P626, DOI 10.1074/jbc.270.2.626	26	79	83	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 18	2001	292	5520					1376	1378		10.1126/science.1060360	http://dx.doi.org/10.1126/science.1060360			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	435DV	11313501	Green Accepted			2022-12-01	WOS:000168862900046
J	Raoult, D; Fournier, PE; Fenollar, F; Jensenius, M; Prioe, T; de Pina, JJ; Caruso, G; Jones, N; Laferl, H; Rosenblatt, JE; Marrie, TJ				Raoult, D; Fournier, PE; Fenollar, F; Jensenius, M; Prioe, T; de Pina, JJ; Caruso, G; Jones, N; Laferl, H; Rosenblatt, JE; Marrie, TJ			Rickettsia africae, a tick-borne pathogen in travelers to sub-Saharan Africa.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDITERRANEAN SPOTTED-FEVER; BITE FEVER; EPIDEMIOLOGICAL FEATURES; PROTEIN ROMPA; INFECTIONS; CONORII; MICROIMMUNOFLUORESCENCE; SEROEPIDEMIOLOGY; DIFFERENTIATION; ANTIBODIES	Background: African tick-bite fever occurs after contact with ticks that carry Rickettsia africae and that parasitize cattle and game. Sporadic reports suggest that this infection has specific clinical and epidemiologic features. Methods: We studied patients who were tested for a rickettsial disease after returning from a visit to Africa or Guadeloupe. To assess the value of the microimmunofluorescence assay, Western blotting, and cross-adsorption assays, we compared the results of these tests in 39 patients in whom African tick-bite fever had been confirmed by the polymerase-chain-reaction assay, cell culture, or both; 50 patients with documented R. conorii infection; and 50 blood donors. These diagnostic criteria were then applied to 376 additional patients who had returned from southern Africa and 2 who had returned from Guadeloupe and whose serum was being tested for rickettsial disease. Results: In the 39 patients with direct evidence of R. africae infection, the combination of microimmunofluorescence assay, Western blotting, and cross-adsorption assays showing antibodies specific for R. africae had a sensitivity of 0.56; however, each test had a positive predictive value and a specificity of 1.0. An additional 80 patients were found to have an R. africae infection on the basis of these serologic criteria. Infections with R. africae were acquired by visitors to 11 African countries and Guadeloupe. The illness was generally mild and was characterized by a rash in 46 percent of the patients; the rash was usually maculopapular or vesicular and rarely purpuric. Ninety-five percent of patients had an inoculation eschar or eschars, and 54 percent of these patients had multiple eschars, a finding that is unusual in patients with rickettsial infection. Conclusions: In this series, R. africae was the cause of nearly all cases of tick-bite rickettsiosis in patients who became ill after a trip to sub-Saharan Africa. (N Engl J Med 2001;344:1504-10.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS,UPRESA 6020, F-13385 Marseille 05, France; Aker Univ Hosp, Dept Internal Med, Oslo, Norway; Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; Hop Instruct Armees Laveran, Biol Lab, Marseille Armees, France; Osped Belluno, Div Malattie Infett, Belluno, Italy; John Radcliffe Hosp, Dept Microbiol & Infect Dis, Oxford OX3 9DU, England; Kaiser Franz Josef Hosp, Dept Med, Vienna, Austria; Mayo Clin, Div Clin Microbiol, Rochester, MN USA; Univ Alberta, Dept Med, Edmonton, AB, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte; University of Oslo; Rigshospitalet; University of Copenhagen; ULSS 1 Dolomiti; Ospedale di Belluno; University of Oxford; Kaiser-Franz-Josef Hospital; Mayo Clinic; University of Alberta	Raoult, D (corresponding author), Univ Mediterranee, Fac Med, Unite Rickettsies, CNRS,UPRESA 6020, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.		RAOULT, Didier/A-8434-2008; Fournier, Pierre-Edouard/AAC-6155-2021; JONES, NICOLA/AAN-4246-2020	RAOULT, Didier/0000-0002-0633-5974; Fournier, Pierre-Edouard/0000-0001-8463-8885; DE PINA, Jean Jacques/0000-0002-2081-3936				BABALIS T, 1993, AM J TROP MED HYG, V48, P784, DOI 10.4269/ajtmh.1993.48.784; Brouqui P, 1997, ARCH INTERN MED, V157, P119, DOI 10.1001/archinte.157.1.119; DEAN AD, 1991, EPI INFO VERSION 5 W; DUPONT HT, 1995, CLIN INFECT DIS, V21, P1126, DOI 10.1093/clinids/21.5.1126; Dupont HT, 1997, CLIN INFECT DIS, V25, P139, DOI 10.1086/514496; Fournier PE, 1998, CLIN INFECT DIS, V27, P316, DOI 10.1086/514664; Fournier PE, 1999, EMERG INFECT DIS, V5, P178, DOI 10.3201/eid0501.990127; Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839; GOLDWASSER RA, 1959, J IMMUNOL, V82, P373; HECHEMY KE, 1983, J CLIN MICROBIOL, V17, P445, DOI 10.1128/JCM.17.3.445-449.1983; HELMICK CG, 1984, J INFECT DIS, V150, P480, DOI 10.1093/infdis/150.4.480; HERREROHERRERO JI, 1993, EUR J EPIDEMIOL, V9, P59, DOI 10.1007/BF00463091; Jensenius M, 1999, SCAND J INFECT DIS, V31, P131, DOI 10.1080/003655499750006155; KELLY P, 1992, LANCET, V340, P982, DOI 10.1016/0140-6736(92)92878-J; KELLY PJ, 1994, J TROP MED HYG, V97, P129; Kelly PJ, 1996, INT J SYST BACTERIOL, V46, P611, DOI 10.1099/00207713-46-2-611; KELLY PJ, 1991, J TROP MED HYG, V94, P304; La Scola B, 2000, CLIN DIAGN LAB IMMUN, V7, P612, DOI 10.1128/CDLI.7.4.612-616.2000; NORVAL RAI, 1983, ZIMBABWE VET J, V13, P3; Parola P, 1998, NEW ENGL J MED, V338, P1391, DOI 10.1056/NEJM199805073381918; Pece S, 1996, MED SCI RES, V24, P435; Pijper A., 1936, Arch Inst Pasteur Tunis, V25, P388; Raoult D, 2000, P NATL ACAD SCI USA, V97, P12800, DOI 10.1073/pnas.220225197; RAOULT D, 1989, J CLIN MICROBIOL, V27, P2073, DOI 10.1128/JCM.27.9.2073-2079.1989; RAOULT D, 1986, AM J TROP MED HYG, V35, P845, DOI 10.4269/ajtmh.1986.35.845; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Rotz L, 1998, Del Med J, V70, P285; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Smoak BL, 1996, EMERG INFECT DIS, V2, P217, DOI 10.3201/eid0203.960309; SONENSHINE DE, 1993, BIOL TICKS, V2, P3; TEYSSEIRE N, 1992, J CLIN MICROBIOL, V30, P455, DOI 10.1128/JCM.30.2.455-460.1992; TROUP JM, 1938, LANCET, V2, P1183; WALKER D, 1998, HARRISONS PRINCIPLES, V1, P1045	33	210	214	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2001	344	20					1504	1510		10.1056/NEJM200105173442003	http://dx.doi.org/10.1056/NEJM200105173442003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	432DP	11357153				2022-12-01	WOS:000168677200003
J	Ansell, P; Roman, E; Fear, NT; Renfrew, MJ				Ansell, P; Roman, E; Fear, NT; Renfrew, MJ			Vitamin K policies and midwifery practice: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							CHILDHOOD-CANCER; PROPHYLAXIS; LEUKEMIA; NEWBORN	Objectives To investigate policies on neonatal vitamin K and their implementation, Design Two phase postal survey. Setting United Kingdom, Participants A 10% random sample of midwives registered with the United Kingdom Central Council for nursing, midwifery, and health visiting, Of 3191 midwives in the sample, 2515 (79%) responded to phase one and 2294 (72%) completed questionnaires on their current jobs (November 1998 to May 1999), In phase two, 853 (62%) of 1383 eligible midwives gave details on 2179 of their earliest jobs (start dates before 1990). Results All the midwives in clinical practice at the time of the survey (2271, 99%) reported that the) were working in areas with official policies on neonatal vitamin K. Seven distinct policies were described: intramuscular vitamin K for all babies (1159, 51.0%); intramuscular vitamin K for babies at "high risk," oral for others (470, 20.7%); oral vitamin K for all babies (323, 14.2%); parental choice for all (124, 5.5%): parental choice for all except babies at high risk. (119, 5.2%); intramuscular vitamin K for babies at high risk only (33, 1.5%); oral vitamin K for babies at high risk only. (17, 0.7%); and a disparate group of policies including intravenous vitamin K for some babies (26, 1.1%). Previous policies were land some may still be) open to individual interpretation and were not always followed. Conclusions Hospital policy is not necessarily a good guide to individual practice. The primary purpose of clinical records is to document patient care, and recording practices reflect this. There is considerable variation in vitamin K policies and midwifery practice in the United Kingdom, and there is no clear consensus on which babies should receive vitamin K intramuscularly.	Univ Leeds, Inst Epidemiol, Leukaemia Res Fund Ctr, Leeds LS2 9LN, W Yorkshire, England; Univ Leeds, Mother & Infant Res Unit, Leeds LS2 9LN, W Yorkshire, England	University of Leeds; University of Leeds	Ansell, P (corresponding author), Univ Leeds, Inst Epidemiol, Leukaemia Res Fund Ctr, Leeds LS2 9LN, W Yorkshire, England.		Fear, Nicola/A-1917-2012; Renfrew, Mary/A-2440-2010	Fear, Nicola/0000-0002-5792-2925; Renfrew, Mary/0000-0003-2905-403X; Roman, Eve/0000-0001-7603-3704				Ansell P, 1996, BRIT MED J, V313, P204, DOI 10.1136/bmj.313.7051.204; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; BARTON JS, 1995, BRIT MED J, V310, P632, DOI 10.1136/bmj.310.6980.632; BARTON JS, 1994, LANCET, V343, P1168, DOI 10.1016/S0140-6736(94)90277-1; *DEP HLTH, 1999, NHS HOSP COMM HLTH S; *DEP HLTH, 1998, VIT K NEWB BAB; EKELUND H, 1993, BRIT MED J, V307, P89, DOI 10.1136/bmj.307.6896.89; GOLDING J, 1992, BRIT MED J, V305, P341, DOI 10.1136/bmj.305.6849.341; HANDEL J, 1991, BRIT MED J, V303, P1109, DOI 10.1136/bmj.303.6810.1109; *ISD SCOTL, 2001, SCOTT HLTH STAT 2000; KLEBANOFF MA, 1993, NEW ENGL J MED, V329, P905, DOI 10.1056/NEJM199309233291301; McKinney PA, 1998, BRIT MED J, V316, P173, DOI 10.1136/bmj.316.7126.173; *NAT CHILDB TRUST, 1994, PAR RIGHTS DEN VIT K; OLSEN JH, 1994, BRIT MED J, V308, P895, DOI 10.1136/bmj.308.6933.895; PARKER L, 1998, BRIT MED J, V316, P184; Passmore SJ, 1998, BRIT MED J, V316, P184, DOI 10.1136/bmj.316.7126.184; Passmore SJ, 1998, BRIT MED J, V316, P178, DOI 10.1136/bmj.316.7126.178; *ROYAL COLL MIDW, 1999, RCM MIDWIVES J, V2, P252; vonKries R, 1996, BRIT MED J, V313, P199, DOI 10.1136/bmj.313.7051.199	19	16	16	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2001	322	7295					1148	+		10.1136/bmj.322.7295.1148	http://dx.doi.org/10.1136/bmj.322.7295.1148			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	433HH	11348908	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-01	WOS:000168748900014
J	Lino, M; Goto, K; Kakegawa, W; Okado, H; Sudo, M; Ishiuchi, S; Miwa, A; Takayasu, Y; Saito, I; Tsuzuki, K; Ozawa, S				Lino, M; Goto, K; Kakegawa, W; Okado, H; Sudo, M; Ishiuchi, S; Miwa, A; Takayasu, Y; Saito, I; Tsuzuki, K; Ozawa, S			Glia-synapse interaction through Ca2+-permeable AMPA receptors in Bergmann glia	SCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; CHANNELS; DESENSITIZATION; TRANSPORTERS; PERMEABILITY; SUBUNIT; NEURONS; FIBERS	Glial cells express a variety of neurotransmitter receptors, Notably, Bergmann glial cells in the cerebellum have Ca2+-permeable alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors (AMPARs) assembled without the GluR2 subunit, To elucidate the role of these Ca2+-permeable AMPARs, we converted them into Ca2+-impermeable receptors by adenoviral-mediated delivery of the GluR2 gene. This conversion retracted the glial processes ensheathing synapses on Purkinje cell dendritic spines and retarded the removal of synaptically released glutamate, Furthermore, it caused multiple innervation of Purkinje cells by the climbing fibers. Thus, the glial Ca2+-permeable AMPARs are indispensable for proper structural and functional relations between Bergmann glia and glutamatergic synapses.	Gunma Univ, Sch Med, Gunma 3718511, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Inst Med Sci, Tokyo 1080071, Japan; Tokyo Metropolitan Inst Neurosci, Inst Neurosci, Dept Neurobiol, Fuchu, Tokyo 1838526, Japan	Gunma University; Japan Science & Technology Agency (JST); University of Tokyo; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Ozawa, S (corresponding author), Gunma Univ, Sch Med, Gunma 3718511, Japan.		Kakegawa, Wataru/G-5569-2016; Kakegawa, Wataru/L-4900-2013	Ozawa, Seiji/0000-0003-4893-3443				Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V256, P1566, DOI 10.1126/science.1317970; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; Isa T, 1996, J PHYSIOL-LONDON, V491, P719, DOI 10.1113/jphysiol.1996.sp021252; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; OZAWA S, 1991, J NEUROPHYSIOL, V66, P2, DOI 10.1152/jn.1991.66.1.2; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Yamada K, 2000, J COMP NEUROL, V418, P106; YAMADA KA, 1993, J NEUROSCI, V13, P3904	20	304	308	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2001	292	5518					926	929		10.1126/science.1058827	http://dx.doi.org/10.1126/science.1058827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	429KB	11340205				2022-12-01	WOS:000168514900043
J	Creed, F; Ratcliffe, J; Fernandez, L; Tomenson, B; Palmer, S; Rigby, C; Guthrie, E; Read, N; Thompson, D				Creed, F; Ratcliffe, J; Fernandez, L; Tomenson, B; Palmer, S; Rigby, C; Guthrie, E; Read, N; Thompson, D			Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; PHYSICAL ABUSE HISTORY; OF-LIFE; MEDICAL OUTCOMES; TREATMENT TRIALS; IMPACT; SYMPTOMS; ILLNESS; MODEL; SF-36	Background: The irritable bowel syndrome (IBS) may lead to considerable impairment of health-related quality of life and high health care costs. It is not clear whether these poor outcomes directly result from severe bower symptoms or reflect a coexisting psychiatric disorder. Objective: To determine whether bowel symptom severity and psychological symptoms directly influence health-related quality of life and health care costs. Design: Cross-sectional survey. Setting: secondary and tertiary gastroenterology clinics. Patients: 257 patients with severe IBS who did not respond to usual treatments and were recruited for a trial of psychological treatment. Measurements: Predictors were abdominal pain, entries in a diary of 10 IBS symptoms, and measures of psychological symptoms. Outcomes were inability to work, health-related quality of life (measured by Medical Outcomes Survey 36-item short-form questionnaire [SF-36] physical component summary scores), and health care and productivity costs. Predictor and outcome measures were compared by using multiple regression and logistic regression analyses. Results: Abdominal pain occurred on average 24 days per month and activities were restricted on 145 days of the previous 12 months. The mean (+/- SD) Hamilton depression score was 11.3 +/-6.1. The SF-36 physical component summary score was low (37.7 +/- 10.6), and the patients had incurred high health care costs ($1743 +/- $2263) over the previous year. Global severity and somatization scores on the Symptom Checklist 90 Revised, abdominal pain, and Hamilton depression scores independently contributed to the physical component score of the SF-36 (adjusted R-2 = 35.2%), but only psychological scores were associated with disability due to ill health. These variables did not accurately predict health care or other costs (adjusted R-2 = 9.3%), History of sexual abuse was not an independent predictor of outcome. Conclusions: Both abdominal and psychological symptoms are independently associated with impaired health-related quality of life in patients with severe IBS, Optimal treatment is likely to require a holistic approach. Since health care and loss of productivity costs are not clearly associated with these symptoms, alleviation of them will not necessarily lead to reduced costs.	Univ Manchester, Sch Psychiat & Behav Sci, Manchester M13 9WL, Lancs, England; Hope Hosp, Manchester, Lancs, England; Belmont Day Hosp, Bolton, England; St Georges Community Hlth, Sheffield, S Yorkshire, England; No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England; Univ York, Ctr Hlth Econ, York YO1 5DD, N Yorkshire, England; Mental Hlth Serv Salford, Salford, Lancs, England	University of Manchester; Northern General Hospital; University of York - UK	Creed, F (corresponding author), Univ Manchester, Sch Psychiat & Behav Sci, Rawnsley Bldg,Oxford Rd, Manchester M13 9WL, Lancs, England.	francis.creed@man.ac.uk		Guthrie, Elspeth/0000-0002-5834-6616				[Anonymous], 1992, GASTROENTEROL INT; Beecham J, 1992, MEASURING MENTAL HLT; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bergmann JF, 1998, EUR J SURG, V164, P87; *BRIT MED ASS ROYA, 1998, BRIT NATL FORMULARY, V35; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Drossman DA, 1998, PSYCHOSOM MED, V60, P258, DOI 10.1097/00006842-199805000-00007; DROSSMAN DA, 1995, DIGEST DIS SCI, V40, P986, DOI 10.1007/BF02064187; Gralnek IM, 2000, GASTROENTEROLOGY, V119, P654, DOI 10.1053/gast.2000.16484; Hahn BA, 1997, ALIMENT PHARM THERAP, V11, P553, DOI 10.1046/j.1365-2036.1997.00160.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hawkey Christopher J., 1999, American Journal of Medicine, V107, p98S; Komaroff AL, 1996, AM J MED, V101, P281, DOI 10.1016/S0002-9343(96)00174-X; Leserman J, 1998, PSYCHOL MED, V28, P417, DOI 10.1017/S0033291797006508; Leserman J, 1996, PSYCHOSOM MED, V58, P4, DOI 10.1097/00006842-199601000-00002; Naliboff BD, 1998, J PSYCHOSOM RES, V45, P485; Naliboff BD, 1998, EUR J SURG, V164, P57; Netten A, 1998, UNIT COSTS HLTH SOCI; Talley NJ, 1996, AM J GASTROENTEROL, V91, P277; van Zanten SJOV, 1999, GUT, V45, P69; Walker EA, 1997, PSYCHOSOM MED, V59, P565, DOI 10.1097/00006842-199711000-00002; Ware J. E, 1994, PHYS MENTAL HLTH SUM; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; Wells KB, 1999, AM J PSYCHIAT, V156, P5, DOI 10.1176/ajp.156.1.5; Whitehead WE, 1996, DIGEST DIS SCI, V41, P2248, DOI 10.1007/BF02071408	28	171	182	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2001	134	9	2	S			860	868		10.7326/0003-4819-134-9_Part_2-200105011-00010	http://dx.doi.org/10.7326/0003-4819-134-9_Part_2-200105011-00010			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	429XK	11346322				2022-12-01	WOS:000168543100010
J	Sijbrands, EJG; Westendorp, RGJ; Defesche, JC; de Meier, PHEM; Smelt, AHM; Kastelein, JJP				Sijbrands, EJG; Westendorp, RGJ; Defesche, JC; de Meier, PHEM; Smelt, AHM; Kastelein, JJP			Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIPOPROTEIN RECEPTOR GENE; CORONARY-ARTERY-DISEASE; ENVIRONMENTAL-FACTORS; HEART-DISEASE; MUTATIONS; MEN	Objective To estimate all cause mortality from untreated familial hypercholesterolaemia free from selection for coronary artery disease. Design Family tree mortality study S Setting Large pedigree in Netherlands traced back to a single pair of ancestors in the 19th century. Subjects All members of pedigree aged over 20 years with 0.5 probability of carrying a mutation for familial hypercholesterolaemia. Main outcome measure All cause mortality. Results A total of 70 deaths took place among 250 people analysed for 6950 person years. Mortality was not increased in carriers of the mutation during the 19th and early 20th century; it rose after 1915, reached its maximum between 1935 and 1964 (standardised mortality ratio 1.78, 95% confidence interval 1.13 to 2.76; P = 0.003), and fell thereafter. Mortality differed significantly between two branches of the pedigree (relative risk 3.20, 95% confidence interval 1.74 to 6.11; P = 0.001). Conclusions Risk of death varies significantly among patients with familial hypercholesterolaemia. This large variability over time and between branches of the pedigree points to a strong interaction with environmental factors. Future research is required to identify patients with familial hypercholesterolaemia who are at extreme risk and need early and vigorous preventive measures.	Univ Amsterdam, Acad Med Ctr, Dept Vasc Med & Gen Internal Med, NL-1105 AZ Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Gen Internal Med, NL-2300 RC Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sijbrands, EJG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med & Gen Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	nrexpert@euronet.nl	Sijbrands, Eric/A-1065-2009; Kastelein, John/AAF-7950-2020	Sijbrands, Eric/0000-0001-8857-7389; 				[Anonymous], 1991, BMJ, V303, P893; BEAUMONT V, 1976, ATHEROSCLEROSIS, V24, P441, DOI 10.1016/0021-9150(76)90136-2; COLEMAN MP, 1989, PERSON YEARS PYRS FU; DEFESCHE JC, 1993, HUM GENET, V92, P567, DOI 10.1007/BF00420940; HARLAN WR, 1966, MEDICINE, V45, P77, DOI 10.1097/00005792-196603000-00001; HAZZARD WR, 1973, J CLIN INVEST, V52, P1569, DOI 10.1172/JCI107333; HILL JS, 1991, ARTERIOSCLER THROMB, V11, P290, DOI 10.1161/01.ATV.11.2.290; Hille ETM, 1997, BLOOD, V89, P1963, DOI 10.1182/blood.V89.6.1963; KOTZE MJ, 1993, CLIN GENET, V43, P295; LOMBARDI P, 1995, J LIPID RES, V36, P860; Muller C, 1939, ARCH INTERN MED, V64, P675; Netea MG, 1996, J CLIN INVEST, V97, P1366, DOI 10.1172/JCI118556; NOBILI A, 1994, BRIT HEART J, V71, P468; ROSENDAAL FR, 1991, LANCET, V337, P260, DOI 10.1016/0140-6736(91)90867-O; ROTHENBERG RB, 1994, EPIDEMIOLOGY, V5, P197, DOI 10.1097/00001648-199403000-00010; SEED M, 1990, NEW ENGL J MED, V322, P1494, DOI 10.1056/NEJM199005243222104; Sijbrands EJG, 2000, ATHEROSCLEROSIS, V149, P421, DOI 10.1016/S0021-9150(99)00336-6; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; WILLIAMS RR, 1986, JAMA-J AM MED ASSOC, V255, P219, DOI 10.1001/jama.255.2.219; WILLIAMS RR, 1992, CLIN EXP PHARM P S20, V19, P1	21	161	161	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2001	322	7293					1019	1022		10.1136/bmj.322.7293.1019	http://dx.doi.org/10.1136/bmj.322.7293.1019			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	428UA	11325764	Green Published, Green Submitted, Bronze			2022-12-01	WOS:000168478700017
J	Johnson, L; Mercer, K; Greenbaum, D; Bronson, RT; Crowley, D; Tuveson, DA; Jacks, T				Johnson, L; Mercer, K; Greenbaum, D; Bronson, RT; Crowley, D; Tuveson, DA; Jacks, T			Somatic activation of the K-ras oncogene causes early onset lung cancer in mice	NATURE			English	Article							TUMOR-DEVELOPMENT; GENE-MUTATIONS; ADENOCARCINOMA; PROGRESSION; MOUSE; TRANSFORMATION; HYPERPLASIA; PREVALENCE; FREQUENT; FOCI	About 30% of human tumours carry ras gene mutations(1,2). Of the three genes in this family (composed of K-ras, N-ras and H-ras), K-ras is the most frequently mutated member in human tumours, including adenocarcinomas of the pancreas (similar to 70-90% incidence), colon (similar to 50%) and lung (similar to 25-50%)(1-6). To constuct mouse tumour models involving K-ras, we used a new gene targeting procedure to create mouse strains carrying oncogenic alleles of K-ras that can be activated only on a spontaneous recombination event in the whole animal. Here we show that mice carrying these mutations were highly predisposed to a range of tumour types, predominantly early onset lung cancer. This model was further characterized by examining the effects of germline mutations in the tumour suppressor gene p53, which is known to be mutated along with K-ras in human tumours. This approach has several advantages over traditional transgenic strategies, including that it more closely recapitulates spontaneous oncogene activation as seen in human cancers.	MIT, Dept Biol, Cambridge, MA 02139 USA; Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA; Tufts Univ, Sch Vet Med, Dept Pathol, Boston, MA 02111 USA; Dana Farber Canc Inst, Div Adult Oncol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Tufts University; Tufts University; Harvard University; Dana-Farber Cancer Institute	Jacks, T (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							ADAMS JM, 1991, SCIENCE, V254, P1161, DOI 10.1126/science.1957168; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOS JL, 1989, CANCER RES, V49, P4682; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; FINNEY RE, 1993, SCIENCE, V260, P1524, DOI 10.1126/science.8502998; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; HASTY P, 1991, NATURE, V350, P243, DOI 10.1038/350243a0; HASTY P, 1991, NATURE, V353, P94, DOI 10.1038/353094b0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; KHOSRAVIFAR R, 1994, CANCER METAST REV, V13, P67, DOI 10.1007/BF00690419; Kitamura H, 1999, AM J CLIN PATHOL, V111, P610; Lerner EC, 1997, ANTI-CANCER DRUG DES, V12, P229; Linnoila R I, 1992, J Natl Cancer Inst Monogr, P61; MILLS NE, 1995, CANCER RES, V55, P1444; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; NAKANISHI K, 1990, ARCH PATHOL LAB MED, V114, P363; PELLEGATA NS, 1994, CANCER RES, V54, P1556; PRETLOW TP, 1991, CANCER RES, V51, P1564; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Sebti Said, 1997, Current Opinion in Oncology, V9, P557, DOI 10.1097/00001622-199711000-00011; SEPERACK PK, 1988, P NATL ACAD SCI USA, V85, P189, DOI 10.1073/pnas.85.1.189; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Thrane EV, 1997, EXP LUNG RES, V23, P35, DOI 10.3109/01902149709046046; Tuveson DA, 1999, ONCOGENE, V18, P5318, DOI 10.1038/sj.onc.1203107; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; YAMASHITA N, 1995, CANCER, V75, P1527, DOI 10.1002/1097-0142(19950315)75:6+<1527::AID-CNCR2820751524>3.0.CO;2-Y; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898	31	873	932	0	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2001	410	6832					1111	1116		10.1038/35074129	http://dx.doi.org/10.1038/35074129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	425HQ	11323676				2022-12-01	WOS:000168285500052
J	Yasuda, R; Noji, H; Yoshida, M; Kinosita, K; Itoh, H				Yasuda, R; Noji, H; Yoshida, M; Kinosita, K; Itoh, H			Resolution of distinct rotational substeps by submillisecond kinetic analysis of F-1-ATPase	NATURE			English	Article							ESCHERICHIA-COLI F1-ATPASE; HEAVY-MEROMYOSIN MOLECULES; THERMOPHILIC BACILLUS PS3; CATALYTIC SITE; ATP SYNTHASE; ALPHA(3)BETA(3)GAMMA COMPLEX; NUCLEOTIDE-BINDING; INHIBITORY MGADP; MOTOR; AFFINITY	The enzyme F-1-ATPase has been shown to be a rotary motor in which the central gamma -subunit rotates inside the cylinder made of alpha (3)beta (3) subunits. At low ATP concentrations, the motor rotates in discrete 120 degrees steps, consistent with sequential ATP hydrolysis on the three beta -subunits. The mechanism of stepping is unknown. Here we show by high-speed imaging that the 120 degrees step consists of roughly 90 degrees and 30 degrees substeps, each taking only a fraction of a millisecond. ATP binding drives the 90 degrees substep, and the 30 degrees substep is probably driven by release of a hydrolysis product. The two substeps are separated by two reactions of about 1 ms, which together occupy most of the ATP hydrolysis cycle. This scheme probably applies to rotation at full speed (similar to 130 revolutions per second at saturating ATP) down to occasional stepping at nanomolar ATP concentrations, and supports the binding-change model for ATP synthesis by reverse rotation of F-1-ATPase.	Keio Univ, Fac Sci & Technol, Dept Phys, Yokohama, Kanagawa 2238522, Japan; Teikyo Univ, Biotechnol Ctr 3F, CREST Genet Programming Team 13, Kawasaki, Kanagawa 2160001, Japan; Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 2268503, Japan; Hamamatsu Photon KK, Tsukuba Res Lab, Tsukuba, Ibaraki 3002635, Japan	Keio University; Japan Science & Technology Agency (JST); Teikyo University; Tokyo Institute of Technology; Hamamatsu Photonics	Kinosita, K (corresponding author), Keio Univ, Fac Sci & Technol, Dept Phys, Yokohama, Kanagawa 2238522, Japan.		Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2000, P NATL ACAD SCI USA, V97, P7243, DOI 10.1073/pnas.120174297; Born M., 2013, PRINCIPLES OPTICS, V6; Boyer P.D., 1981, PRESENT STATUS BINDI, P231; Boyer PD, 2000, BBA-BIOENERGETICS, V1458, P252, DOI 10.1016/S0005-2728(00)00077-3; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; COX GB, 1984, BIOCHIM BIOPHYS ACTA, V768, P201, DOI 10.1016/0304-4173(84)90016-8; CUNNINGHAM D, 1988, J BIOL CHEM, V263, P18850; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Jault JM, 1995, BIOCHEMISTRY-US, V34, P16412, DOI 10.1021/bi00050a023; KATO Y, 1995, BBA-BIOENERGETICS, V1231, P275, DOI 10.1016/0005-2728(95)00087-Y; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; Kinosita K Jr, 2000, Essays Biochem, V35, P3; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; Kunioka Y, 1996, J BIOCHEM-TOKYO, V119, P1024; MANNHERZ HG, 1974, EUR J BIOCHEM, V48, P287, DOI 10.1111/j.1432-1033.1974.tb03767.x; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; Milgrom YM, 1998, BIOCHEM J, V330, P1037; MITCHELL P, 1985, FEBS LETT, V182, P1, DOI 10.1016/0014-5793(85)81142-X; MIYATA H, 1994, J BIOCHEM, V115, P644, DOI 10.1093/oxfordjournals.jbchem.a124389; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Oosawa F, 1986, Adv Biophys, V22, P151, DOI 10.1016/0065-227X(86)90005-5; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; WEBER J, 1993, J BIOL CHEM, V268, P20126; WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722; WOLCOTT RG, 1974, BIOCHEM BIOPH RES CO, V57, P709, DOI 10.1016/0006-291X(74)90604-4; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; ZHOU JM, 1993, J BIOL CHEM, V268, P1531	37	668	686	4	101	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2001	410	6831					898	904		10.1038/35073513	http://dx.doi.org/10.1038/35073513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	423AG	11309608				2022-12-01	WOS:000168152300037
J	Yabuta, NH; Sawatari, A; Callaway, EM				Yabuta, NH; Sawatari, A; Callaway, EM			Two functional channels from primary visual cortex to dorsal visual cortical areas	SCIENCE			English	Article							MONKEY STRIATE CORTEX; BROAD-BAND CHANNELS; MACAQUE MONKEY; COLOR-OPPONENT; OWL MONKEY; NEURONS; CONNECTIONS; PATHWAYS; STREAMS; MT	Relationships between the M and P retino-geniculo-cortical visual pathways and "dorsal" visual areas were investigated by measuring the sources of Local excitatory input to individual neurons in Layer 4B of primary visual cortex. We found that contributions of the M and P pathways to Layer 4B neurons are dependent on cell type. Spiny stellate neurons receive strong M input through Layer 4C alpha and no significant P input through Layer 4C beta. In contrast, pyramidal neurons in Layer 4B receive strong input from both Layers 4C alpha and 4C beta. These observations, along with evidence that direct input from Layer 4B to area MT arises predominantly from spiny stellates, suggest that these different cell types constitute two functionally specialized subsystems.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267	NATIONAL EYE INSTITUTE [R01EY010742, R37EY006837, R01EY006837] Funding Source: NIH RePORTER; NEI NIH HHS [EY10742, EY06837] Funding Source: Medline; NIGMS NIH HHS [GM08107] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berezovskii VK, 2000, J NEUROSCI, V20, P1157, DOI 10.1523/JNEUROSCI.20-03-01157.2000; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BURKHALTER A, 1986, VISION RES, V26, P63, DOI 10.1016/0042-6989(86)90071-4; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; Desimone R., 1989, HDB NEUROPSYCHOLOGY, P267; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; DOBKINS KR, 1993, VISION RES, V33, P1019, DOI 10.1016/0042-6989(93)90238-R; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; LACHICA EA, 1992, P NATL ACAD SCI USA, V89, P3566, DOI 10.1073/pnas.89.8.3566; LEVITT JB, 1994, J COMP NEUROL, V342, P551, DOI 10.1002/cne.903420405; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LUND JS, 1991, J COMP NEUROL, V311, P234, DOI 10.1002/cne.903110206; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Movshon JA, 1996, J NEUROSCI, V16, P7733; ROCKLAND KS, 1992, CEREB CORTEX, V2, P38, DOI 10.1093/cercor/2.1.38; Sawatari A, 2000, NEURON, V25, P459, DOI 10.1016/S0896-6273(00)80908-3; Sawatari A, 1996, NATURE, V380, P442, DOI 10.1038/380442a0; SCHILLER PH, 1990, VISUAL NEUROSCI, V5, P321, DOI 10.1017/S0952523800000420; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; Yabuta NH, 1998, J NEUROSCI, V18, P9489; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	29	89	91	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2001	292	5515					297	300		10.1126/science.1057916	http://dx.doi.org/10.1126/science.1057916			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421QA	11303106	Green Published			2022-12-01	WOS:000168074000050
J	Peterson, BJ; Wollheim, WM; Mulholland, PJ; Webster, JR; Meyer, JL; Tank, JL; Marti, E; Bowden, WB; Valett, HM; Hershey, AE; McDowell, WH; Dodds, WK; Hamilton, SK; Gregory, S; Morrall, DD				Peterson, BJ; Wollheim, WM; Mulholland, PJ; Webster, JR; Meyer, JL; Tank, JL; Marti, E; Bowden, WB; Valett, HM; Hershey, AE; McDowell, WH; Dodds, WK; Hamilton, SK; Gregory, S; Morrall, DD			Control of nitrogen export from watersheds by headwater streams	SCIENCE			English	Article							INORGANIC NITROGEN; FOREST STREAM; AMMONIUM; SIZE; ECOSYSTEMS; PHOSPHORUS; SATURATION; RETENTION; STORAGE; CHANNEL	A comparative N-15-tracer study of nitrogen dynamics in headwater streams from biomes throughout North America demonstrates that streams exert control over nutrient exports to rivers, Lakes, and estuaries. The most rapid uptake and transformation of inorganic nitrogen occurred in the smallest streams. Ammonium entering these streams was removed from the water within a few tens to hundreds of meters. Nitrate was also removed from stream water but traveled a distance 5 to 10 times as long, on average, as ammonium. Despite low ammonium concentration in stream water, nitrification rates were high, indicating that small streams are potentially important sources of atmospheric nitrous oxide. During seasons of high biological activity, the reaches of headwater streams typically export downstream Less than half of the input of dissolved inorganic nitrogen from their watersheds.	Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; Virginia Polytech Inst & State Univ, Dept Biol, Blacksburg, VA 24061 USA; Univ Georgia, Inst Ecol, Athens, GA 30602 USA; Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; Ctr Estudis Avancats Blanes, Blanes 17300, Girona, Spain; Landcare Res, Lincoln 8152, New Zealand; Univ N Carolina, Dept Biol, Greensboro, NC 27402 USA; Univ New Hampshire, Dept Nat Resources, Durham, NH 03824 USA; Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; Procter & Gamble Co, Expt Stream Facil, Milford, OH 45150 USA	Marine Biological Laboratory - Woods Hole; United States Department of Energy (DOE); Oak Ridge National Laboratory; Virginia Polytechnic Institute & State University; University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Landcare Research - New Zealand; University of North Carolina; University of North Carolina Greensboro; University System Of New Hampshire; University of New Hampshire; Kansas State University; Michigan State University; Oregon State University; Procter & Gamble	Peterson, BJ (corresponding author), Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA.		Hamilton, Stephen K/N-2979-2014; Mulholland, Patrick/C-3142-2012; McDowell, William H/E-9767-2010; Martí, Eugènia/J-9146-2012; Wollheim, Wilfred/AAA-3516-2022	Hamilton, Stephen K/0000-0002-4702-9017; McDowell, William H/0000-0002-8739-9047; Martí, Eugènia/0000-0002-6910-4874; Wollheim, Wilfred/0000-0002-5009-3212; Dodds, Walter/0000-0002-6666-8930				Aber J, 1998, BIOSCIENCE, V48, P921, DOI 10.2307/1313296; Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; BORMANN FH, 1968, SCIENCE, V159, P882, DOI 10.1126/science.159.3817.882; Dent CL, 1999, ECOLOGY, V80, P2283, DOI 10.1890/0012-9658(1999)080[2283:SHOSWN]2.0.CO;2; DODDS WK, 1991, J PLANKTON RES, V13, P1339, DOI 10.1093/plankt/13.6.1339; DODDS WK, IN PRESS ECOSYSTEMS; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; HAMILTON SK, IN PRESS BIOGEOCHEMI; HOPKINSON CS, 1995, ESTUARIES, V18, P598, DOI 10.2307/1352380; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Jordan TE, 1996, BIOSCIENCE, V46, P655, DOI 10.2307/1312895; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Lovett GM, 2000, ECOL APPL, V10, P73, DOI 10.1890/1051-0761(2000)010[0073:NSARIF]2.0.CO;2; Meyer JL, 2001, ECOLOGY: ACHIEVEMENT AND CHALLENGE, P295; Mulholland PJ, 2000, ECOL MONOGR, V70, P471, DOI 10.1890/0012-9615(2000)070[0471:NCIAFS]2.0.CO;2; MULHOLLAND PJ, IN PRESS VERH INT VE; Nadelhoffer K, 1999, ENVIRON MONIT ASSESS, V55, P187, DOI 10.1023/A:1006190222768; NEWBOLD JD, 1981, CAN J FISH AQUAT SCI, V38, P860, DOI 10.1139/f81-114; NEWBOLD JD, 1983, FRESHWATER BIOL, V13, P193, DOI 10.1111/j.1365-2427.1983.tb00671.x; NNAIMAN RJ, 1983, PERIPHYTON FRESHWATE, P191; PETERSON BJ, 1985, TELLUS B, V37, P117, DOI 10.1111/j.1600-0889.1985.tb00060.x; Peterson BJ, 1997, CAN J FISH AQUAT SCI, V54, P2361, DOI 10.1139/cjfas-54-10-2361; Seitzinger SP, 1998, GLOBAL BIOGEOCHEM CY, V12, P93, DOI 10.1029/97GB03657; Tank JL, 2000, LIMNOL OCEANOGR, V45, P1013, DOI 10.4319/lo.2000.45.5.1013; TRISKA FJ, 1994, BIOGEOCHEMISTRY, V26, P67, DOI 10.1007/BF02182880; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WEBSTER JR, 1979, ECOL MONOGR, V49, P51, DOI 10.2307/1942572; Wollheim WM, 2001, LIMNOL OCEANOGR, V46, P1, DOI 10.4319/lo.2001.46.1.0001	28	1063	1152	21	531	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2001	292	5514					86	90		10.1126/science.1056874	http://dx.doi.org/10.1126/science.1056874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420FU	11292868				2022-12-01	WOS:000167995200042
J	Thi, WF; Blake, GA; van Dishoeck, EF; van Zadelhoff, GJ; Horn, JMM; Becklin, EE; Mannings, V; Sargent, AI; van den Ancker, ME; Natta, A				Thi, WF; Blake, GA; van Dishoeck, EF; van Zadelhoff, GJ; Horn, JMM; Becklin, EE; Mannings, V; Sargent, AI; van den Ancker, ME; Natta, A			Substantial reservoirs of molecular hydrogen in the debris disks around young stars	NATURE			English	Article							MAIN-SEQUENCE STARS; CIRCUMSTELLAR DISKS; VEGA; DUST; SEARCH; INTERSTELLAR; H-2; AGE	Circumstellar accretion disks transfer matter from molecular clouds to young stars and to the sites of planet formation. The disks observed around pre-main-sequence stars have properties consistent with those expected for the pre-solar nebula from which our own Solar System formed 4.5 Gyr ago(1). But the 'debris' disks that encircle more than 15% of nearby main-sequence stars(2-5) appear to have very small amounts of gas, based on observations of the tracer molecule carbon monoxide(6-8) : these observations have yielded gas/dust ratios much less than 0.1, whereas the interstellar value is about 100 (ref. 9). Here we report observations of the lowest rotational transitions of molecular hydrogen (H-2) that reveal large quantities of gas in the debris disks around the stars beta Pictoris, 49 Ceti and HD135344. The gas masses calculated from the data are several hundreds to a thousand times greater than those estimated from the CO observations, and yield gas/dust ratios of the same order as the interstellar value.	CALTECH 15021, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; CALTECH, SIRTF Sci Ctr, Pasadena, CA 91125 USA; CALTECH 10524, Div Phys Math & Astron, Pasadena, CA 91125 USA; Leiden Observ, NL-2300 RA Leiden, Netherlands; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Osserv Astrofis Arcetri, I-50125 Florence, Italy; Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Leiden University; Leiden University - Excl LUMC; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Istituto Nazionale Astrofisica (INAF); University of California System; University of California Los Angeles	Blake, GA (corresponding author), CALTECH 15021, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	gab@gps.caltech.edu	van Zadelhoff, Gerd-Jan/K-6283-2013					Artymowicz P, 1997, ASTROPHYS J, V490, P863, DOI 10.1086/304889; AUMANN HH, 1984, ASTROPHYS J, V278, pL23, DOI 10.1086/184214; Backman D. E., 1993, PROTOSTARS PLANETS, P1253; Beckwith SVW, 1996, NATURE, V383, P139, DOI 10.1038/383139a0; de Muizon MJ, 1999, ASTRON ASTROPHYS, V350, P875; deGraauw T, 1996, ASTRON ASTROPHYS, V315, pL49; DENT WRF, 1995, MON NOT R ASTRON SOC, V277, pL25; Dunkin SK, 1997, MON NOT R ASTRON SOC, V290, P165, DOI 10.1093/mnras/290.1.165; Fajardo-Acosta SB, 1999, ASTROPHYS J, V520, P215, DOI 10.1086/307458; Greaves JS, 2000, MON NOT R ASTRON SOC, V312, pL1, DOI 10.1046/j.1365-8711.2000.03233.x; Habing HJ, 1999, NATURE, V401, P456, DOI 10.1038/46749; Heap SR, 2000, ASTROPHYS J, V539, P435, DOI 10.1086/309188; HILDEBRAND RH, 1983, Q J ROY ASTRON SOC, V24, P267; Hollenbach D. J., 2000, Protostars and planets 4, P401; Kamp I, 2000, ASTRON ASTROPHYS, V353, P276; Kessler MF, 1996, ASTRON ASTROPHYS, V315, pL27; KLAHR HH, IN PRESS ASTRON J; Lagrange A.-M., 2000, Protostars and planets 4, P639; Lagrange AM, 1998, ASTRON ASTROPHYS, V330, P1091; Navascues DBY, 1999, ASTROPHYS J, V520, pL123, DOI 10.1086/312162; SANDFORD SA, 1993, ASTROPHYS J, V409, pL65, DOI 10.1086/186861; Siess L, 1999, ASTRON ASTROPHYS, V342, P480; Thi WF, 1999, ASTROPHYS J, V521, pL63, DOI 10.1086/312171; THI WF, UNPUB ASTROPHYS J; Valentijn EA, 2000, EXP ASTRON, V10, P215, DOI 10.1023/A:1008169124088; Walker HJ, 2000, ICARUS, V143, P147, DOI 10.1006/icar.1999.6235; WEIDENSCHILLING SJ, 1977, MON NOT R ASTRON SOC, V180, P57, DOI 10.1093/mnras/180.2.57; Zuckerman B, 2000, ASTROPHYS J, V535, P959, DOI 10.1086/308897; ZUCKERMAN B, 1995, NATURE, V373, P494, DOI 10.1038/373494a0	29	96	96	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 4	2001	409	6816					60	63		10.1038/35051033	http://dx.doi.org/10.1038/35051033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	388HT	11343110				2022-12-01	WOS:000166175600036
J	Schwetz, BA				Schwetz, BA			New diabetes glucose test	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2186	2186		10.1001/jama.285.17.2186	http://dx.doi.org/10.1001/jama.285.17.2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325309				2022-12-01	WOS:000168256100007
J	Schwetz, BA				Schwetz, BA			Famotidine labeling change	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Rockville, MD 20857 USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2001	285	17					2186	2186		10.1001/jama.285.17.2186	http://dx.doi.org/10.1001/jama.285.17.2186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	424WC	11325309				2022-12-01	WOS:000168256100009
